Citrus Sinensis ID: 043248
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1092 | 2.2.26 [Sep-21-2011] | |||||||
| Q0WPH8 | 956 | Serine/threonine-protein | yes | no | 0.628 | 0.717 | 0.598 | 0.0 | |
| Q60DG4 | 943 | Serine/threonine-protein | yes | no | 0.522 | 0.605 | 0.570 | 1e-169 | |
| Q94CU5 | 943 | Serine/threonine-protein | no | no | 0.469 | 0.544 | 0.618 | 1e-169 | |
| A2ZMH2 | 591 | Serine/threonine-protein | N/A | no | 0.241 | 0.446 | 0.738 | 1e-126 | |
| Q2QMH1 | 591 | Serine/threonine-protein | no | no | 0.241 | 0.446 | 0.738 | 1e-126 | |
| Q10GB1 | 599 | Serine/threonine-protein | no | no | 0.249 | 0.454 | 0.724 | 1e-125 | |
| Q6ZEZ5 | 585 | Serine/threonine-protein | no | no | 0.249 | 0.464 | 0.713 | 1e-124 | |
| Q9LT35 | 416 | Serine/threonine-protein | no | no | 0.277 | 0.728 | 0.630 | 1e-122 | |
| Q9CAU7 | 606 | Serine/threonine-protein | no | no | 0.241 | 0.435 | 0.712 | 1e-122 | |
| Q9SLI2 | 612 | Serine/threonine-protein | no | no | 0.261 | 0.467 | 0.670 | 1e-122 |
| >sp|Q0WPH8|NEK5_ARATH Serine/threonine-protein kinase Nek5 OS=Arabidopsis thaliana GN=NEK5 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 776 bits (2005), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/720 (59%), Positives = 514/720 (71%), Gaps = 34/720 (4%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYE+MEQIGRGAFGAAILV+H+AE+KKYVLKKIRLARQTERCRRSAHQEM+LIA
Sbjct: 1 MESRMDQYELMEQIGRGAFGAAILVHHKAERKKYVLKKIRLARQTERCRRSAHQEMSLIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG YFPEEKLCKWF QLLLA
Sbjct: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFTQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL SSVVGTPNYMCPELLA
Sbjct: 121 VEYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCC+YEMAA+RPAFKAFDMAGLISK+NRSSIGPLP CYSPSLK LIK
Sbjct: 181 DIPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSLKALIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAESQNS 300
GMLRKNPE+RP+ASE+LKHP+LQ +V+QYRPT A+ +PEKP++ + E RR MAESQNS
Sbjct: 241 GMLRKNPEYRPNASEILKHPYLQPYVEQYRPTLSAASITPEKPLN-SREGRRSMAESQNS 299
Query: 301 SSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQ-PPPCEEEHGPDVCIV 359
+SS+ KD+ D+NI V ++ NK T+TD +DDED + E + V
Sbjct: 300 NSSSE-KDNFYVSDKNIRYVVPSNGNKVTETDSGFVDDEDILDHVQQSAENGNLQSVSAT 358
Query: 360 KMDERAVMKPSHSEQI-STVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQ 418
K D ++KP HS+Q ++ + PKTI++IMM LKE K RENGSPMRS R++ PTQ
Sbjct: 359 KPDGHGILKPVHSDQRPDVIQPRHPKTIRNIMMVLKEEKARENGSPMRSNRSRPSSVPTQ 418
Query: 419 RCNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPK 478
+ N E K+ K +A K+NA T + P+KL DSA R GS KH +PVIDSSPK
Sbjct: 419 KNNVETPSKIPKLGDIAHSSKTNASTP-IPPSKLASDSA-RTPGSFPPKHHMPVIDSSPK 476
Query: 479 TKPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSN-T 537
KPR+D I P+ KH E+ +S K RQ+TPP+ R S +++Q+G DI N + T
Sbjct: 477 LKPRNDRISPSPAAKHEAEEAMSVKRRQRTPPTLPRRTSLIAHQSRQLGADISNMAAKET 536
Query: 538 MKVAPMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSI 597
K+ P V P E E HQ R+ + E ++ VG ++GM +ESSNS+SSS+S+
Sbjct: 537 AKLHPSV-PSESETNSHQ---SRVHASPVSTTPEPKRTSVGSAKGMQSESSNSISSSLSM 592
Query: 598 QAFELCDDATTPFIDMTEQTHNDDDTIVRH-EALEALPPGCSQSHLRSDKSGSTSGENLR 656
QAFELCDDA+TP+IDMTE T DD H E + P S+ +R D
Sbjct: 593 QAFELCDDASTPYIDMTEHTTPDDHRRSCHSEYSYSFPDISSEMMIRRD----------- 641
Query: 657 HDHKTVMCSTDTSEDLLCLQKITGSDGRISSKAPSEEFLSC----NDDIPSSRPSIDDTT 712
+H T M T+ + ++G I+ P E SC DD P++ S + T
Sbjct: 642 -EHSTSMRLTEIPDS------VSGVQNTIAHHQPEREQGSCPTVLKDDSPATLQSYEPNT 694
|
Involved in epidermal-cell morphogenesis in hypocotyls and roots. May act on the microtubule function. May have a secondary role in trichome branching. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q60DG4|NEK4_ORYSJ Serine/threonine-protein kinase Nek4 OS=Oryza sativa subsp. japonica GN=NEK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 596 bits (1537), Expect = e-169, Method: Compositional matrix adjust.
Identities = 343/601 (57%), Positives = 403/601 (67%), Gaps = 30/601 (4%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQ+GRGAFGAAILVNH+ E+KKYVLKKIRLARQTERCR+SAHQEMALIA
Sbjct: 1 MESRMDQYEIMEQVGRGAFGAAILVNHKIERKKYVLKKIRLARQTERCRKSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
R+QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM ELMKK NG YFPEEKL KWFAQL+LA
Sbjct: 61 RLQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMDELMKKLNGTYFPEEKLLKWFAQLVLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
VDYLHSNYVLHRDLKCSNIFLTKDQD+RLGDFGLAKTLK DDL SSVVGTPNYMCPELL
Sbjct: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDIRLGDFGLAKTLKEDDLTSSVVGTPNYMCPELLT 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP+CYS S+KTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPACYSSSMKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPT--FPPAACSPEKPISIAHESRRCMAESQ 298
MLRK+PEHRP+ASE+LK+P+LQ +V+Q RP P PEKP+S + ++RC +ESQ
Sbjct: 241 SMLRKSPEHRPTASEILKNPYLQPYVNQCRPLSDAPTPIRMPEKPLSTSRSNQRCTSESQ 300
Query: 299 NSSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPC---EEEHG-P 354
+SS S SD DS +S DR+ S ++++K D+ SI D D + C E+ G
Sbjct: 301 SSSISCSDIDSTQSSDRSTSGGAPSTDSKL--NDIRSIQDADRADSDEKCVTPEDLRGNK 358
Query: 355 DVCIVKMDERAVMKPSHSEQISTVESKQPKTIKSIMMALK-EGKVRENGSPMRSTRTKAV 413
++ ++ + K H Q ESKQPK I+ IM L+ E ++REN SP+ S+ K
Sbjct: 359 NISGAELKRQDSSKSVH--QHHRGESKQPKIIEKIMTTLREESRLRENNSPVSSSGVKLT 416
Query: 414 GTPTQRCNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVI 473
+ + E S + +P S D + VQ LK P +
Sbjct: 417 SAVSNKNQAEQSSESSRPHSGVSYSSKFGDISSNGWTNTSDECVDPVQVPLQLKQLSPTV 476
Query: 474 DSSPKTKPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDI-PN 532
+ PK K P P K + E+G S KT S R P P R GI I P
Sbjct: 477 EHCPKLKNSGSSTPE--PAKQIAENGSSASGMSKTKSSPSSSRRPSPQRQTVAGIPIVPF 534
Query: 533 TVSNTMKVA---------PMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGM 583
TVS + P +P N+ H +P LI I S+E+ K +G+S+ M
Sbjct: 535 TVSKRAHIKAESEKTPPRPAHSPN---NSLHNLP--PLIPISTNLSEENIK--LGNSQAM 587
Query: 584 P 584
P
Sbjct: 588 P 588
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94CU5|NEK5_ORYSJ Serine/threonine-protein kinase Nek5 OS=Oryza sativa subsp. japonica GN=NEK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 595 bits (1533), Expect = e-169, Method: Compositional matrix adjust.
Identities = 329/532 (61%), Positives = 386/532 (72%), Gaps = 19/532 (3%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
M+SRMDQYE+MEQIGRGAFGAAILVNH+ EKKKYVLKKIRLARQTERCR+SAHQEMALIA
Sbjct: 1 MDSRMDQYEVMEQIGRGAFGAAILVNHKTEKKKYVLKKIRLARQTERCRKSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
R+QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK+NG YFPEEKL KWFAQL LA
Sbjct: 61 RLQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKANGTYFPEEKLLKWFAQLALA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
VDYLHSN+VLHRDLKCSNIFLTKDQD+RLGDFGLAKTLKADDL SSVVGTPNYMCPELLA
Sbjct: 121 VDYLHSNFVLHRDLKCSNIFLTKDQDIRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP CYSPS+K+LIK
Sbjct: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPPCYSPSMKSLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPT--FPPAACSPEKPISIAHESRRCMAESQ 298
MLRK+PEHRP+ASE+LK P+LQ +V+QYRP S EKPI+ + S++ M+ SQ
Sbjct: 241 SMLRKSPEHRPTASEILKSPYLQPYVNQYRPFADISHPIHSLEKPITSSRSSQKSMSGSQ 300
Query: 299 NSSSSASDKDSLRSGDRNISATVLNSENK-----ATDTDLISIDDEDGPEQPPPCEEEHG 353
SS S SD DS++S +RN S +S N A TD +S+ + + +E G
Sbjct: 301 CSSISGSDIDSIQSSERNTSGPSTSSNNTIDTEGAEATDHVSVKNCSRSDDVKSNKETVG 360
Query: 354 PDVCIVKMDERAVMKPSHSEQISTVESKQPKTIKSIMMALK-EGKVRENGSPMRSTRTKA 412
P+ ++ + K H +Q E KQPK IK I+ L+ E K+R+N SP+R++R K
Sbjct: 361 PE-----LERQDSSKSIHVDQRPRNEIKQPKIIKKILTTLREESKLRQNNSPIRASRVK- 414
Query: 413 VGTPTQRCNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPV 472
+ +P+ R E K S +++ AK++ + KR Q S LKH P+
Sbjct: 415 LNSPSNR---EQLSDDSKHSSDISSSSKSSEVTSRESAKVICEPVKRAQASPPLKHLSPI 471
Query: 473 IDSSPKTKPRHDGIPPTGPVKHVGE--DGLSTKTRQKTPPSNMVRRSPFPAR 522
++ SPK K + D P K E D K + +TPPS R S P R
Sbjct: 472 VEHSPKAKIKQDEPLQPDPAKQAMEDVDAAVGKVKNRTPPSYSRRLSIPPRR 523
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2ZMH2|NEK2_ORYSI Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. indica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1162), Expect = e-126, Method: Compositional matrix adjust.
Identities = 195/264 (73%), Positives = 233/264 (88%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
MDQYE++EQIG+GAFG+A+LV H+ EKKKYVLKKIRLARQT+R RRSAHQEM LIA V++
Sbjct: 1 MDQYEVLEQIGKGAFGSALLVRHKLEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEKGCYVCIV GYCEGGDMAE +K++NG YF EEKLCKW QLL+A+DYL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLVQLLMALDYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H+N++LHRD+KCSNIF+ +DQ +RLGDFGLAK L +DDLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCC+YEM A RPAFKAFDM LI+KI +S + PLP+ YS + + LIK MLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAFRGLIKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQ 268
K+PEHRPSA++LLKHP LQ +V Q
Sbjct: 241 KSPEHRPSAAQLLKHPQLQPYVLQ 264
|
May be involved in plant development processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QMH1|NEK2_ORYSJ Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. japonica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1162), Expect = e-126, Method: Compositional matrix adjust.
Identities = 195/264 (73%), Positives = 233/264 (88%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
MDQYE++EQIG+GAFG+A+LV H+ EKKKYVLKKIRLARQT+R RRSAHQEM LIA V++
Sbjct: 1 MDQYEVLEQIGKGAFGSALLVRHKLEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEKGCYVCIV GYCEGGDMAE +K++NG YF EEKLCKW QLL+A+DYL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLVQLLMALDYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H+N++LHRD+KCSNIF+ +DQ +RLGDFGLAK L +DDLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCC+YEM A RPAFKAFDM LI+KI +S + PLP+ YS + + LIK MLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAFRGLIKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQ 268
K+PEHRPSA++LLKHP LQ +V Q
Sbjct: 241 KSPEHRPSAAQLLKHPQLQPYVLQ 264
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10GB1|NEK1_ORYSJ Serine/threonine-protein kinase Nek1 OS=Oryza sativa subsp. japonica GN=NEK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1154), Expect = e-125, Method: Compositional matrix adjust.
Identities = 197/272 (72%), Positives = 235/272 (86%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+QYE++EQIG+GAFG+A+LV H+ EKKKYVLKKIRLARQT+R RRSAHQEM LIA V++
Sbjct: 1 MEQYEVLEQIGKGAFGSALLVRHKVEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEKGCYVCI+ GYCEGGDMAE +K++ G +F EEKLCKW QLL+A+DYL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKRATGDHFSEEKLCKWLVQLLMALDYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H+N++LHRD+KCSNIFLT+DQ +RLGDFGLAK L +DDLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTRDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCC+YEM A RPAFKAFDM LISKI +S + PLP+ YS + + LIK MLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALISKITKSIVSPLPTRYSGAFRGLIKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQYRPTFPPA 276
K+PEHRPSA+ELLKHP LQ +V Q PA
Sbjct: 241 KSPEHRPSAAELLKHPHLQPYVLQVHLKSSPA 272
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZEZ5|NEK3_ORYSJ Serine/threonine-protein kinase Nek3 OS=Oryza sativa subsp. japonica GN=NEK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1146), Expect = e-124, Method: Compositional matrix adjust.
Identities = 194/272 (71%), Positives = 237/272 (87%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+QYE++EQIG+G+FG+A+LV H+ EKK+YVLKKIRLARQT+RCRRSAHQEM LIA+V++
Sbjct: 1 MEQYEVLEQIGKGSFGSALLVRHKVEKKRYVLKKIRLARQTDRCRRSAHQEMELIAKVRN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
PYIVE+K++WVEKGCYVCIV GYCEGGDM+E +KK+N YF EE+LC W QLL+A+DYL
Sbjct: 61 PYIVEYKDSWVEKGCYVCIVIGYCEGGDMSEAIKKANSNYFSEERLCMWLVQLLMALDYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H N++LHRD+KCSNIFLTKDQ++RLGDFGLAK L +DDL SSVVGTP+YMCPELLADIPY
Sbjct: 121 HVNHILHRDVKCSNIFLTKDQNIRLGDFGLAKVLTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCC+YEM A +PAFKAFDM LI+KI++S + PLP+ YS + + LIK MLR
Sbjct: 181 GSKSDIWSLGCCLYEMTALKPAFKAFDMQTLINKISKSVLAPLPTIYSGAFRGLIKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQYRPTFPPA 276
K+P+HRPSA+ELLKHP LQ FV + + PA
Sbjct: 241 KSPDHRPSAAELLKHPHLQPFVLELQLKSSPA 272
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LT35|NEK6_ARATH Serine/threonine-protein kinase Nek6 OS=Arabidopsis thaliana GN=NEK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 205/325 (63%), Positives = 253/325 (77%), Gaps = 22/325 (6%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
MD YE++EQIGRGAFG+A LV H++E++KYV+KKIRLA+QTERC+ +A QEM+LI++++
Sbjct: 1 MDDYEVVEQIGRGAFGSAFLVIHKSERRKYVVKKIRLAKQTERCKLAAIQEMSLISKLKS 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
PYIVE+K++WVEK C VCIVT YCEGGDM +++KKS G + EEKLC+W QLLLA+DYL
Sbjct: 61 PYIVEYKDSWVEKDC-VCIVTSYCEGGDMTQMIKKSRGVFASEEKLCRWMVQLLLAIDYL 119
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H+N VLHRDLKCSNIFLTK+ +VRLGDFGLAK L DDLASS+VGTPNYMCPELLADIPY
Sbjct: 120 HNNRVLHRDLKCSNIFLTKENEVRLGDFGLAKLLGKDDLASSMVGTPNYMCPELLADIPY 179
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G+KSDIWSLGCCM+E+AAH+PAFKA DMA LI+KINRSS+ PLP YS SLK LIK MLR
Sbjct: 180 GYKSDIWSLGCCMFEVAAHQPAFKAPDMAALINKINRSSLSPLPVMYSSSLKRLIKSMLR 239
Query: 245 KNPEHRPSASELLKHPFLQ---------------------HFVDQYRPTFPPAACSPEKP 283
KNPEHRP+A+ELL+HP LQ H ++ R PP S + P
Sbjct: 240 KNPEHRPTAAELLRHPHLQPYLAQCQNLSPVFKPVVSKSEHNTNENRTGLPPKTKSAKTP 299
Query: 284 ISIAHESRRCMAESQNSSSSASDKD 308
I ES +++++SSS+ DK+
Sbjct: 300 IKHNQESEETEKKNKDTSSSSKDKE 324
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAU7|NEK2_ARATH Serine/threonine-protein kinase Nek2 OS=Arabidopsis thaliana GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1129), Expect = e-122, Method: Compositional matrix adjust.
Identities = 188/264 (71%), Positives = 232/264 (87%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+ YE++EQIG+G+FG+A+LV H+ EKK YVLKKIRLARQT R RRSAHQEM LI+++ +
Sbjct: 1 MENYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIHN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEKGCYVCI+ GYC+GGDMAE +KK+NG +F EEKLCKW Q+LLA++YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLVQILLALEYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H+N++LHRD+KCSNIFLTKDQD+RLGDFGLAK L +DDLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCCMYEM A +PAFKAFDM GLI++INRS + PLP+ YS + + L+K MLR
Sbjct: 181 GSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAFRGLVKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQ 268
KNPE RPSA+ELL+ P LQ ++ +
Sbjct: 241 KNPELRPSAAELLRQPLLQPYIQK 264
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SLI2|NEK1_ARATH Serine/threonine-protein kinase Nek1 OS=Arabidopsis thaliana GN=NEK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 197/294 (67%), Positives = 242/294 (82%), Gaps = 8/294 (2%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+QYE +EQIG+G+FG+A+LV H+ EKKKYVLKKIRLARQT+R RRSAHQEM LI++++H
Sbjct: 1 MEQYEFLEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTQRTRRSAHQEMELISKMRH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEK CYVCIV GYCEGGDMA+ +KKSNG +F EEKLCKW QLL+ ++YL
Sbjct: 61 PFIVEYKDSWVEKACYVCIVIGYCEGGDMAQAIKKSNGVHFQEEKLCKWLVQLLMGLEYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HSN++LHRD+KCSNIFLTK+QD+RLGDFGLAK L +DDL SSVVGTP+YMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCC+YEMA +PAFKAFDM LI+KIN++ + PLP+ YS + L+K MLR
Sbjct: 181 GSKSDIWSLGCCIYEMAYLKPAFKAFDMQALINKINKTIVSPLPAKYSGPFRGLVKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFV--------DQYRPTFPPAACSPEKPISIAHES 290
KNPE RPSAS+LL+HP LQ +V + R T PP S ++ + AH S
Sbjct: 241 KNPEVRPSASDLLRHPHLQPYVLDVKLRLNNLRRKTLPPELPSSKRIMKKAHFS 294
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1092 | ||||||
| 296084032 | 823 | unnamed protein product [Vitis vinifera] | 0.651 | 0.863 | 0.701 | 0.0 | |
| 359479228 | 947 | PREDICTED: serine/threonine-protein kina | 0.634 | 0.731 | 0.683 | 0.0 | |
| 255565781 | 957 | ATP binding protein, putative [Ricinus c | 0.643 | 0.734 | 0.668 | 0.0 | |
| 147782356 | 1177 | hypothetical protein VITISV_032788 [Viti | 0.616 | 0.571 | 0.658 | 0.0 | |
| 356539211 | 1039 | PREDICTED: serine/threonine-protein kina | 0.571 | 0.600 | 0.674 | 0.0 | |
| 356550080 | 1040 | PREDICTED: serine/threonine-protein kina | 0.595 | 0.625 | 0.647 | 0.0 | |
| 449530231 | 954 | PREDICTED: serine/threonine-protein kina | 0.620 | 0.710 | 0.613 | 0.0 | |
| 356544760 | 1052 | PREDICTED: serine/threonine-protein kina | 0.567 | 0.589 | 0.676 | 0.0 | |
| 449444815 | 954 | PREDICTED: serine/threonine-protein kina | 0.620 | 0.710 | 0.612 | 0.0 | |
| 356543628 | 1040 | PREDICTED: serine/threonine-protein kina | 0.591 | 0.621 | 0.644 | 0.0 |
| >gi|296084032|emb|CBI24420.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 997 bits (2578), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/734 (70%), Positives = 578/734 (78%), Gaps = 23/734 (3%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQIGRGAFGAAILVNH++EKKKYVLKKIRLARQTERCRRSAHQEMALIA
Sbjct: 1 MESRMDQYEIMEQIGRGAFGAAILVNHKSEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
R+QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA
Sbjct: 61 RIQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSNYVLHRDLKCSNIFLTKD+DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 121 VEYLHSNYVLHRDLKCSNIFLTKDKDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTF-PPAACSPEKPISIAHESRRCMAESQN 299
GMLRKNPEHRPSASE+LKHP+LQ +VDQ+R +F PP A S EKPIS +SR+ MAESQ
Sbjct: 241 GMLRKNPEHRPSASEILKHPYLQPYVDQHRSSFNPPTAYSLEKPISTTRDSRKNMAESQG 300
Query: 300 SSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIV 359
S+SS SDKDSL S ++NISA V+N +NKA DTDL S+DDE G +QP P E+G + C V
Sbjct: 301 SNSSGSDKDSLLSSEKNISAMVINCDNKANDTDLGSVDDEVGSDQPSP-SGENGANTCTV 359
Query: 360 KMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQR 419
KMDER VMK SH E ESKQPKTIK+I MALKEGKVREN SPMR RTK G TQ+
Sbjct: 360 KMDEREVMKSSHDEHGLNAESKQPKTIKNIWMALKEGKVRENSSPMRGNRTKPGGQSTQK 419
Query: 420 CNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKT 479
NTEAS KV KP V+PG KSNAD P K +FDSAKR+QGS+ LKHQLP+ D SPKT
Sbjct: 420 ANTEASLKVPKPSMVSPGFKSNADAPTSIPTKAVFDSAKRIQGSHPLKHQLPMFDPSPKT 479
Query: 480 KPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMK 539
KPRHDGIP GP K V EDGL K RQ+TPPSN+VRRS FP R +QVG D+PN +N +K
Sbjct: 480 KPRHDGIPLPGPSKQVVEDGLPAKPRQRTPPSNVVRRSSFPGRMRQVGPDVPNQTNNIIK 539
Query: 540 VAPMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSIQA 599
V P +E T + VPNGR + R+ Q+S KA+VG S+GM T+SSNSVSSSVS+Q
Sbjct: 540 VGPSEITQEPHKTQYLVPNGRATHVSREIIQQSHKALVGASKGMQTDSSNSVSSSVSLQG 599
Query: 600 FELCDDATTPFIDMTEQTHNDDDTIVRHEALEALPPGCSQSHLRSDKSGSTSGENLRHDH 659
FELCDDATTPF++M EQ + D R E LE+ PP CS L SD+S D+
Sbjct: 600 FELCDDATTPFVNMAEQIPPEHDRGTRTENLESCPPTCS---LVSDESHG-------QDN 649
Query: 660 KTVMCSTDTSEDLLCLQKITGSDGRISSKAPSE-------EFLSCNDDIP---SSRP-SI 708
K+V CS D+S + + IT ++SS A +E E +CNDD S RP ++
Sbjct: 650 KSVQCSVDSSGFVQDPEDITIGGEKVSSGAVTEHPSPVSREVFACNDDTSLGRSIRPETV 709
Query: 709 DDTTLSCPYTNDDK 722
++ L+ + DDK
Sbjct: 710 TESILTSSSSGDDK 723
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359479228|ref|XP_002274007.2| PREDICTED: serine/threonine-protein kinase Nek5-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2482), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/734 (68%), Positives = 562/734 (76%), Gaps = 41/734 (5%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQIGRGAFGAAILVNH++EKKKYVLKKIRLARQTERCRRSAHQEMALIA
Sbjct: 1 MESRMDQYEIMEQIGRGAFGAAILVNHKSEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
R+QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA
Sbjct: 61 RIQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSNYVLHRDLKCSNIFLTKD+DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 121 VEYLHSNYVLHRDLKCSNIFLTKDKDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTF-PPAACSPEKPISIAHESRRCMAESQN 299
GMLRKNPEHRPSASE+LKHP+LQ +VDQ+R +F PP A S EKPIS +SR+ MAESQ
Sbjct: 241 GMLRKNPEHRPSASEILKHPYLQPYVDQHRSSFNPPTAYSLEKPISTTRDSRKNMAESQG 300
Query: 300 SSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIV 359
S+SS SDKDSL S ++NISA V+N +NKA DTDL S+DDE G +QP P E+G + C V
Sbjct: 301 SNSSGSDKDSLLSSEKNISAMVINCDNKANDTDLGSVDDEVGSDQPSP-SGENGANTCTV 359
Query: 360 KMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQR 419
KMDER VMK SH E ESKQPKTIK+I MALKEGKVREN SPMR RTK G TQ+
Sbjct: 360 KMDEREVMKSSHDEHGLNAESKQPKTIKNIWMALKEGKVRENSSPMRGNRTKPGGQSTQK 419
Query: 420 CNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKT 479
NTEAS KV KP V+PG KSNAD P K LP+ D SPKT
Sbjct: 420 ANTEASLKVPKPSMVSPGFKSNADAPTSIPTK------------------LPMFDPSPKT 461
Query: 480 KPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMK 539
KPRHDGIP GP K V EDGL K RQ+TPPSN+VRRS FP R +QVG D+PN +N +K
Sbjct: 462 KPRHDGIPLPGPSKQVVEDGLPAKPRQRTPPSNVVRRSSFPGRMRQVGPDVPNQTNNIIK 521
Query: 540 VAPMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSIQA 599
V P +E T + VPNGR + R+ Q+S KA+VG S+GM T+SSNSVSSSVS+Q
Sbjct: 522 VGPSEITQEPHKTQYLVPNGRATHVSREIIQQSHKALVGASKGMQTDSSNSVSSSVSLQG 581
Query: 600 FELCDDATTPFIDMTEQTHNDDDTIVRHEALEALPPGCSQSHLRSDKSGSTSGENLRHDH 659
FELCDDATTPF++M EQ + D R E LE+ PP CS L SD+S D+
Sbjct: 582 FELCDDATTPFVNMAEQIPPEHDRGTRTENLESCPPTCS---LVSDESHG-------QDN 631
Query: 660 KTVMCSTDTSEDLLCLQKITGSDGRISSKAPSE-------EFLSCNDDIP---SSRP-SI 708
K+V CS D+S + + IT ++SS A +E E +CNDD S RP ++
Sbjct: 632 KSVQCSVDSSGFVQDPEDITIGGEKVSSGAVTEHPSPVSREVFACNDDTSLGRSIRPETV 691
Query: 709 DDTTLSCPYTNDDK 722
++ L+ + DDK
Sbjct: 692 TESILTSSSSGDDK 705
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565781|ref|XP_002523880.1| ATP binding protein, putative [Ricinus communis] gi|223536968|gb|EEF38606.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 938 bits (2425), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/731 (66%), Positives = 561/731 (76%), Gaps = 28/731 (3%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQIGRGAFGAAILV+H++EKKKYVLKKIRLARQTERCRRSAHQEMALIA
Sbjct: 1 MESRMDQYEIMEQIGRGAFGAAILVHHKSEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
R+QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG YFPEEKLCKWF QLLLA
Sbjct: 61 RIQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFTQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLH+N+VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 121 VEYLHANFVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP+LKTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPALKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAESQNS 300
GMLRKNPEHRPSA E+LKHP+LQ +VDQYR +F P SPEKP+S + +SR+ MAESQNS
Sbjct: 241 GMLRKNPEHRPSAPEILKHPYLQPYVDQYRLSFIPPTISPEKPMSNSRDSRKNMAESQNS 300
Query: 301 SSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIVK 360
+SS SDKDSL S +RN A V N +KATDTDL SI DED EQ P EEE+GP + IVK
Sbjct: 301 NSSGSDKDSLLSSERNFPAMVSNCVHKATDTDLASIGDEDVNEQSMPNEEENGPSIYIVK 360
Query: 361 MDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQRC 420
+DE V+K H E S VESKQPKTIKSIMMALKEGK RENGSPMR R K G QR
Sbjct: 361 IDEHRVVKTYHDEHGSNVESKQPKTIKSIMMALKEGKTRENGSPMRGNRIKPGG--LQRS 418
Query: 421 NTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKTK 480
NTEASPKV+KP ++ PGLK N D + P+K LP+IDS+PK+K
Sbjct: 419 NTEASPKVVKPNTLIPGLKCNTDAPTITPSK------------------LPMIDSTPKSK 460
Query: 481 PRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMKV 540
PR+DGIPP+GP+KHV +DGL+ K RQ+TPPSN+VRR FP R +QV D PN ++NT+K
Sbjct: 461 PRYDGIPPSGPLKHV-DDGLAVKPRQRTPPSNLVRRCSFPGRVRQVVTDAPNGITNTVKS 519
Query: 541 APMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSIQAF 600
+P + ENT H V + I ++ +ESQKAV G SRGM T+ SNSVSS VS+QAF
Sbjct: 520 SPTETTEVPENT-HHVLDVHHIHYSKEFREESQKAVAGASRGMQTDGSNSVSSLVSVQAF 578
Query: 601 ELCDDATTPFIDMTEQTHNDDDTIVRHEALEALPPGCSQSHLRSDK-SGSTSGENLRHDH 659
ELCDDATTPF DM EQT ++ + +V L P CS + L K S + S EN + +
Sbjct: 579 ELCDDATTPFGDMVEQTIHEGE-VVTCTGKSELDPSCSLTSLLHPKLSKNVSRENHGYGY 637
Query: 660 KTVMCSTDTS-EDLLCLQKITGSDGRISSKAPSEEFLSCNDDIPSSRPSIDDTTLSCPYT 718
K+ + S +TS DL + T S+G++ S A + + +++ P + DDT LS P
Sbjct: 638 KSAVHSVETSVADLDFPKNTTSSNGKLISSAALDLSVPSSEETPICK---DDTLLSTPNV 694
Query: 719 NDDKPLNRPST 729
D L +T
Sbjct: 695 RPDAVLQSNAT 705
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147782356|emb|CAN67872.1| hypothetical protein VITISV_032788 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2344), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/734 (65%), Positives = 545/734 (74%), Gaps = 61/734 (8%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQIGRGAFGAAILVNH++EKKKYVLKKIRLARQTERCRRSAHQE
Sbjct: 298 MESRMDQYEIMEQIGRGAFGAAILVNHKSEKKKYVLKKIRLARQTERCRRSAHQE----- 352
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA
Sbjct: 353 -----------------GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 395
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSNYVLHRDLKCSNIFLTKD+DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 396 VEYLHSNYVLHRDLKCSNIFLTKDKDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 455
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK
Sbjct: 456 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 515
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTF-PPAACSPEKPISIAHESRRCMAESQN 299
GMLRKNPEHRPSASE+LKHP+LQ +VDQ+R +F PP A S EKPIS +SR+ MAESQ
Sbjct: 516 GMLRKNPEHRPSASEILKHPYLQPYVDQHRSSFNPPTAYSLEKPISTTRDSRKNMAESQG 575
Query: 300 SSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIV 359
S+SS SDKDSL S ++NI A V+N +NKA DTDL S+DDE G +QP P E+G + C V
Sbjct: 576 SNSSGSDKDSLLSSEKNIXAMVINCDNKANDTDLGSVDDEVGSDQPSP-SXENGANXCTV 634
Query: 360 KMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQR 419
KMDER +QPKTIK+I MALKEGKVREN SPMR RTK G TQ+
Sbjct: 635 KMDER----------------EQPKTIKNIWMALKEGKVRENSSPMRGNRTKPGGQSTQK 678
Query: 420 CNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKT 479
NTEAS KV KP V+PG KSNAD P K +FDSAKR+QGS+ LKHQLP+ D SPKT
Sbjct: 679 ANTEASLKVPKPSMVSPGFKSNADAPTSIPTKAVFDSAKRIQGSHPLKHQLPMFDPSPKT 738
Query: 480 KPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMK 539
KPRHDGIP GP K V EDGL K RQ+TPPSN+VRRS FP R +QVG D+PN +N MK
Sbjct: 739 KPRHDGIPLPGPSKQVVEDGLPAKPRQRTPPSNVVRRSSFPGRMRQVGPDVPNQTNNIMK 798
Query: 540 VAPMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSIQA 599
V P +E T + VPNGR + R+ Q+S KA+ G S+GM T+SSNSVSSSVSIQ
Sbjct: 799 VGPSEITQEPHKTQYLVPNGRATHVSREIIQQSHKALAGASKGMQTDSSNSVSSSVSIQG 858
Query: 600 FELCDDATTPFIDMTEQTHNDDDTIVRHEALEALPPGCSQSHLRSDKSGSTSGENLRHDH 659
FELCDDATTPF++M E+ + D R E LE+ PP CS L SD+S D+
Sbjct: 859 FELCDDATTPFVNMAERIPPEHDRGTRTENLESCPPTCS---LVSDESHG-------QDN 908
Query: 660 KTVMCSTDTSEDLLCLQKITGSDGRISSKAPSE-------EFLSCNDDIP---SSRP-SI 708
K+V CS +S + + IT ++SS A +E E +CNDD S RP ++
Sbjct: 909 KSVQCSVXSSGFVQDPEDITIGGEKVSSGAVTEHPSPVSREVFACNDDTSLGRSIRPETV 968
Query: 709 DDTTLSCPYTNDDK 722
++ L+ + DDK
Sbjct: 969 TESILTSSSSGDDK 982
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356539211|ref|XP_003538093.1| PREDICTED: serine/threonine-protein kinase Nek5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/636 (67%), Positives = 499/636 (78%), Gaps = 12/636 (1%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQIGRGAFGAAILV+H+AEKKKYVLKKIRLARQTERCRRSAHQEMALIA
Sbjct: 1 MESRMDQYEIMEQIGRGAFGAAILVHHKAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
R+QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK NGAYFPEEKLCKWF QLLLA
Sbjct: 61 RIQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKLNGAYFPEEKLCKWFTQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCC+YEMAAHRPAFKAFDMAGLISK+NRSSIGPLP CYSPSLKTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCIYEMAAHRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSLKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTF-PPAACSPEKPISIAHESRRCMAESQN 299
GMLRKNPEHRP+ASE+LKHP+LQ +VDQYRP+F PP CSP KPIS ++ R+ MAESQN
Sbjct: 241 GMLRKNPEHRPTASEVLKHPYLQPYVDQYRPSFSPPTTCSPVKPISAVNDHRKNMAESQN 300
Query: 300 SSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIV 359
S+SS+SDKD+L S ++NI+ +N+AT+ D SIDD DG +EE G
Sbjct: 301 SNSSSSDKDTLMSNEKNIATAGPKCDNEATEMDQTSIDD-DG------SDEESGSCNVNA 353
Query: 360 KMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQR 419
K E+ V++PSH++ S VESKQPKTI++IMMALKEGKVRE SPMR R K G TQ+
Sbjct: 354 KTAEQEVVEPSHNKHHSNVESKQPKTIRNIMMALKEGKVREATSPMRGNRIKPSGLSTQK 413
Query: 420 CNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKT 479
+TE K+ KP +AP +K N ++ A A+ D AKR+ GS+ KHQ+ + ++SPK
Sbjct: 414 ISTETLSKLPKPTFIAPSMKPNLESHA-ALARASPDPAKRMMGSHYPKHQILMTEASPKV 472
Query: 480 KPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMK 539
K RHD PP+ VK V DG+S + RQ+TPPS ++RR F R + GID+PN ++T K
Sbjct: 473 KARHDFTPPSALVKQVEGDGVSPRPRQRTPPS-LLRRPSFSGRMRLAGIDVPNAANDTGK 531
Query: 540 VAPMVAPKELENTPHQVPNGRLIRIYRQ-NSQESQKAVVGHSRGMPTESSNSVSSSVSIQ 598
+ +E + +P Q+ NG + I RQ ++E QKA S+G+ T+SSNS SSSVSIQ
Sbjct: 532 LGTNKIVQEPQMSPCQLANGNVPHISRQVTTREPQKAFERSSKGLQTDSSNSASSSVSIQ 591
Query: 599 AFELCDDATTPFIDMTEQTHNDDDTIVRHEALEALP 634
EL DDATT FIDM EQ + + + +E+ P
Sbjct: 592 GCELADDATT-FIDMREQMLPNHEKVNHIVGVESCP 626
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550080|ref|XP_003543418.1| PREDICTED: serine/threonine-protein kinase Nek5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/655 (64%), Positives = 496/655 (75%), Gaps = 5/655 (0%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMD YEIMEQIGRGAFGAAILVNH+AEK KYVLKKIRLARQTERCRRSAHQEM LIA
Sbjct: 1 MESRMDHYEIMEQIGRGAFGAAILVNHKAEKMKYVLKKIRLARQTERCRRSAHQEMTLIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
R+QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMA LMKKSNG YFPEEKLCKWF Q+LLA
Sbjct: 61 RIQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAALMKKSNGIYFPEEKLCKWFTQILLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSN+VLHRDLKCSNIFLTKD DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 121 VEYLHSNFVLHRDLKCSNIFLTKDHDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCC+YEMAAHRPAFKAFDMAGLISKINRSSIGPLP CYSPSLKTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCIYEMAAHRPAFKAFDMAGLISKINRSSIGPLPPCYSPSLKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTF-PPAACSPEKPISIAHESRRCMAESQN 299
GMLRKNPEHRP+ASE+LKHP+L +VDQYR +F P A SPEKPIS H + + SQN
Sbjct: 241 GMLRKNPEHRPTASEILKHPYLLPYVDQYRSSFCTPTAGSPEKPISAVHHALKNKPGSQN 300
Query: 300 SSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIV 359
SSS+++KDSL S ++N + + + K T+ DL SI+D D EQ P EE +G
Sbjct: 301 RSSSSTEKDSLMSNEKNNAKALHKCDCKITEIDLTSIED-DSSEQLLPGEEGNGSSKVNA 359
Query: 360 KMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQR 419
K +E+ + K S++EQ S V SKQPK IK+++ ALK+GK++E SP+RS R K G T +
Sbjct: 360 KTNEKELTKQSNNEQHSNVVSKQPKAIKTVVTALKDGKLKETSSPIRSNRIKVGGVLTHK 419
Query: 420 CNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKT 479
NTE + KP A LK N + AP+K DSAKR+QGSNT KHQLP+I+S+PKT
Sbjct: 420 INTETVSNLPKPNFGAYDLKPNLEVPTTAPSKTTPDSAKRMQGSNTSKHQLPMIESTPKT 479
Query: 480 KPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMK 539
KPRH+ IPP+GPVK V + +KTRQKTPPS +++ F +Q G D+ N +NT K
Sbjct: 480 KPRHNVIPPSGPVKQVEGREVPSKTRQKTPPS-LLKPPSFTGHVRQAGFDVLNAANNTGK 538
Query: 540 VAPMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSIQA 599
+P +E + + HQ+ N L + R+ ++E K S+GM T+ SNSVSSS+SIQ
Sbjct: 539 TSPKKMVREPKMSHHQLTNSHLPHVSREITREPLKTFESSSKGMQTDGSNSVSSSLSIQG 598
Query: 600 FELCDDATTPFIDMTEQTHNDDDTIVRHEALEALPPGCS-QSHLRSDKSGSTSGE 653
FEL D ATT FID++E T D + + E E+ P S S+L D S SGE
Sbjct: 599 FELSDFATT-FIDLSEPTLPDHENLNHTENKESRPDSSSPASYLHFDMSEQLSGE 652
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449530231|ref|XP_004172099.1| PREDICTED: serine/threonine-protein kinase Nek5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2069), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/725 (61%), Positives = 528/725 (72%), Gaps = 47/725 (6%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQIGRGAFGAAILVNH++EKKKYVLKKIRLARQTERCRRSAHQEMALIA
Sbjct: 1 MESRMDQYEIMEQIGRGAFGAAILVNHKSEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG +FPEEKLCKWF QLLLA
Sbjct: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGMHFPEEKLCKWFTQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSN+VLHRDLKCSNIFLTKD+DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 121 VEYLHSNFVLHRDLKCSNIFLTKDKDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAA-CSPEKPISIAHESRRCMAESQN 299
GMLRKNPEHRP+ASELLKHP+LQ +V+QYRP+ P SP+KP + +SRR MAESQN
Sbjct: 241 GMLRKNPEHRPNASELLKHPYLQPYVEQYRPSISPNVDFSPDKP-RLTRDSRRSMAESQN 299
Query: 300 SSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIV 359
S+SS SD+DSL S D+N A N + K TD+D+ S+DD +G E PCEE+ +VC +
Sbjct: 300 SNSSNSDRDSLFSSDKNTPAMTANCDEKVTDSDMASVDDHEGSEPLLPCEEQTH-NVCSL 358
Query: 360 KMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQR 419
K+++ KPS +Q S ES++PKTI++IM+ALKEGK REN SP+R R K+ Q+
Sbjct: 359 KVNDPMHPKPSQEDQ-SNSESRRPKTIRNIMLALKEGKARENYSPVRGNRAKSGVASNQK 417
Query: 420 CNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKT 479
+ PKV+KP PG KS+ DT T+ +LPV+D +PKT
Sbjct: 418 AFADVPPKVIKPPMAVPGSKSSPDT------------------PITVSTKLPVVDPTPKT 459
Query: 480 KPRHDGIPP-TGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVG-IDIPNTVSNT 537
+PRHD PP PVK V EDG+S+K+RQKTPPS ++RR FP RT+QVG D+P+ VS+T
Sbjct: 460 RPRHDSSPPLCRPVKPV-EDGVSSKSRQKTPPS-LLRRPSFPVRTRQVGQQDVPDAVSST 517
Query: 538 MKVAPMVAPKELENTPHQVPNGRLIRIYR-QNSQESQKAVVGH-SRGMPTESSNSVSSSV 595
++ E E T H+V + + + ++E+Q H S+GM T+SSNSVSSSV
Sbjct: 518 ERIRQKETLPE-ERTCHKVHSSHQDHVVSVELTKETQHTSSEHCSKGMQTDSSNSVSSSV 576
Query: 596 SIQAFELCDDATTPFIDMTEQTHNDDDTIVRHEALEAL-PPGCS---QSHLRSDKSGSTS 651
SIQ FE+CDDA TPF D+ E + + + H+ +E + PP CS Q +
Sbjct: 577 SIQGFEICDDAATPFADIAEPVFDHQN--IEHDEIEEIHPPVCSPSLQYEISEHNLLEDK 634
Query: 652 GENLRHDHKTVMCSTDTSEDLLCLQKITGSDGRISSKAPSEEF---------LSCNDDIP 702
G + +D T CS +TS D + L ++ I ++PS E DDIP
Sbjct: 635 GNHGVYDKSTTKCSFETSSDNVNLH---NTEAGIKKESPSVELDHPLRSEGRFIFKDDIP 691
Query: 703 SSRPS 707
S P+
Sbjct: 692 ISMPT 696
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544760|ref|XP_003540815.1| PREDICTED: serine/threonine-protein kinase Nek5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/631 (67%), Positives = 490/631 (77%), Gaps = 11/631 (1%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
MDQYEIMEQIGRGAFGAAILV+H+AEKKKYVLKKIRLARQTERCRRSAHQEMALIAR+QH
Sbjct: 1 MDQYEIMEQIGRGAFGAAILVHHKAEKKKYVLKKIRLARQTERCRRSAHQEMALIARIQH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK NGAYFPEEKLCKWF QLLLAV+YL
Sbjct: 61 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKLNGAYFPEEKLCKWFTQLLLAVEYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HSN+VLHRDLKCSNIFLTKD+DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY
Sbjct: 121 HSNFVLHRDLKCSNIFLTKDRDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
GFKSDIWSLGCC+YEMAAHRPAFKAFDMAGLISKINRSSIGPLP CYSPSLKTLIKGMLR
Sbjct: 181 GFKSDIWSLGCCIYEMAAHRPAFKAFDMAGLISKINRSSIGPLPPCYSPSLKTLIKGMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQYRPTF-PPAACSPEKPISIAHESRRCMAESQNSSSS 303
KNPEHRP+ASE+LKHP+LQ ++DQYRP+F PP +CSPEKPIS + + MAESQNS+SS
Sbjct: 241 KNPEHRPTASEVLKHPYLQPYLDQYRPSFSPPTSCSPEKPISAVNNHPKNMAESQNSNSS 300
Query: 304 ASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIVKMDE 363
+SDKDSL S ++ I+ NKA +TD ISIDD DG E+E G K E
Sbjct: 301 SSDKDSLMSNEKKIAPAGPKCYNKAIETDQISIDD-DG------SEDESGSSNANAKTAE 353
Query: 364 RAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQRCNTE 423
+ VMKPS++E S VESKQPKTI++IMMALKEGKVRE SPMR R K G TQ+ NTE
Sbjct: 354 QEVMKPSNNEHHSNVESKQPKTIRNIMMALKEGKVREATSPMRGNRIKPGGISTQKINTE 413
Query: 424 ASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKTKPRH 483
K+ KP +AP +K N ++ A A+ D AKR+ GS+ KHQ+ + ++SPK K RH
Sbjct: 414 TLSKLPKPTFIAPSMKPNLESPA-ALARASPDPAKRMMGSHYPKHQILMTEASPKVKARH 472
Query: 484 DGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMKVAPM 543
D PP+ K V DG S K RQ+TPPS++ RR F R + GID+PN ++T K+
Sbjct: 473 DLTPPSALAKQVEGDGFSPKPRQRTPPSSL-RRPSFSGRMRLAGIDVPNAANDTGKLGSN 531
Query: 544 VAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSIQAFELC 603
+E E +P Q+ NG + I RQ ++E QKA S+GM T+SSNS SSSVSI+ EL
Sbjct: 532 KIIQEPEMSPCQLANGNVPHISRQVTREPQKAFERSSKGMQTDSSNSASSSVSIKGCELA 591
Query: 604 DDATTPFIDMTEQTHNDDDTIVRHEALEALP 634
DDA T FIDM EQ + + + +E P
Sbjct: 592 DDAKT-FIDMREQMLPNHEKVNHIVGVETCP 621
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444815|ref|XP_004140169.1| PREDICTED: serine/threonine-protein kinase Nek5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/725 (61%), Positives = 527/725 (72%), Gaps = 47/725 (6%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYEIMEQIGRGAFGAAILVNH++EKKKYVLKKIRLARQTERCRRSAHQEMALIA
Sbjct: 1 MESRMDQYEIMEQIGRGAFGAAILVNHKSEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG +FPEEKLCKWF QLLLA
Sbjct: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGMHFPEEKLCKWFTQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSN+VLHRDLKCSNIFLTKD+DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA
Sbjct: 121 VEYLHSNFVLHRDLKCSNIFLTKDKDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYS SLKTLIK
Sbjct: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSQSLKTLIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAA-CSPEKPISIAHESRRCMAESQN 299
GMLRKNPEHRP+ASELLKHP+LQ +V+QYRP+ P SP+KP + +SRR MAESQN
Sbjct: 241 GMLRKNPEHRPNASELLKHPYLQPYVEQYRPSISPNVDFSPDKP-RLTRDSRRSMAESQN 299
Query: 300 SSSSASDKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIV 359
S+SS SD+DSL S D+N A N + K TD+D+ S+DD +G E PCEE+ +VC +
Sbjct: 300 SNSSNSDRDSLFSSDKNTPAMTANCDEKVTDSDMASVDDHEGSEPLLPCEEQTH-NVCSL 358
Query: 360 KMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQR 419
K+++ KPS +Q S ES++PKTI++IM+ALKEGK REN SP+R R K+ Q+
Sbjct: 359 KVNDPMHPKPSQEDQ-SNSESRRPKTIRNIMLALKEGKARENYSPVRGNRAKSGVASNQK 417
Query: 420 CNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKT 479
+ PKV+KP PG KS+ DT T+ +LPV+D +PKT
Sbjct: 418 AFADVPPKVIKPPMAVPGSKSSPDT------------------PITVSTKLPVVDPTPKT 459
Query: 480 KPRHDGIPP-TGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVG-IDIPNTVSNT 537
+PRHD PP PVK V EDG+S+K+RQKTPPS ++RR FP RT+QVG D+P+ VS+T
Sbjct: 460 RPRHDSSPPLCRPVKPV-EDGVSSKSRQKTPPS-LLRRPSFPVRTRQVGQQDVPDAVSST 517
Query: 538 MKVAPMVAPKELENTPHQVPNGRLIRIYR-QNSQESQKAVVGH-SRGMPTESSNSVSSSV 595
++ E E T H+V + + + ++E+Q H S+GM T+SSNSVSSSV
Sbjct: 518 ERIRQKETLPE-ERTCHKVHSSHQDHVVSVELTKETQHTSSEHCSKGMQTDSSNSVSSSV 576
Query: 596 SIQAFELCDDATTPFIDMTEQTHNDDDTIVRHEALEAL-PPGCS---QSHLRSDKSGSTS 651
SIQ FE+CDDA TPF D+ E + + + H+ +E + PP CS Q +
Sbjct: 577 SIQGFEICDDAATPFADIAEPVFDHQN--IEHDEIEEIHPPVCSPSLQYEISEHNLLEDK 634
Query: 652 GENLRHDHKTVMCSTDTSEDLLCLQKITGSDGRISSKAPSEEF---------LSCNDDIP 702
G + +D T CS +TS D + L ++ I ++PS E DDIP
Sbjct: 635 GNHGVYDKSTTKCSFETSSDNVNLH---NTEAGIKKESPSVELDHPLRSEGRFIFKDDIP 691
Query: 703 SSRPS 707
S P+
Sbjct: 692 ISMPT 696
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543628|ref|XP_003540262.1| PREDICTED: serine/threonine-protein kinase Nek5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/652 (64%), Positives = 492/652 (75%), Gaps = 6/652 (0%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
MD YEIMEQIGRGAFGAAILVNH+AEKKKYVLKKIRLARQTERCRRSAHQEMALIAR+QH
Sbjct: 1 MDHYEIMEQIGRGAFGAAILVNHKAEKKKYVLKKIRLARQTERCRRSAHQEMALIARIQH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
PYIV+FKEAWVEKGCYVCIVTGYCEGGDMA LMKKS G YFPEEKLCKWF Q+LLAV+YL
Sbjct: 61 PYIVQFKEAWVEKGCYVCIVTGYCEGGDMAALMKKSIGVYFPEEKLCKWFTQILLAVEYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HSN+VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY
Sbjct: 121 HSNFVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
GFKSDIWSLGCC+YEMAAHRPAFKAFDMAGLISKINRSSIGPLP CYSPSLKTLIKGMLR
Sbjct: 181 GFKSDIWSLGCCIYEMAAHRPAFKAFDMAGLISKINRSSIGPLPPCYSPSLKTLIKGMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQYRPTF-PPAACSPEKPISIAHESRRCMAESQNSSSS 303
KNPEHRP+ASE+LKHP+L +VDQYR +F P A SPE+PIS H R+ ESQNSSSS
Sbjct: 241 KNPEHRPTASEILKHPYLLPYVDQYRSSFCTPTAGSPERPISAVHHPRKNKPESQNSSSS 300
Query: 304 AS-DKDSLRSGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHGPDVCIVKMD 362
S +KDS S ++N + V + K T+ DL SI+D D EQ P EE +G K D
Sbjct: 301 LSPEKDSFMSSEKNTANEVKKCDRKITEIDLTSIED-DSSEQLLPEEEGNGSSRVNAKTD 359
Query: 363 ERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQRCNT 422
E+ + K S++ S SKQPK IK+++ ALK+GK+RE SP+R R K G T + N+
Sbjct: 360 EKELTKQSNNVHHSNAVSKQPKPIKNVVTALKDGKLRETSSPIRGNRIKVGGVLTHKINS 419
Query: 423 EASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPKTKPR 482
E K+ KP A LK N + AP+K DSAKR+QG +T KHQLP+I+S+PKTKPR
Sbjct: 420 ETVSKLPKPNFGAYDLKPNLEVPTTAPSKTTPDSAKRMQGLHTSKHQLPMIESTPKTKPR 479
Query: 483 HDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSNTMKVAP 542
H+ IPP+GPVK V + +K RQKT PS +++ FP +Q G D+PN +NT K +P
Sbjct: 480 HNAIPPSGPVKQVEGREVPSKPRQKTRPS-LLKPPSFPGHVRQAGFDVPNATNNTGKSSP 538
Query: 543 MVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTESSNSVSSSVSIQAFEL 602
E + + HQ+ N L + R+ ++E K S+GM T+SSNSVSSS+SIQ FEL
Sbjct: 539 KKMVWEPKMSHHQLTNTHLPHVSRETTREPLKTFETSSKGMQTDSSNSVSSSLSIQGFEL 598
Query: 603 CDDATTPFIDMTEQTHNDDDTIVRHEALEALPPGCS-QSHLRSDKSGSTSGE 653
D ATT FID++E T D +++ E +E+ P S S+L + S SGE
Sbjct: 599 SDFATT-FIDLSEPTLPDHESLNHTENVESCPYSISCASYLHFEMSEQLSGE 649
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1092 | ||||||
| TAIR|locus:2081383 | 956 | NEK6 ""NIMA (never in mitosis, | 0.587 | 0.671 | 0.615 | 1.9e-256 | |
| TAIR|locus:2020148 | 612 | NEK1 "NIMA-related serine/thre | 0.261 | 0.467 | 0.670 | 4.5e-125 | |
| TAIR|locus:2114885 | 606 | NEK2 "NIMA-related kinase 2" [ | 0.241 | 0.435 | 0.712 | 2.8e-123 | |
| TAIR|locus:2185314 | 568 | NEK3 "NIMA-related kinase 3" [ | 0.241 | 0.464 | 0.715 | 1.3e-121 | |
| TAIR|locus:2077274 | 555 | NEK4 "NIMA-related kinase 4" [ | 0.239 | 0.472 | 0.694 | 1.7e-119 | |
| ZFIN|ZDB-GENE-040426-1392 | 849 | nek4 "NIMA (never in mitosis g | 0.242 | 0.312 | 0.432 | 1.3e-73 | |
| UNIPROTKB|F6V6J5 | 785 | NEK4 "Uncharacterized protein" | 0.239 | 0.333 | 0.425 | 1.2e-67 | |
| UNIPROTKB|E2QRX7 | 839 | NEK4 "Uncharacterized protein" | 0.239 | 0.312 | 0.425 | 2.4e-67 | |
| UNIPROTKB|P51957 | 841 | NEK4 "Serine/threonine-protein | 0.234 | 0.304 | 0.435 | 3.2e-64 | |
| MGI|MGI:1344404 | 792 | Nek4 "NIMA (never in mitosis g | 0.239 | 0.330 | 0.429 | 3.4e-64 |
| TAIR|locus:2081383 NEK6 ""NIMA (never in mitosis, gene A)-related 6"" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1975 (700.3 bits), Expect = 1.9e-256, Sum P(2) = 1.9e-256
Identities = 403/655 (61%), Positives = 472/655 (72%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
MESRMDQYE+MEQIGRGAFGAAILV+H+AE+KKYVLKKIRLARQTERCRRSAHQEM+LIA
Sbjct: 1 MESRMDQYELMEQIGRGAFGAAILVHHKAERKKYVLKKIRLARQTERCRRSAHQEMSLIA 60
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG YFPEEKLCKWF QLLLA
Sbjct: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFTQLLLA 120
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V+YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL SSVVGTPNYMCPELLA
Sbjct: 121 VEYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLA 180
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
DIPYGFKSDIWSLGCC+YEMAA+RPAFKAFDMAGLISK+NRSSIGPLP CYSPSLK LIK
Sbjct: 181 DIPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSLKALIK 240
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAEXXXX 300
GMLRKNPE+RP+ASE+LKHP+LQ +V+QYRPT A+ +PEKP++ + E RR MAE
Sbjct: 241 GMLRKNPEYRPNASEILKHPYLQPYVEQYRPTLSAASITPEKPLN-SREGRRSMAESQNS 299
Query: 301 XXXXXXXXXXXXGDRNISATVLNSENKATDTDLISIDDEDGPEQPPPCEEEHG-PDVCIV 359
D+NI V ++ NK T+TD +DDED + E V
Sbjct: 300 NSSSEKDNFYVS-DKNIRYVVPSNGNKVTETDSGFVDDEDILDHVQQSAENGNLQSVSAT 358
Query: 360 KMDERAVMKPSHSEQI-STVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKAVGTPTQ 418
K D ++KP HS+Q ++ + PKTI++IMM LKE K RENGSPMRS R++ PTQ
Sbjct: 359 KPDGHGILKPVHSDQRPDVIQPRHPKTIRNIMMVLKEEKARENGSPMRSNRSRPSSVPTQ 418
Query: 419 RCNTEASPKVLKPCSVAPGLKSNADTQGLAPAKLMFDSAKRVQGSNTLKHQLPVIDSSPK 478
+ N E K+ K +A K+NA T + P+KL DSA R GS KH +PVIDSSPK
Sbjct: 419 KNNVETPSKIPKLGDIAHSSKTNASTP-IPPSKLASDSA-RTPGSFPPKHHMPVIDSSPK 476
Query: 479 TKPRHDGIPPTGPVKHVGEDGLSTKTRQKTPPSNMVRRSPFPARTKQVGIDIPNTVSN-T 537
KPR+D I P+ KH E+ +S K RQ+TPP+ R S +++Q+G DI N + T
Sbjct: 477 LKPRNDRISPSPAAKHEAEEAMSVKRRQRTPPTLPRRTSLIAHQSRQLGADISNMAAKET 536
Query: 538 MKVAPMVAPKELENTPHQVPNGRLIRIYRQNSQESQKAVVGHSRGMPTEXXXXXXXXXXI 597
K+ P V P E E HQ R+ + E ++ VG ++GM +E +
Sbjct: 537 AKLHPSV-PSESETNSHQ---SRVHASPVSTTPEPKRTSVGSAKGMQSESSNSISSSLSM 592
Query: 598 QAFELCDDATTPFIDMTEQTHNDDDTIVRH-EALEALPPGCSQSHLRSDKSGSTS 651
QAFELCDDA+TP+IDMTE T DD H E + P S+ +R D+ STS
Sbjct: 593 QAFELCDDASTPYIDMTEHTTPDDHRRSCHSEYSYSFPDISSEMMIRRDEH-STS 646
|
|
| TAIR|locus:2020148 NEK1 "NIMA-related serine/threonine kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 4.5e-125, Sum P(3) = 4.5e-125
Identities = 197/294 (67%), Positives = 242/294 (82%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+QYE +EQIG+G+FG+A+LV H+ EKKKYVLKKIRLARQT+R RRSAHQEM LI++++H
Sbjct: 1 MEQYEFLEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTQRTRRSAHQEMELISKMRH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEK CYVCIV GYCEGGDMA+ +KKSNG +F EEKLCKW QLL+ ++YL
Sbjct: 61 PFIVEYKDSWVEKACYVCIVIGYCEGGDMAQAIKKSNGVHFQEEKLCKWLVQLLMGLEYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HSN++LHRD+KCSNIFLTK+QD+RLGDFGLAK L +DDL SSVVGTP+YMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCC+YEMA +PAFKAFDM LI+KIN++ + PLP+ YS + L+K MLR
Sbjct: 181 GSKSDIWSLGCCIYEMAYLKPAFKAFDMQALINKINKTIVSPLPAKYSGPFRGLVKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFV--------DQYRPTFPPAACSPEKPISIAHES 290
KNPE RPSAS+LL+HP LQ +V + R T PP S ++ + AH S
Sbjct: 241 KNPEVRPSASDLLRHPHLQPYVLDVKLRLNNLRRKTLPPELPSSKRIMKKAHFS 294
|
|
| TAIR|locus:2114885 NEK2 "NIMA-related kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1062 (378.9 bits), Expect = 2.8e-123, Sum P(3) = 2.8e-123
Identities = 188/264 (71%), Positives = 232/264 (87%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+ YE++EQIG+G+FG+A+LV H+ EKK YVLKKIRLARQT R RRSAHQEM LI+++ +
Sbjct: 1 MENYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIHN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEKGCYVCI+ GYC+GGDMAE +KK+NG +F EEKLCKW Q+LLA++YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLVQILLALEYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H+N++LHRD+KCSNIFLTKDQD+RLGDFGLAK L +DDLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCCMYEM A +PAFKAFDM GLI++INRS + PLP+ YS + + L+K MLR
Sbjct: 181 GSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAFRGLVKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQ 268
KNPE RPSA+ELL+ P LQ ++ +
Sbjct: 241 KNPELRPSAAELLRQPLLQPYIQK 264
|
|
| TAIR|locus:2185314 NEK3 "NIMA-related kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1059 (377.8 bits), Expect = 1.3e-121, Sum P(3) = 1.3e-121
Identities = 189/264 (71%), Positives = 233/264 (88%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+ YE++EQIG+G+FG+A+LV H+ EKK YVLKKIRLARQT R RRSAHQEM LI+++++
Sbjct: 1 MEHYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIRN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P+IVE+K++WVEKGCYVCIV GYC+GGDMAE +KK+NG F EEKLCKW QLL+A++YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCKGGDMAEAIKKANGVEFSEEKLCKWLVQLLMALEYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H++++LHRD+KCSNIFLTKDQD+RLGDFGLAK L +DDLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HASHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCCMYEM A +PAFKAFDM GLI++INRS + PLP+ YS + ++L+K MLR
Sbjct: 181 GSKSDIWSLGCCMYEMTALKPAFKAFDMQGLINRINRSIVAPLPAQYSTAFRSLVKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFVDQ 268
KNPE RPSAS+LL+ P LQ +V +
Sbjct: 241 KNPELRPSASDLLRQPLLQPYVQK 264
|
|
| TAIR|locus:2077274 NEK4 "NIMA-related kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.7e-119, Sum P(3) = 1.7e-119
Identities = 182/262 (69%), Positives = 230/262 (87%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M++YE++EQIG+G+FG+A+LV H+ E+KKYVLKKIRLARQ++R RRSAHQEM LI+ V++
Sbjct: 1 MERYEVLEQIGKGSFGSALLVRHKQERKKYVLKKIRLARQSDRARRSAHQEMELISTVRN 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P++VE+K++WVEKGCYVCIV GYC+GGDM + +K++ G +FPEEKLC+W QLL+A+DYL
Sbjct: 61 PFVVEYKDSWVEKGCYVCIVIGYCQGGDMTDTIKRACGVHFPEEKLCQWLVQLLMALDYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HSN++LHRD+KCSNIFLTK+QD+RLGDFGLAK L +DDL SSVVGTP+YMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G KSDIWSLGCCMYEMAAH+P FKA D+ LI+KI++ + P+P+ YS S + LIK MLR
Sbjct: 181 GSKSDIWSLGCCMYEMAAHKPPFKASDVQTLITKIHKLIMDPIPAMYSGSFRGLIKSMLR 240
Query: 245 KNPEHRPSASELLKHPFLQHFV 266
KNPE RPSA+ELL HP LQ ++
Sbjct: 241 KNPELRPSANELLNHPHLQPYI 262
|
|
| ZFIN|ZDB-GENE-040426-1392 nek4 "NIMA (never in mitosis gene a)-related kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 667 (239.9 bits), Expect = 1.3e-73, Sum P(3) = 1.3e-73
Identities = 115/266 (43%), Positives = 180/266 (67%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
MD Y + +G+G++G LV H++++K+YV+KK+ L + R RR+A QE L+++++H
Sbjct: 1 MDGYLFVRVVGKGSYGEVNLVRHKSDRKQYVIKKLNLRTSSRRERRAAEQEAQLLSQLKH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P IV ++E+W + C + IV G+CEGGD+ +K+ G PE ++ +WF Q+ +A+ YL
Sbjct: 61 PNIVMYRESWEGEDCQLYIVMGFCEGGDLYHRLKQQKGELLPERQVVEWFVQIAMALQYL 120
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVVGTPNYMCPELLADIP 183
H ++LHRDLK NIFLTK +++GD G+A+ L+ +D+AS+++GTP YM PEL ++ P
Sbjct: 121 HEKHILHRDLKTQNIFLTKTNIIKVGDLGIARVLENQNDMASTLIGTPYYMSPELFSNKP 180
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243
Y +KSD+W+LGCC+YEMA + AF A DM L+ +I + +PS Y P L LIK ML
Sbjct: 181 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIVEGKLPQMPSKYDPQLGELIKRML 240
Query: 244 RKNPEHRPSASELLKHPFLQHFVDQY 269
K PE RP +L+ P+++H + +
Sbjct: 241 CKKPEDRPDVKHILRQPYIKHQISMF 266
|
|
| UNIPROTKB|F6V6J5 NEK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 1.2e-67, Sum P(3) = 1.2e-67
Identities = 112/263 (42%), Positives = 176/263 (66%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y + +GRG++G LV HR + ++YV+KK+ L + R RR+A QE L+++++HP I
Sbjct: 6 YCYLRVVGRGSYGEVTLVRHRRDGRQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V +KE+W + IV G+CEGGD+ +K+ G PE ++ +WF Q+ +A+ YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKERKGQLLPESQVVEWFVQIAMALQYLHEK 125
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGF 186
++LHRDLK N+FLT+ +++GD G+A+ L+ + D+A++++GTP YM PEL ++ PY +
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENNGDMANTLIGTPYYMSPELFSNKPYNY 185
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
KSD+W+LGCC+YEMA + AF A DM L+ +I + P+P YSP L LI+ ML K
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELSELIRTMLSKR 245
Query: 247 PEHRPSASELLKHPFLQHFVDQY 269
PE RPS +L+ P+++H + +
Sbjct: 246 PEERPSVRSILRQPYIKHQISLF 268
|
|
| UNIPROTKB|E2QRX7 NEK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 2.4e-67, Sum P(3) = 2.4e-67
Identities = 112/263 (42%), Positives = 176/263 (66%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y + +GRG++G LV HR + ++YV+KK+ L + R RR+A QE L+++++HP I
Sbjct: 6 YCYLRVVGRGSYGEVTLVRHRRDGRQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V +KE+W + IV G+CEGGD+ +K+ G PE ++ +WF Q+ +A+ YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKERKGQLLPESQVVEWFVQIAMALQYLHEK 125
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGF 186
++LHRDLK N+FLT+ +++GD G+A+ L+ + D+A++++GTP YM PEL ++ PY +
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENNGDMANTLIGTPYYMSPELFSNKPYNY 185
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
KSD+W+LGCC+YEMA + AF A DM L+ +I + P+P YSP L LI+ ML K
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELSELIRTMLSKR 245
Query: 247 PEHRPSASELLKHPFLQHFVDQY 269
PE RPS +L+ P+++H + +
Sbjct: 246 PEERPSVRSILRQPYIKHQISLF 268
|
|
| UNIPROTKB|P51957 NEK4 "Serine/threonine-protein kinase Nek4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 3.2e-64, Sum P(2) = 3.2e-64
Identities = 112/257 (43%), Positives = 172/257 (66%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y + +G+G++G LV HR + K+YV+KK+ L + R RR+A QE L+++++HP I
Sbjct: 6 YCYLRVVGKGSYGEVTLVKHRRDGKQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V +KE+W + IV G+CEGGD+ +K+ G PE ++ +WF Q+ +A+ YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPENQVVEWFVQIAMALQYLHEK 125
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGF 186
++LHRDLK N+FLT+ +++GD G+A+ L+ D+AS+++GTP YM PEL ++ PY +
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHCDMASTLIGTPYYMSPELFSNKPYNY 185
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
KSD+W+LGCC+YEMA + AF A DM L+ +I + P+P YSP L LI+ ML K
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPRDYSPELAELIRTMLSKR 245
Query: 247 PEHRPSASELLKHPFLQ 263
PE RPS +L+ P+++
Sbjct: 246 PEERPSVRSILRQPYIK 262
|
|
| MGI|MGI:1344404 Nek4 "NIMA (never in mitosis gene a)-related expressed kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 3.4e-64, Sum P(2) = 3.4e-64
Identities = 113/263 (42%), Positives = 174/263 (66%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y M +GRG++G LV HR + K+YV+KK+ L + R RR+A QE L+++++HP I
Sbjct: 6 YCYMRVVGRGSYGEVTLVKHRRDGKQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V +KE+W + IV G+CEGGD+ +K+ G PE ++ +WF Q+ +A+ YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPESQVVEWFVQIAMALQYLHEK 125
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGF 186
++LHRDLK N+FLT+ +++GD G+A+ L+ D+AS+++GTP YM PEL ++ PY +
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHGDMASTLIGTPYYMSPELFSNKPYNY 185
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
KSD+W+LGCC+YEMA + AF A DM L+ +I + P+P YS L LI+ ML +
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKVYSTELAELIRTMLSRR 245
Query: 247 PEHRPSASELLKHPFLQHFVDQY 269
PE RPS +L+ P+++H + +
Sbjct: 246 PEERPSVRSILRQPYIKHHISLF 268
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0WPH8 | NEK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5986 | 0.6282 | 0.7175 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00017494001 | SubName- Full=Chromosome chr6 scaffold_15, whole genome shotgun sequence; (936 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1092 | |||
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-119 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-90 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-82 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-78 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-76 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-75 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-71 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-68 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-67 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-67 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-65 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-65 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-65 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-63 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-63 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-60 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-60 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-59 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-54 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-54 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-50 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-49 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-49 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-48 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-47 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-46 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-45 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-45 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-44 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-44 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-43 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-43 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-43 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-43 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-41 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-41 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-40 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-40 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-40 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-40 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-39 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-38 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-37 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-37 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-36 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-36 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-35 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-35 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-34 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-34 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-33 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-33 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-32 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-32 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-32 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-32 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-32 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-32 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-32 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-32 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-32 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-32 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-31 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-31 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-31 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-30 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-30 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-30 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-30 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-30 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-30 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-29 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-29 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-29 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-29 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-29 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-29 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-29 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-28 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-28 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-28 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-28 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-28 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-27 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-27 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-27 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-27 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-27 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-27 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-26 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-26 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-26 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-26 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-25 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-25 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-25 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-25 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-24 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-24 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-24 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-23 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-23 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-22 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-21 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-21 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-21 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-19 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-18 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 367 bits (946), Expect = e-119
Identities = 117/259 (45%), Positives = 176/259 (67%), Gaps = 4/259 (1%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+YEI++QIG+G+FG LV +++ K YVLK+I L+ +E+ R A E+ ++ ++ HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQLLLAVDYL 124
I+++ E++ EKG +CIV Y +GGD+++ +K K G FPEE++ WF QL LA+ YL
Sbjct: 61 IIKYYESFEEKG-KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASSVVGTPNYMCPELLADIP 183
HS +LHRD+K NIFLT + V+LGDFG++K L DLA +VVGTP Y+ PEL + P
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243
Y +KSDIWSLGC +YE+ + F+ ++ L KI + P+PS YS L+ L+ +L
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239
Query: 244 RKNPEHRPSASELLKHPFL 262
+K+PE RPS +++L+ PF+
Sbjct: 240 QKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 289 bits (741), Expect = 4e-90
Identities = 94/258 (36%), Positives = 143/258 (55%), Gaps = 7/258 (2%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
YEI+E++G G+FG L + K +K I+ + + R +E+ ++ +++HP I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNI 59
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V + + ++ + +V YCEGGD+ +L+KK E++ + Q+L A++YLHS
Sbjct: 60 VRLYDVFEDED-KLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALEYLHSK 116
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFK 187
++HRDLK NI L +D V+L DFGLA+ L + ++ VGTP YM PE+L YG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC---YSPSLKTLIKGMLR 244
DIWSLG +YE+ +P F D + K P P SP K LI+ +L
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 245 KNPEHRPSASELLKHPFL 262
K+PE R +A E L+HPF
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 269 bits (688), Expect = 1e-82
Identities = 110/256 (42%), Positives = 171/256 (66%), Gaps = 1/256 (0%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y + +G+G++G LV HR + K+YV+KK+ L + R R++A QE L+++++HP I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V ++E+W + + IV G+CEGGD+ +K+ G PE ++ +WF Q+ +A+ YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGF 186
++LHRDLK N+FLT+ +++GD G+A+ L+ D+AS+++GTP YM PEL ++ PY +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
KSD+W+LGCC+YEMA + AF A DM L+ +I + P+P YSP L LI ML K
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241
Query: 247 PEHRPSASELLKHPFL 262
PE RPS +L+ P++
Sbjct: 242 PEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 9e-78
Identities = 105/257 (40%), Positives = 173/257 (67%), Gaps = 2/257 (0%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y +++IG G+FG AILV + + K+YV+K+I +++ + + R + +E+A+++ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
IV+++E++ E G + IV YCEGGD+ + + G FPE+++ WF Q+ LA+ ++H
Sbjct: 61 IVQYQESFEENGN-LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYG 185
+LHRD+K NIFLTKD ++LGDFG+A+ L + +LA + +GTP Y+ PE+ + PY
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245
KSDIW+LGC +YEM + AF+A +M L+ KI R S P+ S YS L+ L+ + ++
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239
Query: 246 NPEHRPSASELLKHPFL 262
NP RPS + +L+ F+
Sbjct: 240 NPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 1e-76
Identities = 90/263 (34%), Positives = 144/263 (54%), Gaps = 11/263 (4%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
YE++ ++G G+FG H+ K +K ++ + + ++A +E+ ++ R+ HP I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V +A+ +K ++ +V YCEGGD+ + + + E++ K Q+L ++YLHSN
Sbjct: 61 VRLIDAFEDKD-HLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN 117
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLAD-IPYG 185
++HRDLK NI L ++ V++ DFGLAK L ++ VGTP YM PE+L YG
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR------SSIGPLPSCYSPSLKTLI 239
K D+WSLG +YE+ +P F ++ + I R P S S K LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 240 KGMLRKNPEHRPSASELLKHPFL 262
K L K+P RP+A E+L+HP+
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 2e-75
Identities = 109/265 (41%), Positives = 152/265 (57%), Gaps = 9/265 (3%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
YE++E IG+G+FG V +++ K V K+I TE+ ++ E+ ++ ++HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 67 IVEFKEAWVEKGCYVC-IVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDY 123
IV + + +++ IV YCEGGD+A+L++K Y EE + + QLLLA+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 124 LH-----SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPE 177
H N VLHRDLK +NIFL + +V+LGDFGLAK L D A + VGTP YM PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
L + Y KSDIWSLGC +YE+ A P F A + L SKI +P YS L
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240
Query: 238 LIKGMLRKNPEHRPSASELLKHPFL 262
+IK ML +P+ RPS ELL+ P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 1e-71
Identities = 110/252 (43%), Positives = 162/252 (64%), Gaps = 3/252 (1%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
QY ++ +G G+FG A+LV H +KY +K+IRL + + S +E L+A+++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPN 59
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
IV FKE++ G ++ IV YC+GGD+ + +K G FPE+ + +WF Q+ L V ++H
Sbjct: 60 IVAFKESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYG 185
VLHRD+K NIFLT++ V+LGDFG A+ L + A + VGTP Y+ PE+ ++PY
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245
KSDIWSLGC +YE+ + F+A LI K+ + S PLPS YS L++LIK M ++
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238
Query: 246 NPEHRPSASELL 257
NP RPSA+ +L
Sbjct: 239 NPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 4e-68
Identities = 98/256 (38%), Positives = 154/256 (60%), Gaps = 2/256 (0%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
+EI+ +IG+G+FG V +A+K+ Y +K+I L++ R R A E ++A++ YI
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
+ + E++++KG + IV Y E GD+ +L+K G PE+++ ++F Q+LL + +LHS
Sbjct: 62 IRYYESFLDKG-KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLADIPYGF 186
+LHRD+K N+FL +V++GD G+AK L + A+++VGTP Y+ PEL D PY
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
KSD+W+LG +YE + F A + LI KI R P+ YS L LI L K+
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 247 PEHRPSASELLKHPFL 262
RP +LL++P L
Sbjct: 241 YRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 2e-67
Identities = 86/250 (34%), Positives = 127/250 (50%), Gaps = 38/250 (15%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEA 73
+G G FG L + KK +K I+ + +E+ ++ ++ HP IV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK-EDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 74 WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRD 133
+ ++ +V YCEGG + +L+K+ N E+++ + Q+L ++YLHSN ++HRD
Sbjct: 60 FEDENHL-YLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 134 LKCSNIFLTKDQD-VRLGDFGLAKTLK-ADDLASSVVGTPNYMCPELLADIP-YGFKSDI 190
LK NI L D V+L DFGL+K L L ++VGTP YM PE+L Y KSDI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 191 WSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHR 250
WSLG +YE+ P LK LI+ ML+K+PE R
Sbjct: 178 WSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKR 205
Query: 251 PSASELLKHP 260
PSA E+L+H
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 8e-67
Identities = 94/258 (36%), Positives = 157/258 (60%), Gaps = 4/258 (1%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+++++++G+G++G+ V ++ + Y LK++ L +++ R A E+ ++A V HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYL 124
I+ +KEA+++ G +CIV Y GD+++ + K PE+++ + F QLL + L
Sbjct: 61 IISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
H +LHRDLK +NI L + V++GD G++K LK ++A + +GTP+YM PE+ PY
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
+KSDIWSLGC +YEMA P F+A M L K+ R P+P YS L+ I+ ML+
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238
Query: 245 KNPEHRPSASELLKHPFL 262
P+ RP+ ++L P +
Sbjct: 239 VKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 1e-65
Identities = 96/256 (37%), Positives = 152/256 (59%), Gaps = 2/256 (0%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y + +G+GAFG A L + V K++ L R +E+ RR A E+ +++ +QHP I
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
+ + +++ + I Y GG + + + + G F EE + + Q++ AV Y+H
Sbjct: 62 IAYYNHFMDDNTLL-IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGF 186
+LHRD+K NIFLTK ++LGDFG++K L ++ +A +VVGTP YM PEL + Y F
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
KSDIW+LGC +YE+ + F A + L+ KI + + P+ S YS L +L+ +L+++
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240
Query: 247 PEHRPSASELLKHPFL 262
PE RP+A E+L P L
Sbjct: 241 PEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 91/260 (35%), Positives = 143/260 (55%), Gaps = 14/260 (5%)
Query: 12 EQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
E +GRG+FG+ A+ + + +K + L+ +E + +E+ +++ +QHP IV
Sbjct: 6 ELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 69 EFKEA-WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
+ + E+ + I Y GG ++ L+KK G PE + K+ Q+L + YLHSN
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGK-LPEPVIRKYTRQILEGLAYLHSN 120
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA---SSVVGTPNYMCPELLADIPY 184
++HRD+K +NI + D V+L DFG AK L + SV GTP +M PE++ Y
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSIGP-LPSCYSPSLKTLIKGM 242
G +DIWSLGC + EMA +P + + + KI S P +P S K ++
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 243 LRKNPEHRPSASELLKHPFL 262
LR++P+ RP+A ELL+HPFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 1e-65
Identities = 98/255 (38%), Positives = 156/255 (61%), Gaps = 2/255 (0%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+YE + +GRGAFG L +A++K ++K+I + + T+ R +A E ++ + HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
I+E+ E ++E + IV Y GG +AE ++K + E+ + +F Q+LLA+ ++H+
Sbjct: 61 IIEYYENFLEDKA-LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 127 NYVLHRDLKCSNIFLTKDQDV-RLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYG 185
+LHRDLK NI L K + V ++GDFG++K L + A +VVGTP Y+ PEL PY
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245
KSDIW+LGC +YE+A+ + AF+A ++ L+ KI + P+ YSP L+ LI ML
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 246 NPEHRPSASELLKHP 260
+P RP S+++ P
Sbjct: 240 DPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 2e-63
Identities = 104/262 (39%), Positives = 161/262 (61%), Gaps = 8/262 (3%)
Query: 7 QYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+Y + +++G+G+FG LV + AE++ VLK+I + A+QE L++++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQLLLAV 121
HP IV+F +++E+ + CI+T YCEG D+ ++ K G E ++C+WF QLLL V
Sbjct: 61 HPAIVKFHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLA 180
Y+H +LHRDLK NIFL K+ +++GDFG+++ L DLA++ GTP YM PE L
Sbjct: 120 HYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
Y KSDIWSLGC +YEM AF+ + ++ +I LP YS L ++++
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 241 GMLRKNPEHRPSASELLKHPFL 262
ML K+P RPSA+E+L++PF+
Sbjct: 239 SMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 6e-63
Identities = 91/256 (35%), Positives = 149/256 (58%), Gaps = 6/256 (2%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
+EI+E+IG+G FG H+ K+ +K I+L + ++ E+ ++ + +HP I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK--EKIINEIQILKKCKHPNI 59
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V++ ++++K + IV +C GG + +L+K +N E ++ +LL ++YLHSN
Sbjct: 60 VKYYGSYLKKD-ELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN 117
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFK 187
++HRD+K +NI LT D +V+L DFGL+ L +++VGTP +M PE++ PY +K
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIKGMLRK 245
+DIWSLG E+A +P + + KI + L P +S K +K L+K
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237
Query: 246 NPEHRPSASELLKHPF 261
NPE RP+A +LLKHPF
Sbjct: 238 NPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 3e-60
Identities = 86/257 (33%), Positives = 137/257 (53%), Gaps = 17/257 (6%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL-----IARVQHPYIV 68
+G+G+FG +LV + K Y +K ++ ++ + E L ++R+ HP+IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK----KKKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
+ A+ + + +V Y GG++ + K F EE+ + A+++LA++YLHS
Sbjct: 57 KLHYAFQTEE-KLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG 113
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGFK 187
+++RDLK NI L D ++L DFGLAK L ++ ++ GTP Y+ PE+L YG
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247
D WSLG +YEM +P F A D + KI + + P SP + LI G+L+K+P
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL-RFPEFLSPEARDLISGLLQKDP 232
Query: 248 EHR---PSASELLKHPF 261
R A E+ HPF
Sbjct: 233 TKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 5e-60
Identities = 95/258 (36%), Positives = 163/258 (63%), Gaps = 3/258 (1%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+YEI+++IG G+FG L +++ + V+K+I L + + + ++ +E+ L+A+++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
IV F ++ E G + IV YC+GGD+ + + + G F E+++ WF Q+ L + ++H
Sbjct: 61 IVTFFASFQENG-RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 127 NYVLHRDLKCSNIFLTKDQDV-RLGDFGLAKTLK-ADDLASSVVGTPNYMCPELLADIPY 184
+LHRD+K NIFL+K+ V +LGDFG+A+ L + +LA + VGTP Y+ PE+ + PY
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
K+DIWSLGC +YE+ + F+ ++ L+ KI + P+ +S L++LI + +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239
Query: 245 KNPEHRPSASELLKHPFL 262
+P RPS + +LK PFL
Sbjct: 240 VSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 88/263 (33%), Positives = 140/263 (53%), Gaps = 10/263 (3%)
Query: 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
E ++ +G+G+ G V H+ K Y LKKI + E R+ +E+ + + PY+V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLRELKTLRSCESPYVV 62
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN- 127
+ A K + IV Y +GG +A+L+KK PE L Q+L +DYLH+
Sbjct: 63 KCYGA-FYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKR 119
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVVGTPNYMCPELLADIPYGF 186
+++HRD+K SN+ + +V++ DFG++K L+ D ++ VGT YM PE + Y +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAG---LISKINRSSIGPLPS-CYSPSLKTLIKGM 242
+DIWSLG + E A + F L+ I LP+ +SP + I
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 243 LRKNPEHRPSASELLKHPFLQHF 265
L+K+P+ RPSA+ELL+HPF++
Sbjct: 240 LQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 88/256 (34%), Positives = 144/256 (56%), Gaps = 8/256 (3%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLA---RQTERCRRSAHQEMALIARVQHPYIV 68
E +G G+FG+ + + + +K++ LA + + + QE+AL++++QHP IV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
++ E+ + I GG +A+L+KK FPE + + Q+LL ++YLH
Sbjct: 66 QYLGTEREEDN-LYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRN 122
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI-PYGFK 187
+HRD+K +NI + + V+L DFG+AK + A S G+P +M PE++A YG
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS-SIGPLPSCYSPSLKTLIKGMLRKN 246
+DIWSLGC + EMA +P + + + KI RS + P+P S K I L+++
Sbjct: 183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRD 242
Query: 247 PEHRPSASELLKHPFL 262
P RP+A+ELL+HPF+
Sbjct: 243 PSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 6e-54
Identities = 95/264 (35%), Positives = 145/264 (54%), Gaps = 18/264 (6%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKK---YV-LKKIRLARQTERCRRSAHQEMALIARV 62
Y++ + IGRGAFG V ++ + +V +K+I L + E +S QE+ L+ +
Sbjct: 1 NYQLGDLIGRGAFG----VVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL 56
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+HP IV++ + +E + I+ Y E G + +++KK FPE + + Q+L +
Sbjct: 57 KHPNIVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLA 113
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCPELLAD 181
YLH V+HRD+K +NI TKD V+L DFG+A L SVVGTP +M PE++
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---MAGLISKINRSSIGPLPSCYSPSLKTL 238
SDIWSLGC + E+ P + +D MA L +I + PLP SP LK
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPY--YDLNPMAALF-RIVQDDHPPLPEGISPELKDF 230
Query: 239 IKGMLRKNPEHRPSASELLKHPFL 262
+ +K+P RP+A +LLKHP++
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 87/264 (32%), Positives = 146/264 (55%), Gaps = 16/264 (6%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRL-----ARQTERCRRSAHQEMALI 59
+ ++I ++IG+G F + + LKK+++ A+ + C +E+ L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL----KEIDLL 56
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQL 117
++ HP ++++ +++E + IV + GD++ ++K K PE + K+F QL
Sbjct: 57 KQLDHPNVIKYLASFIENN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCP 176
A++++HS ++HRD+K +N+F+T V+LGD GL + + A+ S+VGTP YM P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA--GLISKINRSSIGPLPSC-YSP 233
E + + Y FKSDIWSLGC +YEMAA + F M L KI + PLP+ YS
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235
Query: 234 SLKTLIKGMLRKNPEHRPSASELL 257
L+ L+ + +PE RP S +L
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-49
Identities = 96/266 (36%), Positives = 142/266 (53%), Gaps = 22/266 (8%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y+ +E+IG GA G RA K+ +KK+RL +Q + E+ ++ +HP I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN---KELIINEILIMKDCKHPNI 77
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAEL-------MKKSNGAYFPEEKLCKWFAQLLLA 120
V++ ++++ + +V Y +GG + ++ M + AY +C+ ++L
Sbjct: 78 VDYYDSYLVGD-ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCR---EVLQG 128
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASSVVGTPNYMCPELL 179
++YLHS V+HRD+K NI L+KD V+L DFG A L K +SVVGTP +M PE++
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKT 237
YG K DIWSLG EMA P + + I I PL P +SP K
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263
+ L K+PE RPSA ELL+HPFL+
Sbjct: 249 FLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 5e-49
Identities = 87/290 (30%), Positives = 144/290 (49%), Gaps = 45/290 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK---KIRLARQTERCRRSAHQEMALIARV 62
D ++ + IG G+F +L + K+Y +K K +L + E+ + E ++ R+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRL 58
Query: 63 -QHPYIVE----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF-AQ 116
HP I++ F++ E+ Y V Y G++ + ++K G+ +EK +++ A+
Sbjct: 59 NGHPGIIKLYYTFQD---EENLY--FVLEYAPNGELLQYIRK-YGSL--DEKCTRFYAAE 110
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL------------- 163
+LLA++YLHS ++HRDLK NI L KD +++ DFG AK L +
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 164 --------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL 215
+S VGT Y+ PELL + P G SD+W+LGC +Y+M +P F+ +
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 216 ISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSAS----ELLKHPF 261
KI + P + P K LI+ +L +P+ R + EL HPF
Sbjct: 231 FQKILKLEY-SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-48
Identities = 86/286 (30%), Positives = 126/286 (44%), Gaps = 35/286 (12%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
YE +E++G G +G + + LKKIRL + E +A +E++L+ ++HP I
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V+ + + + +V YC+ D+ + + K G + QLL + Y HS+
Sbjct: 61 VKLLDVIHTERK-LYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHSH 117
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAK--TLKADDLASSVVGTPNYMCPE-LLADIPY 184
+LHRDLK NI + +D ++L DFGLA+ + VV T Y PE LL Y
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI----NRSS---IGPLP------ 228
DIWS+GC EM +P F D I +I S + LP
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236
Query: 229 ------------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
P L+ ML+ NP R SA E LKHP+
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 7e-48
Identities = 79/259 (30%), Positives = 136/259 (52%), Gaps = 7/259 (2%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ + ++E IG+G+FG + + +K I L + E QE+ +++ + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL-EEAEDEIEDIQQEIQFLSQCRSP 59
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
YI ++ +++ KG + I+ YC GG +L+K E + ++LL ++YLH
Sbjct: 60 YITKYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPELLADIPY 184
+HRD+K +NI L+++ DV+L DFG++ L + ++ VGTP +M PE++ Y
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP-SCYSPSLKTLIKGML 243
K+DIWSLG E+A P ++ I +++ L + +S K + L
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235
Query: 244 RKNPEHRPSASELLKHPFL 262
K+P+ RPSA ELLKH F+
Sbjct: 236 NKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 76/264 (28%), Positives = 122/264 (46%), Gaps = 19/264 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKE 72
I +GA+G L ++ Y +K I+ A + E ++++ Q PY+V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132
++ K + +V Y GGD+A L++ E+ + A+++LA++YLHSN ++HR
Sbjct: 61 SFQGKK-NLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 133 DLKCSNIFLTKDQDVRLGDFGLAKT---------LKADDLASSVVGTPNYMCPELLADIP 183
DLK NI + + ++L DFGL+K + +VGTP+Y+ PE++
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC--YSPSLKTLIKG 241
+ D WSLGC +YE P F + I I P S LI
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISK 236
Query: 242 MLRKNPEHRP---SASELLKHPFL 262
+L +PE R S E+ HPF
Sbjct: 237 LLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-46
Identities = 93/270 (34%), Positives = 145/270 (53%), Gaps = 12/270 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D +EI+ ++G GAFG H+ K I++ + E E+ +++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV--EIDILSECKHP 62
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV EA+ + + I+ +C+GG + +M + E ++ Q+L A+++LH
Sbjct: 63 NIVGLYEAYFYEN-KLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH 120
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPELLA---- 180
S+ V+HRDLK NI LT D DV+L DFG+ AK + +GTP +M PE++A
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 181 -DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKT 237
D PY +K+DIWSLG + E+A P + ++ KI +S L PS +S S
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
+K L K+P+ RP+A+ELLKHPF+ D
Sbjct: 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 85/258 (32%), Positives = 136/258 (52%), Gaps = 15/258 (5%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYV-LKKIRL--------ARQTERCRRSAHQEMAL 58
Y ++E +G GAFG V + + + LK+I + R+ ++ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 59 I-ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFA 115
I +++HP IV + + ++E + IV EG + E K F EE++ F
Sbjct: 62 IKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 116 QLLLAVDYLH-SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYM 174
Q++LA+ YLH ++HRDL +NI L +D V + DFGLAK + + +SVVGT Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP-SCYSP 233
CPE++ + PYG K+D+W+ GC +Y+M +P F + +M L +KI + PLP YS
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 234 SLKTLIKGMLRKNPEHRP 251
+ +I L + E RP
Sbjct: 241 DVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 34/286 (11%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y+ + +IG G +G + + +KKI+L ++E ++A +E+ L+ + HP I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
++ + + KG + +V + + D+ +L+K PE + + QLL + + HS+
Sbjct: 61 IKLLDVFRHKG-DLYLVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH 117
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPE-LLADIPYG 185
+LHRDLK N+ + + ++L DFGLA++ + + V T Y PE LL D Y
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 186 FKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGLISKINRSSIGPLPSCYSPSL 235
DIWS+GC E+ + RP F K F G L Y S
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 236 K-------------------TLIKGMLRKNPEHRPSASELLKHPFL 262
L+ ML +P R +A + L HP+
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 85/268 (31%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ YE++++IG G +G A + +K I+L + QE++++ +HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF--EIIQQEISMLKECRHP 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV + +++ + + IV YC GG + ++ + + G E ++ + L + YLH
Sbjct: 61 NIVAYFGSYL-RRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLH 118
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA--SSVVGTPNYMCPELLA--- 180
+HRD+K +NI LT+D DV+L DFG++ L A +A S +GTP +M PE+ A
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-TIAKRKSFIGTPYWMAPEVAAVER 177
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM--AGLISKINRSSIGPLPSC-----YSP 233
Y K DIW+LG E+A +P FD+ + I++S+ P P +SP
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPM--FDLHPMRALFLISKSNFPP-PKLKDKEKWSP 234
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPF 261
IK L K+P+ RP+A++LL+HPF
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 76/262 (29%), Positives = 127/262 (48%), Gaps = 10/262 (3%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCR-RSAHQEMALIARVQHP 65
+E++ IG+GAFG +V R KK + +K + + E+ R+ E ++ + HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMA-ELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
++V ++ + + +V GGD+ L +K F EE++ W +++LA++YL
Sbjct: 61 FLVNLWYSF-QDEENMYLVVDLLLGGDLRYHLSQKVK---FSEEQVKFWICEIVLALEYL 116
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HS ++HRD+K NI L + V + DF +A + D L +S GTP YM PE+L Y
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176
Query: 185 GFKSDIWSLGCCMYEMA-AHRP-AFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
D WSLG YE RP + + I ++ P+ +S I +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236
Query: 243 LRKNPEHRPS--ASELLKHPFL 262
L ++P+ R +L HP+
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-44
Identities = 87/291 (29%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
YE + QIG G +G ++ + LKKIR+ + E +A +E+ L+ +++HP I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 68 VEFKEAWVEKG---CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
V KE KG Y +V Y + D+ L+ S F E ++ + QLL + YL
Sbjct: 61 VRLKEIVTSKGKGSIY--MVFEYMDH-DLTGLLD-SPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL---KADDLASSVVGTPNYMCPELL-A 180
HSN +LHRD+K SNI + D ++L DFGLA+ + D + V+ T Y PELL
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI--------------------- 219
YG + D+WS+GC + E+ +P F+ + KI
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
Query: 220 -NRSSIGPLPS--------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
N P PS L+ +L +P+ R SA + L+H +
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 89/277 (32%), Positives = 139/277 (50%), Gaps = 32/277 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAE----KKKYVLKKIRLARQTERCRRS---AHQEMAL 58
D YE++E IG GA V + A +K +K+I L E+C+ S +E+
Sbjct: 1 DDYELIEVIGVGATA----VVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQA 52
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSN-GAYFPEEKLCKWFAQL 117
+++ HP +V++ ++V + +V Y GG + ++MK S E + ++
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDE-LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS------VVGTP 171
L ++YLHSN +HRD+K NI L +D V++ DFG++ +L AD + VGTP
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTP 170
Query: 172 NYMCPELLA-DIPYGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKINRSSIGPLPS 229
+M PE++ Y FK+DIWS G E+A P K M L+ + L +
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS-LET 229
Query: 230 C-----YSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
YS S + +I L+K+P RP+A ELLKH F
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 79/263 (30%), Positives = 135/263 (51%), Gaps = 16/263 (6%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKE 72
+G G FG LV +++ + + LK ++ E + E ++ HP+IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF-AQLLLAVDYLHSNYVLH 131
+ +K Y+ ++ YC GG++ +++ G + +E +++ A ++LA +YLH+ +++
Sbjct: 61 TFKDKK-YIYMLMEYCLGGELWTILRD-RGLF--DEYTARFYIACVVLAFEYLHNRGIIY 116
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIW 191
RDLK N+ L + V+L DFG AK LK+ + GTP Y+ PE++ + Y F D W
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 192 SLGCCMYEMAAHRPAFKAFDMAGLI--SKINRSSIGPL--PSCYSPSLKTLIKGMLRKNP 247
SLG +YE+ RP F D + + I + G L P+ + K LIK +LR+NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILK-GNGKLEFPNYIDKAAKDLIKQLLRRNP 235
Query: 248 EHR-----PSASELLKHPFLQHF 265
E R ++ KH + F
Sbjct: 236 EERLGNLKGGIKDIKKHKWFNGF 258
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 90/273 (32%), Positives = 136/273 (49%), Gaps = 19/273 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D E + ++G G G V HR K +K IRL E ++ +E+ ++ + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 66 YIVEFKEAWVEKG-CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
YIV F A+ G +C Y +GG + +++K+ G PE L K +L + YL
Sbjct: 60 YIVGFYGAFYNNGDISIC--MEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYL 116
Query: 125 HSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
H + ++HRD+K SNI + ++L DFG++ L + LA + VGT +YM PE +
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGND 175
Query: 184 YGFKSDIWSLGCCMYEMAAHR--------PAFKAFDMAGLISKINRSSIGPLPS-CYSPS 234
Y KSDIWSLG + E+A R P F+ L+ I LPS +SP
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE---LLQYIVNEPPPRLPSGKFSPD 232
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
+ + L K+P RPS ELL+HPF++ +
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 8e-43
Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 30/271 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKK---IRLARQTERCRRSAHQEMALI 59
D +E ++ +G G+FG +LV H+ K Y +L K ++L +Q E E ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-KQVEHV----LNEKRIL 55
Query: 60 ARVQHPYIVE----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
++HP++V F++ + +V Y GG++ ++KS FPE + A
Sbjct: 56 QSIRHPFLVNLYGSFQDDS-----NLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAA 108
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMC 175
Q++LA++YLHS +++RDLK N+ L D +++ DFG AK + ++ GTP Y+
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK--RVKGRTYTLCGTPEYLA 166
Query: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
PE++ YG D W+LG +YEM A P F + + KI PS +SP
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-LEGKVRFPSFFSPDA 225
Query: 236 KTLIKGMLRKNPEHR-----PSASELLKHPF 261
K LI+ +L+ + R +++ HP+
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 82/268 (30%), Positives = 137/268 (51%), Gaps = 25/268 (9%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ ++I+E++G G++G+ H+ + +K + + + +E++++ + P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ----EIIKEISILKQCDSP 58
Query: 66 YIVEFKEAWVEKGCY-----VCIVTGYCEGG---DMAELMKKSNGAYFPEEKLCKWFAQL 117
YIV++ G Y + IV YC G D+ ++ K+ EE++ Q
Sbjct: 59 YIVKYY------GSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQT 108
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVVGTPNYMCP 176
L ++YLHSN +HRD+K NI L ++ +L DFG++ L ++V+GTP +M P
Sbjct: 109 LKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPS 234
E++ +I Y K+DIWSLG EMA +P + I I L P +SP
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE 228
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFL 262
+K L K+PE RPSA +LL+HPF+
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 86/261 (32%), Positives = 149/261 (57%), Gaps = 8/261 (3%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQ 63
+ ++I ++IGRG F ++K LKK+++ + + R+ +E+ L+ ++
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQLLLAV 121
HP ++++ ++++E + IV + GD+++++K K PE + K+F QL AV
Sbjct: 61 HPNVIKYLDSFIEDN-ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCPELLA 180
+++HS V+HRD+K +N+F+T V+LGD GL + + A+ S+VGTP YM PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKA--FDMAGLISKINRSSIGPLPS-CYSPSLKT 237
+ Y FKSDIWSLGC +YEMAA + F ++ L KI + PLP+ YS L+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 238 LIKGMLRKNPEHRPSASELLK 258
L+ + +P+ RP + +
Sbjct: 240 LVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 85/262 (32%), Positives = 134/262 (51%), Gaps = 18/262 (6%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEA 73
IG G FG + + +K+IR+ + + EM ++ ++HP +V++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 74 WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRD 133
V + V I YC GG + EL++ +G E + + QLL + YLHS+ ++HRD
Sbjct: 68 EVHRE-KVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 134 LKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-----SSVVGTPNYMCPELLADIP---YG 185
+K +NIFL + ++LGDFG A LK + S+ GTP YM PE++ +G
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFD-----MAGLISKINRSSIGPLPSCYSPSLKTLIK 240
+DIWSLGC + EMA + + D M + + ++ I P SP K +
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPI-PDSLQLSPEGKDFLD 242
Query: 241 GMLRKNPEHRPSASELLKHPFL 262
L +P+ RP+ASELL+HPF+
Sbjct: 243 RCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 90/288 (31%), Positives = 132/288 (45%), Gaps = 34/288 (11%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ---H 64
YE + +IG GA+G + LKK+R+ E S +E+AL+ +++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 65 PYIVEFKEAW----VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
P IV + ++ + +V + + D+A + K P E + QLL
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
VD+LHS+ ++HRDLK NI +T D V++ DFGLA+ + +SVV T Y PE+L
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL 179
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGLISK--------INRS 222
Y D+WS+GC E+ RP F K FD+ GL S+ + RS
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239
Query: 223 S-----IGPLPSC---YSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
S S L+K ML NP R SA E L+HP+
Sbjct: 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 82/289 (28%), Positives = 130/289 (44%), Gaps = 37/289 (12%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y+I+ +IG GA G R + LKK+ L R A +E+ + QHPY
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
+V+ + + +V +V Y D++E+++ PE ++ + LL V Y+H+
Sbjct: 61 VVKLLDVFPHGSGFV-LVMEYM-PSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHA 117
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LASSVVGTPNYMCPELLADIP- 183
N ++HRDLK +N+ ++ D +++ DFGLA+ ++ L S V T Y PELL
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAG--------------LISKI 219
Y D+W++GC E+ P F F G +KI
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237
Query: 220 ---NRSSIGP---LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
I P SP L+KG+L +P R SA+E L+HP+
Sbjct: 238 TFPESKPIPLEEIFPDA-SPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 86/257 (33%), Positives = 143/257 (55%), Gaps = 8/257 (3%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQ 63
+ + I ++IGRG F + LKK+++ + + R +E+ L+ ++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQLLLAV 121
HP ++++ +++E + IV + GD++ ++K K PE+ + K+F QL A+
Sbjct: 61 HPNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCPELLA 180
+++HS V+HRD+K +N+F+T V+LGD GL + + A+ S+VGTP YM PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAF--KAFDMAGLISKINRSSIGPLPS-CYSPSLKT 237
+ Y FKSDIWSLGC +YEMAA + F ++ L KI + PLPS YS L+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 238 LIKGMLRKNPEHRPSAS 254
L+ + +PE RP +
Sbjct: 240 LVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-40
Identities = 96/317 (30%), Positives = 151/317 (47%), Gaps = 47/317 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH--QEMALIARVQ 63
D +E+++ IGRGAFG LV + + Y +K +R + +R + AH E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF-AQLLLAVD 122
P+IV+ ++ ++ ++ +V Y GGD+ L+ + + FPEE +++ A+L+LA+D
Sbjct: 60 SPWIVKLYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKD--VFPEE-TARFYIAELVLALD 115
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-------------------- 162
+H +HRD+K NI + D ++L DFGL K +
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 163 ----------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM 212
A+S VGTP+Y+ PE+L PYG + D WSLG +YEM P F + +
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235
Query: 213 AGLISKI---NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHR-PSASELLKHPFLQHF--- 265
+KI S P SP LI +L +PE R S E+ HPF +
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294
Query: 266 -VDQYRPTFPPAACSPE 281
+ + +P F P SP
Sbjct: 295 NLRETKPPFVPELSSPL 311
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 93/268 (34%), Positives = 145/268 (54%), Gaps = 16/268 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +EI+ ++G GAFG ++ K I + E E+ ++A HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEILATCNHP 69
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDM-AELMKKSNGAYFPEEK-LCKWFAQLLLAVDY 123
YIV+ A+ G + I+ +C GG + A +++ G P+ + +C+ Q+L A+ Y
Sbjct: 70 YIVKLLGAFYWDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR---QMLEALQY 125
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPEL---- 178
LHS ++HRDLK N+ LT D D++L DFG+ AK +K S +GTP +M PE+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 179 -LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSL 235
+ D PY +K+DIWSLG + EMA P + ++ KI +S L PS +S
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ +K L K+PE RPSA++LL+HPF+
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 9e-40
Identities = 84/264 (31%), Positives = 131/264 (49%), Gaps = 19/264 (7%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT----ERCRRSAHQEMALIARVQHPYI 67
+Q+G GAF + +K++ R T E + +E+ L+AR+ HP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
+ A E + + + GG ++ L+ K GA F E + + QLL + YLH N
Sbjct: 66 IRMLGATCEDSHF-NLFVEWMAGGSVSHLLSKY-GA-FKEAVIINYTEQLLRGLSYLHEN 122
Query: 128 YVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTL-----KADDLASSVVGTPNYMCPELLAD 181
++HRD+K +N+ + + Q +R+ DFG A L A + ++GT +M PE+L
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKINRSSIGP--LPSCYSPSLK 236
YG D+WS+GC + EMA +P + A + LI KI S+ +P SP L+
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI-ASATTAPSIPEHLSPGLR 241
Query: 237 TLIKGMLRKNPEHRPSASELLKHP 260
+ L PE RP + ELLKHP
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 80/266 (30%), Positives = 138/266 (51%), Gaps = 21/266 (7%)
Query: 12 EQIGRGAFGAAI--LVNHRAEKKKYVLKKIRLARQ----TERCRRSAHQEMALIARVQHP 65
E +G+GA+G L N + + +K++ L E+ +E+ L+ ++H
Sbjct: 6 EVLGKGAYGTVYCGLTN---QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV++ ++ + I + GG ++ ++ + G PE CK+ Q+L V YLH
Sbjct: 63 NIVQYLGTCLDD-NTISIFMEFVPGGSISSILNRF-GP-LPEPVFCKYTKQILDGVAYLH 119
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-------KADDLASSVVGTPNYMCPEL 178
+N V+HRD+K +N+ L + ++L DFG A+ L ++ S+ GTP +M PE+
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI--NRSSIGPLPSCYSPSLK 236
+ + YG KSDIWS+GC ++EMA +P + D + I +R + LP +S +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFL 262
+ L ++ RPSA +LL+H FL
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 83/256 (32%), Positives = 133/256 (51%), Gaps = 11/256 (4%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRR---SAHQEMALIARVQHPYIVEF 70
+G+GAFG L ++ +K++ + ++ + E+ L+ +QH IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
+ + I Y GG + + +K + GA E K+ Q+L V+YLHSN ++
Sbjct: 70 YGCLRDDE-TLSIFMEYMPGGSVKDQLK-AYGA-LTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKA----DDLASSVVGTPNYMCPELLADIPYGF 186
HRD+K +NI +V+LGDFG +K L+ SV GTP +M PE+++ YG
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTLIKGMLRK 245
K+D+WS+GC + EM +P + F+ I KI P LPS SP + ++ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246
Query: 246 NPEHRPSASELLKHPF 261
N + RPSA ELL+H F
Sbjct: 247 NAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 3e-39
Identities = 93/322 (28%), Positives = 148/322 (45%), Gaps = 30/322 (9%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERC-RRSAHQEMALIARVQHP- 65
Y I+ ++G G+FG L +K LK + +++ +E+ ++A + HP
Sbjct: 2 YRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS-NGAYFPEEKLCKWFAQLLLAVDYL 124
IV+ + + ++G + +V Y +GG + +L+KK E + AQ+L A++YL
Sbjct: 59 NIVKLYDFFQDEG-SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 125 HSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKTLKADD-------LASSVVGTPNYMCP 176
HS ++HRD+K NI L +D + V+L DFGLAK L L S+ VGTP YM P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 177 ELLADI---PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLIS---KINRSSIGP---- 226
E+L + SDIWSLG +YE+ P F+ + S KI P
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 227 -----LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPE 281
P S + L+K +L K+P++R S+S L H L H +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 282 KPISIAHESRRCMAESQNSSSS 303
P+ ++ S +S +
Sbjct: 298 APLRLSLPPSLEALISSLNSLA 319
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 90/264 (34%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ-EMALIARVQH- 64
Y+ +E IGRGA+GA H + LK I L T S Q E+AL+++++
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL--DTPDDDVSDIQREVALLSQLRQS 59
Query: 65 --PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
P I ++ +++ KG + I+ Y EGG + LMK A E+ + ++L+A+
Sbjct: 60 QPPNITKYYGSYL-KGPRLWIIMEYAEGGSVRTLMKAGPIA---EKYISVIIREVLVALK 115
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLAD 181
Y+H V+HRD+K +NI +T +V+L DFG+A L + S+ VGTP +M PE++ +
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 182 -IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP-SCYSPSLKTLI 239
Y K+DIWSLG +YEMA P + D + I +S L + YS L+ +
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235
Query: 240 KGMLRKNPEHRPSASELLKHPFLQ 263
L + P+ R SA ELLK +++
Sbjct: 236 AACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 87/280 (31%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK--KIRLARQTERCRRSAHQEMALIARV- 62
+E++E IG G +G H+ + +K I + E +E ++ +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-----IKEEYNILRKYS 60
Query: 63 QHPYIVEFKEAWVEKGCYVC-----IVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFA 115
HP I F A+++K +V C GG + +L+K G EE +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYM 174
+ L + YLH N V+HRD+K NI LTK+ +V+L DFG++ L + ++ +GTP +M
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 175 CPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPL 227
PE++A D Y +SD+WSLG E+A +P DM + + KI R+ P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRALFKIPRN---PP 235
Query: 228 PSCYSPSLKT-----LIKGMLRKNPEHRPSASELLKHPFL 262
P+ SP + I L KN E RP ELL+HPF+
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 85/296 (28%), Positives = 139/296 (46%), Gaps = 47/296 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++YE++ +G GA+G + ++A + +KK + + E +++A +E+ ++ +++H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEE-KLCKWFAQLLLAVDYL 124
IV KEA+ KG +V Y E + EL++ S G P+ + W QLL A+ Y
Sbjct: 61 NIVNLKEAFRRKGRLY-LVFEYVER-TLLELLEASPGGLPPDAVRSYIW--QLLQAIAYC 116
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL--KADDLASSVVGTPNYMCPELL-AD 181
HS+ ++HRD+K NI +++ ++L DFG A+ L + + V T Y PELL D
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKINRSSIGPLPS--------- 229
YG D+W++GC M E+ P F D LI K +GPLP
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC----LGPLPPSHQELFSSN 232
Query: 230 -----------------------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
S +K LR +P+ R + ELL+HP+
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 82/274 (29%), Positives = 130/274 (47%), Gaps = 16/274 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++ + ++G GA G+ + + LK I ++ +E+ + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59
Query: 66 YIVEFKEAWV-EKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVD 122
YIV++ A++ E + I YCEGG + + KK G E+ L K +L +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
YLHS ++HRD+K SNI LT+ V+L DFG++ L + LA + GT YM PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMAPERIQGK 178
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-----LISKINRSSIGPLPSC------Y 231
PY SD+WSLG + E+A +R F L+S I L +
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
S K IK L K+P RP+ ++L+HP+++
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 91/283 (32%), Positives = 136/283 (48%), Gaps = 25/283 (8%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQ--EMALIARVQHPYIV 68
+G+G FG ILV +A K Y +LKK + + E AH E ++ +HP++
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE----VAHTLTESRVLQNTRHPFLT 58
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
K ++ +C V Y GG++ S F E++ + A+++ A+ YLHS
Sbjct: 59 ALKYSFQTHD-RLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGFK 187
V++RDLK N+ L KD +++ DFGL K + + GTP Y+ PE+L D YG
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247
D W LG MYEM R F D L I I P SP K+L+ G+L+K+P
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDP 234
Query: 248 EHR-----PSASELLKHPFLQ--HFVDQYRPTFPPAACSPEKP 283
+ R A E+++H F ++ D + P P KP
Sbjct: 235 KQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP----PFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 85/297 (28%), Positives = 135/297 (45%), Gaps = 56/297 (18%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQE--MAL-----IA 60
Y++++Q+G G FG+ L ++ + +KK++ ++ E M L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK--------KKFYSWEECMNLREVKSLR 52
Query: 61 RVQ-HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
++ HP IV+ KE + E + V Y EG ++ +LMK G F E + Q+L
Sbjct: 53 KLNEHPNIVKLKEVFRENDE-LYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE-L 178
+ ++H + HRDLK N+ ++ + V++ DFGLA+ +++ + V T Y PE L
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAG------------LI 216
L Y DIW+LGC M E+ RP F K + G L
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230
Query: 217 SKINRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKHPFL 262
SK+ P SL LIK MLR +P+ RP+AS+ L+HP+
Sbjct: 231 SKLGFR----FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 83/277 (29%), Positives = 128/277 (46%), Gaps = 16/277 (5%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHPYIVEFKE 72
+G+G FG +A K Y KK+ R +R + A E ++ +V +IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132
A+ E +C+V GGD+ + FPE + + AQ++ +++LH +++R
Sbjct: 61 AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 133 DLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWS 192
DLK N+ L +VR+ D GLA LK GTP YM PE+L Y F D ++
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFA 179
Query: 193 LGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTLIKGMLRKNPEH 249
LGC +YEM A R F+ ++ R ++ P +SP K L + +L+K+PE
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239
Query: 250 R-----PSASELLKHPFL------QHFVDQYRPTFPP 275
R SA E+ +HP + P F P
Sbjct: 240 RLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 70/259 (27%), Positives = 115/259 (44%), Gaps = 15/259 (5%)
Query: 9 EIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
E+ +++G GAFG L + V K +E R +E +++ ++ HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV +G + IVT Y GGD+ + ++K + L + Q+ ++YL
Sbjct: 62 NIVRLL-GVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE 119
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP---NYMCPELLADI 182
S +HRDL N +T++ V++ DFGL++ + DD G +M PE L D
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 183 PYGFKSDIWSLGCCMYEM----AAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ KSD+WS G ++E+ P ++ L+ R P P L L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRL---PRPENCPDELYEL 236
Query: 239 IKGMLRKNPEHRPSASELL 257
+ +PE RP+ SEL+
Sbjct: 237 MLQCWAYDPEDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 83/262 (31%), Positives = 134/262 (51%), Gaps = 27/262 (10%)
Query: 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF-- 70
+IG G+ G + ++ ++ +KK+ L +Q R E+ ++ QHP IVE
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHPNIVEMYS 83
Query: 71 -----KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
E WV V + EGG + +++ + EE++ +L A+ +LH
Sbjct: 84 SYLVGDELWV--------VMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLH 132
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPY 184
+ V+HRD+K +I LT D V+L DFG + + S+VGTP +M PE+++ +PY
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLIS-KINRSSIGPL---PSCYSPSLKTLIK 240
G + DIWSLG + EM P + F+ L + K R ++ P SP L++ +
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPY--FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250
Query: 241 GMLRKNPEHRPSASELLKHPFL 262
ML ++P R +A+ELL HPFL
Sbjct: 251 RMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 50/307 (16%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRL-ARQTERC--RRSAHQEMALIARVQ 63
+YE +++G G + + + +KKI+L R+ + +A +E+ L+ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
HP I+ + + K + +V + E D+ +++K + P + + L ++Y
Sbjct: 61 HPNIIGLLDVFGHKSN-INLVFEFMET-DLEKVIKDKSIVLTPADIKS-YMLMTLRGLEY 117
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LASSVVGTPNYMCPELL-- 179
LHSN++LHRDLK +N+ + D ++L DFGLA++ + + + VV T Y PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFG 176
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKINRSSIG----------- 225
A YG D+WS+GC E+ P D G I + +G
Sbjct: 177 ARH-YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA----LGTPTEENWPGVT 231
Query: 226 --PLPSCYSP----SLKT-----------LIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268
P + P LK L++ +L NP R +A + L+HP+ F +
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY---FSND 288
Query: 269 YRPTFPP 275
PT P
Sbjct: 289 PAPTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-35
Identities = 79/285 (27%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKK-IRLARQTERCRRSAHQEMALIARVQHPYIVE 69
+G+G+FG +L + + Y VLKK + L C + + +AL + HP++ +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLTQ 60
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
+ K + V Y GGD+ +++S F E + + A+++L + +LH +
Sbjct: 61 LHSCFQTKD-RLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGI 117
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGFKS 188
++RDLK N+ L + +++ DFG+ K + S+ GTP+Y+ PE+L+ PYG
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177
Query: 189 DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
D W+LG +YEM A + F+ D L I + P S K+++K L KNPE
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPE 236
Query: 249 HRPSAS-----ELLKHPFLQHFVD-------QYRPTFPPAACSPE 281
R ++ HPF + +D + +P F P
Sbjct: 237 KRLGCLPTGEQDIKGHPFFRE-IDWDKLERKEIKPPFKPKIKGRF 280
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 13/259 (5%)
Query: 9 EIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +++G GAFG L K+ V K +E+ +E ++ ++ HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV+ + + IV Y GGD+ + ++K+ L + Q+ ++YL
Sbjct: 62 NIVKLL-GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NYMCPELLADIP 183
S +HRDL N + ++ V++ DFGL++ L DD G P +M PE L +
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 184 YGFKSDIWSLGCCMYEMAAH----RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239
+ KSD+WS G ++E+ P ++ + K R P P+C P L L+
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK-P-PNC-PPELYKLM 237
Query: 240 KGMLRKNPEHRPSASELLK 258
++PE RP+ SEL++
Sbjct: 238 LQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-34
Identities = 83/261 (31%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 11 MEQIGRGAFGAAI--LVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
+E+IG+G+FG + N K+ V KI + E QE+ ++++ PYI
Sbjct: 9 LERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
+ +++ KG + I+ Y GG +L+K E + ++L +DYLHS
Sbjct: 66 RYYGSYL-KGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSER 121
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLADIPYGFK 187
+HRD+K +N+ L++ DV+L DFG+A L + ++ VGTP +M PE++ Y FK
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247
+DIWSLG E+A P ++ I ++S L YS K ++ L K+P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 248 EHRPSASELLKHPFLQHFVDQ 268
RP+A ELLKH F+ + +
Sbjct: 242 RFRPTAKELLKHKFITRYTKK 262
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 87/275 (31%), Positives = 139/275 (50%), Gaps = 16/275 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +EI+ ++G GAFG ++ K I + E E+ ++A HP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHP 62
Query: 66 YIVEFKEA-WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV+ +A + E ++ I +C GG + +M + E ++ Q L A++YL
Sbjct: 63 NIVKLLDAFYYENNLWILI--EFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYL 119
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPELL---- 179
H N ++HRDLK NI T D D++L DFG+ AK + S +GTP +M PE++
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 180 -ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLK 236
D PY +K+D+WSLG + EMA P + ++ KI +S L PS +S K
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRP 271
+K L KN + R + ++LL+HPF+ V+ +P
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFVT--VNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 53/294 (18%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ-----EMALIARV 62
Y+I+ +IG G F + R K Y +K ++ + +S Q E+ + R+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK------KHFKSLEQVNNLREIQALRRL 54
Query: 63 Q-HPYIVEFKEAWVEK--GCYVCIVTGYCEGGDMA--ELMKKSNGAYFPEEKLCKWFAQL 117
HP I+ E ++ G + E DM EL+K PE+++ + QL
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALV----FELMDMNLYELIKGRK-RPLPEKRVKSYMYQL 109
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
L ++D++H N + HRD+K NI L KD ++L DFG + + + + + T Y PE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENI-LIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168
Query: 178 -LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----------------- 219
LL D YG K DIW++GC +E+ + P F + I+KI
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228
Query: 220 ---------NRSSIG---PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
++ G LP+ S L+K +L +P+ R +A + L+HP+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNA-SAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 2e-33
Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 16/260 (6%)
Query: 9 EIMEQIGRGAFGA---AILVNHRAEKKKYVL-KKIRLARQTERCRRSAHQEMALIARVQH 64
+ +++G GAFG L +KK V K ++ +E+ +E ++ ++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK-EDASEQQIEEFLREARIMRKLDH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P +V+ + + IV Y EGGD+ ++K+ L + Q+ ++YL
Sbjct: 61 PNVVKLL-GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYL 118
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NYMCPELLADI 182
S +HRDL N + ++ V++ DFGL++ L DD G P +M PE L +
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 183 PYGFKSDIWSLGCCMYEMAAH----RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ KSD+WS G ++E+ P ++ + R P P+C P L L
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ-P-PNC-PPELYDL 235
Query: 239 IKGMLRKNPEHRPSASELLK 258
+ ++PE RP+ SEL++
Sbjct: 236 MLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 16/260 (6%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ--HPYIV 68
++ I +GAFG+ L R+ + +K ++ + + + + + I +Q PY+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
+ ++ K Y+ +V Y GGD A L+K PE+ ++ A+++L V+ LH
Sbjct: 61 KLYYSFQSKD-YLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKS 188
++HRD+K N+ + + ++L DFGL+ + VGTP+Y+ PE + + S
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 189 DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----PLPSCYSPSLKTLIKGMLR 244
D WSLGC ++E P F A + I I C SP LI +L
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC-SPEAVDLINRLLC 233
Query: 245 KNPEHRPSAS---ELLKHPF 261
+P R A+ E+ HPF
Sbjct: 234 MDPAKRLGANGYQEIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 88/261 (33%), Positives = 133/261 (50%), Gaps = 21/261 (8%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQ--EMALIARVQHPYI 67
+G+G FG ILV +A + Y +K +R +A+ AH E ++ +HP++
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-----EVAHTVTESRVLQNTRHPFL 57
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
K A+ + +C V Y GG++ S F EE+ + A+++ A++YLHS
Sbjct: 58 TALKYAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR 114
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLADIPYGF 186
V++RD+K N+ L KD +++ DFGL K +D + GTP Y+ PE+L D YG
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
D W LG MYEM R F D L I I P SP K+L+ G+L+K+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKD 233
Query: 247 PEHR----PS-ASELLKHPFL 262
P+ R PS A E+++H F
Sbjct: 234 PKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 37/288 (12%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ---EMALIARV 62
+ +E ++ I GA+GA LV H+ ++++ +KKI +Q R Q E ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFA 58
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
++P++V ++ E ++C+V Y EGGD A L+K N P + +FA+ +LA++
Sbjct: 59 ENPFVVSMFCSF-ETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALE 115
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-------------LKADD---LASS 166
YLH+ ++HRDLK N+ +T ++L DFGL+K ++ D L
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISK-INRSSIG 225
V GTP Y+ PE++ YG D W++G +YE F L + I+
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235
Query: 226 P-----LPSCYSPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQHF 265
P LP + LI +LR+NP R A E+ +H F
Sbjct: 236 PEGDEALP----ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 87/324 (26%), Positives = 134/324 (41%), Gaps = 65/324 (20%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPY 66
YE+++ IG GA+G + +K +KKI +R +E+ L+ ++H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHEN 60
Query: 67 IV------------EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
I+ +F + V IVT E D+ +++K + ++F
Sbjct: 61 IIGLLDILRPPSPEDFND--------VYIVTELMET-DLHKVIKSPQ---PLTDDHIQYF 108
Query: 115 -AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV----VG 169
Q+L + YLHS V+HRDLK SNI + + D+++ DFGLA+ + D+ V
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 170 TPNYMCPEL-LADIPYGFKSDIWSLGCCMYEMAAHRPAFK-------------------A 209
T Y PEL L+ Y DIWS+GC E+ +P F
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 210 FDMAGLISKINRSSIGPLPSCYSPSLKTLIKG-----------MLRKNPEHRPSASELLK 258
D+ + S+ R+ + LP L L G ML +P+ R +A E L
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 259 HPFLQHFVDQYRPTFPPAACSPEK 282
HP+L D P P A P
Sbjct: 289 HPYLAQLHD---PEDEPVAKPPFD 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 84/295 (28%), Positives = 128/295 (43%), Gaps = 46/295 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKK----YVLKKIRLARQTERCRRSAHQEMALIAR 61
D+YE + +I G +G V +RA KK LKK+++ ++ E ++ +E+ ++ +
Sbjct: 5 DEYEKLNRIEEGTYG----VVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK 60
Query: 62 VQHPYIVEFKEAWVEKGC-YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
+QHP IV KE V + +V Y E D+ LM+ + E C QLL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSG 118
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK--ADDLASSVVGTPNYMCPEL 178
V +LH N++LHRDLK SN+ L +++ DFGLA+ VV T Y PEL
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPEL 177
Query: 179 LADIP-YGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGL------------ 215
L Y D+WS+GC E+ +P F K F + G
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 216 ----ISKINRSSIGPLPSCYSPSLKT-----LIKGMLRKNPEHRPSASELLKHPF 261
+ L + + L+ +L +P R SA + LKHP+
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 31/289 (10%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIARVQHPYIVE 69
+GRG FG +L ++ + Y +K ++ +AR + +HP++V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 70 FKEAWVEKGCY-----VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
C+ VC V Y GGD LM + F E + + A ++L + YL
Sbjct: 67 LF------ACFQTEDHVCFVMEYAAGGD---LMMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIP 183
H N +++RDLK N+ L + V++ DFGL K + D S+ GTP ++ PE+L +
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS 177
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243
Y D W LG +YEM F D + I + P S ++++ +L
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRLL 236
Query: 244 RKNPEHRPSASE-----LLKHPFLQH------FVDQYRPTFPPAACSPE 281
R+NPE R + E + K PF + + +P F P PE
Sbjct: 237 RRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPE 285
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 80/271 (29%), Positives = 137/271 (50%), Gaps = 16/271 (5%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
+E+IG+G+FG ++ +K I L + E QE+ ++++ PY+ ++
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
+++ KG + I+ Y GG +L++ F E ++ ++L +DYLHS +
Sbjct: 68 YGSYL-KGTKLWIIMEYLGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLADIPYGFKSD 189
HRD+K +N+ L++ DV+L DFG+A L + ++ VGTP +M PE++ Y K+D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 190 IWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249
IWSLG E+A P ++ I +++ L +S K I L K+P
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSF 243
Query: 250 RPSASELLKHPF----------LQHFVDQYR 270
RP+A ELLKH F L +D+++
Sbjct: 244 RPTAKELLKHKFIVKNAKKTSYLTELIDRFK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 87/279 (31%), Positives = 133/279 (47%), Gaps = 19/279 (6%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRS-AHQEMALIARVQHPYIVEFKE 72
IG+G+FG + V R ++ Y LK IR A R + E ++A+V P+IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132
++ + +V + GG++ +++ F + + A+LL A++ LH V++R
Sbjct: 61 SFQSPE-KLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 133 DLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIW 191
DLK NI L + L DFGL K +K DD ++ GTP Y+ PELL Y D W
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 192 SLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIKGMLRKNPEH 249
+LG +YEM P F ++ + KI + PL P + K L+ G+L ++P
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQE---PLRFPDGFDRDAKDLLIGLLSRDPTR 234
Query: 250 R---PSASELLKHPFLQH------FVDQYRPTFPPAACS 279
R A E+ HPF + +P F PA S
Sbjct: 235 RLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSS 273
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 81/268 (30%), Positives = 130/268 (48%), Gaps = 25/268 (9%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQHPY 66
+ + +IG G+FGA + +KK+ + +Q+ + +E+ + +++HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 67 IVEFKEAWVEKGCYV-----CIVTGYCEG--GDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
+E+K GCY+ +V YC G D+ E+ KK E ++ L
Sbjct: 77 TIEYK------GCYLREHTAWLVMEYCLGSASDILEVHKKP----LQEVEIAAICHGALQ 126
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELL 179
+ YLHS+ +HRD+K NI LT+ V+L DFG A + A+S VGTP +M PE++
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSFVGTPYWMAPEVI 183
Query: 180 ADI---PYGFKSDIWSLGCCMYEMAAHRPA-FKAFDMAGLISKINRSSIGPLPSCYSPSL 235
+ Y K D+WSLG E+A +P F M+ L S + +S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ + L+K P+ RPS+ ELLKH F+
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 39/295 (13%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCR-RSAHQEMALIARVQH 64
++ ++ +G+G G LV + K + LK + +R + + E ++A + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P++ A + Y+C+V YC GG++ L+++ G EE + A++LLA++YL
Sbjct: 61 PFLPTL-YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA----------------------DD 162
H +++RDLK NI L + + L DF L+K +
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 163 LAS--------SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG 214
S S VGT Y+ PE+++ +G D W+LG +YEM FK +
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 215 LISKINRSSIGPLPS--CYSPSLKTLIKGMLRKNPEHR----PSASELLKHPFLQ 263
S I + + P S S + LI+ +L K+P R A+E+ +HPF +
Sbjct: 240 TFSNILKKEV-TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 19/283 (6%)
Query: 14 IGRGAFGAAILVNHRAEKKK---YVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
+G+G+FG LV Y +K ++ A R R E ++A V HP+IV+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
A+ +G + ++ + GGD+ + S F EE + + A+L LA+D+LHS ++
Sbjct: 64 HYAFQTEG-KLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPELLADIPYGFKSD 189
+RDLK NI L ++ ++L DFGL+K ++ + A S GT YM PE++ + +D
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 180
Query: 190 IWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249
WS G M+EM F+ D ++ I ++ +G +P SP ++L++ + ++NP +
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-MPQFLSPEAQSLLRALFKRNPAN 239
Query: 250 RPSAS-----ELLKHPFLQH------FVDQYRPTFPPAACSPE 281
R A E+ +HPF + + +P F PA P+
Sbjct: 240 RLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPD 282
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 99/317 (31%), Positives = 148/317 (46%), Gaps = 29/317 (9%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQ--EMALIARVQHPYIV 68
+G+G FG ILV +A + Y +LKK + + E AH E ++ +HP++
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----VAHTLTENRVLQNSRHPFLT 58
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
K ++ + +C V Y GG++ S F E++ + A+++ A+DYLHS
Sbjct: 59 ALKYSF-QTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 129 -VLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGF 186
V++RDLK N+ L KD +++ DFGL K +K + GTP Y+ PE+L D YG
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
D W LG MYEM R F D L I I P SP K+L+ G+L+K+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLSPEAKSLLSGLLKKD 234
Query: 247 PEHR-----PSASELLKHPFLQHFV--DQYRPTFPPAACSPEKPISIAHESRRCMAE--- 296
P+ R A E+++H F V D Y P P KP + R E
Sbjct: 235 PKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP----PFKPQVTSETDTRYFDEEFT 290
Query: 297 SQNSSSSASDKDSLRSG 313
+Q + + D+D
Sbjct: 291 AQMITITPPDQDDSMET 307
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 27/288 (9%)
Query: 14 IGRGAFGAAILV--NHRAEKKKY----VLKKIRLARQTERCRRSAHQ--EMALIARVQHP 65
+G+G +G V A+ K VLKK + R + +AH E ++ V+HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ---KDTAHTKAERNILEAVKHP 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+IV+ A+ + G + ++ Y GG++ M F E+ C + +++ LA+++LH
Sbjct: 61 FIVDLIYAF-QTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPELLADIPY 184
+++RDLK NI L V+L DFGL K ++ + + GT YM PE+L +
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G D WSLG MY+M P F A + I KI + + LP +P + L+K +L+
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN-LPPYLTPEARDLLKKLLK 236
Query: 245 KNPEHR----PS-ASELLKHPFLQH------FVDQYRPTFPPAACSPE 281
+NP R P A+E+ HPF +H + P F P S E
Sbjct: 237 RNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEE 284
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 31/275 (11%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL-----IAR 61
Y ++ G+G FG RA K Y KK+ + +R ++ + MAL + +
Sbjct: 4 HYRVL---GKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGEAMALNEKQILEK 56
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
V ++V A+ K +C+V GGD+ + F EE+ + A++ +
Sbjct: 57 VNSRFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
+ LH +++RDLK NI L +R+ D GLA + + VGT YM PE++ +
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--------PSCYSP 233
Y F D W LGC +YEM + F+ K+ R + +S
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKEDQEEYSEKFSE 230
Query: 234 SLKTLIKGMLRKNPEHR-----PSASELLKHPFLQ 263
+ +++ + +L K+P R A E+ HPF +
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 8e-32
Identities = 85/259 (32%), Positives = 136/259 (52%), Gaps = 12/259 (4%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRL---ARQTERCRRSAHQEMALIARVQHPYIVEF 70
+G+GAFG L ++ K+++ + +T + + E+ L+ +QH IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 71 KEAWVEKG-CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
++ + I Y GG + + +K + GA E K+ Q+L + YLHSN +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGA-LTESVTRKYTRQILEGMSYLHSNMI 127
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS----SVVGTPNYMCPELLADIPYG 185
+HRD+K +NI +V+LGDFG +K L+ ++ SV GTP +M PE+++ YG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTLIKGMLR 244
K+D+WSLGC + EM +P + ++ I KI P LPS S + + G +
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIF 246
Query: 245 KNPEHRPSASELLKHPFLQ 263
HRPSA ELL+HPF Q
Sbjct: 247 VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 9e-32
Identities = 93/283 (32%), Positives = 135/283 (47%), Gaps = 25/283 (8%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQ--EMALIARVQHPYIV 68
+G+G FG ILV +A K Y +LKK + + E AH E ++ +HP++
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE----VAHTLTESRVLKNTRHPFLT 58
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
K ++ K +C V Y GG++ S F E++ + A+++ A+DYLHS
Sbjct: 59 SLKYSFQTKD-RLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLADIPYGFK 187
+++RDLK N+ L KD +++ DFGL K D + GTP Y+ PE+L D YG
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247
D W LG MYEM R F D L I I P S K+L+ G+L K+P
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-KFPRTLSADAKSLLSGLLIKDP 234
Query: 248 EHR-----PSASELLKHPFLQ--HFVDQYR----PTFPPAACS 279
R A E+++H F ++ D Y P F P S
Sbjct: 235 NKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTS 277
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 78/254 (30%), Positives = 133/254 (52%), Gaps = 8/254 (3%)
Query: 11 MEQIGRGAFGAAIL-VNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE 69
+E+IG+G+FG +++R +K V KI + E QE+ ++++ PY+ +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
+ +++ K + I+ Y GG +L++ E ++ ++L +DYLHS
Sbjct: 67 YYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 122
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV-VGTPNYMCPELLADIPYGFKS 188
+HRD+K +N+ L++ +V+L DFG+A L + + VGTP +M PE++ Y K+
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 189 DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
DIWSLG E+A P ++ I +++ L YS LK ++ L K P
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242
Query: 249 HRPSASELLKHPFL 262
RP+A ELLKH F+
Sbjct: 243 FRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 74/250 (29%), Positives = 118/250 (47%), Gaps = 29/250 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKK------IRLARQTERCRRSAHQEMALI 59
D E ++ +G G FG LV R + Y LK IRL +Q + H E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-KQEQH----VHNEKRVL 55
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK------KSNGAYFPEEKLCKW 113
V HP+I+ ++ ++ ++ Y GG++ ++ S G ++ E +C
Sbjct: 56 KEVSHPFIIRLFWTEHDQR-FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC-- 112
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNY 173
A++YLHS +++RDLK NI L K+ ++L DFG AK L+ D ++ GTP Y
Sbjct: 113 ------ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEY 164
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233
+ PE++ + D W+LG +YEM P F + G+ KI + P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFPRHLDL 223
Query: 234 SLKTLIKGML 243
K LIK +L
Sbjct: 224 YAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 86/255 (33%), Positives = 140/255 (54%), Gaps = 13/255 (5%)
Query: 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKE 72
+IG G+ G + ++ K +KK+ L +Q R E+ ++ QH +VE
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 84
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132
+++ G + +V + EGG + +++ + EE++ +L A+ LH+ V+HR
Sbjct: 85 SYL-VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 133 DLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIW 191
D+K +I LT D V+L DFG A+ K S+VGTP +M PEL++ +PYG + DIW
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 192 SLGCCMYEMAAHRPAFKAFDMAGLIS-KINRSSIGP-LPSCY--SPSLKTLIKGMLRKNP 247
SLG + EM P + F+ L + K+ R ++ P L + + SPSLK + +L ++P
Sbjct: 201 SLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258
Query: 248 EHRPSASELLKHPFL 262
R +A+ELLKHPFL
Sbjct: 259 AQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 77/269 (28%), Positives = 138/269 (51%), Gaps = 16/269 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D+ E+++++G+G +G+ V HR +K+IRL E E+ ++ + P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSP 59
Query: 66 YIVEFKEAWVEKGC-YVCIVTGYCEGGDMAELMKKSNGAY-FPEEKLCKWFAQLLLAVDY 123
YIV+F A+ +G Y+C+ Y + G + +L PE+ L + ++ + +
Sbjct: 60 YIVDFYGAFFIEGAVYMCM--EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 124 LHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELL--- 179
L + ++HRD+K +N+ + + V+L DFG++ L A LA + +G +YM PE +
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSG 176
Query: 180 ---ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSP 233
+ Y +SD+WSLG + EMA R + A + ++++ G LPS YS
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFL 262
+ + L K P RP+ ++LL+HP+L
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 87/306 (28%), Positives = 127/306 (41%), Gaps = 58/306 (18%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+YE + +IG+G FG H+ K+ LKK+ + + E +A +E+ ++ ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 66 YIVEFKE-----AWVEKGCYVCI--VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+V E A V +CE D+A L+ N F ++ K LL
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLL 129
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL---KADD--LASSVVGTPNY 173
+ Y+H N +LHRD+K +NI +TKD ++L DFGLA+ K ++ V T Y
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 174 MCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG--------LISKINRSSI 224
PE LL + YG D+W GC M EM P M G LIS++ SI
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI-----MQGNTEQHQLTLISQL-CGSI 243
Query: 225 GP----------------LPSCYSPSLKT-------------LIKGMLRKNPEHRPSASE 255
P LP +K LI +L +P R A
Sbjct: 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303
Query: 256 LLKHPF 261
L H F
Sbjct: 304 ALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 83/263 (31%), Positives = 125/263 (47%), Gaps = 15/263 (5%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHPYIVEFKE 72
+G+G FG RA K Y KK+ R +R A E ++A+V +IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
A+ K +C+V GGD+ + FPE + C + AQ++ +++LH ++
Sbjct: 61 AFQTK-TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVGTPNYMCPELLADIPYGFKSD 189
+RDLK N+ L D +VR+ D GLA LK GTP +M PELL Y F D
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD 179
Query: 190 IWSLGCCMYEMAAHRPAFKA----FDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245
++LG +YEM A R F+A + L +I S+ P +SP+ K+ + +L K
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-TYPDKFSPASKSFCEALLAK 238
Query: 246 NPEHR-----PSASELLKHPFLQ 263
+PE R + L HP +
Sbjct: 239 DPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 94/297 (31%), Positives = 149/297 (50%), Gaps = 33/297 (11%)
Query: 2 ESRM--DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH----QE 55
+ RM + +++++ IGRGAFG LV H++ K+ Y +K L + E +RS +E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK---LLSKFEMIKRSDSAFFWEE 93
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF- 114
++A +IV+ A+ + Y+ +V Y GGD+ LM Y EK +++
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDK-YLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYT 148
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPN 172
A+++LA+D +HS +HRD+K N+ L K ++L DFG + A+ + + VGTP+
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208
Query: 173 YMCPELL----ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI--NRSSIG- 225
Y+ PE+L D YG + D WS+G +YEM F A + G SKI +++S+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268
Query: 226 PLPSCYSPSLKTLIKGMLRKNPEH--RPSASELLKHPFLQHFVDQY-----RPTFPP 275
P S K LI L R E+ HPF ++ DQ+ R T P
Sbjct: 269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN--DQWTFDNIRETVAP 323
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 83/261 (31%), Positives = 129/261 (49%), Gaps = 23/261 (8%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMA----LIARVQHPYIV- 68
IG+G+FG +L H+A+ K Y +K L ++ ++ MA L+ V+HP++V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 69 ---EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
F+ A +K + V Y GG++ +++ FPE + + A++ A+ YLH
Sbjct: 61 LHYSFQTA--DK---LYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH 113
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPY 184
S +++RDLK NI L V L DFGL K ++ S+ GTP Y+ PE+L PY
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
D W LG +YEM P F + D A + I + L S S + L++G+L+
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR-LKPNISVSARHLLEGLLQ 232
Query: 245 KNPEHRPSAS----ELLKHPF 261
K+ R A E+ H F
Sbjct: 233 KDRTKRLGAKDDFLEIKNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 91/306 (29%), Positives = 143/306 (46%), Gaps = 42/306 (13%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
++E + +IG G +G + LKK+R+ + + S+ +E+ L+ ++HP
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 67 IVEFKEAWVEKGC-YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IVE KE V K + +V YCE D+A L+ + F E ++ QLL + YLH
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLD-NMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT--LKADDLASSVVGTPNYMCPELL-ADI 182
N+++HRDLK SN+ LT +++ DFGLA+T L A + VV T Y PELL
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCT 184
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKA------FDM-AGLISKINRSSIGP----LPSCY 231
Y D+W++GC + E+ AH+P D+ L+ N SI P LP
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPLVG 243
Query: 232 SPSLK-------------------TLIKGMLRKNPEHRPSASELLKHPFLQ---HFVD-Q 268
+L L+ +L +P+ R +A E L+ + + + +
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPE 303
Query: 269 YRPTFP 274
PTFP
Sbjct: 304 MMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 79/257 (30%), Positives = 130/257 (50%), Gaps = 17/257 (6%)
Query: 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE-FK 71
+IG G+ G + + ++ +K + L +Q R E+ ++ QH +VE +K
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHQNVVEMYK 85
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
V + +V + + +GG + +++ ++ EE++ +L A+ YLHS V+H
Sbjct: 86 SYLVGEELWV--LMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIH 140
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADIPYGFKSDI 190
RD+K +I LT D V+L DFG + D S+VGTP +M PE+++ PYG + DI
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 191 WSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC-----YSPSLKTLIKGMLRK 245
WSLG + EM P + + + + R P P SP L+ ++ ML +
Sbjct: 201 WSLGIMVIEMVDGEPPYFS---DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 246 NPEHRPSASELLKHPFL 262
P+ R +A ELL HPFL
Sbjct: 258 EPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 21/279 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ--EMALIARV---QHPYIV 68
IG+G FG V + ++ Y +K + ++ + AH E ++ R + P+IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-KKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
K ++ + + +VT Y GG++ ++K F E++ + A+L+LA+++LH
Sbjct: 60 GLKFSF-QTDSDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPE-LLADIPYGF 186
+++RDLK NI L + L DFGL+K L + ++ GT Y+ PE LL + Y
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
D WSLG ++EM F A D + I + + S + +KG+L +N
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN 236
Query: 247 PEHR----PSASELLKHPFLQH------FVDQYRPTFPP 275
P+HR A EL +HPF Q P F P
Sbjct: 237 PQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-30
Identities = 81/277 (29%), Positives = 141/277 (50%), Gaps = 14/277 (5%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
+ +Y I +G GA G + ++ + + +K + + +E + A E+ +
Sbjct: 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC 88
Query: 63 QHPYIVEFKEAWVEKG-------CYVCIVTGYCEGGDMAELMK---KSNGAYFPEEKLCK 112
IV+ E + +K + +V Y GD+ + +K K+N F E +
Sbjct: 89 DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT-FREHEAGL 147
Query: 113 WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA---DDLASSVVG 169
F Q+LLAV ++HS +++HRD+K +NI L + V+LGDFG +K A DD+ + G
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS 229
TP Y+ PE+ PY K+D++SLG +YE+ + F +M ++ K PLP
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267
Query: 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266
SP ++ ++ +L +P+ RPS+S+LL P + F+
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304
|
Length = 496 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 45/303 (14%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
+ +D+++I+ QIG G +G + + LKK+RL + E +A +E+ ++ +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 62 VQHPYIVEFKEAWV----------EKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLC 111
+ H IV KE +KG + +V Y + M L +S +F E+ +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFY-LVFEYMDHDLMGLL--ESGLVHFSEDHIK 119
Query: 112 KWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LASSVVG 169
+ QLL ++Y H LHRD+KCSNI L ++L DFGLA+ +++ ++ V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 170 TPNYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP 228
T Y PE LL + YG D+WS GC + E+ +P F+A + I+R P P
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 229 SCYS-----PSLKT------------------------LIKGMLRKNPEHRPSASELLKH 259
+ + P T L+ ML +P R +A E L
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 260 PFL 262
P+L
Sbjct: 300 PWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 22/265 (8%)
Query: 12 EQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
+++G GAFG L + + +K ++ +E R+ +E ++ ++ HP +V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA-SEEERKDFLKEARVMKKLGHPNVV 59
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS-------NGAYFPEEKLCKWFAQLLLAV 121
+ + +V Y EGGD+ + ++KS + + L + Q+ +
Sbjct: 60 RL-LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP---NYMCPEL 178
+YL S +HRDL N + +D V++ DFGL++ + DD G +M PE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHR----PAFKAFDMAGLISKINRSSIGPLPSCYSPS 234
L D + KSD+WS G ++E+ P ++ + K R P P
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEYCPDE 235
Query: 235 LKTLIKGMLRKNPEHRPSASELLKH 259
L L+ + +PE RP+ SEL++
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 82/281 (29%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKK-IRLARQTERCRRSAHQEMALIARVQHPYIVE 69
+G+G+FG +L + + Y VLKK + L C + + +AL A+ HP++
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
+ K + V Y GGD+ +++S F E + + A++ LA+ +LH + V
Sbjct: 61 LHCCFQTKD-RLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGV 117
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGFKS 188
++RDLK NI L + +L DFG+ K + ++ GTP+Y+ PE+L ++ YG
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 189 DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
D W+LG MYEM A +P F+A + L I + P S +++K + KNP
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPN 236
Query: 249 HR----PSAS---ELLKHPFLQHFVD-------QYRPTFPP 275
R S + +HPF + +D + +P F P
Sbjct: 237 KRLGCVASQGGEDAIKQHPFFKE-IDWVLLEQRKIKPPFKP 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-29
Identities = 92/285 (32%), Positives = 146/285 (51%), Gaps = 26/285 (9%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH----QEM 56
+ + + YE+++ IGRGAFG LV H++ +K Y +K L + E +RS +E
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK---LLSKFEMIKRSDSAFFWEER 94
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF-A 115
++A P++V+ A+ + Y+ +V Y GGD+ LM SN Y EK +++ A
Sbjct: 95 DIMAFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLM--SN--YDVPEKWARFYTA 149
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA--SSVVGTPNY 173
+++LA+D +HS +HRD+K N+ L K ++L DFG + + + + VGTP+Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 174 MCPELL----ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI---NRSSIGP 226
+ PE+L D YG + D WS+G +YEM F A + G SKI S P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269
Query: 227 LPSCYSPSLKTLIKGML--RKNPEHRPSASELLKHPFLQHFVDQY 269
+ S K LI L R+ R E+ +H F ++ DQ+
Sbjct: 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN--DQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 23/272 (8%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRS-AHQEMALIARVQHP 65
QY ++ G+G FG RA K Y K++ R +R S A E ++ +V
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++V A+ K +C+V GGD+ + F EE+ + A++L ++ LH
Sbjct: 61 FVVNLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYG 185
++RDLK NI L +R+ D GLA + + VGT YM PE+L + Y
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--------PLPSCYSPSLKT 237
D W LGC +YEM + F+ K+ R + + +S K+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRK-----EKVKREEVDRRVLETEEVYSAKFSEEAKS 234
Query: 238 LIKGMLRKNPEHR-----PSASELLKHPFLQH 264
+ K +L K+P+ R A E+ +HPF ++
Sbjct: 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 96/316 (30%), Positives = 153/316 (48%), Gaps = 15/316 (4%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
R Y + +GR AA + ++ K+ V+ K + ER A E+ +A
Sbjct: 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACD 123
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFP--EEKLCKWFAQLLLAV 121
H IV+ + + + I+ Y GGD+ + +K+ + P E ++ F Q++LA+
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIME-YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD---DLASSVVGTPNYMCPEL 178
D +HS ++HRDLK +NIFL ++LGDFG +K D+ASS GTP Y+ PEL
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL 242
Query: 179 LADIPYGFKSDIWSLGCCMYE-MAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
Y K+D+WSLG +YE + HRP FK ++ ++ P P S +K
Sbjct: 243 WERKRYSKKADMWSLGVILYELLTLHRP-FKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAES 297
L+ +L KNP RP+ +LL FL++ + ++ + IS H+ + +
Sbjct: 302 LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDI-----VRHSETIS-PHDREEILRQL 355
Query: 298 QNSSSSASDKDSLRSG 313
Q S A S+R G
Sbjct: 356 QESGERAPPPSSIRYG 371
|
Length = 478 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRL---ARQTERCRRSAHQEMALIARVQHPYIVEF 70
+G+GAFG L ++ +K+++ + +T + + E+ L+ + H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 71 KEAWVEKGCY-------VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
GC + I + GG + + +K S GA E K+ Q+L V Y
Sbjct: 70 Y------GCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGA-LTENVTRKYTRQILEGVSY 121
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS----SVVGTPNYMCPELL 179
LHSN ++HRD+K +NI +V+LGDFG +K L+ L+ SV GTP +M PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTL 238
+ YG K+DIWS+GC + EM +P + F+ I KI P LP S +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQ 263
+K + + + RPSA ELL+H F+
Sbjct: 242 LKRIFVE-AKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 80/264 (30%), Positives = 138/264 (52%), Gaps = 19/264 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRL-ARQTERCRRSA------HQEMALIARVQHPY 66
IG G+FG+ L + + + +K++ L + R +E+AL+ +QH
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLLAVDYLH 125
IV++ + ++ ++ I Y GG +A L+ GA+ EE L + F Q+L ++YLH
Sbjct: 68 IVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNY-GAF--EETLVRNFVRQILKGLNYLH 123
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-------SVVGTPNYMCPEL 178
+ ++HRD+K +NI + +++ DFG++K L+A+ L++ S+ G+ +M PE+
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ Y K+DIWSLGC + EM + F I KI ++ +PS S
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDF 243
Query: 239 IKGMLRKNPEHRPSASELLKHPFL 262
++ + RP+A+ELLKHPFL
Sbjct: 244 LEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRS-AHQEMALIARVQHP 65
QY ++ G+G FG RA K Y KK+ R +R S A E ++ +V
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++V A+ K +C+V GGD+ + A F E + + A++ ++ LH
Sbjct: 61 FVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYG 185
+++RDLK NI L +R+ D GLA + VGT YM PE++ + Y
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--------PSCYSPSLKT 237
F D W+LGC +YEM A + F+ KI R + L +SP ++
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARS 234
Query: 238 LIKGMLRKNPEHR-----PSASELLKHPFLQHF 265
L K +L K+P+ R A E+ +HP +
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 92/285 (32%), Positives = 151/285 (52%), Gaps = 26/285 (9%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH----QEM 56
++ + + Y++++ IGRGAFG LV H++ +K Y +K L + E +RS +E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMK---LLSKFEMIKRSDSAFFWEER 94
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF-A 115
++A P++V+ A+ + Y+ +V Y GGD+ LM SN Y EK K++ A
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDK-YLYMVMEYMPGGDLVNLM--SN--YDVPEKWAKFYTA 149
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA--SSVVGTPNY 173
+++LA+D +HS ++HRD+K N+ L K ++L DFG + + + VGTP+Y
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209
Query: 174 MCPELL----ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI--NRSSIG-P 226
+ PE+L D YG + D WS+G ++EM F A + G SKI +++S+ P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269
Query: 227 LPSCYSPSLKTLIKGML--RKNPEHRPSASELLKHPFLQHFVDQY 269
S K LI L R+ R E+ +HPF ++ DQ+
Sbjct: 270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN--DQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 71/230 (30%), Positives = 126/230 (54%), Gaps = 14/230 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+++E++ +G GA+G + H+ K+ +KK + + + E + + +E+ ++ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK-SNGAYFPEEKLCKWFAQLLLAVDYL 124
IVE KEA+ +G + +V Y E +M EL+++ NG P EK+ + QL+ A+ +
Sbjct: 61 NIVELKEAFRRRG-KLYLVFEYVEK-NMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWC 116
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA--SSVVGTPNYMCPELLADI 182
H N ++HRD+K N+ ++ + ++L DFG A+ L A + V T Y PELL
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKINRSSIGPLPS 229
PYG D+WS+GC + E++ +P F D I K+ +GPLP+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKV----LGPLPA 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-29
Identities = 91/293 (31%), Positives = 150/293 (51%), Gaps = 31/293 (10%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
ESR+++YE++++IG G FG LV H+ ++ + K I ER + E+ ++
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 62 VQHPYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMKKSNGAY--FPEEKLCKWFAQLL 118
++H IV + + ++ K + I+ +C+ GD++ ++K + E + QLL
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 119 LAVDYLHS-------NYVLHRDLKCSNIFLTKDQD-----------------VRLGDFGL 154
A+ Y H+ VLHRDLK NIFL+ ++GDFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 155 AKTLKADDLASSVVGTPNYMCPELL--ADIPYGFKSDIWSLGCCMYEMAAHRPAF-KAFD 211
+K + + +A S VGTP Y PELL Y KSD+W+LGC +YE+ + + F KA +
Sbjct: 189 SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248
Query: 212 MAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
+ LIS++ R P+ S L LIK +L + + RPSA + L + +++
Sbjct: 249 FSQLISELKRGPDLPIKG-KSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 79/263 (30%), Positives = 135/263 (51%), Gaps = 24/263 (9%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRL---ARQTERCRRSAHQEMALIARVQHPYIVEF 70
+GRGAFG L ++ +K++ +++T + + E+ L+ ++H IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 71 KEAWVEKGCY-------VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
GC + I Y GG + + +K + GA E ++ Q+L V Y
Sbjct: 70 Y------GCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGA-LTENVTRRYTRQILQGVSY 121
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA----SSVVGTPNYMCPELL 179
LHSN ++HRD+K +NI +V+LGDFG +K ++ ++ SV GTP +M PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTL 238
+ YG K+D+WS+ C + EM +P + ++ I KI P LP S + +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241
Query: 239 IKGMLRKNPEHRPSASELLKHPF 261
+K + + + RP+A LL+HPF
Sbjct: 242 LKQIFVEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 52/299 (17%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARVQHPYIVEFK 71
IGRG++ +LV + ++ Y +K I+ L E ++ HP++V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV--- 59
Query: 72 EAWVEKGCYVC--------IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
G + C V + GGD+ M++ PEE + A++ LA+++
Sbjct: 60 ------GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNF 111
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADI 182
LH +++RDLK N+ L + ++L D+G+ K ++ D S+ GTPNY+ PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG------------LISKINRSSIGPLPSC 230
YGF D W+LG M+EM A R FD+ G L I I +P
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGR---SPFDIVGMSDNPDQNTEDYLFQVILEKQI-RIPRS 227
Query: 231 YSPSLKTLIKGMLRKNPEHR------PSASELLKHPFLQHFVD-------QYRPTFPPA 276
S +++KG L K+P+ R ++ HPF + +D Q P + P
Sbjct: 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR-NIDWDLLEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 73/267 (27%), Positives = 135/267 (50%), Gaps = 18/267 (6%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH--QEMALIAR 61
++ +E+ E +G G+FG + H+ + Y +K ++ R+ + ++ H QE +++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-KREILKMKQVQHVAQEKSILME 74
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+ HP+IV ++ ++ V + + GG++ ++K+ FP + + A+L+LA
Sbjct: 75 LSHPFIVNMMCSFQDEN-RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAF 131
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
+YLHS +++RDLK N+ L V++ DFG AK K D ++ GTP Y+ PE++
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQS 189
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPLPSCYSPSLKTLI 239
+G D W++G +YE A P F FD KI + P+ + + L+
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPF--FDDTPFRIYEKILAGRL-KFPNWFDGRARDLV 246
Query: 240 KGMLRKNPEHR----PSASELLK-HPF 261
KG+L+ + R +K HP+
Sbjct: 247 KGLLQTDHTKRLGTLKGGVADVKNHPY 273
|
Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 92/328 (28%), Positives = 138/328 (42%), Gaps = 58/328 (17%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH--QEMALIARVQ 63
D +E ++ IGRGAFG LV + Y +KK+R + E+ + AH E ++A
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-EQVAHVRAERDILAEAD 59
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+P++V+ ++ ++ Y+ ++ Y GGD M LMKK F EE+ + A+ +LA+D
Sbjct: 60 NPWVVKLYYSFQDEN-YLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIAETILAID 115
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--------------------- 161
+H +HRD+K N+ L ++L DFGL LK
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 162 ------------------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH 203
LA S VGTP+Y+ PE+ Y + D WSLG MYEM
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
Query: 204 RPAFKAFDMAGLISKI---NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHR---PSASELL 257
P F + + KI + P SP K LIK + E R +E+
Sbjct: 236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIK 294
Query: 258 KHPFLQHF----VDQYRPTFPPAACSPE 281
HPF + + + P S
Sbjct: 295 SHPFFKGVDWEHIRERPAPIIPELKSIT 322
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 19/274 (6%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEK---KKYVLKKIRLARQTERCRRSAHQ--EMALIARV 62
+E++ +G GA+G LV K Y +K ++ A ++ + + H E ++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 63 QH-PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+ P++V A+ + + ++ Y GG++ + + +F E ++ + A+++LA+
Sbjct: 62 RRCPFLVTLHYAF-QTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLAL 118
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--DLASSVVGTPNYMCPELL 179
D+LH +++RD+K NI L + V L DFGL+K A+ + A S GT YM PE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 180 ADIPYGFKS--DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR---SSIGPLPSCYSPS 234
G D WSLG +E+ F S+I+R S P P S
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238
Query: 235 LKTLIKGMLRKNPEHR---PSASELLKHPFLQHF 265
+ I+ +L K+P+ R A E+ HPF Q
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 80/265 (30%), Positives = 133/265 (50%), Gaps = 25/265 (9%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQHPYIVE 69
+ +IG G+FGA + + +KK+ + +QT + +E+ + +++HP +E
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 70 FKEAWVEKGCYV-----CIVTGYCEGG--DMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+K GCY+ +V YC G D+ E+ KK E ++ L +
Sbjct: 86 YK------GCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLA 135
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
YLHS+ ++HRD+K NI LT+ V+L DFG A A+S VGTP +M PE++ +
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAM 192
Query: 183 ---PYGFKSDIWSLGCCMYEMAAHRPA-FKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
Y K D+WSLG E+A +P F M+ L S + ++ S +
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQ 263
+ L+K P+ RP+++ELL+H F++
Sbjct: 253 VDYCLQKIPQERPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 86/310 (27%), Positives = 132/310 (42%), Gaps = 43/310 (13%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+Y+ +E IG GA+G KK +KKI A + +E+ ++ +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 66 YIVEFKE---AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
I+ ++ V +V E D+ ++ S+ EE + + QLL +
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH-SDQP-LTEEHIRYFLYQLLRGLK 121
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL--KADD---LASSVVGTPNYMCPE 177
Y+HS V+HRDLK SN+ + +D ++R+GDFG+A+ L + + V T Y PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 178 LLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----------------- 219
LL +P Y D+WS+GC EM R F + + I
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 220 --NRSSIGPLPS-----------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266
R I LP SP L+ ML+ +PE R + + L+HPFL +
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
Query: 267 D-QYRPTFPP 275
D PT PP
Sbjct: 302 DPDDEPTCPP 311
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++YE + +IG G++G +R + +KK + ++ A +E+ ++ +++HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V E + K + +V YC+ + EL K G PE + K Q L AV++ H
Sbjct: 61 NLVNLIEVFRRKR-KLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCH 117
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVGTPNYMCPELL-ADIP 183
+ +HRD+K NI +TK ++L DFG A+ L D + V T Y PELL D
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 184 YGFKSDIWSLGCCMYEMAA---------------------------HRPAFKAFDMAGLI 216
YG D+W++GC E+ H+ F +
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237
Query: 217 SKINRSSIGPLPSCY---SPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
S + PL S + S + +KG L+ +P R S ELL+HP+
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 16/268 (5%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPY 66
+E++E +G G +G H K L I++ TE E+ ++ + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRH---VKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRN 74
Query: 67 IVEFKEAWVEKGC-----YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
I + A+++K + +V +C G + +L+K + G E+ + ++L +
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASSVVGTPNYMCPELLA 180
+LH++ V+HRD+K N+ LT++ +V+L DFG++ L + ++ +GTP +M PE++A
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 181 -----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS-CYSPS 234
D Y ++SDIWSLG EMA P + I R+ L S +S
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKK 254
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFL 262
I+G L KN RPS +LLKHPF+
Sbjct: 255 FIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 77/255 (30%), Positives = 133/255 (52%), Gaps = 11/255 (4%)
Query: 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKE 72
+IG G+ G + + K+ +KK+ L +Q R E+ ++ H +V+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR--ELLFNEVVIMRDYHHENVVDMYN 86
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132
+++ G + +V + EGG + +++ + EE++ +L A+ YLH+ V+HR
Sbjct: 87 SYL-VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 133 DLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIW 191
D+K +I LT D ++L DFG A+ K S+VGTP +M PE+++ +PYG + DIW
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 192 SLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCY--SPSLKTLIKGMLRKNPE 248
SLG + EM P + + +I R ++ P + + S L+ + ML + P
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVREPS 261
Query: 249 HRPSASELLKHPFLQ 263
R +A ELL+HPFL+
Sbjct: 262 QRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 42/298 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D+Y+ + +G GA+G +K +KK+ Q+ + ++E+ L+ + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 66 YIVEFKEAW-----VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++ + + +E V +VT G D+ ++K ++ + Q+L
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQILRG 130
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE-LL 179
+ Y+HS ++HRDLK SNI + +D ++++ DFGLA+ DD + V T Y PE +L
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIML 188
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISKIN 220
+ Y DIWS+GC M E+ + F D + + S+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 221 RSSIGPLP-----------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
R+ I LP S +P L++ ML +P+ R +A+E L HP+L + D
Sbjct: 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 78/268 (29%), Positives = 133/268 (49%), Gaps = 16/268 (5%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPY 66
+E++E +G G +G H K L I++ T QE+ ++ + H
Sbjct: 8 FELVELVGNGTYGQVYKGRH---VKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 67 IVEFKEAWVEKGC-----YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
I + A+++K + +V +C G + +L+K + G EE + ++L +
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASSVVGTPNYMCPELLA 180
+LH + V+HRD+K N+ LT++ +V+L DFG++ L + ++ +GTP +M PE++A
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 181 -----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS-CYSPS 234
D Y FKSD+WSLG EMA P + I R+ L S +S
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFL 262
++ I+ L KN RP+ +L+KHPF+
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 23/269 (8%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRL-----ARQTERCR---RSAHQEMALIARVQ 63
E IG+G +G L + + +K++ L R R + ++ E+ + +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLLAVD 122
H IV++ + Y+ I Y GG + ++ F EE+L ++F Q+L +
Sbjct: 67 HLNIVQYL-GFETTEEYLSIFLEYVPGGSIGSCLRTY--GRF-EEQLVRFFTEQVLEGLA 122
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK---ADDLASSVVGTPNYMCPELL 179
YLHS +LHRDLK N+ + D ++ DFG++K +D S+ G+ +M PE++
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 180 ADIPYGF--KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-NRSSIGPLPSCYSPSLK 236
G+ K DIWSLGC + EM A R + + + K+ N+ S P+P S +L
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 237 TLIKGMLRK----NPEHRPSASELLKHPF 261
+ L NP++RP+A ELL+HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIAR 61
D +EI++ IGRGAFG +V + + Y +K + L R C R +E ++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR---EERDVLVN 57
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+I A+ ++ + +V Y GGD+ L+ K PE+ + A+++LA+
Sbjct: 58 GDRRWITNLHYAFQDEN-NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAI 115
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSV-VGTPNYMCPELL 179
D +H +HRD+K N+ L K+ +RL DFG L AD + S+V VGTP+Y+ PE+L
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 180 ADIP-----YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----NRSSIGPLPSC 230
+ YG + D WSLG CMYEM F A + KI P +
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235
Query: 231 YSPSLKTLIKGMLRKNPEHR---PSASELLKHPF 261
S K LI+ ++ +PE R + HPF
Sbjct: 236 VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 15/268 (5%)
Query: 7 QYEIMEQ-----IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
+YE E +G+G +G + + + +K+I + R + H+E+AL +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSY 61
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLLA 120
++H IV++ + E G + I GG ++ L++ G E+ ++ Q+L
Sbjct: 62 LKHRNIVQYLGSDSENG-FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 121 VDYLHSNYVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTLKA-DDLASSVVGTPNYMCPEL 178
+ YLH N ++HRD+K N+ + T V++ DFG +K L + + GT YM PE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 179 LADIP--YGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRSSIGP-LPSCYSPS 234
+ P YG +DIWSLGC + EMA +P F + K+ I P +P S
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFL 262
K I +P+ R SA +LL+ PFL
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 20/280 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIARVQHPYIVE 69
+G+G+FG +L + + + +K ++ L C + +AL +HP++
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW--EHPFLTH 60
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
+ K ++ V Y GGD+ ++ S F E + + A+++ + +LH +
Sbjct: 61 LFCTFQTKE-HLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGI 117
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGFKS 188
++RDLK N+ L KD +++ DFG+ K + + AS+ GTP+Y+ PE+L Y
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 189 DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
D WS G +YEM + F D L I + P S K + + ++P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 249 HR-PSASELLKHPFLQHFVD-------QYRPTFPPAACSP 280
R ++ +HPF + +D + P F P SP
Sbjct: 237 KRLGVDGDIRQHPFFRG-IDWERLEKREIPPPFKPKVKSP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 76/265 (28%), Positives = 128/265 (48%), Gaps = 25/265 (9%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQHPYIVE 69
+ +IG G+FGA + +KK+ + +Q+ + +E+ + +++HP ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 70 FKEAWVEKGCYV-----CIVTGYCEGG--DMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
++ GCY+ +V YC G D+ E+ KK E ++ L +
Sbjct: 80 YR------GCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
YLHS+ ++HRD+K NI L++ V+LGDFG A + A+ VGTP +M PE++ +
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAM 186
Query: 183 ---PYGFKSDIWSLGCCMYEMAAHRPA-FKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
Y K D+WSLG E+A +P F M+ L S +S +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQ 263
+ L+K P+ RP++ LLKH F+
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 11/261 (4%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y E+IG+GA G A ++ +K++ L +Q ++ E+ ++ +HP
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKHPN 77
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
IV + ++++ G + +V Y GG + +++ ++ +C+ + L A+++LHS
Sbjct: 78 IVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---ECLQALEFLHS 133
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLADIPYG 185
N V+HRD+K NI L D V+L DFG + + S++VGTP +M PE++ YG
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 186 FKSDIWSLGCCMYEMAAHRPAF---KAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
K DIWSLG EM P + LI+ + P S + +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRDFLNRC 252
Query: 243 LRKNPEHRPSASELLKHPFLQ 263
L + E R SA ELL+HPFL+
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 25/264 (9%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQHPYIVE 69
+ +IG G+FGA + +KK+ + +Q+ + +E+ + R++HP +E
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 70 FKEAWVEKGCYV-----CIVTGYCEGG--DMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+K GCY+ +V YC G D+ E+ KK E ++ L +
Sbjct: 90 YK------GCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLA 139
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
YLHS+ ++HRD+K NI LT+ V+L DFG A A+S VGTP +M PE++ +
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAM 196
Query: 183 ---PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC-YSPSLKTL 238
Y K D+WSLG E+A +P + + I ++ L S +S +
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256
Query: 239 IKGMLRKNPEHRPSASELLKHPFL 262
+ L+K P+ RP++ ELLKH F+
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 86/289 (29%), Positives = 127/289 (43%), Gaps = 34/289 (11%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ--- 63
QYE + +IG GA+G LK +R+ + S +E+AL+ R++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 64 HPYIVEFKE----AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
HP IV + + ++ V +V + + D+ + K P E + Q L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELL 179
+D+LH+N ++HRDLK NI +T V+L DFGLA+ + VV T Y PE+L
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGL-----------ISK 218
Y D+WS+GC EM +P F K FD+ GL + +
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 219 INRSSIGPLP-SCYSPSLKT----LIKGMLRKNPEHRPSASELLKHPFL 262
S GP P P ++ L+ ML NP R SA L+HPF
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 81/288 (28%), Positives = 123/288 (42%), Gaps = 38/288 (13%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y+ +E+IG G +G + + LKKIRL + E +A +E++L+ + HP I
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V + V + +V + + D+ + M S + + QLL + Y HS+
Sbjct: 61 VRLLDV-VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT----LKADDLASSVVGTPNYMCPE-LLADI 182
VLHRDLK N+ + ++ ++L DFGLA+ ++ VV T Y PE LL
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGSR 175
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGLISKINRSSIGPLPSCYS 232
Y DIWS+GC EM RP F + F G + + LP
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235
Query: 233 --------------PSLKT----LIKGMLRKNPEHRPSASELLKHPFL 262
P+L L+ ML +P R SA L+HP+
Sbjct: 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 89/325 (27%), Positives = 132/325 (40%), Gaps = 80/325 (24%)
Query: 7 QYEIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIR-LARQTERCRRSAHQEMALIARV 62
+YEI IGRG +G A N + + K+Y +KK + Q +SA +E+AL+ +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGK-DGKEYAIKKFKGDKEQYTGISQSACREIALLREL 59
Query: 63 QHPYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMK---KSNGAYFPEEKLCKWFAQLL 118
+H +V E ++E V ++ Y E D+ +++K ++ P + Q+L
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQD----VRLGDFGLA-------KTLKADDLASSV 167
V YLHSN+VLHRDLK +NI + + V++GD GLA K L D V
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PV 175
Query: 168 VGTPNYMCPELLADIPYGFKS-----DIWSLGCCMYEMAAHRPAFKA------------- 209
V T Y PELL G + DIW++GC E+ P FK
Sbjct: 176 VVTIWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 210 ------FDMAG--------------------LISKINRSSIGPLPSCY-------SPSLK 236
F++ G K L S
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 237 TLIKGMLRKNPEHRPSASELLKHPF 261
L K +L +P R +A E L+HP+
Sbjct: 292 LLRK-LLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 79/260 (30%), Positives = 133/260 (51%), Gaps = 9/260 (3%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y E+IG+GA G A ++ +K+I L +Q ++ E+ ++ +++P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEILVMKELKNPN 77
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
IV F ++++ G + +V Y GG + +++ ++ E ++ + L A+++LH+
Sbjct: 78 IVNFLDSFL-VGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA 133
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPELLADIPYG 185
N V+HRD+K N+ L D V+L DFG A+ S++VGTP +M PE++ YG
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIKGML 243
K DIWSLG EM P + + + I + L P SP + + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253
Query: 244 RKNPEHRPSASELLKHPFLQ 263
+ E R SA ELL+HPFL+
Sbjct: 254 EMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 80/310 (25%), Positives = 135/310 (43%), Gaps = 55/310 (17%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
S++ YEI+ ++G G FG + LKKI + + + +A +E+ ++ ++
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 63 QHPYIVEFKEAWVE--------KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
+HP +V + VE +G V +VT Y + D++ L++ + + C +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGS-VYMVTPYMDH-DLSGLLENPSVKLTESQIKC-YM 121
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-------------TLKAD 161
QLL ++YLH N++LHRD+K +NI + +++ DFGLA+
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 162 DLASSVVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAF 210
+ VV T Y PELL + Y DIW +GC EM RP F
Sbjct: 182 KYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 211 DMAGLISKINRSSIGPLPSC--------YSPSLKT-----------LIKGMLRKNPEHRP 251
+ G ++ LP C Y +L+ L+ +L +P R
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300
Query: 252 SASELLKHPF 261
+AS+ L+HP+
Sbjct: 301 TASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 80/275 (29%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D +EI+E IG+G +G V ++ + +K + + + + + + HP
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP--NHP 79
Query: 66 YIVEFKEAWVEKGCYV----CIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLL 119
+V+F + + V +V C GG + EL+K G E + LL
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPEL 178
+ +LH+N ++HRD+K +NI LT + V+L DFG++ L + L ++ VGTP +M PE+
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 179 LA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233
+A D Y + D+WSLG E+ P + KI R+ P P+ P
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTLLHP 256
Query: 234 -----SLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S I L K+ E RPS + LL+HPF++
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 40/278 (14%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH-PYIVE 69
+ +IGRGAFG + H+ +K+IR E+ ++ ++ ++ R PYIV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST-VDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 70 FKEAWVEKG-CYVCIVTGYCEGGDMAELMKKS-----------NGAYFPEEKLCKWFAQL 117
F A +G C++C+ ELM S + PEE L K
Sbjct: 68 FYGALFREGDCWICM-----------ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 118 LLAVDYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV-VGTPNYMC 175
+ A++YL ++HRD+K SNI L ++ +++L DFG++ L D +A + G YM
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMA 175
Query: 176 PELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP---- 228
PE + Y +SD+WSLG +YE+A + + ++ + ++ + G P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSN 233
Query: 229 ---SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+SPS I L K+ RP ELL+HPF++
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 35/288 (12%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++YE + +G G++G + H+ + +KK + + ++ A +E+ ++ +++H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V E + K +V + + + +L K NG E ++ K+ Q+L +++ H
Sbjct: 61 NLVNLIEVFRRKKRLY-LVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH 117
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVGTPNYMCPELL-ADIP 183
S+ ++HRD+K NI +++ V+L DFG A+TL A ++ + V T Y PELL D
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI------------NRSSIGP-- 226
YG DIW++GC + EM P F D I K ++ +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 227 -LPSC------------YSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
LP S + L K LR +P+ RPS+S+LL H F
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 23/284 (8%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAH--QEMALIARVQ 63
++I+ Q+G+G +G L + + LK R+ + + H E ++ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALK--RMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
++V+ A+ + Y+ + Y GGD L+ +N E+ + A++ AVD
Sbjct: 60 SEWLVKLLYAFQDDE-YLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA 116
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
LH +HRDLK N + ++L DFGL+K + A+SVVG+P+YM PE+L
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKG 174
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-------NRSSIGPLPSCYSPSLK 236
Y F D WSLGC +YE P F + R S
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234
Query: 237 TLIKGMLRKNPEHR-PSASELLKHPFLQHF----VDQYRPTFPP 275
LI ++ +P R S ++ HPF + + + +P F P
Sbjct: 235 DLITKLI-NDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVP 277
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 19/265 (7%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFK 71
E +G G G H ++ +K I L E ++ E+ ++ + PYI+ F
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGFY 65
Query: 72 EAW-VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
A+ VE +C T + +GG + ++ +K PE L + ++ + YL S +L
Sbjct: 66 GAFFVENRISIC--TEFMDGGSL-DVYRK-----IPEHVLGRIAVAVVKGLTYLWSLKIL 117
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDI 190
HRD+K SN+ + V+L DFG++ L + +A + VGT YM PE ++ YG SD+
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 191 WSLGCCMYEMAAHR-PAFKAFDMAG------LISKINRSSIGPLP-SCYSPSLKTLIKGM 242
WSLG E+A R P + G L+ I LP +S I
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC 236
Query: 243 LRKNPEHRPSASELLKHPFLQHFVD 267
+RK P+ RP+ L+ HPF+ + D
Sbjct: 237 MRKQPKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIAR 61
D +EI++ IGRGAFG +V + ++ Y +K + L R C R +E ++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR---EERNVLVN 57
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+I A+ ++ Y+ +V Y GGD+ L+ K PE+ + A+++LA+
Sbjct: 58 GDCQWITTLHYAFQDEN-YLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAI 115
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG-LAKTLKADDLASSV-VGTPNYMCPELL 179
+H + +HRD+K N+ L + +RL DFG K + + SSV VGTP+Y+ PE+L
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 180 ADI-----PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-NRSSIGPLPSC--- 230
+ YG + D WSLG CMYEM F A + KI N PS
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235
Query: 231 YSPSLKTLIKGML--RKNPEHRPSASELLKHPFLQ 263
S K LI+ ++ R+ + + KH F +
Sbjct: 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 36/290 (12%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARVQHPYIVEFK 71
IGRG++ +LV + ++ Y +K ++ L E ++ HP++V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
+ + + V Y GGD+ M++ PEE + A++ LA++YLH +++
Sbjct: 63 SCF-QTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIY 119
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGFKSDI 190
RDLK N+ L + ++L D+G+ K L+ D S+ GTPNY+ PE+L YGF D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 191 WSLGCCMYEMAAHRPAFKAFDMAG------------LISKINRSSIGPLPSCYSPSLKTL 238
W+LG M+EM A R FD+ G L I I +P S ++
Sbjct: 180 WALGVLMFEMMAGR---SPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASV 235
Query: 239 IKGMLRKNPEHR----PSA--SELLKHPFLQHFVD-------QYRPTFPP 275
+K L K+P+ R P +++ HPF ++ VD Q P F P
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN-VDWDLMEQKQVVPPFKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 19/264 (7%)
Query: 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
E + +IG GA G V HR + Y LK I + RR +E+ ++ V HP +V
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVV 135
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLLAVDYLHSN 127
+ + + + + ++ + +GG + G + +E+ A Q+L + YLH
Sbjct: 136 KCHDMF-DHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVARQILSGIAYLHRR 187
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASSVVGTPNYMCPEL----LADI 182
+++HRD+K SN+ + ++V++ DFG+++ L + D +S VGT YM PE L
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 183 PY-GFKSDIWSLGCCMYEMAAHRPAF---KAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
Y G+ DIWSLG + E R F + D A L+ I S P+ S +
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHF 307
Query: 239 IKGMLRKNPEHRPSASELLKHPFL 262
I L++ P R SA +LL+HPF+
Sbjct: 308 ISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 81/289 (28%), Positives = 129/289 (44%), Gaps = 35/289 (12%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQEMALIARVQ-- 63
QYE + +IG GA+G ++V LK++R+ E S +E+A++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 64 -HPYIVEFKE----AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
HP +V + + ++ + +V + + D+ + K P E + QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
+D+LHS+ V+HRDLK NI +T ++L DFGLA+ +SVV T Y PE+
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGLISK--------IN 220
L Y D+WS+GC EM +P F K D+ GL + +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240
Query: 221 RSSIGPLPS----CYSPSLKTLIKGMLRK----NPEHRPSASELLKHPF 261
R + + + + L K +L K NP R SA L HP+
Sbjct: 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 6/257 (2%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERC-RRSAHQEMALIARVQHPYIVEFKE 72
+G+G FG V + K Y KK+ R ++ + A E ++ +V P+IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132
A+ E ++C+V GGD+ + E++ + AQ+ + +LHS +++R
Sbjct: 61 AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 133 DLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWS 192
D+K N+ L + RL D GLA LK + GT YM PE+L + PY + D ++
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 193 LGCCMYEMAAHRPAFKAF----DMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
+GC +YEM A R FK L + + ++ K + + L K PE
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239
Query: 249 HRPSASELLKHPFLQHF 265
R + E P F
Sbjct: 240 DRLGSREKNDDPRKHEF 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 85/308 (27%), Positives = 128/308 (41%), Gaps = 57/308 (18%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH--QEMALIARVQHP 65
+ ++ IG GAFG LV Y +K +R A R ++AH E ++A +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEADNE 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++V+ ++ +K + V Y GGDM L+ + F E+ + A+L A++ +H
Sbjct: 62 WVVKLYYSFQDKDN-LYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH 118
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLA------------------------------ 155
+HRD+K NI + +D ++L DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 156 -------KTLKADD-------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMA 201
K L+ LA S+VGTPNY+ PE+L Y D WS+G +YEM
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 202 AHRPAFKAFDMAGLISK-INRSSIGPLPSC--YSPSLKTLIKGMLRKNPEHR---PSASE 255
+P F A A K IN + +PS S LI + E R A E
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADE 297
Query: 256 LLKHPFLQ 263
+ HPF +
Sbjct: 298 IKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 89/317 (28%), Positives = 146/317 (46%), Gaps = 31/317 (9%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
IG+G+FG +L +++ Y VL+K + ++ E+ A + + L+ ++HP++V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 71 KEAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
++ EK + V Y GG++ +++ F E + + A++ A+ YLHS
Sbjct: 62 HYSFQTAEK---LYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN 116
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGFK 187
+++RDLK NI L V L DFGL K ++ ++ S+ GTP Y+ PE+L PY
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247
D W LG +YEM P F + D++ + I + LP + + L+ G+L K+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL-QLPGGKTVAACDLLVGLLHKDQ 235
Query: 248 EHRPSAS----ELLKHPFLQ--HFVDQYR----PTFPPAAC--------SPEKPISIAHE 289
R A E+ H F ++ D Y P + P PE
Sbjct: 236 RRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSS 295
Query: 290 SRRCMAESQNSSSSASD 306
S + SSSSAS
Sbjct: 296 SVGQTPDLTASSSSASS 312
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 86/296 (29%), Positives = 128/296 (43%), Gaps = 43/296 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D +E + ++G G G V HR K I L + R +E+ ++ P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-IRNQIIRELKVLHECNSP 59
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
YIV F A+ G + I + +GG + +++KK+ PE L K +L + YL
Sbjct: 60 YIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLR 116
Query: 126 SNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
+ ++HRD+K SNI + +++L DFG++ L D +A+S VGT +YM PE L Y
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHY 175
Query: 185 GFKSDIWSLGCCMYEMAAHR------------PAFKAFD--MAGLISKINRSSIGP---- 226
+SDIWSLG + EMA R F S S P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 227 ------------------LPS-CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
LPS +S + + L+KNP+ R EL KHPF++
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 88/325 (27%), Positives = 137/325 (42%), Gaps = 63/325 (19%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+Y+ + IG GA+G H+ K +KKI C+R+ +E+ ++ R +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKHE 63
Query: 66 YIV------------EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
I+ F + V IV E D+ +L+K + + + + +
Sbjct: 64 NIIGILDIIRPPSFESFND--------VYIVQELMET-DLYKLIKTQHLSN---DHIQYF 111
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV----VG 169
Q+L + Y+HS VLHRDLK SN+ L + D+++ DFGLA+ + + V
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 170 TPNYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAF--KAF---------------- 210
T Y PE +L Y DIWS+GC + EM ++RP F K +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231
Query: 211 -DMAGLISKINRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLK 258
D+ +IS R+ I LP L+ ML NP R + E L
Sbjct: 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291
Query: 259 HPFLQHFVDQYRPTFPPAACSPEKP 283
HP+L+ + D P+ P A P
Sbjct: 292 HPYLEQYHD---PSDEPVAEEPFPF 313
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 78/260 (30%), Positives = 131/260 (50%), Gaps = 9/260 (3%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y E+IG+GA G A ++ +K++ L +Q ++ E+ ++ ++P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKNPN 77
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
IV + ++++ G + +V Y GG + +++ ++ E ++ + L A+D+LHS
Sbjct: 78 IVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS 133
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPELLADIPYG 185
N V+HRD+K NI L D V+L DFG A+ S++VGTP +M PE++ YG
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIKGML 243
K DIWSLG EM P + + + I + L P S + + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253
Query: 244 RKNPEHRPSASELLKHPFLQ 263
+ + R SA ELL+HPFL+
Sbjct: 254 EMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 16/271 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D +EI+E IG+G +G V ++ K +K + + + + L A HP
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN--ILKALSDHP 75
Query: 66 YIVEFKEAWVEK----GCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLL 119
+V+F + +K G + +V C GG + +L+K G E + + L+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPEL 178
+ +LH N +HRD+K +NI LT + V+L DFG++ L + L ++ VGTP +M PE+
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 179 LA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCY 231
+A D Y + D+WSLG E+ P + KI R+ L P +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELW 255
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
S I+ L K+ E RP+ S+LL+H F+
Sbjct: 256 SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 18/284 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRS-AHQEMALIARVQH 64
+++ +GRG FG +V +A Y +K ++ + + S +E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF-AQLLLAVDY 123
P+I + + A+ +K + +V Y GGD+ L+ + + +E + +++ A+L+LA+
Sbjct: 61 PWIPQLQYAFQDKD-NLYLVMEYQPGGDLLSLLNRYEDQF--DEDMAQFYLAELVLAIHS 117
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LASSVVGTPNYMCPELLAD 181
+H +HRD+K N+ + + ++L DFG A L A+ + VGTP+Y+ PE+L
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 182 I------PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-NRSSIGPLPS--CYS 232
+ YG + D WSLG YEM R F A + I N P S
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237
Query: 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV-DQYRPTFPP 275
LI+ +L + R L HPF + R + PP
Sbjct: 238 SDFLDLIQSLL-CGQKERLGYEGLCCHPFFSKIDWNNIRNSLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 14/247 (5%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARVQHPYIVEFK 71
IGRG++ +LV + + Y +K ++ L E ++ +P++V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
+ + + +V Y GGD+ M++ PEE + A++ +A+++LH +++
Sbjct: 63 SCF-QTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIY 119
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGFKSDI 190
RDLK N+ L D ++L D+G+ K L D S+ GTPNY+ PE+L YGF D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 191 WSLGCCMYEMAAHRPAFKAF----DMAG---LISKINRSSIGPLPSCYSPSLKTLIKGML 243
W+LG M+EM A R F DM L I I +P S ++KG L
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-RIPRFLSVKASHVLKGFL 238
Query: 244 RKNPEHR 250
K+P+ R
Sbjct: 239 NKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 60/189 (31%), Positives = 82/189 (43%), Gaps = 37/189 (19%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV------VG 169
QLL A+ Y+HS V+HRDLK SNI L D V+L DFGLA++L + V
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 170 TPNYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAF-------------------KA 209
T Y PE LL Y D+WS+GC + EM +P F A
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 210 FDMAGL--------ISKINRSSIGPLP---SCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
D+ + + + PL S L+K +L NP R +A E L+
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
Query: 259 HPFLQHFVD 267
HP++ F +
Sbjct: 295 HPYVAQFHN 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 91/299 (30%), Positives = 138/299 (46%), Gaps = 39/299 (13%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
MDQYE +E+IG G +G R + LKKIRL ++ E +A +E++L+ +QH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 65 PYIVEFKEA-WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLLAVD 122
IV ++ EK Y +V Y + D+ + M S+ + +L K + Q+L +
Sbjct: 61 GNIVRLQDVVHSEKRLY--LVFEYLD-LDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQD-VRLGDFGLAKT--LKADDLASSVVGTPNYMCPE-L 178
Y HS+ VLHRDLK N+ + + + ++L DFGLA+ + VV T Y PE L
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEIL 175
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGLISKINRSSIGPLP 228
L Y DIWS+GC EM +P F K F + G ++ + LP
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235
Query: 229 SCYS--------------PSLKT----LIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
S P+L+ L+ MLR +P R +A L+H + + D
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDAP 294
|
Length = 294 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 80/275 (29%), Positives = 133/275 (48%), Gaps = 21/275 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMA----LIARVQHPYIVE 69
IG+G+FG +L + + K Y +K L ++ R+ MA L+ V+HP++V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 70 FKEAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
++ EK + V + GG++ +++ FPE + + A++ A+ YLHS
Sbjct: 61 LHYSFQTTEK---LYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSI 115
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLADIPYGF 186
+++RDLK NI L V L DFGL K + D ++ GTP Y+ PE++ PY
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
D W LG +YEM P F D+A + I + P S + ++++ +L K+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA-SLTAWSILEELLEKD 234
Query: 247 PEHRPSAS----ELLKHPFLQ--HFVDQYRPTFPP 275
+ R A E+ +HPF + + D + PP
Sbjct: 235 RQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 39/286 (13%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL-IA 60
+ ++ E + +IG G G + + +K++R E +R M L +
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL---MDLDVV 67
Query: 61 RVQH--PYIVEFKEAWVEKGCYVCIVTGY-------CEGGDMAELMKKSNGAYFPEEKLC 111
H PYIV+ CY +T + +L+K+ G PE+ L
Sbjct: 68 LKSHDCPYIVK---------CYGYFITDSDVFICMELMSTCLDKLLKRIQG-PIPEDILG 117
Query: 112 KWFAQLLLAVDYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT 170
K ++ A+ YL + V+HRD+K SNI L +V+L DFG++ L + G
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 171 PNYMCPELLADIP-----YGFKSDIWSLGCCMYEMAAHRPAFKA----FDMAGLISKINR 221
YM PE + D P Y ++D+WSLG + E+A + +K F++ ++KI +
Sbjct: 178 AAYMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV---LTKILQ 233
Query: 222 SSIGPLPS--CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
LP +SP + + L K+ RP ELL+HPF++ +
Sbjct: 234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 71/270 (26%), Positives = 132/270 (48%), Gaps = 21/270 (7%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEK------KKYVLKKIRLARQTERCRRSAHQEMA 57
+ + + + +G G+FG IL ++ E K++ KI +Q + E
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH----VFSERK 83
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
++ + HP+ V ++ ++ Y+ +V + GG+ ++++ FP + C + AQ+
Sbjct: 84 ILNYINHPFCVNLYGSFKDES-YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQI 140
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
+L +YL S +++RDLK N+ L KD +++ DFG AK + D ++ GTP Y+ PE
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPE 198
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
+L ++ +G +D W+LG +YE+ P F A + + KI I P + K
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKH 257
Query: 238 LIKGMLRKNPEHR-----PSASELLKHPFL 262
L+K +L + R A + +HP+
Sbjct: 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 76/257 (29%), Positives = 129/257 (50%), Gaps = 13/257 (5%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
IG+G+FG +L H+AE+K Y VL+K + ++ E + + L+ V+HP++V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE-KHIMSERNVLLKNVKHPFLVGL 61
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
++ + + V Y GG++ +++ P + + A++ A+ YLHS ++
Sbjct: 62 HFSF-QTADKLYFVLDYINGGELFYHLQRERCFLEPRARF--YAAEIASALGYLHSLNIV 118
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPELLADIPYGFKSD 189
+RDLK NI L + L DFGL K ++ + S+ GTP Y+ PE+L PY D
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVD 178
Query: 190 IWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249
W LG +YEM P F + + A + I + P+ + S + L++G+L+K+
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI-TNSARHLLEGLLQKDRTK 237
Query: 250 RPSAS----ELLKHPFL 262
R A E+ H F
Sbjct: 238 RLGAKDDFMEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 85/287 (29%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
++ +E+IG G +G ++ + LKKIRL +TE +A +E++L+ + HP I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 68 VEFKEA-WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
V+ + E Y +V + D+ + M S + P + + QLL + + HS
Sbjct: 62 VKLLDVIHTENKLY--LVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT--LKADDLASSVVGTPNYMCPE-LLADIP 183
+ VLHRDLK N+ + + ++L DFGLA+ + VV T Y PE LL
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKY 177
Query: 184 YGFKSDIWSLGCCMYEMAAHR---PA-------FKAFDMAGLISKINRSSIGPLPSCYSP 233
Y DIWSLGC EM R P F+ F G ++ + LP Y P
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD-YKP 236
Query: 234 SL-------------------KTLIKGMLRKNPEHRPSASELLKHPF 261
S + L+ ML +P R SA L HPF
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 38/288 (13%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+YE +E+IG G +G +R + LK++RL E SA +E+ L+ ++H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLLAVDYLH 125
IV + + + +V YC+ D+ + NG + ++ K F QLL + + H
Sbjct: 61 IVRLYDV-LHSDKKLTLVFEYCDQ-DLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCH 116
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT--LKADDLASSVVGTPNYMCPE-LLADI 182
S+ VLHRDLK N+ + K+ +++L DFGLA+ + ++ VV T Y P+ L
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 175
Query: 183 PYGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKINR----------SSIGPLP--- 228
Y D+WS GC E+A A RP F D+ + +I R + LP
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 229 -----------SCYSPSL----KTLIKGMLRKNPEHRPSASELLKHPF 261
P L + L++ +L NP R SA E L+HP+
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 26/287 (9%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKK-IRLARQTERCRRSAHQEMALIARVQHPYIVE 69
+G+G+FG +L + + Y +LKK + + C + +AL + P++ +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLTQ 65
Query: 70 FKEAW-VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
+ Y V Y GGD+ +++ F E + A++ + + +LHS
Sbjct: 66 LHSCFQTMDRLY--FVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPELLADIPYGFK 187
+++RDLK N+ L + +++ DFG+ K + + GTP+Y+ PE++A PYG
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247
D W+ G +YEM A +P F D L I ++ P S ++ KG+L K+P
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGLLTKHP 240
Query: 248 EHR----PSASELLK-HPFLQHFVD-------QYRPTFPPAACSPEK 282
R P+ ++ H F + +D + +P F P
Sbjct: 241 AKRLGCGPTGERDIREHAFFR-RIDWEKLERREIQPPFKPKVKGRRS 286
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 82/278 (29%), Positives = 135/278 (48%), Gaps = 33/278 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH- 64
D E++E++GRGA+G + H +K+IR ++ +R ++ + R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLL-MDLDISMRSVDC 59
Query: 65 PYIVEFKEAWVEKG-CYVCIVTGYCEGGDMAELMKKS----------NGAYFPEEKLCKW 113
PY V F A +G ++C+ E+M S G PE+ L K
Sbjct: 60 PYTVTFYGALFREGDVWICM-----------EVMDTSLDKFYKKVYDKGLTIPEDILGKI 108
Query: 114 FAQLLLAVDYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV-VGTP 171
++ A++YLHS V+HRD+K SN+ + ++ V+L DFG++ L D +A ++ G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCK 167
Query: 172 NYMCPEL----LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSIGP 226
YM PE L Y KSD+WSLG M E+A R + ++ + ++
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ 227
Query: 227 LPS-CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
LP+ +SP + + L+KN + RP+ ELL+HPF +
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 24/275 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIAR 61
+ +EI++ IGRGAFG +V + K + +K + L R C R +E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR---EERDVLVN 57
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+ +I A+ ++ + +V Y GGD+ L+ K PE+ + A++++A+
Sbjct: 58 GDNQWITTLHYAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS--VVGTPNYMCPELL 179
D +H + +HRD+K NI + + +RL DFG L D S VGTP+Y+ PE+L
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 180 ADIP-----YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-NRSSIGPLPSC--- 230
+ YG + D WSLG CMYEM F A + KI N P+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235
Query: 231 YSPSLKTLIKGMLRKNPEHRPSAS---ELLKHPFL 262
S K LI+ ++ EHR + + +HPF
Sbjct: 236 VSEDAKDLIRRLICSR-EHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 76/298 (25%), Positives = 141/298 (47%), Gaps = 42/298 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D+Y ++Q+G GA+G R K +KK+ Q+E + A++E+ L+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 66 YIVEFKEAW-----VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++ + + +++ +V + G D+ +LMK E+++ Q+L
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQMLKG 130
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
+ Y+H+ ++HRDLK N+ + +D ++++ DFGLA+ + D + V T Y PE++
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVIL 188
Query: 181 D-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISKIN 220
+ + Y DIWS+GC M EM +P FK D + L S+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 221 RSSIGPLPSC-----------YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
++ + LP +P +++ ML + E R +A+E L HP+ + F D
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 69/259 (26%), Positives = 116/259 (44%), Gaps = 10/259 (3%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRS-AHQEMALIARVQHPYIVEFKE 72
+G+G FG RA K Y KK+ R +R + A E ++ +V ++V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132
A+ K +C+V GGD+ + F E++ + A+L ++ L +++R
Sbjct: 68 AYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 133 DLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWS 192
DLK NI L +R+ D GLA + + VGT YM PE++ + Y F D W
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWG 186
Query: 193 LGCCMYEMAAHRPAFKAFDMAGLISKINR---SSIGPLPSCYSPSLKTLIKGMLRKNPEH 249
LGC +YEM + F+ +++R +S K++ + +L KNP+
Sbjct: 187 LGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKE 246
Query: 250 R-----PSASELLKHPFLQ 263
R A+ + +HP +
Sbjct: 247 RLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 78/274 (28%), Positives = 137/274 (50%), Gaps = 21/274 (7%)
Query: 8 YEIMEQIGRGAFGAAILVNHRA---EKKKYVLKKIRLARQTERCRRSAHQ--EMALIARV 62
+E+++ +G GA+G LV + K Y +K ++ A ++ + + H E ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 63 -QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
Q P++V A+ + + ++ Y GG++ S F E+++ + +++LA+
Sbjct: 62 RQSPFLVTLHYAF-QTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCPELL 179
++LH +++RD+K NI L + V L DFGL+K D++ A S GT YM P+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 180 A--DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR---SSIGPLPSCYSPS 234
D + D WS+G MYE+ F ++I+R S P P S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
Query: 235 LKTLIKGMLRKNPEHR----PS-ASELLKHPFLQ 263
K +I+ +L K+P+ R PS A E+ KHPF Q
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 38/288 (13%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
++ +E++G G + +R + LK+I L + E +A +E++L+ ++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHEN 59
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFP-EEKLCKWFA-QLLLAVDYL 124
IV + + + +V Y + D+ + M ++G + K F QLL + +
Sbjct: 60 IVRLHDV-IHTENKLMLVFEYMDK-DLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT--LKADDLASSVVGTPNYMCPE-LLAD 181
H N VLHRDLK N+ + K +++L DFGLA+ + + ++ VV T Y P+ LL
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGLISKINRSSIGPLPSC- 230
Y DIWS+GC M EM RP F K F + G ++ I LP
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235
Query: 231 -----------------YSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
P L+ +L+ NPE R SA + L+HP+
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 33/300 (11%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y ++Q+G GA+G+ + +K +KK+ Q+E + A++E+ L+ +QH
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
++ + + Y M ++K G E+K+ Q+L + Y+HS
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD-IPYG 185
++HRDLK N+ + +D ++++ DFGLA+ AD + V T Y PE++ + + Y
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEVILNWMHYN 193
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISKINRSSIGP 226
DIWS+GC M EM + FK D + L K +S I
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253
Query: 227 LPSC-----------YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
LP SP L++ ML + + R +A+E L+HP+ F D T
Sbjct: 254 LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQ 313
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 9/260 (3%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y E+IG+GA G A ++ ++++ L +Q ++ E+ ++ ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPN 78
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
IV + ++++ G + +V Y GG + +++ ++ E ++ + L A+++LHS
Sbjct: 79 IVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS 134
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGL-AKTLKADDLASSVVGTPNYMCPELLADIPYG 185
N V+HRD+K NI L D V+L DFG A+ S++VGTP +M PE++ YG
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIKGML 243
K DIWSLG EM P + + + I + L P S + + L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 244 RKNPEHRPSASELLKHPFLQ 263
+ E R SA ELL+H FL+
Sbjct: 255 DMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 33/269 (12%)
Query: 14 IGRGAFGAAILVNHRAEKKKY---VLKK-IRLARQTERCRRSAHQEMALIARVQHPYIVE 69
+G+G+FG +L + + Y VLKK + L C + + ++L AR HP++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL-AR-NHPFLTQ 60
Query: 70 FKEAWVEKGCYVCI--------VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
Y C V + GGD+ ++KS F E + + A++ A+
Sbjct: 61 L---------YCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSAL 109
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNYMCPELLA 180
+LH +++RDLK N+ L + +L DFG+ K + S+ GTP+Y+ PE+L
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
++ YG D W++G +YEM F+A + L I + P+ S ++K
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILK 228
Query: 241 GMLRKNPEHRPSA------SELLKHPFLQ 263
+ KNP R + +L+HPF +
Sbjct: 229 AFMTKNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 19/265 (7%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
YE+++++G G +G + + +K I+L + QE+ ++ +H I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF--SLIQQEIFMVKECKHCNI 68
Query: 68 VEFKEAWVEK-GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
V + +++ + ++C+ YC GG + ++ + E ++ + L + YLHS
Sbjct: 69 VAYFGSYLSREKLWICM--EYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHS 124
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLA---DI 182
+HRD+K +NI LT + DV+L DFG+A + A S +GTP +M PE+ A +
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 183 PYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSC-----YSPSLK 236
Y DIW++G E+A P F M L +++S+ P P +S +
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNFQP-PKLKDKTKWSSTFH 242
Query: 237 TLIKGMLRKNPEHRPSASELLKHPF 261
+K L KNP+ RP+A LL H F
Sbjct: 243 NFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 80/290 (27%), Positives = 123/290 (42%), Gaps = 41/290 (14%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y +E+IG G +G ++ + +KKIRL + E +A +E++L+ +QHP I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK-----SNGAYFPEEKLCKWFAQLLLAVD 122
V ++ +++ I E M +KK G Y E + + Q+L +
Sbjct: 62 VCLQDVLMQESRLYLIF----EFLSMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPE-LLA 180
+ HS VLHRDLK N+ + ++L DFGLA+ + + V T Y PE LL
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-------------- 226
Y DIWS+G EMA +P F + +I R P
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 227 ---LPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKHPFL 262
P SL++ L++ ML +P R SA + L HP+
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 75/268 (27%), Positives = 132/268 (49%), Gaps = 21/268 (7%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +E++++IG G +G + + +K I+L + QE+ ++ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF--AVVQQEIIMMKDCKHS 66
Query: 66 YIVEFKEAWVEKG-CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV + +++ + ++C+ +C GG + ++ + E ++ + L + YL
Sbjct: 67 NIVAYFGSYLRRDKLWICM--EFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA--SSVVGTPNYMCPELLA-- 180
HS +HRD+K +NI LT + V+L DFG++ + A +A S +GTP +M PE+ A
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA-TIAKRKSFIGTPYWMAPEVAAVE 181
Query: 181 -DIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSC-----YSP 233
Y DIW++G E+A P F M L + +S+ P P +S
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKSNFQP-PKLKDKMKWSN 239
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPF 261
S +K L KNP+ RP+A +LL+HPF
Sbjct: 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-22
Identities = 74/273 (27%), Positives = 135/273 (49%), Gaps = 20/273 (7%)
Query: 8 YEIMEQIGRGAFGAAILVNHRA---EKKKYVLKKIRLARQTERCRRSAHQ--EMALIARV 62
+E+++ +G GA+G LV K Y +K ++ A ++ + H E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 63 -QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
Q P++V A+ + + ++ Y GG+M + + + F E+++ + +++LA+
Sbjct: 62 RQSPFLVTLHYAF-QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILAL 118
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL--KADDLASSVVGTPNYMCPELL 179
++LH +++RD+K NI L + V L DFGL+K + + S GT YM PE++
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 180 -ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSL 235
+G D WSLG ++E+ F S+++R + P PS P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 236 KTLIKGMLRKNPEHR-----PSASELLKHPFLQ 263
+ L+ +LRK+P+ R ASE+ +HPF +
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHR------AEKKKYVLKKIRLARQTERCRRSAHQEMA 57
R + E + +G G G+ V H A+K ++ K + +Q R E+
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-------ELQ 55
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
++ + PYIV F A++ + +C+ + + G + + KK G P E L K +
Sbjct: 56 IMHECRSPYIVSFYGAFLNEN-NICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAV 112
Query: 118 LLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
+ + YL++ + ++HRD+K SNI + ++L DFG++ L + +A + VGT YM P
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTSTYMSP 171
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA--------FDMAGLISKINRSSIGPLP 228
E + Y KSD+WSLG + E+A + F D G++ + + P P
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231
Query: 229 ----SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S + L+ + L K+P RP+ +L P
Sbjct: 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 9e-22
Identities = 68/282 (24%), Positives = 121/282 (42%), Gaps = 20/282 (7%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIARVQHPYI 67
+ +G+G+FG L + + + +K ++ L C + ++L +HP++
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW--EHPFL 58
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
+ K + V Y GGD+ ++ + P + A+++ + +LHS
Sbjct: 59 THLYCTFQTKE-NLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSK 115
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPELLADIPYGF 186
+++RDLK NI L D +++ DFG+ K + D + GTP+Y+ PE+L Y
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
D WS G +YEM + F D L I R P + K ++ + +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-RMDNPCYPRWLTREAKDILVKLFVRE 234
Query: 247 PEHRPSA-SELLKHPFLQHFVD-------QYRPTFPPAACSP 280
PE R ++ +HPF + +D + P F P S
Sbjct: 235 PERRLGVKGDIRQHPFFRE-IDWSALEEREIEPPFKPKVKSA 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 68/282 (24%), Positives = 135/282 (47%), Gaps = 24/282 (8%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARVQHPYIVEFK 71
+G+G+FG +L + + Y +K ++ + Q + + ++ L + + P++ +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 72 EAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
+ V++ + V Y GGD+ +++ F E + + A++ + + +LH +
Sbjct: 68 SCFQTVDR---LYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCPELLADIPYGFKS 188
++RDLK N+ L + +++ DFG+ K D + + + GTP+Y+ PE++A PYG
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 189 DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
D W+ G +YEM A +P F D L I ++ P S ++ KG++ K+P
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGLMTKHPS 241
Query: 249 HR-----PSASELLKHPFLQHFVD-------QYRPTFPPAAC 278
R ++ +H F + +D + +P F P C
Sbjct: 242 KRLGCGPEGERDIREHAFFRR-IDWDKLENREIQPPFKPKVC 282
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-21
Identities = 75/245 (30%), Positives = 105/245 (42%), Gaps = 52/245 (21%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D +E ++ IGRGAFG LV + Y +K +R A E+ +++A I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK------EQVAHI-RAERD 53
Query: 66 YIVEFKEAWVEKGCY-------VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+VE AWV K Y + ++ + GGDM L+ K + EE + A+ +
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETV 111
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA------------------ 160
LA+D +H +HRD+K N+ L V+L DFGL LK
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 161 ------------------DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA 202
LA S VGTP+Y+ PE+ Y D WSLG MYEM
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 203 HRPAF 207
P F
Sbjct: 232 GYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-21
Identities = 68/279 (24%), Positives = 128/279 (45%), Gaps = 18/279 (6%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIARVQHPYIVE 69
+G+G+FG +L + + + + +K ++ L C + +AL ++P++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW--ENPFLTH 60
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
+ K ++ V + GGD+ + + F + + A+++ + +LHS +
Sbjct: 61 LYCTFQTKE-HLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCPELLADIPYGFKS 188
++RDLK N+ L +D +++ DFG+ K + D+ AS+ GTP+Y+ PE+L + Y F
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 189 DIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
D WS G +YEM + F D L I R P + K +++ + ++P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESI-RVDTPHYPRWITKESKDILEKLFERDPT 236
Query: 249 HRPSASELLK-HPFLQHF------VDQYRPTFPPAACSP 280
R ++ HPF + + P F P SP
Sbjct: 237 RRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 57/259 (22%), Positives = 105/259 (40%), Gaps = 22/259 (8%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER------CRRSAHQEMALIARVQHP 65
+++G G+FG V R E K I +A + + +E A++ + H
Sbjct: 1 KKLGDGSFG----VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++ + + +VT G + + ++K +F LC + Q+ + YL
Sbjct: 57 NLIRLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN------YMCPELL 179
S +HRDL NI L D V++GDFGL + L ++ V + + PE L
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCAPESL 172
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRS-SIGPLPSCYSPSLKT 237
+ SD+W G ++EM + + + ++ KI++ P +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYN 232
Query: 238 LIKGMLRKNPEHRPSASEL 256
++ NP RP+ + L
Sbjct: 233 VMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 77/283 (27%), Positives = 136/283 (48%), Gaps = 22/283 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMALIARVQHPYIV 68
IGRG FG K Y +K +I++ +Q E + ++L++ P+IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
A+ +C + GGD+ + S F E+++ + +++L ++++H+ +
Sbjct: 61 CMTYAFHTPD-KLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD-IPYGFK 187
V++RDLK +NI L + VR+ D GLA +S VGT YM PE+L Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 188 SDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTLIKGMLR 244
+D +SLGC ++++ F+ +I+R ++ LP +SP LK+L++G+L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 245 KNPEHR-----PSASELLKHPFLQHFVDQ--YRPTFPPAACSP 280
++ R A E+ +H F + Q Y +PP P
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 71/300 (23%), Positives = 118/300 (39%), Gaps = 58/300 (19%)
Query: 14 IGRGAFGAAI--LVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFK 71
IG+ I L H+ +KKI L ++ + QE+ ++QHP I+ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
+++ + +V+ G +L+K PE + +L A+DY+HS +H
Sbjct: 66 TSFIVDS-ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLA--------KTLKADDLASSVVGTPNYMCPELL-ADI 182
R +K S+I L+ D V L + + D S V ++ PE+L ++
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 183 P-YGFKSDIWSLG--CCMYEMA-AHRPAFKAFDMAGLISKINRSSIGPLPS--------- 229
Y KSDI+S+G C E+A H P L+ K+ G +P
Sbjct: 185 QGYNEKSDIYSVGITAC--ELANGHVPFKDMPATQMLLEKVR----GTVPCLLDKSTYPL 238
Query: 230 ---------------------------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
+S ++ L+++PE RPSAS+LL H F
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-21
Identities = 69/286 (24%), Positives = 135/286 (47%), Gaps = 20/286 (6%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARVQHP 65
+ + +G+G+FG +L + + Y +K ++ + Q + + ++ L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++ + + + + V Y GGD+ +++ F E + A++ + + +LH
Sbjct: 62 FLTQLHSCF-QTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH 118
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCPELLADIPY 184
S +++RDLK N+ L + +++ DFG+ K D + + + GTP+Y+ PE++A PY
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
G D W+ G +YEM A + F+ D L I ++ P S + KG++
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-YPKSMSKEAVAICKGLMT 237
Query: 245 KNPEHR----PSASELLK-HPFLQHFVD-------QYRPTFPPAAC 278
K+P R P +K H F + ++D + +P + P AC
Sbjct: 238 KHPGKRLGCGPEGERDIKEHAFFR-YIDWEKLERKEVQPPYKPKAC 282
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-21
Identities = 73/323 (22%), Positives = 132/323 (40%), Gaps = 70/323 (21%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH------------QEMALIAR 61
+G G +G K +KK+++ + + +E+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
++H I+ + +VE ++ +V D+ +++ + + K Q+L +
Sbjct: 77 IKHENIMGLVDVYVEGD-FINLVMDIMAS-DLKKVVDRKIRLTESQVKCILL--QILNGL 132
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA---------------KTLKADDLASS 166
+ LH Y +HRDL +NIF+ ++ DFGLA +T++ + +S
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 167 VVGTPNYMCPELL--ADIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAG 214
V T Y PELL A+ Y F D+WS+GC E+ +P F + F++ G
Sbjct: 193 KVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 215 LISKIN--RSSIGPLPSCYSP----SLKTLIK-----------GMLRKNPEHRPSASELL 257
++ N ++ PL + ++P LKT+ +L+ NP R SA E L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 258 KHPFLQHFVDQYRPTFPPAACSP 280
KH + + P C P
Sbjct: 312 KHEYFKSD---------PLPCDP 325
|
Length = 335 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-20
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 10/282 (3%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
E + D +E + ++G G G V+H+ K I L + R +E+ ++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-IRNQIIRELQVLHE 59
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
PYIV F A+ G + I + +GG + +++KK+ PE+ L K ++ +
Sbjct: 60 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 116
Query: 122 DYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
YL + ++HRD+K SNI + +++L DFG++ L D +A+S VGT +YM PE L
Sbjct: 117 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQ 175
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-PLPSCYSPSLKTLI 239
Y +SDIWS+G + EMA R D L G P S SP +
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235
Query: 240 KGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPE 281
+ + P+ RP + L + V++ P P E
Sbjct: 236 RPLSSYGPDSRPPMAIF---ELLDYIVNEPPPKLPSGVFGAE 274
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-20
Identities = 84/313 (26%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++Y+ + +G GA+G+ ++K +KK+ Q+ R ++E+ L+ ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 66 YIVEFKEAW-----VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++ + + +E V +VT G D+ ++K +E + QLL
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIYQLLRG 130
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
+ Y+HS ++HRDLK SN+ + +D ++R+ DFGLA+ +ADD + V T Y PE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIML 188
Query: 181 D-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISKIN 220
+ + Y DIWS+GC M E+ + F D + + S+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248
Query: 221 RSSIGPLPSCYSPSLKTLIKG-----------MLRKNPEHRPSASELLKHPFLQHFVD-Q 268
R I LP LK + +G ML + + R SASE L HP+ + D +
Sbjct: 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308
Query: 269 YRPTFPPAACSPE 281
P P SPE
Sbjct: 309 DEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 85/311 (27%), Positives = 137/311 (44%), Gaps = 56/311 (18%)
Query: 6 DQYEIMEQIGRGAFG----AAILVNHRAEKKKYVLKKIR---LARQTERCRRSAHQEMAL 58
++Y ++ +G GAFG A + + K ++K LA++T R E+ L
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-------ELKL 62
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QL 117
+ ++H I+ + ++ + VT G D+ L+ + E++ ++F Q+
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT----SRPLEKQFIQYFLYQI 117
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
L + Y+HS V+HRDLK SNI + ++ D+++ DFGLA+ D + V T Y PE
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYYRAPE 175
Query: 178 -LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA----------FDMAG-----LISKI-- 219
+L Y + DIWS GC EM +P F D+ G +I+ I
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235
Query: 220 -------------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266
PS L++ ML +P+ R SA+E L HP+L +
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295
Query: 267 DQYRPTFPPAA 277
D PT P A
Sbjct: 296 D---PTDEPVA 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-20
Identities = 72/245 (29%), Positives = 101/245 (41%), Gaps = 52/245 (21%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +E ++ IGRGAFG LV + Y +K +R A E+ E R +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-------EQVGHIRAERD 53
Query: 66 YIVEFKEAWVEKGCY-------VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+VE WV K Y + ++ + GGDM L+ K + EE+ + A+ +
Sbjct: 54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETV 111
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA------------------ 160
LA+D +H +HRD+K N+ L V+L DFGL LK
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 161 ------------------DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA 202
LA S VGTP+Y+ PE+ Y D WSLG MYEM
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 203 HRPAF 207
P F
Sbjct: 232 GYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-20
Identities = 80/291 (27%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
E + D +E + ++G G G V H+ K I L + R +E+ ++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA-IRNQIIRELQVLHE 59
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
PYIV F A+ G + I + +GG + +++K++ PEE L K +L +
Sbjct: 60 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGL 116
Query: 122 DYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
YL + ++HRD+K SNI + +++L DFG++ L D +A+S VGT +YM PE L
Sbjct: 117 AYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQ 175
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHR---PAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
Y +SDIWS+G + E+A R P A ++ + + P SP
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP---- 231
Query: 238 LIKGMLRKNPEHRP-------SASELLKHPFLQHFVDQYRPTFPPAACSPE 281
R P RP S + L + V++ P P +P+
Sbjct: 232 ------RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 276
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 78/283 (27%), Positives = 137/283 (48%), Gaps = 22/283 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMALIARVQHPYIV 68
IGRG FG K Y +K +I++ +Q E + ++L++ P+IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
A+ + + GGD+ + S F E ++ + A+++L ++++H+ +
Sbjct: 61 CMSYAF-HTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD-IPYGFK 187
V++RDLK +NI L + VR+ D GLA +S VGT YM PE+L + Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSS 176
Query: 188 SDIWSLGCCMYE-MAAHRP--AFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
+D +SLGC +++ + H P K D I ++ + LP +SP L++L++G+L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 245 KNPEHR-----PSASELLKHPFLQHFVDQ--YRPTFPPAACSP 280
++ R A E+ +HPF + Q + +PP P
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIPP 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 81/298 (27%), Positives = 123/298 (41%), Gaps = 47/298 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH- 64
D YE +E+IG G +G + K LKK RL E +A +E++L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 65 PYIVEF--KEAWVEKGCYVCI--VTGYCEGGDMAELM---KKSNGAYFPEEKLCKWFAQL 117
YIV E EK + V Y + D+ + M + G P + + + QL
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDV-RLGDFGLAK--TLKADDLASSVVGTPNYM 174
L V + H + V+HRDLK N+ + K + + ++ D GL + ++ +V T Y
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178
Query: 175 CPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAGLISK----- 218
PE LL Y DIWS+GC EM+ +P F F + G ++
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 219 ---------------INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
+ S P SP L++ MLR +P R SA L HP+
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVP---DLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 76/314 (24%), Positives = 132/314 (42%), Gaps = 65/314 (20%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRS--AH--QEMALIAR 61
+ + ++ IG+GAFG LV + K Y +K + ++E ++ AH E ++A
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL---KSEMFKKDQLAHVKAERDVLAE 57
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
P++V ++ + Y+ ++ + GGD+ ++ K + F E+ + A+ +LA+
Sbjct: 58 SDSPWVVSLYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAI 114
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADD------------------ 162
+ +H +HRD+K NI + + ++L DFGL+ K D
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 163 -----------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSL 193
+A S VGTP+Y+ PE+ YG + D WSL
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 194 GCCMYEMAAHRPAFKAFDMAGLISKI---NRSSIGPLPSCYSPSLKTLIKGMLRKNPEH- 249
G M+E P F + + KI + P S + LI+ ++ N E+
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENR 293
Query: 250 --RPSASELLKHPF 261
R A E+ HPF
Sbjct: 294 LGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 87/318 (27%), Positives = 135/318 (42%), Gaps = 58/318 (18%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y ++ IGRGA+G + +K +KKI A + +E+ L+ + H
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 67 IVEFKEAW--VEKGCY--VCIVTGYCEGGDMAELMK-------KSNGAYFPEEKLCKWFA 115
++ K+ + + V IV ELM +S+ + C++F
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVY---------ELMDTDLHQIIRSSQTLSDDH--CQYFL 114
Query: 116 -QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGTPNY 173
QLL + Y+HS VLHRDLK SN+ L + D+++ DFGLA+T + D + V T Y
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 174 MCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKI---------- 219
PELL + Y D+WS+GC E+ +P F D LI+++
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 220 ------NRSSIGPLP-----------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
R I LP +P L++ ML +P R + E L HP+L
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
Query: 263 QHFVDQYRPTFPPAACSP 280
D P+ P +P
Sbjct: 295 ASLHD---PSDEPVCQTP 309
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 41/312 (13%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
+ +Y+ ++ IG GA G + +KK+ Q + + A++E+ L+ V H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
I+ + + Y M + + E++ Q+L + +L
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HS ++HRDLK SNI + D +++ DFGLA+T + + V T Y PE++ + Y
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI------------------------N 220
DIWS+GC M EM H+ F D +K+ N
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 221 RSSIGPL--PSCYSPSL---------------KTLIKGMLRKNPEHRPSASELLKHPFLQ 263
R L P + SL + L+ ML +P R S E L+HP++
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315
Query: 264 HFVDQYRPTFPP 275
+ D PP
Sbjct: 316 VWYDPAEVEAPP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+++ Y+ ++++G G++ + + LK+IRL E +A +E +L+ ++
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIREASLLKDLK 61
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H IV + + + +V Y + D+ + M G F QLL + Y
Sbjct: 62 HANIVTLHDI-IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF-QLLRGLAY 118
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL--AKTLKADDLASSVVGTPNYMCPE-LLA 180
H VLHRDLK N+ +++ +++L DFGL AK++ + ++ VV T Y P+ LL
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLG 177
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAF-----------KAFDMAGLISKINRSSIGPLPS 229
Y D+W +GC YEMA RP F K F + G ++ + P
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 230 -------CYSPSL--------------KTLIKGMLRKNPEHRPSASELLKHPFL 262
Y P + L L+ P+ R SA+E +KHP+
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-18
Identities = 84/312 (26%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH--QEMALIARVQHP 65
+ ++ +G GAFG L K Y +K +R R + AH E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR-NQVAHVKAERDILAEADNE 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++V ++ +K + V Y GGDM L+ + FPE+ + A+L AV+ +H
Sbjct: 62 WVVRLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH 118
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGL---------AKTLKADD-------------- 162
+HRD+K NI + +D ++L DFGL +K ++ D
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 163 -------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCM 197
LA S+VGTPNY+ PE+L Y D WS+G +
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 198 YEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTLIKGMLRKNPEHR---P 251
YEM +P F A K+ P + SP LI + R PE R
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKN 297
Query: 252 SASELLKHPFLQ 263
A E+ HPF +
Sbjct: 298 GADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-18
Identities = 86/322 (26%), Positives = 130/322 (40%), Gaps = 59/322 (18%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARV 62
M +Y+I+ IG+G G L ++ LKKIR L+ + ++ +E + A +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADL 59
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK---------------SNGAYFPE 107
HP IV + G V Y EG + L+K S GA+
Sbjct: 60 IHPGIVPVYSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 108 -EKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA--KTLKADDLA 164
K+C ++Y+HS VLHRDLK NI L +V + D+G A K L+ +DL
Sbjct: 119 FHKICA-------TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 165 SS-----------------VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAF 207
+VGTP+YM PE L +P +DI++LG +Y+M +
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 208 ------KAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
K ++S I + +P P L + L +P R S+ + LK
Sbjct: 232 RRKKGRKISYRDVILSPIEVAPYREIP----PFLSQIAMKALAVDPAERYSSVQELKQDL 287
Query: 262 LQHFVDQYRPT-FPPAACSPEK 282
H Q P A +K
Sbjct: 288 EPHL--QGSPEWTVKATLMTKK 307
|
Length = 932 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 94/343 (27%), Positives = 139/343 (40%), Gaps = 81/343 (23%)
Query: 7 QYEIMEQIGRGAFG--AAILVNHRAEKKKYVLKKIR-----LARQTERCRRSAHQEMALI 59
+Y+I E IG+G++G + + H EK +KKI ++ T R E+ L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKINDVFEHVSDATRILR-----EIKLL 53
Query: 60 ARVQHPYIVEFKEAWVE------KGCYVCIVTGYCEGGDMAELMK-------KSNGAYFP 106
++HP IVE K + K YV ELM+ K+N P
Sbjct: 54 RLLRHPDIVEIKHIMLPPSRREFKDIYVVF-----------ELMESDLHQVIKANDDLTP 102
Query: 107 EEKLCKWFA-QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--- 162
E ++F QLL A+ Y+H+ V HRDLK NI D +++ DFGLA+ D
Sbjct: 103 EHH--QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 163 -LASSVVGTPNYMCPELLADI--PYGFKSDIWSLGCCMYEMAAHRPAFKA---------- 209
+ V T Y PEL Y DIWS+GC E+ +P F
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220
Query: 210 FDMAG-----LISKINR-------SSIGP-LPSCYS-------PSLKTLIKGMLRKNPEH 249
D+ G IS++ SS+ P +S P L++ +L +P+
Sbjct: 221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD 280
Query: 250 RPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRR 292
RP+A E L P+ + R + P + E RR
Sbjct: 281 RPTAEEALADPYFKGLAKVER----EPSAQPITKLEFEFERRR 319
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKK---YVLKKIRLARQTERCRRSAHQEMALI 59
+ ++Q+G G FG L + V K E+ R +E+ ++
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60
Query: 60 ARVQHPYIVEFKEAWVEK--GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+ H IV++K EK G + ++ Y G + + +++ + ++L + +Q+
Sbjct: 61 RTLDHENIVKYK-GVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQI 118
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN----- 172
+DYL S +HRDL NI + + V++ DFGLAK L D V P
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-DYYYVKEPGESPIF 177
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAH 203
+ PE L + SD+WS G +YE+ +
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-17
Identities = 78/327 (23%), Positives = 146/327 (44%), Gaps = 49/327 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++Y+ + +G GA+G+ + +KK+ Q+ + ++E+ L+ ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 66 YIVEFKEAW-----VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++ + + +E+ V +VT + G D+ ++K ++ + Q+L
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQILRG 132
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
+ Y+HS ++HRDLK SN+ + +D ++++ DFGLA+ DD + V T Y PE++
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIML 190
Query: 181 D-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---------------AGLISKIN---- 220
+ + Y DIWS+GC M E+ R F D A L+ KI+
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 221 RSSIGPLPSC-----------YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
R+ I L +P L++ ML + + R +A++ L H + + D
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD-- 308
Query: 270 RPTFPPAACSPEKPISIAHESRRCMAE 296
P P A P + ESR + +
Sbjct: 309 -PDDEPVA----DPYDQSFESRDLLID 330
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 67/262 (25%), Positives = 113/262 (43%), Gaps = 12/262 (4%)
Query: 2 ESRMDQYEIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL 58
E + + + IG G FG + ++ EK +K + R QE +
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV-REKFLQEAYI 60
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ + HP+IV+ E + IV G++ ++ N L + QL
Sbjct: 61 MRQFDHPHIVKLIGVITENPVW--IVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLS 117
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTP-NYMCP 176
A+ YL S +HRD+ N+ ++ V+LGDFGL++ L+ + +S P +M P
Sbjct: 118 TALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 177 ELLADIPYGFKSDIWSLGCCMYE--MAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234
E + + SD+W G CM+E M +P F+ +I +I P+P P+
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRIENGERLPMPPNCPPT 236
Query: 235 LKTLIKGMLRKNPEHRPSASEL 256
L +L+ +P RP +EL
Sbjct: 237 LYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 12/251 (4%)
Query: 7 QYEIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
++ + ++G G FG + N K +LK L +Q + +E+ + R++
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSDDLLKQQD-----FQKEVQALKRLR 60
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H +++ A G V I+T E G + ++ G P L Q+ + Y
Sbjct: 61 HKHLISL-FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP-NYMCPELLADI 182
L +HRDL NI + +D ++ DFGLA+ +K D SS P + PE +
Sbjct: 120 LEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG 179
Query: 183 PYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
+ KSD+WS G +YEM + + + + + +I P P+ + ++
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239
Query: 242 MLRKNPEHRPS 252
PE RPS
Sbjct: 240 CWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 70/257 (27%), Positives = 127/257 (49%), Gaps = 11/257 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ ++++IG G FG L + EK+K +K IR +E +E ++ ++ HP
Sbjct: 4 SELTLVQEIGSGQFGLVWL-GYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHP 59
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+ E+ +C+V + E G +++ ++ G F +E L + + YL
Sbjct: 60 KLVQLYGVCTERSP-ICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLE 117
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP---NYMCPELLADI 182
S+ V+HRDL N + ++Q V++ DFG+ + + DD +S GT + PE+ +
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 183 PYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
Y KSD+WS G M+E+ + + ++ + ++ IN P S S+ L++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236
Query: 242 MLRKNPEHRPSASELLK 258
++ PE RPS S LL
Sbjct: 237 CWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 56/202 (27%), Positives = 83/202 (41%), Gaps = 42/202 (20%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMC 175
Q+L + +LHS ++HRDLK SNI + D +++ DFGLA+T + + V T Y
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGL- 215
PE++ + Y DIWS+GC M EM F D M+ L
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245
Query: 216 -----------------ISKINRSSIGPLPSCYSPSLKT-----LIKGMLRKNPEHRPSA 253
++ + P S LK L+ ML +PE R S
Sbjct: 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305
Query: 254 SELLKHPFLQHFVDQYRPTFPP 275
+ L+HP++ + D PP
Sbjct: 306 DDALQHPYINVWYDPSEVEAPP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 10/208 (4%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+ D YE +E++G G++ + K LK IRL ++ E +A +E +L+ ++
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL-QEEEGTPFTAIREASLLKGLK 61
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEE-KLCKWFAQLLLAVD 122
H IV + + + +V Y D+ + M K G PE KL + QLL +
Sbjct: 62 HANIVLLHDI-IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL--FLFQLLRGLS 117
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL--AKTLKADDLASSVVGTPNYMCPE-LL 179
Y+H Y+LHRDLK N+ ++ +++L DFGL AK++ + ++ VV T Y P+ LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAF 207
Y D+W +GC EM AF
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 82/307 (26%), Positives = 125/307 (40%), Gaps = 58/307 (18%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+Y + +G G+ G K+ +KKI L + + A +E+ +I R+ H
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVK-HALREIKIIRRLDHDN 63
Query: 67 IVEFKEAWVEKGC-------------YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
IV+ E G V IV Y E D+A ++++ EE +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LSEEHARLF 119
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDV-RLGDFGLAKTLKAD-----DLASSV 167
QLL + Y+HS VLHRDLK +N+F+ + V ++GDFGLA+ + L+ +
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 168 VGTPNYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAF---KAFDMAGLI------- 216
V T Y P LL+ Y D+W+ GC EM +P F + LI
Sbjct: 180 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 217 -------------SKINRSSIGP-------LPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256
S + P LP +L L + +L NP R +A E
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ-ILTFNPMDRLTAEEA 297
Query: 257 LKHPFLQ 263
L HP++
Sbjct: 298 LMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 62/266 (23%), Positives = 126/266 (47%), Gaps = 19/266 (7%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
M + ++++ IG+G FG +L ++R K +K I+ + ++ E +++ +++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIK----NDATAQAFLAEASVMTQLR 57
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H +V+ VE+ + IVT Y G + + ++ + + L K+ + A++Y
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP----NYMCPELL 179
L +N +HRDL N+ +++D ++ DFGL K ASS T + PE L
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE------ASSTQDTGKLPVKWTAPEAL 171
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ + KSD+WS G ++E+ + R + + ++ ++ + P P + +
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQH 264
+K + RPS +L + L+H
Sbjct: 232 MKQCWHLDAATRPSFLQLREQ--LEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 61/252 (24%), Positives = 117/252 (46%), Gaps = 11/252 (4%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
++++G G FG V H + + + I++ R+ +E ++ ++ HP +V+
Sbjct: 9 LKELGSGQFG----VVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
++ + IVT Y G + +++ G E L + + A++YL SN +
Sbjct: 65 YGVCTKQRP-IFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP---NYMCPELLADIPYGFK 187
HRDL N + +D V++ DFGLA+ + D SS GT + PE+ + K
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSK 181
Query: 188 SDIWSLGCCMYEM-AAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246
SD+WS G M+E+ + + ++ F + ++ ++ P + T++ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEK 241
Query: 247 PEHRPSASELLK 258
PE RP+ +LL
Sbjct: 242 PEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 74/305 (24%), Positives = 131/305 (42%), Gaps = 61/305 (20%)
Query: 8 YEIMEQIGRGAFGAAILVNH--RAEKKKYVLKKI-RLARQTERCRRSAHQEMALIARVQH 64
YE+++++G+GA+G + +E++ +KKI + + +R+ + L H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 65 PYIVE-------FKEAWVEKGCYVCIVTGYCEGGDMAELMKKS---NGAYFPEEKLCKWF 114
I F + E Y ++ D+ ++++ A+F + F
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEA-----DLHQIIRSGQPLTDAHF------QSF 110
Query: 115 A-QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-----KADDLASSVV 168
Q+L + Y+HS VLHRDLK N+ + D ++++ DFGLA+ + + V
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 169 GTPNYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-------- 219
T Y PE +L+ Y D+WS+GC + E+ +P FK D +++I
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230
Query: 220 --NRSSIG-----------------PLPSCY---SPSLKTLIKGMLRKNPEHRPSASELL 257
S IG P S + +P L++ +L +P R S E L
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
Query: 258 KHPFL 262
+HP+L
Sbjct: 291 EHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-16
Identities = 77/312 (24%), Positives = 125/312 (40%), Gaps = 41/312 (13%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
+ +Y+ ++ IG GA G +KK+ Q + + A++E+ L+ V H
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
I+ + + Y M + + E++ Q+L + +L
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 139
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HS ++HRDLK SNI + D +++ DFGLA+T + + + V T Y PE++ + Y
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 199
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISKI-----N 220
DIWS+GC M E+ F+ D M L + N
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259
Query: 221 RSSIGPL------PSCYSPS------LKT-----LIKGMLRKNPEHRPSASELLKHPFLQ 263
R + P PS LKT L+ ML +P+ R S E L+HP++
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
Query: 264 HFVDQYRPTFPP 275
+ D PP
Sbjct: 320 VWYDPAEAEAPP 331
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 41/312 (13%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
+ +Y+ ++ IG GA G ++ +KK+ Q + + A++E+ L+ V H
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
I+ + + Y M + + E++ Q+L + +L
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
HS ++HRDLK SNI + D +++ DFGLA+T + + V T Y PE++ + Y
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY---SPSLKT---- 237
DIWS+GC M EM F D +K+ P P P+++T
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 238 ----------------------------------LIKGMLRKNPEHRPSASELLKHPFLQ 263
L+ ML + R S E L+HP++
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322
Query: 264 HFVDQYRPTFPP 275
+ D PP
Sbjct: 323 VWYDPSEAEAPP 334
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 41/263 (15%)
Query: 17 GAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP------YIVEF 70
G FG ++ H+ +K +V K I+ A+ HQ M +P Y V
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIK-AKNFNAIEPMVHQLMK-----DNPNFIKLYYSVTT 80
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
+ V ++ Y + GD+ +L+KK E ++ K QL+ A++ LH + ++
Sbjct: 81 LKGHV-------LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 131 HRDLKCSNIFLT--KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKS 188
H D+K N+ KD+ + L D+GL K + S GT +Y PE + Y
Sbjct: 132 HNDIKLENVLYDRAKDR-IYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSF 187
Query: 189 DIWSLGCCMYEMAAHRPAFKAF--------DMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
D W++G YE+ + FK + K + P S + ++
Sbjct: 188 DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KL-PFIKNVSKNANDFVQ 242
Query: 241 GMLRKNPEHR-PSASELLKHPFL 262
ML+ N +R + +E++KHPFL
Sbjct: 243 SMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 11/219 (5%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
QE ++ +++H +V+ E+ Y IVT Y G + + +K G Y +L
Sbjct: 50 QEAQVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTP- 171
AQ+ + Y+ +HRDL+ +NI + ++ ++ DFGLA+ ++ ++ A P
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 167
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSC 230
+ PE + KSD+WS G + E+ R + ++ ++ R P P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 227
Query: 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
SL L+ RK PE RP+ +LQ F++ Y
Sbjct: 228 CPESLHDLMCQCWRKEPEERPT------FEYLQAFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 76/292 (26%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+M+ Y +E++G G + + + LK+IRL + E +A +E++L+ ++
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLK 62
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H IV + V + +V Y + D+ + M G + + Q+L + Y
Sbjct: 63 HANIVTLHDI-VHTDKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAY 119
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL--AKTLKADDLASSVVGTPNYMCPE-LLA 180
H VLHRDLK N+ + + +++L DFGL AK++ ++ VV T Y P+ LL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKA----------FDMAGLISKINRSSIG----- 225
Y + D+W +GC +EMA+ RP F F + G ++ I
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238
Query: 226 ---------PLPSC-YSPSLKT----LIKGMLRKNPEHRPSASELLKHPFLQ 263
P P ++P L T L+ L+ + R SA E +KH + +
Sbjct: 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 5/202 (2%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
E L+ ++QHP +V ++ Y I+T Y E G + + +K G KL
Sbjct: 50 AEANLMKQLQHPRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTP- 171
AQ+ + ++ +HRDL+ +NI +++ ++ DFGLA+ ++ ++ A P
Sbjct: 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI 167
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSC 230
+ PE + + KSD+WS G + E+ + R + +I + R P P
Sbjct: 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDN 227
Query: 231 YSPSLKTLIKGMLRKNPEHRPS 252
L L++ ++ PE RP+
Sbjct: 228 CPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 40/290 (13%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y +E++G G++ R + LK I + + E +A +E +L+ ++H I
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANI 65
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V + + + V Y D+A+ M + G P F QLL + Y+H
Sbjct: 66 VLLHDI-IHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMF-QLLRGLAYIHGQ 122
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLA--KTLKADDLASSVVGTPNYMCPE-LLADIPY 184
++LHRDLK N+ ++ +++L DFGLA K++ + +S VV T Y P+ LL Y
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDY 181
Query: 185 GFKSDIWSLGCCMYEMAAHRPAF-----------KAFDMAGL--------ISKIN--RSS 223
DIW GC EM +PAF K + + G+ +SK+ +
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241
Query: 224 IGPLPSCYS-----------PSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
P + L ML P+ R SA + L HP+
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 81/306 (26%), Positives = 124/306 (40%), Gaps = 75/306 (24%)
Query: 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH-------- 64
IG GAFG V + K+ LKK+ Q + +E+ ++ +H
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 65 ----PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK-------SNGAYFPEEKLCKW 113
P+I F+E +V + ELM+ S + K
Sbjct: 67 ILQPPHIDPFEEIYV-----------------VTELMQSDLHKIIVSPQPLSSDH--VKV 107
Query: 114 FA-QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVG 169
F Q+L + YLHS +LHRD+K N+ + + +++ DFGLA+ + D+ + VV
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV- 166
Query: 170 TPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKA------FDM---------- 212
T Y PE+L Y DIWS+GC E+ R F+A D+
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 213 -------AGLISKINRSSIGP--LPSCYSPSLKT------LIKGMLRKNPEHRPSASELL 257
G + I R P LP Y+ S + L+ ML +P+ R SA++ L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 258 KHPFLQ 263
HP+L
Sbjct: 287 AHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 60/267 (22%), Positives = 115/267 (43%), Gaps = 15/267 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ ++++++G G FG + K ++ + S +E ++ +++H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV----AVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+ E+ Y IVT Y G + + +K G L AQ+ + Y+
Sbjct: 62 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTP-NYMCPELLADIP 183
+HRDL+ +NI + ++ DFGLA+ ++ ++ A P + PE
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+ KSD+WS G + E+ R + + ++ ++ R P P SL L+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC 239
Query: 243 LRKNPEHRPSASELLKHPFLQHFVDQY 269
+K+PE RP+ +LQ F++ Y
Sbjct: 240 WKKDPEERPT------FEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 8/207 (3%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+++ Y ++++G G + + + LK+IRL + E +A +E++L+ ++
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLK 61
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H IV + + C + +V Y + D+ + + G + + QLL + Y
Sbjct: 62 HANIVTLHDIIHTERC-LTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSY 118
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL--AKTLKADDLASSVVGTPNYMCPE-LLA 180
H +LHRDLK N+ + + +++L DFGL AK++ ++ VV T Y P+ LL
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAF 207
Y D+W +GC +YEMA RP F
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
QE ++ +++H +V+ A + + IVT Y G + + +K G +L
Sbjct: 50 QEAQIMKKLRHDKLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT--P 171
AQ+ + YL S +HRDL NI + ++ ++ DFGLA+ ++ DD ++ G P
Sbjct: 109 AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFP 167
Query: 172 -NYMCPELLADIPYG---FKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGP 226
+ PE YG KSD+WS G + E+ + R + ++ ++ R P
Sbjct: 168 IKWTAPEA---ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP 224
Query: 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
P L L+ K+PE RP+ +LQ F++ Y
Sbjct: 225 RPPNCPEELYDLMLQCWDKDPEERPTFE------YLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 70/262 (26%), Positives = 124/262 (47%), Gaps = 19/262 (7%)
Query: 9 EIMEQIGRGAFGAAIL--VNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+I E IG G FG + +++ +V K + TE+ RR E +++ + HP
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
I+ E V K V I+T + E G + +++++G F +L + + YL
Sbjct: 67 IIHL-EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLSE 124
Query: 127 -NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK---ADDLASSVVGTP---NYMCPELL 179
NYV HRDL NI + + ++ DFGL++ L+ +D +S +G + PE +
Sbjct: 125 MNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAG--LISKINRSSIGPLPSCYSPSL 235
A + SD+WS G M+E+ ++ RP +DM+ +I+ I + P P +L
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDVINAIEQDYRLPPPMDCPTAL 240
Query: 236 KTLIKGMLRKNPEHRPSASELL 257
L+ +K+ RP +++
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 67/274 (24%), Positives = 126/274 (45%), Gaps = 21/274 (7%)
Query: 10 IMEQIGRGAFGAAILV---NHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+ ++G GAFG L N E+ K ++ L ++ R+ H+E L+ +QH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDM----------AELMKKSNG-AYFPEEKLCKWFA 115
IV+F VE G + +V Y + GD+ A LM + N A + ++
Sbjct: 69 IVKFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPN 172
Q+ + YL S + +HRDL N + ++ V++GDFG+++ + + D + +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCY 231
+M PE + + +SD+WSLG ++E+ + + + +I I + + P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 247
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
+ L+ G ++ P R + E+ H LQ+
Sbjct: 248 PKEVYDLMLGCWQREPHMRLNIKEI--HSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-15
Identities = 56/187 (29%), Positives = 76/187 (40%), Gaps = 39/187 (20%)
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV---VGTPNY 173
LL A+ YLH ++HRD+K NIFL + ++ LGDFG A L A GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAF----------------KAFDMAGLIS 217
PELLA PY K+DIWS G ++EM+ + + L
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313
Query: 218 KINRS------------------SIGPLPSCYSPS--LKTLIKGMLRKNPEHRPSASELL 257
N S +I P+ Y ++ LI ML + E RPSA ++L
Sbjct: 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373
Query: 258 KHPFLQH 264
P
Sbjct: 374 SLPLFTK 380
|
Length = 392 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 74/289 (25%), Positives = 113/289 (39%), Gaps = 54/289 (18%)
Query: 11 MEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
+ +G G FG L + + V K ++ +E+ ++ + H I
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 68 VEFKEAWVEKGCYVCIVTGYC-EGGD------MAELMKKSNGAYFPEEKLCKWFAQLLL- 119
V++K GC C E G M + S Y P+ KL AQLLL
Sbjct: 69 VKYK------GC--------CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN--LAQLLLF 112
Query: 120 ------AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN- 172
+ YLHS + +HRDL N+ L D+ V++GDFGLAK + V +
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 173 ---YMCPELLADIPYGFKSDIWSLGCCMYEMAAH-----RPAFKAFDMAG---------- 214
+ E L + + + SD+WS G +YE+ H P K +M G
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232
Query: 215 LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
LI + R P P + L+K + RP+ L+ P L+
Sbjct: 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI--PILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-15
Identities = 81/308 (26%), Positives = 123/308 (39%), Gaps = 61/308 (19%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH--QEMALIARVQHPYIV 68
++ +G GAFG L Y +K +R R + AH E ++A + ++V
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVV 64
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
+ ++ +K + V Y GGDM L+ + FPE + A+L LA++ +H
Sbjct: 65 KLYYSFQDKDN-LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG 121
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK------------------------ADD-- 162
+HRD+K NI + D ++L DFGL + DD
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 163 ----------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM 200
LA S+VGTPNY+ PE+L Y D WS+G ++EM
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 201 AAHRPAFKA-FDMAGLISKINRSSIGPLPSC--YSPSLKTLIKGMLRKNPEHR---PSAS 254
+P F A + IN + +P SP LI L + E R A
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI-TKLCCSAEERLGRNGAD 300
Query: 255 ELLKHPFL 262
++ HPF
Sbjct: 301 DIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 8/207 (3%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+++ Y ++++G G + + LK+IRL + E +A +E++L+ ++
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLK 62
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H IV + + + +V Y + L N KL + QLL ++Y
Sbjct: 63 HANIVTLHDI-IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL--FLFQLLRGLNY 119
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL--AKTLKADDLASSVVGTPNYMCPE-LLA 180
H VLHRDLK N+ + + +++L DFGL AK++ ++ VV T Y P+ LL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAF 207
Y + D+W +GC YEM+ RP F
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 67/260 (25%), Positives = 117/260 (45%), Gaps = 27/260 (10%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
M+++G G FG L RA+ K +K I + +E ++ ++ HP +V+
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 71 KEAWV-EKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
+K Y IVT + E G + +++ G ++ L + ++YL N
Sbjct: 65 YGVCTQQKPLY--IVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-PNYMC-PELLADIPYGFK 187
+HRDL N ++ V++ DFG+ + + D+ SS P PE+ Y K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 188 SDIWSLGCCMYEMAAH-RPAFKA---FDMAGLISKINRSSIGPLPSCYSPSL--KTLIKG 241
SD+WS G M+E+ + F+ +++ +IS+ R Y P L T+ +
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR--------LYRPKLASMTVYEV 233
Query: 242 MLR---KNPEHRPSASELLK 258
M + PE RP+ +ELL+
Sbjct: 234 MYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 66/260 (25%), Positives = 116/260 (44%), Gaps = 27/260 (10%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYV------LKKIRLARQTERCRRSAHQEMALIARVQHP 65
+++G G FG+ + + + K V LK+ +A + R A ++A++ HP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREAS----VMAQLDHP 56
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV + V KG + +V G + + L K+ P L + Q+ + + YL
Sbjct: 57 CIV--RLIGVCKGEPLMLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYL 111
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTP-NYMCPELLA 180
S + +HRDL N+ L ++ DFG+++ L A A++ P + PE
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC-- 169
Query: 181 DIPYG-F--KSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236
I YG F KSD+WS G ++E ++ + A +I+ + P P +
Sbjct: 170 -INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIY 228
Query: 237 TLIKGMLRKNPEHRPSASEL 256
+++ + PE RP+ SEL
Sbjct: 229 SIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 66/199 (33%), Positives = 80/199 (40%), Gaps = 49/199 (24%)
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV---VGTPNY 173
+L A+ YLH N ++HRD+K NIF+ DV LGDFG A D A+ GT
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIAT 249
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG---------LISKINRSS 223
PELLA PYG DIWS G ++EMA H F+ + G LI I RS
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI--IRRSG 307
Query: 224 IGP---------------LPSCYSPS------------------LKTLIKGMLRKNPEHR 250
P + S L+ LI ML + HR
Sbjct: 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367
Query: 251 PSASELLKHPFLQHFVDQY 269
PSA LL Q D Y
Sbjct: 368 PSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
QE ++ +++H +V E+ Y IVT + G + + +K+ +G Y +L
Sbjct: 50 QEAQIMKKLRHDKLVPLYAVVSEEPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTP- 171
AQ+ + Y+ +HRDL+ +NI + + ++ DFGLA+ ++ ++ A P
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSC 230
+ PE + KSD+WS G + E+ R + ++ ++ R P P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQG 227
Query: 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
SL L+K +K+P+ RP+ ++Q F++ Y
Sbjct: 228 CPESLHELMKLCWKKDPDERPT------FEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/257 (22%), Positives = 111/257 (43%), Gaps = 19/257 (7%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH---QEMALIAR 61
+ + + E IG G FGA + + +Y +K+ A + +C +A +E A++ +
Sbjct: 5 LQKLTLGEIIGEGEFGAVL-------QGEYTGQKV--AVKNIKCDVTAQAFLEETAVMTK 55
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+ H +V + G Y IV G++ ++ A +L ++ + +
Sbjct: 56 LHHKNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP-NYMCPELLA 180
+YL S ++HRDL NI +++D ++ DFGLA + + P + PE L
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALK 170
Query: 181 DIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239
+ KSD+WS G ++E+ ++ R + + + + + P + L+
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230
Query: 240 KGMLRKNPEHRPSASEL 256
P+ RPS +L
Sbjct: 231 TSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 69/254 (27%), Positives = 113/254 (44%), Gaps = 15/254 (5%)
Query: 14 IGRGAFGAAILVNHRAEKKK--YVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFK 71
IG G FG + K+ V K A TE+ RR E +++ + HP I+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL- 70
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
E V K V IVT Y E G + ++K +G F +L + + YL +H
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVH 129
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTP---NYMCPELLADIPYGFK 187
RDL NI + + ++ DFGL++ L+ D + A + G + PE +A +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 188 SDIWSLGCCMYEMAAH--RPAFKAFDMAG--LISKINRSSIGPLPSCYSPSLKTLIKGML 243
SD+WS G M+E+ ++ RP ++M+ +I I P P +L L+
Sbjct: 190 SDVWSYGIVMWEVMSYGERP---YWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCW 246
Query: 244 RKNPEHRPSASELL 257
+K+ RP +++
Sbjct: 247 QKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ----EMALIARV-QHPYIV 68
+G GAFG + K + K+ + S + E+ +++ + H IV
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
A G + ++T YC GD+ +++ ++ E L + Q+ + +L S
Sbjct: 103 NLLGA-CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN------YMCPELLADI 182
+HRDL N+ LT + V++ DFGLA+ + D S+ V N +M PE + +
Sbjct: 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWMAPESIFNC 218
Query: 183 PYGFKSDIWSLGCCMYEM 200
Y F+SD+WS G ++E+
Sbjct: 219 VYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVC-------IVTGYCEGGDMAELMKKSNGAYFP 106
+E A++ ++HP +V+ VC I+T + G++ + +++ N
Sbjct: 51 KEAAVMKEIKHPNLVQL--------LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 102
Query: 107 EEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166
L Q+ A++YL +HRDL N + ++ V++ DFGL++ + D ++
Sbjct: 103 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 161
Query: 167 VVGTP---NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH----RPAFKAFDMAGLISKI 219
G + PE LA + KSD+W+ G ++E+A + P + L+ K
Sbjct: 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221
Query: 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256
R P C P + L++ + NP RPS +E+
Sbjct: 222 YRME-RP-EGC-PPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-14
Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 23/246 (9%)
Query: 33 KYVLKKIR-LARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGG 91
+ +K +R A + E R +E AL AR+ HP IV ++ + V Y G
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 92 DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVR--- 148
+ E++ ++GA E + Q+L A+ H+ ++HRDLK NI +++
Sbjct: 65 TLREVLA-ADGALPAGETG-RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 149 LGDFGLAKTL----KADDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM 200
+ DFG+ L AD + V+GTP Y PE L P SD+++ G E
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLEC 182
Query: 201 AAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPS-----LKTLIKGMLRKNPEHRPSASE 255
+ + +A ++ + + P+ P L +++ L K+P R +++
Sbjct: 183 LTGQRVVQGASVAEILYQ----QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAP 238
Query: 256 LLKHPF 261
L F
Sbjct: 239 ALAERF 244
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 60/275 (21%), Positives = 113/275 (41%), Gaps = 23/275 (8%)
Query: 2 ESRMDQYEIMEQIGRGAFG------AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQE 55
E ++ ++ ++G+G+FG A +V E + V K + R R E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETR--VAIKTVNENASMRERIEFLNE 59
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--------SNGAYFPE 107
+++ ++V V G +V GD+ ++
Sbjct: 60 ASVMKEFNCHHVVRLL-GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 108 EKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---A 164
+K + A++ + YL + +HRDL N + +D V++GDFG+ + + D
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRS 222
+ +M PE L D + KSD+WS G ++EMA A +P ++ ++ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP-YQGLSNEEVLKFVIDG 237
Query: 223 SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELL 257
LP L L++ + NP+ RP+ E++
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 13 QIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
++GRG +G + ++K+Y LK+I + SA +E+AL+ ++HP ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 71 KEAWVEKGCY-VCIVTGYCEGGDMAELMK-----KSNGA--YFPEEKLCKWFAQLLLAVD 122
++ ++ V ++ Y E D+ ++K K+N P + Q+L +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQD----VRLGDFGLAKTLKAD-----DLASSVVGTPNY 173
YLH+N+VLHRDLK +NI + + V++ D G A+ + DL VV T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 174 MCPELLADIPYGFKS-DIWSLGCCMYEMAAHRPAF 207
PELL + K+ DIW++GC E+ P F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/267 (21%), Positives = 122/267 (45%), Gaps = 14/267 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ ++++++G G FG + + + K +K ++ + + + +E L+ +QH
Sbjct: 6 ESIKLVKKLGAGQFGE-VWMGYYNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHD 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V A V K + I+T Y G + + +K G KL + AQ+ + Y+
Sbjct: 62 KLVRLY-AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTP-NYMCPELLADIP 183
+HRDL+ +N+ +++ ++ DFGLA+ ++ ++ A P + PE +
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+ KSD+WS G +YE+ + + + + ++S + R P L ++K
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240
Query: 243 LRKNPEHRPSASELLKHPFLQHFVDQY 269
++ E RP+ +LQ +D +
Sbjct: 241 WKEKAEERPTFD------YLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 65/261 (24%), Positives = 109/261 (41%), Gaps = 21/261 (8%)
Query: 14 IGRGAFGAAI--LVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI---- 67
+G G FG+ + +N K +K +++A T E + HP +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 68 -VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSN----GAYFPEEKLCKWFAQLLLAVD 122
V + E ++ + + GD+ + S Y P + L K+ + ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTP-NYMCPELL 179
YL S +HRDL N L ++ +V + DFGL+K + D + P ++ E L
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAH----RPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
AD Y KSD+WS G M+E+A P + ++ + + NR + P C L
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--LKQPPDCLD-GL 243
Query: 236 KTLIKGMLRKNPEHRPSASEL 256
+L+ NP+ RPS L
Sbjct: 244 YSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 58/270 (21%), Positives = 109/270 (40%), Gaps = 30/270 (11%)
Query: 11 MEQIGRGAFGAAILV----NHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+ +GRG FG L + VL K + E + +E+ + ++ H
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEK----------LCKWFAQ 116
+V E + ++ Y + GD+ + ++ + + LC Q
Sbjct: 70 VVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC---TQ 125
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LASSVVGTPNYM 174
+ L +D+L + +HRDL N ++ ++V++ L+K + + + + ++
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISKINRSSIG----PLP 228
PE + + + KSD+WS G M+E+ P + D +NR G P+P
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRLQAGKLELPVP 241
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
L L+ NP+ RPS SEL+
Sbjct: 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 13 QIGRGAFGAAILVNHRAEK--KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
++GRG +G + K + Y LK+I + SA +E+AL+ ++HP ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 71 KEAWVEKGCY-VCIVTGYCEGGDMAELMK-----KSNG--AYFPEEKLCKWFAQLLLAVD 122
++ ++ V ++ Y E D+ ++K K+N P + Q+L +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQD----VRLGDFGLAKTLKAD-----DLASSVVGTPNY 173
YLH+N+VLHRDLK +NI + + V++ D G A+ + DL VV T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL-DPVVVTFWY 181
Query: 174 MCPELLADIPYGFKS-DIWSLGCCMYEMAAHRPAF 207
PELL + K+ DIW++GC E+ P F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 36/275 (13%)
Query: 11 MEQIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
++Q+G+G FG+ L + + V+ +L T R +E+ ++ +QH IV
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 69 EFKEAWVEKGCY------VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
++K CY + +V Y G + + ++K + KL + +Q+ ++
Sbjct: 69 KYKGV-----CYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGME 122
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN-----YMCPE 177
YL S +HRDL NI + + V++GDFGL K L D V P + PE
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWYAPE 181
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAH-----RPAFKAFDMAG-----------LISKINR 221
L + + SD+WS G +YE+ + P + M G LI +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 222 SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256
+ P P + ++K +P RPS SEL
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 29/229 (12%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCK 112
+E+ ++ + H IV++K E G + ++ + G + E + + N ++ K
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLK 113
Query: 113 WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA--------DDLA 164
+ Q+ +DYL S +HRDL N+ + + V++GDFGL K ++ DDL
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM-----AAHRPAFKAFDMAG----- 214
S V + PE L + SD+WS G +YE+ + P M G
Sbjct: 174 SPVF----WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229
Query: 215 -----LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
L+ + P P + L++ P R + L++
Sbjct: 230 MTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 3/149 (2%)
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
E L+ V HP ++ K+ V C+V + D+ + K + ++ L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAI-TCMVLPHYSS-DLYTYLTKRSRPLPIDQALII-E 163
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYM 174
Q+L + YLH+ ++HRD+K NIF+ V +GD G A+ + GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAH 203
PE+LA Y K+DIWS G ++EM A+
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEMLAY 252
|
Length = 357 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-13
Identities = 53/174 (30%), Positives = 92/174 (52%), Gaps = 5/174 (2%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ-EMALIARVQ 63
++++ I++ I RGAFG L + K Y +K ++ A + Q E +A +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
P+IV + ++ V +V Y GGD+ L+ YF EE K+ +++ LA+DY
Sbjct: 63 SPFIVHLYYS-LQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDY 119
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCP 176
LH + ++HRDLK N+ ++ + ++L DFGL+K TL + ++ TP+ P
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 53/244 (21%), Positives = 106/244 (43%), Gaps = 9/244 (3%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFK 71
+++G G FG + A K+ ++ + + E ++ +QH +V+
Sbjct: 12 KKLGAGQFGEVWM----ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
++ Y I+T + G + + +K G+ P KL + AQ+ + ++ +H
Sbjct: 68 AVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTP-NYMCPELLADIPYGFKSD 189
RDL+ +NI ++ ++ DFGLA+ ++ ++ A P + PE + + KSD
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 190 IWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248
+WS G + E+ + R + +I + R P P L ++ + PE
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPE 245
Query: 249 HRPS 252
RP+
Sbjct: 246 ERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 80/324 (24%), Positives = 129/324 (39%), Gaps = 71/324 (21%)
Query: 9 EIMEQIGRG--AFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
E+ +IGRG + L H ++ L TE ++ E+ L +HP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL----AVD 122
I+ + G ++ +++ + G L+K YFPE +L ++
Sbjct: 61 IMTSWTVFT-TGSWLWVISPFMAYGSANSLLK----TYFPEGMSEALIGNILFGALRGLN 115
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRL-GDFGLAKTLKADDLASSVVGTPNY-------M 174
YLH N +HR++K S+I ++ D V L G L ++ A V P + +
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175
Query: 175 CPELLADIPYGF--KSDIWSLGCCMYEMAAHRPAFKAFDM-------------------- 212
PELL YG+ KSDI+S+G E+A R F+ DM
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ--DMLRTQMLLQKLKGPPYSPLDI 233
Query: 213 --------------AGLISKINRSSI--------------GPLPSCYSPSLKTLIKGMLR 244
+G+ S I S + P +SP+ + L++ L+
Sbjct: 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQ 293
Query: 245 KNPEHRPSASELLKHPFLQHFVDQ 268
++PE RPSAS LL H F + +Q
Sbjct: 294 QDPEKRPSASSLLSHAFFKQVKEQ 317
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 10 IMEQIGRGAFGAAIL--VNHRAEKKKYVLKKIRLARQT--ERCRRSAHQEMALIARVQHP 65
+ ++G GAFG L H + L ++ ++T R+ +E L+ QH
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYF-------------PEEKLCK 112
IV+F E + +V Y E GD+ + ++ S+G +L +
Sbjct: 69 NIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 113 WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVG 169
Q+ + YL S + +HRDL N + D V++GDFG+++ + D + +
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 170 TPNYMCPELLADIPYG---FKSDIWSLGCCMYEM 200
+M PE I Y +SD+WS G ++E+
Sbjct: 187 PIRWMPPE---SIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 63/272 (23%), Positives = 120/272 (44%), Gaps = 25/272 (9%)
Query: 13 QIGRGAFGAAILV---NHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE 69
++G GAFG L N E+ K ++ L +E R+ +E L+ +QH +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDM----------AELMKKSNGAYFPEEKLCKWF---AQ 116
F E G + +V Y GD+ A+++ + L + +Q
Sbjct: 72 FYGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNY 173
+ + YL S + +HRDL N + + V++GDFG+++ + + D + + +
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISKINRSSIGPLPSCY 231
M PE + + +SDIWS G ++E+ + +P ++ + I I + P
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IECITQGRELERPRTC 249
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
P + +++G ++ P+ R ++ H LQ
Sbjct: 250 PPEVYAIMQGCWQREPQQRMVIKDI--HSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-12
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG---LAKTLKADDLASSVVGTPN 172
QLL A+DY+H ++HRD+K N+ + +D+ LGDFG A+ + + GT +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAH 203
PE+LA PY DIWS G ++E A H
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358
|
Length = 461 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 8/192 (4%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFK 71
E+IGRG FG RA+ +K R + + QE ++ + HP IV
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 59
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
+K + IV +GGD ++ + G ++L + ++YL S + +H
Sbjct: 60 GVCTQKQP-IYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN----YMCPELLADIPYGFK 187
RDL N +T+ +++ DFG+++ + D + +S G + PE L Y +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 188 SDIWSLGCCMYE 199
SD+WS G ++E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 22/265 (8%)
Query: 14 IGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI--- 67
+G G FG+ + + K +K ++L T E A + HP +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 68 --VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS----NGAYFPEEKLCKWFAQLLLAV 121
V F+ + ++K ++ + + GD+ + S P + L K+ + L +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTP-NYMCPEL 178
+YL + +HRDL N L +D V + DFGL+K + + D + P ++ E
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAH----RPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234
LAD Y KSD+W+ G M+E+A P + ++ + NR + C
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--LKQPEDCLD-E 243
Query: 235 LKTLIKGMLRKNPEHRPSASELLKH 259
L L+ R +P+ RP+ ++L +
Sbjct: 244 LYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 22/250 (8%)
Query: 17 GAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE 76
G +LV ++ ++LK +R + + R R + +I P +V + V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT------IIPHCV-PNMVCLHKYIVS 56
Query: 77 KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKC 136
+ V +V + EGG + + K PEE + +W A++++A+D LH ++ RDL
Sbjct: 57 EDS-VFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113
Query: 137 SNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCC 196
+NI L ++L F + + +D Y PE+ D WSLG
Sbjct: 114 NNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAI 171
Query: 197 MYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSA--- 253
++E+ + + S IN + +P S ++L++ +L+ NP R A
Sbjct: 172 LFELLTGKTLVECHP-----SGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226
Query: 254 --SELLKHPF 261
++ HPF
Sbjct: 227 GVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 56/254 (22%), Positives = 119/254 (46%), Gaps = 15/254 (5%)
Query: 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE 69
++++G G FG +V + + +Y + I++ ++ +E ++ ++ H +V+
Sbjct: 8 FLKELGTGQFG---VVKYGKWRGQYDVA-IKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEE--KLCKWFAQLLLAVDYLHSN 127
K + IVT Y G + +++ + P + ++CK + + YL S
Sbjct: 64 LYGV-CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCE---GMAYLESK 119
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP---NYMCPELLADIPY 184
+HRDL N + V++ DFGL++ + D+ SS VG+ + PE+L +
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKF 178
Query: 185 GFKSDIWSLGCCMYEM-AAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243
KSD+W+ G M+E+ + + ++ F+ + + K+++ P S + ++
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW 238
Query: 244 RKNPEHRPSASELL 257
+ E RP+ +LL
Sbjct: 239 HEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-12
Identities = 38/90 (42%), Positives = 51/90 (56%), Gaps = 2/90 (2%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV--VGTPNY 173
QLL AV+Y+H ++HRD+K NIFL D + LGDFG A + + A VGT
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAH 203
PE+LA Y +DIWS G + +M +H
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 38 KIRLARQT--ERCRRSAHQE----MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGG 91
KI +A +T +R R QE M + + H YIV + G + +VT G
Sbjct: 36 KIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL--LGICPGASLQLVTQLSPLG 93
Query: 92 DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGD 151
+ + +++ + P+ +L W Q+ + YL + ++HR+L NI L D V++ D
Sbjct: 94 SLLDHVRQHRDSLDPQ-RLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 152 FGLAKTLKADD--LASSVVGTP-NYMCPELLADIPYGFKSDIWSLGCCMYEM-------- 200
FG+A L DD S TP +M E + Y +SD+WS G ++EM
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
Query: 201 AAHRPAFKAFDMAGLISKINR 221
A RP ++ L+ K R
Sbjct: 213 AGMRPH----EVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 56/255 (21%), Positives = 107/255 (41%), Gaps = 27/255 (10%)
Query: 13 QIGRGAFGAAILVNHRAEK--KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
++G G FG ++ +K K +K ++ + +E ++ ++ +PYIV
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 71 -----KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
E+W+ +V E G + + ++K+ + E+ + + Q+ + + YL
Sbjct: 62 IGICEAESWM-------LVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE 112
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP----NYMCPELLAD 181
+HRDL N+ L ++ DFGL+K L AD+ + PE +
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 182 IPYGFKSDIWSLGCCMYEMAAH--RP--AFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
+ KSD+WS G M+E ++ +P K ++ +I R + C P +
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--MECPQRC-PPEMYD 229
Query: 238 LIKGMLRKNPEHRPS 252
L+K + RP
Sbjct: 230 LMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 62/264 (23%), Positives = 113/264 (42%), Gaps = 32/264 (12%)
Query: 14 IGRGAFG------AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
+G GAFG A ++ + + +K +R + ++ +E L++ HP I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL-LAVD---- 122
V+ + I+ EGGD+ ++ + F L +LL + +D
Sbjct: 62 VKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAKG 118
Query: 123 --YLHSNYVLHRDLKCSNIFLT-----KDQDVRLGDFGLAKTL-KADDLASSVVGTPN-- 172
YL + +HRDL N ++ D+ V++GDFGLA+ + K+D G
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRP--AFKAFDMAGLISKINRSSIGPLP 228
+M PE L D + +SD+WS G M+E+ +P A ++ ++ R +
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR--LQKPE 236
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPS 252
+C + L+ ++P RP+
Sbjct: 237 NC-PDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 60/269 (22%), Positives = 119/269 (44%), Gaps = 26/269 (9%)
Query: 13 QIGRGAFGAAILV---NHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE 69
++G GAFG L N K K ++ L T R+ +E L+ +QH +IV+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMK---------------KSNGAYFPEEKLCKWF 114
F + G + +V Y + GD+ + ++ ++ G + L
Sbjct: 72 FYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML-HIA 129
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTP 171
+Q+ + YL S + +HRDL N + + V++GDFG+++ + + D + +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISKINRSSIGPLPS 229
+M PE + + +SD+WS G ++E+ + +P F+ +I I + + P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIECITQGRVLERPR 248
Query: 230 CYSPSLKTLIKGMLRKNPEHRPSASELLK 258
+ ++ G ++ P+ R + E+ K
Sbjct: 249 VCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 37/259 (14%)
Query: 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH----PYIV 68
++G G FG ++ KK+ + L + E+ R EM A + H PYIV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR---DEMMREAEIMHQLDNPYIV 58
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGA-----------YFPEEKLCKWFAQL 117
+ G CE + +M+ ++G + + Q+
Sbjct: 59 R--------------MIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV 104
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTP-NY 173
+ + YL +HRDL N+ L ++ DFGL+K L ADD A S P +
Sbjct: 105 SMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYS 232
PE + + +SD+WS G M+E ++ + +K ++S I + P+
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECP 224
Query: 233 PSLKTLIKGMLRKNPEHRP 251
P + L+K E RP
Sbjct: 225 PEMYALMKDCWIYKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 36/287 (12%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAIL---VNHRAEKKKYVLK---KIRLARQTERCRRSAHQE 55
E D+ + + +G G FG ++ + EK V K K+ + TE+ E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 56 MALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS---------NGAYF 105
M ++ + +H I+ A + G IV Y G++ E ++ N
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVE-YASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 106 PEEKL-------CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158
PEE+L C + Q+ ++YL S +HRDL N+ +T+D +++ DFGLA+ +
Sbjct: 133 PEEQLSFKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 159 KADDLASSVVG---TPNYMCPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFKAFD 211
D +M PE L D Y +SD+WS G ++E+ + P +
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 212 MAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
+ L+ + +R PS + L +++ P RP+ +L++
Sbjct: 251 LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 45/203 (22%), Positives = 94/203 (46%), Gaps = 6/203 (2%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
E ++ +++HP +++ A + IVT + G + E ++ G +L
Sbjct: 50 AEAQIMKKLRHPKLIQLY-AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP-- 171
AQ+ + YL + +HRDL N+ + ++ ++ DFGLA+ +K +D+ + G
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFP 167
Query: 172 -NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPS 229
+ PE + KSD+WS G + E+ + R + A ++ ++++ P P
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP 227
Query: 230 CYSPSLKTLIKGMLRKNPEHRPS 252
L ++ +++P+ RP+
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 20/195 (10%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ----EMALIARVQHPYI 67
IG+G FG +L ++R +K +K ++ +A Q E +++ ++HP +
Sbjct: 12 ATIGKGEFGDVMLGDYR--GQKVAVKCLK-------DDSTAAQAFLAEASVMTTLRHPNL 62
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN 127
V+ V +G + IVT Y G + + ++ A + + + ++YL
Sbjct: 63 VQLL-GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAK--TLKADDLASSVVGTPNYMCPELLADIPYG 185
+HRDL N+ +++D ++ DFGLAK + D V T PE L + +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFS 177
Query: 186 FKSDIWSLGCCMYEM 200
KSD+WS G ++E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 63/283 (22%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 6 DQYEIMEQIGRGAFGAAILVN----HRAEKKKYVLKKIRLARQ--TERCRRSAHQEMALI 59
D+ + + +G G FG ++ + + K+ V +++ + TE+ EM ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 60 ARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS---------NGAYFPEEK 109
+ +H I+ A + G IV Y G++ E ++ + A P+E+
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVE-YASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 110 L-------CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162
+ C + Q+ ++YL S +HRDL N+ +T++ +++ DFGLA+ + D
Sbjct: 134 MTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 163 LASSVVG---TPNYMCPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFKAFDMAGL 215
+M PE L D Y +SD+WS G M+E+ + P ++ L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 216 ISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
+ + +R P+ + L +++ P HRP+ +L++
Sbjct: 252 LKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
E ++A V HP++V + V ++T G + + ++ + L W
Sbjct: 58 DEAYVMASVDHPHVVRL--LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY-LLNW 114
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG--TP 171
Q+ + YL ++HRDL N+ + Q V++ DFGLAK L D+ G P
Sbjct: 115 CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 172 -NYMCPELLADIPYGFKSDIWSLGCCMYEM 200
+M E + Y KSD+WS G ++E+
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 66/290 (22%), Positives = 126/290 (43%), Gaps = 44/290 (15%)
Query: 2 ESRMDQYEIMEQIGRGAFG-----AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEM 56
E D+ + + +G GAFG A+ +++ E +K ++ TE+ EM
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEM 66
Query: 57 ALIARV-QHPYIVEFKEAWVEKG-CYVCIVTGYCEGGDMAELMK---------KSNGAYF 105
++ + +H I+ ++G YV V Y G++ + ++ +
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 106 PEEKL-------CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158
PEE L + Q+ +++L S +HRDL N+ +T+D +++ DFGLA+ +
Sbjct: 125 PEETLTQKDLVSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 159 KADDLASSVVGTPN------YMCPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFK 208
D T N +M PE L D Y +SD+WS G ++E+ + P
Sbjct: 183 HHIDYYRK---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239
Query: 209 AFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
++ L+ + R + +C + L L++ + P RP+ +L++
Sbjct: 240 VEELFKLLKEGYR--MEKPQNC-TQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 20/268 (7%)
Query: 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--TERCRRSAHQEMALIARVQHPYI 67
I + IG G FG + KK + I+ + +++ R E +++ + HP I
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS- 126
+ E V K V I+T Y E G + + +++++G F +L + + YL
Sbjct: 68 IRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM 125
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG--TP-NYMCPELLADIP 183
NYV HRDL NI + + ++ DFGL++ L+ + + G P + PE +A
Sbjct: 126 NYV-HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 184 YGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAG--LISKINRSSIGPLP-SCYSPSLKTL 238
+ SD+WS G M+E+ ++ RP +DM+ +I + P P C S L L
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP---YWDMSNQDVIKAVEDGYRLPPPMDCPSA-LYQL 240
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQHFV 266
+ +K+ RP+ S+++ L +
Sbjct: 241 MLDCWQKDRNERPTFSQIVST--LDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-11
Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 40/273 (14%)
Query: 7 QYEIMEQIGRGAFGAAI--LVNHRAEKKK--YVLKKIRLARQTERCRRSAHQEMALIARV 62
+++ ++ +G GAFG L EK K +K++R A + + + E ++A V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV 66
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGD---MAELMK--------KSNGAYFPEEKLC 111
+P+ VC + G C + +LM + + + L
Sbjct: 67 DNPH--------------VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 112 KWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP 171
W Q+ ++YL ++HRDL N+ + Q V++ DFGLAK L AD+ G
Sbjct: 113 NWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 172 ---NYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRP--AFKAFDMAGLISKINRSSI 224
+M E + Y +SD+WS G ++E+ +P A +++ ++ K R
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 230
Query: 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELL 257
P P + + ++ + + RP EL+
Sbjct: 231 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 27/168 (16%)
Query: 108 EKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV 167
E L + Q+ +++L S +HRDL NI L+++ V++ DFGLA+ + D
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD------ 226
Query: 168 VGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFKAFD 211
P+Y M PE + D Y +SD+WS G ++E+ A+ P + +
Sbjct: 227 ---PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 212 MAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
++ + P +P + +++ NPE RP+ SEL++
Sbjct: 284 --EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 27/272 (9%)
Query: 9 EIMEQIGRGAFGAA-----ILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+E++G GAFG N R +K ++ + ++ QE L++ +Q
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQ 66
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKS----NGAYFPEEKLCKWF---- 114
HP IV K C++ Y GD+ E L++ S GA +E +
Sbjct: 67 HPNIVCLLGV-CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 115 -----AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASS 166
Q+ ++YL S++ +HRDL N + + V++ DFGL++ + + D + S
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISKINRSSI 224
+ +M PE + + +SDIWS G ++E+ ++ +P + F +I I +
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIEMIRSRQL 244
Query: 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256
P P + L+ + P RP ++
Sbjct: 245 LPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 12 EQIGRGAFGAAIL--VNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE 69
++IG G FG +L + K + V+K++R A T + QE+ + HP +++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG--AYFPEEKLCKWFA-QLLLAVDYLHS 126
+E Y+ +V +C GD+ ++ + G A ++ + + A ++ + +LH
Sbjct: 60 CLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELL---- 179
+H DL N LT D V++GD+GLA +D ++ PEL+
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 180 -----ADIPYGFKSDIWSLGCCMYEM--AAHRP 205
D KS+IWSLG M+E+ AA +P
Sbjct: 179 QDLLPKDQTK--KSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 14 IGRGAFGAAI--LVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFK 71
IG G FG ++ K+ V K TE+ R+ E +++ + H I+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL- 71
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVL 130
E V K I+T Y E G + + ++ +G + + L + + YL NYV
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-LVGMLRGIAAGMKYLSDMNYV- 129
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG---TP-NYMCPELLADIPYGF 186
HRDL NI + + + ++ DFGL++ L+ D + P + PE +A +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 187 KSDIWSLGCCMYEMAAH--RP 205
SD+WS G M+E+ + RP
Sbjct: 190 ASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 33/268 (12%)
Query: 11 MEQIGRGAFGAAIL-------VNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
ME++G AFG ++H LK I +Q QE +L+A +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG----EFQQEASLMAELH 65
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE--LMKKSN---GAYFPEEKLCK------ 112
HP IV V + VC++ Y GD+ E +M+ + G E+ K
Sbjct: 66 HPNIVCLLGV-VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 113 ----WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LAS 165
Q+ ++YL S++ +H+DL NI + + V++ D GL++ + + D +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISKINRSS 223
+ +M PE + + SDIWS G ++E+ + +P + F +I + +
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEVIEMVRKRQ 243
Query: 224 IGPLPSCYSPSLKTLIKGMLRKNPEHRP 251
+ P P + +L+ ++ P RP
Sbjct: 244 LLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-10
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
Y++ IG G+FG +K +KK+ Q + ++E+ ++ + H I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINI 121
Query: 68 VEFKEAWV-------EKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQLL 118
+ K+ + EK ++ +V + + + MK N P + + QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLT-KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
A+ Y+HS ++ HRDLK N+ + ++L DFG AK L A + S + + Y PE
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240
Query: 178 L-LADIPYGFKSDIWSLGCCMYEMAAHRPAF 207
L L Y D+WSLGC + EM P F
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 60/258 (23%), Positives = 107/258 (41%), Gaps = 22/258 (8%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT--ERCRRSAHQEMALIARVQHPYIVE 69
E+IG+G FG ++ K ++ R T +R QE ++ + HP IV+
Sbjct: 1 EKIGKGNFGDV----YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129
V+K + IV GG + ++K +KL + ++YL S
Sbjct: 57 LIGVCVQKQP-IYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN----YMCPELLADIPYG 185
+HRDL N + ++ +++ DFG+++ + + + G + PE L Y
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-----PLPSCYSPSLKTLIK 240
+SD+WS G ++E + G+ ++ R I P P + L+
Sbjct: 174 SESDVWSYGILLWETF----SLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML 229
Query: 241 GMLRKNPEHRPSASELLK 258
+PE+RPS SE+
Sbjct: 230 QCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 107 EEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166
E+ +C F Q+ +++L S +HRDL NI L+++ V++ DFGLA+ + D
Sbjct: 179 EDLICYSF-QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD----- 232
Query: 167 VVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFKAF 210
P+Y M PE + D Y +SD+WS G ++E+ A+ P K
Sbjct: 233 ----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288
Query: 211 DMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
+ ++ + P +P + + P RP+ SEL++H
Sbjct: 289 EE--FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 61/273 (22%), Positives = 112/273 (41%), Gaps = 25/273 (9%)
Query: 2 ESRMDQYEIMEQIGRGAFGAA----ILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMA 57
E + ME++G FG + E+ + V K + R E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM----KKSNGAYFPEEKLCK- 112
+ +R+QHP IV V K + ++ YC D+ E + S+ ++K K
Sbjct: 61 MRSRLQHPNIVCLL-GVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 113 ---------WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162
Q+ +++L S++V+H+DL N+ + +V++ D GL + + A D
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 163 --LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISK 218
L + + +M PE + + SDIWS G ++E+ ++ +P + + +I
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQDVIEM 238
Query: 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRP 251
I + P P + TL+ + P RP
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 71/321 (22%), Positives = 124/321 (38%), Gaps = 51/321 (15%)
Query: 14 IGRGAFGAAILVN------HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPY 66
+G G FG ++ + K V K+ T++ EM ++ + +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS---------NGAYFPEEKL-CKWFA- 115
I+ A + G +V Y G++ E ++ + PEE+L K
Sbjct: 80 IINLLGACTQDGPLYVLVE-YASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 116 ---QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG--- 169
Q+ ++YL S +HRDL N+ +T+D +++ DFGLA+ + D
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPA-FKAFDMAGLISKINRSSIGPLP 228
+M PE L D Y +SD+WS G ++E+ + + + L + P
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 258
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASEL------------------LKHPFLQHFVDQYR 270
+ + L +++ P RP+ +L L PF +QY
Sbjct: 259 ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPF-----EQYS 313
Query: 271 PTFP--PAACSPEKPISIAHE 289
P P P++CS AH+
Sbjct: 314 PGCPDSPSSCSSGDDSVFAHD 334
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 27/221 (12%)
Query: 6 DQYEIMEQIGRGAFGAAILV-------------NHRAEKKKYVLKKIRLARQTERCRRSA 52
Q + E++G G FG L + V K+ A T+ R
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 53 HQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM----------AELMKKSNG 102
+E+ +++R+++P I+ V +C++T Y E GD+ + +N
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDP-LCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 103 AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162
L Q+ + YL S +HRDL N + +++ DFG+++ L + D
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 163 ---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM 200
+ V +M E + + SD+W+ G ++EM
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 14/106 (13%)
Query: 106 PEEKLC-----KWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160
PEE+L Q+ ++YL S +HRDL N+ +T+D +++ DFGLA+ +
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 161 DDLASSVVGTPN------YMCPELLADIPYGFKSDIWSLGCCMYEM 200
D T N +M PE L D Y +SD+WS G M+E+
Sbjct: 187 IDYYKK---TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 39/157 (24%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 106 PEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-- 163
+K+ + ++ + YL++N +HRDL N + +D V++GDFG+ + + D
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKIN 220
+ +M PE L D + SD+WS G ++E+A A +P ++ ++ +
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVM 235
Query: 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELL 257
+ P L L++ + NP+ RPS E++
Sbjct: 236 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 60/281 (21%), Positives = 115/281 (40%), Gaps = 37/281 (13%)
Query: 12 EQIGRGAFGAAILVN----HRAEKKKY---------VLKKIRLARQ--TERCRRSAHQEM 56
E++G G FG L + K + VL +++ R+ + R +E+
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM---------KKSNGAYFPE 107
+++R++ P I+ + +C++T Y E GD+ + + +K++
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 108 EKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LA 164
L Q+ + YL S +HRDL N + K+ +++ DFG+++ L + D +
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYE---MAAHRPAFKAFD------MAGL 215
V +M E + + SD+W+ G ++E + +P + D
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249
Query: 216 ISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256
R P P+ SL L+ R+N + RPS E+
Sbjct: 250 FRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 71/293 (24%), Positives = 121/293 (41%), Gaps = 43/293 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRA------EKKKYVLKKIRLARQTERCRRSAHQEMALI 59
+ E + IG+GAFG + RA E V K+ + + +E AL+
Sbjct: 5 NNIEYVRDIGQGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM 62
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK------------------KSN 101
A HP IV+ G +C++ Y GD+ E ++ K
Sbjct: 63 AEFDHPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 102 GAYFP---EEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158
P E+LC Q+ + YL +HRDL N + ++ V++ DFGL++ +
Sbjct: 122 LNPLPLSCTEQLCI-AKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 159 KADDL--ASSVVGTP-NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMA 213
+ D AS P +M PE + Y +SD+W+ G ++E+ ++ +P + MA
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---YYGMA 237
Query: 214 G--LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
+I + ++ P L L++ K P RPS + + + LQ
Sbjct: 238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI--NRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-09
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 108 EKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV 167
E L + Q+ + +L S +HRDL NI LT + ++ DFGLA+ ++ D S+
Sbjct: 214 EDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND---SNY 270
Query: 168 VGTPN------YMCPELLADIPYGFKSDIWSLGCCMYEM 200
V N +M PE + + Y F+SD+WS G ++E+
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 53/233 (22%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS-------------- 100
E L+ +V HP++++ A + G + IV Y + G + +++S
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVE-YAKYGSLRSFLRESRKVGPSYLGSDGNR 111
Query: 101 NGAYF--PEEK------LCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDF 152
N +Y P+E+ L + Q+ + YL ++HRDL N+ + + + +++ DF
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171
Query: 153 GLAKTLKADD--LASSVVGTP-NYMCPELLADIPYGFKSDIWSLGCCMYEM----AAHRP 205
GL++ + +D + S P +M E L D Y +SD+WS G ++E+ P
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
Query: 206 AFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
+ L+ R P S + L+ ++ P+ RP+ +++ K
Sbjct: 232 GIAPERLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 106 PEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-- 163
P + L ++ + ++YL S +HRDL N L ++ V + DFGL+K + + D
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170
Query: 164 ASSVVGTP-NYMCPELLADIPYGFKSDIWSLGCCMYEMA 201
P ++ E LAD Y SD+W+ G M+E+
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 60/265 (22%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLK---KIRLARQ--TERCRRSAHQEMALIARV-QHPYI 67
IG G FG I RA KK LK I++ ++ +E R E+ ++ ++ HP I
Sbjct: 10 IGEGNFGQVI----RAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS--------------NGAYFPEEKLCKW 113
+ A +G Y+ I Y G++ + ++KS + ++L ++
Sbjct: 66 INLLGACENRG-YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP-N 172
+ + + YL +HRDL N+ + ++ ++ DFGL++ + + ++ P
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-YVKKTMGRLPVR 183
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCY 231
+M E L Y KSD+WS G ++E+ + + A L K+ + P
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNC 243
Query: 232 SPSLKTLIKGMLRKNPEHRPSASEL 256
+ L++ R P RP +++
Sbjct: 244 DDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 12 EQIGRGAFGAAIL--VNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE 69
++IG G FG IL VN + V+K++R++ + + +E +QH +++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQ 59
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGA--YFPEEKLCKWFA-QLLLAVDYLHS 126
E Y+ +V +C GD+ ++ A P+ + A ++ L + +LH
Sbjct: 60 CLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LASSVVGTP-NYMCPELLADIP 183
N +H DL N LT D V++GD+GL+ +D + + P ++ PEL+ ++
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 184 YGF-------KSDIWSLGCCMYEM 200
+S++WSLG ++E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 75/318 (23%), Positives = 120/318 (37%), Gaps = 68/318 (21%)
Query: 9 EIMEQIGRGAFGAAILVN---HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
E++ IGRG F + VN ++ + +++I L T E+ + HP
Sbjct: 1 ELLTVIGRG-FEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHP 59
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV ++ ++ + +VT + G +L+ E + +L A+DY+H
Sbjct: 60 NIVPYRATFIADN-ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK----------ADDLASSVVGTPNYMC 175
+HR +K S+I ++ D V L GL L D V ++
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 176 PELLADIPYGF--KSDIWSLGCCMYEMAAHRPAFKAFDMAG---LISKIN---------- 220
PE+L G+ KSDI+S+G E+A FK DM L+ K+N
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK--DMPATQMLLEKLNGTVPCLLDTT 234
Query: 221 ----------------------------------RSSIGPLPSCYSPSLKTLIKGMLRKN 246
SS P +SP ++ L++N
Sbjct: 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN 294
Query: 247 PEHRPSASELLKHPFLQH 264
P+ RPSAS LL H F +
Sbjct: 295 PDARPSASTLLNHSFFKQ 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEE--KLCKWFAQLLL 119
+QHP I++ VE Y+ +V YCE GD+ + + + L + ++
Sbjct: 52 LQHPNILQCLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS---VVGTPNYMCP 176
V ++H + LH DL N FLT D V++GD+G+ + +D + ++ P
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 177 ELLADIPYGF-------KSDIWSLGCCMYEM 200
EL+ + G S++W+LG ++E+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 57/264 (21%), Positives = 111/264 (42%), Gaps = 26/264 (9%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLK---KIRLARQ--TERCRRSAHQEMALIARV-QHPYI 67
IG G FG + +A KK L+ I+ ++ ++ R E+ ++ ++ HP I
Sbjct: 3 IGEGNFGQVL----KARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS--------------NGAYFPEEKLCKW 113
+ A +G Y+ + Y G++ + ++KS + ++L +
Sbjct: 59 INLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNY 173
A + +DYL +HRDL NI + ++ ++ DFGL++ + + +
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYS 232
M E L Y SD+WS G ++E+ + + A L K+ + P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237
Query: 233 PSLKTLIKGMLRKNPEHRPSASEL 256
+ L++ R+ P RPS +++
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 24/207 (11%)
Query: 72 EAWVEKGC---YVCIVTGYCEGGDM---AELMK--------KSNGAYFPEEKLCKWFAQL 117
EA+V G YVC + G C + +LM + N + L W Q+
Sbjct: 59 EAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP---NYM 174
+ YL ++HRDL N+ + V++ DFGLA+ L D+ G +M
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFKAFDMAGLISKINRSSIGPLPSC 230
E + + +SD+WS G ++E+ A A ++ L+ K R + P C
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER--LPQPPIC 236
Query: 231 YSPSLKTLIKGMLRKNPEHRPSASELL 257
++K + + E RP EL+
Sbjct: 237 TIDVYMIMVKCWM-IDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 42/168 (25%), Positives = 79/168 (47%), Gaps = 28/168 (16%)
Query: 107 EEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166
E+ +C F Q+ +++L S +HRDL NI L+++ V++ DFGLA+ + D
Sbjct: 174 EDLICYSF-QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD----- 227
Query: 167 VVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFKAF 210
P+Y M PE + D Y +SD+WS G ++E+ A+ P +
Sbjct: 228 ----PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283
Query: 211 DMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
+ ++ + P +P + ++ + +P+ RP+ S L++
Sbjct: 284 E--EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 36/224 (16%)
Query: 12 EQIGRGAFGAAIL---------------VNHRAEKKKYVLKKIRLARQTERCRRSAHQEM 56
E++G G FG L N R + V KI + R +E+
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK---------KSNGAYFPE 107
+++R++ P I+ V++ +C++T Y E GD+ + + N A P
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDP-LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 108 EKLCKWFAQLLLAV--------DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159
L LL V YL S +HRDL N + ++ +++ DFG+++ L
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 160 ADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM 200
A D + V +M E + + SD+W+ G ++E+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 59/283 (20%), Positives = 107/283 (37%), Gaps = 43/283 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH----QEMALIAR 61
D ++ +G GAFG +R V ++ + E C E ++++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL-LA 120
H IV E+ I+ GGD+ ++++ PE LL A
Sbjct: 66 FNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPR--PERPSSLTMKDLLFCA 122
Query: 121 VD------YLHSNYVLHRDLKCSNIFLT---KDQDVRLGDFGLAKTLKADDL---ASSVV 168
D YL N+ +HRD+ N LT + ++ DFG+A+ + +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182
Query: 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS----- 223
+M PE D + K+D+WS G ++E+ F + G + R++
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI---------FSL-GYMPYPGRTNQEVME 232
Query: 224 -------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
+ P C P + ++ + PE RP+ + +L+
Sbjct: 233 FVTGGGRLDPPKGCPGPVYR-IMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 108 EKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV 167
+ L ++ +Q+ +D+L S +HRD+ N+ LT + ++ DFGLA+ + D S+
Sbjct: 212 DDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND---SNY 268
Query: 168 VGTPN------YMCPELLADIPYGFKSDIWSLGCCMYEM 200
V N +M PE + D Y +SD+WS G ++E+
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 60/266 (22%), Positives = 114/266 (42%), Gaps = 28/266 (10%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLK-KIRLARQTERCRRSAHQ----EMALIARV-QHPYI 67
IG G FG + +A KK L+ + R E + H+ E+ ++ ++ HP I
Sbjct: 15 IGEGNFGQVL----KARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS--------------NGAYFPEEKLCKW 113
+ A +G Y+ + Y G++ + ++KS + ++L +
Sbjct: 71 INLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP-N 172
A + +DYL +HRDL NI + ++ ++ DFGL++ + + ++ P
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-YVKKTMGRLPVR 188
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCY 231
+M E L Y SD+WS G ++E+ + + A L K+ + P
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 248
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELL 257
+ L++ R+ P RPS +++L
Sbjct: 249 DDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPN 172
Q+ + YLH V+H+D+ N + ++ V++ D L++ L D L +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRP--AFKAFDMAGLISKINRSSIGPLP 228
+M E L + Y SD+WS G ++E+ P F+MA + R +
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR--LAQPI 242
Query: 229 SCYSP-SLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
+C P L ++ +PE RPS S+L L F
Sbjct: 243 NC--PDELFAVMACCWALDPEERPSFSQL--VQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 9/193 (4%)
Query: 14 IGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
+G GAFG I V K V KI + E ++A + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
+ + +VT G + + + + + L W Q+ + YL ++
Sbjct: 75 LGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP---NYMCPELLADIPYGFK 187
HRDL N+ + V++ DFGLA+ L+ D+ + G +M E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 188 SDIWSLGCCMYEM 200
SD+WS G ++E+
Sbjct: 192 SDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 11/157 (7%)
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELL 179
YL++ +HRDL N + D V++GDFG+ + + D + +M PE L
Sbjct: 134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
Query: 180 ADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
D + SD+WS G ++E+ A +P ++ ++ + P +
Sbjct: 194 KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMDGGYLDQPDNCPERVTD 252
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFP 274
L++ + NP+ RP+ E+ + D P+FP
Sbjct: 253 LMRMCWQFNPKMRPTFLEI-----VNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 17/214 (7%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
E ++ + HP IV+ ++ + IV GGD ++K ++L K+
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQP-IYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKF 98
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN- 172
+ YL S +HRDL N + ++ +++ DFG+++ + DD S G
Sbjct: 99 ALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQI 156
Query: 173 ---YMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI--GPL 227
+ PE L Y +SD+WS G ++E + G+ ++ R + G
Sbjct: 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTNQQAREQVEKGYR 212
Query: 228 PSCYSPSLKTLIKGMLR---KNPEHRPSASELLK 258
SC + K M R PE+RP SEL K
Sbjct: 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 38/160 (23%), Positives = 57/160 (35%), Gaps = 27/160 (16%)
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYM 174
A L + L LHR K NI LT D ++L KT + P +M
Sbjct: 21 AVCLQCLGALRE---LHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSR------PDPYFM 71
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234
PE++ Y K+DI+SLG +YE + + L S
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEALDYELP--YNEEREL----------------SAI 113
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFP 274
L+ L+ GM +P R + + + F+ P
Sbjct: 114 LEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLP 153
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 3/88 (3%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT---PN 172
Q+ +++L S +HRDL N+ L + + V++ DFGLA+ + D S T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEM 200
+M PE + D Y SD+WS G ++E+
Sbjct: 305 WMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 55/251 (21%), Positives = 101/251 (40%), Gaps = 13/251 (5%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--TERCRRSAHQEMALIARVQHPYIVEFK 71
+G G FG + K+ + I R +++ RR E + + H IV
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL- 71
Query: 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131
E + +G + IVT Y G + ++K G +L L + YL +H
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVH 130
Query: 132 RDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN--YMCPELLADIPYGFKSD 189
+ L + + D ++ F + K++ + +++ G + PE + + SD
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASD 190
Query: 190 IWSLGCCMYEMAAH--RPAFKAFDMAG--LISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245
+WS G M+E+ ++ RP +DM+G +I + P P L L+ +K
Sbjct: 191 VWSFGIVMWEVMSYGERP---YWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQK 247
Query: 246 NPEHRPSASEL 256
RP S++
Sbjct: 248 ERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS----SVVGTP 171
Q+ ++YL S +HRDL N L + V++ DFGLA+ + + S + P
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 172 -NYMCPELLADIPYGFKSDIWSLGCCMYEM----AAHRPAFKAFDMAGLISKINRSSIGP 226
+M E L + KSD+WS G ++E+ A P +FD+ + + R
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL---L 222
Query: 227 LPSCYSPSLKTLIKGMLR---KNPEHRPSASEL 256
P Y P L + ML PE RP+ SEL
Sbjct: 223 QPE-YCPD--PLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 43/202 (21%), Positives = 81/202 (40%), Gaps = 26/202 (12%)
Query: 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLK--- 135
+ ++ YC G + E++ K EK + +L +A+D Y L++
Sbjct: 95 PRLSLILEYCTRGYLREVLDK--------EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146
Query: 136 ---CSNIFL-TKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI--PYGFKSD 189
S FL T++ +++ GL K L + V Y ++L DI Y K D
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 190 IWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-PLPSCYSPSLKTLIKGMLRKNPE 248
I+SLG ++E+ + F+ + I + LP +K +++ +
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSI 264
Query: 249 HRPSASELLKHPFLQHFVDQYR 270
RP+ E+L + + Y+
Sbjct: 265 KRPNIKEIL------YNLSLYK 280
|
Length = 283 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 48/161 (29%), Positives = 65/161 (40%), Gaps = 34/161 (21%)
Query: 11 MEQIGRGAFGAAILVNHRAEKKKYVLKK------------IRLARQTERCRRSA---HQE 55
M+ I RGA A + K V+K R+ R ER RR A +
Sbjct: 1 MKLIKRGA--EAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRR--ERTRREARIMSR- 55
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
A A V P + E IV Y EG + +L+ SNG E L +
Sbjct: 56 -ARKAGVNVPAVYFVD---PENFI---IVMEYIEGEPLKDLIN-SNGMEELE--LSREIG 105
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156
L+ LHS ++H DL SN+ L+ + L DFGLA+
Sbjct: 106 -RLVGK--LHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 49/296 (16%)
Query: 9 EIMEQIGRGAFGAAIL---------------VNHRAEKKKYVLKKIRLARQTERCRRSAH 53
+E++G G FG L N A+ V K+ ++ R
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS---------NGAY 104
+E+ +++R+ P I C++ Y E GD+ + ++K N
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPL-CMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 105 FPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164
L Q+ + YL S +HRDL N + K+ +++ DFG+++ L + D
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY- 185
Query: 165 SSVVGTP----NYMCPELLADIPYGFKSDIWSLGCCMYEMAA--------HRPAFKAFDM 212
V G +M E + + KSD+W+ G ++E+ H + +
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245
Query: 213 AGLI-SKINRSSIGPLPS-CYSPSLKTLIKGML---RKNPEHRPSASELLKHPFLQ 263
AG R P P C P K + + ML R++ E RP+ E+ H FLQ
Sbjct: 246 AGHFFRDDGRQIYLPRPPNC--P--KDIYELMLECWRRDEEDRPTFREI--HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 86/350 (24%), Positives = 123/350 (35%), Gaps = 115/350 (32%)
Query: 4 RMDQYEIMEQIGRGAFGA---AILVNHRAEK-KKYVLKKIR-----LARQTERCRRSAHQ 54
+ D + + +++G GAFG A LVN +++K KYVLKK ER RR+
Sbjct: 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPN 189
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKLCK- 112
A + ++ +K +V Y EG +A+LM+ Y E L
Sbjct: 190 S---CADFVYGFLEPVSS---KKEDEYWLVWRY-EGESTLADLMQSKEFPYNVEPYLLGK 242
Query: 113 -----------------WFAQLLLAVDYLHSNYVLHRDLKCSN-IFLTKDQDVRLGDFGL 154
Q+L A+D LHS ++HRD+K N IF ++ D G
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 155 AKTLKADDLASSVVGTPNYMCPELLAD--------------------------------- 181
A L+ VG NY+ E L D
Sbjct: 303 AADLR--------VGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353
Query: 182 --IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLIS-----KIN-------RSSIGPL 227
+P F DI+S G +MA P ++ LI K N R + P
Sbjct: 354 LNLPDRF--DIYSAGLIFLQMAF--PNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPR 407
Query: 228 PSCYSPSLK--------------TLIKGMLRKNPEHRPSASELLKHPFLQ 263
SP L+ L+K M+R R SA L HP+
Sbjct: 408 A---SPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP 226
++GTP+Y+ PELL P+G D W+LG C++E P F + I I P
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-P 598
Query: 227 LP---SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
P S + + I+ +L +P R EL +HP H VD
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF-HGVD 641
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-05
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP- 65
+++I+ +G G FG + R ++K+Y KI R + R A E+ + +V+
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKI--VRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 66 -----YIVEFKEAWVEKGCYVCIVT---GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+++ + + + ++CIV G C + +MK F L + Q
Sbjct: 187 PADRFPLMKIQRYFQNETGHMCIVMPKYGPCL---LDWIMKHGP---FSHRHLAQIIFQT 240
Query: 118 LLAVDYLHSN-YVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTLKAD-------DLA---- 164
+A+DY H+ +++H DLK NI + T D V D + L D DL
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILMETSDTVV---DPVTNRALPPDPCRVRICDLGGCCD 297
Query: 165 -----SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM 200
+++V T +Y PE++ + + + +D+WS+GC +YE+
Sbjct: 298 ERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 5/115 (4%)
Query: 89 EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVR 148
E L+ +S + + L + Q+ +++L S +HRDL N+ + + + V+
Sbjct: 222 ERTRRDTLINESPALSYMD--LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 149 LGDFGLAKTLKADDLASSVVGT--P-NYMCPELLADIPYGFKSDIWSLGCCMYEM 200
+ DFGLA+ + D S T P +M PE + + Y SD+WS G ++E+
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 45/174 (25%), Positives = 65/174 (37%), Gaps = 50/174 (28%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLK--------------KIRLARQTERCRRSAHQEMALI 59
I +GA AI+ K V+K +IR ER R E L+
Sbjct: 2 IAKGA--EAIIYLGDFLGLKAVIKERVPKSYRHPELDERIR----RERTRN----EARLL 51
Query: 60 AR-----VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
+R V P + + + IV Y EG + +++++ N E
Sbjct: 52 SRARKAGVNTPVVYDV---DPDNKT---IVMEYIEGKPLKDVIEEGNDELLRE------- 98
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-----LKADDL 163
L+ LH ++H DL SNI + D + L DFGL K KA DL
Sbjct: 99 IGRLVGK--LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIEDKAVDL 149
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 22/162 (13%)
Query: 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH--PYI 67
++ + G L+ + + YVLK + R + L+AR P +
Sbjct: 2 SIKLLKGGLTNRVYLL--GTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPKV 58
Query: 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS- 126
+ E+ G ++ + EG + E+ ++ E + + A+LL LH
Sbjct: 59 LASGES---DGWSYLLME-WIEGETLDEVSEEEK------EDIAEQLAELLAK---LHQL 105
Query: 127 -NYVL-HRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLAS 165
VL H DL NI + + + + D+ A A DLA+
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAA 147
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 29/146 (19%), Positives = 51/146 (34%), Gaps = 13/146 (8%)
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-------DVRLGDFGLAKT-LKADDLASSV 167
QL A+ YL ++H ++ NI + + ++L D G+ T L ++ +
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI 168
Query: 168 VGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPA-FKAFDMAGLISKINRSSIGP 226
A + +D WS G + E+ ++ + P
Sbjct: 169 PWIAPECIRNGQASL--TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
Query: 227 LPSCYSPSLKTLIKGMLRKNPEHRPS 252
+P C L LI +P RPS
Sbjct: 227 MPDC--AELANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1092 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.11 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.48 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.32 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.17 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.02 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.88 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.35 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.23 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.08 | |
| PLN02236 | 344 | choline kinase | 95.91 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.69 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.65 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.38 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.04 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.98 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.52 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.68 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.64 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.81 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.73 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.91 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 87.24 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 86.23 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=460.82 Aligned_cols=254 Identities=33% Similarity=0.607 Sum_probs=235.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.+|...+.||+|||+.||.+.+..+|..||+|++.+... ....++.+.+|++|.++|+|||||+++++|.+.+ ++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-NVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-ceEEE
Confidence 569999999999999999999999999999999976543 3445678999999999999999999999996555 88999
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
+|+|..++|..++++.. .|+|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||.....+ +.
T Consensus 97 LELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999999544 4999999999999999999999999999999999999999999999999999998754 67
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
..+.||||.|+|||++.+..+++.+||||+||+||.||.|++||......+...+|....+. +|..++.++++||.+||
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS-MPSHLSAEAKDLIRKLL 253 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-cccccCHHHHHHHHHHh
Confidence 78999999999999999999999999999999999999999999999999999999887664 77899999999999999
Q ss_pred ccCCCCCCCHHHHHhChhhH
Q 043248 244 RKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwFq 263 (1092)
+.||.+|||++++|.|+||.
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred cCCcccCCCHHHHhcCHhhh
Confidence 99999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=447.93 Aligned_cols=259 Identities=33% Similarity=0.500 Sum_probs=225.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-----HHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-----CRRSAHQEMALIARVQHPYIVEFKEAWVEK 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-----~~r~f~rEIqILkqL~HPNIVKL~gvF~e~ 77 (1092)
...+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+...... ....+.+|+.+|++|+|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 345788999999999999999999999999999999976543221 123467999999999999999999999666
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCEEEeecCc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD---QDVRLGDFGL 154 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d---G~LKLiDFGL 154 (1092)
+ ++||||||++||+|++.+-.++. +.+..-+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+
T Consensus 249 d-s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 D-SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred C-ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 5 67899999999999999987764 8889999999999999999999999999999999999766 5699999999
Q ss_pred cccccccccCccccCCCCcCCchhhccCCC---CccccchhHHHHHHHHHhCCCCCcccChHH-HHHHhhccCCCCC---
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLADIPY---GFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-LISKINRSSIGPL--- 227 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~g~~y---S~KSDVWSLGVILYELLTGr~PF~g~d~~d-li~kI~~~~i~pl--- 227 (1092)
|+..+...++.+.|||+.|.|||++.+..+ ..++|+|||||+||.+|+|.+||....... +..+|.++.+...
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 999999999999999999999999976543 348899999999999999999998754443 6666666655433
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
...+++++.+||.+||..||++|||++|+|+||||+.
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 3457999999999999999999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=435.04 Aligned_cols=257 Identities=33% Similarity=0.604 Sum_probs=237.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++.+.++.||+|..|+||++.|+.+++.+|+|.+... ......+.+.+|+++++.++|||||.+|+.|..++..++|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4667789999999999999999999999999999543 455667889999999999999999999999988775688999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+||+|+++++..+. ++|..+..++.++++||.|||. ++||||||||+|||++..|.+||||||.+..+-.. ..
T Consensus 158 EYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 99999999999998754 9999999999999999999995 99999999999999999999999999999988766 67
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc-----ChHHHHHHhhccCCCCCCCC-CCHHHHHH
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-----DMAGLISKINRSSIGPLPSC-YSPSLKTL 238 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~-----d~~dli~kI~~~~i~plPs~-iS~eLkDL 238 (1092)
.+++||..|||||.+.+..|+.++||||||+.++||++|+.||... +..+++..|.....+.+|.. +|+++++|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 8899999999999999999999999999999999999999999874 77889999998888888886 99999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
|..||++||.+|+++.|+++|||++++.
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=432.30 Aligned_cols=259 Identities=32% Similarity=0.606 Sum_probs=239.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||+||+++.+.+++.||+|++++....+. ..+...+|..||..++||.||+++..|+..+ .+|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-KLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-eEE
Confidence 57899999999999999999999999999999999987765443 4677889999999999999999999997766 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc-ccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l-~~d 161 (1092)
||+||+.||.|+..|++.+. |+|..++.|+..|+.||.|||++|||||||||+||||+.+|+++|+||||++.. ..+
T Consensus 102 lVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999999998765 999999999999999999999999999999999999999999999999999954 445
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....+.|||+.|||||++.+..|+..+|+||||+++|+|++|.+||.+.+...+..+|.+......+..++.++++||++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~ 259 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKK 259 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHH
Confidence 56777899999999999999999999999999999999999999999999999999999988777777799999999999
Q ss_pred hcccCCCCCC----CHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRP----SASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRP----SaeELLqHPwFq~~ 265 (1092)
+|.+||++|. .+.++.+||||..+
T Consensus 260 LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 260 LLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HhccCHHHhcCCCCChHHhhcCcccccC
Confidence 9999999995 78999999999764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=428.24 Aligned_cols=261 Identities=30% Similarity=0.549 Sum_probs=231.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
|++|+.+.++|+|+||+||+|+++.+|+.||||++.-+.......+..+||+.+|++|+|+|+|.|+++|.... .+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-klhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-KLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-eeEEE
Confidence 68899999999999999999999999999999999888777888899999999999999999999999997665 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-cccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~ 163 (1092)
+|||+..-|.++-...++ ++...+..|++|++.|+.|||+++||||||||+||||+.+|.+||||||+|+.+. +++.
T Consensus 80 FE~~dhTvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 999987555554433333 8999999999999999999999999999999999999999999999999999887 7777
Q ss_pred CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-----------------
Q 043248 164 ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----------------- 225 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----------------- 225 (1092)
++.++.|+||+|||++.| ..|+..+|||++||++.||++|.+.|.+.+..+++..|......
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 888999999999999977 78999999999999999999999999999988888887542111
Q ss_pred ---C-------CC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 226 ---P-------LP---SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 226 ---p-------lP---s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+ +. ..++.-+.||+++||..||.+|++.+|+|.|+||..|...
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 0 00 1246678899999999999999999999999999888764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=429.92 Aligned_cols=259 Identities=32% Similarity=0.616 Sum_probs=234.6
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc---HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecC
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT---ERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKG 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s---e~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d 78 (1092)
...++|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4678999999999999999999999999999999977654211 234556778999999999 999999999997666
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCcccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKT 157 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~~ 157 (1092)
.+|||||||.||+|+++|...+ .+.|..++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 94 -~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 -KIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred -eEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 5889999999999999999844 49999999999999999999999999999999999999999 9999999999999
Q ss_pred c-cccccCccccCCCCcCCchhhccCC-C-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCC-CH
Q 043248 158 L-KADDLASSVVGTPNYMCPELLADIP-Y-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY-SP 233 (1092)
Q Consensus 158 l-~~d~~~st~vGTp~YmAPEVL~g~~-y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~i-S~ 233 (1092)
. ..+....+.+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+...+..+|....+ .+|..+ +.
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~~~S~ 249 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSYLLSP 249 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCCcCCH
Confidence 8 5777889999999999999999987 8 5899999999999999999999999998888888776655 467777 99
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
++++||++||..||.+|+|+.+++.||||+..
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999999999999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=438.35 Aligned_cols=259 Identities=32% Similarity=0.572 Sum_probs=236.3
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-HHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
....+|.+++.||.|+|++||+|.++.+++.||||++.+.....+ ..+.+.+|-.+|.+| .||.|++|+..|++.. .
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-s 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-S 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-c
Confidence 356799999999999999999999999999999999977654433 345677899999999 8999999999997765 6
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+|+||+++|+|.++|++.+. |++..++.|+.||+.||+|||++|||||||||+||||+.+|+++|+|||.|..+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 8899999999999999998765 99999999999999999999999999999999999999999999999999998764
Q ss_pred cccC--------------ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC
Q 043248 161 DDLA--------------SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP 226 (1092)
Q Consensus 161 d~~~--------------st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p 226 (1092)
.... ..++||..|.+||+|.+...++.+|||+||||||+|+.|.+||.+.+...++++|....+.
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~- 305 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE- 305 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-
Confidence 3211 3478999999999999999999999999999999999999999999999999999988774
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
++..+++.+.+||+++|..||.+|+|+++|.+||||..+
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 788899999999999999999999999999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=424.71 Aligned_cols=258 Identities=29% Similarity=0.600 Sum_probs=237.7
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|.+.+.||+|+||+||+|+++.++..||||.+..........+.+..|+.+|+.|+|||||.+++++...+ ++|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-FIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-eEE
Confidence 4688999999999999999999999999999999999888777778889999999999999999999999875544 899
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC------CCEEEeecCccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD------QDVRLGDFGLAK 156 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d------G~LKLiDFGLA~ 156 (1092)
||||||+||+|.++|++.+. ++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999998765 9999999999999999999999999999999999999764 348999999999
Q ss_pred cccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc--CCCCCCCCCCHH
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS--SIGPLPSCYSPS 234 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~--~i~plPs~iS~e 234 (1092)
.+..+.+..+.||++.|||||++....|+.|+|+||+|+|||+|++|++||......+++..+.+. ....++..++..
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCc
Confidence 999999999999999999999999999999999999999999999999999999988888877654 334456667888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
+.+|+...|+.++..|.+..+.+.|+++.
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~ 272 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLA 272 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhcc
Confidence 88999999999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=443.26 Aligned_cols=261 Identities=26% Similarity=0.554 Sum_probs=243.6
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecc-cccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks-~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
+.++-|++.+-||+|+.|.|-+|++..+|+.+|||++.+. ...+.....+.+|+.||+-|.||||+++|++|..+. ++
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-~l 87 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-HL 87 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-eE
Confidence 4578899999999999999999999999999999999765 334444567899999999999999999999996554 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|.||++||.|++++.+++. |++.+++++++||+.|+.|||..+|+||||||+|+||+..++|||+|||+|..-.++
T Consensus 88 ylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 899999999999999998875 999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.+..+.||++.|.|||++.|.+| +.++||||+|||||.||+|+.||.+.+...++.++.++.+ .+|.+++.++++||+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLR 244 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHH
Confidence 99999999999999999999999 7899999999999999999999999999999999998876 588999999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+||..||.+|+|.+||++|||+..+..
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999999999987654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=436.27 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=232.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|.++++||.|.||.||+|..+.++..||||+++......+. -.-.||+..|++|+ |||||+|.++|.+++..+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 578999999999999999999999999999999999766544322 23458999999999 9999999999999887899
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||+. +|+++++.+ ++.|++..|+.||.||++||+|+|++|++||||||+|||+.....|||+|||+|+......
T Consensus 87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 99999974 999999987 5789999999999999999999999999999999999999988899999999999999888
Q ss_pred cCccccCCCCcCCchhhc-cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC----------------
Q 043248 163 LASSVVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---------------- 225 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---------------- 225 (1092)
.++.++.|+||+|||+|. ..-|+.+.|||++|||++|+++-++.|.|.++.+++.+|......
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 889999999999999985 566899999999999999999999999999999999998542111
Q ss_pred -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 226 -------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 226 -------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+-..++.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1112268899999999999999999999999999999753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=422.00 Aligned_cols=258 Identities=32% Similarity=0.569 Sum_probs=227.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
-+++|++++.||+||||.||+|+.+.+|..||+|+++++.... .....+..|-.+|....+++||+||..|++.+ ++|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-YLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-eeE
Confidence 4689999999999999999999999999999999998775433 33567888999999999999999999997766 889
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d- 161 (1092)
|||||++||++..+|.+.+. |++..++.|+.+++.|+.-||+.|+|||||||+|+|||..|++||.||||+.-+...
T Consensus 218 LiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999998775 999999999999999999999999999999999999999999999999998533110
Q ss_pred ---------------------c--------------------------cCccccCCCCcCCchhhccCCCCccccchhHH
Q 043248 162 ---------------------D--------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLG 194 (1092)
Q Consensus 162 ---------------------~--------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLG 194 (1092)
. +....+|||.|||||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 01134799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcccChHHHHHHhhccC---CCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhChhhHhH
Q 043248 195 CCMYEMAAHRPAFKAFDMAGLISKINRSS---IGPLPSCYSPSLKTLIKGMLRKNPEHRP---SASELLKHPFLQHF 265 (1092)
Q Consensus 195 VILYELLTGr~PF~g~d~~dli~kI~~~~---i~plPs~iS~eLkDLIrkcLqkDPskRP---SaeELLqHPwFq~~ 265 (1092)
|||||||.|.+||.+.+......+|..-. ..+....++.+++|||.+||. ||.+|. +++||.+||||+.+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999999999888886533 223445578999999999999 999996 59999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=394.06 Aligned_cols=256 Identities=26% Similarity=0.525 Sum_probs=226.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..+++|++.+.||+|+||.||+|.++.+++.||+|.+...... ......+.+|+.++++++||||++++++|...+ .+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 93 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-RV 93 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-EE
Confidence 3578999999999999999999999999999999999754322 223456889999999999999999999986655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 89999999999999998754 3899999999999999999999999999999999999999999999999999876543
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ..++..++..+++||++
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKG 248 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHH
Confidence 234689999999999999999999999999999999999999999887777666666543 34677789999999999
Q ss_pred hcccCCCCCCC-----HHHHHhChhhHh
Q 043248 242 MLRKNPEHRPS-----ASELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPS-----aeELLqHPwFq~ 264 (1092)
||++||.+|++ ++++++||||..
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999987 799999999975
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=387.94 Aligned_cols=254 Identities=28% Similarity=0.507 Sum_probs=224.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++.+.||+|+||.||+|.++.+++.||+|.+...... ......+.+|+.++++++||||+++++++.+. ..+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEE
Confidence 5899999999999999999999999999999998754322 22345688999999999999999999888654 478899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+.+++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--c
Confidence 99999999999998754 3899999999999999999999999999999999999999999999999999876533 2
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
...+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..... .++..++..+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-CCCccCCHHHHHHHHHHcC
Confidence 346799999999999998999999999999999999999999998887777777665543 4566789999999999999
Q ss_pred cCCCCCCC-----HHHHHhChhhHhH
Q 043248 245 KNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 245 kDPskRPS-----aeELLqHPwFq~~ 265 (1092)
+||.+|++ ++++++||||..+
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCC
Confidence 99999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=381.37 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=221.1
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.|++.+.||+|+||.||++.++.+++.||+|.+...... ......+.+|+.++++++|+||++++++|...+ .+|+||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-eEEEEE
Confidence 489999999999999999999999999999998754322 223345778999999999999999999986655 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+++|+|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 99999999998876555568999999999999999999999999999999999999999999999999998775554445
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHH---HHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL---ISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dl---i~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
...|+..|+|||++.+..|+.++|||||||++|+|++|+.||........ +..........++..++.++.+||++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 66899999999999999999999999999999999999999987554322 222222233345667899999999999
Q ss_pred cccCCCCCCC-----HHHHHhChhhHhH
Q 043248 243 LRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
|+.||.+|++ ++++++||||..+
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999997 8999999999775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=422.27 Aligned_cols=258 Identities=31% Similarity=0.524 Sum_probs=230.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~ly 82 (1092)
+.+.|+.+++||+|.||.||+|++..+|+.||+|++++....+.+.....|||.||++|+||||++|.+...+. .+.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 45678899999999999999999999999999999999988888888999999999999999999999999887 57899
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||+|||+. +|.-++... +..|++.+|+.||.||+.||.|||++||+|||||..|||||.+|.+||+|||||+++....
T Consensus 195 lVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999986 888888653 3459999999999999999999999999999999999999999999999999999876544
Q ss_pred --cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---------CC--
Q 043248 163 --LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---------LP-- 228 (1092)
Q Consensus 163 --~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---------lP-- 228 (1092)
.+...+.|.||+|||+|.| ..|+..+|+||+||||.||+.|++.|.+....+++.+|.+....+ +|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 4566788999999999977 469999999999999999999999999999999999886532211 11
Q ss_pred -----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 229 -----------------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 229 -----------------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
..++..+.+|+..||..||.+|.|+.++|+|+||.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 12467888999999999999999999999999994
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=420.53 Aligned_cols=265 Identities=62% Similarity=1.098 Sum_probs=256.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|.+++++|+|+||.+++++++.+++.|++|++......+..++...+|+.++++++|||||.+++.|.++++++||
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999999988888888999999999999999999999999999998999
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||+||+||+|.++|++.++..|+|+.++.|+.||+.||.|||+++|+|||||+.|||+++++.|+|.|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999999998877
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
...+++||+.||+||++.+.+|+.++|||||||++|||++-+++|.+.+...++.+|....+.+++..++.+++.+|+.|
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 243 LRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
|.++|..||++.++|.+|.++.+...
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~~~~ 267 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRYLVE 267 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhHHHh
Confidence 99999999999999999999877643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=408.14 Aligned_cols=249 Identities=39% Similarity=0.704 Sum_probs=230.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEE-EEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKE-AWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~g-vF~e~d~~lyL 83 (1092)
+.+|+|++.||+|.||.||++.+..+|+.+|.|.+.........+..+..|+.+|++|+|||||++++ .|.+...-++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45699999999999999999999999999999999988778888889999999999999999999998 56565655899
Q ss_pred EEeecCCCCHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 84 VTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVDYLHS--NY--VLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 84 VMEYceGGSL~DLLkk--k~gk~LSEeqI~kIa~QILsALaYLHS--kG--IIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
|||||++|+|..+|+. +.++.++|..++.++.|++.||.+||+ .. |+||||||.||+|+.+|.+||.||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999974 455679999999999999999999998 44 99999999999999999999999999998
Q ss_pred ccccc-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC-CCCCHHH
Q 043248 158 LKADD-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP-SCYSPSL 235 (1092)
Q Consensus 158 l~~d~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP-s~iS~eL 235 (1092)
+.... ...+++|||+||+||++.+.+|++++||||+||++|||+.-++||.+.+...+..+|.+..+.++| ..+|..+
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l 257 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDL 257 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHH
Confidence 87654 456789999999999999999999999999999999999999999999999999999999988888 7789999
Q ss_pred HHHHHHhcccCCCCCCCH
Q 043248 236 KTLIKGMLRKNPEHRPSA 253 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSa 253 (1092)
..||..|+..|+..||+.
T Consensus 258 ~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHccCCcccCCCc
Confidence 999999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=378.32 Aligned_cols=254 Identities=28% Similarity=0.512 Sum_probs=213.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++|+||++++++|...+ .+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-KLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-EEEEEE
Confidence 5899999999999999999999999999999999766544445567889999999999999999999986554 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--c
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--L 163 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--~ 163 (1092)
||++++.|..+.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 80 EYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999987666554432 348999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------------------
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-------------------- 223 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-------------------- 223 (1092)
.....|++.|+|||++.+..++.++|||||||++|+|++|++||...+..+....+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334679999999999998899999999999999999999999998765443332221100
Q ss_pred -CC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 -IG----------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 -i~----------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.. .....++.++.+||++||++||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=404.93 Aligned_cols=257 Identities=34% Similarity=0.639 Sum_probs=222.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe-EEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC-YVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~-~lyL 83 (1092)
..+|...+.||+|+||.||++.++.+|..+|||.+....... .+.+.+|+.+|++|+|||||++++....... .++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 346889999999999999999999999999999987663222 5678999999999999999999997555554 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCccccccc--
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAKTLKA-- 160 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~~l~~-- 160 (1092)
+|||+.||+|.+++++.++ .|++..++.+.+||++||+|||++|||||||||+|||++. ++.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999876 6999999999999999999999999999999999999999 69999999999987763
Q ss_pred --cccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcc-cChHHHHHHhhc-cCCCCCCCCCCHHH
Q 043248 161 --DDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGLISKINR-SSIGPLPSCYSPSL 235 (1092)
Q Consensus 161 --d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g-~d~~dli~kI~~-~~i~plPs~iS~eL 235 (1092)
........||+.|||||++.++ ....++|||||||+++||+||++||.. ......+..+.. ...+.+|..++.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 2224457899999999999853 334699999999999999999999988 344444444433 33557888899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
++||.+||.++|++|||++++|+|||++.
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=376.52 Aligned_cols=256 Identities=30% Similarity=0.446 Sum_probs=213.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcC-CCcEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEe----c
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRA-EKKKYVLKKIRLARQTERCRRSAHQEMALIARV---QHPYIVEFKEAWVE----K 77 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~-tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL---~HPNIVKL~gvF~e----~ 77 (1092)
++|++++.||+|+||.||+|.+.. ++..||+|.+......+.....+.+|+.+++.+ +||||++++++|.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 489999999999999999999854 468899999876543333334455677776665 69999999998853 3
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
...+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456889999996 5999999876555689999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC------------
Q 043248 158 LKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------ 225 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------ 225 (1092)
...........|++.|+|||++.+..++.++|||||||++|+|++|++||.+....+.+.++......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 76555555678999999999999889999999999999999999999999987766655555321100
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 --------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 --------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+...++..+.+||.+||++||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112367888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=395.70 Aligned_cols=256 Identities=27% Similarity=0.554 Sum_probs=236.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
-+++|++++.||.|+||.|.+++++.+|..||+|++.+...- ....+...+|..+|+.+.||++++|++.|.+.. ++|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~ly 120 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NLY 120 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eEE
Confidence 368999999999999999999999999999999999766433 234567889999999999999999999997766 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
|||||++||.|+.++++.+. |++..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999999998765 999999999999999999999999999999999999999999999999999988755
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
..+.||||.|+|||++...+|+.++|.|+|||++|||+.|.+||...+...+..+|....+. +|..++.++++||+++
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-FPSYFSSDAKDLLKKL 275 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-CCcccCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999999887764 7888999999999999
Q ss_pred cccCCCCC-----CCHHHHHhChhhHhH
Q 043248 243 LRKNPEHR-----PSASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskR-----PSaeELLqHPwFq~~ 265 (1092)
|+.|-.+| ....+|..||||+..
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCcccccc
Confidence 99999999 367899999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=389.00 Aligned_cols=250 Identities=32% Similarity=0.581 Sum_probs=218.0
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||++++++|...+ .+||||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-EEEEEEeCCCC
Confidence 479999999999999999999999999975432 2233456778999999999999999999886655 78899999999
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccCccccC
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVVG 169 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~st~vG 169 (1092)
++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+|
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 80 GELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99999998654 48999999999999999999999999999999999999999999999999987542 2233445689
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPsk 249 (1092)
|+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.......+..... .++..++.++.+||++||.+||++
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999999999999999999999988777666666654433 467778999999999999999999
Q ss_pred CC-----CHHHHHhChhhHhH
Q 043248 250 RP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 250 RP-----SaeELLqHPwFq~~ 265 (1092)
|| ++.++++||||...
T Consensus 237 R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 237 RLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred cCCCCCCCHHHHHcCCCcCCC
Confidence 99 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=382.89 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=212.4
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----eEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----CYVC 82 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~~ly 82 (1092)
+|++.+.||+|+||.||+|.++.++..||||++............+.+|+.+++.++||||+++++++.... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999998754333333456889999999999999999999886433 3578
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+|||||. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 9999995 689999876543 8999999999999999999999999999999999999999999999999997653221
Q ss_pred ----cCccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc---------------
Q 043248 163 ----LASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR--------------- 221 (1092)
Q Consensus 163 ----~~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~--------------- 221 (1092)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2234679999999999876 6789999999999999999999999987654332221110
Q ss_pred ------------cCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 222 ------------SSIGP---LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 222 ------------~~i~p---lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
....+ ....+++.+.+||.+||+.||++|||++++|+||||+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000 01235788999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=387.34 Aligned_cols=256 Identities=33% Similarity=0.565 Sum_probs=218.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++|+||++++++|...+ .+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-YLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-eEEEE
Confidence 589999999999999999999999999999999976432 2233456788999999999999999999986654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||||.||+|.+++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 80 ~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999999998754 39999999999999999999999999999999999999999999999999987543211
Q ss_pred -------------------------------------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCC
Q 043248 163 -------------------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRP 205 (1092)
Q Consensus 163 -------------------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~ 205 (1092)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 1123479999999999999999999999999999999999999
Q ss_pred CCcccChHHHHHHhhccCCC---CCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhChhhHhH
Q 043248 206 AFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTLIKGMLRKNPEHRPS---ASELLKHPFLQHF 265 (1092)
Q Consensus 206 PF~g~d~~dli~kI~~~~i~---plPs~iS~eLkDLIrkcLqkDPskRPS---aeELLqHPwFq~~ 265 (1092)
||...+.......+...... +....+++++++||++||. +|.+|++ +.++++||||..+
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99988776666655432211 1223468999999999996 9999997 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=386.67 Aligned_cols=256 Identities=34% Similarity=0.596 Sum_probs=221.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.++..++|+||++++++|.+.+ .+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-HLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-eEEEE
Confidence 58999999999999999999999999999999997653322 33456888999999999999999999886554 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
|||+.|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999998763 48999999999999999999999999999999999999999999999999998765433
Q ss_pred ----------------------------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH
Q 043248 163 ----------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG 214 (1092)
Q Consensus 163 ----------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d 214 (1092)
......||+.|+|||++.+..++.++|||||||+||+|++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2334579999999999999999999999999999999999999999887666
Q ss_pred HHHHhhc--cC-CCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHhChhhHhH
Q 043248 215 LISKINR--SS-IGPLPSCYSPSLKTLIKGMLRKNPEHRPS-ASELLKHPFLQHF 265 (1092)
Q Consensus 215 li~kI~~--~~-i~plPs~iS~eLkDLIrkcLqkDPskRPS-aeELLqHPwFq~~ 265 (1092)
...++.. .. ..+....+++++.+||.+||. +|.+|++ ++++++||||+.+
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6666554 11 112223369999999999997 9999999 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=383.60 Aligned_cols=255 Identities=27% Similarity=0.493 Sum_probs=220.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++..++||||++++++|...+ .+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-YLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-EEEEE
Confidence 5799999999999999999999999999999999765322 223456888999999999999999999986554 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence 99999999999998654 389999999999999999999999999999999999999999999999999986654 34
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC---CCCC----CCCCHHHHH
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---GPLP----SCYSPSLKT 237 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i---~plP----s~iS~eLkD 237 (1092)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .+.. ..++.++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 567899999999999998999999999999999999999999998777666555543211 1111 246899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||.+||..+|.+|+++.++++||||...
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999999763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=416.52 Aligned_cols=261 Identities=34% Similarity=0.626 Sum_probs=241.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
|++|-+.+.||+|.||.||+|+.+.+.+.||||.+.+....+...+.+.+|+.|++.|+|||||.++++| +....+|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-Et~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-ETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-cccceEEEE
Confidence 6899999999999999999999999999999999998888888888999999999999999999999999 455588999
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
.|||.| +|+.+|...+. ++|+.++.++.+++.||.|||+++|+|||+||.|||+...|.+|+||||+|+.+.... .
T Consensus 80 te~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 999987 99999998765 9999999999999999999999999999999999999999999999999999987654 3
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
.....|||.|||||++.+.+|+..+|+||||||+|||+.|++||.......++..|...... +|...+..|.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-PPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-CcccccHHHHHHHHHHh
Confidence 45567999999999999999999999999999999999999999999999999999877654 45678999999999999
Q ss_pred ccCCCCCCCHHHHHhChhhHhHhhhcC
Q 043248 244 RKNPEHRPSASELLKHPFLQHFVDQYR 270 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwFq~~~d~~~ 270 (1092)
.+||.+|.|..+++.|||++.......
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~~~~~ 262 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKINIAE 262 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhhhhhc
Confidence 999999999999999999987665443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=376.37 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=213.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++.+.||.|+||.||+|.++.++..||+|.+...... .....+.+|+.++++++||||+++++++...+ .+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTER-CLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-eEEE
Confidence 578999999999999999999999999999999998654322 12345678999999999999999999986654 6889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||+++ +|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9999975 8999887654 347899999999999999999999999999999999999999999999999987654322
Q ss_pred cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-----------------
Q 043248 163 LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI----------------- 224 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i----------------- 224 (1092)
......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2344578999999999865 5689999999999999999999999988765554443321100
Q ss_pred ----C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 225 ----G--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 225 ----~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
. .....++.++++||++||++||.+|+|++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 0112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=389.11 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=216.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||+||+|.++.+++.||+|++...... ......+.+|+.++.+++|+||++++++|.+.. .+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-NLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-eEEEE
Confidence 5899999999999999999999999999999999764322 233456788999999999999999999986654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||||+||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999998754 38999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------------------------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCc
Q 043248 163 ----------------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFK 208 (1092)
Q Consensus 163 ----------------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~ 208 (1092)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 1124579999999999999999999999999999999999999999
Q ss_pred ccChHHHHHHhhccCC-CCCC--CCCCHHHHHHHHHhcccCCC---CCCCHHHHHhChhhHhH
Q 043248 209 AFDMAGLISKINRSSI-GPLP--SCYSPSLKTLIKGMLRKNPE---HRPSASELLKHPFLQHF 265 (1092)
Q Consensus 209 g~d~~dli~kI~~~~i-~plP--s~iS~eLkDLIrkcLqkDPs---kRPSaeELLqHPwFq~~ 265 (1092)
+........++..... ..++ ..+++++++||.+|+. ++. .||+++|+++||||+..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 8887777766654221 1122 2468999999999775 444 45899999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=389.43 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=216.4
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||+|.++.+++.||+|++...... ......+.+|+.+++.++|+||++++++|...+ .+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-NLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-EEEEE
Confidence 4799999999999999999999999999999998654321 223456788999999999999999999996654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc---
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--- 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d--- 161 (1092)
||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999998754 3899999999999999999999999999999999999999999999999997533110
Q ss_pred -----------------------------------------ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHH
Q 043248 162 -----------------------------------------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM 200 (1092)
Q Consensus 162 -----------------------------------------~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYEL 200 (1092)
......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 001235799999999999999999999999999999999
Q ss_pred HhCCCCCcccChHHHHHHhhccCC---CCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhChhhHhH
Q 043248 201 AAHRPAFKAFDMAGLISKINRSSI---GPLPSCYSPSLKTLIKGMLRKNPEHRP---SASELLKHPFLQHF 265 (1092)
Q Consensus 201 LTGr~PF~g~d~~dli~kI~~~~i---~plPs~iS~eLkDLIrkcLqkDPskRP---SaeELLqHPwFq~~ 265 (1092)
++|+.||.+.+.......+..... .+....++.++.+||.+|+ .+|.+|+ ++.++++||||+.+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999998876665555443211 1223357899999999977 5999999 99999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=389.13 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=215.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..|++++.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.+++.++|+||++++++|.+.+ .+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-NLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-EEEEE
Confidence 369999999999999999999999999999999976432 2334567889999999999999999999997654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc---
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--- 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d--- 161 (1092)
||||+||+|.+++.+... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999999987553 899999999999999999999999999999999999999999999999997543210
Q ss_pred ---------------------------------------------ccCccccCCCCcCCchhhccCCCCccccchhHHHH
Q 043248 162 ---------------------------------------------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCC 196 (1092)
Q Consensus 162 ---------------------------------------------~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVI 196 (1092)
......+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 01124579999999999999899999999999999
Q ss_pred HHHHHhCCCCCcccChHHHHHHhhccC---CCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHHhChhhHhH
Q 043248 197 MYEMAAHRPAFKAFDMAGLISKINRSS---IGPLPSCYSPSLKTLIKGMLR--KNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 197 LYELLTGr~PF~g~d~~dli~kI~~~~---i~plPs~iS~eLkDLIrkcLq--kDPskRPSaeELLqHPwFq~~ 265 (1092)
+|+|++|..||...+......++.... ..+....+++++.+||.+||. .++..|++++++++||||...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999998877655554443211 112233579999999999664 455569999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=389.27 Aligned_cols=256 Identities=26% Similarity=0.547 Sum_probs=224.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCC-cEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEK-KKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tG-k~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|++.+.||+|+||.||+|.++..+ ..||+|.+..... .......+.+|+.+++.++||||++++++|...+ .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES-YL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-EE
Confidence 4678999999999999999999976655 6899999865432 2233456888999999999999999999996655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+.||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 899999999999999987653 899999999999999999999999999999999999999999999999999876532
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .++..++..+.++|++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLMKK 261 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHH
Confidence 3456899999999999998999999999999999999999999998877666666665433 4677789999999999
Q ss_pred hcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
||+.||.+|+ +++++++||||..+
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999995 89999999999753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=386.30 Aligned_cols=257 Identities=30% Similarity=0.548 Sum_probs=227.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|..++.||+|.||.||+|.+..+|+.||||+++.....+.......||+.+|+.++|+||+.|+++|...+ .+.||
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-~l~lV 79 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-NLSLV 79 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-ceEEE
Confidence 46899999999999999999999999999999999988777666778999999999999999999999997766 45699
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
+||++ .+|+..|+.+. ..|+...++.|+.+++.||+|||+++|+||||||.|+|++.+|.+||+|||+++.+......
T Consensus 80 fEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 80 FEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 99997 59999998765 45999999999999999999999999999999999999999999999999999998765433
Q ss_pred -ccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC--------------
Q 043248 165 -SSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP-------------- 228 (1092)
Q Consensus 165 -st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP-------------- 228 (1092)
...+.|.||+|||++.| ..|+..+||||.|||+.||+-|.+.|.+.+..+++..|.+....+.+
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 33488999999999866 56999999999999999999999999999998988888653222111
Q ss_pred -------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 229 -------------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 229 -------------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
...+.++.||+.+||.+||.+|+++.|+|+|+||..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 113567889999999999999999999999999975
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=403.22 Aligned_cols=263 Identities=29% Similarity=0.544 Sum_probs=225.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH------------HHHHHHHHHHHHHhcCCCCcceE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER------------CRRSAHQEMALIARVQHPYIVEF 70 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~------------~~r~f~rEIqILkqL~HPNIVKL 70 (1092)
..+++|++++.||+|.||.|.+|++..+++.||||++.+...... ..+...+|+.||++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 468999999999999999999999999999999999865432211 23578899999999999999999
Q ss_pred EEEEEecC-eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEE
Q 043248 71 KEAWVEKG-CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 71 ~gvF~e~d-~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKL 149 (1092)
+++..+.. ..+|||+|||..|.+...- .....|++.+++.|++.++.||+|||.+|||||||||.|+||+.+|.+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 99987653 6899999999988776432 12223899999999999999999999999999999999999999999999
Q ss_pred eecCccccccc------cccCccccCCCCcCCchhhccC---CC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHh
Q 043248 150 GDFGLAKTLKA------DDLASSVVGTPNYMCPELLADI---PY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI 219 (1092)
Q Consensus 150 iDFGLA~~l~~------d~~~st~vGTp~YmAPEVL~g~---~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI 219 (1092)
+|||.+..+.. +......+|||.|+|||.+.++ .| +++.||||+||+||-|+.|+.||.+....++..+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 99999987732 2334457899999999998662 23 78999999999999999999999999999999999
Q ss_pred hccCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 220 NRSSIGPLPS--CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 220 ~~~~i~plPs--~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
....+. +|. .+.++++|||++||.+||.+|+++.++..|||..+..+.
T Consensus 332 vn~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 332 VNDPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred hcCccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 876553 333 378999999999999999999999999999999765443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=384.38 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=216.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++.+.||+|+||.||++.+..+|..||+|++............+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999999765444445567889999999999999999999986543
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||||+++ +|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 357899999975 67766643 2789999999999999999999999999999999999999999999999999876
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC---------------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS--------------- 223 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~--------------- 223 (1092)
..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 55544556789999999999999999999999999999999999999998765433322221100
Q ss_pred ---------CC-----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 ---------IG-----------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 ---------i~-----------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.. ......+..+++||.+||++||++|||+.|+|+||||..+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 00 011124678999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=419.37 Aligned_cols=257 Identities=28% Similarity=0.550 Sum_probs=232.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|.+++.||+|.||+|+++..+.+++.||||.+++.... ....+..+.|..|+.... ||.+++|+.+|+.++ ++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-HL 444 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-eE
Confidence 478999999999999999999999999999999999877543 334667888888888775 999999999997666 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-c
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-A 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~ 160 (1092)
|+||||+.||+|..+++.. .|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..- .
T Consensus 445 ~fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 8999999999965554432 39999999999999999999999999999999999999999999999999998754 6
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
+....+.|||+.|||||++.+..|+..+|+|||||+|||||.|..||.+.++.+++..|..... ..|..++.++.+|++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMR 600 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHH
Confidence 7778899999999999999999999999999999999999999999999999999999987654 468889999999999
Q ss_pred HhcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
++|.++|++|.. +++|.+||||..+
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccC
Confidence 999999999975 5899999999874
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=379.67 Aligned_cols=248 Identities=31% Similarity=0.548 Sum_probs=216.6
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||++++++|... ..+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCc
Confidence 7999999999999999999999999875432 233345678899999999999999999988655 47889999999999
Q ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCccccCCC
Q 043248 93 MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVGTP 171 (1092)
Q Consensus 93 L~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~vGTp 171 (1092)
|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+
T Consensus 80 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 80 LFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999998754 389999999999999999999999999999999999999999999999999876432 22344568999
Q ss_pred CcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 043248 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRP 251 (1092)
Q Consensus 172 ~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRP 251 (1092)
.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++..+++++.+||.+||.+||.+|+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-RFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 99999999999999999999999999999999999998877777666665433 46677899999999999999999997
Q ss_pred ---CHHHHHhChhhHhH
Q 043248 252 ---SASELLKHPFLQHF 265 (1092)
Q Consensus 252 ---SaeELLqHPwFq~~ 265 (1092)
++.++|.||||...
T Consensus 237 ~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 237 GYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCHHHHHcCCCcCCC
Confidence 58999999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.16 Aligned_cols=255 Identities=31% Similarity=0.473 Sum_probs=211.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEec----Ce
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV---QHPYIVEFKEAWVEK----GC 79 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL---~HPNIVKL~gvF~e~----d~ 79 (1092)
+|++++.||+|+||.||+|.++.+++.||+|.+............+.+|+.+++.+ +||||++++++|... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875432222223345566666655 799999999988643 34
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+++||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 68899999975 89999887655569999999999999999999999999999999999999999999999999998776
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC----------------
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS---------------- 223 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~---------------- 223 (1092)
.........|+..|+|||++.+..++.++|||||||++|+|++|++||..........++....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 5544556678999999999998899999999999999999999999998776555444432210
Q ss_pred --CC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 --IG--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 --i~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.. .....++..+.+||.+||++||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=388.46 Aligned_cols=256 Identities=30% Similarity=0.501 Sum_probs=216.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.+|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++++++|+||++++++|...+ .+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-EEEEE
Confidence 369999999999999999999999999999999875432 2334567889999999999999999999997655 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc---
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--- 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d--- 161 (1092)
||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 80 MDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999999998754 3899999999999999999999999999999999999999999999999997533100
Q ss_pred ---------------------------------------------ccCccccCCCCcCCchhhccCCCCccccchhHHHH
Q 043248 162 ---------------------------------------------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCC 196 (1092)
Q Consensus 162 ---------------------------------------------~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVI 196 (1092)
......+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 01123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCcccChHHHHHHhhccC---CCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhChhhHhH
Q 043248 197 MYEMAAHRPAFKAFDMAGLISKINRSS---IGPLPSCYSPSLKTLIKGMLRKNPEHRPS---ASELLKHPFLQHF 265 (1092)
Q Consensus 197 LYELLTGr~PF~g~d~~dli~kI~~~~---i~plPs~iS~eLkDLIrkcLqkDPskRPS---aeELLqHPwFq~~ 265 (1092)
||+|++|+.||.+.+......++.... ..+....+++++.++|.+|+ .+|.+|++ ++++++||||+.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999999877666555554321 11223457999999999987 59999987 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=388.45 Aligned_cols=255 Identities=28% Similarity=0.519 Sum_probs=215.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||++.++.+++.||||++..... .......+.+|+.++++++||||++++++|...+ ++|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-YLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-eeEEE
Confidence 589999999999999999999999999999999865432 2233456888999999999999999999996654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||||+||+|.+++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999999998654 48999999999999999999999999999999999999999999999999986432100
Q ss_pred ----------------------------------------------cCccccCCCCcCCchhhccCCCCccccchhHHHH
Q 043248 163 ----------------------------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCC 196 (1092)
Q Consensus 163 ----------------------------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVI 196 (1092)
.....+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012479999999999999999999999999999
Q ss_pred HHHHHhCCCCCcccChHHHHHHhhccC-CCCCC--CCCCHHHHHHHHHhcccCCCCC---CCHHHHHhChhhHh
Q 043248 197 MYEMAAHRPAFKAFDMAGLISKINRSS-IGPLP--SCYSPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQH 264 (1092)
Q Consensus 197 LYELLTGr~PF~g~d~~dli~kI~~~~-i~plP--s~iS~eLkDLIrkcLqkDPskR---PSaeELLqHPwFq~ 264 (1092)
+|+|++|..||...+.......+.... ...++ ..++.++++||.+||. +|.+| +++.++++||||..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999998877766666554321 11223 2478999999999997 67665 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=378.00 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=219.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++.+.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.+++.++|+||++++++|...+ .+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-NLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-eEEEE
Confidence 579999999999999999999999999999999976543 2234566888999999999999999999886654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
|||++|++|.+++.+... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 80 MEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred ECCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999987632 499999999999999999999999999999999999999999999999999987654332
Q ss_pred -CccccCCCCcCCchhhc------cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-C--CCCCCCCH
Q 043248 164 -ASSVVGTPNYMCPELLA------DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-G--PLPSCYSP 233 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~------g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~--plPs~iS~ 233 (1092)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||..........++..... . +....++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 23357999999999986 45678999999999999999999999988776666665543221 1 22235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+.+||.+||. +|.+||+++++++||||...
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 99999999998 99999999999999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=384.26 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=218.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||++++++|....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 468999999999999999999999999999999999765444455567889999999999999999999886433
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||||+++ +|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357899999975 78777753 2789999999999999999999999999999999999999999999999999877
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-------------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------- 225 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------- 225 (1092)
..........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++......
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 6555556678999999999999999999999999999999999999999887665544443221000
Q ss_pred ----------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 226 ----------------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 226 ----------------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
......+..+++||.+||+.||.+|||+.++|+||||..+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 001112467899999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=355.84 Aligned_cols=256 Identities=43% Similarity=0.902 Sum_probs=227.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++++.||+|+||.||++.++.+++.||+|++..........+.+.+|+.++++++|+|++++++.|...+..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999999976555555566788999999999999999999988666667899999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~s 165 (1092)
|+++++|.+++.......+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 999999999998765556899999999999999999999999999999999999999999999999999876432 2234
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........+..++..+.+||.+||+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhcc
Confidence 45789999999999998999999999999999999999999988777666666666655566777899999999999999
Q ss_pred CCCCCCCHHHHHhChhh
Q 043248 246 NPEHRPSASELLKHPFL 262 (1092)
Q Consensus 246 DPskRPSaeELLqHPwF 262 (1092)
+|.+||++.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=378.58 Aligned_cols=253 Identities=28% Similarity=0.546 Sum_probs=217.2
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHH---HhcCCCCcceEEEEEEecCeEEEE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALI---ARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqIL---kqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
|++++.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++ +.++||||++++++|...+ .+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-HVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-EEEE
Confidence 7899999999999999999999999999999975432 122234566665554 5668999999999986554 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DD 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~ 162 (1092)
||||++|++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 80 v~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 80 VMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999999988653 389999999999999999999999999999999999999999999999999875432 22
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
.....+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..... ..+..++..+.+||++|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRL 235 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence 34457899999999999999999999999999999999999999998887777776665443 35667899999999999
Q ss_pred cccCCCCCC-----CHHHHHhChhhHhH
Q 043248 243 LRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
|+.||.+|| ++.++++||||..+
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=381.74 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=217.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++++.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 578999999999999999999999999999999999765555555667889999999999999999999986443
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||||+++ +|...+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357899999975 67777653 2789999999999999999999999999999999999999999999999999877
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC--------------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-------------- 224 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-------------- 224 (1092)
..........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 655555667899999999999999999999999999999999999999987664433322211000
Q ss_pred ---------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 225 ---------------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 225 ---------------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.......+.++++||.+||..||++|||+.|+|+||||..+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0011123567899999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=380.65 Aligned_cols=250 Identities=32% Similarity=0.589 Sum_probs=217.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
+.||+|+||.||++.++.+|..||+|.+..... .......+.+|+.+++.++||||++++++|...+ .+||||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-EEEEEEeCCCC
Confidence 479999999999999999999999999975432 2233456778999999999999999999986655 78899999999
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCccccC
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVG 169 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~vG 169 (1092)
++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........|
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 80 GELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 99999987654 489999999999999999999999999999999999999999999999999876432 223345679
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPsk 249 (1092)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++..+++++.+||.+||.+||.+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999999999999999999999988777666666654433 356778999999999999999999
Q ss_pred CC-----CHHHHHhChhhHhH
Q 043248 250 RP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 250 RP-----SaeELLqHPwFq~~ 265 (1092)
|+ ++.++++|+||...
T Consensus 237 R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 237 RLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCC
Confidence 98 99999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=380.45 Aligned_cols=249 Identities=32% Similarity=0.582 Sum_probs=216.8
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
+.||+|+||.||++.++.+++.||+|++..... .......+.+|+.+++.++||||++++++|...+ .+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-RLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-EEEEEEeCCCC
Confidence 479999999999999999999999999975432 2233456788999999999999999999886554 78899999999
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCccccC
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVG 169 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~vG 169 (1092)
++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+|
T Consensus 80 g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 80 GELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99999987654 489999999999999999999999999999999999999999999999999876432 223345689
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPsk 249 (1092)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++..++.++.+||++||++||.+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-KFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc-cCCCCCCHHHHHHHHHHcCCCHHH
Confidence 9999999999998999999999999999999999999988777666666554433 467778999999999999999999
Q ss_pred CC-----CHHHHHhChhhHh
Q 043248 250 RP-----SASELLKHPFLQH 264 (1092)
Q Consensus 250 RP-----SaeELLqHPwFq~ 264 (1092)
|+ ++.++++||||..
T Consensus 237 R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 237 RLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=371.74 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=209.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||+|.++.+++.||+|++....... ....+.+|+.+++.++||||+++++++.... .+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKE-TLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCC-eEEE
Confidence 4689999999999999999999999999999999987543222 2345678999999999999999999986654 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-c
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-D 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~ 162 (1092)
||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 999996 58888887643 34899999999999999999999999999999999999999999999999998754322 2
Q ss_pred cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhccCCC---------------
Q 043248 163 LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRSSIG--------------- 225 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~~i~--------------- 225 (1092)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2345678999999999865 4588999999999999999999999986432 2222222110000
Q ss_pred -------CCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 226 -------PLP---------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 226 -------plP---------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
..+ ..++..+.+||.+||++||.+|+|+.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 1235678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.80 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=217.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++||||++++++|...+ .+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EEEE
Confidence 4689999999999999999999999999999999987543 3344567899999999999999999999987655 6789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||++|++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999999998754 389999999999999999999986 6999999999999999999999999998766432
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc---------------------
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR--------------------- 221 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~--------------------- 221 (1092)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+...+...+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 23456799999999999998999999999999999999999999976554333222111
Q ss_pred -------------------------cCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 222 -------------------------SSIGPL-PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 222 -------------------------~~i~pl-Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
...... ...++.++.+||.+||++||++|||+.++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 001111 1246789999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=392.46 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=228.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----cCeEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE----KGCYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e----~d~~l 81 (1092)
.+|..++.||+|+||.|+.+.++.+|+.||||++..........++..||+.+|+.++|+||+.+++++.. .-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45666899999999999999999999999999998776777778899999999999999999999999875 23568
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA- 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~- 160 (1092)
|+|+|++ +.+|...|+.... |++..+..+++||+.||+|+|+.+|+||||||.|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 9999999 5699999987654 89999999999999999999999999999999999999999999999999999863
Q ss_pred --cccCccccCCCCcCCchhh-ccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC------------
Q 043248 161 --DDLASSVVGTPNYMCPELL-ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------ 225 (1092)
Q Consensus 161 --d~~~st~vGTp~YmAPEVL-~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------ 225 (1092)
...++.++.|.||+|||++ ....|+..+||||+||||.||++|++.|.|.+...++..|......
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 5556788999999999988 4678999999999999999999999999998877776666331110
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 226 ------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 226 ------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.+-...++.+.+|+.+||..||.+|+|++|+|+||||..+.+.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 0112468899999999999999999999999999999987763
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=395.96 Aligned_cols=258 Identities=32% Similarity=0.564 Sum_probs=232.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~l 81 (1092)
.-+.|++.+.||+|.||.||+|.++.+|+.+|+|.+.+.... ......+.+|+.+|++|. |||||.++++|.... .+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eE
Confidence 345799999999999999999999999999999999766543 224567899999999998 999999999996665 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC----CCEEEeecCcccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD----QDVRLGDFGLAKT 157 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d----G~LKLiDFGLA~~ 157 (1092)
|+|||+|.||.|++.|... .+++..+..++.||+.++.|||+.||+||||||+|||+... +.+|++|||++..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 8999999999999999887 29999999999999999999999999999999999999543 4799999999999
Q ss_pred ccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCHH
Q 043248 158 LKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPS 234 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~e 234 (1092)
...+......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+........++....+. +....++..
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 98877788999999999999999999999999999999999999999999999988888888776543 233447999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+++||++||..||.+|+|+.++|+|||+...
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999998754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=399.29 Aligned_cols=254 Identities=28% Similarity=0.555 Sum_probs=233.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
-.+|++.+.||+|.||.|.+|.....|+.||||.++++... +...-.+.+|+.||..|+||||+++|++|...+ .+.|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-KIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-KIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-eEEE
Confidence 35899999999999999999999999999999999876543 334456889999999999999999999996555 6779
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||..+|.|++||.+.+. |++.+++.||+||+.|+.|||+++++|||||.+|||||.++++||+||||+..+....+
T Consensus 131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 9999999999999998765 99999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
..++||++-|.+||+++|.+| ++.+|.|||||+||.|+.|..||.+.+...++.+|..+.+.+.+ -+..+.-||++|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~--~PSdA~gLIRwm 286 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE--TPSDASGLIRWM 286 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC--CCchHHHHHHHH
Confidence 999999999999999999999 89999999999999999999999999999999999988765433 356788999999
Q ss_pred cccCCCCCCCHHHHHhChhhH
Q 043248 243 LRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq 263 (1092)
|..||++|.|++++..|=|++
T Consensus 287 LmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HhcCcccchhHHHHhhhheee
Confidence 999999999999999996654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=378.44 Aligned_cols=250 Identities=32% Similarity=0.590 Sum_probs=216.4
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||++++++|...+ .+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-EEEEEEeCCCC
Confidence 479999999999999999999999999975432 2223456778999999999999999999886655 78899999999
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccCcccc
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVV 168 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~st~v 168 (1092)
++|..++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 80 GELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 99999987654 48999999999999999999997 799999999999999999999999999987543 222334567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .++..+++++.+||++||++||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHhhcCHH
Confidence 99999999999999999999999999999999999999988777666666554433 46677899999999999999999
Q ss_pred CCC-----CHHHHHhChhhHhH
Q 043248 249 HRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 249 kRP-----SaeELLqHPwFq~~ 265 (1092)
+|+ ++.++++||||...
T Consensus 237 ~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 237 QRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HhCCCCCCCHHHHhcCCCcCCC
Confidence 997 99999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=384.79 Aligned_cols=258 Identities=31% Similarity=0.540 Sum_probs=220.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..+++|++.+.||+|+||.||++.++.+++.||+|.+...... ......+.+|+.+++.++||||++++++|.. +..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~ 118 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYL 118 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEE
Confidence 3467899999999999999999999999999999999754322 2233457789999999999999999998865 4478
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 8999999999999998754 3899999999999999999999999999999999999999999999999999876543
Q ss_pred cc--CccccCCCCcCCchhhccC----CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-CCCCC--CCC
Q 043248 162 DL--ASSVVGTPNYMCPELLADI----PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-GPLPS--CYS 232 (1092)
Q Consensus 162 ~~--~st~vGTp~YmAPEVL~g~----~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~plPs--~iS 232 (1092)
.. ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+......++..... ..++. .++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 22 2456799999999998653 478999999999999999999999999887777777654321 12232 479
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHhChhhHh
Q 043248 233 PSLKTLIKGMLRKNPEH--RPSASELLKHPFLQH 264 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~ 264 (1092)
.++++||++||..+|.+ |++++++++||||+.
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=366.48 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=220.1
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.|++.+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++|+||++++++|...+ .+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-eEEEEE
Confidence 599999999999999999999999999999998754322 222345778999999999999999999886554 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 99999999999876555569999999999999999999999999999999999999999999999999998765444445
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHh---hccCCCCCCCCCCHHHHHHHHHh
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI---NRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI---~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
..+|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+ ........+..++..+.+||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 568999999999999889999999999999999999999999876543322222 12222334566899999999999
Q ss_pred cccCCCCCC-----CHHHHHhChhhHh
Q 043248 243 LRKNPEHRP-----SASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRP-----SaeELLqHPwFq~ 264 (1092)
|..||.+|| +++++++||||..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999 9999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=377.20 Aligned_cols=250 Identities=26% Similarity=0.518 Sum_probs=216.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.++.+++.||+|.+..... .......+..|..++..+ +||||++++++|...+ .+|+|||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-RLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-EEEEEEcCCC
Confidence 479999999999999999999999999875432 222345667788888876 6999999999986554 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~st~v 168 (1092)
|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........
T Consensus 80 ~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 80 GGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 999999998754 38999999999999999999999999999999999999999999999999987643 223344567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...+...+..... .++..++.++.+||++||++||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999999999999999999999888777777765433 35667899999999999999999
Q ss_pred CCCCH------HHHHhChhhHhH
Q 043248 249 HRPSA------SELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSa------eELLqHPwFq~~ 265 (1092)
+|+++ +++++||||..+
T Consensus 237 ~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 237 MRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HCCCCCCCCCHHHHHcCCCcCCC
Confidence 99998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=374.08 Aligned_cols=255 Identities=25% Similarity=0.526 Sum_probs=220.3
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEecCeEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHP-YIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HP-NIVKL~gvF~e~d~~lyLV 84 (1092)
+|++++.||+|+||.||+|.++.+++.||+|++..... .....+.+..|+.++..+.|+ +|++++++|...+ .+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-EEEEE
Confidence 59999999999999999999999999999999976432 223345677899999999765 5788888886554 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-cccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~ 163 (1092)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ....
T Consensus 80 ~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999999997654 38999999999999999999999999999999999999999999999999987532 2223
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..... .++..++.++.+||++||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-SYPKSLSKEAVSICKGLL 236 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHh
Confidence 3456799999999999999999999999999999999999999998887777777765433 466778999999999999
Q ss_pred ccCCCCCCCH-----HHHHhChhhHhH
Q 043248 244 RKNPEHRPSA-----SELLKHPFLQHF 265 (1092)
Q Consensus 244 qkDPskRPSa-----eELLqHPwFq~~ 265 (1092)
.+||.+|+++ +++++||||...
T Consensus 237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 237 TKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999976 899999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=373.95 Aligned_cols=254 Identities=28% Similarity=0.529 Sum_probs=212.3
Q ss_pred CeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEecccc--cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQ--TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~--se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
+|++++.||+|+||.||++++. .+++.||+|++..... .......+.+|+.+++.+ +|+||++++++|...+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-K 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC-E
Confidence 5999999999999999998864 5789999999875432 222345678899999999 5999999999886554 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+|||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 8899999999999999987543 89999999999999999999999999999999999999999999999999986543
Q ss_pred cc--cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccCCCCCCCCCCH
Q 043248 161 DD--LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIGPLPSCYSP 233 (1092)
Q Consensus 161 d~--~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~i~plPs~iS~ 233 (1092)
.. .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+. .....++..++.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIGP 236 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCH
Confidence 22 23346799999999999765 478999999999999999999999975322 22222222 223356677899
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHhChhhHh
Q 043248 234 SLKTLIKGMLRKNPEHRP-----SASELLKHPFLQH 264 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRP-----SaeELLqHPwFq~ 264 (1092)
.+.+||.+||+.||++|+ +++++++||||+.
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=373.55 Aligned_cols=251 Identities=31% Similarity=0.553 Sum_probs=218.0
Q ss_pred EEEEeecCceEEEEEEE---cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 11 MEQIGRGAFGAAILVNH---RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~d---K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
++.||+|+||.||++.+ ..+|+.||+|++............+.+|+.++++++||||++++++|...+ .+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-KLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-EEEEEEcC
Confidence 36899999999999886 357899999999765443334456778999999999999999999986654 78899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccCcc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASS 166 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~st 166 (1092)
++|++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 99999999997654 3899999999999999999999999999999999999999999999999998865443 23345
Q ss_pred ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccC
Q 043248 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKN 246 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkD 246 (1092)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++..++..+.+||++||++|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcC
Confidence 6799999999999998999999999999999999999999998887777766665443 456778999999999999999
Q ss_pred CCCCCC-----HHHHHhChhhHhH
Q 043248 247 PEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 247 PskRPS-----aeELLqHPwFq~~ 265 (1092)
|.+||+ +.+++.||||..+
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999 7889999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=395.35 Aligned_cols=260 Identities=28% Similarity=0.523 Sum_probs=229.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++|++++.||+|..|+||+|+.+.++..+|+|++.+.... .....++..|-.||+.++||.++.||..|.. +.+.|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEE
Confidence 46788999999999999999999999999999999766433 3345678889999999999999999999954 558999
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc---
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA--- 160 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~--- 160 (1092)
|||||.||+|..+++++.++.|++..++.|+..++.||+|||..|||+|||||+||||.++|+|.|.||.|+....-
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998642210
Q ss_pred -------------------------------cc-----------------------cCccccCCCCcCCchhhccCCCCc
Q 043248 161 -------------------------------DD-----------------------LASSVVGTPNYMCPELLADIPYGF 186 (1092)
Q Consensus 161 -------------------------------d~-----------------------~~st~vGTp~YmAPEVL~g~~yS~ 186 (1092)
.. .....+||-.|+|||++.|...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 00 012347999999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-CCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHHhChh
Q 043248 187 KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-PLPSCYSPSLKTLIKGMLRKNPEHRPS----ASELLKHPF 261 (1092)
Q Consensus 187 KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~-plPs~iS~eLkDLIrkcLqkDPskRPS----aeELLqHPw 261 (1092)
++|+|+|||+|||||.|..||.+.+....+.+|...... +-...++..++|||+++|.+||.+|.. +.||.+|||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 999999999999999999999999999999988765443 222257899999999999999999998 999999999
Q ss_pred hHhH
Q 043248 262 LQHF 265 (1092)
Q Consensus 262 Fq~~ 265 (1092)
|+.+
T Consensus 395 F~gV 398 (459)
T KOG0610|consen 395 FEGV 398 (459)
T ss_pred ccCC
Confidence 9875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=407.66 Aligned_cols=253 Identities=31% Similarity=0.580 Sum_probs=229.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
...|...++||+|+.|.||.|....+++.||||.+.+..... ++.+.+|+.+|+.++|+|||++++.|...+ .+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-eLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGD-ELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccc-eeEEE
Confidence 457888999999999999999999999999999998765544 467899999999999999999999997764 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|||++||+|.+.+.... ++|.+|..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.... .
T Consensus 349 MEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999999999998654 8999999999999999999999999999999999999999999999999999887665 5
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHHH
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIrk 241 (1092)
..+.+||++|||||++....|++++||||||++++||+-|++||-..+...-++.|...... ..+..+|+.|++|+.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 67889999999999999999999999999999999999999999987776666666554443 3467799999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhH
Q 043248 242 MLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq 263 (1092)
||+.|+.+|+++.|+|+||||+
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhh
Confidence 9999999999999999999994
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=376.07 Aligned_cols=250 Identities=28% Similarity=0.556 Sum_probs=211.8
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||++.++.+++.||+|++...... ......+.+|..++..+ +||||++++++|...+ .+|+|||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-RLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-EEEEEEeCCC
Confidence 4799999999999999999999999999765332 23345678899999988 7999999999986654 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc-cccccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l-~~d~~~st~v 168 (1092)
|++|..++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .........+
T Consensus 80 ~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 80 GGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 999999987654 3999999999999999999999999999999999999999999999999998753 2233345678
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--------hHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--------MAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--------~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......+........++..++..+.+||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999996321 11222222223333567778999999999
Q ss_pred HhcccCCCCCCC------HHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPS------ASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPS------aeELLqHPwFq~ 264 (1092)
+||++||.+|++ ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999987 799999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=374.49 Aligned_cols=250 Identities=28% Similarity=0.541 Sum_probs=216.9
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.++.+++.||+|.+..... .......+..|..++..+ +||||++++++|...+ .+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-RLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-eEEEEEeCCC
Confidence 469999999999999999999999999876432 223345567788888866 7999999999996655 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 80 GGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 999999997654 389999999999999999999999999999999999999999999999999876432 22344567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... ..+..++.++.+||++||++||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHH
Confidence 99999999999999999999999999999999999999999888887777765543 35566899999999999999999
Q ss_pred CCC-------CHHHHHhChhhHhH
Q 043248 249 HRP-------SASELLKHPFLQHF 265 (1092)
Q Consensus 249 kRP-------SaeELLqHPwFq~~ 265 (1092)
+|+ +++++++||||..+
T Consensus 237 ~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 237 KRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HcCCCCCCCCCHHHHhcCCccCCC
Confidence 999 99999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=388.00 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=232.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++-+.||+|.|+.||.+.++.+|+.+|+|++..........+.+.+|+.|-+.|+||||++|++.+.+.+ +.|||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~-~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-eeEEEE
Confidence 6789999999999999999999999999999999777666666778999999999999999999999885544 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCEEEeecCccccccccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD---QDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d---G~LKLiDFGLA~~l~~d~ 162 (1092)
|++.|++|..-|-... .++|..+-.+++||+++|.|||.+||||||+||+|+|+-.. --+||+|||+|..+..+.
T Consensus 90 e~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred ecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 9999999988776653 38999999999999999999999999999999999999533 359999999999999777
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPSLKTLI 239 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~eLkDLI 239 (1092)
.....+|||.|||||++...+|+..+|||+.|||||.||.|++||++.+...+...|.+..+.. ....+++++++||
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 7778899999999999999999999999999999999999999999999889999998876653 3345799999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
++||..||.+|+|+.|+|+|||+..
T Consensus 248 rrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999999964
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=374.18 Aligned_cols=250 Identities=30% Similarity=0.577 Sum_probs=216.1
Q ss_pred EEEEeecCceEEEEEEEc---CCCcEEEEEEEecccc--cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 11 MEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQ--TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~--se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++.||+|+||.||++.+. .+++.||+|.+..... .......+.+|+.+++.++||||++++++|...+ .+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-KLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-eEEEEE
Confidence 368999999999999864 5788999999875432 1223345778999999999999999999986654 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~ 164 (1092)
||+.|++|.+++...+ .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999999998754 388999999999999999999999999999999999999999999999999875432 2233
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++..++..+.+||++||+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHcc
Confidence 456799999999999988899999999999999999999999998887777777665443 4667789999999999999
Q ss_pred cCCCCCC-----CHHHHHhChhhHh
Q 043248 245 KNPEHRP-----SASELLKHPFLQH 264 (1092)
Q Consensus 245 kDPskRP-----SaeELLqHPwFq~ 264 (1092)
++|++|+ +++++++||||..
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999 8999999999965
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.40 Aligned_cols=254 Identities=24% Similarity=0.506 Sum_probs=219.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+|++++.||+|+||.||+|.++.+++.||+|.+..... .......+..|..++..+ +|++|++++++|...+ .+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-RLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-EEEEE
Confidence 58999999999999999999999999999999876432 122334566778888777 5889999999886654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-ccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~ 163 (1092)
|||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999999976543 89999999999999999999999999999999999999999999999999976432 223
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+..... .++..++.++.+||.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLM 236 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHHHHHc
Confidence 3456899999999999999999999999999999999999999999888777777765443 456778999999999999
Q ss_pred ccCCCCCCC-----HHHHHhChhhHh
Q 043248 244 RKNPEHRPS-----ASELLKHPFLQH 264 (1092)
Q Consensus 244 qkDPskRPS-----aeELLqHPwFq~ 264 (1092)
+++|.+|++ ..++++||||..
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 237 TKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred ccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999997 489999999965
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=380.47 Aligned_cols=256 Identities=31% Similarity=0.496 Sum_probs=217.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|+.++.+++|+||++++++|...+ .+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-NLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-EEEEE
Confidence 579999999999999999999999999999999975432 2233467788999999999999999999986554 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||||+||+|.+++.+... +++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999987543 8999999999999999999999999999999999999999999999999987543210
Q ss_pred ----------------------------------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCc
Q 043248 163 ----------------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFK 208 (1092)
Q Consensus 163 ----------------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~ 208 (1092)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 1123579999999999999999999999999999999999999999
Q ss_pred ccChHHHHHHhhccCC-CCCC--CCCCHHHHHHHHHhcccCCCCCC---CHHHHHhChhhHhH
Q 043248 209 AFDMAGLISKINRSSI-GPLP--SCYSPSLKTLIKGMLRKNPEHRP---SASELLKHPFLQHF 265 (1092)
Q Consensus 209 g~d~~dli~kI~~~~i-~plP--s~iS~eLkDLIrkcLqkDPskRP---SaeELLqHPwFq~~ 265 (1092)
.........++..... ..++ ..++.++++||.+|+. +|.+|+ +++++++||||+..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 8877766666653211 1122 2378999999999874 999998 58999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=383.62 Aligned_cols=258 Identities=31% Similarity=0.534 Sum_probs=218.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
...++|++.+.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.+++.++||||++++++|... ..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-KYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEE
Confidence 346799999999999999999999999999999999865332 222345677899999999999999999998654 478
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 8999999999999999754 3899999999999999999999999999999999999999999999999999876543
Q ss_pred cc--CccccCCCCcCCchhhccCC----CCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-CCCC--CCCC
Q 043248 162 DL--ASSVVGTPNYMCPELLADIP----YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-GPLP--SCYS 232 (1092)
Q Consensus 162 ~~--~st~vGTp~YmAPEVL~g~~----yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~plP--s~iS 232 (1092)
.. ....+||+.|+|||++.+.. ++.++|||||||+||+|++|+.||...+......++..... ..++ ..++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 24567999999999997543 78999999999999999999999998887777776654321 1223 3468
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHhChhhHh
Q 043248 233 PSLKTLIKGMLRKNPEH--RPSASELLKHPFLQH 264 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~ 264 (1092)
..++++|.+||..++.+ |+++.++++||||+.
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 99999999999866544 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=349.04 Aligned_cols=255 Identities=38% Similarity=0.724 Sum_probs=228.4
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|.+.+.||+|+||.||++.++.+++.|++|.+............+.+|+.+++.++||||+++++++...+ .+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-KLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-EEEEEEE
Confidence 589999999999999999999999999999998766555556678889999999999999999999987654 7889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
|++|++|.+++....+..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999999999987655569999999999999999999999999999999999999999999999999988765432 233
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.......++..++..+.++|.+||+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence 45789999999999998899999999999999999999999998887777777776666667777899999999999999
Q ss_pred CCCCCCCHHHHHhChhh
Q 043248 246 NPEHRPSASELLKHPFL 262 (1092)
Q Consensus 246 DPskRPSaeELLqHPwF 262 (1092)
+|++||++.++++|||+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=355.25 Aligned_cols=252 Identities=36% Similarity=0.647 Sum_probs=214.5
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
|++++.||+|+||+||++.+..+++.||+|.+..............+|+.++++++|+||+++++++.... .+++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-YLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-EEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-cccccccc
Confidence 89999999999999999999999999999999887666655556677999999999999999999997744 67799999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc-cccccCcc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASS 166 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l-~~d~~~st 166 (1092)
+.+++|.+++..... +++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+ ........
T Consensus 80 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999985443 899999999999999999999999999999999999999999999999999864 22334556
Q ss_pred ccCCCCcCCchhhc-cCCCCccccchhHHHHHHHHHhCCCCCcccCh---HHHHHHhhccCCC-CC--CCCCCHHHHHHH
Q 043248 167 VVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---AGLISKINRSSIG-PL--PSCYSPSLKTLI 239 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~---~dli~kI~~~~i~-pl--Ps~iS~eLkDLI 239 (1092)
..++..|+|||++. +..++.++||||||+++|+|++|..||..... ............. .. .......+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 78999999999998 88889999999999999999999999998732 2222222211110 01 111237999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+||+.||++||++.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=390.90 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=213.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-------
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK------- 77 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~------- 77 (1092)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|+||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 468999999999999999999999999999999886432 2234799999999999999999887432
Q ss_pred CeEEEEEEeecCCCCHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGL 154 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkk--k~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGL 154 (1092)
..++++||||+++ +|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 2357899999975 78777753 2334589999999999999999999999999999999999998665 699999999
Q ss_pred cccccccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC---------
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI--------- 224 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i--------- 224 (1092)
+..+.........+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+....+.+..+.....
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 987765555556789999999999866 4689999999999999999999999988765554444332100
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 225 -------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 225 -------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
..++...+.++.+||.+||++||.+|+|+.|+|+||||..+.+
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0123446789999999999999999999999999999988765
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=370.31 Aligned_cols=250 Identities=24% Similarity=0.499 Sum_probs=213.6
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.++.++..||+|.+...... ......+..|..++..+ +||||++++++|...+ .+|+|||||.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-HLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-EEEEEECCCC
Confidence 4799999999999999999999999999764321 12234566677777754 8999999999997655 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|++|..++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... .......+
T Consensus 80 ~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 80 GGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999999998754 389999999999999999999999999999999999999999999999999875322 22344568
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ...++..++.++++||++||..||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999988877666666543 3345667899999999999999999
Q ss_pred CCCCH-HHHHhChhhHhH
Q 043248 249 HRPSA-SELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSa-eELLqHPwFq~~ 265 (1092)
+|+++ +++++||||...
T Consensus 237 ~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 237 RRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HcCCChHHHHcCCCcCCC
Confidence 99998 588899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=369.69 Aligned_cols=250 Identities=25% Similarity=0.493 Sum_probs=213.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHh-cCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIAR-VQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkq-L~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.+..+++.||+|.+...... ......+..|..++.. ++||||++++++|...+ .+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-HLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 4799999999999999999999999999764322 2223445566666664 48999999999986554 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|++|..++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 80 GGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999999998754 389999999999999999999999999999999999999999999999999976532 23344568
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+... ...++..++.++.+||.+||..+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999988877776666543 3456777899999999999999999
Q ss_pred CCCCH-HHHHhChhhHhH
Q 043248 249 HRPSA-SELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSa-eELLqHPwFq~~ 265 (1092)
+|+++ .++++||||...
T Consensus 237 ~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 237 KRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HcCCChHHHHcCcccCCC
Confidence 99986 588899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.91 Aligned_cols=250 Identities=31% Similarity=0.541 Sum_probs=212.7
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMA-LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIq-ILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||+||+|.++.+|+.||+|++...... ......+.+|.. +++.++||||++++++|...+ .+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-KLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-EEEEEEcCCC
Confidence 4799999999999999999999999999754321 122234444544 567899999999999986654 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 ~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 80 GGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999999998654 489999999999999999999999999999999999999999999999999875432 23344567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+...+...+..... .++..++..+.+||++||++||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCHH
Confidence 99999999999999999999999999999999999999998887777777665543 34556799999999999999999
Q ss_pred CCCCH----HHHHhChhhHhH
Q 043248 249 HRPSA----SELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSa----eELLqHPwFq~~ 265 (1092)
+|+++ .++++||||..+
T Consensus 237 ~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 237 KRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCC
Confidence 99987 699999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=368.62 Aligned_cols=258 Identities=30% Similarity=0.520 Sum_probs=215.4
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.++..++|+||++++++|... ..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEE
Confidence 589999999999999999999999999999999975322 222345678899999999999999999998655 478899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
|||+.|++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999997643 3489999999999999999999999999999999999999999999999999876654322
Q ss_pred -CccccCCCCcCCchhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC----CCCCCCCCCH
Q 043248 164 -ASSVVGTPNYMCPELLAD-----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS----IGPLPSCYSP 233 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g-----~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~----i~plPs~iS~ 233 (1092)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.... .......++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 223579999999999963 457889999999999999999999999877766666654321 1122234789
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHhChhhHhH
Q 043248 234 SLKTLIKGMLRKNPEH--RPSASELLKHPFLQHF 265 (1092)
Q Consensus 234 eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~~ 265 (1092)
.+++||++||..++.+ |+++.++++||||...
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 9999999999764444 7899999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=361.19 Aligned_cols=251 Identities=28% Similarity=0.486 Sum_probs=211.2
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
||+|+||.||++.++.+|+.||+|.+....... .....+..|+.++++++||||++++++|... ..+|+||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-THLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-CeEEEEEecCCCCC
Confidence 799999999999999999999999986543222 2234556799999999999999999988654 57889999999999
Q ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCC
Q 043248 93 MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN 172 (1092)
Q Consensus 93 L~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~ 172 (1092)
|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............|+..
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 99998776655689999999999999999999999999999999999999999999999999987765444445679999
Q ss_pred cCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 173 YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
|+|||++.+..++.++|||||||++|+|++|+.||..... ..................++.++++||.+||++||.
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 9999999988899999999999999999999999976432 222233332222222346799999999999999999
Q ss_pred CCCCH----HHHHhChhhHhH
Q 043248 249 HRPSA----SELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSa----eELLqHPwFq~~ 265 (1092)
+||++ ++++.|+||+.+
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=401.68 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=222.4
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-C-----CCcceEEEEEEecCeE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-H-----PYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-H-----PNIVKL~gvF~e~d~~ 80 (1092)
+|.|++.||+|.||+|.+|.+..+++.||||+++.. ....+....|+.||+.|+ | -|||+++++|...+ +
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-H 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-c
Confidence 799999999999999999999999999999999743 455667788999999997 4 48999999997666 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC--CEEEeecCccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ--DVRLGDFGLAKTL 158 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG--~LKLiDFGLA~~l 158 (1092)
+|||+|+++ .+|+++|+.+...+|+...++.++.||+.||.+||+.||||+|||||||||..-+ .|||+|||+|+..
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 899999995 6999999999999999999999999999999999999999999999999997544 6999999999987
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-------------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------- 225 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------- 225 (1092)
...-. +++-+++|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+++..|......
T Consensus 342 ~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 342 SQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred CCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 75533 889999999999999999999999999999999999999999999998888887431000
Q ss_pred ----C----------------------------------CC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 043248 226 ----P----------------------------------LP-----------SCYSPSLKTLIKGMLRKNPEHRPSASEL 256 (1092)
Q Consensus 226 ----p----------------------------------lP-----------s~iS~eLkDLIrkcLqkDPskRPSaeEL 256 (1092)
. .| ......+.+||++||..||.+|+|+.++
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 0 01 0113468999999999999999999999
Q ss_pred HhChhhHhHhhh
Q 043248 257 LKHPFLQHFVDQ 268 (1092)
Q Consensus 257 LqHPwFq~~~d~ 268 (1092)
|+||||......
T Consensus 500 l~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 500 LNHPFLTGTSLE 511 (586)
T ss_pred hcCccccccccc
Confidence 999999865443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=366.41 Aligned_cols=249 Identities=29% Similarity=0.506 Sum_probs=211.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHH-HHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEM-ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEI-qILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|. .+++.++||||++++++|...+ .+|+|||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-KLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 4799999999999999999999999998754321 22233444554 4678899999999999886554 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~st~v 168 (1092)
|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 80 GGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999999887654 38999999999999999999999999999999999999999999999999987542 223344567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ..++...+..+.++|.+||+++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHh
Confidence 9999999999999899999999999999999999999999888777666665543 345667889999999999999999
Q ss_pred CCCCH----HHHHhChhhHh
Q 043248 249 HRPSA----SELLKHPFLQH 264 (1092)
Q Consensus 249 kRPSa----eELLqHPwFq~ 264 (1092)
+|+++ .++++|+||..
T Consensus 237 ~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 237 RRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred hcCCCCCCHHHHhCCCCcCC
Confidence 99865 59999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=361.69 Aligned_cols=258 Identities=28% Similarity=0.496 Sum_probs=218.7
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+||+.+++++...+ .+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-EEEEEE
Confidence 488999999999999999999999999999998754322 223345778999999999999999999886654 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+.|++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99999999999976655569999999999999999999999999999999999999999999999999997765444444
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---HHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+........+..++.++.+||++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 568999999999999989999999999999999999999999864321 12222222222234566889999999999
Q ss_pred cccCCCCCCC-----HHHHHhChhhHhH
Q 043248 243 LRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
|+.||.+|+| ++|+++||||..+
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=373.14 Aligned_cols=251 Identities=28% Similarity=0.548 Sum_probs=210.6
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.++.++ +||||++++++|...+ .+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-EEEEEEeCCC
Confidence 479999999999999999999999999976532 223345677888888876 7999999999986655 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~st~v 168 (1092)
+++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 80 GGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999999887654 38999999999999999999999999999999999999999999999999987542 223344568
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc--------ChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF--------DMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~--------d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... .......+........+|..++..+.+||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999999531 111222222223333567788999999999
Q ss_pred HhcccCCCCCCC------HHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPS------ASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPS------aeELLqHPwFq~~ 265 (1092)
+||++||.+|++ +.++++||||..+
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=395.02 Aligned_cols=264 Identities=30% Similarity=0.554 Sum_probs=234.1
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---- 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---- 78 (1092)
...++|++.+.||+|+||+||+|.+..+++.||||.+............+.+|+.++..++|+||+++++.|...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999999999999999999876655666677889999999999999999988775432
Q ss_pred ---eEEEEEEeecCCCCHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 79 ---CYVCIVTGYCEGGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 79 ---~~lyLVMEYceGGSL~DLLkkk~--gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
..+++||||+.+|+|.++|.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 24789999999999999997532 3458999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCC
Q 043248 154 LAKTLKAD---DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC 230 (1092)
Q Consensus 154 LA~~l~~d---~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~ 230 (1092)
++..+... ......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+....+..+......+++..
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 99866432 223456899999999999999999999999999999999999999999888888888777777778888
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+++++.+||.+||..+|.+||++.++++|||++.+.
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 999999999999999999999999999999987654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.20 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=227.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-eEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-CYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~~lyL 83 (1092)
++.|+.+..|++|.||.||.|+++.++..||+|+++.....+.+--...||+.+|.+++|||||.+.++..-.+ ..+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 57899999999999999999999999999999999887766665556789999999999999999999886443 56899
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
|||||+. +|..++..-. ..|...+++.++.|++.||+|||.++|+|||||++|+|++..|.+||+|||+|+.+....
T Consensus 155 VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9999986 9999998765 459999999999999999999999999999999999999999999999999999987653
Q ss_pred cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC----------C-----
Q 043248 163 LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----------P----- 226 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----------p----- 226 (1092)
.+...+.|.||+|||++.+. .|+..+|+||+|||+.||+++++.|.+....+++.+|.+.... .
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 45567889999999999775 5899999999999999999999999999999988888542111 0
Q ss_pred ---------------CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 227 ---------------LPSC-YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 227 ---------------lPs~-iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
++.. +++...+|+..+|.+||.+|.|++|+|+|.||.+
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 1111 4578889999999999999999999999999975
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=391.74 Aligned_cols=255 Identities=23% Similarity=0.443 Sum_probs=207.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC------CCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH------PYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H------PNIVKL~gvF~e~d 78 (1092)
.++|+++++||+|+||+||+|.+..+++.||||++.... ...+.+..|+.+++.++| .+|++++++|....
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 478999999999999999999999999999999986432 223445567777777654 45899999998777
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCC------------
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQ------------ 145 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG------------ 145 (1092)
.++|||||++ |++|.+++.+.+ .+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 7899999998 678999987654 48999999999999999999998 5999999999999998765
Q ss_pred ----CEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc
Q 043248 146 ----DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR 221 (1092)
Q Consensus 146 ----~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~ 221 (1092)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+..+.+..+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 499999998864332 23457899999999999999999999999999999999999999987665443333221
Q ss_pred cCCC-------------------------C---------------C-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhCh
Q 043248 222 SSIG-------------------------P---------------L-PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHP 260 (1092)
Q Consensus 222 ~~i~-------------------------p---------------l-Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHP 260 (1092)
.... + . ....+..+.+||.+||++||.+|||++|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 1000 0 0 001145678999999999999999999999999
Q ss_pred hhHhHhh
Q 043248 261 FLQHFVD 267 (1092)
Q Consensus 261 wFq~~~d 267 (1092)
||..+..
T Consensus 440 ~~~~~~~ 446 (467)
T PTZ00284 440 YVLKYYP 446 (467)
T ss_pred cccccCC
Confidence 9987654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=376.93 Aligned_cols=254 Identities=30% Similarity=0.496 Sum_probs=212.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||++++++|...+ .+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-EIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-eEEE
Confidence 3678999999999999999999999999999999986543 3344567889999999999999999999986544 7789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||+++++|.... .+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 150 v~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 150 LLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 99999999986532 25788899999999999999999999999999999999999999999999998765332
Q ss_pred cCccccCCCCcCCchhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccCh---HHHHHHhhccCCCCCCCCCCHH
Q 043248 163 LASSVVGTPNYMCPELLAD-----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---AGLISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-----~~yS~KSDVWSLGVILYELLTGr~PF~g~d~---~dli~kI~~~~i~plPs~iS~e 234 (1092)
......||..|+|||++.. ..++.++|||||||++|+|++|+.||..... ......+........+..++.+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2345689999999998843 2346799999999999999999999974332 2233333333334456678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+.+||.+||..||++||++.|+|+||||...
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999999763
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=346.51 Aligned_cols=255 Identities=38% Similarity=0.720 Sum_probs=227.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.+..++..+|+|.+............+.+|+.++++++|+||+++++++... ..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-KALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-CEEEEEEe
Confidence 69999999999999999999999999999999976654555567888999999999999999999988654 47889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCccccccccccCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~d~~~s 165 (1092)
|++|++|.+++....+..+++..++.++.|++.+|.|||++||+|+||||+||+++.++ .++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999876555689999999999999999999999999999999999998654 58999999998876554445
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+......+++..++..+.++|.+||..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence 56789999999999988899999999999999999999999998877777777766666667777899999999999999
Q ss_pred CCCCCCCHHHHHhChhh
Q 043248 246 NPEHRPSASELLKHPFL 262 (1092)
Q Consensus 246 DPskRPSaeELLqHPwF 262 (1092)
+|.+|||+.++++||||
T Consensus 240 ~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 240 DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.95 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=213.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
..++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++|+||++++++|....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457999999999999999999999999999999998765444444566788999999999999999999885432
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|++|+++ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 3578999998 67999888643 3899999999999999999999999999999999999999999999999999876
Q ss_pred cccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------------
Q 043248 159 KADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-------------- 223 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-------------- 223 (1092)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 533 345679999999999876 568999999999999999999999998765444333322110
Q ss_pred --------CCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 224 --------IGP--------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 224 --------i~p--------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
... .....++.+.+||.+||..||.+|||+.|+|+||||..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 1123567789999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=378.14 Aligned_cols=258 Identities=31% Similarity=0.532 Sum_probs=218.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
...++|++.+.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.+++.++||||++++++|... .++
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~ 118 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYL 118 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEE
Confidence 346899999999999999999999999999999999865332 222345678899999999999999999998654 478
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||+||+|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 89999999999999997643 899999999999999999999999999999999999999999999999999876543
Q ss_pred cc--CccccCCCCcCCchhhccC----CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-C--CCCCCCC
Q 043248 162 DL--ASSVVGTPNYMCPELLADI----PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-G--PLPSCYS 232 (1092)
Q Consensus 162 ~~--~st~vGTp~YmAPEVL~g~----~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~--plPs~iS 232 (1092)
.. ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+......++..... . +....++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 22 2356799999999999654 378999999999999999999999999887777777654321 1 2223589
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHhChhhHh
Q 043248 233 PSLKTLIKGMLRKNPEH--RPSASELLKHPFLQH 264 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~ 264 (1092)
..+++||.+||..++.+ |++++++++|+||+.
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 99999999999854443 789999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.44 Aligned_cols=255 Identities=38% Similarity=0.707 Sum_probs=228.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++++.||.|+||.||.+.+..++..+++|.+............+.+|+.++++++|+||++++++|.+. ..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEE
Confidence 69999999999999999999999999999999877655555567788999999999999999999999765 47889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
||++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999999987645568999999999999999999999999999999999999999999999999998765433 334
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|+..|+|||++.+..++.++|||||||++|+|++|..||...........+......+.+..++.++.++|.+||..
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 56789999999999888899999999999999999999999998887777777776666666667899999999999999
Q ss_pred CCCCCCCHHHHHhChhh
Q 043248 246 NPEHRPSASELLKHPFL 262 (1092)
Q Consensus 246 DPskRPSaeELLqHPwF 262 (1092)
+|.+||++.++++|+|+
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.64 Aligned_cols=255 Identities=40% Similarity=0.810 Sum_probs=227.7
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.+..+++.|++|.+............+.+|+.++++++|+||++++++|... ...|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-GNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-CeEEEEEe
Confidence 69999999999999999999999999999999876544444556788999999999999999999998655 47889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-Cc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-AS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~-~s 165 (1092)
|+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++........ ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999999999876555689999999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+........+..++.++.++|.+||+.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence 35688999999999988899999999999999999999999998888888777777776667778899999999999999
Q ss_pred CCCCCCCHHHHHhChhh
Q 043248 246 NPEHRPSASELLKHPFL 262 (1092)
Q Consensus 246 DPskRPSaeELLqHPwF 262 (1092)
+|.+||++.++++||||
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=384.52 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=223.2
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----eEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----CYVC 82 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~~ly 82 (1092)
.|.-.+++|.|+||.||+|....+++.||||++...... -.+|+++|+.+.|||||+|+.+|.... -++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 588899999999999999999999999999999876532 236999999999999999998887543 2567
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCcccccc
Q 043248 83 IVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKTLK 159 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~~l~ 159 (1092)
+||||++. +|+.+++.- .+..++...++-|++||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999975 999999842 23458899999999999999999999999999999999999977 889999999999999
Q ss_pred ccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-------------
Q 043248 160 ADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------- 225 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------- 225 (1092)
.+.....+..|++|+|||++.| ..|+.+.||||.||++.||+-|++.|.+.+..+++..|.+....
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 8888889999999999999876 56899999999999999999999999999888888777442110
Q ss_pred -----------C----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 226 -----------P----LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 226 -----------p----lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+ +....++++.+|+.++|+++|.+|.++.|+|.||||...++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 233468899999999999999999999999999999998775
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=363.54 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=214.9
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
-.+++|.+.+.||+|+||.||++.++.+++.||+|.+....... ....+.+|+.++++++|+||+++++++...+ .+|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 80 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTDK-SLT 80 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeCC-eEE
Confidence 46889999999999999999999999999999999987543222 2345678999999999999999999986655 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 99999975 8888887654 348999999999999999999999999999999999999999999999999987654322
Q ss_pred -cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-----------------
Q 043248 163 -LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS----------------- 223 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~----------------- 223 (1092)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2334578999999999865 568999999999999999999999998766544433332110
Q ss_pred ----CC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 224 ----IG--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 224 ----i~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.. .....++.++.+||.+||..||.+|+|+.|+|+||||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 01124688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=369.31 Aligned_cols=250 Identities=28% Similarity=0.557 Sum_probs=216.3
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||++.++.++..||+|.+..... .......+.+|+.+++.+ +||||++++++|...+ .+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-RLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 479999999999999999999999999976532 223345677888888888 6999999999986655 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|++|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 ~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 80 GGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999999998764 389999999999999999999999999999999999999999999999999875322 22234567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++..++..+.+||++||.+||.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccCCHH
Confidence 99999999999999999999999999999999999999998877766666654433 45667899999999999999999
Q ss_pred CCCCH-----HHHHhChhhHhH
Q 043248 249 HRPSA-----SELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSa-----eELLqHPwFq~~ 265 (1092)
+||++ .++++||||...
T Consensus 237 ~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 237 KRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HcCCCCCCCHHHHhcCCCcCCC
Confidence 99999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.91 Aligned_cols=256 Identities=43% Similarity=0.734 Sum_probs=228.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE-KGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e-~d~~lyLVM 85 (1092)
+|++++.||.|+||.||++.+..++..||+|.+............+.+|+.+++.++|+||+++++++.. .+..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999987665556566778899999999999999999998765 345788999
Q ss_pred eecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 86 GYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLH-----SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 86 EYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLH-----SkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
||+++++|.+++... ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764 2345899999999999999999999 899999999999999999999999999999887
Q ss_pred ccccc-CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 159 KADDL-ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 159 ~~d~~-~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
..... .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+.......++..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 65443 44567899999999998888999999999999999999999999988777777777776666778888999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
++.+||+.+|.+||++.++++|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.72 Aligned_cols=254 Identities=31% Similarity=0.565 Sum_probs=218.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc---HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT---ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s---e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
+.|++.+.||+|+||.||.+.+..+++.|++|.+...... ......+.+|+.++++++||||+++++++...+ .+|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence 5799999999999999999999999999999998754322 223456888999999999999999999997655 888
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||++|++|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999999998754 38999999999999999999999999999999999999999999999999987654322
Q ss_pred cC----ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc-cCCCCCCCCCCHHHHH
Q 043248 163 LA----SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR-SSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 163 ~~----st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~-~~i~plPs~iS~eLkD 237 (1092)
.. ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. .....++..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 11 345688999999999998899999999999999999999999987655544444332 2333466778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
||++||.++|.+|||+.++++|+||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=367.97 Aligned_cols=254 Identities=20% Similarity=0.413 Sum_probs=210.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEE-----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNH-----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~d-----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.++..+ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 36899999999999999999975 2445789999986442 233346788999999999 8999999999987777
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------------------------------------------------------- 101 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------------------------------------------------------- 101 (1092)
..+|+|||||+||+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 77899999999999999997532
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---CccccCCCCcCC
Q 043248 102 ---GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMC 175 (1092)
Q Consensus 102 ---gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmA 175 (1092)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....++..|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 12377889999999999999999999999999999999999999999999999986543211 123356678999
Q ss_pred chhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHH-HHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 043248 176 PELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG-LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSA 253 (1092)
Q Consensus 176 PEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~d-li~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSa 253 (1092)
||++.+..|+.++|||||||+||+|++ |..||.+..... ....+........+..+++.+.+||.+||+.||.+|||+
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 999999899999999999999999997 999998755433 333333333344566789999999999999999999999
Q ss_pred HHHHhC
Q 043248 254 SELLKH 259 (1092)
Q Consensus 254 eELLqH 259 (1092)
.++++.
T Consensus 325 ~el~~~ 330 (338)
T cd05102 325 SALVEI 330 (338)
T ss_pred HHHHHH
Confidence 999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=388.35 Aligned_cols=260 Identities=32% Similarity=0.525 Sum_probs=227.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC-CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE-KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t-Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
...|.+.+.||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+++.++||||++++++|...+ .+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-KLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-EEEE
Confidence 44599999999999999999998887 7888888775432 233456778999999999999999999997655 7889
Q ss_pred EEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
||||++||+|.++|... ....|++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999999988643 2345899999999999999999999999999999999999999999999999999876543
Q ss_pred c---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 162 D---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...++..+......+++..++.++.+|
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 302 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL 302 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999888878777777766667777889999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|.+||..+|++||++.+++.|+|++.+..
T Consensus 303 i~~~L~~dP~~Rps~~~~l~~~~~~~~~~ 331 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLHTEFLKYVAN 331 (478)
T ss_pred HHHHhccChhhCcCHHHHHhCHHHHHHHH
Confidence 99999999999999999999999976544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.70 Aligned_cols=257 Identities=29% Similarity=0.500 Sum_probs=216.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||.|+||.||++.+..++..+|+|.+.... .......+.+|+.++++++|+||++++++|...+ .+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-EEEE
Confidence 4689999999999999999999999999999999887643 2334567889999999999999999999997755 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||+.|++|.+++.... .+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999999998754 389999999999999999999975 7999999999999999999999999998765432
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHh-----------------------
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----------------------- 219 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI----------------------- 219 (1092)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......+...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 234567999999999999989999999999999999999999999765433222111
Q ss_pred ---------------------hccCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 220 ---------------------NRSSIGPLP-SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 220 ---------------------~~~~i~plP-s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.......++ ..++.++++||.+||++||++|||+.|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 111111111 1357889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.89 Aligned_cols=250 Identities=24% Similarity=0.492 Sum_probs=213.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIAR-VQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkq-L~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.+..+++.||+|.+..... .......+..|..++.. ++||||++++++|...+ .+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-NLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-EEEEEEeCCC
Confidence 479999999999999999999999999976432 12223455667777775 48999999999987655 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
||+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 80 ~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 80 GGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999999998654 389999999999999999999999999999999999999999999999999875422 22334567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ..++..++.++.+||.+||+.+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHh
Confidence 9999999999999999999999999999999999999999888777766665433 235666899999999999999999
Q ss_pred CCCCHH-HHHhChhhHhH
Q 043248 249 HRPSAS-ELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSae-ELLqHPwFq~~ 265 (1092)
+|+++. ++++||||...
T Consensus 237 ~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 237 RRLGVKGDIRQHPFFREI 254 (316)
T ss_pred hcCCChHHHHcCcccCCC
Confidence 999996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=367.71 Aligned_cols=258 Identities=28% Similarity=0.504 Sum_probs=216.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++.+.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.++..++|+||++++++|...+ .+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-NLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-EEEEE
Confidence 589999999999999999999999999999999865322 2223445778999999999999999999886554 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
|||+.||+|.+++.+... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 80 MDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999986432 489999999999999999999999999999999999999999999999999876543322
Q ss_pred -CccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC----CCCCCCCCH
Q 043248 164 -ASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI----GPLPSCYSP 233 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i----~plPs~iS~ 233 (1092)
....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+......++..... ......++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 23457999999999986 34688999999999999999999999998887777776654321 122245799
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHhChhhHhH
Q 043248 234 SLKTLIKGMLRKNPEH--RPSASELLKHPFLQHF 265 (1092)
Q Consensus 234 eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~~ 265 (1092)
++++||++||..++.+ |++++++++||||..+
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 9999999999765544 6899999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=359.05 Aligned_cols=250 Identities=32% Similarity=0.560 Sum_probs=209.6
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
||+|+||+||++.++.+++.||+|++....... .....+..|+.+++.++|+||++++++|... ..+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-CeEEEEEeCCCCCC
Confidence 799999999999999999999999987543222 2335677899999999999999999888654 46889999999999
Q ss_pred HHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCccccC
Q 043248 93 MAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVG 169 (1092)
Q Consensus 93 L~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~st~vG 169 (1092)
|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.... ......|
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 99888542 23458999999999999999999999999999999999999999999999999998765432 2334679
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH----HHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA----GLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~----dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
++.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ...++..++..+.+|+.+||+.
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999999765432 222222222 2234566899999999999999
Q ss_pred CCCCCC-----CHHHHHhChhhHhH
Q 043248 246 NPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 246 DPskRP-----SaeELLqHPwFq~~ 265 (1092)
||++|+ +++++++||||+.+
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999 88999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=368.83 Aligned_cols=251 Identities=27% Similarity=0.536 Sum_probs=212.3
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||++.++.+++.||+|++...... ......+.+|+.++.++ +|+||++++++|...+ .+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-RLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-EEEEEEeCCC
Confidence 4799999999999999999999999999765332 23345678899999888 6999999999986655 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~st~v 168 (1092)
|++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 80 GGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 999999987654 39999999999999999999999999999999999999999999999999987532 233345578
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc------ChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF------DMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~------d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|..||... ................++..++..+.++|++|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999999999999632 22222333333333456778899999999999
Q ss_pred cccCCCCCCC------HHHHHhChhhHhH
Q 043248 243 LRKNPEHRPS------ASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRPS------aeELLqHPwFq~~ 265 (1092)
|.+||.+|++ ++++++||||...
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999997 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=381.00 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=223.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcE-EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKK-YVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~-VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+...+.+.||+|+||+||.+.++. .. ||+|++..........+.|.+|+.+|.+|+|||||++++++.+....++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 344566779999999999999864 44 999999876655555788999999999999999999999997776568899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEcCCC-CEEEeecCcccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY-VLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG-IIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~d- 161 (1092)
|||+++|+|.+++.......|+...+..|+.||+.||.|||+++ |||||||++|||++.++ ++||+|||+++.....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999999998854456999999999999999999999999 99999999999999998 9999999999887754
Q ss_pred ccCccccCCCCcCCchhhc--cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhh-ccCCCCCCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLA--DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN-RSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~--g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~-~~~i~plPs~iS~eLkDL 238 (1092)
.......||+.|||||++. +..|+.++||||||++||||+||+.||...........+. ......++..+++.+..|
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 3344478999999999999 6799999999999999999999999999887755555554 555666788899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|.+||..||.+||++.+++.- +..+..
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~~--l~~~~~ 305 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVSR--LESIMS 305 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHHH--HHHHHH
Confidence 999999999999999999863 444433
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.14 Aligned_cols=257 Identities=29% Similarity=0.516 Sum_probs=216.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.++..++|+||++++++|... ..+|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-NYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence 689999999999999999999999999999999875322 222345577899999999999999999988655 478899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
|||+.||+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999999998743 2489999999999999999999999999999999999999999999999999987654332
Q ss_pred -CccccCCCCcCCchhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-CCCC---CCCCH
Q 043248 164 -ASSVVGTPNYMCPELLAD-----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-GPLP---SCYSP 233 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g-----~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~plP---s~iS~ 233 (1092)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+......++..... ..++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 223579999999999875 4678999999999999999999999998777666666544321 1222 34689
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHhChhhHh
Q 043248 234 SLKTLIKGMLRKNPEH--RPSASELLKHPFLQH 264 (1092)
Q Consensus 234 eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~ 264 (1092)
++++||.+||...+.+ |++++++++|+||+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 9999999999876654 479999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=374.60 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=214.2
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----eEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----CYVC 82 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~~ly 82 (1092)
+|++.+.||+|+||.||++.+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++...+ ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999999999999999998654444444567889999999999999999999987554 2678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999996 58888886544 48999999999999999999999999999999999999999999999999998654322
Q ss_pred --cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc-----------------
Q 043248 163 --LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS----------------- 222 (1092)
Q Consensus 163 --~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~----------------- 222 (1092)
......+++.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+...++..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 23345789999999999774 4799999999999999999999999887655544443211
Q ss_pred ------CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 223 ------SI--------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 223 ------~i--------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.. ..+....++++.+||.+||++||.+|||+.++|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00 01223457899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=382.68 Aligned_cols=262 Identities=29% Similarity=0.496 Sum_probs=226.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..+.|++...||.|..++||+|+.+..+..||||++...+.... ...+.+|+..|+.++||||++++..|.... .+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS-ELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc-eeEE
Confidence 35789999999999999999999999999999999998876665 678999999999999999999999997766 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||.||.+|++.++++..-...|.|..|..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999999998766669999999999999999999999999999999999999999999999999876654322
Q ss_pred ---c-CccccCCCCcCCchhhc--cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHH-HHhhccCCCC--------C
Q 043248 163 ---L-ASSVVGTPNYMCPELLA--DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLI-SKINRSSIGP--------L 227 (1092)
Q Consensus 163 ---~-~st~vGTp~YmAPEVL~--g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli-~kI~~~~i~p--------l 227 (1092)
. +.+.+||++|||||++. ...|++|+||||||++..||.+|..||........+ .++......+ .
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 1 15678999999999963 467999999999999999999999999887665543 3333332211 1
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
...++..++.+|..||++||.+|||++++|+|+||++...
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 1225678999999999999999999999999999987543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.31 Aligned_cols=258 Identities=28% Similarity=0.499 Sum_probs=220.0
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++|+||+.++++|...+ .+|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-EEEEEE
Confidence 4889999999999999999999999999999986543222 22345778999999999999999998886654 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 99999999999876655569999999999999999999999999999999999999999999999999997665444444
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc---cCCCCCCCCCCHHHHHHHHHh
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR---SSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~---~~i~plPs~iS~eLkDLIrkc 242 (1092)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.. ......+..++.++.+|+.+|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 56899999999999988999999999999999999999999987655433333322 112234556889999999999
Q ss_pred cccCCCCCCC-----HHHHHhChhhHhH
Q 043248 243 LRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
|+.||++||+ +.+++.|+||..+
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=367.87 Aligned_cols=250 Identities=29% Similarity=0.521 Sum_probs=211.9
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMA-LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIq-ILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|.. +++.++||||++++++|...+ .+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-KLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-EEEEEEcCCC
Confidence 4699999999999999999999999999754321 222334455554 567799999999999886655 7789999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~st~v 168 (1092)
|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 80 GGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 999999987654 48999999999999999999999999999999999999999999999999987543 223344567
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...... ++..++..+.++|++||.++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV-LRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCcc-CCCCCCHHHHHHHHHHhccCHH
Confidence 999999999999999999999999999999999999999988877777776654432 3445789999999999999999
Q ss_pred CCCCH----HHHHhChhhHhH
Q 043248 249 HRPSA----SELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSa----eELLqHPwFq~~ 265 (1092)
+||++ .++++||||...
T Consensus 237 ~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 237 RRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred hcCCCCCCHHHHhcCCCcCCC
Confidence 99876 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=367.07 Aligned_cols=250 Identities=30% Similarity=0.529 Sum_probs=211.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHH-HHHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQE-MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rE-IqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.++.+++.||+|++...... ......+..| ..+++.++|+||++++++|...+ .+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-eEEEEEeCCC
Confidence 4799999999999999999999999999754321 1122333444 34577899999999999986655 6789999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 ~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 80 GGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999999987543 88999999999999999999999999999999999999999999999999875432 23344568
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .++..++..+.++|.+||+++|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CCCCCCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999999999999999999998887777766655433 34456899999999999999999
Q ss_pred CCCCHH----HHHhChhhHhH
Q 043248 249 HRPSAS----ELLKHPFLQHF 265 (1092)
Q Consensus 249 kRPSae----ELLqHPwFq~~ 265 (1092)
+|+++. ++++|+||..+
T Consensus 237 ~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 237 KRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HCCCCCCCHHHHhcCcccCCC
Confidence 999865 89999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=370.31 Aligned_cols=249 Identities=30% Similarity=0.518 Sum_probs=209.8
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhc---CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARV---QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL---~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
||+|+||.||+|.++.+++.||+|++...... ......+..|..++..+ .||||++++++|.... .+|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-DLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-eEEEEEcCCC
Confidence 79999999999999999999999998654321 22233455566676655 6999999999986654 7889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-cccCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... .......+
T Consensus 80 ~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 80 GGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999998654 389999999999999999999999999999999999999999999999999876432 33345678
Q ss_pred CCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCC
Q 043248 169 GTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247 (1092)
Q Consensus 169 GTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDP 247 (1092)
||..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...........++.++.+||++||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence 99999999999754 48999999999999999999999999888777777766554433334578999999999999999
Q ss_pred CCCC----CHHHHHhChhhHhH
Q 043248 248 EHRP----SASELLKHPFLQHF 265 (1092)
Q Consensus 248 skRP----SaeELLqHPwFq~~ 265 (1092)
.+|| ++.++++||||...
T Consensus 238 ~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 238 QHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHCCCCCCCHHHHhcCccccCC
Confidence 9998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=365.48 Aligned_cols=255 Identities=24% Similarity=0.522 Sum_probs=219.3
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+|++.+.||+|+||.||+|.++.+++.||+|++..... .......+..|+.++..+. |++|++++++|...+ .+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-RLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-EEEEE
Confidence 58899999999999999999999999999999875432 2223456777888888885 577888988886554 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
|||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999999987543 999999999999999999999999999999999999999999999999998764332 22
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..... ..+..++.++.+|+.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-SYPKSLSKEAVSICKGLM 236 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHc
Confidence 3456799999999999998999999999999999999999999998887777777665443 356678999999999999
Q ss_pred ccCCCCCCC-----HHHHHhChhhHhH
Q 043248 244 RKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 244 qkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
+++|.+|++ ..++++||||..+
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 237 TKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999997 5899999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=380.72 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=225.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCe----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY-IVEFKEAWVEKGC---- 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN-IVKL~gvF~e~d~---- 79 (1092)
+..|+.+++||+|+||+||+|+.+.+|+.||+|+++.....+..-....+|+.+|+.|+|+| |+.|++++...+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 44577788899999999999999999999999999887655444556789999999999999 9999999977664
Q ss_pred -EEEEEEeecCCCCHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 80 -YVCIVTGYCEGGDMAELMKKSNG--AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 80 -~lyLVMEYceGGSL~DLLkkk~g--k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.+++||||++ .+|..++..... ..++...++.+++||+.||+|||++||+||||||+||||+..|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 7889999996 599999987653 358889999999999999999999999999999999999999999999999999
Q ss_pred ccc-ccccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--------
Q 043248 157 TLK-ADDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-------- 226 (1092)
Q Consensus 157 ~l~-~d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p-------- 226 (1092)
.+. +.......++|.||+|||++.+. .|+...||||+|||++||+++++.|.+....+++..|.+....+
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 877 34446678899999999999876 68999999999999999999999999999888888875421111
Q ss_pred ---------C-----C-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 227 ---------L-----P-------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 227 ---------l-----P-------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+ + ...++...+++.+||+++|.+|.|+..+|.||||...
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0 0 1123578999999999999999999999999999764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=380.45 Aligned_cols=249 Identities=30% Similarity=0.420 Sum_probs=204.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++|+||||++++++|.... ..|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNK-FTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-eeEEE
Confidence 468999999999999999999999999999999753 234678999999999999999999996654 77899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc--c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--D 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d--~ 162 (1092)
|||+. ++|..++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 162 ~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99995 68999887654 3899999999999999999999999999999999999999999999999999754322 2
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC-------hHHHHHHhhc--------------
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------MAGLISKINR-------------- 221 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d-------~~dli~kI~~-------------- 221 (1092)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ....+..+..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2345689999999999999999999999999999999999998775321 1111111100
Q ss_pred ------------c-CCCC--CC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 222 ------------S-SIGP--LP-----SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 222 ------------~-~i~p--lP-----s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
. ...+ .+ ..++.++.+||.+||++||.+|||+.|+|+||||+.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0 0000 00 1245689999999999999999999999999999764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=374.85 Aligned_cols=268 Identities=27% Similarity=0.500 Sum_probs=237.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc------ccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR------QTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~------~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~ 77 (1092)
.+.|.-.+.||+|..++|-.+.++.+|+.+|+|++.... ......+.-.+|+.||+++ .||+|++|.++|..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes- 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES- 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-
Confidence 456788899999999999999999999999999985432 2334556677899999998 69999999999955
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
+..+++|+|+|+.|.|+++|...-. ++|+..+.||+||+.|+.|||.++|+||||||+|||++++.++||.|||+++.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 4478899999999999999987654 99999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccCCCCcCCchhhcc------CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCC
Q 043248 158 LKADDLASSVVGTPNYMCPELLAD------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLP 228 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL~g------~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plP 228 (1092)
+..+......||||+|+|||.+.. ..|+..+|+|++|||||.||.|.+||+.....-++..|..+.+. +.-
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 999999999999999999999853 46899999999999999999999999998877778888776554 334
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhhcCCCCCC
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~~~P~~pp 275 (1092)
.+++...+|||.+||+.||.+|+|+.|+|+||||..+..+..+.+.|
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 55789999999999999999999999999999999988766555443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.66 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=211.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||++.++.+++.||+|.+..........+.+.+|+.++++++|+||++++++|.... .+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-KLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-EEEEEE
Confidence 5899999999999999999999999999999988654333333456788999999999999999999986654 778999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
||++++.|..++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred eccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9999988888776543 38999999999999999999999999999999999999999999999999998765443 23
Q ss_pred ccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------------------
Q 043248 165 SSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-------------------- 223 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-------------------- 223 (1092)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34568899999999866 567899999999999999999999998766544333321100
Q ss_pred -CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 -IGP---------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 -i~p---------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
... ....++..+.+||.+||+.+|++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 012357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=355.46 Aligned_cols=259 Identities=29% Similarity=0.523 Sum_probs=222.4
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++|+||+++++++... ...|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-TYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-CEEEEE
Confidence 58999999999999999999999999999999997654332 3456788999999999999999999998654 478899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
|||+.|++|.+++.......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999999987655569999999999999999999999999999999999999999999999999987653221
Q ss_pred ----------------------------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH
Q 043248 163 ----------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG 214 (1092)
Q Consensus 163 ----------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d 214 (1092)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1123468899999999998889999999999999999999999998877666
Q ss_pred HHHHhhccCCCC-CCCCCCHHHHHHHHHhcccCCCCCCC----HHHHHhChhhHhH
Q 043248 215 LISKINRSSIGP-LPSCYSPSLKTLIKGMLRKNPEHRPS----ASELLKHPFLQHF 265 (1092)
Q Consensus 215 li~kI~~~~i~p-lPs~iS~eLkDLIrkcLqkDPskRPS----aeELLqHPwFq~~ 265 (1092)
....+....... ....++..+.+||.+||..+|++||| ++++|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 666555433221 12226899999999999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.17 Aligned_cols=262 Identities=24% Similarity=0.426 Sum_probs=216.3
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|++++.||.|+||.||+|.++.++..||+|.+....... ....+.+|+.+++.++|+||++++++|...+ .+|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-~~~ 80 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEK-SLT 80 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCC-eEE
Confidence 46889999999999999999999999999999999987543222 2345678999999999999999999986554 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+. ++|..++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 9999997 58999887653 348999999999999999999999999999999999999999999999999987654322
Q ss_pred -cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC----------------
Q 043248 163 -LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---------------- 224 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i---------------- 224 (1092)
......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2334567899999999865 4578899999999999999999999988766544433321100
Q ss_pred -----C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 225 -----G--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 225 -----~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
. .....++..+++||.+||..||.+|||++|+|+||||+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 0 0112467889999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=342.56 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=218.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||.|+||.||++....++..+++|++....... ....+.+|+.+++.++|+||+++++.+...+ .+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-ELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-EEEEEE
Confidence 58999999999999999999999999999999987654444 4567889999999999999999999886654 788999
Q ss_pred eecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 86 GYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
||++|++|.+++..... ..+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999986532 4589999999999999999999999999999999999999999999999999877654322
Q ss_pred ----CccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC-----CCCCH
Q 043248 164 ----ASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP-----SCYSP 233 (1092)
Q Consensus 164 ----~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP-----s~iS~ 233 (1092)
.....|+..|++||++... .++.++|+|||||++|+|++|+.||..........++.......+. ..++.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 2345789999999999776 7899999999999999999999999877655545444433222221 25678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+.+||.+||..||++||++.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=367.45 Aligned_cols=258 Identities=24% Similarity=0.444 Sum_probs=236.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++.+.||+|.||.||+|+.+.++..||+|++.+...... ....+.+|++|...|+||||+++|++|.+.. .+|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riy 98 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIY 98 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeE
Confidence 36899999999999999999999999999999999987653332 3456889999999999999999999996655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+++||..+|+|+..|.......|++.....|+.|++.||.|||.++||||||||+|+|++..+.+||+|||.+.... ..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SN 177 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CC
Confidence 99999999999999997777779999999999999999999999999999999999999999999999999998876 45
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
...+.|||..|++||...+..++..+|+|++|++.||++.|.+||......+...+|.+..+. +|..++.++.|+|.+|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-FPSTISGGAADLISRL 256 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-CCcccChhHHHHHHHH
Confidence 577899999999999999999999999999999999999999999998888888888877654 6788999999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~ 264 (1092)
|.++|.+|....|++.|||+..
T Consensus 257 l~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999975
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=345.22 Aligned_cols=253 Identities=29% Similarity=0.525 Sum_probs=218.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-------ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-------e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 588999999999999999999999999999988654322 223456889999999999999999999986654
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
+.++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 7789999999999999998754 38999999999999999999999999999999999999999999999999988765
Q ss_pred ccc-------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCC
Q 043248 160 ADD-------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYS 232 (1092)
Q Consensus 160 ~d~-------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS 232 (1092)
... ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+....+.++.......++..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence 321 1123468899999999998889999999999999999999999998766655555555544555677789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
..+.++|++||+.+|.+||++.++++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=347.16 Aligned_cols=257 Identities=28% Similarity=0.541 Sum_probs=216.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC---
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG--- 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d--- 78 (1092)
.--+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+|+.+++++ +|+||++++++|...+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3446899999999999999999999999999999998754322 34677899999998 6999999999987542
Q ss_pred --eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 79 --CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 79 --~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
..+|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 468899999999999999987655568999999999999999999999999999999999999999999999999998
Q ss_pred ccccc-ccCccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-CCCCC
Q 043248 157 TLKAD-DLASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-GPLPS 229 (1092)
Q Consensus 157 ~l~~d-~~~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~plPs 229 (1092)
..... .......|+..|+|||++. +..|+.++|||||||++|+|++|..||...........+..... .....
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 65432 2234567999999999985 34688899999999999999999999976655444443333222 22334
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.++..+.+||.+||..+|.+|||+.++++||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=349.39 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=210.0
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++++.||+|+||.||+|.++.++..||+|++......+.....+.+|+.++++++||||++++++|...+ .+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-RLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-eEEEEEe
Confidence 599999999999999999999999999999998765444434466788999999999999999999987654 7789999
Q ss_pred ecCCCCHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 87 YCEGGDMAELMKKSN-GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 87 YceGGSL~DLLkkk~-gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
|+. ++|.+++.... +..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 997 58988887543 2458999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc---------------------
Q 043248 165 SSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS--------------------- 222 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~--------------------- 222 (1092)
....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 33467899999999865 45789999999999999999999999876543322221100
Q ss_pred -------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 223 -------SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 223 -------~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
........++.++.+||++||+.||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0001123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=363.24 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=209.7
Q ss_pred EEEEEeec--CceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 10 IMEQIGRG--AFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 10 IlKkLGkG--gFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
++++||+| +|++||++.++.+|+.||+|.+..........+.+.+|+.+++.++||||++++++|...+ .+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-EEEEEEec
Confidence 57889999 7889999999999999999999766555555677888999999999999999999997655 77899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-----
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD----- 162 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~----- 162 (1092)
+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999987554558999999999999999999999999999999999999999999999998654432111
Q ss_pred ---cCccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-------------
Q 043248 163 ---LASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI------------- 224 (1092)
Q Consensus 163 ---~~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i------------- 224 (1092)
......++..|+|||++.+ ..|+.++|||||||++|+|++|+.||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1123457788999999975 4689999999999999999999999976443322222111100
Q ss_pred --------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 225 --------------------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 225 --------------------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+....+++.+.+||++||++||++|||++++++||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 011123567899999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.59 Aligned_cols=255 Identities=45% Similarity=0.864 Sum_probs=229.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.+..++..|++|.+............+.+|+.+++.++|+|++++++.+... ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 69999999999999999999999999999999987665555667788999999999999999999998765 57889999
Q ss_pred ecCCCCHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 87 YCEGGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 87 YceGGSL~DLLkkk~--gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|+++++|.+++.... ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999999998753 3459999999999999999999999999999999999999999999999999998765543 3
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..............+++..++..+.+++.+||
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 34467899999999998888999999999999999999999999888877777777777777788889999999999999
Q ss_pred ccCCCCCCCHHHHHhChhh
Q 043248 244 RKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwF 262 (1092)
..+|++||++.++|+||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=363.28 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=217.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
..++|++++.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++|+||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 467899999999999999999999999999999998654444444566778999999999999999999986443
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||||+.+ +|.+++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357899999964 888887643 889999999999999999999999999999999999999999999999999877
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC------------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP------------ 226 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p------------ 226 (1092)
..........|+..|+|||++.+..++.++|||||||++|+|++|+.||...+......++......+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 65544455678999999999999999999999999999999999999998766544333321100000
Q ss_pred ------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 227 ------------------------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 227 ------------------------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.+...+..+.+||.+||+.||.+|||+.|+|+||||..++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 011245678999999999999999999999999999987763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=350.31 Aligned_cols=254 Identities=31% Similarity=0.587 Sum_probs=222.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++...+ .+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-NLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-eEEEE
Confidence 5899999999999999999999999999999998754322 233467889999999999999999999986654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence 99999999999998764 4899999999999999999999999999999999999999999999999999876544 3
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... ...++..++..++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHHHcc
Confidence 4557899999999998888899999999999999999999999887765555555433 234667789999999999999
Q ss_pred cCCCCCC-----CHHHHHhChhhHhH
Q 043248 245 KNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 245 kDPskRP-----SaeELLqHPwFq~~ 265 (1092)
.+|.+|+ +++++++||||..+
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999 99999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=347.51 Aligned_cols=255 Identities=30% Similarity=0.579 Sum_probs=222.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||.|+||.||++.+..++..||+|.+..... ......+.+|+.+++.++|+||++++++|... ..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEE
Confidence 589999999999999999999999999999999876532 22345678899999999999999999998765 5788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~ 164 (1092)
||+++++|.+++... .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999999999999865 4899999999999999999999999999999999999999999999999999877644 223
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCC-CCHHHHHHHHHhc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC-YSPSLKTLIKGML 243 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~-iS~eLkDLIrkcL 243 (1092)
....|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.......++.. ++.++.++|.+||
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 455788999999999988899999999999999999999999987776555555555444444444 7899999999999
Q ss_pred ccCCCCCCCHHHHHhChhhHhH
Q 043248 244 RKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwFq~~ 265 (1092)
..+|++|||++++++||||...
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCC
Confidence 9999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=346.27 Aligned_cols=254 Identities=30% Similarity=0.532 Sum_probs=214.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||.|+||.||+|.+..+|..|++|++............+.+|+.++++++|+||+++++++... ..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEec
Confidence 69999999999999999999999999999999987654445556788999999999999999999998664 47889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--cC
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LA 164 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--~~ 164 (1092)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99 999999997654 458999999999999999999999999999999999999999999999999998775443 23
Q ss_pred ccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-------------------
Q 043248 165 SSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI------------------- 224 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i------------------- 224 (1092)
....|+..|+|||.+.+. .++.++|||||||++|+|++|.++|.+......+..+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 446789999999998654 468999999999999999999999977655443333221100
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 225 ----------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 225 ----------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
.......+..+.+||.+||.++|.+||+++++|+||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 001124578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=338.47 Aligned_cols=253 Identities=34% Similarity=0.630 Sum_probs=219.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ---TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~---se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+|+..+.||+|+||.||+|.+..++..|++|.+..... .....+.+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEE
Confidence 68899999999999999999998999999999865432 233456788999999999999999999988654 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+++++|.+++.... .+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999999999998754 389999999999999999999999999999999999999999999999999887655444
Q ss_pred CccccCCCCcCCchhhccCC-CCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc-cCCCCCCCCCCHHHHHHHHH
Q 043248 164 ASSVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR-SSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~-yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~-~~i~plPs~iS~eLkDLIrk 241 (1092)
.....|+..|++||.+.... ++.++|+|||||++|+|++|..||...........+.. .....++..++..+.+|+++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 45667899999999997766 89999999999999999999999987665555544443 33445666789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhh
Q 043248 242 MLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwF 262 (1092)
||+.+|.+||++.+++.||||
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=387.68 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=240.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
-+-|.+.+.||+|-|+.|.+|++--+|..||||++.+.+........+++|+..|+.++|||||+||++. +....+|||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceEEEE
Confidence 3568999999999999999999999999999999999888888888999999999999999999999987 555588999
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCcccccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~~l~~d~~ 163 (1092)
+|+-+||+|++||.++.. ++.|..+++||+||+.|+.|||+..+|||||||+||+|.+ -|-+||.|||++..+.++..
T Consensus 96 LELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999999988764 4999999999999999999999999999999999998864 57899999999999999999
Q ss_pred CccccCCCCcCCchhhccCCCC-ccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYG-FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS-~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
..+.||+..|-|||++.|..|+ +++||||||||||.|++|++||+..+..+.+..|....+. .|..++.++++||..|
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-vPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-VPSHVSKECRDLIQSM 253 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-CchhhhHHHHHHHHHH
Confidence 9999999999999999999995 6889999999999999999999999999999999888775 7888999999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
|..||.+|.++++|..|+|++..-
T Consensus 254 LvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HhcCchhhccHHHHhccccccCCC
Confidence 999999999999999999998643
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.62 Aligned_cols=251 Identities=43% Similarity=0.815 Sum_probs=222.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++|+||++++++|... ..+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEe
Confidence 69999999999999999999999999999999875432 23456778899999999999999999998655 47889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
|+++++|.+++....+..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999999987655668999999999999999999999999999999999999999999999999998765432 233
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......+.+..++..+.+||.+||+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence 46789999999999988899999999999999999999999998887777777777766677788899999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 043248 246 NPEHRPSASELLKH 259 (1092)
Q Consensus 246 DPskRPSaeELLqH 259 (1092)
||.+||++.+++.-
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=337.52 Aligned_cols=256 Identities=33% Similarity=0.601 Sum_probs=225.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||+|.+..+++.|++|++...... .....+.+|+.++..++|+||++++++|... ..+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEE
Confidence 4799999999999999999999999999999998765433 4456788999999999999999999998665 5788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||+++++|.+++.... .+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999998753 48999999999999999999999 99999999999999999999999999999877544332
Q ss_pred -ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc---ChHHHHHHhhccCCCCCCCC-CCHHHHHHH
Q 043248 165 -SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF---DMAGLISKINRSSIGPLPSC-YSPSLKTLI 239 (1092)
Q Consensus 165 -st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~---d~~dli~kI~~~~i~plPs~-iS~eLkDLI 239 (1092)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||... ........+........+.. ++..+.++|
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 2567889999999999888999999999999999999999999776 44555555555555556666 889999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+||..+|++||++.++++||||+.+
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=344.26 Aligned_cols=253 Identities=28% Similarity=0.559 Sum_probs=220.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+|++.+.||.|+||.||++.+..++..||+|.+....... ...+.+.+|+.++++++||||++++++|.. +..+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence 5999999999999999999999999999999997654322 345678899999999999999999998855 44788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+.|++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 80 DLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred eCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999999998763 48999999999999999999999999999999999999999999999999998776554445
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh--HHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM--AGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~--~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ...+.+.........+..++..+.++|.+||
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHc
Confidence 66789999999999888899999999999999999999999987663 2333333332444567778999999999999
Q ss_pred ccCCCCCCCH--HHHHhChhh
Q 043248 244 RKNPEHRPSA--SELLKHPFL 262 (1092)
Q Consensus 244 qkDPskRPSa--eELLqHPwF 262 (1092)
..+|.+|+++ .|+++||||
T Consensus 238 ~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 238 ERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cCChhHcCCccHHHHhcCCCC
Confidence 9999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.95 Aligned_cols=255 Identities=36% Similarity=0.765 Sum_probs=223.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.++.++..||+|.+..........+.+.+|+.+++.++|+||+++++++.. +..+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 6999999999999999999999999999999987654333445677899999999999999999998855 457889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-EEEeecCccccccccc-cC
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD-VRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~-LKLiDFGLA~~l~~d~-~~ 164 (1092)
|+.+++|.+++....+..+++..+..++.||+.||.|||+++|+|+||||+||+++.++. ++|+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999998766556899999999999999999999999999999999999998864 6999999998765432 22
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+......+....++..+.++|.+||.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 33468999999999988889999999999999999999999998877777777666666666666788999999999999
Q ss_pred cCCCCCCCHHHHHhChhh
Q 043248 245 KNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 245 kDPskRPSaeELLqHPwF 262 (1092)
.+|++|||+.++++||||
T Consensus 240 ~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 240 VSPRDRPSITSILKRPFL 257 (257)
T ss_pred cChhhCcCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.72 Aligned_cols=253 Identities=30% Similarity=0.498 Sum_probs=207.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.++++++|+||++++++|.... .+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-KLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-ceEEEEe
Confidence 699999999999999999999999999999998765433333456778999999999999999999986654 7889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
|+++ +|.+++....+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.... ...
T Consensus 80 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 80 YCDQ-DLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred cCCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 9975 88888876443 48999999999999999999999999999999999999999999999999998664332 233
Q ss_pred cccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCC-cccChHHHHHHhhcc-------------------CC
Q 043248 166 SVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAF-KAFDMAGLISKINRS-------------------SI 224 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF-~g~d~~dli~kI~~~-------------------~i 224 (1092)
...++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+.......+... ..
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 45688999999998764 4789999999999999999988875 444433333222110 00
Q ss_pred ---------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 225 ---------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 225 ---------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
......+++++.+||.+||+.||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 01122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.16 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=216.0
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe-----
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE----- 76 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e----- 76 (1092)
...+.|++.+.||.|+||.||++.+..+++.||+|.+.... .....+..|+.+++++ +|+||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 34578999999999999999999999999999999986542 2335677899999998 69999999999863
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.+..+|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 24578999999999999999987665568999999999999999999999999999999999999999999999999987
Q ss_pred ccccc-ccCccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-CCCC
Q 043248 157 TLKAD-DLASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-PLPS 229 (1092)
Q Consensus 157 ~l~~d-~~~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~-plPs 229 (1092)
..... .......|+..|+|||++. +..++.++|||||||++|+|++|..||...........+...... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 65422 2234467899999999985 356888999999999999999999999776544444333332222 2334
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.++..+.+||.+||..||.+||++.|+|+||||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.62 Aligned_cols=258 Identities=31% Similarity=0.563 Sum_probs=216.5
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC--
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG-- 78 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d-- 78 (1092)
....++|++.+.||.|+||.||+|.++.+++.|++|.+..... ....+.+|+.+++++ .|+||++++++|....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 3457899999999999999999999999999999999875432 235688999999999 7999999999987543
Q ss_pred ---eEEEEEEeecCCCCHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 79 ---CYVCIVTGYCEGGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 79 ---~~lyLVMEYceGGSL~DLLkkk~--gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
..+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 46789999999999999987643 4458999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-ccCccccCCCCcCCchhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC
Q 043248 154 LAKTLKAD-DLASSVVGTPNYMCPELLAD-----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL 227 (1092)
Q Consensus 154 LA~~l~~d-~~~st~vGTp~YmAPEVL~g-----~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl 227 (1092)
++...... .......|+..|+|||++.. ..++.++|||||||+||+|++|..||...........+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765432 22344678999999998853 3468899999999999999999999987655555555444322222
Q ss_pred --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 228 --PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 228 --Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
+..++.++.+||.+||..||.+|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 23367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.50 Aligned_cols=252 Identities=30% Similarity=0.584 Sum_probs=214.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc----cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ----TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~----se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
+|++.+.||+|+||.||++.. .++..+|+|.+..... .......+.+|+.+++.++|+||++++++|.+. ..+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEE
Confidence 689999999999999999986 5788999998865432 122345688999999999999999999998765 5788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc--
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-- 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-- 160 (1092)
+||||++|++|.+++.+.. .+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 79 IFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999998754 389999999999999999999999999999999999999999999999999876532
Q ss_pred -----cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc--cCCCCCCCCCCH
Q 043248 161 -----DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR--SSIGPLPSCYSP 233 (1092)
Q Consensus 161 -----d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~--~~i~plPs~iS~ 233 (1092)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ......+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 1122345789999999999998999999999999999999999999987655443333322 233456677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
++.+||++||..+|.+||++.++++||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.28 Aligned_cols=255 Identities=33% Similarity=0.537 Sum_probs=214.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++||||++++++|...+ .+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-EISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-EEEEEe
Confidence 57999999999999999999999999999999886542 2334566889999999999999999999997655 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||++|++|.+++.+.. .+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++...... ..
T Consensus 79 ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 79 EHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cc
Confidence 9999999999998764 48999999999999999999997 69999999999999999999999999998765432 23
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc----------------------
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS---------------------- 222 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~---------------------- 222 (1092)
....|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 4567899999999998888999999999999999999999999765433322222110
Q ss_pred --------------CCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 223 --------------SIGPLP-SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 223 --------------~i~plP-s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.....+ ..++.++.+||.+||..+|++||++.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000111 1367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.74 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=216.4
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC--
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG-- 78 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d-- 78 (1092)
+...++|.+.+.||+|+||.||++.+..+++.+|+|.+..... ....+.+|+.+++++ +||||++++++|...+
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 3567899999999999999999999999999999999864322 234567899999998 8999999999987543
Q ss_pred --eEEEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 79 --CYVCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 79 --~~lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
..+|+||||++|++|.++++.. ....+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 4688999999999999998642 234589999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-cCccccCCCCcCCchhhccC-----CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--
Q 043248 155 AKTLKADD-LASSVVGTPNYMCPELLADI-----PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-- 226 (1092)
Q Consensus 155 A~~l~~d~-~~st~vGTp~YmAPEVL~g~-----~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p-- 226 (1092)
+....... ......|+..|+|||++... .++.++|||||||++|+|++|+.||...........+.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 88765432 22345789999999998543 36889999999999999999999998776555555544332221
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
.+..++..+.+||.+||+.+|++||++.++++||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2445678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=343.45 Aligned_cols=256 Identities=32% Similarity=0.570 Sum_probs=219.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||++.++.+++.|++|.+...... .....+.+|+.++++++||||++++++|... ..+|+|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEE
Confidence 5789999999999999999999999999999998765332 4456788999999999999999999998665 5788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||+.+++|.+++.... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999999998753 358999999999999999999999 9999999999999999999999999999876643322
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc-----ChHHHHHHhhccCCCCCCCC-CCHHHHHH
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-----DMAGLISKINRSSIGPLPSC-YSPSLKTL 238 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~-----d~~dli~kI~~~~i~plPs~-iS~eLkDL 238 (1092)
....|+..|+|||.+.+..++.++|||||||++|+|++|..||... ........+........+.. ++.++.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2277899999999999999999999999999999999999999754 23334444433333333433 78999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
|.+||..+|.+|||+.+++.||||+.+
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=346.88 Aligned_cols=257 Identities=35% Similarity=0.601 Sum_probs=219.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||.|+||.||++.+..++..||+|.+.... ......+.+|+.++++++|+||++++++|... ..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-CeEEEE
Confidence 468999999999999999999999899999999987542 33346788899999999999999999998664 478899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999999987654 348999999999999999999999999999999999999999999999999987654322 2
Q ss_pred CccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHH
Q 043248 164 ASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLK 236 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLk 236 (1092)
.....|+..|++||++. ...++.++|+|||||++|+|++|+.||...+......++...... ..+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 33457899999999985 345788999999999999999999999887766655555544322 23456789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+||.+||+.+|.+||++.++++||||...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=337.21 Aligned_cols=252 Identities=32% Similarity=0.568 Sum_probs=216.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||.|+||.||++.+..+++.+++|.+...... ....+.+|+.++++++||||+++++++...+ .+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRD-KLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCC-EEEEEE
Confidence 6899999999999999999999999999999999765332 4567889999999999999999999886654 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 80 EYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred eCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999999988752 248999999999999999999999999999999999999999999999999988765432 23
Q ss_pred ccccCCCCcCCchhhccC---CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC----CCCCCCHHHHH
Q 043248 165 SSVVGTPNYMCPELLADI---PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP----LPSCYSPSLKT 237 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~---~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p----lPs~iS~eLkD 237 (1092)
....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+......+ ....++.++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 445789999999999776 78999999999999999999999998876555444444332211 22345788999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPF 261 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPw 261 (1092)
||++||..+|..|||+.+++.|+|
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.11 Aligned_cols=251 Identities=32% Similarity=0.624 Sum_probs=216.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||++.+..++..|++|.+..... ...+.+|+.+++.++|+||++++++|... ..+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEE
Confidence 689999999999999999999998899999999865422 56788999999999999999999998765 4788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 78 EYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred ecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999997644 358999999999999999999999999999999999999999999999999998765443 23
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHHHh
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIrkc 242 (1092)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+...... ..+..++..+.+||.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 3456889999999999989999999999999999999999999876554443333322221 23345788999999999
Q ss_pred cccCCCCCCCHHHHHhChhh
Q 043248 243 LRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwF 262 (1092)
|+.+|.+|||+.++|+||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=341.83 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=209.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMA-LIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIq-ILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||++.++.+|+.||+|.+.......... .+..|+. .++.++||||+++++++...+ .+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG-DVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEE
Confidence 58999999999999999999999999999999987654433333 3444555 466779999999999986554 68899
Q ss_pred EeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|||++ ++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 5888888653 224589999999999999999999997 9999999999999999999999999999876544
Q ss_pred ccCccccCCCCcCCchhhcc----CCCCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHHhhccCCCCCC-CCCCHHH
Q 043248 162 DLASSVVGTPNYMCPELLAD----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINRSSIGPLP-SCYSPSL 235 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g----~~yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~kI~~~~i~plP-s~iS~eL 235 (1092)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ....+..+.......++ ..++.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 33344678999999998864 457899999999999999999999997532 22333333332222222 3578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+||.+||..+|.+||++.++++||||...
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=339.34 Aligned_cols=254 Identities=31% Similarity=0.534 Sum_probs=216.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ---TERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~---se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~l 81 (1092)
.+|++.+.||+|+||.||.+.+..++..|++|.+..... .......+.+|+.++++++|+||+++++++.+. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 689999999999999999999999999999998864322 223456788999999999999999999988664 3568
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||++|++|.+++..... +++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 899999999999999986543 889999999999999999999999999999999999999999999999998765422
Q ss_pred c----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-CCCCCCCCCHHHH
Q 043248 162 D----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-IGPLPSCYSPSLK 236 (1092)
Q Consensus 162 ~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-i~plPs~iS~eLk 236 (1092)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||........+.++.... ....+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 1 1234568999999999988889999999999999999999999998765554444443322 2345666788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
++|.+||. +|++||+++++++|||+
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 99999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=353.91 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=195.2
Q ss_pred EEEEeecCceEEEEEEEc--CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEEEEEEee
Q 043248 11 MEQIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYVCIVTGY 87 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK--~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~lyLVMEY 87 (1092)
.++||+|+||.||+|.++ .+++.||+|.+..... ...+.+|+.+++.++||||++++++|... +..+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999976 4678999999865432 23467899999999999999999998653 4578899999
Q ss_pred cCCCCHHHHHHHcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCEEEeecCccc
Q 043248 88 CEGGDMAELMKKSN-------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL----TKDQDVRLGDFGLAK 156 (1092)
Q Consensus 88 ceGGSL~DLLkkk~-------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL----D~dG~LKLiDFGLA~ 156 (1092)
+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++.
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 96 58998886432 2248999999999999999999999999999999999999 455789999999998
Q ss_pred cccccc----cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccCh---------HHHHHHhhcc
Q 043248 157 TLKADD----LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---------AGLISKINRS 222 (1092)
Q Consensus 157 ~l~~d~----~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~---------~dli~kI~~~ 222 (1092)
.+.... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||..... ..++..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 765322 2345678999999999976 4589999999999999999999999965321 1111111100
Q ss_pred C----------------------------CC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 223 S----------------------------IG---------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 223 ~----------------------------i~---------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
. .. ......+..+.+||++||++||.+|+|++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00 0011135678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.70 Aligned_cols=255 Identities=32% Similarity=0.554 Sum_probs=216.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ---TERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~---se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~l 81 (1092)
..|++.+.||+|+||.||++.+..++..|++|++..... .......+.+|+.++++++||||+++++++... +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998865432 223445788999999999999999999988654 4678
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
+++|||+++++|.+++..... +++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 899999999999999976543 899999999999999999999999999999999999999999999999998765432
Q ss_pred c----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-CCCCCCCCCHHHH
Q 043248 162 D----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-IGPLPSCYSPSLK 236 (1092)
Q Consensus 162 ~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-i~plPs~iS~eLk 236 (1092)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||........+..+.... ...++..++..++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 1 1223568899999999998889999999999999999999999998766555444443322 2345566788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
+|| +||..+|++||+++|+++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999 67778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.50 Aligned_cols=259 Identities=30% Similarity=0.497 Sum_probs=215.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-eEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-CYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~~ly 82 (1092)
.+++|++.+.||+|+||.||+|.++.+|..||+|.+............+.+|+.++++++|+||+++++++.... ..+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 468999999999999999999999999999999998755433322334567999999999999999999987653 4678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999975 8988887643 358999999999999999999999999999999999999999999999999998765432
Q ss_pred -cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---------------
Q 043248 163 -LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--------------- 225 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--------------- 225 (1092)
......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 2233456888999999865 56799999999999999999999999887766655544321100
Q ss_pred ---CC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 226 ---PL-----------PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 226 ---pl-----------Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.. ...+++.+.+||.+||+.||++|||+.+++.||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00 0125788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.17 Aligned_cols=254 Identities=22% Similarity=0.402 Sum_probs=219.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCC-----cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEK-----KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tG-----k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
.+++|++++.||+|+||.||+|.+...+ ..|++|.+.... .......+.+|+.++.+++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 4578999999999999999999986655 679999886443 3334567889999999999999999999886544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
..|++|||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+
T Consensus 82 -~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 82 -PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 67899999999999999986421 348889999999999999999999999999999999999999
Q ss_pred CCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhh
Q 043248 145 QDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKIN 220 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~ 220 (1092)
+.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999997654322 2234467889999999988899999999999999999998 999999888888877777
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.......+..++.++.+|+.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 766667778899999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.96 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=218.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
...+|++.+.||+|+||.||++.+..++..|++|.+....... ...+.+|+.+++.+.|+||++++++|.... ..|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD-ELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-EEEE
Confidence 4579999999999999999999999999999999987654333 356888999999999999999999987644 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||++|++|.+++... .+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred eecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999999998753 37899999999999999999999999999999999999999999999999987654332
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIK 240 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIr 240 (1092)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+...... ..+..++..+.+||.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 223457899999999999888999999999999999999999999877654443333322221 234567889999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||.++|.+||++.++++||||..
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.94 Aligned_cols=251 Identities=28% Similarity=0.497 Sum_probs=211.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||++++++|...+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-RISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-EEEEEE
Confidence 47999999999999999999999999999999987543 2334467889999999999999999999997655 677999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+++++|..+. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~ 151 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAK 151 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-ccc
Confidence 999999997642 2789999999999999999999999999999999999999999999999999876533 234
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh-------HHHHHHhhccCCCC-CCCCCCHHHHH
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-------AGLISKINRSSIGP-LPSCYSPSLKT 237 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-------~dli~kI~~~~i~p-lPs~iS~eLkD 237 (1092)
..+|+..|+|||++.+..++.++|+|||||++|+|++|..||..... ......+....... ....++.++.+
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 56899999999999998999999999999999999999999965321 12222222221112 23347889999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||.+||+.+|.+||+++++++||||...
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.67 Aligned_cols=254 Identities=29% Similarity=0.522 Sum_probs=214.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.++++++|+||++++++|... ..+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-GRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-CEEEEEE
Confidence 589999999999999999999999999999999876544455567788999999999999999999999764 4788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--c
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--L 163 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--~ 163 (1092)
||++++.|..++.+.. .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 80 EYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred ecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9999877766655433 38999999999999999999999999999999999999999999999999998776543 3
Q ss_pred CccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-------------------
Q 043248 164 ASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS------------------- 223 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~------------------- 223 (1092)
.....++..|+|||++.+. .++.++||||||+++|+|++|++||.+....+....+....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3456789999999999887 78999999999999999999999998765544333221100
Q ss_pred --CC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 --IG----------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 --i~----------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.. ..+..++.++.+||++||..+|++||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1222348889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.11 Aligned_cols=256 Identities=34% Similarity=0.602 Sum_probs=216.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.|++++.||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++|+||++++++|...+ .+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-KLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-eEEEEE
Confidence 5799999999999999999999999999999998654 2334567888999999999999999999986655 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~ 164 (1092)
||++|++|..++.+.. ..+++..++.++.||+.+|.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 89 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 89 EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred ecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9999999998886544 34899999999999999999999999999999999999999999999999998754322 122
Q ss_pred ccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHH
Q 043248 165 SSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKT 237 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkD 237 (1092)
....++..|+|||++. ...++.++|||||||++|+|++|..||...+......++...... ..+..++.++.+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 3457889999999984 345788999999999999999999999877655544444433222 234567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||++||..+|++||+++++++||||..+
T Consensus 248 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999999998643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.52 Aligned_cols=254 Identities=30% Similarity=0.562 Sum_probs=214.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT----ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s----e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
+|+..+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+||++++++|.+.+ .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-eEE
Confidence 589999999999999999999999999999998754321 224567889999999999999999999986655 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCcccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~d 161 (1092)
+||||+.|++|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++..+...
T Consensus 80 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999998654 489999999999999999999999999999999999998776 5999999998776533
Q ss_pred c-----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhh----ccCCCCCCCCCC
Q 043248 162 D-----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN----RSSIGPLPSCYS 232 (1092)
Q Consensus 162 ~-----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~----~~~i~plPs~iS 232 (1092)
. ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+. .......+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 1223568899999999988889999999999999999999999997654332222221 122334566688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
+++.+++.+||..+|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=333.74 Aligned_cols=253 Identities=33% Similarity=0.608 Sum_probs=215.7
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.+..+++.|++|.+..........+.+.+|+.+++.++|+||+++++++... ..+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEe
Confidence 69999999999999999999999999999999987665555677899999999999999999999987554 47889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--- 163 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~--- 163 (1092)
|+++++|.+++.... .+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 80 YCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred cCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999998654 388999999999999999999999999999999999999999999999999987654322
Q ss_pred --CccccCCCCcCCchhhccCC---CCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHHhhccCCCCCCCC--CCHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIP---YGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINRSSIGPLPSC--YSPSL 235 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~---yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~kI~~~~i~plPs~--iS~eL 235 (1092)
.....++..|+|||++.+.. ++.++|||||||++|+|++|..||...+ .......+.......++.. ++..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 22356889999999997766 8899999999999999999999997653 2233333332222333433 48899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+||++||+.+|.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=339.88 Aligned_cols=252 Identities=28% Similarity=0.489 Sum_probs=209.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-KLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-EEEEE
Confidence 45799999999999999999999999999999998754322 2346778999999999999999999987654 77899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999999997654 48999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC----CCCCCCCHHHH
Q 043248 164 ASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----PLPSCYSPSLK 236 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----plPs~iS~eLk 236 (1092)
.....|+..|+|||.+. ...++.++|||||||++|+|++|..||...........+...... .....++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 33457899999999884 445788999999999999999999999654433322222222111 11234688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPF 261 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPw 261 (1092)
+||++||..+|++||+++++|+|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=349.72 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=218.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
...+|++++.||+|+||.||++.+..+++.||+|.+....... ...+.+|+.+++.++|+||++++++|...+ .+|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD-ELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCC-EEEE
Confidence 4579999999999999999999999999999999987654332 356788999999999999999999986654 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||++|++|.+++.+. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred eecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999999999753 379999999999999999999999999999999999999999999999999877654322
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIr 240 (1092)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...... ..+..++..+.+||.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 23457899999999999988999999999999999999999999876543332222222111 234567889999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+||..+|.+||++.++++||||+....
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccccc
Confidence 999999999999999999999976443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=327.30 Aligned_cols=254 Identities=34% Similarity=0.608 Sum_probs=222.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-eEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-CYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~~lyLVM 85 (1092)
+|++.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.++++++|+||+++++++.... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 589999999999999999999999999999999776554455678889999999999999999999887652 5788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc--
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-- 163 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~-- 163 (1092)
||+++++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999998765 589999999999999999999999999999999999999999999999999988776543
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHHhhc-cCCCCCCCCCCHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINR-SSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~kI~~-~~i~plPs~iS~eLkDLIr 240 (1092)
.....++..|++||.+.+..++.++||||||+++|+|++|..||.... .......+.. .....++..++..+.+||.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 445678999999999988889999999999999999999999998765 2233333332 3344567778999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwF 262 (1092)
+||+.+|.+||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=333.45 Aligned_cols=254 Identities=37% Similarity=0.746 Sum_probs=227.3
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.++.+++.+++|.+............+.+|+.++++++|+||++++++|... ..+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence 69999999999999999999999999999999987655555566788899999999999999999998665 57889999
Q ss_pred ecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 87 YCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 87 YceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|+++++|..++... .+..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 99999999998762 2245899999999999999999999999999999999999999999999999999877655 34
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
....|+..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+........+..++.++.++|.+||.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence 45678999999999999999999999999999999999999999888877777777777777777889999999999999
Q ss_pred cCCCCCCCHHHHHhChhh
Q 043248 245 KNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 245 kDPskRPSaeELLqHPwF 262 (1092)
.+|.+||++.++++||++
T Consensus 239 ~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 239 VKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.65 Aligned_cols=259 Identities=30% Similarity=0.544 Sum_probs=217.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++++.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++|+||++++++|...+ .+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-AVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-eEEEEE
Confidence 57999999999999999999999999999999887542 3333467889999999999999999999886654 788999
Q ss_pred eecCCCCHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 86 GYCEGGDMAELMKKSN-GAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~-gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||++|++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++..+... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence 9999999999987631 2248999999999999999999997 59999999999999999999999999998766432 2
Q ss_pred CccccCCCCcCCchhhccC------CCCccccchhHHHHHHHHHhCCCCCcccChHHHH---HHhhccCCCCCCCCCCHH
Q 043248 164 ASSVVGTPNYMCPELLADI------PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLI---SKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~------~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli---~kI~~~~i~plPs~iS~e 234 (1092)
.....|+..|+|||++.+. .++.++|+|||||++|+|++|+.||......... ..+.......++..++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 3445788999999998543 3588999999999999999999999765443332 333334444566678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+.+||.+||+.+|.+||++.+++.||||..+..
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=386.74 Aligned_cols=255 Identities=34% Similarity=0.581 Sum_probs=229.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
..|+.++.||+|.||.||+|.+..+++.||||++...... .....+.+|+.+|.+++++||.++|+.|.... .++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~-~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-KLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecc-cHHHHH
Confidence 4688889999999999999999999999999999876443 34577899999999999999999999996644 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-C
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-A 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~-~ 164 (1092)
|||.||++.++++.... +.|..+..++++++.||.|||.++.+|||||+.|||+...|.+||+|||.+..+..... .
T Consensus 91 ey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999999986553 58999999999999999999999999999999999999999999999999998876543 3
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
.+++||++|||||++.+..|+.++||||||++.|||++|.+||........+..|.+...+.+...+++.+++||..||.
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhh
Confidence 78899999999999999999999999999999999999999998877755555666666666777899999999999999
Q ss_pred cCCCCCCCHHHHHhChhhHh
Q 043248 245 KNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 245 kDPskRPSaeELLqHPwFq~ 264 (1092)
+||+.||++.++|+|+|++.
T Consensus 249 k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred cCcccCcCHHHHhhhHHHHh
Confidence 99999999999999999976
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.60 Aligned_cols=252 Identities=28% Similarity=0.520 Sum_probs=210.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+ .+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-KLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-EEEEE
Confidence 4589999999999999999999999999999999875432 22345778999999999999999999986655 77899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|||+++++|.+++...+ .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999999999997655 38999999999999999999999999999999999999999999999999987654321 2
Q ss_pred CccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--C--CCCCCHHHH
Q 043248 164 ASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--L--PSCYSPSLK 236 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--l--Ps~iS~eLk 236 (1092)
.....|+..|+|||++. ...++.++|+|||||++|+|++|..||..................+ . ...++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 23457999999999984 4568899999999999999999999997654433333222221111 1 124678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPF 261 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPw 261 (1092)
+||.+||+.+|++||+++++++|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.42 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=211.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++++.||.|+||.||+|.++.++..||||++............+.+|+.++++++||||+++++++...+ .+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-KLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-cEEEEee
Confidence 589999999999999999999999999999998765444434457889999999999999999999986544 7789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
|+. ++|..++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 996 589999887655669999999999999999999999999999999999999999999999999987664332 223
Q ss_pred cccCCCCcCCchhhccCC-CCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC---------------------
Q 043248 166 SVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS--------------------- 223 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~-yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~--------------------- 223 (1092)
...++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+......++....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 346788999999887644 5889999999999999999999998765544333322110
Q ss_pred -------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 -------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 -------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.......++.+++++|.+||+.||.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 001123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.49 Aligned_cols=253 Identities=35% Similarity=0.596 Sum_probs=224.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.+..+++.|++|.+............+.+|+.++++++|+|++++++++... ..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence 69999999999999999999999999999999987765555667899999999999999999999988665 57889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-Cc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-AS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~-~s 165 (1092)
|+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred cCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999998764 489999999999999999999999999999999999999999999999999987764432 23
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|+..|+|||.+.+..++.++|||+||+++|+|++|..||..........+........++..++..+.++|.+||..
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhC
Confidence 45789999999999888889999999999999999999999987766555555555555667778899999999999999
Q ss_pred CCCCCCCHHHHHhChhh
Q 043248 246 NPEHRPSASELLKHPFL 262 (1092)
Q Consensus 246 DPskRPSaeELLqHPwF 262 (1092)
+|++||++.+++.||||
T Consensus 238 ~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 238 DPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ChhhCcCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=340.14 Aligned_cols=257 Identities=30% Similarity=0.540 Sum_probs=213.3
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe----c
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE----K 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e----~ 77 (1092)
...++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.+ +|+||++++++|.. .
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 356799999999999999999999999999999998754321 234577899999999 69999999998853 3
Q ss_pred CeEEEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
+..+|+||||++|++|.+++... ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 45789999999999999988642 2335889999999999999999999999999999999999999999999999998
Q ss_pred ccccccc-cCccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CC
Q 043248 156 KTLKADD-LASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PL 227 (1092)
Q Consensus 156 ~~l~~d~-~~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--pl 227 (1092)
....... ......|+..|+|||++. +..++.++|||||||++|+|++|+.||...........+...... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence 8765332 233457999999999985 345789999999999999999999999876654444443322211 23
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
+..++..+.+||.+||+.+|++|||+.++++|+||
T Consensus 252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 44568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=346.18 Aligned_cols=258 Identities=29% Similarity=0.522 Sum_probs=221.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
...+|++.+.||.|+||.||++.+..+++.|++|.+...... ....+.+|+.+++.++|+||++++++|...+ .+|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGD-ELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCc-eEEE
Confidence 346799999999999999999999999999999998754332 2456788999999999999999999986544 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+.+++|..++... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999999998754 389999999999999999999999999999999999999999999999999886654322
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIr 240 (1092)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...... ..+..++..+.+||+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence 23457899999999999888999999999999999999999999887765544444332221 235567899999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+||..+|.+||++.++++||||+....
T Consensus 251 ~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHhhcChhhCCCHHHHhhChHhhhccc
Confidence 999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=342.49 Aligned_cols=254 Identities=32% Similarity=0.556 Sum_probs=215.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
-|++.+.||.|+||.||++.+..++..+++|.+.... ......+.+|+.+++.++|+||++++++|...+ ..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-EEEEEEE
Confidence 4788999999999999999999999999999986542 233456788999999999999999999987655 7789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~s 165 (1092)
|+++++|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999999999886533 34899999999999999999999999999999999999999999999999998765322 2234
Q ss_pred cccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHH
Q 043248 166 SVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTL 238 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDL 238 (1092)
...|+..|+|||++. +..++.++|||||||++|+|++|.+||...+.......+...... ..+..++.++.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 457899999999983 455788999999999999999999999887766655555443222 2345678999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
|.+||+.+|.+||+++++++||||..
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEec
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.13 Aligned_cols=254 Identities=28% Similarity=0.507 Sum_probs=211.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||+|.++.+++.||+|.+............+.+|+.+++.++||||++++++|.. +..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence 58999999999999999999999899999999886554444445668889999999999999999999865 45788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~ 164 (1092)
||++++.|..++..... +++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++...... ...
T Consensus 80 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99999999888765433 899999999999999999999999999999999999999999999999998876433 223
Q ss_pred ccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc---------------------
Q 043248 165 SSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS--------------------- 222 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~--------------------- 222 (1092)
....++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 44578999999999875 45788999999999999999999999765543332222210
Q ss_pred CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 223 SIG---------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 223 ~i~---------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
... .....++..+.+|+.+||.++|.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0122467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=340.15 Aligned_cols=251 Identities=18% Similarity=0.296 Sum_probs=214.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++.+.||+|+||.||+|.++ ..+..||+|.+..... ......+.+|+.++++++||||+++++++... ..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCc
Confidence 468999999999999999999875 4456899999875432 33356788999999999999999999998654 478
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 89999999999999998654 34899999999999999999999999999999999999999999999999987654332
Q ss_pred ccCc--cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 162 DLAS--SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~s--t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
.... ...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+.++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 2221 2335678999999999999999999999999999774 999999888777777776665556777889999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q 043248 239 IKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLq 258 (1092)
+.+||+.+|.+||+++++++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=343.23 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=209.6
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---- 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---- 78 (1092)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 4578999999999999999999999999999999998655433333445678999999999999999999876543
Q ss_pred ---eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 79 ---CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 79 ---~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
...|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 356899999964 8888887654 34899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC---C-
Q 043248 156 KTLKADD-----LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---G- 225 (1092)
Q Consensus 156 ~~l~~d~-----~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i---~- 225 (1092)
..+.... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 8664322 12234678899999988664 478899999999999999999999987665433322221000 0
Q ss_pred --------------C-------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 --------------P-------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 --------------p-------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
. .+...+..+.+||.+||..||.+|||++++|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=342.53 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=209.8
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCe----E
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGC----Y 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~----~ 80 (1092)
++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.+. |+||+++++++...+. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5799999999999999999999999999999998765433333456788999999995 6999999998876543 4
Q ss_pred EEEEEeecCCCCHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSN---GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAK 156 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~---gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~ 156 (1092)
.|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7899999986 8988887543 235899999999999999999999999999999999999998 8899999999987
Q ss_pred ccccc-ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC----------
Q 043248 157 TLKAD-DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---------- 224 (1092)
Q Consensus 157 ~l~~d-~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i---------- 224 (1092)
.+... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+........++.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 65432 12233467889999998865 4579999999999999999999999987655444333321100
Q ss_pred ---------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 225 ---------G--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 225 ---------~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
. .....++.++.+||.+||.++|.+||++.++|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 01124688899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=344.81 Aligned_cols=256 Identities=25% Similarity=0.463 Sum_probs=213.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc---HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT---ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s---e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+|++.+.||+|+||.||+|.+..+++.|++|.+...... ......+..|+.++++++|+||++++++|.. +..+|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence 599999999999999999999999999999999765433 3334567789999999999999999999977 457889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 889999997654 358999999999999999999999999999999999999999999999999998765432
Q ss_pred cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-----------------
Q 043248 163 LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI----------------- 224 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i----------------- 224 (1092)
......++..|+|||.+.+ ..++.++|||||||++|+|++|.++|.+......+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2334467889999999854 4678999999999999999999998877665444433321100
Q ss_pred -----C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 225 -----G-----PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 225 -----~-----plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
. ......+..+.+||.+||.++|++|||+.+++.|+||.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0 0113347889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=362.03 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=200.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.+|++++.||+|+||.||+|.+..++..||+|..... ....|+.++++++|+||++++++|...+ ..|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEE
Confidence 4799999999999999999999999999999975432 2345899999999999999999997655 678999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 137 e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9995 58888887644 358999999999999999999999999999999999999999999999999997654443444
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCC-CcccChH---------HHHHHhhc-cCC--CCC-----
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPA-FKAFDMA---------GLISKINR-SSI--GPL----- 227 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~P-F~g~d~~---------dli~kI~~-~~i--~pl----- 227 (1092)
...||..|+|||++.+..|+.++|||||||++|+|+++..+ |...... ..+..+.. ... ..+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 56799999999999999999999999999999999985444 4331110 11111100 000 000
Q ss_pred -------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 228 -------------------------PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 228 -------------------------Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
...++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0134667788999999999999999999999999974
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=342.53 Aligned_cols=261 Identities=31% Similarity=0.475 Sum_probs=214.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|++.+.||+|+||.||++.++.+++.||+|.+............+.+|+.++++++|+||+++++++.... .+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-RLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-eEEEE
Confidence 57999999999999999999999999999999998765443344467888999999999999999999986654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCcccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAKTLKAD-D 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~~l~~d-~ 162 (1092)
|||++ ++|.+++.......+++..++.++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++...... .
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99996 58888887665555788999999999999999999999999999999999985 457999999999765432 1
Q ss_pred cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-----------------
Q 043248 163 LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI----------------- 224 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i----------------- 224 (1092)
......|+..|+|||++.+ ..++.++|||||||++|+|++|++||......+.+.++.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 2234567899999999866 4578999999999999999999999987655444443321100
Q ss_pred ------C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 225 ------G-----PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 225 ------~-----plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. .....++.++.++|.+||+.+|++||++.++++||||..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 0 012346788999999999999999999999999999987643
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=336.10 Aligned_cols=249 Identities=31% Similarity=0.582 Sum_probs=215.8
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
||.|+||.||++.+..+++.|++|.+...... ......+.+|+.+++.++|+||+++++++... ..+|+||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCc
Confidence 69999999999999999999999999765432 23456788999999999999999999988654 47889999999999
Q ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCC
Q 043248 93 MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN 172 (1092)
Q Consensus 93 L~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~ 172 (1092)
|.+++.+... +++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............|+..
T Consensus 80 L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 80 LWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 9999987543 89999999999999999999999999999999999999999999999999988765543445678999
Q ss_pred cCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--hHHHHHHhhc-cCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 043248 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINR-SSIGPLPSCYSPSLKTLIKGMLRKNPEH 249 (1092)
Q Consensus 173 YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--~~dli~kI~~-~~i~plPs~iS~eLkDLIrkcLqkDPsk 249 (1092)
|++||.+.+..++.++|+||||+++|+|++|..||.... ......++.. ......+...+.++.+||.+||..+|.+
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence 999999988889999999999999999999999998766 5555555542 2333455566899999999999999999
Q ss_pred CCC-----HHHHHhChhhHhH
Q 043248 250 RPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 250 RPS-----aeELLqHPwFq~~ 265 (1092)
|++ +.|+++||||+.+
T Consensus 238 R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 238 RLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CcCCcccCHHHHhcChhhhCC
Confidence 999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.42 Aligned_cols=257 Identities=30% Similarity=0.498 Sum_probs=215.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-eEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-CYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~~ly 82 (1092)
.+++|++.+.||.|+||.||+|.+..+++.+++|.+............+.+|+.++++++||||+++++++...+ ..+|
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 467899999999999999999999999999999999765544444456778999999999999999999886652 5788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d- 161 (1092)
+||||+.+ +|.+++..... .+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 83 lv~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999975 99999876543 5899999999999999999999999999999999999999999999999999877654
Q ss_pred ccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-----------------
Q 043248 162 DLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS----------------- 223 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~----------------- 223 (1092)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||..........++....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 233445688999999998764 46899999999999999999999998765544433322110
Q ss_pred -------------CCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 -------------IGPLPSC-YSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 -------------i~plPs~-iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
...++.. ++..+.+||++||+.+|++|||+.|+|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 58889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=341.48 Aligned_cols=255 Identities=30% Similarity=0.559 Sum_probs=220.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
..|+.++.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+.|+||++++++|.... .+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-KLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-EEEEEE
Confidence 468889999999999999999999999999999875432 333567889999999999999999999986654 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
||++|++|.+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 82 e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999999999998753 38999999999999999999999999999999999999999999999999997665432 22
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.......++..++..+.+||.+||.
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 34568889999999988889999999999999999999999998776655555554444444555678899999999999
Q ss_pred cCCCCCCCHHHHHhChhhHhH
Q 043248 245 KNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 245 kDPskRPSaeELLqHPwFq~~ 265 (1092)
.+|++||++.++++|+||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.91 Aligned_cols=251 Identities=36% Similarity=0.679 Sum_probs=217.3
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||+|+||.||++.+..+++.+++|++..... .....+.+|+.++++++|+||++++++|... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 58999999999999999999998999999999976543 3456788999999999999999999998665 46789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st 166 (1092)
|++|++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999999999998753 3489999999999999999999999999999999999999999999999999988765543455
Q ss_pred ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCC--CCHHHHHHHHHhcc
Q 043248 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC--YSPSLKTLIKGMLR 244 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~--iS~eLkDLIrkcLq 244 (1092)
..|+..|++||.+.+..++.++||||||+++|+|++|..||...+.......+........+.. ++..+.++|.+||+
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 6789999999999888899999999999999999999999987754444444433333333333 38899999999999
Q ss_pred cCCCCCCCHHHHHhChh
Q 043248 245 KNPEHRPSASELLKHPF 261 (1092)
Q Consensus 245 kDPskRPSaeELLqHPw 261 (1092)
.||.+|||+.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=340.91 Aligned_cols=251 Identities=31% Similarity=0.540 Sum_probs=212.0
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||++++++|...+ .+|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-DLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-eEEEEEecCCCCc
Confidence 69999999999999999999999998754322 222445678999999999999999999986554 7889999999999
Q ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCC
Q 043248 93 MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN 172 (1092)
Q Consensus 93 L~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~ 172 (1092)
|.+++.......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.............++..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 99999876655699999999999999999999999999999999999999999999999999887654444445678899
Q ss_pred cCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---HHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 043248 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249 (1092)
Q Consensus 173 YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPsk 249 (1092)
|++||++.+..++.++|||||||++|+|++|+.||...... ..+...........+..+++.+.++|.+||+.+|.+
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999998888999999999999999999999999775432 112222222233455668999999999999999999
Q ss_pred CC-----CHHHHHhChhhHhH
Q 043248 250 RP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 250 RP-----SaeELLqHPwFq~~ 265 (1092)
|| ++.++++||||..+
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 89999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=400.45 Aligned_cols=265 Identities=32% Similarity=0.540 Sum_probs=222.6
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCY 80 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~ 80 (1092)
+..+++|++++.||+|+||.||+|.++.++..||+|.+............+.+|+.++++|+||||++++++|... ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3567999999999999999999999999999999999987655555667889999999999999999999998654 457
Q ss_pred EEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCcEEEcCC-------
Q 043248 81 VCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSN-------YVLHRDLKCSNIFLTKD------- 144 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSk-------GIIHRDLKPENILLD~d------- 144 (1092)
+|||||||++++|.++|... ....|++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999753 223599999999999999999999985 49999999999999642
Q ss_pred ----------CCEEEeecCccccccccccCccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccCh
Q 043248 145 ----------QDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM 212 (1092)
Q Consensus 145 ----------G~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~ 212 (1092)
+.+||+|||++..+.........+||+.|+|||++.+ ..++.++||||||||||+|++|..||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3489999999987765555556789999999999864 4588999999999999999999999986554
Q ss_pred HHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 213 AGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 213 ~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
...+..............++.++.+||..||..+|.+||++.|+|.|+||....
T Consensus 249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 433333332222222234689999999999999999999999999999997653
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=362.95 Aligned_cols=248 Identities=29% Similarity=0.464 Sum_probs=203.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEc--CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK--~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+|++++.||+|+||.||+|... ..++.|++|.+... ....+|+.++++|+||||++++++|.... .+|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKS-TVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCC-EEEE
Confidence 47999999999999999999764 35678999987643 23457999999999999999999986654 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+. ++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 164 v~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EehhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999996 58999885443 499999999999999999999999999999999999999999999999999976654321
Q ss_pred ---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---HHHHHhhcc---------------
Q 043248 164 ---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKINRS--------------- 222 (1092)
Q Consensus 164 ---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---dli~kI~~~--------------- 222 (1092)
.....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ..+..+...
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 23467999999999999999999999999999999999999999764321 111111100
Q ss_pred -----------CCC--CCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 223 -----------SIG--PLP-----SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 223 -----------~i~--plP-----s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
... ..+ ..++.++.+||++||..||.+|||+.++|.||||.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 000 011 134678899999999999999999999999999975
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.84 Aligned_cols=256 Identities=31% Similarity=0.582 Sum_probs=219.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.|++.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++|+||++++++|...+ .+|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-KLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccCC-ceEEEE
Confidence 4577788999999999999999999999999988754322 34567889999999999999999999986544 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-C
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-A 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~-~ 164 (1092)
||+++++|.+++... .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 999999999998643 389999999999999999999999999999999999999999999999999876654322 2
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.......+...++..+.+||.+||+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 33468899999999998889999999999999999999999998765555544444444444555678899999999999
Q ss_pred cCCCCCCCHHHHHhChhhHhHh
Q 043248 245 KNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 245 kDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+|.+||++.++++||||..+.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999998764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=336.98 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=206.9
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecC-eEEEEEE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKG-CYVCIVT 85 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d-~~lyLVM 85 (1092)
|++++.||+|+||.||++.+..+++.||+|++......... ....+|+.++.++. |+||+++++++.... ..+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 78999999999999999999999999999998754332222 23457888899885 999999999987651 4688999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++..........
T Consensus 80 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 80 ELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred ecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 99974 8888887643 35899999999999999999999999999999999999999 999999999998776554445
Q ss_pred cccCCCCcCCchhhc-cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC---------------CC----
Q 043248 166 SVVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS---------------IG---- 225 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~---------------i~---- 225 (1092)
...++..|+|||++. +..++.++|||||||++|+|++|..||.+.+..+.+..+.... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 567899999999874 4557899999999999999999999998766544433332100 00
Q ss_pred ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 ---------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 ---------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+...++..+.+||.+||.++|++||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.39 Aligned_cols=257 Identities=30% Similarity=0.521 Sum_probs=217.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||++++++|... ..+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-RHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-CEEEEE
Confidence 579999999999999999999999999999998875432 123345778999999999999999999988654 478899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc---
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--- 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d--- 161 (1092)
|||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999999997754 4899999999999999999999999999999999999999999999999988642110
Q ss_pred -------------ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--C
Q 043248 162 -------------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--P 226 (1092)
Q Consensus 162 -------------~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--p 226 (1092)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0111346788999999998888999999999999999999999999887776666665544322 1
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhChhhHhH
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPS---ASELLKHPFLQHF 265 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPS---aeELLqHPwFq~~ 265 (1092)
....++.++.+||.+||+++|++||+ +.++|+||||...
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 22357899999999999999999998 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=342.29 Aligned_cols=256 Identities=27% Similarity=0.510 Sum_probs=216.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+.++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++... ..+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEE
Confidence 4678999999999999999999999999999999886543 233456788999999999999999999999766 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||+++++|.+++.+.+ .+++..+..++.|++.+|.|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999999987654 48999999999999999999997 69999999999999999999999999998755322
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh-----------HHHHHHhhccCCCCCCCC-
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-----------AGLISKINRSSIGPLPSC- 230 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-----------~dli~kI~~~~i~plPs~- 230 (1092)
......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ......+.......++..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 23346799999999999888899999999999999999999999986443 123333333222223322
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
++..+.+||.+||++||.+|||+.|+++|+||.+
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 7789999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.89 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=215.0
Q ss_pred eEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe-----
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC----- 79 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~----- 79 (1092)
|++.+.||+|+||.||.|....+ +..||+|.+............+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987654 4789999987655555556678999999999999999999998765432
Q ss_pred EEEEEEeecCCCCHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSN----GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~----gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
..++||||+.+++|..++.... ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 4789999999999999986532 235899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCC
Q 043248 156 KTLKADDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 156 ~~l~~d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~i 231 (1092)
..+...... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence 876543221 12235678999999988889999999999999999998 99999887777777776666555677788
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+..+.++|.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.18 Aligned_cols=246 Identities=25% Similarity=0.444 Sum_probs=216.7
Q ss_pred EEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeec
Q 043248 12 EQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++.. +..+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEec
Confidence 4799999999999999866 8999999997664443 45778899999999999999999998876 55788999999
Q ss_pred CCCCHHHHHHHcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 89 EGGDMAELMKKSN-------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 89 eGGSL~DLLkkk~-------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
++++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999998752 245899999999999999999999999999999999999999999999999999877654
Q ss_pred c---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 162 D---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 162 ~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
. ......++..|+|||.+....++.++|||||||++|+|++ |..||...........+........+..++.++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence 2 2334567889999999988889999999999999999998 69999988887777777766555677778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhC
Q 043248 238 LIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqH 259 (1092)
++.+||..+|.+|||+.+++++
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.79 Aligned_cols=254 Identities=30% Similarity=0.576 Sum_probs=220.3
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
-|++++.||+|+||.||++.+..++..||+|.+..... ......+.+|+.++++++|+||++++++|...+ .+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-KLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-eEEEEEE
Confidence 47889999999999999999999999999998865433 234467889999999999999999999986654 7789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
|+++++|..++... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 83 ~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999999998653 38999999999999999999999999999999999999999999999999987654332 123
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
...|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.......++..++.++.++|.+||..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 45688999999999888889999999999999999999999987766665555554444456667889999999999999
Q ss_pred CCCCCCCHHHHHhChhhHhH
Q 043248 246 NPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 246 DPskRPSaeELLqHPwFq~~ 265 (1092)
+|.+||++.++++||||.+.
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.44 Aligned_cols=253 Identities=22% Similarity=0.394 Sum_probs=217.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG- 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC-
Confidence 4578999999999999999999874 3467899999875433 33456788999999999999999999998665
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD 146 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~ 146 (1092)
...|+||||++|++|.+++...+ ...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 47889999999999999997643 134788999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhcc
Q 043248 147 VRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRS 222 (1092)
Q Consensus 147 LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~ 222 (1092)
++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999997653322 1233456788999999999999999999999999999998 99999888777777777766
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 223 SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 223 ~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
.....+..++..+.+||.+||+.||.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666667778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.91 Aligned_cols=254 Identities=33% Similarity=0.483 Sum_probs=213.1
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEecCe----E
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV---QHPYIVEFKEAWVEKGC----Y 80 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL---~HPNIVKL~gvF~e~d~----~ 80 (1092)
|++.+.||+|+||.||++.++.++..||+|.+............+.+|+.+++++ +|+||++++++|...+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999976544443345566787777666 59999999999976553 4
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|++|||+.+ +|.+++.......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 8899999975 899998875544689999999999999999999999999999999999999999999999999988765
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---------------
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--------------- 225 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--------------- 225 (1092)
........++..|+|||++.+..++.++|+|||||++|+|++|++||......+...++......
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 54445566889999999999889999999999999999999999999887766555544321100
Q ss_pred -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 -----------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 -----------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.....++..+.+||.+||+.||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0011245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.64 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=205.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC----------------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA----------------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~----------------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIV 68 (1092)
-++|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999998643 34579999887543 334456788999999999999999
Q ss_pred eEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 043248 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG-----------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLH 131 (1092)
Q Consensus 69 KL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~g-----------------k~LSEeqI~kIa~QILsALaYLHSkGIIH 131 (1092)
+++++|...+ .+|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++||+|
T Consensus 83 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 83 RLLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999997655 67899999999999999975321 23677889999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh--CCCC
Q 043248 132 RDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA--HRPA 206 (1092)
Q Consensus 132 RDLKPENILLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT--Gr~P 206 (1092)
|||||+|||++.++.+||+|||++..+..... .....++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543321 223456788999999988899999999999999999986 6678
Q ss_pred CcccChHHHHHHhhc-------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 207 FKAFDMAGLISKINR-------SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 207 F~g~d~~dli~kI~~-------~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
|........+..+.. ......+..++..+.+||.+||+.+|.+|||+.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 877655444433321 1111234557889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.50 Aligned_cols=258 Identities=31% Similarity=0.530 Sum_probs=214.8
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~lyLV 84 (1092)
++|++.+.||.|+||.||++.+..++..||+|.+...... .....+.+|+.++++++||||++++++|... ...+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5799999999999999999999999999999998755332 3456788999999999999999999988654 4578899
Q ss_pred EeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 85 TGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
|||++|++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999999999987642 23458999999999999999999999999999999999999999999999999987654322
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC-----hHHHHHHhhccCCCCCC------CCC
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-----MAGLISKINRSSIGPLP------SCY 231 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d-----~~dli~kI~~~~i~plP------s~i 231 (1092)
.....++..|++||.+.+..++.++|||||||++|+|++|..||.... ..+....+.......++ ..+
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence 234567889999999999899999999999999999999999997652 22333333322111111 235
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
++.+.+||.+||..+|.+|||+.|+++||||+..
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 6789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.57 Aligned_cols=251 Identities=20% Similarity=0.366 Sum_probs=217.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..+|.+.+.||+|+||.||+|.++.++..|++|.+.... .....+.+|+.+++.++|+||+++++++...+ .+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-CcEEE
Confidence 457999999999999999999999999999999986432 22456888999999999999999999886544 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999999999998766556899999999999999999999999999999999999999999999999999876543322
Q ss_pred c--cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 S--SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 s--t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
. ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.......+........+..++.++.++|.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1 2234567999999999899999999999999999998 999999887777766666554555677789999999999
Q ss_pred hcccCCCCCCCHHHHHhC
Q 043248 242 MLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqH 259 (1092)
||+.+|++||++.++++.
T Consensus 241 cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HccCCcccCCCHHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.04 Aligned_cols=255 Identities=28% Similarity=0.478 Sum_probs=206.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++.+.||+|+||.||++.++.+++.||+|.+....... ....+.+|+.++++++|+||+++++++... ...|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEE
Confidence 4789999999999999999999999999999999987543221 123466899999999999999999998655 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 v~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9999985 99999876543 58999999999999999999999999999999999999999999999999987543221
Q ss_pred cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHHhhccC-----------------
Q 043248 163 LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINRSS----------------- 223 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~kI~~~~----------------- 223 (1092)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1223457889999999865 458899999999999999999999997654 222222111100
Q ss_pred -------CC-----CCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 -------IG-----PLPSCYS--PSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 -------i~-----plPs~iS--~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.. .....++ ..+.++|.+||+.+|.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.79 Aligned_cols=250 Identities=20% Similarity=0.392 Sum_probs=214.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|+++++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++++... ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEE
Confidence 3578999999999999999999864 567799998764322 245788999999999999999999988654 46789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+.+++|.+++.......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999999876656689999999999999999999999999999999999999999999999999987654321
Q ss_pred --CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+....++.++.+|+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122345678999999988889999999999999999998 99999887777777766655444455668899999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 043248 241 GMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLq 258 (1092)
+||..+|++||+++++++
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.13 Aligned_cols=247 Identities=26% Similarity=0.472 Sum_probs=193.9
Q ss_pred EEEEeecCceEEEEEEEcC--CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCeEEEEEEee
Q 043248 11 MEQIGRGAFGAAILVNHRA--EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE-KGCYVCIVTGY 87 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~--tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e-~d~~lyLVMEY 87 (1092)
..+||+|+||.||+|.++. ++..||+|.+..... ...+.+|+.+++.++||||++++++|.. .+..+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3689999999999999754 568899998865432 2346789999999999999999998864 34578899999
Q ss_pred cCCCCHHHHHHHc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCEEEeecCccc
Q 043248 88 CEGGDMAELMKKS-------NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL----TKDQDVRLGDFGLAK 156 (1092)
Q Consensus 88 ceGGSL~DLLkkk-------~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL----D~dG~LKLiDFGLA~ 156 (1092)
+.+ +|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 965 888887632 12348899999999999999999999999999999999999 456789999999998
Q ss_pred cccccc----cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChH---------HHHHHhhcc
Q 043248 157 TLKADD----LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---------GLISKINRS 222 (1092)
Q Consensus 157 ~l~~d~----~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---------dli~kI~~~ 222 (1092)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 765332 1234578999999999976 45799999999999999999999999653211 011100000
Q ss_pred ----------------------------C---------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 223 ----------------------------S---------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 223 ----------------------------~---------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
. ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000111235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.66 Aligned_cols=254 Identities=21% Similarity=0.400 Sum_probs=216.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEE----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNH----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~d----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
.+++|++.+.||+|+||.||+|.+ ...+..|++|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ- 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-
Confidence 467899999999999999999985 34567899999875432 334467888999999999999999999886654
Q ss_pred EEEEEEeecCCCCHHHHHHHcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 80 YVCIVTGYCEGGDMAELMKKSN---------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~---------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 6789999999999999986432 1237889999999999999999999999999999999999999
Q ss_pred CCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhh
Q 043248 145 QDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKIN 220 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~ 220 (1092)
+.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999998664332 2233456778999999988889999999999999999998 999998877666666666
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.....+.+..++..+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665556777889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.12 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=212.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||++.++. +..+|+|.+...... ...+.+|+.+++.++||||++++++|...+ .+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-PLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCC-CEEEE
Confidence 4689999999999999999998754 567999987644322 346788999999999999999999886554 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+++++|.+++....+ .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999999976443 4899999999999999999999999999999999999999999999999998865433222
Q ss_pred --ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 --SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 --st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+........+...+..+.+|+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 12235568999999998899999999999999999999 999999888777777777665555667788999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q 043248 242 MLRKNPEHRPSASELLK 258 (1092)
Q Consensus 242 cLqkDPskRPSaeELLq 258 (1092)
||+.+|.+||++.++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.18 Aligned_cols=248 Identities=23% Similarity=0.432 Sum_probs=215.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++.+.||+|+||.||++... +..|++|.+.... ....+.+|+.++++++|+|++++++++...+..+|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 4678999999999999999999764 7789999886432 235678899999999999999999987776667889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--
Confidence 999999999999998766556899999999999999999999999999999999999999999999999998765432
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+........+..++..+.+||.+|
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 223445678999999998889999999999999999997 9999988777777766665544556667899999999999
Q ss_pred cccCCCCCCCHHHHHhC
Q 043248 243 LRKNPEHRPSASELLKH 259 (1092)
Q Consensus 243 LqkDPskRPSaeELLqH 259 (1092)
|..+|++|||+.+++++
T Consensus 236 l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 236 WHLDAATRPSFLQLREQ 252 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=329.95 Aligned_cols=254 Identities=33% Similarity=0.634 Sum_probs=213.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++|++.+.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++||||++++++|...+ .+|+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~ 79 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNI 79 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-eEEE
Confidence 478999999999999999999999999999999886533 23344566888999999999999999999987655 7789
Q ss_pred EEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
||||+++++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999999988642 2234899999999999999999999999999999999999999999999999998876543
Q ss_pred cc-CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--hHHHHHHhhccCCCCCC-CCCCHHHHH
Q 043248 162 DL-ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGPLP-SCYSPSLKT 237 (1092)
Q Consensus 162 ~~-~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--~~dli~kI~~~~i~plP-s~iS~eLkD 237 (1092)
.. .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .......+......+.+ ..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 21 234578899999999988889999999999999999999999996543 23444444443333332 357789999
Q ss_pred HHHHhcccCCCCCCCHHHHHhC
Q 043248 238 LIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqH 259 (1092)
+|.+||..+|.+||++.++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=332.53 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=212.4
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCc--EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----CeE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKK--KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-----GCY 80 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk--~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-----d~~ 80 (1092)
|.+.+.||+|+||.||+|.+..++. .+|+|.+............+.+|+.+++.++|+||+++++++... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999877765 589998876554555567788999999999999999999976432 124
Q ss_pred EEEEEeecCCCCHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSN----GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~----gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 679999999999999885422 2348999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCC
Q 043248 157 TLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYS 232 (1092)
Q Consensus 157 ~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS 232 (1092)
.+..... .....+++.|++||++.+..++.++|||||||++|+|++ |..||...........+........+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 7654322 122346678999999999899999999999999999999 899998877777666666655445566788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..+.++|.+||+.+|.+|||+.+++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.97 Aligned_cols=254 Identities=33% Similarity=0.561 Sum_probs=215.1
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCeEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ---HPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~---HPNIVKL~gvF~e~d~~lyL 83 (1092)
.|++++.||+|+||.||+|.+..+++.|++|.+...... .....+.+|+.++++++ |||+++++++|... ..+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEEE
Confidence 588999999999999999999999999999998754322 23456778999999996 99999999988654 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||++|++|.+++... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999999998653 48999999999999999999999999999999999999999999999999998765433
Q ss_pred cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCC-CCCHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS-CYSPSLKTLIK 240 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs-~iS~eLkDLIr 240 (1092)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.......++. .++.++.+|+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 2334578999999999864 457899999999999999999999998876655544443333333333 37889999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+||..||++||++.+++.|+||++.
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhcc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=332.18 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=210.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc--------cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--------TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~--------se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 68999999999999999999999999999998864311 112245678899999999999999999988654
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+++||||+.|++|.+++.+.. .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 47789999999999999998764 4899999999999999999999999999999999999999999999999999765
Q ss_pred cccc---cCccccCCCCcCCchhhccCC--CCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-CCC----CC
Q 043248 159 KADD---LASSVVGTPNYMCPELLADIP--YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-IGP----LP 228 (1092)
Q Consensus 159 ~~d~---~~st~vGTp~YmAPEVL~g~~--yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-i~p----lP 228 (1092)
.... ......|+..|+|||++.+.. ++.++|+||||+++|+|++|..||...........+.... ... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 123456889999999987654 7899999999999999999999997655544443332221 111 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
..++..+.+||.+||.++|.+||+++++|+||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2468899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=331.79 Aligned_cols=255 Identities=20% Similarity=0.338 Sum_probs=217.0
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCC-----CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAE-----KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~t-----Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~ 77 (1092)
-..++|++.+.||+|+||.||++.++.. +..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3467999999999999999999998644 3789999986443 223345678899999999999999999998665
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEE
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSN--------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~--------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKL 149 (1092)
...|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 46889999999999999997532 123678899999999999999999999999999999999999999999
Q ss_pred eecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCC
Q 043248 150 GDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIG 225 (1092)
Q Consensus 150 iDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~ 225 (1092)
+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 99999886644322 233456789999999988889999999999999999998 99999888777777776655555
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..+..++..+.+||.+||+.+|++|||+.+++..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 6777789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.49 Aligned_cols=254 Identities=29% Similarity=0.546 Sum_probs=217.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc---ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR---QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~---~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~l 81 (1092)
.+|++.+.||+|+||.||++.+..+++.|++|.+.... ........+.+|+.++++++|+||+++++++... ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875432 1233456788999999999999999999988664 3567
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
++||||+++++|.+++..... +++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 899999999999999986543 889999999999999999999999999999999999999999999999999865431
Q ss_pred ----ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc-CCCCCCCCCCHHHH
Q 043248 162 ----DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS-SIGPLPSCYSPSLK 236 (1092)
Q Consensus 162 ----~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~-~i~plPs~iS~eLk 236 (1092)
.......|+..|+|||++.+..++.++|+|||||++|+|++|+.||........+.++... ....++..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 1123456899999999999888999999999999999999999999877655555554433 23456778899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
++|.+||. ++.+||++.+++.|||.
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=326.63 Aligned_cols=253 Identities=33% Similarity=0.641 Sum_probs=214.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++|+||++++++|... ...++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~l 79 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNI 79 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEE
Confidence 4789999999999999999999999999999998865332 233356788999999999999999999999765 47789
Q ss_pred EEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
||||+++++|..++... ....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999998752 2345899999999999999999999999999999999999999999999999998766433
Q ss_pred c-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--hHHHHHHhhccCCCCCCC-CCCHHHHH
Q 043248 162 D-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGPLPS-CYSPSLKT 237 (1092)
Q Consensus 162 ~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--~~dli~kI~~~~i~plPs-~iS~eLkD 237 (1092)
. ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.... .......+......+.+. .++..+.+
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 2 2234578999999999998899999999999999999999999996543 233444444444445554 67889999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q 043248 238 LIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLq 258 (1092)
+|.+||..+|.+|||+.++++
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=330.70 Aligned_cols=252 Identities=21% Similarity=0.381 Sum_probs=215.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++.+.||+|+||.||+|.++.. ...||+|.+.... .......+.+|+.++++++|+||+++++++...+ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR-PV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC-ce
Confidence 36899999999999999999998654 4578999886543 3334567888999999999999999999886544 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++....+ .+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 899999999999999987543 5899999999999999999999999999999999999999999999999999887521
Q ss_pred c-cC--ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 162 D-LA--SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 162 ~-~~--st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
. .. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11 12234578999999998899999999999999999997 99999887777777777665555667778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhC
Q 043248 238 LIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqH 259 (1092)
|+.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=335.73 Aligned_cols=254 Identities=21% Similarity=0.412 Sum_probs=215.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC-----CcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE-----KKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t-----Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~ 77 (1092)
..++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.+++++ +|+||++++++|...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 457899999999999999999998644 37899998875433 33345688999999999 799999999998655
Q ss_pred CeEEEEEEeecCCCCHHHHHHHc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKS--------------NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK 143 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk--------------~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~ 143 (1092)
+ .+|+||||+.+++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~-~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 89 G-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred C-CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 4 688999999999999999753 2345899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHh
Q 043248 144 DQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKI 219 (1092)
Q Consensus 144 dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI 219 (1092)
++.+||+|||++..+..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999999987654322 122335578999999998899999999999999999997 99999988777777666
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
........+..++..+.+|+.+||..+|++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6655555667788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=338.96 Aligned_cols=258 Identities=21% Similarity=0.399 Sum_probs=214.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCc--EEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKK--KYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk--~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ly 82 (1092)
++|++.+.||+|+||.||+|..+.++. .+++|.+... ........+.+|+.++.++ +||||+++++++...+ .+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-YLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-cce
Confidence 689999999999999999999877765 4677776532 2233346688899999999 7999999999886654 678
Q ss_pred EEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEE
Q 043248 83 IVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVR 148 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LK 148 (1092)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997642 12488999999999999999999999999999999999999999999
Q ss_pred EeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCC
Q 043248 149 LGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPL 227 (1092)
Q Consensus 149 LiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~pl 227 (1092)
|+|||++..............+..|+|||++.+..++.++|||||||++|+|++ |..||..........++........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999999865432211122233557999999998899999999999999999997 9999988877777777766555556
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+..++..+.+||.+||..+|.+||+++++++. +..+..
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~--l~~~~~ 277 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ--LSRMLE 277 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHH
Confidence 67789999999999999999999999999876 344443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.80 Aligned_cols=259 Identities=29% Similarity=0.472 Sum_probs=211.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----e
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----C 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~ 79 (1092)
.-++|++.+.||+|+||.||++.+..+|..||+|.+..... ......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 34789999999999999999999999999999999864322 233456778999999999999999998876443 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
..|+||||+.+ +|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 57899999965 888887643 38999999999999999999999999999999999999999999999999987654
Q ss_pred ccc----cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC----------
Q 043248 160 ADD----LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---------- 224 (1092)
Q Consensus 160 ~d~----~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i---------- 224 (1092)
... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 322 1234578999999998754 5689999999999999999999999977654332222211000
Q ss_pred --------------C------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 225 --------------G------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 225 --------------~------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. .....++.++.+||.+||+.+|++|||+.++++||||..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 011235788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.03 Aligned_cols=253 Identities=20% Similarity=0.342 Sum_probs=212.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
-++|++.+.||+|+||.||++.++. .+..||+|++..... ......+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 4689999999999999999998652 356799998854322 223456889999999999999999999885544
Q ss_pred EEEEEEeecCCCCHHHHHHHcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEee
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNG--------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~g--------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiD 151 (1092)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 67899999999999999976321 2357788999999999999999999999999999999999999999999
Q ss_pred cCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCC
Q 043248 152 FGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPL 227 (1092)
Q Consensus 152 FGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~pl 227 (1092)
||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999876543221 112345778999999998899999999999999999998 7899988877776666666555566
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+..++..+.+||.+||+.+|++|||+.+++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=343.48 Aligned_cols=251 Identities=22% Similarity=0.379 Sum_probs=212.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcE----EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKK----YVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~----VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--C
Confidence 46899999999999999999998766654 8999886432 233456788999999999999999999988654 3
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
.++|+||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 568999999999999998754 3488999999999999999999999999999999999999999999999999987754
Q ss_pred cccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 161 DDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 161 d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
.... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...+......+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 3322 12234668999999999999999999999999999997 9999988776655555544444455666789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhC
Q 043248 237 TLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqH 259 (1092)
+++.+||..+|.+||++.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.80 Aligned_cols=254 Identities=21% Similarity=0.407 Sum_probs=211.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEE--EEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY--VLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~V--AIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
.+++|++.+.||+|+||.||+|.++.++..+ ++|.+... ........+.+|+.++.++ +|+||+++++++...+ .
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~-~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-Y 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-C
Confidence 4679999999999999999999998877654 66665432 2334456788899999999 8999999999986554 6
Q ss_pred EEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC
Q 043248 81 VCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD 146 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~ 146 (1092)
+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 889999999999999997643 124789999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCC
Q 043248 147 VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIG 225 (1092)
Q Consensus 147 LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~ 225 (1092)
+||+|||++.............++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence 99999999864332211122234667999999988889999999999999999998 99999887766666655544333
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..+..++..+.+||.+||+.+|++||++++++++
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4555678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=378.60 Aligned_cols=262 Identities=25% Similarity=0.496 Sum_probs=241.5
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++.|.+.+.||+|.|+.|.++.+..++..||||.+.+...+......+.+|+.+|+.|+|||||+++.++.... .+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-TLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-eeE
Confidence 5678999999999999999999999999999999999988877777777999999999999999999999885544 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+.+|.+++++.+.+. +.+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+..+.
T Consensus 132 lV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999998875 7789999999999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
+..++||++.|.|||++.+..| ++++|+||+|++||-|+.|..||.+.+...+........+. ++..++.+++++|++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-Ip~~ms~dce~lLrk 288 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-IPFYMSCDCEDLLRK 288 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec-ccceeechhHHHHHH
Confidence 9999999999999999999988 78999999999999999999999998887776666655543 677789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+|..+|.+|++++++..|.|+......
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999765543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.04 Aligned_cols=257 Identities=28% Similarity=0.491 Sum_probs=208.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++.+.||.|+||.||++.++.++..||+|.+............+.+|+.+++.++|+||+++++++....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 478999999999999999999999999999999998654333322345678999999999999999999876443
Q ss_pred --eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 79 --CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 79 --~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
..+|+||||+.+ +|..++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 347899999975 6777776533 359999999999999999999999999999999999999999999999999997
Q ss_pred ccccccc------------CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC
Q 043248 157 TLKADDL------------ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS 223 (1092)
Q Consensus 157 ~l~~d~~------------~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~ 223 (1092)
....... .....|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 6543221 123467889999998865 457899999999999999999999998766554444332110
Q ss_pred CC----------------------CC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 224 IG----------------------PL-------PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 224 i~----------------------pl-------Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.. .. ...+++.+.+||.+||+.+|.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 00 01245678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.65 Aligned_cols=253 Identities=29% Similarity=0.474 Sum_probs=210.5
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++|+||+++++++... ...|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence 7889999999999999999999999999999876544443445678899999999999999999998655 578899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCcc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASS 166 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~st 166 (1092)
++ ++|.+++.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 689999987654458999999999999999999999999999999999999999999999999997654322 2233
Q ss_pred ccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc-----------------------
Q 043248 167 VVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS----------------------- 222 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~----------------------- 222 (1092)
..++..|+|||++.+. .++.++|||||||++|+|++|+.||...+......++...
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4678899999988664 5789999999999999999999999876544333322111
Q ss_pred -----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 223 -----SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 223 -----~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
........++..+.++|.+||+.+|.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0001123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=328.50 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=207.0
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGG 91 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGG 91 (1092)
+.||+|+||.||+|.++.+++.||+|.+... ........+.+|+.++++++|+||++++++|.... .+|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CeEEEEeeccCC
Confidence 4699999999999999999999999987643 23444567889999999999999999999986654 678999999999
Q ss_pred CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc---ccc
Q 043248 92 DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS---SVV 168 (1092)
Q Consensus 92 SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s---t~v 168 (1092)
+|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++.......... ...
T Consensus 79 ~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 79 DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999997643 348999999999999999999999999999999999999999999999999987654322111 112
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDP 247 (1092)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||+.+|
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 2456999999998889999999999999999997 999998776666555555544455677789999999999999999
Q ss_pred CCCCCHHHHHh
Q 043248 248 EHRPSASELLK 258 (1092)
Q Consensus 248 skRPSaeELLq 258 (1092)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=340.40 Aligned_cols=242 Identities=16% Similarity=0.225 Sum_probs=207.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--c-CeEEEEEEee
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVE--K-GCYVCIVTGY 87 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e--~-d~~lyLVMEY 87 (1092)
..||+|++|.||+|.+ +|+.||+|.+...... ....+.+.+|+.+|++++||||++++++|.+ . ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 6899999998765432 2335678899999999999999999999876 2 3468899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st 166 (1092)
|.||+|.+++.... .+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ...
T Consensus 104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFK 179 (283)
T ss_pred CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--ccc
Confidence 99999999998754 48999999999999999999998 49999999999999999999999999998865432 234
Q ss_pred ccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc-CCCCCCCCCCHHHHHHHHHhc
Q 043248 167 VVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS-SIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~-~i~plPs~iS~eLkDLIrkcL 243 (1092)
..|+..|+|||++.+ ..|+.++|||||||++|+|++|+.||...+...+...+... ....++..++..+++||.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 578999999999976 68999999999999999999999999988777766666433 233455568999999999999
Q ss_pred ccCCCCCCCHHHHHhC
Q 043248 244 RKNPEHRPSASELLKH 259 (1092)
Q Consensus 244 qkDPskRPSaeELLqH 259 (1092)
+.||++|||+.++++.
T Consensus 260 ~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 260 SHDSIKRPNIKEILYN 275 (283)
T ss_pred cCCcccCcCHHHHHHH
Confidence 9999999999999964
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.37 Aligned_cols=261 Identities=30% Similarity=0.473 Sum_probs=214.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----e
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----C 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~ 79 (1092)
..++|++.+.||+|+||.||++.+..++..||||.+............+.+|+.+++.++|+||+++++++.... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 356899999999999999999999999999999998754333333456778999999999999999999876443 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 5789999996 68999987654 49999999999999999999999999999999999999999999999999998765
Q ss_pred cc-ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc---------------
Q 043248 160 AD-DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS--------------- 222 (1092)
Q Consensus 160 ~d-~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~--------------- 222 (1092)
.. .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 43 33345678999999998864 56899999999999999999999999775433222211100
Q ss_pred ---------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 223 ---------------SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 223 ---------------~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
........++.++.+||++||+.+|.+|||+.++++||||..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000112347889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.94 Aligned_cols=253 Identities=32% Similarity=0.591 Sum_probs=218.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyL 83 (1092)
++|.+.+.||+|+||.||++.++.++..|++|.+..... .......+.+|+.+++++. |+||++++++|... ..+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-ENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-ceEEE
Confidence 589999999999999999999999999999999875432 2333467888999999998 99999999988554 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+++++|.+++.+.. .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999999998764 499999999999999999999999999999999999999999999999999887654321
Q ss_pred ---------------------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc
Q 043248 164 ---------------------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS 222 (1092)
Q Consensus 164 ---------------------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~ 222 (1092)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 22346789999999998888999999999999999999999999987765555555433
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhChhh
Q 043248 223 SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSA----SELLKHPFL 262 (1092)
Q Consensus 223 ~i~plPs~iS~eLkDLIrkcLqkDPskRPSa----eELLqHPwF 262 (1092)
. ..++..+++.+.+||.+||+.+|.+||++ +++++||||
T Consensus 238 ~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 E-YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred C-CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2 24566789999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.09 Aligned_cols=255 Identities=32% Similarity=0.503 Sum_probs=204.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcC--CCcEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRA--EKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYVC 82 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~--tGk~VAIKkIkks~-~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~ly 82 (1092)
+|++.+.||+|+||.||+|.++. ++..||+|.+.... ........+.+|+.+++.++||||++++++|... +..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 59999999999999999999988 89999999987643 1122235677899999999999999999999766 25789
Q ss_pred EEEeecCCCCHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC----CCCEEEeecCcc
Q 043248 83 IVTGYCEGGDMAELMKKSN---GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK----DQDVRLGDFGLA 155 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~---gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~----dG~LKLiDFGLA 155 (1092)
+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 7887776432 225899999999999999999999999999999999999999 889999999999
Q ss_pred cccccccc----CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHH---------HHHHhh-
Q 043248 156 KTLKADDL----ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG---------LISKIN- 220 (1092)
Q Consensus 156 ~~l~~d~~----~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d---------li~kI~- 220 (1092)
........ .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+..... .+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643321 234578899999998866 457899999999999999999999997643221 000000
Q ss_pred ------------------------ccCCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 221 ------------------------RSSIGPLP-----------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 221 ------------------------~~~i~plP-----------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.......+ ...+.++.++|.+||+.||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.27 Aligned_cols=253 Identities=29% Similarity=0.457 Sum_probs=209.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|++.+.||.|+||.||+|.+..+|..||+|.+....... ....+.+|+.++++++|+||++++++|...+ .+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-TPSTAIREISLMKELKHENIVRLHDVIHTEN-KLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-chHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-cEEEEEe
Confidence 5999999999999999999999999999999987653322 2345678999999999999999999997655 6789999
Q ss_pred ecCCCCHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 87 YCEGGDMAELMKKSN-GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 87 YceGGSL~DLLkkk~-gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
|+++ +|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9985 8998887643 2358999999999999999999999999999999999999999999999999997654321 22
Q ss_pred ccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-----------------CC
Q 043248 165 SSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-----------------GP 226 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-----------------~p 226 (1092)
....++..|++||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..... ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 34567899999999865 4578999999999999999999999987765544443321100 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 227 -----------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 227 -----------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
+...++..+.++|.+||+.||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112357789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=333.98 Aligned_cols=255 Identities=19% Similarity=0.309 Sum_probs=214.9
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~ 77 (1092)
...++|++.+.||+|+||.||+|.+.. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 345789999999999999999999987 77889999876432 233345688899999999999999999988665
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEE
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNG-----AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRL 149 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~g-----k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKL 149 (1092)
+ ..|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++ .+||
T Consensus 82 ~-~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 82 L-PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred C-CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 5 56799999999999999986542 2489999999999999999999999999999999999998765 5999
Q ss_pred eecCccccccccccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCC
Q 043248 150 GDFGLAKTLKADDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIG 225 (1092)
Q Consensus 150 iDFGLA~~l~~d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~ 225 (1092)
+|||++......... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999999876432211 12233567999999998899999999999999999996 99999987776666666555555
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..+..++..+.+|+.+||+.+|++||++.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5667789999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=329.85 Aligned_cols=243 Identities=21% Similarity=0.357 Sum_probs=210.0
Q ss_pred EEeecCceEEEEEEE--cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 13 QIGRGAFGAAILVNH--RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 13 kLGkGgFGtVYLA~d--K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
.||+|+||.||+|.+ ..++..+|+|++............+.+|+.+++.+.|+||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence 689999999999965 4567899999987665555566788999999999999999999998743 356799999999
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc----Ccc
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL----ASS 166 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~----~st 166 (1092)
++|.+++.... .+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++........ ...
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999997654 489999999999999999999999999999999999999999999999999987654322 112
Q ss_pred ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......+.+..++.++.+||.+||+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 234578999999988889999999999999999997 9999998877777777776666667778999999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 043248 246 NPEHRPSASELLKH 259 (1092)
Q Consensus 246 DPskRPSaeELLqH 259 (1092)
||.+||++++|.+.
T Consensus 238 ~p~~Rp~~~~i~~~ 251 (257)
T cd05116 238 GVDERPGFAVVELR 251 (257)
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.26 Aligned_cols=255 Identities=28% Similarity=0.503 Sum_probs=209.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..+.+.....||+|+||.||++.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEE
Confidence 3445556678999999999999999999999999886543 23345788999999999999999999988665 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYF--PEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~L--SEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~~l~~ 160 (1092)
||||+.+++|.+++..... .+ ++..+..++.||+.||+|||++||+||||||+||+++. .+.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999999986532 24 78899999999999999999999999999999999976 67899999999876643
Q ss_pred cc-cCccccCCCCcCCchhhccC--CCCccccchhHHHHHHHHHhCCCCCcccChHH-HHHHh-hccCCCCCCCCCCHHH
Q 043248 161 DD-LASSVVGTPNYMCPELLADI--PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-LISKI-NRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 161 d~-~~st~vGTp~YmAPEVL~g~--~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d-li~kI-~~~~i~plPs~iS~eL 235 (1092)
.. ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||....... ..... .......++..++.++
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence 22 23345689999999998654 37899999999999999999999997643221 11111 1222334666788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+|+++||+.+|.+|||+.+++.||||
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=335.42 Aligned_cols=254 Identities=19% Similarity=0.342 Sum_probs=212.1
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~ 77 (1092)
...++|++.+.||+|+||.||+|.++. .+..||+|.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345799999999999999999997652 3567999987654322 2334577899999999999999999998665
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEE
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSN--------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~--------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKL 149 (1092)
+ ..|+||||+.+|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 82 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 82 Q-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred C-CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 5 6789999999999999997632 123467788999999999999999999999999999999999999999
Q ss_pred eecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCC
Q 043248 150 GDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIG 225 (1092)
Q Consensus 150 iDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~ 225 (1092)
+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999886543221 122345678999999998899999999999999999998 78999887777766666655555
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
..+..++..+.+|+.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 566777899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.20 Aligned_cols=253 Identities=28% Similarity=0.526 Sum_probs=214.4
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.|.....||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||+++++.|...+ ..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-ELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-eEEEEE
Confidence 45666788999999999999999999999999986532 233456889999999999999999999986554 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 99 e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred eCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 999999999988643 38999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--CCCCCCHHHHHHHHHh
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--lPs~iS~eLkDLIrkc 242 (1092)
....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....... ....++..+.+||.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 34578999999999998899999999999999999999999998776655544443322111 2234688999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~ 264 (1092)
|..+|.+|||++++++||||..
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhc
Confidence 9999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=328.92 Aligned_cols=249 Identities=22% Similarity=0.406 Sum_probs=213.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||+|.+. .+..+|+|.+....... ..+.+|+.++++++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC--CCcEE
Confidence 4678999999999999999999865 56679999987654332 457889999999999999999988743 34679
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+.+++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999999876555689999999999999999999999999999999999999999999999999987654322
Q ss_pred C--ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 A--SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 ~--st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
. ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+......+.+...+..+.+|+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 1 12345668999999988889999999999999999999 99999887777777777655455566778899999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 043248 241 GMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLq 258 (1092)
+||.++|.+|||+.+++.
T Consensus 238 ~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 238 QCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.95 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=219.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----eEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----CYVC 82 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~~ly 82 (1092)
+|++.+.||.|+||.||+|.+..++..|++|++..........+.+.+|+.+++.++|+||+++++++.... ..+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999999999999998765433444567889999999999999999999887654 4678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999997 48999987654 59999999999999999999999999999999999999999999999999998776543
Q ss_pred ----cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC------------
Q 043248 163 ----LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------ 225 (1092)
Q Consensus 163 ----~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------ 225 (1092)
......++..|+|||++.+. .++.++|+|||||++|+|++|.+||...+.......+......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 23456789999999999887 7899999999999999999999999887765544444321110
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 226 ------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 226 ------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.....++..+.+||.+||+++|.+||+++++++||||+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 011235788999999999999999999999999999987655
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.96 Aligned_cols=258 Identities=27% Similarity=0.479 Sum_probs=209.4
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|+..+.||+|+||.||++.+..++..||+|.+...... .....+.+|+.++.++. |+||+++++++...+ ..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-DCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-cEEEE
Confidence 5778889999999999999999999999999998754333 33556888999999996 999999999886644 67799
Q ss_pred EeecCCCCHHHHH---HHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 85 TGYCEGGDMAELM---KKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 85 MEYceGGSL~DLL---kkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
|||+.+ +|.++. .......+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 655543 333334599999999999999999999974 999999999999999999999999999987654
Q ss_pred cccCccccCCCCcCCchhhccC---CCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhccCCCC----CCCCCC
Q 043248 161 DDLASSVVGTPNYMCPELLADI---PYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRSSIGP----LPSCYS 232 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~---~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~~i~p----lPs~iS 232 (1092)
........|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ...+.++....... ....++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 4444455789999999999765 689999999999999999999999976542 12222222221111 122478
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.++.+||.+||+++|++|||++++++||||+.+.
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 8999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=346.56 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=215.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
..++|++++.||+|+||.||++.+..++..||+|.+............+.+|+.+++.++|+||++++++|....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999999999999999998654444445567889999999999999999999986543
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||||+ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 2468999999 77999888753 3899999999999999999999999999999999999999999999999999866
Q ss_pred cccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------------
Q 043248 159 KADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-------------- 223 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-------------- 223 (1092)
... .....+++.|++||++.+ ..++.++|+|||||++|+|++|..||...+......++....
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 169 DSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred ccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 432 234567899999999876 458899999999999999999999998765443333322110
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 ----------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 ----------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+..+...++..+.++|.+||..||.+|||+.+++.||||+.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00122356788999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=338.99 Aligned_cols=258 Identities=29% Similarity=0.509 Sum_probs=217.7
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
...++|++.+.||+|+||.||++.+..++..|++|.+...... ....+.+|+.+++.++||||++++++|...+ ..|
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~ 92 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLVGD-ELW 92 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeeeCC-cEE
Confidence 3457999999999999999999999989999999998654322 2456888999999999999999999986655 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+|+||+++++|.+++.+.. +++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEecCCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999999999997643 7899999999999999999999999999999999999999999999999887654332
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLI 239 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLI 239 (1092)
......|++.|++||.+.+..++.++|+|||||++|+|++|+.||...+.......+...... ..+..++..+.+||
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 233457889999999998888999999999999999999999999876554433333222211 12344678899999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
++||..+|.+||++.+++.|+||+...
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=327.68 Aligned_cols=247 Identities=28% Similarity=0.529 Sum_probs=205.8
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHH-HHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMAL-IARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqI-LkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||.|+||.||+|.+..+++.||+|.+...... ......+..|..+ ...++|+||++++++|... ..+|+||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-DYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-CeEEEEEeccC
Confidence 6799999999999999999999999998654321 2222334444444 4456899999999998654 47889999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccC
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG 169 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vG 169 (1092)
|++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..... .....|
T Consensus 81 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 81 GGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence 999999998754 389999999999999999999999999999999999999999999999999876543 234568
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCHHHHHHHHHhcccC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTLIKGMLRKN 246 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~eLkDLIrkcLqkD 246 (1092)
+..|++||.+.+..++.++||||||+++|+|++|..||...+.......+...... .....++..+.++|.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 89999999998888999999999999999999999999887776665555443322 233457899999999999999
Q ss_pred CCCCC---CHHHHHhChhhHh
Q 043248 247 PEHRP---SASELLKHPFLQH 264 (1092)
Q Consensus 247 PskRP---SaeELLqHPwFq~ 264 (1092)
|++|| +++|+|.||||..
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHccCCCcHHHHHcChHhhc
Confidence 99999 5589999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.18 Aligned_cols=248 Identities=23% Similarity=0.404 Sum_probs=210.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.+..+ ..||+|++...... ...+.+|+.+++.++|+||+++++++.+ ...|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEE
Confidence 46899999999999999999988655 45999998754332 2467889999999999999999987743 357899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+.+++|.+++.+.....+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999999998765556899999999999999999999999999999999999999999999999999876543321
Q ss_pred --ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 --SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 --st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+.+||.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 23346678999999988899999999999999999999 899998877666666665444344556688999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q 043248 242 MLRKNPEHRPSASELLK 258 (1092)
Q Consensus 242 cLqkDPskRPSaeELLq 258 (1092)
||+.+|.+||++.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=329.97 Aligned_cols=253 Identities=32% Similarity=0.517 Sum_probs=211.9
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEEEEEEe
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYVCIVTG 86 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~lyLVME 86 (1092)
|++.+.||.|+||.||++.+..+++.+|+|.+............+.+|+.++++++|+||+++++++... ....|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999999999999999987643334456688899999999999999999999766 357889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--cC
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LA 164 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--~~ 164 (1092)
|+++ +|.+++.... ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 9975 8999887653 358999999999999999999999999999999999999999999999999998775443 23
Q ss_pred ccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC------------------
Q 043248 165 SSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------------ 225 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------------ 225 (1092)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 34567889999998765 46789999999999999999999999877655544443321100
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 ------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 ------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+...++..+.++|++||..+|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.18 Aligned_cols=249 Identities=22% Similarity=0.420 Sum_probs=214.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.-++|+++++||+|+||.||+|..+ +++.||+|.+...... ...+.+|+.++++++|+||+++++++.. ..+|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEE
Confidence 4578999999999999999999865 5678999998754432 3467889999999999999999988743 35789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+.+++|.+++....+..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999999876666789999999999999999999999999999999999999999999999999987653322
Q ss_pred --CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+......+.+..++.++.++|.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122345678999999998889999999999999999998 99999887776666666655555666778899999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 043248 241 GMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLq 258 (1092)
+||..+|++||++++++.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 238 LCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHccCChhhCCCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=347.50 Aligned_cols=259 Identities=30% Similarity=0.495 Sum_probs=213.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec---CeEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK---GCYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~---d~~ly 82 (1092)
++|++.+.||.|+||.||++.++.++..||+|++............+.+|+.+++.++||||++++++|... ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999999999999999876543333456677899999999999999999887642 35788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9999996 58999887544 38999999999999999999999999999999999999999999999999987654322
Q ss_pred -----cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc--------------
Q 043248 163 -----LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS-------------- 222 (1092)
Q Consensus 163 -----~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~-------------- 222 (1092)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 1234578999999999865 46899999999999999999999999876544332222110
Q ss_pred -----------CCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 223 -----------SIGP-----LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 223 -----------~i~p-----lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.... +...++.++.+||++||+.+|.+||++++++.||||..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000 11336889999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=325.66 Aligned_cols=247 Identities=30% Similarity=0.539 Sum_probs=212.8
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
||.|+||.||++.+..+++.|++|.+..... .......+.+|+.++++++|+||+++++.+.. +..+|+||||+.|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 6899999999999999999999999865433 22445678899999999999999999988854 457889999999999
Q ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc---------c
Q 043248 93 MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---------L 163 (1092)
Q Consensus 93 L~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~---------~ 163 (1092)
|.+++.+.. .+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 80 LASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999998755 48999999999999999999999999999999999999999999999999987654331 1
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCC--CCHHHHHHHHH
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC--YSPSLKTLIKG 241 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~--iS~eLkDLIrk 241 (1092)
.....++..|++||.+.+..++.++||||||+++|+|++|..||...........+..... ..+.. ++..+.+||++
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 236 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISK 236 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHH
Confidence 2345688899999999888899999999999999999999999988877776666655332 23333 38999999999
Q ss_pred hcccCCCCCCCH---HHHHhChhhHh
Q 043248 242 MLRKNPEHRPSA---SELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPSa---eELLqHPwFq~ 264 (1092)
||+.+|.+|||+ .++|+||||..
T Consensus 237 ~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 237 LLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HhcCCHhhcCCCccHHHHhcCccccC
Confidence 999999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.26 Aligned_cols=254 Identities=20% Similarity=0.375 Sum_probs=217.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
.+.+|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.++..++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45678999999999999999998754 35789999987543 2334567889999999999999999999986655
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
..++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||++.+
T Consensus 82 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 82 -PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 6789999999999999986321 1247888999999999999999999999999999999999999
Q ss_pred CCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhh
Q 043248 145 QDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKIN 220 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~ 220 (1092)
+.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999886643321 233456789999999988889999999999999999998 899999888888888887
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.....+.+..++..+.+|+.+||+.+|.+||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 777777788899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.31 Aligned_cols=248 Identities=28% Similarity=0.521 Sum_probs=200.6
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHH---HHHhcCCCCcceEEEEEEecCeEEEEEEeec
Q 043248 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMA---LIARVQHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIq---ILkqL~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
.||+|+||.||++.+..+++.||+|.+...... ......+.+|.. ++....|+||+.++++|...+ .+|+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-KLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-eEEEEEecC
Confidence 489999999999999999999999988654322 111222334443 333457999999999886655 678999999
Q ss_pred CCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcccc
Q 043248 89 EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVV 168 (1092)
Q Consensus 89 eGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~v 168 (1092)
.|++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .....
T Consensus 80 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 80 NGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcC
Confidence 9999999997654 38999999999999999999999999999999999999999999999999987654322 23457
Q ss_pred CCCCcCCchhhc-cCCCCccccchhHHHHHHHHHhCCCCCcccChH--HHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 169 GTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA--GLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 169 GTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~--dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
|+..|+|||.+. +..++.++|||||||++|+|++|..||...... .............++..++.++.++|++||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999986 466899999999999999999999999754321 22222222222345667899999999999999
Q ss_pred CCCCCC-----CHHHHHhChhhHh
Q 043248 246 NPEHRP-----SASELLKHPFLQH 264 (1092)
Q Consensus 246 DPskRP-----SaeELLqHPwFq~ 264 (1092)
||.+|+ ++.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999977
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.69 Aligned_cols=256 Identities=23% Similarity=0.418 Sum_probs=217.0
Q ss_pred CCeEEEEEEeecCceEEEEEEE-----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNH-----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~d-----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
++|.+.+.||+|+||.||++.. ..++..+|+|.+.... ......+.+|+.++++++|+||++++++|... ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-Cc
Confidence 5799999999999999999985 2345678999886432 33456788999999999999999999998654 47
Q ss_pred EEEEEeecCCCCHHHHHHHcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEE
Q 043248 81 VCIVTGYCEGGDMAELMKKSN-----------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~-----------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKL 149 (1092)
+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 789999999999999997543 124899999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCC
Q 043248 150 GDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIG 225 (1092)
Q Consensus 150 iDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~ 225 (1092)
+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999986543321 223345778999999998899999999999999999998 99999888777777777766655
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
..+..++.++.+|+.+||+.+|.+|||+.+++.. |+.+.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~--l~~~~ 280 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL--LQNLA 280 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH--HHHHH
Confidence 6667789999999999999999999999999763 55544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.29 Aligned_cols=252 Identities=19% Similarity=0.361 Sum_probs=212.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcE----EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKK----YVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~----VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
..++|++++.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--
Confidence 356899999999999999999998877764 7899886543 333456788999999999999999999988653
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
..+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 3568999999999999997643 348999999999999999999999999999999999999999999999999998775
Q ss_pred ccccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 160 ADDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 160 ~d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
..... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 43221 12234678999999998899999999999999999998 999998776665555555544445566789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhC
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.++|.+||..||++||++.+++..
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.50 Aligned_cols=249 Identities=20% Similarity=0.368 Sum_probs=212.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||++.+. .++.||+|.+...... .+.+.+|+.++++++|+||+++++++...+ .+|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-PIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCC-Ceeee
Confidence 468999999999999999999975 4578999998754322 356788999999999999999999886554 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+.+++|.+++....+..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999998765556899999999999999999999999999999999999999999999999999877533211
Q ss_pred c--cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 S--SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 s--t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
. ...++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+......+.+..++..+.+++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 1 1123457999999998899999999999999999999 999998877766666665554444566788999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q 043248 242 MLRKNPEHRPSASELLK 258 (1092)
Q Consensus 242 cLqkDPskRPSaeELLq 258 (1092)
||+.+|.+||++.++++
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.17 Aligned_cols=249 Identities=20% Similarity=0.372 Sum_probs=212.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+.++++++||||++++++|.... .+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-PIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCC-CcEEE
Confidence 4689999999999999999998754 456999988654322 346888999999999999999999986554 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+.+++|.+++..... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999999976543 5899999999999999999999999999999999999999999999999998766443221
Q ss_pred c--cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 S--SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 s--t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
. ...++..|++||++.+..++.++|||||||++|+|++ |..||...........+........+...+..+.+++.+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1 2235578999999998889999999999999999998 999998877766666666655555667788999999999
Q ss_pred hcccCCCCCCCHHHHHhC
Q 043248 242 MLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqH 259 (1092)
||..+|.+||++.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=329.84 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=216.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..+|++++.||.|+||.||+|.++. +..+++|.+..... .....+.+|+.+++.++|+||+++++++...+ .+|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCC-CeEEE
Confidence 4579999999999999999999987 88999999875432 23456888999999999999999999886554 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
|||+++++|.+++....+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999999876666689999999999999999999999999999999999999999999999999987654322
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
.....++..|++||++.+..++.++|||||||++|+|++ |+.||...........+......+.+..++..+.++|.+|
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence 122345678999999988899999999999999999998 8999988777777777665555556677899999999999
Q ss_pred cccCCCCCCCHHHHHh
Q 043248 243 LRKNPEHRPSASELLK 258 (1092)
Q Consensus 243 LqkDPskRPSaeELLq 258 (1092)
|+.+|.+|||+.++++
T Consensus 241 l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 241 WAAEPEDRPSFKALRE 256 (261)
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.96 Aligned_cols=258 Identities=31% Similarity=0.506 Sum_probs=212.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---- 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---- 78 (1092)
..+++|++.+.||+|+||.||+|.++.+++.||+|.+............+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4578999999999999999999999999999999998765433333456778999999999999999999886543
Q ss_pred -----eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 79 -----CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 79 -----~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
..+|+||||+++ +|..++.... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 378899999986 7877776542 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc--cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-----
Q 043248 154 LAKTLKADD--LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----- 225 (1092)
Q Consensus 154 LA~~l~~d~--~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----- 225 (1092)
++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 998765432 2223456788999998865 45789999999999999999999999876554444333221100
Q ss_pred ------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 ------------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 ------------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.....++..+.+||.+||..+|.+||++.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.77 Aligned_cols=253 Identities=33% Similarity=0.619 Sum_probs=212.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++|++.+.||+|+||.||++.++.+++.|+||.+..... .......+.+|+.+++.++|+||++++++|...+ .+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~ 79 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNI 79 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEE
Confidence 5789999999999999999999999999999998865432 2334467889999999999999999999987655 7789
Q ss_pred EEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
||||+.|++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999999998742 2235899999999999999999999999999999999999999999999999998876543
Q ss_pred c-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh--HHHHHHhhccCCCCC-CCCCCHHHHH
Q 043248 162 D-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM--AGLISKINRSSIGPL-PSCYSPSLKT 237 (1092)
Q Consensus 162 ~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~--~dli~kI~~~~i~pl-Ps~iS~eLkD 237 (1092)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.+... ......+......+. ...++..+.+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2 22345789999999999988899999999999999999999999976433 233333333333332 2457889999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q 043248 238 LIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLq 258 (1092)
||.+||..+|.+|||+.++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=367.08 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=201.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..+|.+.+.||+|+||.||++.+..+++.||+|.... ..+.+|+.+|++|+|+||+++++++...+ ..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGG-LTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECC-EEEEE
Confidence 3579999999999999999999999999999996432 23567999999999999999999886655 67799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
|||+. ++|..++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 239 ~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 239 LPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 99995 68999887643 359999999999999999999999999999999999999999999999999998764322
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--------hHHHHHHhhccCC--CCCC---
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--------MAGLISKINRSSI--GPLP--- 228 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--------~~dli~kI~~~~i--~plP--- 228 (1092)
......||..|+|||++.+..++.++|||||||+||+|++|..++.... ...+...+..... ..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234579999999999999999999999999999999999876543211 1111111111100 0000
Q ss_pred ----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 229 ----------------------------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 229 ----------------------------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
..++..+.+||.+||++||.+|||+.|+|+||||+
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 12456899999999999999999999999999996
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=349.31 Aligned_cols=253 Identities=23% Similarity=0.441 Sum_probs=210.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCe
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~ 79 (1092)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.++.++ +|+||++++++|...+.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 58999999999999999999754 3457899999875432 23345678899999999 89999999999887777
Q ss_pred EEEEEEeecCCCCHHHHHHHcCC---------------------------------------------------------
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNG--------------------------------------------------------- 102 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~g--------------------------------------------------------- 102 (1092)
.+++||||+.+++|.++|.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 88999999999999999975321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---CccccCCCCcCCch
Q 043248 103 --AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPE 177 (1092)
Q Consensus 103 --k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPE 177 (1092)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..... .....++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 2578999999999999999999999999999999999999999999999999987643221 22345677899999
Q ss_pred hhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHH-HHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 043248 178 LLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG-LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASE 255 (1092)
Q Consensus 178 VL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~d-li~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeE 255 (1092)
++.+..++.++|||||||+||+|++ |..||.+....+ ....+........+..+++++.+++.+||+.+|++||++.+
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 325 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSE 325 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999999999997 999998754333 22333333333455667899999999999999999999999
Q ss_pred HHhC
Q 043248 256 LLKH 259 (1092)
Q Consensus 256 LLqH 259 (1092)
+++|
T Consensus 326 ll~~ 329 (337)
T cd05054 326 LVEI 329 (337)
T ss_pred HHHH
Confidence 9987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.14 Aligned_cols=254 Identities=30% Similarity=0.552 Sum_probs=216.0
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|...+.||.|+||.||++.+..++..+++|++..... .....+.+|+.+++.++|+||++++++|... ...|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-DELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcC-CeEEEEEe
Confidence 45667899999999999999999999999998864332 2345688999999999999999999988654 47789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
|+.|++|.+++... .+++..++.++.||+.||+|||++||+||||+|+||+++.++.++|+|||++....... ...
T Consensus 97 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 99999999999872 38999999999999999999999999999999999999999999999999887654322 223
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC--CCCCCHHHHHHHHHhc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIKGML 243 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl--Ps~iS~eLkDLIrkcL 243 (1092)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........ +..++..+.+||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 45689999999999888899999999999999999999999988776666655554422222 2236889999999999
Q ss_pred ccCCCCCCCHHHHHhChhhHhHh
Q 043248 244 RKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+++|++||++.++++||||....
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.63 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=204.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||+|.+..++..|++|.+...... .....+.+|+.+++.++|+||+++++++... ...|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEE
Confidence 357899999999999999999999999999999998654321 2223567899999999999999999998654 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-c
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-D 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~ 162 (1092)
||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... .
T Consensus 81 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 999996 67877776543 34788999999999999999999999999999999999999999999999998764322 2
Q ss_pred cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChH-HHHHHhhcc------------------
Q 043248 163 LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRS------------------ 222 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~-dli~kI~~~------------------ 222 (1092)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +.+.++...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2334567899999999875 45788999999999999999999999764421 221111100
Q ss_pred ---CC----C-C---CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 223 ---SI----G-P---LP--SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 223 ---~i----~-p---lP--s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.. . . .. ...+..+.+|+.+||..||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 0 0 00 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.60 Aligned_cols=248 Identities=21% Similarity=0.420 Sum_probs=215.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||.|+||.||++... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEE
Confidence 4578999999999999999999864 78899999875533 35678899999999999999999999866 457789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999999999987765568999999999999999999999999999999999999999999999999998774332
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+||.+|
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 23345667999999988889999999999999999997 9999988877776666665544455667899999999999
Q ss_pred cccCCCCCCCHHHHHhC
Q 043248 243 LRKNPEHRPSASELLKH 259 (1092)
Q Consensus 243 LqkDPskRPSaeELLqH 259 (1092)
|..+|++||++.++++.
T Consensus 236 l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 236 WELDPAKRPTFKQLREQ 252 (256)
T ss_pred hccChhhCcCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.76 Aligned_cols=256 Identities=36% Similarity=0.630 Sum_probs=220.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.-+.|++.+.||.|+||.||++.+..++..|++|.+..... ....+.+|+.+++.++|+||++++++|... ...|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEE
Confidence 45679999999999999999999998999999999976543 345678899999999999999999998766 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
|+||++|++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999998764 248999999999999999999999999999999999999999999999999887654322
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC--CCCCCHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIK 240 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl--Ps~iS~eLkDLIr 240 (1092)
......++..|++||++.+..++.++|+|||||++|+|++|..||...+.......+........ +..++..+.+||.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 22345688899999999888899999999999999999999999988766555544443333322 2337889999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||+.+|.+||++.+++.|+||.+
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=343.30 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=207.5
Q ss_pred EEEeec--CceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRG--AFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkG--gFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
..||+| +||+||++.+..+|+.||+|.+..........+.+.+|+.+++.++||||++++++|...+ .+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-WLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-ceEEEEeccc
Confidence 456776 9999999999999999999999766555555678889999999999999999999997655 6789999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc------
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL------ 163 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~------ 163 (1092)
+++|.+++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999999876555689999999999999999999999999999999999999999999999986543321110
Q ss_pred --CccccCCCCcCCchhhccC--CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc-CC--------------
Q 043248 164 --ASSVVGTPNYMCPELLADI--PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS-SI-------------- 224 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~--~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~-~i-------------- 224 (1092)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||............... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 1112356679999999763 4789999999999999999999999875543332222110 00
Q ss_pred -------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 225 -------------------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 225 -------------------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.+....++..+.+||++||+.||++|||+.++|+||||......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 01112356789999999999999999999999999999887764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=330.56 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=213.2
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
|++.+.||.|++|.||++.+..+++.+++|.+............+.+|+.++++++|+||+++++++... ..+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence 7788999999999999999999999999999876654444556788899999999999999999988665 477899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCcc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASS 166 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~st 166 (1092)
+++ +|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 975 8888887654 358999999999999999999999999999999999999999999999999998776543 2334
Q ss_pred ccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--------------------
Q 043248 167 VVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-------------------- 225 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~-------------------- 225 (1092)
..++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.+.++......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5688899999999776 7899999999999999999999999877665554443221100
Q ss_pred ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 ---------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 ---------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.....++.++.+||.+||+.||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.31 Aligned_cols=250 Identities=23% Similarity=0.407 Sum_probs=203.6
Q ss_pred CCCe-EEEEEEeecCceEEEEEE----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-C
Q 043248 5 MDQY-EIMEQIGRGAFGAAILVN----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-G 78 (1092)
Q Consensus 5 IDrY-eIlKkLGkGgFGtVYLA~----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d 78 (1092)
.++| ++++.||+|+||+||++. ...++..||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4677 999999999999998865 345688899999875432 23446678899999999999999999987654 3
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||||+.+++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 46889999999999999997643 899999999999999999999999999999999999999999999999999876
Q ss_pred ccccc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---------------HHHHHh
Q 043248 159 KADDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---------------GLISKI 219 (1092)
Q Consensus 159 ~~d~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---------------dli~kI 219 (1092)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 54321 12234567799999998888999999999999999999999998643210 011111
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
......+.+..++.++.+|+.+||+.+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111222345567899999999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.59 Aligned_cols=248 Identities=24% Similarity=0.422 Sum_probs=211.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.+|++.+.||+|+||.||++.++ .+..+|+|.+...... ...+.+|+.++++++|+||+++++++...+ ..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-PIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-ceEEEE
Confidence 47899999999999999999886 4678999988644322 245778999999999999999999886554 778999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||++|++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred ecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999986543 58999999999999999999999999999999999999999999999999987664332211
Q ss_pred --cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 166 --SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 166 --t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+........+..++.++.+|+.+|
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 1223457999999998899999999999999999998 8999988777777777665555556677899999999999
Q ss_pred cccCCCCCCCHHHHHhC
Q 043248 243 LRKNPEHRPSASELLKH 259 (1092)
Q Consensus 243 LqkDPskRPSaeELLqH 259 (1092)
|..+|++|||+.++++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.52 Aligned_cols=249 Identities=22% Similarity=0.400 Sum_probs=211.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++...||+|+||.||++.+... ..+|+|.+..... ....+.+|+.+++.++|+|++++++++.. ...|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEE
Confidence 457899999999999999999987655 4689998765432 23567889999999999999999988743 35679
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+.+++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999999876555689999999999999999999999999999999999999999999999999986643321
Q ss_pred --CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+......+.+..++..+.+|++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 122346678999999988889999999999999999999 99999887766666666555444556678899999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 043248 241 GMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLq 258 (1092)
+||.++|.+||+++++++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=353.72 Aligned_cols=253 Identities=23% Similarity=0.417 Sum_probs=207.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC-----CcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE-----KKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t-----Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.+... +..||+|++...... .....+.+|+.+++.+ +|+||++++++|...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 45799999999999999999986543 357999999754333 2356688999999999 8999999999986655
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------------------------------------------------------- 101 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------------------------------------------------------- 101 (1092)
.+|+|||||.+|+|.+++....
T Consensus 116 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 116 -PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred -CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 6789999999999999986532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---Cccc
Q 043248 102 -----------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSV 167 (1092)
Q Consensus 102 -----------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~---~st~ 167 (1092)
...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12378889999999999999999999999999999999999999999999999986543321 1123
Q ss_pred cCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhcc-CCCCCCCCCCHHHHHHHHHhccc
Q 043248 168 VGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRS-SIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 168 vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~-~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
.++..|+|||++.+..++.++|||||||++|+|++ |+.||............... .....+..+++++.++|.+||+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 354 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNL 354 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCC
Confidence 35567999999998899999999999999999997 99999876543333333322 22334556789999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 043248 246 NPEHRPSASELLKH 259 (1092)
Q Consensus 246 DPskRPSaeELLqH 259 (1092)
||.+|||+.++++.
T Consensus 355 dp~~RPs~~~l~~~ 368 (374)
T cd05106 355 EPTERPTFSQISQL 368 (374)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.40 Aligned_cols=258 Identities=24% Similarity=0.432 Sum_probs=212.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.-++|++.+.||+|+||.||++.+..+++.||+|++............+.+|+.++++++|+||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 458999999999999999999999999999999998765433444566888999999999999999999886432
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|++++++ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3467888887 77999888653 3899999999999999999999999999999999999999999999999998765
Q ss_pred cccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------------
Q 043248 159 KADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-------------- 223 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-------------- 223 (1092)
... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 171 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred ccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 432 345678999999999866 568899999999999999999999997655443333221100
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 ----------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 ----------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
........+..+.+||.+||+.||.+|+++.+++.||||+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 00011235788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=319.65 Aligned_cols=249 Identities=24% Similarity=0.432 Sum_probs=216.6
Q ss_pred eEEEEEEeecCceEEEEEEEcCCC----cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEK----KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tG----k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++.+.||.|+||.||++.+...+ ..||+|.+....... ....+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEE
Confidence 467899999999999999998766 889999986553322 456788999999999999999999998765 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
+|||+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999875543389999999999999999999999999999999999999999999999999987765432
Q ss_pred Ccc--ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 ASS--VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 ~st--~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
... ..++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+........+..++.++.+++.
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML 238 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 221 336789999999988889999999999999999998 89999888877777777766666677778999999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 043248 241 GMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLq 258 (1092)
+||..+|++|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 239 QCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHCcCChhhCcCHHHHHh
Confidence 999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=357.59 Aligned_cols=258 Identities=31% Similarity=0.604 Sum_probs=232.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.|++|..+++||+|.||.|-+|+.+.+++.||||++++.... ......-..|-.+|+..+||.+..|...|+.++ .+|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-rlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-RLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-eEE
Confidence 578999999999999999999999999999999999765432 233445667889999999999999998886655 899
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc-cccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~-l~~d 161 (1092)
+||||..||.|+-.|.+... |++..++.|-..|+.||.|||+++||+||||.+|+|+|++|++||+|||+++. +..+
T Consensus 245 FVMeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 99999999999999987654 99999999999999999999999999999999999999999999999999985 4556
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....+.||||.|+|||++....|+..+|.|.+||++|||++|+.||...+...++..|....+ .+|..++++++.|+..
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-KFPRTLSPEAKTLLSG 401 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-cCCccCCHHHHHHHHH
Confidence 678899999999999999999999999999999999999999999999998888888876655 4788999999999999
Q ss_pred hcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
+|.+||.+|. .+.|+.+|+||..+
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999996 48899999999653
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.79 Aligned_cols=258 Identities=22% Similarity=0.412 Sum_probs=215.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC-------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA-------EKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~-------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e 76 (1092)
.++|.+.+.||+|+||.||++.+.. +...+|+|.+..... ......+.+|+.+++.+ +|+||++++++|..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3789999999999999999998643 235699999875432 33345688899999999 79999999999866
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
.+ .+|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||++|++||||||+|||++
T Consensus 96 ~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 96 DG-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred CC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 55 67899999999999999986432 2478899999999999999999999999999999999999
Q ss_pred CCCCEEEeecCccccccccccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.++|+|||++......... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 9999999999998766432211 12234568999999998889999999999999999998 8999988777666666
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+........+..++.++.+||.+||..+|.+||++.+++++ |..+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~--l~~~~ 300 (307)
T cd05098 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIL 300 (307)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHHH
Confidence 66555556677789999999999999999999999999986 54443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.56 Aligned_cols=254 Identities=30% Similarity=0.534 Sum_probs=214.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.-|.....||+|+||.||++.+..++..||+|.+...... ....+.+|+.+++.+.||||++++++|...+ .+|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-ELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCC-eEEEEE
Confidence 3455667899999999999999999999999998654322 2456788999999999999999999886654 778999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~ 164 (1092)
||+++++|..++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 999999999988653 38999999999999999999999999999999999999999999999999987654332 23
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHHHh
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIrkc 242 (1092)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+...... .....++..+.++|.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 3467899999999999889999999999999999999999999877665555544332211 12335688999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHhH
Q 043248 243 LRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~~ 265 (1092)
|+.+|.+||++.++++||||...
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccC
Confidence 99999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.59 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=212.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCc---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk---~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++.+.||+|+||.||+|.++.++. .+|+|.+..... ......+.+|+.++++++||||+++++++... ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-Ccc
Confidence 4689999999999999999999875543 689998865432 33456788999999999999999999998654 478
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 899999999999999987543 4899999999999999999999999999999999999999999999999999876543
Q ss_pred cc--C--ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 162 DL--A--SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 162 ~~--~--st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
.. . ....++..|++||++.+..++.++|+|||||++|+|++ |..||......+....+......+.+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 21 1 11223567999999998899999999999999999886 9999988776666666665544455666789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLq 258 (1092)
+++.+||+++|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=367.28 Aligned_cols=261 Identities=30% Similarity=0.515 Sum_probs=230.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+.|+..+.||+||||.||.++-+.+|+.||+|++.+.+.... ......+|-.||.+++.+.||.+-..|... ..+|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-d~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-DALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-CceE
Confidence 35788999999999999999999999999999999866544332 345678899999999999999998777554 4899
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||..|.||+|...|...+...|++..++.|+.+|+.||++||+.+||+|||||+|||||+.|+++|+|+|||..+..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999999999887789999999999999999999999999999999999999999999999999999999988
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc---cCCCCCCCCCCHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR---SSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~---~~i~plPs~iS~eLkDLI 239 (1092)
.....+||.+|||||++.+..|++..|+|||||+||+|+.|+.||.......-...+.+ .....++..+|+++++|.
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc 421 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLC 421 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHH
Confidence 88888999999999999999999999999999999999999999987654433323322 223356788999999999
Q ss_pred HHhcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 240 KGMLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 240 rkcLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
+.+|++||.+|. .++++.+||||+.+
T Consensus 422 ~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 422 EGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 999999999996 57899999999764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.06 Aligned_cols=248 Identities=27% Similarity=0.528 Sum_probs=202.0
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHH---HHHHHhcCCCCcceEEEEEEecCeEEEEEEeec
Q 043248 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQE---MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rE---IqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
.||+|+||.||++.+..+++.||+|.+....... .....+..| +.+++...||||+.++++|...+ .+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-EEEEEEecC
Confidence 4899999999999999999999999987543221 111122233 34555568999999999886655 788999999
Q ss_pred CCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcccc
Q 043248 89 EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVV 168 (1092)
Q Consensus 89 eGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~v 168 (1092)
.|++|..++.... .+++..++.|+.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+... ......
T Consensus 80 ~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 80 NGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcC
Confidence 9999999987654 4899999999999999999999999999999999999999999999999998765432 233457
Q ss_pred CCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccC---hHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 169 GTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---MAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 169 GTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d---~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.... ..... .........++..++..+.++|.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 9999999999974 468999999999999999999999998652 22222 222222334566689999999999999
Q ss_pred cCCCCCC-----CHHHHHhChhhHhH
Q 043248 245 KNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 245 kDPskRP-----SaeELLqHPwFq~~ 265 (1092)
.+|.+|+ ++.++++||||..+
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCccccCC
Confidence 9999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.00 Aligned_cols=254 Identities=28% Similarity=0.526 Sum_probs=214.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..+|++.+.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.++||||++++++|...+ ..|+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEEE
Confidence 457999999999999999999999999999999986543 23334467889999999999999999999997655 6789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+. |+|.+++..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 999997 578777765433 4899999999999999999999999999999999999999999999999998765432
Q ss_pred CccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC-CCCCCHHHHHHH
Q 043248 164 ASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL-PSCYSPSLKTLI 239 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl-Ps~iS~eLkDLI 239 (1092)
....|+..|+|||++. ...++.++||||||+++|+|++|..||...+.......+........ +..++..+.+||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 3457889999999884 45688999999999999999999999988776655555443322222 334788999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+||..+|.+||++.+++.||||..
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHhcCChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.10 Aligned_cols=253 Identities=22% Similarity=0.414 Sum_probs=207.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEE-----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNH-----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~d-----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.+ ..++..||+|++..... ......+.+|+.++..+ +||||++++++|...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34899999999999999999974 34567899999865432 22345788999999999 8999999999986655
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCC--------------------------------------------------------
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNG-------------------------------------------------------- 102 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~g-------------------------------------------------------- 102 (1092)
..|+|||||+||+|.+++.....
T Consensus 113 -~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 113 -PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred -cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 67899999999999999975321
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc--
Q 043248 103 -----------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-- 163 (1092)
Q Consensus 103 -----------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~-- 163 (1092)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 2478889999999999999999999999999999999999999999999999986643321
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHH-HHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG-LISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~d-li~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+........+...+.++.+||.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 351 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK 351 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence 112335567999999999999999999999999999997 899997754333 33333333333445667889999999
Q ss_pred HhcccCCCCCCCHHHHHhC
Q 043248 241 GMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqH 259 (1092)
+||+.||++||++.++++.
T Consensus 352 ~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.55 Aligned_cols=254 Identities=19% Similarity=0.307 Sum_probs=215.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
-++|++.+.||+|+||.||+|.+.. .+..|++|.+... ........+.+|+.+++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4689999999999999999999876 3577888887643 3344456788999999999999999999988776667
Q ss_pred EEEEEeecCCCCHHHHHHHcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNG------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~g------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
.++++||+.+++|.+++..... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 8899999999999999976432 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCC
Q 043248 155 AKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSC 230 (1092)
Q Consensus 155 A~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~ 230 (1092)
++.+..... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+...+...+........+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPIN 243 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCc
Confidence 986643321 123346778999999998889999999999999999998 9999988776666665555444344556
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
++.++.+++.+||..+|++|||+.++++.
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 272 (280)
T cd05043 244 CPDELFAVMACCWALDPEERPSFSQLVQC 272 (280)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.08 Aligned_cols=243 Identities=21% Similarity=0.363 Sum_probs=207.1
Q ss_pred EEEeecCceEEEEEEEcCCC---cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeec
Q 043248 12 EQIGRGAFGAAILVNHRAEK---KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tG---k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
+.||+|+||.||+|.+...+ ..||+|.+...... .....+.+|+.+++++.|+||+++++++.. ..+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeC
Confidence 47999999999999876655 78999998765443 345678899999999999999999998743 3578999999
Q ss_pred CCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc---
Q 043248 89 EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS--- 165 (1092)
Q Consensus 89 eGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s--- 165 (1092)
.+++|.+++.... .+++..++.++.||+.||+|||.+|++|+||||+|||++.++.+||+|||++..........
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999998755 48999999999999999999999999999999999999999999999999998765432211
Q ss_pred -cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 166 -SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 166 -t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+......+.+..++..+.+||.+||
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 235 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW 235 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence 1123467999999998899999999999999999997 99999887776666666655555566778899999999999
Q ss_pred ccCCCCCCCHHHHHhC
Q 043248 244 RKNPEHRPSASELLKH 259 (1092)
Q Consensus 244 qkDPskRPSaeELLqH 259 (1092)
..+|++||++.++++.
T Consensus 236 ~~~p~~Rp~~~~l~~~ 251 (257)
T cd05060 236 KYRPEDRPTFSELEST 251 (257)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.90 Aligned_cols=258 Identities=25% Similarity=0.462 Sum_probs=210.2
Q ss_pred CeEEEEEEeecCceEEEEEEEcCC--CcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec---CeE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAE--KKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK---GCY 80 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~t--Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~---d~~ 80 (1092)
+|++.+.||+|+||.||++.+... +..||+|++............+.+|+.+++++ +|+||+++++++... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 599999999999999999999888 89999999875433333455678899999999 599999999875432 245
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+++||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 789999986 58999987544 489999999999999999999999999999999999999999999999999986543
Q ss_pred cc-----cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc------------
Q 043248 161 DD-----LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS------------ 222 (1092)
Q Consensus 161 d~-----~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~------------ 222 (1092)
.. ......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 1234578999999998765 56899999999999999999999999876543333221110
Q ss_pred ------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 223 ------------------SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 223 ------------------~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+......++..+.+||.+||+.+|.+|||+.+++.||||.++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 001112235789999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=324.64 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=212.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCc---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk---~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
++.|++.+.||+|+||.||+|.++.+++ .||+|.+.... .......+..|+.++++++||||+++++++... ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-Cce
Confidence 5679999999999999999999887765 59999886542 344456789999999999999999999988554 467
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
++||||+++++|.+++....+ .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 899999999999999986543 4899999999999999999999999999999999999999999999999998765433
Q ss_pred ccCcc---cc---CCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHH
Q 043248 162 DLASS---VV---GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 162 ~~~st---~v---GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~e 234 (1092)
..... .. ++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+......+.+..++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 21111 11 2357999999998899999999999999999886 99999887777666666554444555667899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+.+++.+||..+|.+||++.+++..
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=320.72 Aligned_cols=251 Identities=23% Similarity=0.394 Sum_probs=215.3
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
--.++|++.+.||+|+||.||++.+. .+..|++|.+...... ...+.+|+.++++++|+||+++++++... ..++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEE-EPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecC-CceE
Confidence 34679999999999999999999975 4577999988754332 35678899999999999999999988554 4678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999987665568999999999999999999999999999999999999999999999999988765322
Q ss_pred c--CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 043248 163 L--ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 163 ~--~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLI 239 (1092)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+........++......+.+...+.++.+++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM 237 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 112234568999999998889999999999999999998 9999988777777777766544556666789999999
Q ss_pred HHhcccCCCCCCCHHHHHh
Q 043248 240 KGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLq 258 (1092)
.+||..+|.+||++.++++
T Consensus 238 ~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.38 Aligned_cols=245 Identities=25% Similarity=0.436 Sum_probs=202.9
Q ss_pred CCCCeEEEEEE--eecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQI--GRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkL--GkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
..++|++.+.+ |+|+||.||++.++.++..+|+|.+........ |+.....+ +|+||++++++|...+ .
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~-~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLK-G 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCC-e
Confidence 45678887776 999999999999999999999999865432211 22222222 6999999999997765 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCcccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLK 159 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~ 159 (1092)
+|+||||++|++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 889999999999999998764 489999999999999999999999999999999999999988 99999999987665
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH-----HHHHhhccCCCCCCCCCCHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-----LISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d-----li~kI~~~~i~plPs~iS~e 234 (1092)
.. ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... +.... ......+..+++.
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 236 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKN 236 (267)
T ss_pred CC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHH
Confidence 33 23468999999999999899999999999999999999999997543221 11111 2222344568999
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHhChhhH
Q 043248 235 LKTLIKGMLRKNPEHRPS-ASELLKHPFLQ 263 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPS-aeELLqHPwFq 263 (1092)
+.+||.+||+.+|.+|++ ++++|+||||+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999996
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=330.28 Aligned_cols=253 Identities=21% Similarity=0.380 Sum_probs=214.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
...+|.+.+.||+|+||.||++.+. .++..+++|.+.... ......+.+|+.++++++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3568999999999999999999854 345668888875432 233456889999999999999999999986544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
..++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 81 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 67899999999999999976431 348899999999999999999999999999999999999999
Q ss_pred CCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhh
Q 043248 145 QDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKIN 220 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~ 220 (1092)
+.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999997654332 1233456788999999999899999999999999999998 999998877777777666
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.......+..++..+.+|+.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 665555666788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.31 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=215.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC---- 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~---- 79 (1092)
.-++|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+++++.|+||++++++|...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3468999999999999999999999999999999986543334445667889999999999999999988765442
Q ss_pred -EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 80 -YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 80 -~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.+|+|+||+ +++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 478999999 56999998753 3899999999999999999999999999999999999999999999999999876
Q ss_pred cccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC------------
Q 043248 159 KADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------ 225 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------ 225 (1092)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 543 345678999999999865 46789999999999999999999999876655444433221100
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 226 ------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 226 ------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.....++..+.+||.+||+.+|.+|||+.++++||||..+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 011235889999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.94 Aligned_cols=257 Identities=20% Similarity=0.327 Sum_probs=211.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcE----EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKK----YVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~----VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
..++|++++.||+|+||.||+|.+..++.. +++|.+... ........+..|+.++..+.||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--C
Confidence 357899999999999999999999877764 666766432 222334567788889999999999999998743 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
..++|+||+.+|+|.+++....+ .+++..++.|+.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 46789999999999999986543 48999999999999999999999999999999999999999999999999998664
Q ss_pred ccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 160 ADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 160 ~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
... ......++..|++||++.+..++.++|||||||++|+|++ |..||.+.........+........+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 332 1223456778999999998899999999999999999998 999998876655545454444444556678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+++.+||..+|.+|||+.++++. |..+.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~--l~~~~ 269 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANE--FTRMA 269 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH--HHHHH
Confidence 999999999999999999999874 44433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=378.19 Aligned_cols=255 Identities=36% Similarity=0.611 Sum_probs=224.8
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.|.|+..||.|+||.||+|.++.++-..|.|.+... .+.....+.-|+.||..+.||+||+|++.|...+ .+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEEEE
Confidence 4578899999999999999999999988888988643 3344567888999999999999999999875544 688999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-ccccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-ADDLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d~~~ 164 (1092)
|||.||-...++...+. .|++.+|..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+.... .....
T Consensus 109 EFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999999987654 59999999999999999999999999999999999999999999999999876543 23345
Q ss_pred ccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--CCCCCCHHHHH
Q 043248 165 SSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSCYSPSLKT 237 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--lPs~iS~eLkD 237 (1092)
..++|||+|||||+.. ..+|++++||||||++|.+|..+.+|....+....+-+|.+...+. .|+.|+..|.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 6789999999999874 5789999999999999999999999999888888888887765543 46789999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
|+++||.+||..||++.++|+||||+.
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCccccc
Confidence 999999999999999999999999974
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.69 Aligned_cols=254 Identities=39% Similarity=0.762 Sum_probs=214.3
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc---ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR---QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~---~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+|.+.+.||+|+||.||++.+...+..+++|.++... ........+.+|+.+++.++||||+++++++.... ..|+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence 6999999999999999999998877777776654322 12222345667899999999999999999886554 6789
Q ss_pred EEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
||||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999998642 2345899999999999999999999999999999999999974 67999999998776433
Q ss_pred -ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 162 -DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 162 -~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+........+..++.++.++|.
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 2334566899999999998888999999999999999999999999877766666666655555566778899999999
Q ss_pred HhcccCCCCCCCHHHHHhChhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwF 262 (1092)
+||..+|++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=322.32 Aligned_cols=252 Identities=20% Similarity=0.348 Sum_probs=213.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCc---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk---~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|+..+.||+|+||.||+|.++.++. .+++|++..... ......+.+|+.++++++|+||+++++++...+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-PA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-Cc
Confidence 4589999999999999999999876655 689998865432 333567889999999999999999999986554 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 82 MIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 89999999999999997654 34899999999999999999999999999999999999999999999999998766432
Q ss_pred ccC----ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 162 DLA----SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 162 ~~~----st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.......+...+......+.+..++.++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 211 11123457999999988889999999999999999997 9999988777777777766555555666789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhC
Q 043248 237 TLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqH 259 (1092)
+|+.+||+.+|.+||++.++++.
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.24 Aligned_cols=252 Identities=31% Similarity=0.512 Sum_probs=210.1
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEEEe
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
|++.+.||+|+||.||+|....+++.|++|.+....... ......+|+..+++++ |+||++++++|.. +...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEe
Confidence 789999999999999999999999999999986543322 1234457899999999 9999999999866 457889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st 166 (1092)
|+ +++|.+++....+..+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 78999999876545689999999999999999999999999999999999999999999999999987765555556
Q ss_pred ccCCCCcCCchhhc-cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC---------------------
Q 043248 167 VVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI--------------------- 224 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i--------------------- 224 (1092)
..|+..|+|||++. +..++.++|+||||+++|+|++|++||......+...++.....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 77899999999884 45578999999999999999999999987665444433321100
Q ss_pred --------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 225 --------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 225 --------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.......+..+.+||++||+.+|++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00111236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.75 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=211.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----e
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-----C 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-----~ 79 (1092)
.++|.+.+.||+|+||.||+|.+..++..||+|++......+.....+.+|+.+++.++|+||++++++|.... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47999999999999999999999999999999998754433434456789999999999999999999986543 2
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+.. +|..++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 46899999964 7776652 238999999999999999999999999999999999999999999999999987654
Q ss_pred ccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC---------------
Q 043248 160 ADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS--------------- 223 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~--------------- 223 (1092)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 169 AE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred CC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 32 334578899999999866 568999999999999999999999998866544433322110
Q ss_pred -------CC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 -------IG--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 -------i~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.. .....++..+.+||.+||+.||.+||++++++.||||+.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 011235778999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.89 Aligned_cols=248 Identities=29% Similarity=0.524 Sum_probs=209.4
Q ss_pred EEEEEEeecCceEEEEEEEc----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 9 EIMEQIGRGAFGAAILVNHR----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.+.+.||.|.||.||.|.+. ..+..|+||.+... ........+.+|+.++++++||||+++++++...+ .+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-PLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-SEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccc-ccccc
Confidence 57899999999999999988 45678999999543 33444678899999999999999999999998544 47799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||||.+|+|.++|.......+++..+..|+.||+.||.|||+++|+|++|++.|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999998745569999999999999999999999999999999999999999999999999998773221
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
......+...|+|||++.+..++.++||||||+++|||++ |+.||...+......++........+..++..+.++|.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence 2233456778999999998889999999999999999999 78999988888888888776666677788999999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 043248 241 GMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLq 258 (1092)
+||..+|.+||++.++++
T Consensus 240 ~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHT-SSGGGS--HHHHHH
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=321.89 Aligned_cols=245 Identities=22% Similarity=0.398 Sum_probs=210.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++||||+++++++.... .|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG--LYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC--cEE
Confidence 45789999999999999999986 467889999986532 2356788999999999999999999986543 679
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+.+++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999998766556899999999999999999999999999999999999999999999999998765422
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...........+........+..++..+.+|+.+|
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence 223344678999999988889999999999999999997 9999988877776666665544445567889999999999
Q ss_pred cccCCCCCCCHHHHHh
Q 043248 243 LRKNPEHRPSASELLK 258 (1092)
Q Consensus 243 LqkDPskRPSaeELLq 258 (1092)
|+.+|.+||++.+++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.40 Aligned_cols=260 Identities=31% Similarity=0.494 Sum_probs=214.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec-CeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~-d~~l 81 (1092)
..++|++.+.||+|+||.||+|.+..++..+|+|++............+.+|+.+++++ +|+||++++++|... ...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45789999999999999999999998999999998865433333445677899999999 999999999988654 4468
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+. ++|..++... .+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 89999997 4999998764 4889999999999999999999999999999999999999999999999999866433
Q ss_pred c------cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc------------
Q 043248 162 D------LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS------------ 222 (1092)
Q Consensus 162 ~------~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~------------ 222 (1092)
. ....+.|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 2 2234578999999998854 56789999999999999999999999876544333222111
Q ss_pred ---------------C---CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 223 ---------------S---IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 223 ---------------~---i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. .......++.++.+||.+||+.+|.+|||+.++++||||+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 0 00111236889999999999999999999999999999988644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=342.13 Aligned_cols=255 Identities=30% Similarity=0.459 Sum_probs=207.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC------
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG------ 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d------ 78 (1092)
-++|++.+.||.|+||.||+|.++.++..||+|++..... ...+.+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4799999999999999999999999999999999866543 23456888999999999999999998775443
Q ss_pred -------eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEe
Q 043248 79 -------CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLG 150 (1092)
Q Consensus 79 -------~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLi 150 (1092)
..+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 25789999997 5898888643 3899999999999999999999999999999999999975 4578999
Q ss_pred ecCccccccccc----cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--
Q 043248 151 DFGLAKTLKADD----LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-- 223 (1092)
Q Consensus 151 DFGLA~~l~~d~----~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-- 223 (1092)
|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999997654321 1223468889999998754 567899999999999999999999998765443333321110
Q ss_pred ----------------------CC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 224 ----------------------IG-----PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 224 ----------------------i~-----plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.. .+...++.++.+||.+||+.||.+|||++++|.||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 0123467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=342.42 Aligned_cols=259 Identities=23% Similarity=0.453 Sum_probs=212.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEE-----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNH-----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~d-----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
-++|++.+.||+|+||.||+|.+ ..+++.||||.+..... ......+.+|+.++.++ +|+||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 46899999999999999999984 35678999999875432 23345788899999999 6899999999887777
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCC--------------------------------------------------------
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNG-------------------------------------------------------- 102 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~g-------------------------------------------------------- 102 (1092)
..+|+|||||++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 778899999999999999975321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---CccccCC
Q 043248 103 ---------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGT 170 (1092)
Q Consensus 103 ---------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~---~st~vGT 170 (1092)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 2367888899999999999999999999999999999999999999999999876532211 1223456
Q ss_pred CCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChH-HHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 171 PNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMA-GLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 171 p~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~-dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+........+..+++++.+++..||+.+|.
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~ 324 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 324 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 78999999998899999999999999999996 99999765432 23333333333445666788999999999999999
Q ss_pred CCCCHHHHHhChhhHhHh
Q 043248 249 HRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 249 kRPSaeELLqHPwFq~~~ 266 (1092)
+||++.++++| ++.+.
T Consensus 325 ~Rps~~eil~~--l~~~~ 340 (343)
T cd05103 325 QRPTFSELVEH--LGNLL 340 (343)
T ss_pred hCcCHHHHHHH--HHHHH
Confidence 99999999987 55543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=327.21 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=209.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCC----------------cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEK----------------KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tG----------------k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI 67 (1092)
..++|++++.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.++++++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 4579999999999999999999876544 5579998875533 2445678899999999999999
Q ss_pred ceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 043248 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSN---------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSN 138 (1092)
Q Consensus 68 VKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~---------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPEN 138 (1092)
++++++|... ..+++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+|+||||+|
T Consensus 82 ~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 82 ARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999998665 47789999999999999997654 1248999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh--CCCCCcccChH
Q 043248 139 IFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA--HRPAFKAFDMA 213 (1092)
Q Consensus 139 ILLD~dG~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT--Gr~PF~g~d~~ 213 (1092)
|+++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999988654332 1223456778999999988889999999999999999997 77888776655
Q ss_pred HHHHHhhcc-------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 214 GLISKINRS-------SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 214 dli~kI~~~-------~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
..+..+... ...+.+..++.++.+||.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 555544322 112234456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=332.57 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=200.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCHHHHH
Q 043248 18 AFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM 97 (1092)
Q Consensus 18 gFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLL 97 (1092)
++|.||.+....+++.||+|++............+.+|+.+++.++|+||++++++|...+ ..|++|||+.+++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-eEEEEEeccCCCCHHHHH
Confidence 4456677777779999999999876444555678999999999999999999999986655 678999999999999999
Q ss_pred HHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--------cCccccC
Q 043248 98 KKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--------LASSVVG 169 (1092)
Q Consensus 98 kkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--------~~st~vG 169 (1092)
.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+....... ......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 87655568999999999999999999999999999999999999999999999999887553221 1233457
Q ss_pred CCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccChHHHH-HHhhccCC----------------------
Q 043248 170 TPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLI-SKINRSSI---------------------- 224 (1092)
Q Consensus 170 Tp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli-~kI~~~~i---------------------- 224 (1092)
+..|+|||++.+ ..|+.++|||||||++|+|++|..||......... .++.....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 888999999966 45889999999999999999999999865433222 22110000
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 225 ----------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 225 ----------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
......++.++.+||.+||..||++|||+.++|+||||+..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 001112356788999999999999999999999999998664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=330.83 Aligned_cols=253 Identities=22% Similarity=0.419 Sum_probs=214.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc-------CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR-------AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK-------~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e 76 (1092)
.++|++.+.||+|+||.||+|.+. ..+..||+|.+.... .....+.+.+|+.+++.+ +||||++++++|..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 468999999999999999999753 234578999886442 233456788999999999 89999999999866
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
.. .+|+||||+.+++|.+++..... ..++...++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 93 DG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred CC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 54 77899999999999999986421 2477888999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....++...
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 999999999999987653321 222345678999999998899999999999999999998 8899988887777777
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+........+..++..+.+||.+||..+|.+||++.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 76655555667789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=327.57 Aligned_cols=251 Identities=22% Similarity=0.385 Sum_probs=211.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
-.+|++.++||+|+||.||++... .++..+++|.+... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR- 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-
Confidence 357889999999999999999742 35678888887643 3344567889999999999999999999886554
Q ss_pred EEEEEEeecCCCCHHHHHHHcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNG-------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD 146 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~g-------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~ 146 (1092)
.+|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 67899999999999999976432 24789999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhcc
Q 043248 147 VRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRS 222 (1092)
Q Consensus 147 LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~ 222 (1092)
++|+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999876543221 223345678999999999899999999999999999998 99999877766666666655
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 223 SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 223 ~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
.....+..+++.+.+||.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 241 RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 444556678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=320.76 Aligned_cols=246 Identities=21% Similarity=0.333 Sum_probs=204.0
Q ss_pred EEEeecCceEEEEEEEcC---CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeec
Q 043248 12 EQIGRGAFGAAILVNHRA---EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~---tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++...+...|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998653 34578999875432 23335678889999999999999999998776666788999999
Q ss_pred CCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-----
Q 043248 89 EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL----- 163 (1092)
Q Consensus 89 eGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~----- 163 (1092)
.+++|.+++..... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 80 KHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 99999999976543 367888899999999999999999999999999999999999999999999976543211
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
.....++..|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+........+..++..+.+++.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 123346778999999988899999999999999999999 5777877776666666655444455666789999999999
Q ss_pred cccCCCCCCCHHHHHhC
Q 043248 243 LRKNPEHRPSASELLKH 259 (1092)
Q Consensus 243 LqkDPskRPSaeELLqH 259 (1092)
|..+|++||++.++++.
T Consensus 239 l~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 239 WHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.38 Aligned_cols=258 Identities=22% Similarity=0.404 Sum_probs=214.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc-------CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR-------AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK-------~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e 76 (1092)
-++|.+.+.||+|+||.||++.+. .....+|+|.+..... ......+.+|+.+++++ +||||++++++|..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 368999999999999999999863 2345789998765432 33355688899999999 69999999998865
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
.+ .+|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~-~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 90 EG-PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred CC-ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 44 6789999999999999997642 13488899999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987653221 112234467999999998899999999999999999998 8999988877777776
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+........+..++.++.+||.+||..+|++|||+.++++. +..+.
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~~ 294 (314)
T cd05099 249 LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA--LDKVL 294 (314)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHH
Confidence 66555445667788999999999999999999999999974 44443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.30 Aligned_cols=256 Identities=21% Similarity=0.377 Sum_probs=217.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCc----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKK----KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk----~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
..++|++.+.||+|+||.||+|.++.++. .+|+|.+..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS--S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 34689999999999999999999877665 588888765432 3345678899999999999999999998865 4
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
..++||||+.+++|.+++..... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 67899999999999999987543 38999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCc---cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 160 ADDLAS---SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 160 ~d~~~s---t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
...... ...++..|+|||.+....++.++|+|||||++|+|++ |..||......++...+......+.+...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 332211 1223567999999988899999999999999999998 999999888777777776655556667788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+++.+||..+|.+||++.++++- |..+
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~--l~~~ 268 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINE--FSKM 268 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH--HHHH
Confidence 999999999999999999999863 5444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.88 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=211.2
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
|++.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++|+||+++++++... ..+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence 7888999999999999999999999999999986643444456678899999999999999999988665 478899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCcc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASS 166 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~st 166 (1092)
++ ++|.+++.+.. ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 97 58999998763 248999999999999999999999999999999999999999999999999998765432 2334
Q ss_pred ccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------------------CC
Q 043248 167 VVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS--------------------IG 225 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~--------------------i~ 225 (1092)
..++..|+|||.+.+. .++.++|||||||++|+|++|.+||........+.++.... ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5667889999998766 78999999999999999999999998766544433332100 00
Q ss_pred --------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 226 --------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 226 --------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.....++..+.++|++||..+|++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0011247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=328.18 Aligned_cols=256 Identities=29% Similarity=0.517 Sum_probs=211.9
Q ss_pred CeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEeccccc--HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQT--ERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~s--e~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
.|++.+.||.|+||.||++.+. .+|..||+|.+...... ....+.+.+|+.+++++ +|+||++++++|... ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-TK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-Ce
Confidence 5899999999999999999875 47899999998754321 12345678899999999 599999999888654 47
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 889999999999999998754 389999999999999999999999999999999999999999999999999987654
Q ss_pred ccc--CccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccCCCCCCCCCC
Q 043248 161 DDL--ASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIGPLPSCYS 232 (1092)
Q Consensus 161 d~~--~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~i~plPs~iS 232 (1092)
... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ..+...+.. ...+.+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 236 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCC
Confidence 322 234568999999999865 3468899999999999999999999974322 222222222 2334566789
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHhChhhHhHh
Q 043248 233 PSLKTLIKGMLRKNPEHRP-----SASELLKHPFLQHFV 266 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRP-----SaeELLqHPwFq~~~ 266 (1092)
..+.+|+++||+.+|++|+ ++++++.||||+.+.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.11 Aligned_cols=245 Identities=34% Similarity=0.627 Sum_probs=214.1
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
||.|+||.||++.+..+++.|++|.+...... ......+..|+.++++++|+||++++++|.. +..+|+||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 69999999999999989999999998765332 2245678889999999999999999998854 457889999999999
Q ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccCccccCCC
Q 043248 93 MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTP 171 (1092)
Q Consensus 93 L~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~st~vGTp 171 (1092)
|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......|+.
T Consensus 80 L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 80 LFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999998764 3899999999999999999999999999999999999999999999999999876543 2344567899
Q ss_pred CcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 043248 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRP 251 (1092)
Q Consensus 172 ~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRP 251 (1092)
.|++||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ....++..++..+.+||++||..||++||
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 99999999888889999999999999999999999987776555555554 33456777899999999999999999999
Q ss_pred CH---HHHHhChhh
Q 043248 252 SA---SELLKHPFL 262 (1092)
Q Consensus 252 Sa---eELLqHPwF 262 (1092)
++ +++++||||
T Consensus 237 ~~~~~~~l~~~~~f 250 (250)
T cd05123 237 GSGGAEEIKAHPFF 250 (250)
T ss_pred CcccHHHHHhCCCC
Confidence 99 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=393.29 Aligned_cols=258 Identities=33% Similarity=0.542 Sum_probs=225.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.-++|.|++.||+|+||.|.+++++.+++.||+|++.+-... ......|..|-.+|..-+.+=|++++..|++.. ++|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~-~LY 151 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER-YLY 151 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-ceE
Confidence 457899999999999999999999999999999998753222 122356888999999888899999999997655 889
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||++||+|..++.+.. .+++..++.|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-.+..+.
T Consensus 152 lVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999999999998876 49999999999999999999999999999999999999999999999999999887554
Q ss_pred c--CccccCCCCcCCchhhc----c-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-CCCC--CCCC
Q 043248 163 L--ASSVVGTPNYMCPELLA----D-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-GPLP--SCYS 232 (1092)
Q Consensus 163 ~--~st~vGTp~YmAPEVL~----g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~plP--s~iS 232 (1092)
. ....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||+..+..+.+.+|....- ..+| ..+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 3 45678999999999994 3 5799999999999999999999999999999999999876421 1234 4589
Q ss_pred HHHHHHHHHhcccCCCCCCC---HHHHHhChhhHhH
Q 043248 233 PSLKTLIKGMLRKNPEHRPS---ASELLKHPFLQHF 265 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPS---aeELLqHPwFq~~ 265 (1092)
.++++||+++|. +|+.|.. ++++..||||...
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 999999999884 6888988 9999999999764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.71 Aligned_cols=259 Identities=20% Similarity=0.398 Sum_probs=215.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC-------CcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE-------KKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWV 75 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t-------Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~ 75 (1092)
...+|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++ +|+||++++++|.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 345899999999999999999986432 2368999876432 333456788999999999 7999999999986
Q ss_pred ecCeEEEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 043248 76 EKGCYVCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL 141 (1092)
Q Consensus 76 e~d~~lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL 141 (1092)
..+ .+|+||||+.+++|.+++.+.. ...++...+..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 89 QDG-PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred cCC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 654 6789999999999999998642 1237788899999999999999999999999999999999
Q ss_pred cCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHH
Q 043248 142 TKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLIS 217 (1092)
Q Consensus 142 D~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~ 217 (1092)
+.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999986653321 122234567999999999999999999999999999998 899999888777777
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 218 KINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 218 kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+........+..++.++.+||.+||+.+|.+||++.+++++ +..+.
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~--l~~~~ 294 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED--LDRVL 294 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHHh
Confidence 776655555667788999999999999999999999999987 54443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.95 Aligned_cols=249 Identities=26% Similarity=0.452 Sum_probs=211.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..+|++.+.||.|+||.||++.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++.... .+|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERS-PICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCC-ceEEE
Confidence 468999999999999999999875 4678999988654332 245778999999999999999999886554 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+.+++|.+++....+ .+++..++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999999999976543 4889999999999999999999999999999999999999999999999998765433211
Q ss_pred --ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 --SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 --st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+...+..+.+|+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 12335578999999988889999999999999999998 999998877777777766554444566678999999999
Q ss_pred hcccCCCCCCCHHHHHhC
Q 043248 242 MLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqH 259 (1092)
||+.+|.+|||+.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=319.24 Aligned_cols=244 Identities=21% Similarity=0.386 Sum_probs=207.1
Q ss_pred EEEeecCceEEEEEEEcC-CC--cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeec
Q 043248 12 EQIGRGAFGAAILVNHRA-EK--KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~-tG--k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
+.||+|+||.||++.+.. .+ ..||+|.+...... ...+.+.+|+.++++++|+||+++++++.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEec
Confidence 468999999999999865 33 36899998765443 456788999999999999999999999876 5788999999
Q ss_pred CCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc----C
Q 043248 89 EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL----A 164 (1092)
Q Consensus 89 eGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~----~ 164 (1092)
++++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+..... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999999876534589999999999999999999999999999999999999999999999999987654221 1
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhcc-CCCCCCCCCCHHHHHHHHHh
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRS-SIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~-~i~plPs~iS~eLkDLIrkc 242 (1092)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+... .....+..++..+.+++.+|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 23457788999999999899999999999999999998 99999877666665555432 22234556789999999999
Q ss_pred cccCCCCCCCHHHHHh
Q 043248 243 LRKNPEHRPSASELLK 258 (1092)
Q Consensus 243 LqkDPskRPSaeELLq 258 (1092)
|+.+|++||++.++++
T Consensus 238 l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 238 WAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCcccCCCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=326.66 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=214.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 35789999999999999999998753 67889999886543 2334567889999999999999999999886544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSN 138 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPEN 138 (1092)
.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 82 -PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred -ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 6789999999999999997532 1247888999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHH
Q 043248 139 IFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG 214 (1092)
Q Consensus 139 ILLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~d 214 (1092)
||++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543321 122345667999999998899999999999999999997 889998877777
Q ss_pred HHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 215 LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 215 li~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
....+......+.+..++.++.+||.+||+.+|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77777666555566778899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.82 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=210.7
Q ss_pred cCCCCeEE-EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH------------HHHHHHHHHHHHHhcCCCCcce
Q 043248 3 SRMDQYEI-MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER------------CRRSAHQEMALIARVQHPYIVE 69 (1092)
Q Consensus 3 sRIDrYeI-lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~------------~~r~f~rEIqILkqL~HPNIVK 69 (1092)
+.-++|.. .+.||.|+||.||+|.++.+++.||+|++........ ....+.+|+.+++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 45578875 5779999999999999999999999999865432210 0124678999999999999999
Q ss_pred EEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEE
Q 043248 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 70 L~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKL 149 (1092)
++++|... ..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|
T Consensus 85 ~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 85 LVDVYVEG-DFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred eeEEEecC-CcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 99998655 47889999997 58999987654 3899999999999999999999999999999999999999999999
Q ss_pred eecCcccccccc---------------ccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChH
Q 043248 150 GDFGLAKTLKAD---------------DLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA 213 (1092)
Q Consensus 150 iDFGLA~~l~~d---------------~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~ 213 (1092)
+|||++...... .......++..|+|||++.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999766511 112234578899999998764 4689999999999999999999999887765
Q ss_pred HHHHHhhccCCC---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 214 GLISKINRSSIG---------------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 214 dli~kI~~~~i~---------------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+....+...... ......+..+.+||.+||+.+|++|||++++|.||||+..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 554443221100 0112347889999999999999999999999999999754
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=327.82 Aligned_cols=255 Identities=20% Similarity=0.374 Sum_probs=211.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... ......+.+|+.+++.++||||+++++.|...+ ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-PL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-Cc
Confidence 58999999999999999998753 235688887764432 333467889999999999999999999986655 67
Q ss_pred EEEEeecCCCCHHHHHHHcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 043248 82 CIVTGYCEGGDMAELMKKSN----------------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNI 139 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~----------------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENI 139 (1092)
|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 79999999999999987531 12478899999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHH
Q 043248 140 FLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGL 215 (1092)
Q Consensus 140 LLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dl 215 (1092)
|++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999976533221 122345678999999988889999999999999999998 9999988777766
Q ss_pred HHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 216 ISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 216 i~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
...+........+..++.++.+|+.+||+.+|.+||++.++++. |+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~--l~~~ 286 (290)
T cd05045 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE--LEKM 286 (290)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH--HHHH
Confidence 66665544445677789999999999999999999999999874 5543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.51 Aligned_cols=243 Identities=21% Similarity=0.377 Sum_probs=205.5
Q ss_pred EEeecCceEEEEEEEc--CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 13 QIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK--~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
.||+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.++++++|+||+++++++.. ..+++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCC
Confidence 4899999999999775 445678999886542 34445678899999999999999999998743 357899999999
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC----cc
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA----SS 166 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~----st 166 (1092)
++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......... ..
T Consensus 79 ~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 79 GPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999987543 34899999999999999999999999999999999999999999999999999865433211 11
Q ss_pred ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
..++..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+...++++.++|.+||.+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 223568999999988889999999999999999996 9999988777777777766665667777899999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 043248 246 NPEHRPSASELLKH 259 (1092)
Q Consensus 246 DPskRPSaeELLqH 259 (1092)
+|++||++.++++.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.40 Aligned_cols=246 Identities=22% Similarity=0.413 Sum_probs=203.4
Q ss_pred EEEeecCceEEEEEEEcCCCcE--EEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeec
Q 043248 12 EQIGRGAFGAAILVNHRAEKKK--YVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~--VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
+.||+|+||.||++.++.++.. +++|.+... ........+.+|+.++.++ +||||++++++|...+ .+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeC
Confidence 3689999999999999887764 577776532 2233456788999999999 8999999999986655 678999999
Q ss_pred CCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 89 EGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 89 eGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
.+++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997643 12478999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCH
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~ 233 (1092)
+..............+..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+........+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 864332211122234567999999988899999999999999999996 9999988777666666655444445566789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
++.+|+.+||..+|.+|||+.++++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.04 Aligned_cols=249 Identities=20% Similarity=0.399 Sum_probs=212.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||++.+. .+..+++|.+... ......+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEE
Confidence 4689999999999999999999864 4567999987643 2234568889999999999999999998866 46789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+++++|.+++.+.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999876555688999999999999999999999999999999999999999999999999976643321
Q ss_pred --CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+.......+......+.+..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 122345677999999988889999999999999999998 99999987777766666655444556678899999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 043248 241 GMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLq 258 (1092)
+||+.+|++||++.++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.80 Aligned_cols=259 Identities=26% Similarity=0.478 Sum_probs=210.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++.+.||+|+||.||++.+..+++.||+|.+....... ....+.+|+.++.++. |+||++++++|.... .+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-DVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCC-eEE
Confidence 5689999999999999999999999889999999987653333 2345566777666664 999999999986654 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
+||||+. ++|..++..... .+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++..+...
T Consensus 91 ~v~e~~~-~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEeeccC-cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9999985 478888776443 58999999999999999999997 59999999999999999999999999999876544
Q ss_pred ccCccccCCCCcCCchhhccCC----CCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhccCCCCC--CCCCCHH
Q 043248 162 DLASSVVGTPNYMCPELLADIP----YGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRSSIGPL--PSCYSPS 234 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~----yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~~i~pl--Ps~iS~e 234 (1092)
.......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... .+....+.......+ ...++.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 4444456888999999987554 78899999999999999999999976332 233333332222222 2347889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+.+||.+||..+|.+||+++++++|+||..+.
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 99999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.14 Aligned_cols=244 Identities=21% Similarity=0.353 Sum_probs=206.2
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGG 91 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGG 91 (1092)
++||+|+||.||++... ++..||+|.+.... .......+.+|+.+++.++||||+++++++...+ ..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCC
Confidence 36899999999999864 68899999886543 2334456889999999999999999999986655 678999999999
Q ss_pred CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc--cccC
Q 043248 92 DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS--SVVG 169 (1092)
Q Consensus 92 SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s--t~vG 169 (1092)
+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++.......... ...+
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9999987654 348999999999999999999999999999999999999999999999999987654332211 2234
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
+..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||+.+|+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 567999999998889999999999999999998 9999988776666666655544455667889999999999999999
Q ss_pred CCCCHHHHHhC
Q 043248 249 HRPSASELLKH 259 (1092)
Q Consensus 249 kRPSaeELLqH 259 (1092)
+||++.++++.
T Consensus 237 ~Rp~~~~l~~~ 247 (250)
T cd05085 237 NRPKFSELQKE 247 (250)
T ss_pred cCCCHHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.74 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=213.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..++|.+.+.||+|+||.||+|.+... ...|+||....... ....+.+.+|+.++++++|+||+++++++... .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN--P 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--C
Confidence 346899999999999999999987654 45688898765432 33456788999999999999999999988543 4
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
.|+||||+++++|.+++..... .+++..++.++.||+.||+|||++|++|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 6799999999999999976543 489999999999999999999999999999999999999999999999999987654
Q ss_pred cccC--ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 161 DDLA--SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 161 d~~~--st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
.... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 4322 12234567999999988889999999999999999986 99999887777766666665555667778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhC
Q 043248 238 LIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqH 259 (1092)
||.+||..+|.+|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.17 Aligned_cols=255 Identities=29% Similarity=0.494 Sum_probs=220.7
Q ss_pred CCCCeEEE-EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec---C
Q 043248 4 RMDQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK---G 78 (1092)
Q Consensus 4 RIDrYeIl-KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~---d 78 (1092)
..++|.+. +.||-|--|.|..|.++.+|+.+|+|++... ....+|+.+.-.. .|||||.++++|... .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 56788885 6699999999999999999999999988643 3455677765555 599999999998532 2
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEEeecCcc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRLGDFGLA 155 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKLiDFGLA 155 (1092)
..+.||||.++||.|+..|+.++...|+|.++..|++||..|+.|||+.+|.||||||+|+|+...+ .+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 4567999999999999999999888899999999999999999999999999999999999997544 5999999999
Q ss_pred ccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC----hHHHHHHhhccCCC---CCC
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSIG---PLP 228 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d----~~dli~kI~~~~i~---plP 228 (1092)
+.........+-|.|++|.|||++...+|+..+|+||+|||+|.||+|.+||+... ..++..+|....+. +..
T Consensus 212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 98887777788899999999999999999999999999999999999999997532 33566666665543 223
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.++|++++++|+++|..+|.+|.|+++++.|||+...
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 4579999999999999999999999999999999753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=337.75 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=212.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.-++|++++.||.|+||.||++.+..+++.||+|++............+.+|+.+++.++||||++++++|...+..+|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 45789999999999999999999999999999998865433333456678899999999999999999999776667889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+ +++|..++... .+++..+..++.||+.||.|||++||+|+||+|.|||++.++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred Eeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 99999 56899888643 3789999999999999999999999999999999999999999999999998765432
Q ss_pred CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc---------------------
Q 043248 164 ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR--------------------- 221 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~--------------------- 221 (1092)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 234578889999998865 5789999999999999999999999976543221111100
Q ss_pred ---c-CCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 222 ---S-SIGP-----LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 222 ---~-~i~p-----lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
. .... ....++..+.++|++||+.+|++||++++++.||||..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0 0000 1124678999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=362.24 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=194.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcE-EEEEE--------------E-ecccccHHHHHHHHHHHHHHHhcCCCCcc
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKK-YVLKK--------------I-RLARQTERCRRSAHQEMALIARVQHPYIV 68 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~-VAIKk--------------I-kks~~se~~~r~f~rEIqILkqL~HPNIV 68 (1092)
+++|++++.||+|+||.||+|..+..... +++|. + +...........+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 57899999999999999999876543222 12221 1 01111223345688999999999999999
Q ss_pred eEEEEEEecCeEEEEEEeecCCCCHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 043248 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSN---GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ 145 (1092)
Q Consensus 69 KL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~---gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG 145 (1092)
+++++|...+ ..|+|++++. ++|..++.... ........++.|+.||+.||.|||++||+||||||+|||++.++
T Consensus 227 ~l~~~~~~~~-~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEA-NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECC-eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999997665 6779999995 57888775432 11234677889999999999999999999999999999999999
Q ss_pred CEEEeecCccccccccc--cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcc-c--ChHHHHHHhh
Q 043248 146 DVRLGDFGLAKTLKADD--LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA-F--DMAGLISKIN 220 (1092)
Q Consensus 146 ~LKLiDFGLA~~l~~d~--~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g-~--d~~dli~kI~ 220 (1092)
.+||+|||++..+.... .....+||..|+|||++.+..|+.++|||||||+||+|++|..++.. . .....+.++.
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 99999999998775432 22346899999999999999999999999999999999998754432 1 1111221111
Q ss_pred cc----------------------CCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 221 RS----------------------SIGPL---------PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 221 ~~----------------------~i~pl---------Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.. .+... ...++..+.++|.+||++||.+|||+.|+|.||||..
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 10 00000 0124567888999999999999999999999999965
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=360.54 Aligned_cols=244 Identities=24% Similarity=0.440 Sum_probs=217.1
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeec
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYc 88 (1092)
++++.||+|.||.||+|.+..+ ..||+|.++..... ...|.+|+++|++|+|+|||+|++++...+ -+||||||+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m 283 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYM 283 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEec
Confidence 4678999999999999998643 47999998754332 356779999999999999999999996655 678999999
Q ss_pred CCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcc--
Q 043248 89 EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS-- 166 (1092)
Q Consensus 89 eGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st-- 166 (1092)
..|+|.++|+...+..+...+...++.||++|++||.++++|||||-..|||++.+..+||+|||||+....+.....
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999999987777899999999999999999999999999999999999999999999999999996554432211
Q ss_pred ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc
Q 043248 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk 245 (1092)
.--...|.|||.+...+|+.++|||||||+||||+| |+.||.+....+.+..+.++...+-|..++.++.+++..||..
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~ 443 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHE 443 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhC
Confidence 122356999999999999999999999999999997 9999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHH
Q 043248 246 NPEHRPSASELL 257 (1092)
Q Consensus 246 DPskRPSaeELL 257 (1092)
+|++|||++.+.
T Consensus 444 ~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 444 DPEDRPTFETLR 455 (468)
T ss_pred CcccCCCHHHHH
Confidence 999999999665
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.94 Aligned_cols=250 Identities=31% Similarity=0.527 Sum_probs=211.5
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
...||+|+||.||++.++.++..||+|++.... ......+.+|+.+++.++|+||++++++|...+ ..|+||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-EEEEEEecCCC
Confidence 467999999999999999999999999886432 233466889999999999999999999987655 77899999999
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCccccC
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVG 169 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~st~vG 169 (1092)
++|.+++... .+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++....... ......|
T Consensus 102 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 102 GALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9999987543 38999999999999999999999999999999999999999999999999987654322 2234578
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--CCCCCCHHHHHHHHHhcccCC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSCYSPSLKTLIKGMLRKNP 247 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--lPs~iS~eLkDLIrkcLqkDP 247 (1092)
+..|++||.+.+..++.++|+|||||++|+|++|..||.+.........+....... ....++..+.++|.+||+.+|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 999999999988889999999999999999999999998776655444443322211 223468899999999999999
Q ss_pred CCCCCHHHHHhChhhHhHh
Q 043248 248 EHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 248 skRPSaeELLqHPwFq~~~ 266 (1092)
.+||++.+++.||||....
T Consensus 259 ~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 259 AQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ccCcCHHHHhcChHHhccC
Confidence 9999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.81 Aligned_cols=251 Identities=20% Similarity=0.388 Sum_probs=205.3
Q ss_pred CeEEEEEEeecCceEEEEEEE----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNH----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~d----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~l 81 (1092)
-|++++.||+|+||.||++.. +.++..||+|.+..... ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478999999999999999974 46788999999865432 33356788999999999999999999988765 3567
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
++||||++|++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999997653 24899999999999999999999999999999999999999999999999999876533
Q ss_pred cc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc---------------ChHHHHHHhhcc
Q 043248 162 DL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF---------------DMAGLISKINRS 222 (1092)
Q Consensus 162 ~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~---------------d~~dli~kI~~~ 222 (1092)
.. .....|+..|+|||++.+..++.++|||||||++|+|++++.|+... ........+...
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 21 22345677899999998888999999999999999999987665321 011111222222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 223 SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 223 ~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
...+.+..++..+.+||.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2334456688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.56 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=203.1
Q ss_pred CCeEEEEEEeecCceEEEEEEE----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNH----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~d----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~ 80 (1092)
.+|++++.||+|+||.||++.. ..++..||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4899999999999999999874 4578899999986542 33456788999999999999999999987543 356
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 8899999999999999976532 489999999999999999999999999999999999999999999999999987654
Q ss_pred cccC----ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH----------------HHHHHhh
Q 043248 161 DDLA----SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA----------------GLISKIN 220 (1092)
Q Consensus 161 d~~~----st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~----------------dli~kI~ 220 (1092)
.... ....++..|+|||++.+..++.++|||||||++|+|++|..++...... .+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 3211 1123445699999999889999999999999999999987766432211 0111112
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.....+.+..++.++.+||.+||..+|++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 222223455678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.20 Aligned_cols=253 Identities=22% Similarity=0.421 Sum_probs=209.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEE-----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNH-----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~d-----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
.++|.+.+.||+|+||.||++.+ ..++..||+|.+..... ......+.+|+.+++++ +|+||++++++|...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 45899999999999999999975 34456899998865432 33346788999999999 7999999999886655
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.+|+||||+.+++|.+++.......+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 113 -~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 113 -PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 6789999999999999998755555899999999999999999999999999999999999999999999999999865
Q ss_pred cccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhc-cCCCCCCCCCCH
Q 043248 159 KADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINR-SSIGPLPSCYSP 233 (1092)
Q Consensus 159 ~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~-~~i~plPs~iS~ 233 (1092)
.... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..........+... ......+...+.
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCH
Confidence 4332 1223356778999999998899999999999999999998 9999987665444333332 222234456789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
++.+|+.+||.++|++||++.++++.
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.92 Aligned_cols=244 Identities=23% Similarity=0.375 Sum_probs=206.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGG 91 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGG 91 (1092)
++||.|+||.||++.+.. ++.|++|.+...... .....+.+|+.++++++|+||+++++++.... ..|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-PIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-CeEEEEEcCCCC
Confidence 479999999999999877 999999988765443 34567889999999999999999999886554 678999999999
Q ss_pred CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC---cccc
Q 043248 92 DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA---SSVV 168 (1092)
Q Consensus 92 SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~---st~v 168 (1092)
+|.+++..... .+++..+..++.|++.+|.|||++|++||||||+|||++.++.++|+|||++......... ....
T Consensus 78 ~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 78 SLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99999976543 4889999999999999999999999999999999999999999999999998765422211 1123
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDP 247 (1092)
++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+........+..++..+.+|+.+||..+|
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 3567999999988899999999999999999998 899998877666666655443334566778999999999999999
Q ss_pred CCCCCHHHHHhC
Q 043248 248 EHRPSASELLKH 259 (1092)
Q Consensus 248 skRPSaeELLqH 259 (1092)
.+|||+.++++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.84 Aligned_cols=253 Identities=28% Similarity=0.529 Sum_probs=213.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..|...+.||+|+||.||++.+..++..||+|.+..... .......+.+|+.+++.++|+|++++++++.... ..|+|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEE
Confidence 357889999999999999999999999999999875432 3334567888999999999999999999986655 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+.| +|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..... .
T Consensus 104 ~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~ 178 (317)
T cd06635 104 MEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---A 178 (317)
T ss_pred EeCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---c
Confidence 999975 7888776543 3489999999999999999999999999999999999999999999999999876543 2
Q ss_pred ccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-CCCCCCCHHHHHHHH
Q 043248 165 SSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-PLPSCYSPSLKTLIK 240 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~-plPs~iS~eLkDLIr 240 (1092)
....|+..|+|||++. ...++.++|||||||++|+|++|..||...+.......+...... .....++..+.+||.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 3457899999999974 456889999999999999999999999887766656655544332 233457889999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||+.+|.+||++.++++|+|+..
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhc
Confidence 999999999999999999999843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=368.13 Aligned_cols=247 Identities=29% Similarity=0.527 Sum_probs=208.2
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEE-EEEec-----Ce
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKE-AWVEK-----GC 79 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~g-vF~e~-----d~ 79 (1092)
+++|.+.|.+|||+.||+|.+...|..||+|++... .+...+.+.+|+.+|++|+ |+|||.+++ .+... ..
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 567899999999999999999888899999999765 5666788999999999997 999999999 43322 24
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.++|+||||.||.|-+++.+.....|+|.++++||+|+++|+++||..+ |||||||.|||||..+|++||||||.+..
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 6789999999999999998765556999999999999999999999998 99999999999999999999999999875
Q ss_pred ccccc-cC---------ccccCCCCcCCchhh---ccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC
Q 043248 158 LKADD-LA---------SSVVGTPNYMCPELL---ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI 224 (1092)
Q Consensus 158 l~~d~-~~---------st~vGTp~YmAPEVL---~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i 224 (1092)
.-... .. -...-|+.|+|||.+ .+.+.+.|+|||+|||+||.|+....||....... |....+
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng~Y 271 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNGNY 271 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEeccc
Confidence 43221 00 012468999999987 57788999999999999999999999998763322 222222
Q ss_pred C-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 225 G-PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 225 ~-plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
. +....++..+++||+.||+.||++||++.+++.+
T Consensus 272 ~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 272 SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2 2235689999999999999999999999999976
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.34 Aligned_cols=252 Identities=20% Similarity=0.357 Sum_probs=205.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCC--------------cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEK--------------KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tG--------------k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL 70 (1092)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 468999999999999999999875432 358999887542 33445678899999999999999999
Q ss_pred EEEEEecCeEEEEEEeecCCCCHHHHHHHcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 043248 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG----------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIF 140 (1092)
Q Consensus 71 ~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~g----------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENIL 140 (1092)
+++|... ...|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||++|++|+||||+|||
T Consensus 83 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 83 LGVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9998654 477899999999999999965321 13688899999999999999999999999999999999
Q ss_pred EcCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh--CCCCCcccChHHH
Q 043248 141 LTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA--HRPAFKAFDMAGL 215 (1092)
Q Consensus 141 LD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT--Gr~PF~g~d~~dl 215 (1092)
++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543321 122345678999999988889999999999999999987 6788887665544
Q ss_pred HHHhhc-------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 216 ISKINR-------SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 216 i~kI~~-------~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
+..+.. ......+..++..+.+||.+||+.+|.+||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 433321 1112234557899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.94 Aligned_cols=252 Identities=28% Similarity=0.533 Sum_probs=211.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.|...+.||+|+||.||+|.+..++..|++|++..... .......+.+|+.+++.++|+|+++++++|.... ..|+||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 100 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-TAWLVM 100 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-EEEEEE
Confidence 46778899999999999999999999999999865432 2334456888999999999999999999986654 778999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
||+. ++|.+++.... ..+++..++.++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++..... ..
T Consensus 101 e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~ 175 (313)
T cd06633 101 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---AN 175 (313)
T ss_pred ecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CC
Confidence 9996 57888876544 3489999999999999999999999999999999999999999999999999865432 34
Q ss_pred cccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-CCCCCCHHHHHHHHH
Q 043248 166 SVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTLIKG 241 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p-lPs~iS~eLkDLIrk 241 (1092)
...|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+....... ....++..+++||.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 567899999999984 4568889999999999999999999998876655555554433322 233467889999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||+++|.+||++.+++.||||..
T Consensus 256 ~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 256 CLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HccCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.18 Aligned_cols=252 Identities=22% Similarity=0.416 Sum_probs=204.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC----------------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA----------------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~----------------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIV 68 (1092)
-++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986532 34568999886542 334456788999999999999999
Q ss_pred eEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 043248 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNG---------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNI 139 (1092)
Q Consensus 69 KL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~g---------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENI 139 (1092)
++++++...+ .+|+||||+.+++|.+++..... ..+++..+..++.||+.||+|||++||+|+||||+||
T Consensus 83 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 83 RLLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999986655 67899999999999999976432 2367889999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh--CCCCCcccChHH
Q 043248 140 FLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA--HRPAFKAFDMAG 214 (1092)
Q Consensus 140 LLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT--Gr~PF~g~d~~d 214 (1092)
|++.++.++|+|||++..+..... .....++..|++||+..+..++.++|||||||++|+|++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543321 122344678999999988889999999999999999998 778997765544
Q ss_pred HHHHhh-------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 215 LISKIN-------RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 215 li~kI~-------~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
.+.... .....+.+..++..+.+|+.+||+.||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 433221 11122344567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.72 Aligned_cols=252 Identities=33% Similarity=0.636 Sum_probs=213.3
Q ss_pred CeEEEEEEeecCceEEEEEEEcC-CCcEEEEEEEeccc--------ccHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRA-EKKKYVLKKIRLAR--------QTERCRRSAHQEMALIAR-VQHPYIVEFKEAWVE 76 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~-tGk~VAIKkIkks~--------~se~~~r~f~rEIqILkq-L~HPNIVKL~gvF~e 76 (1092)
.|++.+.||+|+||.||++.+.. .++.+|+|.+.... ........+.+|+.++.+ ++|+||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48999999999999999999987 68899999885432 223334567788888875 799999999999866
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
.+ ..|+||||++|++|.+++... ....+++..++.++.|++.+|.|||+ .||+|+||+|+|||++.++.++|+|||
T Consensus 81 ~~-~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 ND-RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CC-eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 54 788999999999999988542 33458999999999999999999996 789999999999999999999999999
Q ss_pred ccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCC-CCC
Q 043248 154 LAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS-CYS 232 (1092)
Q Consensus 154 LA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs-~iS 232 (1092)
++.............|+..|++||.+.+..++.++||||||+++|+|++|+.||...+.......+......+.+. .++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 9987765544456678999999999998889999999999999999999999998877666666665554444333 578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..+.+||++||+.||++||++.|+..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.05 Aligned_cols=253 Identities=26% Similarity=0.522 Sum_probs=213.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..|+..+.||+|+||.||++.++.++..+++|.+.... ........+.+|+.+++.++|+|++++++++.... ..|+|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-eeEEE
Confidence 46888899999999999999999999999999986532 23334456788999999999999999999987654 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||+. ++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 99996 58888776543 34899999999999999999999999999999999999999999999999998765432
Q ss_pred ccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-CCCCCCHHHHHHHH
Q 043248 165 SSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTLIK 240 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p-lPs~iS~eLkDLIr 240 (1092)
....|+..|+|||++. ...++.++|||||||++|+|++|..||...+.......+....... ....++..+.+||+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence 3457889999999984 3467889999999999999999999998776555555544433322 23467889999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||+++|.+||+++++++|+|+..
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.39 Aligned_cols=252 Identities=19% Similarity=0.352 Sum_probs=210.1
Q ss_pred eEEEEEEeecCceEEEEEEEcC---CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----e
Q 043248 8 YEIMEQIGRGAFGAAILVNHRA---EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-----C 79 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~---tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-----~ 79 (1092)
|++.+.||+|+||.||+|.++. ++..||||.+..........+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 7788999999999999998653 5788999998765555555667889999999999999999999886432 2
Q ss_pred EEEEEEeecCCCCHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSN----GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~----gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
..+++++|+.+++|..++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478999999999998875432 124788999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCC
Q 043248 156 KTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 156 ~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~i 231 (1092)
........ .....++..|++||.+.+..++.++|||||||++|+|++ |++||...+.......+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 87643321 122345678999999998889999999999999999998 89999887776666666554443445567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+..+.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.46 Aligned_cols=255 Identities=28% Similarity=0.513 Sum_probs=209.8
Q ss_pred CeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEeccccc--HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQT--ERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~s--e~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
+|++.+.||+|+||.||++.+. .++..||+|.+...... ......+.+|+.++.++ +|+||++++++|... ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD-TK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-CE
Confidence 5899999999999999998864 46788999998754322 22345678899999999 599999999988554 47
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+||||+.+++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||||.||+++.++.++|+|||++..+..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 889999999999999987654 389999999999999999999999999999999999999999999999999876543
Q ss_pred ccc--CccccCCCCcCCchhhccCC--CCccccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccCCCCCCCCCC
Q 043248 161 DDL--ASSVVGTPNYMCPELLADIP--YGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIGPLPSCYS 232 (1092)
Q Consensus 161 d~~--~st~vGTp~YmAPEVL~g~~--yS~KSDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~i~plPs~iS 232 (1092)
... .....|+..|++||.+.+.. ++.++||||||+++|+|++|..||..... ......+.. ...+.+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMS 236 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcccC
Confidence 321 22356899999999987655 68899999999999999999999964322 222222222 2335666788
Q ss_pred HHHHHHHHHhcccCCCCCCC---HHHHHhChhhHhH
Q 043248 233 PSLKTLIKGMLRKNPEHRPS---ASELLKHPFLQHF 265 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPS---aeELLqHPwFq~~ 265 (1092)
..+.++|.+||+.+|++||| +.++|+||||+.+
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999999998 5677999999774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=345.55 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=208.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC-----CcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE-----KKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t-----Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~ 77 (1092)
..++|+++++||+|+||.||+|.+... +..||+|++.... .......+.+|+.+++++. ||||++++++|...
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 456888999999999999999987433 3579999986543 2334567889999999996 99999999999665
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcC--------------------------------------------------------
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSN-------------------------------------------------------- 101 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~-------------------------------------------------------- 101 (1092)
+ .+|||||||++|+|.++|....
T Consensus 114 ~-~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 114 G-PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred C-ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 4 6789999999999999986532
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC
Q 043248 102 --------------------------------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK 143 (1092)
Q Consensus 102 --------------------------------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~ 143 (1092)
...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124788889999999999999999999999999999999999
Q ss_pred CCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHH-HHHH
Q 043248 144 DQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG-LISK 218 (1092)
Q Consensus 144 dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~d-li~k 218 (1092)
++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999999986543221 223456788999999999899999999999999999997 999997654333 2333
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+........+..++.++.+||.+||+.+|++||++.++.+.
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 33333334566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=359.73 Aligned_cols=251 Identities=28% Similarity=0.534 Sum_probs=219.7
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
|.-++.||+|+||.||.|.+..+...||||++..+.. .......+..|+..|++|+|||+|.+.++|.... ..|+|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-TAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-hHHHHHH
Confidence 4556789999999999999999999999999976643 3445678999999999999999999999996544 6789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st 166 (1092)
||-| +-.+++.-.. ++|-+-.|..|..+.+.||+|||+++.||||||..||||++.|.|||+|||.|..+.+ .++
T Consensus 107 YClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---Ans 181 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANS 181 (948)
T ss_pred HHhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhc
Confidence 9964 7888876544 4589999999999999999999999999999999999999999999999999988764 467
Q ss_pred ccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC-CCCCHHHHHHHHHh
Q 043248 167 VVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP-SCYSPSLKTLIKGM 242 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP-s~iS~eLkDLIrkc 242 (1092)
++|||+|||||++. .+.|+-++||||||++..+|.-.++|+...+...-++.|-...-+.++ ..|+..|..||..|
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 261 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence 89999999999985 467999999999999999999999999888877777777665544444 44899999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~ 264 (1092)
|++-|.+|||.+++|+|+|+.+
T Consensus 262 LqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HhhCcccCCcHHHHhhcchhcc
Confidence 9999999999999999999854
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.44 Aligned_cols=246 Identities=21% Similarity=0.381 Sum_probs=204.6
Q ss_pred EEEeecCceEEEEEEEcCCC------cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 12 EQIGRGAFGAAILVNHRAEK------KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tG------k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.||+|+||.||++.++... ..+++|.+..... ......+.+|+.+++.++||||++++++|...+ ..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEE
Confidence 46999999999999986544 6789998764322 233457888999999999999999999986554 678999
Q ss_pred eecCCCCHHHHHHHcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-----CEEEeecCcc
Q 043248 86 GYCEGGDMAELMKKSN-----GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-----DVRLGDFGLA 155 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~-----gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-----~LKLiDFGLA 155 (1092)
||+++++|.+++.... ...+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999997542 23478899999999999999999999999999999999999877 8999999998
Q ss_pred cccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCC
Q 043248 156 KTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 156 ~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~i 231 (1092)
........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 76543321 122345678999999998899999999999999999998 99999877766666665554444556678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+..+.+||.+||..+|.+||++.++++.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 266 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEI 266 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 8999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=316.96 Aligned_cols=253 Identities=20% Similarity=0.395 Sum_probs=210.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
.++|++++.||+|+||.||+|..+. ..+.|++|.+.... .......+.+|+.++++++|+||+++++++... .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-E 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-C
Confidence 3689999999999999999999764 34678888875432 233456788999999999999999999988554 4
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeec
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGA-------YFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDF 152 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk-------~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDF 152 (1092)
..|+||||+++++|.+++...... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 678999999999999999865521 4899999999999999999999999999999999999999999999999
Q ss_pred Cccccccccc--cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCC-CCCC
Q 043248 153 GLAKTLKADD--LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSI-GPLP 228 (1092)
Q Consensus 153 GLA~~l~~d~--~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i-~plP 228 (1092)
|++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..... ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 9987543222 1233456778999999988889999999999999999998 8899987666555555543322 2345
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..++..+.++|.+||+.+|.+||++.+++++
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 5678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=313.46 Aligned_cols=236 Identities=19% Similarity=0.284 Sum_probs=194.2
Q ss_pred EEEeecCceEEEEEEEcCCC----------cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 12 EQIGRGAFGAAILVNHRAEK----------KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tG----------k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
+.||+|+||.||++.+..++ ..+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR--DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec--CCc
Confidence 46999999999999998776 34777766543221 5678899999999999999999998876 356
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-------CEEEeecCc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-------DVRLGDFGL 154 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-------~LKLiDFGL 154 (1092)
|+||||+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 799999999999999987553 489999999999999999999999999999999999999887 799999999
Q ss_pred cccccccccCccccCCCCcCCchhhccC--CCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCC
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLADI--PYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~g~--~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~i 231 (1092)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||................ ..+...
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~ 229 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--RLPMPD 229 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--CCCCCC
Confidence 987654 2334577889999999876 78999999999999999999 588887665433333332222 222333
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
...+.+||.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=361.90 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=216.4
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCC
Q 043248 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
.||+|.||+||.|++..+...+|||.+.... .....-+..|+.+.++|+|.|||++++.+.+++ ++-|+||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCc
Confidence 5999999999999999999999999886432 334567889999999999999999999985555 8889999999999
Q ss_pred HHHHHHHcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCccccccc-cccCcccc
Q 043248 93 MAELMKKSNGAYF--PEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAKTLKA-DDLASSVV 168 (1092)
Q Consensus 93 L~DLLkkk~gk~L--SEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~~l~~-d~~~st~v 168 (1092)
|.++|..+= +++ .|..+-.|.+||++||.|||++.|||||||-+|+|++. .|.+||.|||.++.+.. .....++.
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 999998753 346 78999999999999999999999999999999999964 67899999999987654 34566788
Q ss_pred CCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccChH--HHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 169 GTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA--GLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 169 GTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~--dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
||.-|||||++.. ..|+.++|||||||++.||.||++||...... .++.--....-+++|+.++.++++||.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 9999999999954 46899999999999999999999999754322 2222222334467899999999999999999
Q ss_pred cCCCCCCCHHHHHhChhhHhHhhhcCCC
Q 043248 245 KNPEHRPSASELLKHPFLQHFVDQYRPT 272 (1092)
Q Consensus 245 kDPskRPSaeELLqHPwFq~~~d~~~P~ 272 (1092)
.+|.+||++.++|+.||++.-....++.
T Consensus 818 pd~~~R~sA~~LL~DpFlq~~~kk~r~~ 845 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQDPFLQHNNKKPRPK 845 (1226)
T ss_pred CCcccCccHHHhccCcccccCCCCCCCC
Confidence 9999999999999999998764444433
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=357.55 Aligned_cols=252 Identities=33% Similarity=0.539 Sum_probs=207.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLV 84 (1092)
..|+++++||+||.+.||++... +...||+|++...........-+.+|+.+|.+|+ |.+||+||+|- -.+.++|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-v~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-VTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-ccCceEEEE
Confidence 47999999999999999999864 4567888888777777778889999999999995 89999999875 446699999
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
|||- ..+|..+|++.... ++.-.++.|..||+.|+.++|.+||||.||||.|+||- .|.+||+|||.|..+..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 9986 46999999887653 44348999999999999999999999999999999997 7899999999999887654
Q ss_pred -cCccccCCCCcCCchhhccC-----------CCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhcc----CCC
Q 043248 163 -LASSVVGTPNYMCPELLADI-----------PYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRS----SIG 225 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~-----------~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~----~i~ 225 (1092)
.....+||+.||+||.+... +.+.++||||||||||+|+.|++||..+.. ..-+..|... .++
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 34567999999999998532 256899999999999999999999976542 2222222221 122
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.++. ..++.++++.||+.||++||++.++|+|||++-
T Consensus 596 ~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 2222 234999999999999999999999999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=323.89 Aligned_cols=251 Identities=19% Similarity=0.338 Sum_probs=209.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCc----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK----KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk----~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.++|++.+.||+|+||.||++.+..++. .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP--T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--C
Confidence 4689999999999999999999887776 468887764432 33344678899999999999999999988643 3
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
.++|+||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 568999999999999998654 2489999999999999999999999999999999999999999999999999987653
Q ss_pred ccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 161 DDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 161 d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 322 122345678999999999899999999999999999997 9999987665555555544444445566788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhC
Q 043248 237 TLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqH 259 (1092)
+++.+||..+|++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.22 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=207.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-Ce
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~ 79 (1092)
.++|++.+.||+|+||.||++.+. .++..||+|.+...... .....+.+|+.+++.++|+||+++++++... +.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 357899999999999999999865 34889999998765443 3456789999999999999999999987652 34
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
..|+||||+++++|.+++..... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67899999999999999986543 48999999999999999999999999999999999999999999999999998776
Q ss_pred ccccC----ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---------------HHHHHhh
Q 043248 160 ADDLA----SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---------------GLISKIN 220 (1092)
Q Consensus 160 ~d~~~----st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---------------dli~kI~ 220 (1092)
..... ....++..|++||.+.+..++.++|||||||++|+|++|..||...... .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 33211 1234556799999998889999999999999999999999998653221 1222222
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.....+.+..++.++.+|+.+||.++|.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 222233445677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=361.50 Aligned_cols=150 Identities=31% Similarity=0.573 Sum_probs=134.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|+++++||+|+||.||+|.+..+++.||||++.... ........+.+|+.++..++|+||+++++++...+ ++|
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~~ 80 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-NVY 80 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-EEE
Confidence 4789999999999999999999999999999999997543 23444567889999999999999999998886544 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
|||||+.|++|.+++...+ .+++..++.|+.||+.||.|||.+||+||||||+||||+.++.+||+|||++.
T Consensus 81 lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999997654 38999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.81 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=193.7
Q ss_pred EEEeecCceEEEEEEEcC--CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRA--EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~--tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++|+||+++++++.... .+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-ceEEEEEeCC
Confidence 368999999999996432 3456788876543 23344567888999999999999999999886554 6789999999
Q ss_pred CCCHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---
Q 043248 90 GGDMAELMKKSNG---AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--- 163 (1092)
Q Consensus 90 GGSL~DLLkkk~g---k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~--- 163 (1092)
+|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999986532 2356788899999999999999999999999999999999999999999999875433221
Q ss_pred CccccCCCCcCCchhhcc-------CCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCC-----CCCCCC
Q 043248 164 ASSVVGTPNYMCPELLAD-------IPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSI-----GPLPSC 230 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g-------~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i-----~plPs~ 230 (1092)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||......+...++..... ..++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 123345678999999743 356889999999999999998 7889987665555554433322 123445
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
++..+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7889999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=316.13 Aligned_cols=239 Identities=19% Similarity=0.316 Sum_probs=194.8
Q ss_pred EEEeecCceEEEEEEEcCCCc-------EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 12 EQIGRGAFGAAILVNHRAEKK-------KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk-------~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+.||+|+||.||+|.++..+. .|++|.+.... ....+.+.+|+.+++.+.||||+++++++.... ..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEE
Confidence 369999999999999865544 37777765332 233457888999999999999999999997655 57799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--------EEEeecCccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD--------VRLGDFGLAK 156 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~--------LKLiDFGLA~ 156 (1092)
|||+.+|+|..++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999986543 5899999999999999999999999999999999999987764 6999999987
Q ss_pred cccccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhC-CCCCcccChHHHHHHhhccCCCCCCCCCCHH
Q 043248 157 TLKADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~dli~kI~~~~i~plPs~iS~e 234 (1092)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++| ..||.............. ...++...+.+
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLPAPKWTE 231 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--cccCCCCCcHH
Confidence 65432 34568889999999976 4579999999999999999998 567766555443332221 23455566789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+.+||.+||+++|++|||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.26 Aligned_cols=260 Identities=29% Similarity=0.505 Sum_probs=213.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCc----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKK----KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk----~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
.+..|++++.||+|.||.||+|..+.++. .||||+++.............+|+.+++.|+||||+.|..+|...+.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 35689999999999999999997655533 68999998765555555678899999999999999999999998888
Q ss_pred EEEEEEeecCCCCHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC----CCEEEeec
Q 043248 80 YVCIVTGYCEGGDMAELMKKSN---GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD----QDVRLGDF 152 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~---gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d----G~LKLiDF 152 (1092)
.+++++||.+. +|+.+|+.+. .+.++...++.|++||+.|+.|||++.|+||||||.|||+..+ |.+||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999976 9999997542 2458999999999999999999999999999999999999877 88999999
Q ss_pred Cccccccccc----cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccCh---------HHHHHH
Q 043248 153 GLAKTLKADD----LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---------AGLISK 218 (1092)
Q Consensus 153 GLA~~l~~d~----~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~---------~dli~k 218 (1092)
|+++.+...- ....++.|.||+|||++.|. .|+.+.|||++|||+.||++-.+.|.+... .+++..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999886431 23456789999999999775 589999999999999999999999976321 133333
Q ss_pred hhccCCCC----------CCC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 219 INRSSIGP----------LPS--------------------------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 219 I~~~~i~p----------lPs--------------------------~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
|......+ +|+ .-++...+|+.+||.+||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 32211000 010 014457899999999999999999999999999
Q ss_pred Hh
Q 043248 263 QH 264 (1092)
Q Consensus 263 q~ 264 (1092)
..
T Consensus 341 ~~ 342 (438)
T KOG0666|consen 341 TE 342 (438)
T ss_pred cc
Confidence 74
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=354.68 Aligned_cols=252 Identities=30% Similarity=0.449 Sum_probs=220.0
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGG 91 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGG 91 (1092)
+.||+|.||+||-++++.+|+.||||++.+.+........+.+|++||+++.||.||.|...|.. ...+++|||.+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhhcc-
Confidence 78999999999999999999999999998777666666788899999999999999999887744 4578899999965
Q ss_pred CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEEeecCccccccccccCcccc
Q 043248 92 DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRLGDFGLAKTLKADDLASSVV 168 (1092)
Q Consensus 92 SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKLiDFGLA~~l~~d~~~st~v 168 (1092)
++.++|.....+.|++...+.++.||+.||.|||-++|+|+||||+|||+.... .+||||||+|+.+++..+....+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 666666655556799999999999999999999999999999999999996543 69999999999999999999999
Q ss_pred CCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc-ChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCC
Q 043248 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNP 247 (1092)
Q Consensus 169 GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~-d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDP 247 (1092)
||+.|+|||++.+..|....|+||+|||+|--|+|..||... ++.+++++..-.........+++++.|||..+|+..-
T Consensus 728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm 807 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKM 807 (888)
T ss_pred CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999754 4445555443332222234578999999999999999
Q ss_pred CCCCCHHHHHhChhhHhH
Q 043248 248 EHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 248 skRPSaeELLqHPwFq~~ 265 (1092)
.+|.|+++.|.|||++.+
T Consensus 808 ~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 808 RKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHhcchHhhccchhhhcc
Confidence 999999999999999764
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.84 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=193.4
Q ss_pred EEEeecCceEEEEEEEc--CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK--~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||+|... .++..+++|.+...... .....+.+|+.++++++||||+++++++.+.. .+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-PYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-CcEEEEECCC
Confidence 46899999999999754 34567999988655332 23356888999999999999999999886654 6789999999
Q ss_pred CCCHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---
Q 043248 90 GGDMAELMKKSNG---AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--- 163 (1092)
Q Consensus 90 GGSL~DLLkkk~g---k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~--- 163 (1092)
+++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999999975421 2356778889999999999999999999999999999999999999999999875443321
Q ss_pred CccccCCCCcCCchhhccC-------CCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCC-----CCCCCC
Q 043248 164 ASSVVGTPNYMCPELLADI-------PYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSI-----GPLPSC 230 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~-------~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i-----~plPs~ 230 (1092)
.....|+..|+|||++.+. .++.++|||||||++|+|++ |..||................. ..+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 1234578889999998542 35789999999999999996 9999987665544333222111 122234
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
.+..+.+++.+|+ .+|.+|||++++++
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=365.73 Aligned_cols=255 Identities=27% Similarity=0.366 Sum_probs=208.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++|++.++||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++...+ ..|+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-PVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-EEEE
Confidence 6899999999999999999999999999999999875432 2344567889999999999999999999986654 7789
Q ss_pred EEeecCCCCHHHHHHHcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 84 VTGYCEGGDMAELMKKSN---------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~---------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
||||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999999987421 12356678899999999999999999999999999999999999999999999
Q ss_pred cccccccc-------------------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHH
Q 043248 155 AKTLKADD-------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL 215 (1092)
Q Consensus 155 A~~l~~d~-------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dl 215 (1092)
+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 98662110 11234799999999999999999999999999999999999999987554333
Q ss_pred HHHhhccCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhCh
Q 043248 216 ISKINRSSIG--PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHP 260 (1092)
Q Consensus 216 i~kI~~~~i~--plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHP 260 (1092)
.......... .....+++.+.+++.+||..||++|++..+.+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2221111111 11235788999999999999999998877766553
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=312.97 Aligned_cols=229 Identities=24% Similarity=0.382 Sum_probs=192.0
Q ss_pred cCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCHHHH
Q 043248 17 GAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL 96 (1092)
Q Consensus 17 GgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DL 96 (1092)
|.||.||++.++.+++.||+|.+.... .+.+|...+....||||+++++++... ..+|+||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987542 223345555566799999999998665 478899999999999999
Q ss_pred HHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCCcCCc
Q 043248 97 MKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCP 176 (1092)
Q Consensus 97 Lkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAP 176 (1092)
+.+... +++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|+||
T Consensus 76 l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aP 151 (237)
T cd05576 76 ISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAP 151 (237)
T ss_pred HHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCC
Confidence 987543 899999999999999999999999999999999999999999999999988665432 2344567889999
Q ss_pred hhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---
Q 043248 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSA--- 253 (1092)
Q Consensus 177 EVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSa--- 253 (1092)
|.+.+..++.++|+||+||++|+|++|+.+|...... +.......++..++..+++||.+||++||++|+++
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 9998888999999999999999999999887643221 11111123556689999999999999999999985
Q ss_pred --HHHHhChhh
Q 043248 254 --SELLKHPFL 262 (1092)
Q Consensus 254 --eELLqHPwF 262 (1092)
+++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=355.36 Aligned_cols=236 Identities=30% Similarity=0.554 Sum_probs=208.1
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
-++.||.|+.|.||+++.+ ++.||||+++.- -..+|+-|++|+|+||+.+.++|.... .||||||||.
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa 195 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCA 195 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCc-eeEEeeeccc
Confidence 4678999999999999864 588999998632 234788899999999999999996655 6789999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccC
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG 169 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vG 169 (1092)
.|-|+..|+..+. +.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++....-.....++|
T Consensus 196 ~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred cccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhh
Confidence 9999999987654 89999999999999999999999999999999999999999999999999998876666677899
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc-CCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS-SIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~-~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
|..|||||++.+.+.+.++|||||||+|||||||..||...+-..++.-+-.. .--+.|..++..|+-||+.||+-.|.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR 353 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR 353 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999999999999999876654444433322 22367888999999999999999999
Q ss_pred CCCCHHHHHhC
Q 043248 249 HRPSASELLKH 259 (1092)
Q Consensus 249 kRPSaeELLqH 259 (1092)
.||++.++|.|
T Consensus 354 NRPSFrqil~H 364 (904)
T KOG4721|consen 354 NRPSFRQILLH 364 (904)
T ss_pred CCccHHHHHHH
Confidence 99999999998
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=347.31 Aligned_cols=251 Identities=28% Similarity=0.550 Sum_probs=216.7
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
|.++.+||+|+||.||+|.++.+|..+|||++.... ....+..|+.||++++.|++|++|+.|..+. .+||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-DLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-DLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCC-ceEeehhh
Confidence 567889999999999999999999999999986542 2456888999999999999999999886554 58899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccCcc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASS 166 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~st 166 (1092)
|..|++.+++.-++ +.|++.+|..+++..+.||+|||...-||||||..||||+.+|..||+|||.+-.+... ...++
T Consensus 110 CGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 110 CGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred cCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99999999997654 46999999999999999999999999999999999999999999999999999766432 34567
Q ss_pred ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHHHhcc
Q 043248 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 167 ~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIrkcLq 244 (1092)
+.||+.|||||++..-.|..++||||||++..||.-|++||.......-+..|-....+ .-|+.|+.++.|||+.||.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 89999999999999999999999999999999999999999775443322222222111 1345689999999999999
Q ss_pred cCCCCCCCHHHHHhChhhHh
Q 043248 245 KNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 245 kDPskRPSaeELLqHPwFq~ 264 (1092)
++|++|-|+.++++|+|+++
T Consensus 269 K~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 269 KKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred CCHHHHHHHHHHhhhhhhcC
Confidence 99999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.79 Aligned_cols=257 Identities=31% Similarity=0.540 Sum_probs=223.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+.+|.-.++||+|.||+||+++++.+++.||+|.++.....+..-....+|+.+++.|+|.|||+++++... +..+.+|
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlv 79 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLV 79 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEe
Confidence 457888899999999999999999999999999999988877777889999999999999999999998744 5577899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
+|||.. +|..+....++ .+..+.++.++.|++.||.|||++++.||||||.|+||+.+|.+||+|||+++.++-.- -
T Consensus 80 fe~cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHHhhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 999975 89988887765 48999999999999999999999999999999999999999999999999999887443 3
Q ss_pred CccccCCCCcCCchhhccCC-CCccccchhHHHHHHHHH-hCCCCCcccChHHHHHHhhccCCCC---------------
Q 043248 164 ASSVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKINRSSIGP--------------- 226 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~-yS~KSDVWSLGVILYELL-TGr~PF~g~d~~dli~kI~~~~i~p--------------- 226 (1092)
.+..+.|.||++|.++.|.+ |+...|+||.|||+.||. .|++.|.+.+..+++..|.+....+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 45567899999999997754 799999999999999998 5999999999888888875432111
Q ss_pred -CC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 227 -LP------------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 227 -lP------------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.| ..++..-+++++++|.-+|.+|++++++++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 11 112445789999999999999999999999999964
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=311.30 Aligned_cols=239 Identities=19% Similarity=0.273 Sum_probs=191.3
Q ss_pred EEEeecCceEEEEEEEcCC------------CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 12 EQIGRGAFGAAILVNHRAE------------KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~t------------Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
+.||+|+||.||++..... ...+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 4689999999999985422 2357888765432 233457888999999999999999999986654
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-------EEEeec
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD-------VRLGDF 152 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~-------LKLiDF 152 (1092)
..++||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 5679999999999999887644 34899999999999999999999999999999999999987654 899999
Q ss_pred CccccccccccCccccCCCCcCCchhhc-cCCCCccccchhHHHHHHHHH-hCCCCCcccChHHHHHHhhccCCCCCCCC
Q 043248 153 GLAKTLKADDLASSVVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKINRSSIGPLPSC 230 (1092)
Q Consensus 153 GLA~~l~~d~~~st~vGTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELL-TGr~PF~g~d~~dli~kI~~~~i~plPs~ 230 (1092)
|++..... .....|+..|+|||++. +..++.++|||||||++|+|+ .|..||............. ... .....
T Consensus 157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~-~~~~~ 231 (262)
T cd05077 157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-GQC-MLVTP 231 (262)
T ss_pred CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-cCc-cCCCC
Confidence 99876532 23456888999999986 567899999999999999997 5888887755443322222 111 12233
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+.++.+||.+||+.||.+||++.+++++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 46789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=337.52 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=208.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d 78 (1092)
.++|.+.+.||+|+||.||+|.+. ..++.||+|++...... .....+.+|+.+|..+. ||||++++++|...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 357888999999999999999864 34578999999764333 23456889999999997 999999999997655
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCC--------------------------------------------------------
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNG-------------------------------------------------------- 102 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~g-------------------------------------------------------- 102 (1092)
.+|+|||||.+|+|.+++.+...
T Consensus 115 -~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 115 -PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred -CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 67899999999999999975421
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 103 ----------------------------------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 103 ----------------------------------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
..|++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 2367778899999999999999999999999999999999
Q ss_pred CCCCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 99999999999998653322 1223467888999999998889999999999999999998 8999977554444333
Q ss_pred -hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 219 -INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 219 -I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+........+..++.++.+||.+||..+|.+||++.++++.
T Consensus 354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33333334566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.62 Aligned_cols=238 Identities=21% Similarity=0.276 Sum_probs=190.8
Q ss_pred EEeecCceEEEEEEEcCC------------------------CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc
Q 043248 13 QIGRGAFGAAILVNHRAE------------------------KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~t------------------------Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIV 68 (1092)
.||+|+||.||++....+ ...|++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999875422 2357888875432 23345688899999999999999
Q ss_pred eEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---
Q 043248 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ--- 145 (1092)
Q Consensus 69 KL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG--- 145 (1092)
++++++.... ..|+||||+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCC-ceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999987655 6779999999999999987643 3489999999999999999999999999999999999997644
Q ss_pred ----CEEEeecCccccccccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHH-hCCCCCcccChHHHHHHh
Q 043248 146 ----DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKI 219 (1092)
Q Consensus 146 ----~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELL-TGr~PF~g~d~~dli~kI 219 (1092)
.++|+|||++...... ....++..|+|||++.+ ..++.++|||||||++|+|+ +|..||...........+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 3899999987654322 23467888999998865 56899999999999999984 799999876544433322
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
... ...+......+.+||.+||+.+|++||++.++|++
T Consensus 235 ~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred Hhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 221 12344466789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.19 Aligned_cols=248 Identities=19% Similarity=0.256 Sum_probs=192.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHH---------HHHHHHHHHHHHhcCCCCcceEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERC---------RRSAHQEMALIARVQHPYIVEFKEA 73 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~---------~r~f~rEIqILkqL~HPNIVKL~gv 73 (1092)
++|++.++||+|+||.||+|.+..+ +..+++|........... ......++..+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 6899999999999999999998877 667777765433221100 1122334455667789999999987
Q ss_pred EEecC---eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEe
Q 043248 74 WVEKG---CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLG 150 (1092)
Q Consensus 74 F~e~d---~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLi 150 (1092)
+.... .+.++++|++. .++.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 65443 24578888874 47777776543 26789999999999999999999999999999999999999999999
Q ss_pred ecCccccccccc--------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh-HH-------
Q 043248 151 DFGLAKTLKADD--------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AG------- 214 (1092)
Q Consensus 151 DFGLA~~l~~d~--------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~d------- 214 (1092)
|||++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ..
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999998764221 12234699999999999999999999999999999999999999987632 21
Q ss_pred -HHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 215 -LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 215 -li~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
.+..+..... .....+..+.++++.||..+|++||++.++++
T Consensus 249 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 DFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2222222211 22345789999999999999999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=381.85 Aligned_cols=254 Identities=29% Similarity=0.500 Sum_probs=223.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+|+-...||.|.||.||-|.+..+|...|+|-+............+.+|+.++..|+|||+|++|++=...+ .++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-kv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-KVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-HHHHHHH
Confidence 677788999999999999999999999999988776555445567889999999999999999999865555 6779999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc----
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---- 162 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~---- 162 (1092)
||+||+|.+++...+ ..+|...+.|..|++.||.|||++|||||||||+||||+.+|.+|+.|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999999999997643 37888899999999999999999999999999999999999999999999998876542
Q ss_pred -cCccccCCCCcCCchhhccC---CCCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADI---PYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~---~yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
....+.||+.|||||++.+. ..+-++|||||||++.||+||+.||...+ ...++.++-.+..+.+|..++.+.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 23467899999999999664 45779999999999999999999998654 55677777777888899999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
||..||..||++|+++.|+|.|-|-+
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhccc
Confidence 99999999999999999999997654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=333.79 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=201.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
-+.|.-...||+|+||.||+|.... +..||||++....... .+.|.+|+.++.+++|||||+|++||.+.+...+||
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 3567777899999999999999754 4899999876544332 345999999999999999999999998777556799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEcCCCCEEEeecCccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY---VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA- 160 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG---IIHRDLKPENILLD~dG~LKLiDFGLA~~l~~- 160 (1092)
+||+++|+|.++|.......++|....+|+.+++.||+|||... |||||||+.|||||.+++.||+|||+|.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998755326899999999999999999999854 99999999999999999999999999977665
Q ss_pred cccCccc-cCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC------hHHHHHHh-hccC----CCC-C
Q 043248 161 DDLASSV-VGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD------MAGLISKI-NRSS----IGP-L 227 (1092)
Q Consensus 161 d~~~st~-vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d------~~dli~kI-~~~~----i~p-l 227 (1092)
....... .||.+|++||++..+..+.++|||||||+|+||++|+.+..... ...+.... .... +++ +
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 3333333 89999999999998899999999999999999999998876432 11211111 1111 111 1
Q ss_pred C-CCCC--H---HHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 228 P-SCYS--P---SLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 228 P-s~iS--~---eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
. ..+. . .+..+..+|++.+|.+||++.|+++.
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 1 2233 2 25567789999999999999998653
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.04 Aligned_cols=244 Identities=22% Similarity=0.364 Sum_probs=192.2
Q ss_pred EEEeecCceEEEEEEEcCC--CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAE--KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~t--Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.||+|+||.||++..... ...+++|.+..... ......+.+|+.+++.++||||++++++|.... .+|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-PYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCC-ccEEEEecCC
Confidence 3699999999999975433 23456666654322 334567889999999999999999999986544 6789999999
Q ss_pred CCCHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc---cC
Q 043248 90 GGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LA 164 (1092)
Q Consensus 90 GGSL~DLLkkk~--gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~---~~ 164 (1092)
+++|.+++.+.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999999998642 2336777889999999999999999999999999999999999999999999986432211 12
Q ss_pred ccccCCCCcCCchhhcc-------CCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCC-----CCCCCCC
Q 043248 165 SSVVGTPNYMCPELLAD-------IPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSI-----GPLPSCY 231 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g-------~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i-----~plPs~i 231 (1092)
...+|+..|+|||++.. ..++.++|||||||++|+|++ |..||......+....+..... ..+...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34578899999999843 245789999999999999996 5778877666555555433221 2234457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
+..+.+++.+|| .+|.+||+++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=290.39 Aligned_cols=241 Identities=37% Similarity=0.666 Sum_probs=208.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCHHHHH
Q 043248 18 AFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM 97 (1092)
Q Consensus 18 gFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLL 97 (1092)
+||.||++.+..+++.+++|++........ ...+.+|+..+++++|+||+++++++... ...+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999876543332 56788999999999999999999988665 4678999999999999999
Q ss_pred HHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCCcCCch
Q 043248 98 KKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177 (1092)
Q Consensus 98 kkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPE 177 (1092)
..... +++..++.++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++.............++..|++||
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 87554 8999999999999999999999999999999999999999999999999999887655556677899999999
Q ss_pred hhccCCCCccccchhHHHHHHHHHhCCCCCcc-cChHHHHHHhhccCCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHH
Q 043248 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGLISKINRSSIGPLPSC--YSPSLKTLIKGMLRKNPEHRPSAS 254 (1092)
Q Consensus 178 VL~g~~yS~KSDVWSLGVILYELLTGr~PF~g-~d~~dli~kI~~~~i~plPs~--iS~eLkDLIrkcLqkDPskRPSae 254 (1092)
.+.+..++.++|||+||+++|+|++|..||.. .+.......+........... ++.++.+++.+||..+|++||++.
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 236 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE 236 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence 99988899999999999999999999999987 444444444444333322222 788999999999999999999999
Q ss_pred HHHhChhh
Q 043248 255 ELLKHPFL 262 (1092)
Q Consensus 255 ELLqHPwF 262 (1092)
++++||||
T Consensus 237 ~~~~~~~~ 244 (244)
T smart00220 237 EALQHPFF 244 (244)
T ss_pred HHhhCCCC
Confidence 99999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.63 Aligned_cols=254 Identities=27% Similarity=0.470 Sum_probs=213.4
Q ss_pred eEE-EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEEE
Q 043248 8 YEI-MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 8 YeI-lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
|++ .+.||+|+|+.|--|....+|..||||++.+. .-..+.++.+|++++.+++ |+||++|+++|.+. ..+||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-TRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-ceEEEEE
Confidence 444 36799999999999999999999999999765 3445678999999999985 99999999999554 4788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEEeecCccccccccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKLiDFGLA~~l~~d~ 162 (1092)
|.+.||.|...|.++.. |+|.++..+++.|+.||.|||.+||.||||||+|||-.... -+|||||.|...+....
T Consensus 156 EKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred ecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999999999988754 99999999999999999999999999999999999986554 38999999886654322
Q ss_pred --------cCccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccc-------C--------hHH
Q 043248 163 --------LASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-------D--------MAG 214 (1092)
Q Consensus 163 --------~~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~-------d--------~~d 214 (1092)
...+-+|+..|||||+.. ...|+.++|.||||||||.||+|.+||.+. + ...
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 123568999999999872 356899999999999999999999999762 2 134
Q ss_pred HHHHhhccCCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 215 LISKINRSSIGPLPS----CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 215 li~kI~~~~i~plPs----~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
++..|..+.+. +|. .+|.+++++|..+|..++..|.++.++++|||++....
T Consensus 314 LFesIQEGkYe-FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 314 LFESIQEGKYE-FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHhccCCc-CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 55555555443 443 37999999999999999999999999999999987654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=347.67 Aligned_cols=248 Identities=26% Similarity=0.473 Sum_probs=214.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++..+...||+|.||+||.|.+.. .||||++..........+.|.+|+..+++-+|.||+=+.+++...+ + .||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-L-AII 465 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-e-eee
Confidence 3556788999999999999999875 4999999988888888899999999999999999999999997766 3 799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc---cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK---AD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~---~d 161 (1092)
+-+|+|-+|+.+|..... .|....++.|+.||++|+.|||.++|||||||..||||.+++.|||.||||+.... ..
T Consensus 466 TqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred ehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 999999999999986553 48999999999999999999999999999999999999999999999999987543 23
Q ss_pred ccCccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC----CCCCCCHH
Q 043248 162 DLASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP----LPSCYSPS 234 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p----lPs~iS~e 234 (1092)
.......|+..|||||++. ..+|++++|||||||++|||++|..||.......++..+-++...+ ...+.+.+
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA 624 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence 3344557889999999994 4689999999999999999999999999655555555555543322 23446779
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHh
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLq 258 (1092)
+++|+..||.+++++||.+.+||.
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=340.73 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=216.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-----ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-----e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
.++|.++++||+|||+.||+|.+...++.||||+-...... +...+...+|..|.+.|.||.||++|++|.-...
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46899999999999999999999999999999987554322 3345678899999999999999999999998888
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc---CCCCEEEeecCc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLT---KDQDVRLGDFGL 154 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD---~dG~LKLiDFGL 154 (1092)
.+|-|+|||+|.+|..+|+.+.. +++++++.|+.||+.||.||.+.. |||.||||.||||- .-|.|||.||||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 99999999999999999998765 899999999999999999999874 99999999999995 346899999999
Q ss_pred ccccccccc--------CccccCCCCcCCchhhcc----CCCCccccchhHHHHHHHHHhCCCCCcccChHH-HHHH--h
Q 043248 155 AKTLKADDL--------ASSVVGTPNYMCPELLAD----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-LISK--I 219 (1092)
Q Consensus 155 A~~l~~d~~--------~st~vGTp~YmAPEVL~g----~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d-li~k--I 219 (1092)
+..+..+.. .....||.||++||++.- .+.+.++||||+|||||..+.|+.||....... ++.. |
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 999876532 344679999999998843 246899999999999999999999997654322 2211 1
Q ss_pred hcc--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 220 NRS--SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 220 ~~~--~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+. ...+.-..++.++++||++||++--+.|..+.++..||||..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111 111233457999999999999999999999999999999853
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=349.18 Aligned_cols=260 Identities=24% Similarity=0.459 Sum_probs=234.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+.+++++..||-||||.|-++........+|+|++++... .....+.+..|-.||..++.+.||+||..|.+.. ++|
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-yvY 496 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-YVY 496 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-hhh
Confidence 45677888999999999999998877666689998876543 2334567889999999999999999999996655 899
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
++||-|-||.|+..+..++. |.+..++.|+..+++|++|||++|||+|||||+|++|+.+|-+||.|||+|+.+..+.
T Consensus 497 mLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999999987764 9999999999999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-CCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-IGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-i~plPs~iS~eLkDLIrk 241 (1092)
...++|||+.|.|||++.+...+.++|+||||+++||||+|.+||.+.+.......|.+.. .-.+|..+...+.+||++
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK 654 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999888877776642 335788899999999999
Q ss_pred hcccCCCCCCC-----HHHHHhChhhHhHh
Q 043248 242 MLRKNPEHRPS-----ASELLKHPFLQHFV 266 (1092)
Q Consensus 242 cLqkDPskRPS-----aeELLqHPwFq~~~ 266 (1092)
++..+|.+|.. +.+|.+|.||..|-
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 99999999975 89999999998763
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.61 Aligned_cols=258 Identities=25% Similarity=0.524 Sum_probs=225.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
+..+|.++..||+|+||.|.++..+.+.+.||||+++++.... ...+.-+.|-.+|... +-|.+++|+.+|+.-+ .+
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-RL 425 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-RL 425 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-he
Confidence 3457889999999999999999999999999999998764322 2233444566666655 4688999999887655 68
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc-cc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KA 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l-~~ 160 (1092)
|+||||+.||+|-..|++.+. |.|..+..|+..|+-||-|||++|||+||||.+||||+.+|++||+|||++..- -.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 899999999999999998765 999999999999999999999999999999999999999999999999999854 34
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
+....+.|||+.|+|||++...+|+..+|+||+||+|||||.|.+||.+.+..+++..|..... ..|..+|.++.++++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPKslSkEAv~ick 582 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPKSLSKEAVAICK 582 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcccccHHHHHHHH
Confidence 4556789999999999999999999999999999999999999999999999999999986654 467889999999999
Q ss_pred HhcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
..|.+.|.+|.. -.+|-.||||..+
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999965 3688899999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=340.54 Aligned_cols=261 Identities=23% Similarity=0.412 Sum_probs=223.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCc---E-EEEEEEec-ccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKK---K-YVLKKIRL-ARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk---~-VAIKkIkk-s~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++-.+.++||+|+||.||+|..+..+. . ||+|.... ..........+++|+++|++++|||||++||+.....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34566678999999999999999876532 3 89998876 3356667889999999999999999999999987766
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
-+|||||+|.||+|.++|++... .++..+...++.+.+.||+|||++++|||||-..|+|+..++.+||+|||+++.-
T Consensus 235 -Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 235 -PLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred -ccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 46799999999999999998764 5899999999999999999999999999999999999999999999999998876
Q ss_pred cccccCccc-cCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHh-hccCCCCCCCCCCHHH
Q 043248 159 KADDLASSV-VGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKI-NRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 159 ~~d~~~st~-vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI-~~~~i~plPs~iS~eL 235 (1092)
......... --...|+|||.+....|++++|||||||++||+++ |..||.+....+...++ ......+.+...+.++
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 532222212 24568999999999999999999999999999998 88999999999999999 4455556777788899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
..++.+||..+|++|+++.++.+ +++.+...
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~~ 423 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK--KLEALEKK 423 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH--HHHHHHhc
Confidence 99999999999999999999987 36555443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.84 Aligned_cols=253 Identities=27% Similarity=0.481 Sum_probs=209.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--C----CcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH--P----YIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H--P----NIVKL~gvF~e~d 78 (1092)
-++|.++++||+|.||.|..+.+..++..||+|+++.. ...++...-|+.+|++|.+ | -++++.++|.-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 57999999999999999999999999999999998643 3345567779999999943 2 2678888885544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---------------
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK--------------- 143 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~--------------- 143 (1092)
+.|||+|.+ |.+++++|+.++...|+...++.+.+||+.+++|||+.+++|.||||+|||+..
T Consensus 165 -hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 165 -HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred -ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 889999999 679999999988888999999999999999999999999999999999999831
Q ss_pred -----CCCEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH---H
Q 043248 144 -----DQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG---L 215 (1092)
Q Consensus 144 -----dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d---l 215 (1092)
...|+|+|||.|....+.. .+.+.|..|+|||++.+.+++..+||||+||||+||++|...|+.-+..+ +
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 2348999999998776553 77889999999999999999999999999999999999999998765443 2
Q ss_pred HHHhhccC-----------------CCCCCCC----------------------C---CHHHHHHHHHhcccCCCCCCCH
Q 043248 216 ISKINRSS-----------------IGPLPSC----------------------Y---SPSLKTLIKGMLRKNPEHRPSA 253 (1092)
Q Consensus 216 i~kI~~~~-----------------i~plPs~----------------------i---S~eLkDLIrkcLqkDPskRPSa 253 (1092)
++.|.... .-.++.. . -.++.|||++||.+||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 33322100 0000100 0 1247899999999999999999
Q ss_pred HHHHhChhhHh
Q 043248 254 SELLKHPFLQH 264 (1092)
Q Consensus 254 eELLqHPwFq~ 264 (1092)
.|+|.||||..
T Consensus 401 ~EAL~HpFF~~ 411 (415)
T KOG0671|consen 401 REALSHPFFAR 411 (415)
T ss_pred HHHhcCHHhhc
Confidence 99999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=340.34 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=214.7
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
-|..++.||-|+||.|.++....+...||+|.+++.+... .....+..|..||..-..+-||+||..|++++ .+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEEE
Confidence 4778899999999999999999999999999998765433 33556778999999999999999999998877 577999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc---
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--- 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--- 162 (1092)
+|++||+|-.+|.+.+- |.|..++.|+..|..|+++.|+.|+|||||||+|||||.+|+|||.||||+.-+....
T Consensus 709 dYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 99999999999988764 9999999999999999999999999999999999999999999999999997552110
Q ss_pred ----------------------------------------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh
Q 043248 163 ----------------------------------------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA 202 (1092)
Q Consensus 163 ----------------------------------------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT 202 (1092)
.....+||+.|+|||++....|+.-+|+||.|||||+|+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 0012379999999999999999999999999999999999
Q ss_pred CCCCCcccChHHHHHHhhcc---CCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhChhhHhH
Q 043248 203 HRPAFKAFDMAGLISKINRS---SIGPLPSCYSPSLKTLIKGMLRKNPEHRP---SASELLKHPFLQHF 265 (1092)
Q Consensus 203 Gr~PF~g~d~~dli~kI~~~---~i~plPs~iS~eLkDLIrkcLqkDPskRP---SaeELLqHPwFq~~ 265 (1092)
|++||......+...++..- .-.+...+++.++.+||.+++ .+++.|. .++++..||||+.+
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 99999877665544444321 111344568999999999865 4677785 47789999999764
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=344.77 Aligned_cols=254 Identities=30% Similarity=0.545 Sum_probs=214.8
Q ss_pred CCe-EEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc--ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-eEE
Q 043248 6 DQY-EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR--QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-CYV 81 (1092)
Q Consensus 6 DrY-eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~--~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~~l 81 (1092)
++| +....||+|+|-+||+|.+..+|..||=-.++... .......+|..|+.+|+.|+|||||++|.+|.+.. ..+
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 345 34578999999999999999999988844333322 23344578999999999999999999999998754 357
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcC-CCCEEEeecCccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTK-DQDVRLGDFGLAKTL 158 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~-dG~LKLiDFGLA~~l 158 (1092)
.+|+|++..|+|..|+++.+. ++.+.++.|++||+.||.|||++. |||||||.+||||+. .|.|||+|+|||..+
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 799999999999999998875 888999999999999999999985 999999999999975 478999999999998
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc-ChHHHHHHhhccCCC-CCCCCCCHHHH
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSIG-PLPSCYSPSLK 236 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~-d~~dli~kI~~~~i~-plPs~iS~eLk 236 (1092)
....... .+|||.|||||.+. ..|...+||||||+.|+||+|+..||..- +...+..++..+..+ .+...-.++++
T Consensus 197 r~s~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 197 RKSHAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR 274 (632)
T ss_pred hccccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence 8665444 89999999999998 69999999999999999999999999764 455555555544332 23344478999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||.+||.. .++|+|+.|+|+||||..
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 999999999 999999999999999974
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=318.58 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=215.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++.+++..||.|.-|+|+++..+.+|..+|||.+......++..+ +...+.++... .+|+||+.++||..+. .++|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kR-ILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKR-ILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHH-HHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHH
Confidence 4556778899999999999999999999999999998877666554 44556555554 4999999999997654 5678
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
.||.+. ..++.++++- ...++|..+-++...++.||.||-+ +||||||+||+|||||..|++||||||.+-.+-...
T Consensus 169 cMelMs-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 169 CMELMS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 899884 3455555543 4569999999999999999999996 589999999999999999999999999998887777
Q ss_pred cCccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCccc-ChHHHHHHhhccCCCCCC--CCCCHHHH
Q 043248 163 LASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSIGPLP--SCYSPSLK 236 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~-d~~dli~kI~~~~i~plP--s~iS~eLk 236 (1092)
......|-+.|||||.+. ...|+.++||||||++|+||.||..||.+- ...+.+.++.....+.++ ..+++.|.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 777888999999999983 567999999999999999999999999984 344666666665444333 33799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+|+..||.+|+.+||...++|+|||+..+
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 99999999999999999999999998653
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.45 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=206.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec----CeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK----GCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~----d~~ 80 (1092)
-+||+|.++||.|||+.||++++..+++.||+|++.... ....+...+|+...++++|||+++++++.... ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 469999999999999999999999999999999997654 34467889999999999999999998875432 346
Q ss_pred EEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 81 VCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.||++.|+..|+|.+.|... ++..++|.++..|+.+|++||++||+.. ++||||||.|||+...+.++|.|||.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 88999999999999998754 3446999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc----------CccccCCCCcCCchhhcc---CCCCccccchhHHHHHHHHHhCCCCCcccChHH--HHHHhhc
Q 043248 157 TLKADDL----------ASSVVGTPNYMCPELLAD---IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG--LISKINR 221 (1092)
Q Consensus 157 ~l~~d~~----------~st~vGTp~YmAPEVL~g---~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d--li~kI~~ 221 (1092)
...-.-. ......|..|+|||++.- ...+.++|||||||+||.|+.|..||...-..+ +--.+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 7642211 112357889999999954 456899999999999999999999995321100 0001111
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 222 SS-IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 222 ~~-i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.. ..+....+++.+..||+.||+.||.+||++.+++.+
T Consensus 258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11 112334489999999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=342.29 Aligned_cols=244 Identities=30% Similarity=0.510 Sum_probs=209.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+.|.+...+|.|+|+.|-.+.+..+++.+++|++.... ....+|+.++... +||||++++++|. .+.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~-~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYE-DGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceec-CCceee
Confidence 4678999999999999999999999999999999997652 2233466555544 7999999999984 455889
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-cCCCCEEEeecCcccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL-D~dG~LKLiDFGLA~~l~~d 161 (1092)
+|||++.|+.|.+.|..... +. .++..|+++|+.|+.|||++|||||||||+|||+ +..++++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999999998877653 33 7888999999999999999999999999999999 68899999999999988765
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH-HHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~-dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
..+-+-|..|.|||++....|+.++||||||++||+||+|+.||...... ++...+. .+.+...+|..+++||.
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~---~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ---MPKFSECVSDEAKDLLQ 544 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc---CCccccccCHHHHHHHH
Confidence 44557789999999999999999999999999999999999999865443 4444443 33445889999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwF 262 (1092)
+||+.||.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=358.38 Aligned_cols=254 Identities=33% Similarity=0.631 Sum_probs=205.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-------
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK------- 77 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~------- 77 (1092)
+.+|+.+++||+||||.||+++++-+|..||||++.... .......+.+|+.+|.+|+|||||++|..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 356788999999999999999999999999999998876 566678899999999999999999988643100
Q ss_pred --------------------------------------------------------------------------------
Q 043248 78 -------------------------------------------------------------------------------- 77 (1092)
Q Consensus 78 -------------------------------------------------------------------------------- 77 (1092)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 043248 78 -----------------------G--------CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126 (1092)
Q Consensus 78 -----------------------d--------~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS 126 (1092)
+ ..+||-||||+...|.+++.++.... ....++++|+||++||+|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 0 35799999999988888887665311 478899999999999999999
Q ss_pred CCccccCCCCCcEEEcCCCCEEEeecCcccccc----c---------------cccCccccCCCCcCCchhhccC---CC
Q 043248 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK----A---------------DDLASSVVGTPNYMCPELLADI---PY 184 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~----~---------------d~~~st~vGTp~YmAPEVL~g~---~y 184 (1092)
+|||||||||.||||+.++.|||+|||+|.... . ....+..+||..|+|||++.+. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998722 0 0123456899999999999765 49
Q ss_pred CccccchhHHHHHHHHHhCCCCCcc-cChHHHHHHhhccCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhCh
Q 043248 185 GFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGLISKINRSSIGPL---PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHP 260 (1092)
Q Consensus 185 S~KSDVWSLGVILYELLTGr~PF~g-~d~~dli~kI~~~~i~pl---Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHP 260 (1092)
+.|+||||||+|||||+. ||.- ......+.++....++.. ...--+.-..+|++||+.||.+|||+.|+|++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 999999999999999984 5653 344455566664444322 111123456899999999999999999999999
Q ss_pred hhH
Q 043248 261 FLQ 263 (1092)
Q Consensus 261 wFq 263 (1092)
||.
T Consensus 873 llp 875 (1351)
T KOG1035|consen 873 LLP 875 (1351)
T ss_pred CCC
Confidence 886
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=343.74 Aligned_cols=251 Identities=24% Similarity=0.439 Sum_probs=219.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.+.++.+.||+|+||.||+|+.. .....||||.++... ....+..|.||+.++..|+|||||+|++++.+.+ -
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGD-P 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-e
Confidence 34567889999999999998854 334679999987553 3445678999999999999999999999998776 5
Q ss_pred EEEEEeecCCCCHHHHHHHcC--------CC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEE
Q 043248 81 VCIVTGYCEGGDMAELMKKSN--------GA----YFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVR 148 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~--------gk----~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LK 148 (1092)
+|+|+|||..|+|.++|.... +. .|+..+.+.|+.||+.|++||-++.+|||||-..|+||.++..||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 669999999999999997532 22 388999999999999999999999999999999999999999999
Q ss_pred EeecCccccccccccCcc---ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCC
Q 043248 149 LGDFGLAKTLKADDLASS---VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSI 224 (1092)
Q Consensus 149 LiDFGLA~~l~~d~~~st---~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i 224 (1092)
|+|||+++.....+++.. ..-..+|||||.+..++|+.++|||||||+|||+++ |+.||.+....+.+..+.....
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 999999987655443322 223468999999999999999999999999999996 9999999999999999999988
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 225 ~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
-+-|++++.++.+|+..||+.+|.+||++.||-.
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 8899999999999999999999999999999854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=346.49 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=217.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCc-----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKK-----KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk-----~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
+.-++.+.||+|+||.||.|....... .||+|.+... ........|.+|..+|+.++|||||++++++.+.+ .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-P 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-C
Confidence 355788999999999999999865433 3899988755 33455678999999999999999999999998854 5
Q ss_pred EEEEEeecCCCCHHHHHHHcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 81 VCIVTGYCEGGDMAELMKKSN-----GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~-----gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
.+|++|||+||+|..+|++.+ ...|+..+.+.++.||+.|+.||+++++|||||...|+||+....+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 679999999999999999761 245889999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCc-cc--cCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCC
Q 043248 156 KTLKADDLAS-SV--VGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 156 ~~l~~d~~~s-t~--vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~i 231 (1092)
+.+...+++. .. .-...|||||.+....|+.++|||||||+|||+++ |..||...+..+.+..+....+-+.|..+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C 929 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC 929 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence 9443332221 11 22357999999999999999999999999999997 99999999988888877777777889999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
+..+.++|..||+.+|++||++..|++
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999999997
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=331.94 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=178.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC----CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEE----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE----KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWV---- 75 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t----Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~---- 75 (1092)
..++|++.+.||+|+||.||+|.+..+ +..||+|++......+. ...+ .++...+.++..++..|.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 568999999999999999999999988 99999998764322111 1111 112222223322222211
Q ss_pred -ecCeEEEEEEeecCCCCHHHHHHHcCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 043248 76 -EKGCYVCIVTGYCEGGDMAELMKKSNGA------------------YFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKC 136 (1092)
Q Consensus 76 -e~d~~lyLVMEYceGGSL~DLLkkk~gk------------------~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKP 136 (1092)
..+..+++||||+.+++|.+++...... ...+..+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 3345688999999999999999754311 112345678999999999999999999999999
Q ss_pred CcEEEcC-CCCEEEeecCcccccccc--ccCccccCCCCcCCchhhccC----------------------CCCccccch
Q 043248 137 SNIFLTK-DQDVRLGDFGLAKTLKAD--DLASSVVGTPNYMCPELLADI----------------------PYGFKSDIW 191 (1092)
Q Consensus 137 ENILLD~-dG~LKLiDFGLA~~l~~d--~~~st~vGTp~YmAPEVL~g~----------------------~yS~KSDVW 191 (1092)
+|||++. ++.+||+|||++..+... ......+|++.|+|||++... .+..++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 578999999999865432 233457899999999976432 234467999
Q ss_pred hHHHHHHHHHhCCCCCcccChHHHHHH-hhccCC---------C-----------CCCCCCCHHHHHHHHHhcccCCCCC
Q 043248 192 SLGCCMYEMAAHRPAFKAFDMAGLISK-INRSSI---------G-----------PLPSCYSPSLKTLIKGMLRKNPEHR 250 (1092)
Q Consensus 192 SLGVILYELLTGr~PF~g~d~~dli~k-I~~~~i---------~-----------plPs~iS~eLkDLIrkcLqkDPskR 250 (1092)
||||+||+|+++..++... ...+.. +..... . .........+.+||.+||++||++|
T Consensus 364 SlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999999977655321 111111 110000 0 0001123346699999999999999
Q ss_pred CCHHHHHhChhhHh
Q 043248 251 PSASELLKHPFLQH 264 (1092)
Q Consensus 251 PSaeELLqHPwFq~ 264 (1092)
||+.++|+||||+.
T Consensus 442 ~ta~e~L~Hpff~~ 455 (566)
T PLN03225 442 ISAKAALAHPYFDR 455 (566)
T ss_pred CCHHHHhCCcCcCC
Confidence 99999999999965
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.16 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=214.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-------
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG------- 78 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d------- 78 (1092)
+.|+-+.+||+|.||.||+|+.+.+|+.||+|++....+.+.+-....+|+.+|..|+|+|++.++++|....
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566778999999999999999999999999988765555555667889999999999999999998775331
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||.+|+. +|.-+|.... ..|+...|..+|.+++.||.|+|+..|+|||+|++|+||+.+|.+||+|||+++.+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 348999999975 8998886542 45999999999999999999999999999999999999999999999999999776
Q ss_pred cccc-----cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC--------
Q 043248 159 KADD-----LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-------- 224 (1092)
Q Consensus 159 ~~d~-----~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-------- 224 (1092)
.... .+...+.|.+|++||.+.| ..|+.+.|||+.|||+.+|++|.+.|.+.....++..|.....
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 5432 1234567999999999876 5689999999999999999999999999888777766643211
Q ss_pred -------------CCCCCC-------------CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 225 -------------GPLPSC-------------YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 225 -------------~plPs~-------------iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
.+++.. -++++.+|+.++|.+||.+|+.++++|+|.||.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 111111 145788999999999999999999999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=335.77 Aligned_cols=258 Identities=31% Similarity=0.569 Sum_probs=226.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec----C
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK----G 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~----d 78 (1092)
.-+.|+|.+.||.|.+|.||++.++.++..+|+|++......+ ..+..|..+|+.+ .|||++.+|++|.-. +
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3467999999999999999999999999999999987654433 5677788999887 699999999998743 4
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.++|||||||.||+.-++++...+..+.|..|..|++.++.||.|||.+.++|||||-.|||++.++.|||+|||++..+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 68999999999999999999887888999999999999999999999999999999999999999999999999999887
Q ss_pred ccc-ccCccccCCCCcCCchhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--CCCC
Q 043248 159 KAD-DLASSVVGTPNYMCPELLAD-----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSC 230 (1092)
Q Consensus 159 ~~d-~~~st~vGTp~YmAPEVL~g-----~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--lPs~ 230 (1092)
... ....+.+||++|||||++.. ..|+..+|+||||++..||.-|.+|+-..-....+..|.+...+. -+..
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 654 34567899999999999954 357889999999999999999999998877766666666554432 3567
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
++.+|.+||..||.+|..+||+..++|+|||+.+
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 8999999999999999999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=305.43 Aligned_cols=255 Identities=24% Similarity=0.454 Sum_probs=216.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCe-EE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGC-YV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~-~l 81 (1092)
..++|++++++|+|.|+.||.|.+..++..++||+++.. ..+.+.+|+.||+.|. ||||++|+++..+... ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 468899999999999999999999999999999998754 3467889999999997 9999999999876642 35
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKA 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~ 160 (1092)
.+|+||+++.+...+-.. |+...|+.++.+|+.||.|||++||+|||+||.|++|+... .++|+|||+|.++..
T Consensus 111 aLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 689999998777766543 78899999999999999999999999999999999999764 699999999999998
Q ss_pred cccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCC-cccChHHHHHHhhccC---------------
Q 043248 161 DDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAF-KAFDMAGLISKINRSS--------------- 223 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF-~g~d~~dli~kI~~~~--------------- 223 (1092)
+...+..+.+..|..||++.. ..|+...|+|||||+|..|+..+-|| .+.+..+++.+|.+..
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 887888899999999999965 56899999999999999999877666 5666666666653210
Q ss_pred CC---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 224 IG---------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 224 i~---------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+. .....+++++.||+.++|.+|..+|+|+.|++.||||......
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 00 0112247899999999999999999999999999999876653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=316.75 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=222.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----e
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-----C 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-----~ 79 (1092)
..||.-++.+|.|+- .|..|.+.-.++.||+|++..........++..+|+.++..++|+||++++.+|.-.. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888999999999 8889999999999999998776655556788999999999999999999999996443 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+.. +|...+.- .+.-+.+..|+.|++.|++|||+.||+||||||+||++..++.+||.|||+++..+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 57899999964 89888873 27889999999999999999999999999999999999999999999999999888
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-------------
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP------------- 226 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p------------- 226 (1092)
..-..+.++.|+.|.|||++.+..|...+||||+|||+.||++|+..|.+.+..+++.++......+
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 7767788999999999999999889999999999999999999999999988877777764321110
Q ss_pred -----------------CC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 227 -----------------LP-----------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 227 -----------------lP-----------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+| ..-...+.+++.+||..+|++|.+++++|+||||+-|...
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 00 0113468899999999999999999999999999966443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.65 Aligned_cols=258 Identities=27% Similarity=0.559 Sum_probs=221.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ly 82 (1092)
+++|++++.||+|+|+.|.+++++.+.+.||+|++++...++ ....-...|-.+..+- +||.+|.|+.+|+... .++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes-rlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES-RLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-eEE
Confidence 678999999999999999999999999999999987654332 2234455666666665 7999999999886544 778
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc-cccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~-l~~d 161 (1092)
+|.||++||+|-..++++.. |+++.++.|...|+.||.|||++|||+||||.+|+|++..|++||.|+|+++. +..+
T Consensus 328 fvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 99999999999988887665 99999999999999999999999999999999999999999999999999975 4667
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcc-------cChHHHHHHhhccCCCCCCCCCCHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA-------FDMAGLISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g-------~d~~dli~kI~~~~i~plPs~iS~e 234 (1092)
+..+++|||+.|+|||++.+..|++.+|.|+|||+++||+.|+.||.. .+..+.+.++.-...-.+|..++-.
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvk 485 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVK 485 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehh
Confidence 788999999999999999999999999999999999999999999963 2334444444433333577888888
Q ss_pred HHHHHHHhcccCCCCCC------CHHHHHhChhhHhH
Q 043248 235 LKTLIKGMLRKNPEHRP------SASELLKHPFLQHF 265 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRP------SaeELLqHPwFq~~ 265 (1092)
+..+++..|.+||.+|. .+.++..|+||..+
T Consensus 486 as~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 486 ASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred hHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 99999999999999995 47899999999854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=323.36 Aligned_cols=246 Identities=25% Similarity=0.431 Sum_probs=218.7
Q ss_pred EEEEEEeecCceEEEEEEEcCC----CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 9 EIMEQIGRGAFGAAILVNHRAE----KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~t----Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.+.++||.|.||.||.|.+... .-.||||..+.+...+. .+.|..|..+|++++|||||+|++++.+.. .|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e~P--~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVEQP--MWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeeccc--eeEE
Confidence 3567899999999999987533 44588998887655444 788999999999999999999999997765 6899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||++.-|.|..+|+.+.. .|+......|+.||+.||+|||+..+|||||-..|||+....-+||+|||+++.+..+.++
T Consensus 469 mEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999999997654 5899999999999999999999999999999999999999999999999999998877655
Q ss_pred ccccC--CCCcCCchhhccCCCCccccchhHHHHHHHHH-hCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 SSVVG--TPNYMCPELLADIPYGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 st~vG--Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELL-TGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....| ..-|||||.++-..++.++|||-|||.+||++ .|..||.+-...+.+..+.++...+.|.++++.+..|+.+
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSK 627 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHH
Confidence 44444 34699999999999999999999999999987 5999999998889999999999999999999999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q 043248 242 MLRKNPEHRPSASELLK 258 (1092)
Q Consensus 242 cLqkDPskRPSaeELLq 258 (1092)
||+++|.+||.+.++..
T Consensus 628 cWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 628 CWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HhccCcccCCcHHHHHH
Confidence 99999999999988764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=331.98 Aligned_cols=245 Identities=29% Similarity=0.489 Sum_probs=198.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----eE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-----CY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-----~~ 80 (1092)
.-|..-+.||+||||.||.++++.+|+.||||.++... ....++...+|+++|++|+|+|||+++++=.... ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 45667789999999999999999999999999987643 2334566788999999999999999988643222 13
Q ss_pred EEEEEeecCCCCHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCC--EEEeecCcc
Q 043248 81 VCIVTGYCEGGDMAELMKKS-NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT--KDQD--VRLGDFGLA 155 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk-~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD--~dG~--LKLiDFGLA 155 (1092)
-.+|||||.||+|+.++.+- +..+|++.+++.++..+..||.|||++||+||||||.||++- .+|. .||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 46999999999999999753 334599999999999999999999999999999999999984 3343 799999999
Q ss_pred ccccccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccC-------
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSS------- 223 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~------- 223 (1092)
+.+..+......+||+.|++||++.. ..|+..+|.|||||++|+.+||..||..... .+....+....
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 99999999999999999999999984 8899999999999999999999999965322 22333322111
Q ss_pred -------------CCCCCCCCCH----HHHHHHHHhcccCCCCCC
Q 043248 224 -------------IGPLPSCYSP----SLKTLIKGMLRKNPEHRP 251 (1092)
Q Consensus 224 -------------i~plPs~iS~----eLkDLIrkcLqkDPskRP 251 (1092)
.-+.+..++. .+..++..+|..+|.+|.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0122333333 355788889999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=318.45 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=189.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc----------------CCCcEEEEEEEecccccHH------------HHHHHHHH
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR----------------AEKKKYVLKKIRLARQTER------------CRRSAHQE 55 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK----------------~tGk~VAIKkIkks~~se~------------~~r~f~rE 55 (1092)
..++|++.++||+|+||.||+|.+. ..++.||||++........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3579999999999999999999752 3456799999865422110 11223457
Q ss_pred HHHHHhcCCCCc-----ceEEEEEEec-------CeEEEEEEeecCCCCHHHHHHHcCC---------------------
Q 043248 56 MALIARVQHPYI-----VEFKEAWVEK-------GCYVCIVTGYCEGGDMAELMKKSNG--------------------- 102 (1092)
Q Consensus 56 IqILkqL~HPNI-----VKL~gvF~e~-------d~~lyLVMEYceGGSL~DLLkkk~g--------------------- 102 (1092)
+.++.+++|.++ ++++++|... ....|+||||+++++|.+++....+
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 6677776532 2357899999999999999874321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCcc--ccCCCCcCCchhh
Q 043248 103 -AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS--VVGTPNYMCPELL 179 (1092)
Q Consensus 103 -k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st--~vGTp~YmAPEVL 179 (1092)
..+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++..+........ ..+++.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1245678899999999999999999999999999999999999999999999976654332222 2347899999988
Q ss_pred ccCC--------------------CC--ccccchhHHHHHHHHHhCCC-CCcccChHH-----------HHHHhhccCCC
Q 043248 180 ADIP--------------------YG--FKSDIWSLGCCMYEMAAHRP-AFKAFDMAG-----------LISKINRSSIG 225 (1092)
Q Consensus 180 ~g~~--------------------yS--~KSDVWSLGVILYELLTGr~-PF~g~d~~d-----------li~kI~~~~i~ 225 (1092)
.... |+ ...||||+|||+|+|++|.. ||....... .+..+....+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5322 22 24799999999999999875 775321111 11111111111
Q ss_pred -CCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHhChhhH
Q 043248 226 -PLPSCYSPSLKTLIKGMLRKNP---EHRPSASELLKHPFLQ 263 (1092)
Q Consensus 226 -plPs~iS~eLkDLIrkcLqkDP---skRPSaeELLqHPwFq 263 (1092)
......++.+++|+.+||.++| .+|+|++|+|+||||.
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 1233468999999999999866 6899999999999995
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=312.81 Aligned_cols=133 Identities=27% Similarity=0.449 Sum_probs=119.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----C---CCcceEEEEEEec
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-----H---PYIVEFKEAWVEK 77 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-----H---PNIVKL~gvF~e~ 77 (1092)
++|-+.++||.|-|++||+|++....+.||+|+.+.. +...+....||.+|++++ | .+||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 6999999999999999999999999999999999754 445677889999999984 2 4699999999865
Q ss_pred ---CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEc
Q 043248 78 ---GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 78 ---d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD 142 (1092)
+.++|||+|++ |-+|..+|++.+.+.++...+++|++|||.||.|||. .||||.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 46899999999 6799999999988889999999999999999999995 5999999999999973
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=319.36 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=212.9
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC------CCcceEEEEEE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH------PYIVEFKEAWV 75 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H------PNIVKL~gvF~ 75 (1092)
|-.-++|.+....|+|-|++|..|.+..-|..||||+|+. ++...+.-.+|+.||++|+. -|+++|+..|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3345699999999999999999999999999999999974 45556677889999999973 47899998885
Q ss_pred ecCeEEEEEEeecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecC
Q 043248 76 EKGCYVCIVTGYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFG 153 (1092)
Q Consensus 76 e~d~~lyLVMEYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFG 153 (1092)
..+ ++|||+|-+ ..+|.++|++-+. .+|....++.|+.||+-||..|-..||+|.||||+|||+++.- .+||||||
T Consensus 505 hkn-HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 505 HKN-HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hcc-eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 554 899999998 4699999987542 3588899999999999999999999999999999999999765 58999999
Q ss_pred ccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--CC------
Q 043248 154 LAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS--IG------ 225 (1092)
Q Consensus 154 LA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~--i~------ 225 (1092)
.|........ ..+..+.+|.|||++.|.+|+...|+||+||+||||+||+..|.+.....++....... ++
T Consensus 583 SA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 583 SASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 9998876654 45667899999999999999999999999999999999999999876554444332100 00
Q ss_pred -----------------------------------C-------------CCC---CCCHHHHHHHHHhcccCCCCCCCHH
Q 043248 226 -----------------------------------P-------------LPS---CYSPSLKTLIKGMLRKNPEHRPSAS 254 (1092)
Q Consensus 226 -----------------------------------p-------------lPs---~iS~eLkDLIrkcLqkDPskRPSae 254 (1092)
+ ++. .+-..|++||.+||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 0 000 0113588999999999999999999
Q ss_pred HHHhChhhHh
Q 043248 255 ELLKHPFLQH 264 (1092)
Q Consensus 255 ELLqHPwFq~ 264 (1092)
++|+||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999963
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=321.32 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=223.1
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCC---cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEK---KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tG---k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+.++.++||+|.||.|+.+.+...+ ..||||.++...... ....|.+|+.+|.+|+|+|+++||++.... -+.|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q--p~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ--PAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc--hhhH
Confidence 4456789999999999999987543 458999998765554 457899999999999999999999998763 4669
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
|||+++.|+|.+.|.+.....|.....+.|+.||+.|+.||.++++|||||-..|+||-....|||+||||.+.++..+.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999999986566788999999999999999999999999999999999999888999999999999887664
Q ss_pred CccccC----CCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 164 ASSVVG----TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 164 ~st~vG----Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
++...+ ...|+|||.|...+|+.++|||+|||+||||++ |+.||.+-....++.+|.....-+-|..+++.+.++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i 347 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI 347 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence 443332 356999999999999999999999999999996 899999999999999999887778899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhH
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
++.||..+|.+|||+..|...-++.
T Consensus 348 mk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHhccCCccccccHHHHHHhHHHH
Confidence 9999999999999999997654443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=313.20 Aligned_cols=247 Identities=21% Similarity=0.392 Sum_probs=221.4
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
..+.++||-|.||.||.+.++.-.-.||||.++- ......+|..|..+|+.++|||+|+|+++|.... -+|||+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-PFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-PFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-CeEEEEec
Confidence 3467899999999999999999999999999863 3455678999999999999999999999997655 57799999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV 167 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~ 167 (1092)
|..|+|.+||.+.+...++.-.+++++.||..|++||..+++|||||-..|+|+.++..+|++||||++++..+.+ ...
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAH 423 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecc
Confidence 9999999999998887788888899999999999999999999999999999999999999999999999986643 222
Q ss_pred cC---CCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 168 VG---TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 168 vG---Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
.| ..-|.|||-|....++.++|||+|||+|||+.| |-.||.+.+.......+.+.....-|+.+++.+..|++.||
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW 503 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACW 503 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence 33 356999999999999999999999999999986 89999999988888888778778889999999999999999
Q ss_pred ccCCCCCCCHHHHHhC
Q 043248 244 RKNPEHRPSASELLKH 259 (1092)
Q Consensus 244 qkDPskRPSaeELLqH 259 (1092)
+..|.+||++.|+-+.
T Consensus 504 ~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 504 NWSPSDRPSFAEIHQA 519 (1157)
T ss_pred cCCcccCccHHHHHHH
Confidence 9999999999998653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=332.08 Aligned_cols=238 Identities=21% Similarity=0.277 Sum_probs=187.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
..|...+.||+|+||.||+|.++.++..||+|++...... ...|+.++++++|||||+++++|...+ ..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEK-GAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCC-CCEEEE
Confidence 3456678999999999999999999999999988643221 224688899999999999999997655 678999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH---SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLH---SkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999999963 789999999999999999999 6699999999999999988887775 665543322
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC-----hHHHHHHhhcc-----CCCC-C----
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-----MAGLISKINRS-----SIGP-L---- 227 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d-----~~dli~kI~~~-----~i~p-l---- 227 (1092)
.....|+..|+|||++.+..|+.++|||||||++|||++|+.||.... ...+....... ...+ +
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 223478999999999999999999999999999999999999985321 11111111100 0000 0
Q ss_pred --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 228 --PSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 228 --Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+.....++.+++.+||+.+|++|||+.|+++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 01112357789999999999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=296.98 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=206.5
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHH-HHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL-IARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqI-LkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
+-+..||.|+||+|++..++.+|+..|||+++....... ...+..|+.. ++.-++||||++|+.....+ ..||.||+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~EG-dcWiCMEL 144 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-DCWICMEL 144 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-ceeeeHHH
Confidence 345789999999999999999999999999987655333 3445556554 44557999999999876555 45689999
Q ss_pred cCCCCHHHHHH---HcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 88 CEGGDMAELMK---KSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 88 ceGGSL~DLLk---kk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
++ .+|..+-+ ......++|..+-.|....+.||.||-+ ..||||||||+|||++..|.+||||||.+-.+...-.
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 95 46655433 3344458999999999999999999985 5899999999999999999999999999987766555
Q ss_pred CccccCCCCcCCchhhc--cCCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhccCCCCC--CC---CCCHHH
Q 043248 164 ASSVVGTPNYMCPELLA--DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRSSIGPL--PS---CYSPSL 235 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~--g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~~i~pl--Ps---~iS~eL 235 (1092)
.+...|-..|||||.+. +..|+.++||||||++|||+.||..|+.+++. .+++..+.....+.+ +. .++..+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 56678999999999984 45699999999999999999999999988653 455555554433322 11 268899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
..||..||.+|-..||...+++++||+..+..
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 99999999999999999999999999876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=245.07 Aligned_cols=212 Identities=40% Similarity=0.742 Sum_probs=186.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCH
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM 93 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL 93 (1092)
||.|++|.||++....+++.+++|++....... ....+.+|+..++.++|++|+++++++... ...+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcH
Confidence 689999999999998889999999997654432 346788999999999999999999998665 477899999999999
Q ss_pred HHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCccccccccc-cCccccCCC
Q 043248 94 AELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAKTLKADD-LASSVVGTP 171 (1092)
Q Consensus 94 ~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~~l~~d~-~~st~vGTp 171 (1092)
.+++.... ..+++..++.++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+..
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 99998752 23899999999999999999999999999999999999998 8999999999998765442 233456888
Q ss_pred CcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 043248 172 NYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHR 250 (1092)
Q Consensus 172 ~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskR 250 (1092)
.|++||.+... .++.+.|+|+||+++|+| ..+.+++.+||+.+|.+|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccC
Confidence 99999999877 889999999999999999 678999999999999999
Q ss_pred CCHHHHHhCh
Q 043248 251 PSASELLKHP 260 (1092)
Q Consensus 251 PSaeELLqHP 260 (1092)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=312.96 Aligned_cols=257 Identities=23% Similarity=0.420 Sum_probs=227.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCC---cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEK---KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tG---k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
....|.+.||.|-||.||.+..+..| ..||||.++.. ..+..++.|..|+.||-++.||||++|.++..... -++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-PVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-eeE
Confidence 34578999999999999999998776 45899999765 44556788999999999999999999999985544 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||.|||++|+|+.+|+++.++ |+..++...++.|+.|++||-+.|+|||||...|||++.+-.+|++||||++.+..+.
T Consensus 707 IiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999999988865 9999999999999999999999999999999999999999999999999999875543
Q ss_pred -cCccccC---CCCcCCchhhccCCCCccccchhHHHHHHHHH-hCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 163 -LASSVVG---TPNYMCPELLADIPYGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 163 -~~st~vG---Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELL-TGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
...+..| ...|.|||.+...+++.++||||+|++|||.+ .|..||+.....+.+..|.....-+.|-.++..+..
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 2222222 25799999999999999999999999999966 699999999999999999999888889999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|+..||++|=.+||.+.||+.+ |.++..
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~--lDklIr 893 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVST--LDKLIR 893 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHH--HHHHhc
Confidence 9999999999999999999986 555443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=301.87 Aligned_cols=250 Identities=23% Similarity=0.394 Sum_probs=210.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
...+.++||+|.||.|.+|+.. .+..||+|+++... ....++.|.+|+++|.+|+||||+.|+++|..++ -+|+|+|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHHH
Confidence 3467899999999999999863 47899999998654 3445788999999999999999999999997766 5779999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc-
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS- 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s- 165 (1092)
|++.|+|..++.++....+.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+..++...
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999998854445667778899999999999999999999999999999999999999999999765544332
Q ss_pred --cccCCCCcCCchhhccCCCCccccchhHHHHHHHHH--hCCCCCcccChHHHHHHhhcc-------CCCCCCCCCCHH
Q 043248 166 --SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRS-------SIGPLPSCYSPS 234 (1092)
Q Consensus 166 --t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELL--TGr~PF~g~d~~dli~kI~~~-------~i~plPs~iS~e 234 (1092)
..+-...|||+|.+..++++.++|+|+||+++||++ +...||......+.+.+.... .+...|..++..
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~ 775 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQG 775 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHH
Confidence 234457899999999999999999999999999975 578899876665555554322 223466778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+.++|.+||..+-++||+++++..|
T Consensus 776 lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 776 LYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred HHHHHHHHhchhhhcCCCHHHHHHH
Confidence 9999999999999999999999764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=303.00 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=214.9
Q ss_pred eEEEEEEeecCceEEEEEEEcC-------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCe
Q 043248 8 YEIMEQIGRGAFGAAILVNHRA-------EKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~-------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~ 79 (1092)
..+.+.||.|+||.|++|.... ....||||.++..... ...+.+..|+.+|+.+ +|+||+.+++++.. ..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~ 375 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DG 375 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-CC
Confidence 3566799999999999987431 1456899998766554 5577899999999999 59999999999977 55
Q ss_pred EEEEEEeecCCCCHHHHHHHcC------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 043248 80 YVCIVTGYCEGGDMAELMKKSN------G--------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ 145 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~------g--------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG 145 (1092)
.+++|+|||..|+|..++...+ . ..|+..+...+++||+.|++||++.++|||||-..|||+..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 7889999999999999998765 0 1388999999999999999999999999999999999999999
Q ss_pred CEEEeecCccccccccccCc--cccC--CCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccC-hHHHHHHh
Q 043248 146 DVRLGDFGLAKTLKADDLAS--SVVG--TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFD-MAGLISKI 219 (1092)
Q Consensus 146 ~LKLiDFGLA~~l~~d~~~s--t~vG--Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d-~~dli~kI 219 (1092)
.+||+|||+++......... ...| ...|||||.+....|+.++||||||++||||++ |..||.+.. ..++...+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l 535 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL 535 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence 99999999999765443332 1222 235999999999999999999999999999997 899998855 56666677
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
..+.....|..++.++.+|++.||..+|++||++.++.+. |..
T Consensus 536 ~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~--~~~ 578 (609)
T KOG0200|consen 536 KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF--FEK 578 (609)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH--HHH
Confidence 7777778899999999999999999999999999999863 544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=291.00 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=208.9
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe----EEEEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC----YVCIVT 85 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~----~lyLVM 85 (1092)
--+.||-|+||.||.+.+..+|+.|++|++......-...+.+++|+.+|..++|.|++..+++.+.... .+|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3478999999999999999999999999997666666667889999999999999999999887654431 356788
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--c
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--L 163 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--~ 163 (1092)
|++. .+|..+|-.-. .|+...++-+++||+.||+|||+.||.||||||.|+|++.+..+||||||+++....++ .
T Consensus 137 ELmQ-SDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHH-hhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 8884 57887776543 48999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-----------------
Q 043248 164 ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----------------- 225 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----------------- 225 (1092)
+...+.|.+|+|||++.| ..|+..+||||+|||+.||+..+..|...+..+++..|......
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 344577899999999976 56899999999999999999999999887776666665321110
Q ss_pred --------CCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 226 --------PLP--------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 226 --------plP--------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.++ ..-..+..+++.++|..||++|++.++++.|+|+.+.
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 011 1123467789999999999999999999999988653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-29 Score=244.81 Aligned_cols=212 Identities=33% Similarity=0.581 Sum_probs=181.9
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
|.+.+.||.|+||.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++++... ...++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEec
Confidence 67899999999999999999988999999999765433 2456788999999999999999999988654 467899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--cCc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LAS 165 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~--~~s 165 (1092)
+.+++|.+++...... +++..+..++.+++.+|.|||++|++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999999875432 7899999999999999999999999999999999999999999999999998876543 345
Q ss_pred cccCCCCcCCchhh-ccCCCCccccchhHHHHHHHHHhCCCCCcc-cC-hHHHHHHhhcc
Q 043248 166 SVVGTPNYMCPELL-ADIPYGFKSDIWSLGCCMYEMAAHRPAFKA-FD-MAGLISKINRS 222 (1092)
Q Consensus 166 t~vGTp~YmAPEVL-~g~~yS~KSDVWSLGVILYELLTGr~PF~g-~d-~~dli~kI~~~ 222 (1092)
...++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+ ...+...+...
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 56788999999998 677788899999999999999999999977 33 33555555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=298.35 Aligned_cols=202 Identities=26% Similarity=0.441 Sum_probs=179.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHH------HHHHHHHHHHHHhcC---CCCcceEEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERC------RRSAHQEMALIARVQ---HPYIVEFKEAW 74 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~------~r~f~rEIqILkqL~---HPNIVKL~gvF 74 (1092)
.+..|..++.||.|+||.|++|.++.+...|+||.+.+.+..... .-.+--|++||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 456799999999999999999999999999999999876533221 123667999999998 99999999999
Q ss_pred EecCeEEEEEEeec-CCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 75 VEKGCYVCIVTGYC-EGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 75 ~e~d~~lyLVMEYc-eGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
.++ .++||+||-. +|.+|+++|..+.. ++|.++..|++|++.|+++||++||||||||-+|+.++.+|-+||+|||
T Consensus 639 Edd-d~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDD-DYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecC-CeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 554 4788999975 67799999988765 9999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcc
Q 043248 154 LAKTLKADDLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKA 209 (1092)
Q Consensus 154 LA~~l~~d~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g 209 (1092)
.+...+.+ .+..++||..|.|||++.|.+| +..-|||+||++||.++....||+.
T Consensus 716 saa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99877755 4678899999999999999999 7889999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=307.35 Aligned_cols=240 Identities=26% Similarity=0.394 Sum_probs=189.1
Q ss_pred EEEeecCceE-EEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGA-AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGt-VYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+.+|.|+-|+ ||+|.. .|+.||||.+-. .+...+.+|+.+|+.- .|||||++|+.= ......||..|.|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-QDRQFLYIALELCA 586 (903)
T ss_pred HHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-cCCceEEEEehHhh
Confidence 5688998885 888986 578999998753 3456788999999988 599999998643 33457899999996
Q ss_pred CCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CC--CEEEeecCccccccccc
Q 043248 90 GGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQ--DVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 90 GGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG--~LKLiDFGLA~~l~~d~ 162 (1092)
. +|.+++... ..........+.++.|++.||+|||+.+||||||||.||||.. ++ .++|+|||+++.+..+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 4 999999874 1111112456889999999999999999999999999999976 34 58999999999887653
Q ss_pred c----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhC-CCCCcccChHHHHHHhhccCCC--CCCCCCCHHH
Q 043248 163 L----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIG--PLPSCYSPSL 235 (1092)
Q Consensus 163 ~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~dli~kI~~~~i~--plPs~iS~eL 235 (1092)
. .....||-+|+|||++....-..++|||||||++|+.++| ..||...... ..+|...... .+......++
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchHHH
Confidence 2 3456799999999999988888899999999999998885 8999764332 2233322211 1222122289
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+||.+||.++|..||++.++|.||||
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 999999999999999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=298.74 Aligned_cols=255 Identities=28% Similarity=0.550 Sum_probs=212.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
-++|+++..+|.|.||.||+++++.+++..|+|.++...-. ...-+.+|+-+++..+|||||.+++.|...+ .+||.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~d-klwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhc-CcEEE
Confidence 47899999999999999999999999999999999865322 2356778999999999999999999996655 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
||||.||+|.+.-.- .+.+++.++....+..++||+|||++|-+|||||-.|||++..|.+||+|||.+-.+... ..
T Consensus 91 MEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 999999999997543 446999999999999999999999999999999999999999999999999998766543 23
Q ss_pred CccccCCCCcCCchhh---ccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC----CCCCCCHHHH
Q 043248 164 ASSVVGTPNYMCPELL---ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP----LPSCYSPSLK 236 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL---~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p----lPs~iS~eLk 236 (1092)
.....||++|||||+. ....|...+|||++|+...||---++|....-.........+..+.+ -...+++.|.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 4567899999999987 46789999999999999999977666654333222222222222222 3455899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+|++.+|.++|++||+++.+|+|||+..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeecc
Confidence 9999999999999999999999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=277.65 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=198.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcC---CCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRA---EKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~---tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~ 79 (1092)
..+.|.++++||.|.|++||++.+.. ..+.||+|.+...... ..+.+|+.+|..+ .+.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd- 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNND- 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCC-
Confidence 45678999999999999999999887 7899999999765433 3578899999999 4899999999885554
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKTL 158 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~~l 158 (1092)
.+++||||++.....++... ++..+++.|++.++.||+++|.+|||||||||.|||++.. +.-.|+|||+|...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 78899999999888888764 6789999999999999999999999999999999999754 57899999999722
Q ss_pred cccc--------------c-------------------------------CccccCCCCcCCchhhcc-CCCCccccchh
Q 043248 159 KADD--------------L-------------------------------ASSVVGTPNYMCPELLAD-IPYGFKSDIWS 192 (1092)
Q Consensus 159 ~~d~--------------~-------------------------------~st~vGTp~YmAPEVL~g-~~yS~KSDVWS 192 (1092)
.... . .-...||++|+|||++.+ ...+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1000 0 001259999999999965 45688999999
Q ss_pred HHHHHHHHHhCCCCCccc-ChHHHHHHh---------------------hc----------------c------------
Q 043248 193 LGCCMYEMAAHRPAFKAF-DMAGLISKI---------------------NR----------------S------------ 222 (1092)
Q Consensus 193 LGVILYELLTGr~PF~g~-d~~dli~kI---------------------~~----------------~------------ 222 (1092)
.|||+..+++++.||... +..+.+..+ .. .
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 999999999999998431 110000000 00 0
Q ss_pred -CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 223 -SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 223 -~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
........++..+.+|+.+||..||.+|+|++++|+||||...
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0001122245578999999999999999999999999999754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=272.00 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=188.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHH--hcCCCCcceEEEEEEecC---eE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA--RVQHPYIVEFKEAWVEKG---CY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILk--qL~HPNIVKL~gvF~e~d---~~ 80 (1092)
.+.++.+.||+|.||.||.|.++ |..||||++....+ +..++|.+|.+ .|+|+||+.+++.=.... .+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 46789999999999999999885 68899999975543 23445555555 569999999987533222 46
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-----C---CccccCCCCCcEEEcCCCCEEEeec
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-----N---YVLHRDLKCSNIFLTKDQDVRLGDF 152 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-----k---GIIHRDLKPENILLD~dG~LKLiDF 152 (1092)
+|||.+|.+.|+|+|+|.+.. ++.+...+++.-++.||+|||. + .|.|||||..|||+.+++.+.|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 899999999999999999854 8999999999999999999994 2 3999999999999999999999999
Q ss_pred Cccccccccc-----cCccccCCCCcCCchhhccCC----C-C-ccccchhHHHHHHHHHhC----------CCCCccc-
Q 043248 153 GLAKTLKADD-----LASSVVGTPNYMCPELLADIP----Y-G-FKSDIWSLGCCMYEMAAH----------RPAFKAF- 210 (1092)
Q Consensus 153 GLA~~l~~d~-----~~st~vGTp~YmAPEVL~g~~----y-S-~KSDVWSLGVILYELLTG----------r~PF~g~- 210 (1092)
|||....... ..+..+||..|||||+|.... | + ..+||||||.++||++.. .+||...
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9998876542 345679999999999995432 2 2 468999999999999753 4677542
Q ss_pred ----ChHHHHHHhhccC-CCCCCCCCC-----HHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 211 ----DMAGLISKINRSS-IGPLPSCYS-----PSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 211 ----d~~dli~kI~~~~-i~plPs~iS-----~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
+..++..-+.... .+.+|..+. ..+..|++.||..+|.-|.|+--+.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3333333332222 233444432 24667899999999999999877765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=286.94 Aligned_cols=253 Identities=19% Similarity=0.323 Sum_probs=217.0
Q ss_pred EEEEEEeecCceEEEEEEEcCCCc----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKK----KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk----~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+..++||+|+||+||++.+...|+ +||||++... ........+.+|+.+|..|.|||+++|++++.... +.||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 346899999999999999876655 4677776543 23333467889999999999999999999987665 6689
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
++|+++|.|.++++.++. .+-.+..+.|..||++|+.|||+++++||||-..|||+..-..+||.|||+++....+...
T Consensus 776 tq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 999999999999998654 4888999999999999999999999999999999999999999999999999998876544
Q ss_pred cccc---CCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 165 SSVV---GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 165 st~v---GTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
...- -..-|||-|.+....|+.++|||||||++|||+| |..|+.+....++...+.....-+.|...+-++.-++.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 3332 2356899999999999999999999999999986 99999998888888877777777778889999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+||..|+..||++.++... |.++..
T Consensus 935 kCwmid~~~rp~fkel~~~--fs~~ar 959 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAEE--FSRMAR 959 (1177)
T ss_pred HHhccCcccCccHHHHHHH--HHHHhc
Confidence 9999999999999999865 655544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=227.22 Aligned_cols=253 Identities=35% Similarity=0.572 Sum_probs=208.0
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCC-CcceEEEEEEecCeEEEEEE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHP-YIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-~~r~f~rEIqILkqL~HP-NIVKL~gvF~e~d~~lyLVM 85 (1092)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.... ..++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-SLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-EEEEEE
Confidence 889999999999999999987 7889999877655543 567899999999999988 7999999994444 578999
Q ss_pred eecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCccccccccc-
Q 043248 86 GYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~d~- 162 (1092)
+|+.+++|.+++..... ..+.+..+..++.|++.+|.|+|+.|++||||||+||+++..+ .++++|||++..+....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977765431 1489999999999999999999999999999999999999988 69999999998665443
Q ss_pred ------cCccccCCCCcCCchhhcc---CCCCccccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccCCC----
Q 043248 163 ------LASSVVGTPNYMCPELLAD---IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIG---- 225 (1092)
Q Consensus 163 ------~~st~vGTp~YmAPEVL~g---~~yS~KSDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~i~---- 225 (1092)
......|+..|++||.+.+ ..++...|+|++|+++++++.|..||..... ......+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 3467789999999999987 5788999999999999999999999887663 3444444333322
Q ss_pred CCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 226 PLPSCY----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 226 plPs~i----S~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
...... ...+.+++.+++..+|..|.+..+...++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 111111 157899999999999999999999998866543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=298.35 Aligned_cols=202 Identities=15% Similarity=0.185 Sum_probs=149.6
Q ss_pred hcCC-CCcceEEEEEEec------CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 043248 61 RVQH-PYIVEFKEAWVEK------GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRD 133 (1092)
Q Consensus 61 qL~H-PNIVKL~gvF~e~------d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRD 133 (1092)
.++| .||++++++|... ...++++|||+ +++|+++|.... ..+++..++.|+.||+.||.|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3445 5788888877211 12466788887 569999997533 4499999999999999999999999999999
Q ss_pred CCCCcEEEcCC-------------------CCEEEeecCccccccccc-----------------cCccccCCCCcCCch
Q 043248 134 LKCSNIFLTKD-------------------QDVRLGDFGLAKTLKADD-----------------LASSVVGTPNYMCPE 177 (1092)
Q Consensus 134 LKPENILLD~d-------------------G~LKLiDFGLA~~l~~d~-----------------~~st~vGTp~YmAPE 177 (1092)
|||+||||+.. +.+||+|||+++...... .....+||++|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999653 445666666665321100 001246899999999
Q ss_pred hhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 043248 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELL 257 (1092)
Q Consensus 178 VL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELL 257 (1092)
++.+..|+.++|||||||+||||++|.+||..... .+..+......+..........+++.+||.++|.+||++.|+|
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 99999999999999999999999999988764321 2222222212111111245667999999999999999999999
Q ss_pred hChhhHhHh
Q 043248 258 KHPFLQHFV 266 (1092)
Q Consensus 258 qHPwFq~~~ 266 (1092)
+||||....
T Consensus 264 ~h~~~~~~~ 272 (793)
T PLN00181 264 QSEFINEPR 272 (793)
T ss_pred hchhhhhhh
Confidence 999997643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=273.67 Aligned_cols=244 Identities=22% Similarity=0.357 Sum_probs=188.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEec---Ce
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR--VQHPYIVEFKEAWVEK---GC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkq--L~HPNIVKL~gvF~e~---d~ 79 (1092)
++..+++.+||+|.||.||+|... ++.||||++... .+..+.+|..|.+. ++|+||++++++=... ..
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 345677899999999999999874 599999998643 34556667776664 5899999999753221 23
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---------CCccccCCCCCcEEEcCCCCEEEe
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS---------NYVLHRDLKCSNIFLTKDQDVRLG 150 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS---------kGIIHRDLKPENILLD~dG~LKLi 150 (1092)
.++||++|.+.|+|.+||+.+. +++...++++.-|+.||+|||+ ..|+|||||..|||+..++...|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 6889999999999999999876 8999999999999999999995 249999999999999999999999
Q ss_pred ecCcccccccccc---CccccCCCCcCCchhhccCCC------CccccchhHHHHHHHHHhCCCCCc-c-----------
Q 043248 151 DFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPY------GFKSDIWSLGCCMYEMAAHRPAFK-A----------- 209 (1092)
Q Consensus 151 DFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~y------S~KSDVWSLGVILYELLTGr~PF~-g----------- 209 (1092)
|||||..+..+.. .-..+||.+|||||+|.+..- -.+.||||+|.+||||++....+. +
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999998875432 223789999999999976431 136899999999999998764442 1
Q ss_pred -----cChHHHHHHhh-ccCCCCCCCCC-----CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 210 -----FDMAGLISKIN-RSSIGPLPSCY-----SPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 210 -----~d~~dli~kI~-~~~i~plPs~i-----S~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
....++...+. +..++.++..+ -..+++.+..||..|++.|.|+.=+-+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 11222222222 22333344333 356889999999999999999865543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=250.23 Aligned_cols=218 Identities=29% Similarity=0.500 Sum_probs=176.5
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEecCeEEEEEEe
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR-VQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkq-L~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
...+..||+|+||.|-+.++..+|...|+|.+........ .....+|+.+..+ ..+|.+|.+|+.+...+ .+||.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-dvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-QKRLLMDLDIIMRTVDCPFTVHFYGALFREG-DVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-HHHHHHhhhhhccCCCCCeEEEeehhhhccc-cEEEeHH
Confidence 3345789999999999999999999999999987655444 4556667766655 47999999999876555 6889999
Q ss_pred ecCCCCHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 87 YCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 87 YceGGSL~DLLkk--k~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
.++ .+|..+-++ ..+..++|..+-+|+..++.||.|||++ .+||||+||+|||++.+|++|+||||.+-.+...-.
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 996 477665543 2445699999999999999999999976 899999999999999999999999999877765544
Q ss_pred CccccCCCCcCCchhhc----cCCCCccccchhHHHHHHHHHhCCCCCccc-ChHHHHHHhhccCCCCCC
Q 043248 164 ASSVVGTPNYMCPELLA----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSIGPLP 228 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~----g~~yS~KSDVWSLGVILYELLTGr~PF~g~-d~~dli~kI~~~~i~plP 228 (1092)
.+...|...|||||.+. ...|+.++||||||++++||.+++.||..+ ...+++.++....-+.+|
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 44467888999999884 347999999999999999999999999764 455666666655443333
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=253.05 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=197.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+.|.|.+.||.|.||.+-+|+++.++..+++|.+..... ..+.|.+|+..--.| .|.||+.-|++-.+...+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 34789999999999999999999999999999999875432 346788888776666 48899998876555555888
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCCEEEeecCccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK--DQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~--dG~LKLiDFGLA~~l~~ 160 (1092)
++|||++.|+|..-+...+ +-|.....++.|+++||.|||++++||||||.+||||-. ...+||||||+....+.
T Consensus 99 F~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999999886543 889999999999999999999999999999999999943 34799999999876553
Q ss_pred cccCccccCCCCcCCchhhc---cCC--CCccccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccCCCCCC---
Q 043248 161 DDLASSVVGTPNYMCPELLA---DIP--YGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIGPLP--- 228 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~---g~~--yS~KSDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~i~plP--- 228 (1092)
. ....--+..|.+||+.. +.. ..+..|+|.||+|+|.+|+|+.||+.... .-...+.........|
T Consensus 176 t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 176 T--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred e--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 2 22223456799999763 233 36789999999999999999999985322 2222233333333333
Q ss_pred CCCCHHHHHHHHHhcccCCCCC---CCHHHHHhChhhHhH
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQHF 265 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskR---PSaeELLqHPwFq~~ 265 (1092)
..+++.+..+.++-|..++++| .++....+.-|....
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 3368899999999999999999 555555566676543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=227.27 Aligned_cols=161 Identities=22% Similarity=0.275 Sum_probs=131.0
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCC
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT 170 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGT 170 (1092)
|+|.+++...+ ..|++..++.|+.||+.||.|||+++ ||+|||++.++.+++ ||++...... ...|+
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 68999998643 35999999999999999999999999 999999999999999 9999876543 23789
Q ss_pred CCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH-HHHHHhhccCCCC------CCCCCCH--HHHHHHHH
Q 043248 171 PNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRSSIGP------LPSCYSP--SLKTLIKG 241 (1092)
Q Consensus 171 p~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~-dli~kI~~~~i~p------lPs~iS~--eLkDLIrk 241 (1092)
+.|+|||++.+..|+.++|||||||++|+|++|+.||...... .....+....... .+..++. .+.+||.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999999999999999999999999999999999764322 2222222111111 1222333 69999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||..+|.+||++.++++|+|+..
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=234.34 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=196.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCC-cEEEEEEEecccccHHHHHHHHHHHHHHHhcCC----CCcceEEEEEEecCeEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEK-KKYVLKKIRLARQTERCRRSAHQEMALIARVQH----PYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tG-k~VAIKkIkks~~se~~~r~f~rEIqILkqL~H----PNIVKL~gvF~e~d~~l 81 (1092)
+|++.++||+|+||.||++.+...+ ..+|+|.......... ..+..|..++..+.. .++..+++.+...+.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999988775 6788887765422211 145667788887762 68999998885445577
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-----CCEEEeecCccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-----QDVRLGDFGLAK 156 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-----G~LKLiDFGLA~ 156 (1092)
||||+.+ |.+|.++......+.|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|+|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8999998 7899999977766679999999999999999999999999999999999999865 359999999998
Q ss_pred ccc--ccc--------c-CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc---
Q 043248 157 TLK--ADD--------L-ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS--- 222 (1092)
Q Consensus 157 ~l~--~d~--------~-~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~--- 222 (1092)
.+. ... . .....||..|.++.+..+...+.+.|+||++.++.+|+.|..||..........++...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 332 111 1 22356999999999999999999999999999999999999999775533223333222
Q ss_pred CCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 223 SIGP-LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 223 ~i~p-lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.... .....+.++..+...+-..+...+|....+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 233356788888888888899999998888764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-26 Score=271.43 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=204.4
Q ss_pred CCe-EEEEEEeecCceEEEEEEEcCCCcEEEEEEEe----cccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 6 DQY-EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 6 DrY-eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIk----ks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
+.| .....+|.|+||.|+.+......+.++.|.+. ...........+..|+.+-..|.|+|++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 35688999999999999888887777777654 2222223333477888899999999998877666555544
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+. +||||++ +|+.++..... +....+..++.||+.||+|||+.||.|||||++|+++..+|.+||+|||.+..+..
T Consensus 397 ~~-~mE~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 397 LQ-SMEYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hh-hhhcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 43 4999999 99999987633 88999999999999999999999999999999999999999999999999987754
Q ss_pred cc-----cCccccCCCCcCCchhhccCCCCc-cccchhHHHHHHHHHhCCCCCcccChHHHH--HHhhcc------CCCC
Q 043248 161 DD-----LASSVVGTPNYMCPELLADIPYGF-KSDIWSLGCCMYEMAAHRPAFKAFDMAGLI--SKINRS------SIGP 226 (1092)
Q Consensus 161 d~-----~~st~vGTp~YmAPEVL~g~~yS~-KSDVWSLGVILYELLTGr~PF~g~d~~dli--~kI~~~------~i~p 226 (1092)
.. .....+|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||......+.. ...... ....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 32 345678999999999999999965 679999999999999999999865444332 111111 1112
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+...++.+.+.+|.+||+.+|.+|.|+++|++.+||+.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 334467889999999999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=242.17 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=214.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCC-----cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEK-----KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tG-----k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.|+++..++-+|.||.||.|.++... +.|.+|.++. ...+.....+..|--++..+.|||+..+.++..+....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46788888999999999999876443 3344555433 23344456788888899999999999999999888777
Q ss_pred EEEEEeecCCCCHHHHHHHcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 81 VCIVTGYCEGGDMAELMKKSN------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
.++++.+..-|+|..++...+ .+.++..++..++.|+..|++|||++||||.||-..|++|++.-.+||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 788899999999999998432 23467788899999999999999999999999999999999999999999999
Q ss_pred cccccccccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCC
Q 043248 155 AKTLKADDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSC 230 (1092)
Q Consensus 155 A~~l~~d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~ 230 (1092)
++.+.+.++. ........||++|.+.+..|+..+|+|||||+||||+| |+.|+...+..++...+..+..-..|.+
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~N 522 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFN 522 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCC
Confidence 9877655432 22234567999999999999999999999999999997 9999999999999998888888788999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
++.++..++.-||+..|++||+++|+...
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 99999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=234.96 Aligned_cols=175 Identities=18% Similarity=0.230 Sum_probs=136.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcC-CCcEEEEEEEeccc---ccHHHHHHHHHHHHHHHhcCCCCcce-EEEEEEec
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRA-EKKKYVLKKIRLAR---QTERCRRSAHQEMALIARVQHPYIVE-FKEAWVEK 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~-tGk~VAIKkIkks~---~se~~~r~f~rEIqILkqL~HPNIVK-L~gvF~e~ 77 (1092)
-..++|++.+.||+|+||+||+|.++. ++..||||++.... ........+.+|+.+|++|+|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 357899999999999999999999876 67778999875321 12334567899999999999999985 4432
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEcCCCCEEEeecCccc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDL-KCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDL-KPENILLD~dG~LKLiDFGLA~ 156 (1092)
+ ..|||||||+|++|... . . .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||++.
T Consensus 91 ~-~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 G-KDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred C-CcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 2 46899999999999732 1 1 11 1468899999999999999999999 9999999989999999999999
Q ss_pred ccccccc---------CccccCCCCcCCchhhccCC------CCccccch
Q 043248 157 TLKADDL---------ASSVVGTPNYMCPELLADIP------YGFKSDIW 191 (1092)
Q Consensus 157 ~l~~d~~---------~st~vGTp~YmAPEVL~g~~------yS~KSDVW 191 (1092)
.+..... .....+++.|++||.+.-.. .+...|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7654321 12457888999999985322 23456767
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=223.31 Aligned_cols=243 Identities=18% Similarity=0.262 Sum_probs=191.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.|+|.++||.|.||.+|++.+.-++..||||.-..... .-.+..|....+.| ..++|.+.| ||-..+.+-.||+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vY-YFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVY-YFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCcee-eeccccchhhhhh
Confidence 69999999999999999999999999999998643322 22345577777776 478999988 4545566777999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-----CEEEeecCccccccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-----DVRLGDFGLAKTLKA 160 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-----~LKLiDFGLA~~l~~ 160 (1092)
|++ |.+|+|++.-.+. .|+.+.+..++.|++.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+.+..
T Consensus 104 dLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999 7899999988764 599999999999999999999999999999999999997544 489999999998865
Q ss_pred ccc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---HHHHHhhccCCC----
Q 043248 161 DDL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKINRSSIG---- 225 (1092)
Q Consensus 161 d~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---dli~kI~~~~i~---- 225 (1092)
... .....||..||+-....|...+.+.|+-|||-+|+++|.|..||.+-... .-..+|-.....
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 432 34567999999999999999999999999999999999999999985443 333444322221
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeEL 256 (1092)
.+-..++.++...++..=..+-.+-|..+-+
T Consensus 262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred HHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 2334567777777776655555556665433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-23 Score=237.78 Aligned_cols=239 Identities=28% Similarity=0.509 Sum_probs=200.0
Q ss_pred EeecCceEEEEEE---EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEEEeecC
Q 043248 14 IGRGAFGAAILVN---HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 14 LGkGgFGtVYLA~---dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
+|.|+||.|+++. -...+..||+|..++.......+.....|..++..++ ||.+++++..|+... .++++++|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-KLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-chhHhhhhcc
Confidence 7999999999854 3455778899987655433222224556778888886 999999998885544 7789999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccC
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG 169 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vG 169 (1092)
||.|+..+..... +.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-..... ||
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---cc
Confidence 9999998876553 889999999999999999999999999999999999999999999999999876544333 99
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEH 249 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPsk 249 (1092)
|..|||||+++ .+...+|.||||+++|+|++|..||.. +....|.+... .+|..++..+++++..++..+|..
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~-~~p~~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL-EMPRELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc-CCchhhhHHHHHHHHHHHhhCHHH
Confidence 99999999998 677899999999999999999999988 45555555443 467788999999999999999999
Q ss_pred CCC-----HHHHHhChhhHhH
Q 043248 250 RPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 250 RPS-----aeELLqHPwFq~~ 265 (1092)
|.- +.++++|+||+.+
T Consensus 229 rLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 229 RLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HhccCcchhHHHhccchheee
Confidence 964 5899999999764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=207.13 Aligned_cols=246 Identities=20% Similarity=0.254 Sum_probs=193.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH-PYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H-PNIVKL~gvF~e~d~~ly 82 (1092)
+.+.|+++++||.|+||.+|++....+|..||||.-....... .+..|..+.+.|++ ..|..++.++.+.. +-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~-ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKD-YNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccc-cce
Confidence 4689999999999999999999999999999999876543322 35568888888865 66777776665544 667
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCEEEeecCcccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD---QDVRLGDFGLAKTLK 159 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d---G~LKLiDFGLA~~l~ 159 (1092)
+||+++ |.+|++++.-... .|+...++-++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+.
T Consensus 88 lVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999999 7899999986653 49999999999999999999999999999999999999633 469999999998775
Q ss_pred ccc--------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHH---HhhccCCC---
Q 043248 160 ADD--------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLIS---KINRSSIG--- 225 (1092)
Q Consensus 160 ~d~--------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~---kI~~~~i~--- 225 (1092)
... ......||..|.+-....+...+.+.|+-|+|.+|.++..|..||++.......+ +|......
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 432 2234679999999888888888999999999999999999999999865443333 23222221
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 043248 226 -PLPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256 (1092)
Q Consensus 226 -plPs~iS~eLkDLIrkcLqkDPskRPSaeEL 256 (1092)
.+-..++.++.-.+..|-..--++-|...-+
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 2334568888888888876666666765433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=203.49 Aligned_cols=172 Identities=16% Similarity=0.229 Sum_probs=136.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHH------HHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRS------AHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~------f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
++|+++++||.|+||.||++.. ++..+|+|.+....... ..... +.+|+..+.++.|++|..+..++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 6899999999999999999765 46689999986543222 22222 678999999999999999998876442
Q ss_pred -------eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEee
Q 043248 79 -------CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 79 -------~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiD 151 (1092)
...+|||||++|.+|.++.. +++ ..+.+++.+|..||..|++||||||+||+++.+| ++|+|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 24689999999999988732 343 2466999999999999999999999999999888 99999
Q ss_pred cCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHH
Q 043248 152 FGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMA 201 (1092)
Q Consensus 152 FGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELL 201 (1092)
||............ .++....|..++|+|+||+++..+.
T Consensus 178 fg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 99887664332211 1445566788999999999998765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-21 Score=195.16 Aligned_cols=142 Identities=16% Similarity=0.127 Sum_probs=111.4
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH------------------------HHHHHHHHHHHHHhcCCCC
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER------------------------CRRSAHQEMALIARVQHPY 66 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~------------------------~~r~f~rEIqILkqL~HPN 66 (1092)
...||+|+||.||+|.+. +|+.||+|+++....... ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 899999999976532110 0123345999999998887
Q ss_pred cceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEcCCC
Q 043248 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL-HSNYVLHRDLKCSNIFLTKDQ 145 (1092)
Q Consensus 67 IVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYL-HSkGIIHRDLKPENILLD~dG 145 (1092)
+.....+. ... .+|||||++|++|...+.... .+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++
T Consensus 81 v~~p~~~~-~~~--~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPIL-LKS--HVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEE-ecC--CEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 74433222 222 269999999987766543332 489999999999999999999 799999999999999998 57
Q ss_pred CEEEeecCcccccc
Q 043248 146 DVRLGDFGLAKTLK 159 (1092)
Q Consensus 146 ~LKLiDFGLA~~l~ 159 (1092)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=233.27 Aligned_cols=219 Identities=31% Similarity=0.536 Sum_probs=170.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
-++|..+++|-.|+||.||+++|+.+.+.+|+ ++.+.. .|++ ||.. |.++. +.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-------------lilR-----nilt----~a~np---fvv 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-------------LILR-----NILT----FAGNP---FVV 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccc-------------hhhh-----cccc----ccCCc---cee
Confidence 35789999999999999999999999999999 443221 0111 1222 21221 122
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc----
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA---- 160 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~---- 160 (1092)
|+-..+++.-+. ++... +.+++|||+.||+|||+||+|.+|+.-|++|+.|||++...--
T Consensus 136 ------gDc~tllk~~g~--lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGP--LPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ------chhhhhcccCCC--Ccchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 455666654333 33332 7899999999999999999999999999999999999864311
Q ss_pred ----c--------ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--
Q 043248 161 ----D--------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-- 226 (1092)
Q Consensus 161 ----d--------~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p-- 226 (1092)
+ ......|||+.|+|||++....|+..+|+|++|+|+|+++-|+.||.++...+++..+....+.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0 01234589999999999999999999999999999999999999999999998888887655432
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHhChhhHhH
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQHF 265 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskR---PSaeELLqHPwFq~~ 265 (1092)
-...+.++++++|.++|..+|..| ..+-++.+|+||+.+
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 234468899999999999999999 567888899999764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=186.41 Aligned_cols=144 Identities=15% Similarity=0.110 Sum_probs=113.2
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc------------------------HHHHHHHHHHHHHHHhcCCC
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT------------------------ERCRRSAHQEMALIARVQHP 65 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s------------------------e~~~r~f~rEIqILkqL~HP 65 (1092)
+.+.||+|+||+||+|.+. +|+.||||+++..... ......+.+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998764211 00122346789999999999
Q ss_pred CcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCC
Q 043248 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 66 NIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~d 144 (1092)
++.....++.. . .||||||++|+++...+.... .+++..+..++.|++.+|.+||. +||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~-~--~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLK-K--NVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEec-C--CEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence 87554433322 2 369999999886544322222 37889999999999999999999 9999999999999999 8
Q ss_pred CCEEEeecCccccccc
Q 043248 145 QDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~ 160 (1092)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=236.62 Aligned_cols=242 Identities=22% Similarity=0.271 Sum_probs=177.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH---HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE---RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se---~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+|...+.||++.|=+|.+|++.+ | .|+||++.+..... ...+ ..+|++ ...++|||.+.+..+ ...+...|
T Consensus 23 ~e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~q-rL~~ik-~~l~~~pn~lPfqk~-~~t~kAAy 97 (1431)
T KOG1240|consen 23 VECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQ-RLEEIK-FALMKAPNCLPFQKV-LVTDKAAY 97 (1431)
T ss_pred cceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHH-HHHHHH-HHhhcCCcccchHHH-HHhhHHHH
Confidence 378889999999999999998754 4 48899886544221 2222 223344 445689999998765 35556778
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc--cc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL--KA 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l--~~ 160 (1092)
||.+|... +|+|.|..+.. |..-+.+.|+.||+.||.-||..||+|||||.+||||+.-.-+.|+||...+-. .+
T Consensus 98 lvRqyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 98 LVRQYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 99999965 99999987654 788888999999999999999999999999999999999889999999866432 22
Q ss_pred cc------cCccccCCCCcCCchhhccC----------C-CCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhcc
Q 043248 161 DD------LASSVVGTPNYMCPELLADI----------P-YGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRS 222 (1092)
Q Consensus 161 d~------~~st~vGTp~YmAPEVL~g~----------~-yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~ 222 (1092)
+. ++.+...-.+|+|||.+... . .+++.||||+||+++||++ |+++|..... .+....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----LAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----HhHhcc
Confidence 21 11222233579999988531 1 4678999999999999986 7999964321 111111
Q ss_pred C-CC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 223 S-IG---PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 223 ~-i~---plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
. .. -+...-+..++++|..|++.||++|.++++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 00 0011124478999999999999999999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=187.48 Aligned_cols=187 Identities=18% Similarity=0.166 Sum_probs=143.5
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH--HHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEEE
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER--CRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~--~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.+...|++|+||+||++.. .+..++.+.+........ ....+.+|+.+|++|. |++|++++++. ..|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----GRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----CEEEEE
Confidence 4668899999999997765 677788777765443221 2235789999999995 58899998752 357999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDL-KCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDL-KPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999999764421 1 1357889999999999999999999 799999999999999999999865543210
Q ss_pred --------------ccccCCCCcCCchhhccC-CCC-ccccchhHHHHHHHHHhCCCCCcccC
Q 043248 165 --------------SSVVGTPNYMCPELLADI-PYG-FKSDIWSLGCCMYEMAAHRPAFKAFD 211 (1092)
Q Consensus 165 --------------st~vGTp~YmAPEVL~g~-~yS-~KSDVWSLGVILYELLTGr~PF~g~d 211 (1092)
....+++.|+.|+...-. ..+ ...+.++.|+-+|.++|+..++..+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 012367889999876432 333 67788999999999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=196.70 Aligned_cols=236 Identities=22% Similarity=0.279 Sum_probs=150.7
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCC----------CCcceEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQH----------PYIVEFKEAWV 75 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~H----------PNIVKL~gvF~ 75 (1092)
.+.....||.|+|+.||.+.+..+|+.+|+|.+...... ....+.+.+|......+.+ -.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 455678999999999999999999999999988654422 2234555555544444322 12222222211
Q ss_pred --------ecC---eE-----EEEEEeecCCCCHHHHHHH---cCCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 043248 76 --------EKG---CY-----VCIVTGYCEGGDMAELMKK---SNGAY--FPEEKLCKWFAQLLLAVDYLHSNYVLHRDL 134 (1092)
Q Consensus 76 --------e~d---~~-----lyLVMEYceGGSL~DLLkk---k~gk~--LSEeqI~kIa~QILsALaYLHSkGIIHRDL 134 (1092)
... .. ++++|.-+ .++|.+++.. ..... +.......+..|+++.+++||..||+|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 11 25677777 4588887653 22111 112233456699999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeecCccccccccccCccccCCCCcCCchhhcc--------CCCCccccchhHHHHHHHHHhCCCC
Q 043248 135 KCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD--------IPYGFKSDIWSLGCCMYEMAAHRPA 206 (1092)
Q Consensus 135 KPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g--------~~yS~KSDVWSLGVILYELLTGr~P 206 (1092)
+|+|+|++.+|.++|.||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|++|..|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999887766543222 345678999998743 3578899999999999999999999
Q ss_pred CcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 043248 207 FKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHR 250 (1092)
Q Consensus 207 F~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskR 250 (1092)
|........... .+..-. .+++.++.||+.+|+.+|.+|
T Consensus 250 f~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 986433221111 111122 578899999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=219.02 Aligned_cols=233 Identities=21% Similarity=0.321 Sum_probs=173.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ---HPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~---HPNIVKL~gvF~e~d~~l 81 (1092)
-+.|.|.+.||+|+||+||.|.... |+.||+|+-+.....+ |+--.+++.+|+ -+.|+.+...+.-.+..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S- 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNAS- 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCcc-
Confidence 3578999999999999999999876 9999999876654333 222334555555 23455555544444433
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-------CCEEEeecCc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-------QDVRLGDFGL 154 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-------G~LKLiDFGL 154 (1092)
+||+||.+.|+|.+++... +.+++..++.++.||+..|++||..||||+||||+|+||... ..++|+|||.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 4899999999999999843 458999999999999999999999999999999999999532 2499999999
Q ss_pred ccccc---ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC----CC
Q 043248 155 AKTLK---ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----PL 227 (1092)
Q Consensus 155 A~~l~---~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----pl 227 (1092)
+..+. .+..+...++|-.+-.+|.+.|.++++++|.|+|+.++|-||.|+..= ...+... .+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~~ 916 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTNF 916 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccccc
Confidence 97654 333566778999999999999999999999999999999999986321 1111111 12
Q ss_pred CCCCCH-HHHHHHHHhcccCCCCCCCHHHHH
Q 043248 228 PSCYSP-SLKTLIKGMLRKNPEHRPSASELL 257 (1092)
Q Consensus 228 Ps~iS~-eLkDLIrkcLqkDPskRPSaeELL 257 (1092)
+..+.. ...+|+..+|..|-..=|.+.++.
T Consensus 917 ~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 917 PRYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred hhhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 333333 345788899984433335655554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-19 Score=199.65 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=179.7
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCC-----------------------------------cEEEEEEEeccc---c
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEK-----------------------------------KKYVLKKIRLAR---Q 44 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tG-----------------------------------k~VAIKkIkks~---~ 44 (1092)
.++++|+|...||+|.-..||.+....+| -+.|||.+..-. .
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 46788999999999999999998765421 123455443211 1
Q ss_pred cHHHHHHHHHHH------HHH--------Hh--------cCCCCcceEEEEEEec-------------------------
Q 043248 45 TERCRRSAHQEM------ALI--------AR--------VQHPYIVEFKEAWVEK------------------------- 77 (1092)
Q Consensus 45 se~~~r~f~rEI------qIL--------kq--------L~HPNIVKL~gvF~e~------------------------- 77 (1092)
.....+...+|+ .++ +. -+|||||++...|.+.
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 122223333332 011 11 2499999998887533
Q ss_pred -CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE--cCCC--CEEEeec
Q 043248 78 -GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL--TKDQ--DVRLGDF 152 (1092)
Q Consensus 78 -d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL--D~dG--~LKLiDF 152 (1092)
+..+|+||..+.. +|..++-.+. .+....+-++.|+++|+.|||++||.|||+|.+|||+ ++++ .++|+||
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 2357899998865 8999998765 5778888899999999999999999999999999999 3343 4899999
Q ss_pred Cccccccccc----c---CccccCCCCcCCchhhccCC-----C-CccccchhHHHHHHHHHhCCCCCcccChHHH-HHH
Q 043248 153 GLAKTLKADD----L---ASSVVGTPNYMCPELLADIP-----Y-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL-ISK 218 (1092)
Q Consensus 153 GLA~~l~~d~----~---~st~vGTp~YmAPEVL~g~~-----y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dl-i~k 218 (1092)
|.+-.-+.-. + .-..-|.-..||||+....+ . -.++|.|+.|.+.||++....||+......+ ...
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 9775432211 1 11234778899999985422 1 3589999999999999999999987443221 122
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSAS 254 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSae 254 (1092)
..+..++.+|+.+++.+++++..+|+.||++|++..
T Consensus 470 Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 470 YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 455667789999999999999999999999999854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=179.62 Aligned_cols=136 Identities=15% Similarity=0.195 Sum_probs=107.2
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-----CCCCcceEEEEEEecC--eE-E
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-----QHPYIVEFKEAWVEKG--CY-V 81 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-----~HPNIVKL~gvF~e~d--~~-l 81 (1092)
-.++||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||++++++|..+. .+ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 357899999999995 6666655 68888654322 245689999999999 5799999999997763 24 4
Q ss_pred EEEEee--cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCcEEEcCC----CCEEEeecCc
Q 043248 82 CIVTGY--CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV-DYLHSNYVLHRDLKCSNIFLTKD----QDVRLGDFGL 154 (1092)
Q Consensus 82 yLVMEY--ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsAL-aYLHSkGIIHRDLKPENILLD~d----G~LKLiDFGL 154 (1092)
.+|||| +.+++|.+++++.. +++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 478999 55899999997632 6666 36688888888 99999999999999999999743 3799999543
Q ss_pred c
Q 043248 155 A 155 (1092)
Q Consensus 155 A 155 (1092)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-19 Score=203.87 Aligned_cols=178 Identities=33% Similarity=0.545 Sum_probs=142.5
Q ss_pred eEEEEEEeecCCCCHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKK-SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkk-k~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.++||.|++|...+|.+||.. ......+...+..++.|+..+++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 368999999999999999974 334456788899999999999999 9999999999999999999999999999988
Q ss_pred ccccc-------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCc-ccChHHHHHHhhccCCCCCCC
Q 043248 158 LKADD-------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFK-AFDMAGLISKINRSSIGPLPS 229 (1092)
Q Consensus 158 l~~d~-------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~-g~d~~dli~kI~~~~i~plPs 229 (1092)
..... .....+||.+||+||++.+..|+.++|||+||+|||||+. +|. .......+..+....+++...
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHh
Confidence 76655 4556789999999999999999999999999999999986 221 122223344444444442222
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.-.+.-.+|+.+||...|.+||++.+.-.|.|.
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 223344599999999999999988777777664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.5e-18 Score=179.28 Aligned_cols=145 Identities=18% Similarity=0.128 Sum_probs=114.2
Q ss_pred CeEEEEEEeecCceEEEEEE-EcCCCcEEEEEEEeccccc----------------------HHHHHHHHHHHHHHHhcC
Q 043248 7 QYEIMEQIGRGAFGAAILVN-HRAEKKKYVLKKIRLARQT----------------------ERCRRSAHQEMALIARVQ 63 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~-dK~tGk~VAIKkIkks~~s----------------------e~~~r~f~rEIqILkqL~ 63 (1092)
-|.+.+.||+|+||.||+|. +..+|..||+|++...... ......+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 7778999999998754211 011234678999999997
Q ss_pred CCC--cceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEE
Q 043248 64 HPY--IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY-VLHRDLKCSNIF 140 (1092)
Q Consensus 64 HPN--IVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG-IIHRDLKPENIL 140 (1092)
+.+ ++++++ .. ..||||||++|.+|..++.... .+....+..++.||+.+|.+||.+| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~---~~--~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIA---WR--RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeE---ec--CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 533 344443 22 2469999999988877653322 3667778899999999999999999 999999999999
Q ss_pred EcCCCCEEEeecCcccccc
Q 043248 141 LTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 141 LD~dG~LKLiDFGLA~~l~ 159 (1092)
++ ++.++|+|||++....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=187.52 Aligned_cols=241 Identities=17% Similarity=0.281 Sum_probs=197.1
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEee
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
..++.+|...-.|..|.+++. |..+++|++..........+.|..|+-.|+-+.||||+.+++.+.... .+.++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEeeee
Confidence 346677888889999999875 456788888777666777788999999999999999999999997765 45689999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCEEE--eecCcccccccccc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTKDQDVRL--GDFGLAKTLKADDL 163 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~dG~LKL--iDFGLA~~l~~d~~ 163 (1092)
++.|+|+.++.......++..++.+++..|+.|++|||+.. |.--.|....+++|++...+| +|--++..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 99999999999887767888999999999999999999985 444568999999999876554 45433322
Q ss_pred CccccCCCCcCCchhhccCCCC---ccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc-cCCCCCCCCCCHHHHHHH
Q 043248 164 ASSVVGTPNYMCPELLADIPYG---FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR-SSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS---~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~-~~i~plPs~iS~eLkDLI 239 (1092)
.......+.||+||.+...+-+ ..+|+|||.+++|||.|...||......+.-.++.- .....+|..++..+..|+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 1223457899999999776543 578999999999999999999998877666556543 344568888999999999
Q ss_pred HHhcccCCCCCCCHHHHH
Q 043248 240 KGMLRKNPEHRPSASELL 257 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELL 257 (1092)
.-|+..||.+||.++.++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 999999999999998876
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=164.34 Aligned_cols=136 Identities=26% Similarity=0.280 Sum_probs=111.3
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT------ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s------e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.||+|++|.||+|.+ .|..+++|+....... ......+.+|+.++..+.|++|+....++...+ ..++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-NFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-CCEEEE
Confidence 6799999999999987 6778999976532211 112346788999999999999877666654444 467999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
||++|++|.+++.... . ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999987532 2 7889999999999999999999999999999999 78999999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-17 Score=162.72 Aligned_cols=133 Identities=26% Similarity=0.300 Sum_probs=104.5
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEEeccc-cc-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QT-----ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~s-----e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
.||+|+||.||++.. .+..+++|...... .. ......+.+|+.++..+.|+++....-++.... ..++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-NKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-CCEEEEE
Confidence 489999999999984 56789999864321 11 112356788999999999887544433333333 4579999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
|++|++|.+++.... . .++.|++.+|.+||+.|++|+|++|.||+++ ++.++|+|||++...
T Consensus 78 ~~~g~~l~~~~~~~~------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcH------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999999876432 1 7899999999999999999999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.6e-19 Score=209.18 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=205.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC-CcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE-KKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t-Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~ly 82 (1092)
...|.+.+.||+|+|+.|-++....+ ...+|.|.+............+..|..+-+.+. |.|++.+++.....+ ..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-ccc
Confidence 45799999999999999999887433 445566666544433444555666888888887 999999999876555 667
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEcCCC-CEEEeecCccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH-SNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKA 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLH-SkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~ 160 (1092)
++++|..|+++++.+........+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999999994222224778888999999999999999 99999999999999999999 999999999998765
Q ss_pred -cc---cCccccC-CCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHH-hhccC---CCCCCCC
Q 043248 161 -DD---LASSVVG-TPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISK-INRSS---IGPLPSC 230 (1092)
Q Consensus 161 -d~---~~st~vG-Tp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~k-I~~~~---i~plPs~ 230 (1092)
.. .....+| ++.|+|||.+.+..| +...|+||+|+++..+++|..||........... ..... .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 22 2345678 999999999988554 7899999999999999999999976544332111 11111 1123345
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
++....+++.++|..+|..|.+.+++..++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 6888999999999999999999999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.6e-17 Score=163.83 Aligned_cols=139 Identities=19% Similarity=0.188 Sum_probs=109.9
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc--------------------HHHHHHHHHHHHHHHhcCCCC-
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT--------------------ERCRRSAHQEMALIARVQHPY- 66 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s--------------------e~~~r~f~rEIqILkqL~HPN- 66 (1092)
|.+.+.||+|+||.||++.+. +|+.||||++...... ......+.+|+.++..+.|.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999875 7999999987653210 011223677899999998774
Q ss_pred -cceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 043248 67 -IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ 145 (1092)
Q Consensus 67 -IVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG 145 (1092)
++.+++. ...++||||++|++|..+... .....++.+|+.++.++|..||+|+||||+||+++.++
T Consensus 96 ~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW-----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec-----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4444432 234799999999998775421 34567889999999999999999999999999999999
Q ss_pred CEEEeecCccccccc
Q 043248 146 DVRLGDFGLAKTLKA 160 (1092)
Q Consensus 146 ~LKLiDFGLA~~l~~ 160 (1092)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999866553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.4e-16 Score=181.20 Aligned_cols=138 Identities=21% Similarity=0.187 Sum_probs=108.7
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEe-ccccc-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR-LARQT-----ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIk-ks~~s-----e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.|...++||+|+||.||++.+... .+++|+.. ..... ......+.+|+.+++.++|++++..+.++.... .
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~ 410 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-E 410 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-C
Confidence 445678999999999999987543 34444332 11111 122356889999999999999988776655543 4
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||++...
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 579999999999999885 346789999999999999999999999999999 5789999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.7e-16 Score=154.05 Aligned_cols=139 Identities=19% Similarity=0.199 Sum_probs=101.0
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHH----------------------HHHHHHHHHHhcCCCC--
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRR----------------------SAHQEMALIARVQHPY-- 66 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r----------------------~f~rEIqILkqL~HPN-- 66 (1092)
.+.||+|+||+||+|.+. ++..||||.+........... ....|+..+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999976 789999998875432211111 1135666666665443
Q ss_pred cceEEEEEEecCeEEEEEEeecCCCCHHH-HHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCC
Q 043248 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 67 IVKL~gvF~e~d~~lyLVMEYceGGSL~D-LLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~d 144 (1092)
+.+++.+. ..++||||++|+.+.. .+.... .. ..+..++.+++.++.++|. +||+|+||||+||+++ +
T Consensus 81 ~~~~~~~~-----~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDLN-----RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEecC-----CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 45555432 2479999999854322 122111 11 6688999999999999999 9999999999999999 8
Q ss_pred CCEEEeecCccccccc
Q 043248 145 QDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~ 160 (1092)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 8999999999976653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-15 Score=175.54 Aligned_cols=198 Identities=23% Similarity=0.385 Sum_probs=155.9
Q ss_pred HHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCC
Q 043248 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV-LHRDLKCS 137 (1092)
Q Consensus 59 LkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGI-IHRDLKPE 137 (1092)
|+.+.|.|+.++++.+.+. ...++|.+||..|+|.+.+.... ..+++.+...+++.|+.||+|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578899999999999877 46779999999999999998743 348999999999999999999998776 99999999
Q ss_pred cEEEcCCCCEEEeecCcccccccc---ccCccccCCCCcCCchhhccCC-------CCccccchhHHHHHHHHHhCCCCC
Q 043248 138 NIFLTKDQDVRLGDFGLAKTLKAD---DLASSVVGTPNYMCPELLADIP-------YGFKSDIWSLGCCMYEMAAHRPAF 207 (1092)
Q Consensus 138 NILLD~dG~LKLiDFGLA~~l~~d---~~~st~vGTp~YmAPEVL~g~~-------yS~KSDVWSLGVILYELLTGr~PF 207 (1092)
|++++....+||.|||+....... .......-..-|.|||.+.+.. -+.+.||||||+++||+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 1111122345699999996532 366799999999999999999999
Q ss_pred ccc----ChHHHHHHhhccCCC-CCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 208 KAF----DMAGLISKINRSSIG-PLPS-----CYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 208 ~g~----d~~dli~kI~~~~i~-plPs-----~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
... +..+++..+...... ..|. ...+++..+++.||..+|..||+++++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 762 223455554441211 1111 24557889999999999999999998864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-14 Score=154.64 Aligned_cols=138 Identities=24% Similarity=0.290 Sum_probs=106.4
Q ss_pred EEEe-ecCceEEEEEEEcCCCcEEEEEEEecccc-----------cHHHHHHHHHHHHHHHhcCCCCc--ceEEEEEEec
Q 043248 12 EQIG-RGAFGAAILVNHRAEKKKYVLKKIRLARQ-----------TERCRRSAHQEMALIARVQHPYI--VEFKEAWVEK 77 (1092)
Q Consensus 12 KkLG-kGgFGtVYLA~dK~tGk~VAIKkIkks~~-----------se~~~r~f~rEIqILkqL~HPNI--VKL~gvF~e~ 77 (1092)
..|| .||.|+||.+... +..+++|.+..... .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 7888999998763 67899998753211 01223567889999999998875 6777665443
Q ss_pred CeE---EEEEEeecCC-CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 78 GCY---VCIVTGYCEG-GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 78 d~~---lyLVMEYceG-GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
... .++||||++| .+|.+++... .+++.. +.||+.+|.+||++||+|+||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 332 2599999997 6899988653 255543 6789999999999999999999999999988899999999
Q ss_pred ccccc
Q 043248 154 LAKTL 158 (1092)
Q Consensus 154 LA~~l 158 (1092)
.+...
T Consensus 188 ~~~~~ 192 (239)
T PRK01723 188 RGELR 192 (239)
T ss_pred CcccC
Confidence 88754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.6e-15 Score=136.71 Aligned_cols=132 Identities=18% Similarity=0.225 Sum_probs=109.7
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEecCeEEEEEEee
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH--PYIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H--PNIVKL~gvF~e~d~~lyLVMEY 87 (1092)
+++.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| .++++++.++... ...|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEe
Confidence 46889999999999999744 7899998865432 3567889999999976 5899998877544 467899999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN---YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk---GIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
+.|+.+..+ +......++.+++.+|++||.. +++|+||+|+||+++..+.++|+|||++..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877654 4466678899999999999985 799999999999999888999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.4e-14 Score=165.72 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=193.0
Q ss_pred CeEEEEEEee--cCceEEEEEEE--cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 7 QYEIMEQIGR--GAFGAAILVNH--RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 7 rYeIlKkLGk--GgFGtVYLA~d--K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|+-............=.+|+...+.+ .|+|.++.+..+...+ ..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~-~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG-IL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC-cc
Confidence 4567889999 99999999888 88999999998543332222222334566666666 4999999888775544 77
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL----AVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAK 156 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILs----ALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~ 156 (1092)
++-+|+|. .+|..+..... ..++...++.++.+... ||.++|+.+++|-|+||.||++..+ ..+++.|||+..
T Consensus 194 fiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 79999995 68888776543 34889999999999999 9999999999999999999999999 789999999999
Q ss_pred cccccccCcc------ccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-CCCCCC
Q 043248 157 TLKADDLASS------VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-IGPLPS 229 (1092)
Q Consensus 157 ~l~~d~~~st------~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-i~plPs 229 (1092)
.+....+... ..|...|++||++++ .+++..|+|++|.++.+-.+|-..+.......+ ..+.... ...+-.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccccCchhhhc
Confidence 8877654322 257888999999977 778999999999999998887666543311111 1111111 112223
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
..+.++...+..|++.++..|+++..+++|+++..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 34666777999999999999999999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.1e-14 Score=172.40 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=200.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
-++.+.+.+-+-+|.|+.++.+.-..+|...++|.......... ..+.+..+-.++-...+|-++.....|.... -.+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs-P~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS-PLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-Ccc
Confidence 36778899999999999999999888887777776544322111 1122223333333334455555433332222 457
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d- 161 (1092)
+|++|+.|++|...+...+. .+++-++.++..+..+++|||...+.|+|++|.|+|+..+|..++.|||+......-
T Consensus 881 L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 99999999999999987663 788888999999999999999999999999999999999999999999843221100
Q ss_pred -------------------------------ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043248 162 -------------------------------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF 210 (1092)
Q Consensus 162 -------------------------------~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~ 210 (1092)
.......||+.|.+||.+.+...+..+|+|++|+++++.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0012346899999999999999999999999999999999999999999
Q ss_pred ChHHHHHHhhccCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHH---HHHhChhhHhH
Q 043248 211 DMAGLISKINRSSIGP--LPSCYSPSLKTLIKGMLRKNPEHRPSAS---ELLKHPFLQHF 265 (1092)
Q Consensus 211 d~~dli~kI~~~~i~p--lPs~iS~eLkDLIrkcLqkDPskRPSae---ELLqHPwFq~~ 265 (1092)
.....+.++......+ -+...+.++++++.++|..++.+|..+. ++..|+||+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 8888888887665542 3455789999999999999999998877 88999999753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.5e-12 Score=146.10 Aligned_cols=145 Identities=14% Similarity=0.195 Sum_probs=100.0
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccccH--------------------------------HHHH------HHH
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE--------------------------------RCRR------SAH 53 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se--------------------------------~~~r------~f~ 53 (1092)
+.||.|++|+||+|..+ +|+.||||+.+...... .... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999975 78999999986432110 0001 133
Q ss_pred HHHHHHHhc----CCCCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 043248 54 QEMALIARV----QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL-AVDYLHSNY 128 (1092)
Q Consensus 54 rEIqILkqL----~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILs-ALaYLHSkG 128 (1092)
+|+..+.++ +|.+-+.+-.+|.+-....+|||||++|++|.++...... .+. ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555544 2333344434443323345799999999999988754321 122 2345555555 478899999
Q ss_pred ccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 129 IIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
++|+|+||.||+++.++.++|+|||++..+...
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999877643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-12 Score=151.90 Aligned_cols=150 Identities=15% Similarity=0.282 Sum_probs=102.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc--------------------------------HHHHHH
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT--------------------------------ERCRRS 51 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s--------------------------------e~~~r~ 51 (1092)
.+..|+. +.||+|++|+||.|..+.+|+.||||+.+..... +...+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 8999999999999999888999999999744210 011222
Q ss_pred ------HHHHHHHHHhcC----CCCcceEEEEEEecCeEEEEEEeecCCCCHHHHH--HHcCC--CCCCHHHHHHHHHHH
Q 043248 52 ------AHQEMALIARVQ----HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM--KKSNG--AYFPEEKLCKWFAQL 117 (1092)
Q Consensus 52 ------f~rEIqILkqL~----HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLL--kkk~g--k~LSEeqI~kIa~QI 117 (1092)
+.+|+..+.++. +.+.+.+-.+|.+-....+|||||++|+.|.++. ...+. ..+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 333443333332 4444444445544333456999999999998753 32221 124455555666666
Q ss_pred HHHHHHHHHCCccccCCCCCcEEEcCCC----CEEEeecCcccccccc
Q 043248 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQ----DVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 118 LsALaYLHSkGIIHRDLKPENILLD~dG----~LKLiDFGLA~~l~~d 161 (1092)
+ ..|++|+|+||.||+++.+| .++++|||++..+...
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4 58999999999999999888 8999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=120.94 Aligned_cols=128 Identities=19% Similarity=0.173 Sum_probs=95.2
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEEEEEeecC
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~lyLVMEYce 89 (1092)
++.|+.|.++.||.+... +..|++|........ ...+.+|+.+++.+.+.++ .+++.+. .. ..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~--~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFD-PE--TGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEe-CC--CCeEEEEecC
Confidence 578999999999999864 778999987543211 1235678888888865554 4555433 22 2368999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV-----LHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGI-----IHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
|.++... . . ....++.+++.+|+.||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 75 G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887653 0 1 123457899999999999985 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.2e-12 Score=146.58 Aligned_cols=251 Identities=25% Similarity=0.298 Sum_probs=186.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc-CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR-AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK-~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+|.++..||.|.|+.||.+... .++..|++|.+............-..|+.+...+ .|.++++++..|.... ..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-QGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-ccc
Confidence 567889999999999999998866 7788899997765544443333445566666655 4888998887776555 345
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCcccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~~l~~d 161 (1092)
|-.|||+++++...+.-. ..+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||....+.-.
T Consensus 343 ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred CchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 999999999988776432 237889999999999999999999999999999999999876 78899999988653211
Q ss_pred ccCccccCCCCcC--CchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 043248 162 DLASSVVGTPNYM--CPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 162 ~~~st~vGTp~Ym--APEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLI 239 (1092)
.......-+|+ +++......+..++|+|+||.-+++.++|.+.-.... ....+...... ........+..+.
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p-~~~~~~~~~q~~~ 494 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTP-NLPGLKLQLQVLL 494 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeeccccc-CCCchHHhhhhhh
Confidence 11122333444 5555567778899999999999999999875543322 22223333232 2333447888999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+.++..++..|+.+.++..|.-|..
T Consensus 495 kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhcCCccccchhhhhhcccchhhh
Confidence 9999999999999999998876654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-10 Score=138.06 Aligned_cols=168 Identities=18% Similarity=0.328 Sum_probs=132.1
Q ss_pred EEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCC
Q 043248 24 LVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGA 103 (1092)
Q Consensus 24 LA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk 103 (1092)
.+..+.++..|.|........ .....+.+.+..|+.|+||||+++++.+...+ .+|||+|.+. -|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeeccc--cHHHHHHHh---
Confidence 466788889998888765543 33456778889999999999999999986665 7889999985 688888874
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-CccccCCCCcCCchhhcc
Q 043248 104 YFPEEKLCKWFAQLLLAVDYLH-SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPELLAD 181 (1092)
Q Consensus 104 ~LSEeqI~kIa~QILsALaYLH-SkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~-~st~vGTp~YmAPEVL~g 181 (1092)
....+..-++||+.||.||| +.+++|++|.-..|+++..|..||.+|-++........ .....---.|..|+.+..
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 46788899999999999998 66899999999999999999999999988765543221 122222234666765533
Q ss_pred CCCCccccchhHHHHHHHHHhC
Q 043248 182 IPYGFKSDIWSLGCCMYEMAAH 203 (1092)
Q Consensus 182 ~~yS~KSDVWSLGVILYELLTG 203 (1092)
.. -..|.|.|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 467999999999999988
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.3e-10 Score=121.85 Aligned_cols=140 Identities=17% Similarity=0.179 Sum_probs=102.2
Q ss_pred EEEeecCceEEEEEEEcC------CCcEEEEEEEecccc-----------c---------HHHHHH----HHHHHHHHHh
Q 043248 12 EQIGRGAFGAAILVNHRA------EKKKYVLKKIRLARQ-----------T---------ERCRRS----AHQEMALIAR 61 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~------tGk~VAIKkIkks~~-----------s---------e~~~r~----f~rEIqILkq 61 (1092)
..||.|.-+.||.|.... .+..+|+|+.+.... . ...... ..+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 357899998743210 0 011222 3389999999
Q ss_pred cCC--CCcceEEEEEEecCeEEEEEEeecCCCCHHH-HHHHcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCC
Q 043248 62 VQH--PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLAVDYL-HSNYVLHRDLKCS 137 (1092)
Q Consensus 62 L~H--PNIVKL~gvF~e~d~~lyLVMEYceGGSL~D-LLkkk~gk~LSEeqI~kIa~QILsALaYL-HSkGIIHRDLKPE 137 (1092)
+.. -++++++.+ . .-+|||||+++..+.. .++.. .+++..+..++.+++.+|.+| |+.||||+||++.
T Consensus 83 l~~~Gv~vP~pi~~--~---~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--K---KHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--c---CCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 864 466777754 2 2358999998754432 23321 256677788899999999999 8999999999999
Q ss_pred cEEEcCCCCEEEeecCccccccc
Q 043248 138 NIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 138 NILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
|||+. ++.++|+|||.+.....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCCC
Confidence 99997 57899999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-11 Score=132.95 Aligned_cols=203 Identities=27% Similarity=0.437 Sum_probs=145.1
Q ss_pred HHHHhcCCCCcceEEEEEEecC----eEEEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 043248 57 ALIARVQHPYIVEFKEAWVEKG----CYVCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNY-- 128 (1092)
Q Consensus 57 qILkqL~HPNIVKL~gvF~e~d----~~lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkG-- 128 (1092)
.-|-++-|.|||+++.||.+.. ....++.||+.-|+|..+|++. ....+......+|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3344556999999999987554 3467899999999999999864 3345778889999999999999999885
Q ss_pred ccccCCCCCcEEEcCCCCEEEeecCccccc---cc--cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhC
Q 043248 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTL---KA--DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH 203 (1092)
Q Consensus 129 IIHRDLKPENILLD~dG~LKLiDFGLA~~l---~~--d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTG 203 (1092)
|+|+++..+-|++..+|-+|+.---..... .. ........|-++|.+||.=.-....-.+|||+||+..++|..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999998887777532111111 00 1112234577899999987666667899999999999999877
Q ss_pred CCC-CcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 204 RPA-FKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 204 r~P-F~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
..- -........-..+....+. + -...-+++|.+||+..|..||++.++|.||.+-
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~-l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIG-L---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcceeehhhhhhhheee-c---cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 644 2222221111111111111 0 122335899999999999999999999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.3e-10 Score=113.32 Aligned_cols=142 Identities=14% Similarity=0.158 Sum_probs=105.3
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEecC--eEEEEEEe
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP--YIVEFKEAWVEKG--CYVCIVTG 86 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HP--NIVKL~gvF~e~d--~~lyLVME 86 (1092)
.+.||.|.++.||++... +|..|++|........ .....+.+|+.+++.+.+. ++.+++.+..... ...++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 367899999999999864 3678999987654321 1234677899999998763 4577776654432 24579999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS---------------------------------------- 126 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS---------------------------------------- 126 (1092)
|++|.+|.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988776532 126777777778888888888873
Q ss_pred ----------------CCccccCCCCCcEEEcC--CCCEEEeecCcccc
Q 043248 127 ----------------NYVLHRDLKCSNIFLTK--DQDVRLGDFGLAKT 157 (1092)
Q Consensus 127 ----------------kGIIHRDLKPENILLD~--dG~LKLiDFGLA~~ 157 (1092)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 56689999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-08 Score=119.46 Aligned_cols=215 Identities=20% Similarity=0.294 Sum_probs=158.9
Q ss_pred eEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---cCeEEEEEEeecCC-CCHHH
Q 043248 20 GAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE---KGCYVCIVTGYCEG-GDMAE 95 (1092)
Q Consensus 20 GtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e---~d~~lyLVMEYceG-GSL~D 95 (1092)
.+.|++....+|..|++|++...+.. .......-+++++++.|.|||++.++|.. .+..+++|++|+++ ++|++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 47899999999999999999433211 11233446788999999999999999873 34678899999875 46777
Q ss_pred HHHH-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 96 LMKK-------------SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 96 LLkk-------------k~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+--. ..+...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+.+++|...|.......+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 6421 123347889999999999999999999999999999999999988888888888776665443
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
. |.+.. -.+-|.-.||.+++.|.+|..--...+... +.. ...+-..++.+++++|..+
T Consensus 448 ~-------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~---~s~---~~~I~~~yS~D~rn~v~yl 505 (655)
T KOG3741|consen 448 T-------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQ---SSH---LTRITTTYSTDLRNVVEYL 505 (655)
T ss_pred C-------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchH---HHH---HHHhhhhhhHHHHHHHHHH
Confidence 0 11111 246799999999999999964422211111 110 1123345788999999999
Q ss_pred cccCCCCCCCHHHHHhC
Q 043248 243 LRKNPEHRPSASELLKH 259 (1092)
Q Consensus 243 LqkDPskRPSaeELLqH 259 (1092)
...++++ -++.+++.|
T Consensus 506 ~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 506 ESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HhcCccc-ccHHHHHHH
Confidence 9998887 788898876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.3e-08 Score=109.30 Aligned_cols=137 Identities=15% Similarity=0.040 Sum_probs=97.2
Q ss_pred ceEEEEEEEcCCCcEEEEEEEecccccHHHHH---------HHHHHHHHHHhcCCCCc--ceEEEEEEec----CeEEEE
Q 043248 19 FGAAILVNHRAEKKKYVLKKIRLARQTERCRR---------SAHQEMALIARVQHPYI--VEFKEAWVEK----GCYVCI 83 (1092)
Q Consensus 19 FGtVYLA~dK~tGk~VAIKkIkks~~se~~~r---------~f~rEIqILkqL~HPNI--VKL~gvF~e~----d~~lyL 83 (1092)
...|+.+.. .|+.|.||........+..+. .+.+|...+..|..-+| +.++.++... ....+|
T Consensus 35 ~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 35 GRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 334555543 567899997643322211111 37788888888854443 4445555332 224679
Q ss_pred EEeecCCC-CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-------CCCEEEeecCcc
Q 043248 84 VTGYCEGG-DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-------DQDVRLGDFGLA 155 (1092)
Q Consensus 84 VMEYceGG-SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-------dG~LKLiDFGLA 155 (1092)
|||++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999986 8999986432233567788899999999999999999999999999999975 357999999987
Q ss_pred cc
Q 043248 156 KT 157 (1092)
Q Consensus 156 ~~ 157 (1092)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-08 Score=106.81 Aligned_cols=133 Identities=22% Similarity=0.269 Sum_probs=95.9
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEE-EecccccHH-----HHHHHHHHHHHHHhcCCCCc--ceEEEEEEecCeEEEE
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKK-IRLARQTER-----CRRSAHQEMALIARVQHPYI--VEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKk-Ikks~~se~-----~~r~f~rEIqILkqL~HPNI--VKL~gvF~e~d~~lyL 83 (1092)
..+++|+-+.+|.+... |..+++|. +.+...... ....-.+|+.++.++.--.| +.++++ +.... .|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~-~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNG-LI 76 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCC-EE
Confidence 46789999999999663 33455553 333322222 23456779999998865444 444443 44433 49
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
+|||++|..|.+++... ...++..+=.-+.-||..||+|+||.++||++..+ .+.++||||+..-.
T Consensus 77 ~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~ 142 (204)
T COG3642 77 VMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSD 142 (204)
T ss_pred EEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccccc
Confidence 99999999999888764 24677778888899999999999999999999854 49999999987543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.5e-08 Score=103.83 Aligned_cols=146 Identities=21% Similarity=0.249 Sum_probs=105.7
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEE-eccccc-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKI-RLARQT-----ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkI-kks~~s-----e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+.+|-+|+-+.|+.+.+ .|+.++||.- .+.... .-.+.+..+|+.+|.++.--.|.--.=+|.+... -.|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeE
Confidence 678899999999999975 5777777743 222211 2234567889999998864444222223333332 248
Q ss_pred EEeecCC-CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---EEEeecCccccc
Q 043248 84 VTGYCEG-GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTL 158 (1092)
Q Consensus 84 VMEYceG-GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~---LKLiDFGLA~~l 158 (1092)
+|||++| .++.+++...............++.+|-..|.-||.++|||+||..+||++..++. +.|+|||++..-
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 8999987 57888887765444445555889999999999999999999999999999987763 589999998653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.3e-09 Score=128.00 Aligned_cols=150 Identities=19% Similarity=0.301 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCccccccccccC----------ccccCCCCcCCchhhccCC
Q 043248 115 AQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA----------SSVVGTPNYMCPELLADIP 183 (1092)
Q Consensus 115 ~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~----------st~vGTp~YmAPEVL~g~~ 183 (1092)
.+...||.|+|.. ++||++|.|++|+++..+..||+.|+++........+ ....-...|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3444899999965 8999999999999999999999999998766542111 1123456799999999988
Q ss_pred CCccccchhHHHHHHHHH-hCCCCCcccChH---HHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 184 YGFKSDIWSLGCCMYEMA-AHRPAFKAFDMA---GLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 184 yS~KSDVWSLGVILYELL-TGr~PF~g~d~~---dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+.++|+|||||++|-+. .|+..|...... .+..........-....+++++++=|.++|..++..||++.+++.-
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 899999999999999998 677666554321 1111112222223456789999999999999999999999999999
Q ss_pred hhhHh
Q 043248 260 PFLQH 264 (1092)
Q Consensus 260 PwFq~ 264 (1092)
+||..
T Consensus 266 ~ff~D 270 (700)
T KOG2137|consen 266 PFFSD 270 (700)
T ss_pred cccCC
Confidence 99964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.1e-08 Score=101.20 Aligned_cols=128 Identities=20% Similarity=0.232 Sum_probs=85.6
Q ss_pred EEEEEEEcCCCcEEEEEEEeccc------------------------ccHHHHHHHHHHHHHHHhcCCC--CcceEEEEE
Q 043248 21 AAILVNHRAEKKKYVLKKIRLAR------------------------QTERCRRSAHQEMALIARVQHP--YIVEFKEAW 74 (1092)
Q Consensus 21 tVYLA~dK~tGk~VAIKkIkks~------------------------~se~~~r~f~rEIqILkqL~HP--NIVKL~gvF 74 (1092)
.||.|.. .+|..+|+|+.+... ..........+|+..|.++..- ++++++.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3888886 567899999875321 1112234677899999999866 56777644
Q ss_pred EecCeEEEEEEeecC--CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEEcCCCCEEEee
Q 043248 75 VEKGCYVCIVTGYCE--GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY-LHSNYVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 75 ~e~d~~lyLVMEYce--GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaY-LHSkGIIHRDLKPENILLD~dG~LKLiD 151 (1092)
..+ +|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|
T Consensus 79 -~~~---~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 -NRN---VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp -ETT---EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred -eCC---EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence 333 49999998 76665544322 2245567788888885555 579999999999999999966 999999
Q ss_pred cCcccccc
Q 043248 152 FGLAKTLK 159 (1092)
Q Consensus 152 FGLA~~l~ 159 (1092)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887655
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.3e-07 Score=96.72 Aligned_cols=107 Identities=19% Similarity=0.194 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHhcCCCC--cceEEEEEEecC---eEEEEEEeecCCC-CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHH
Q 043248 50 RSAHQEMALIARVQHPY--IVEFKEAWVEKG---CYVCIVTGYCEGG-DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123 (1092)
Q Consensus 50 r~f~rEIqILkqL~HPN--IVKL~gvF~e~d---~~lyLVMEYceGG-SL~DLLkkk~gk~LSEeqI~kIa~QILsALaY 123 (1092)
....+|...+..|..-+ +++.+++..... ...+||+|+++|. +|.+++..... ++......++.++...++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 45778888888875433 455665554422 2457999999884 79999986433 5677888999999999999
Q ss_pred HHHCCccccCCCCCcEEEcCCC---CEEEeecCccccc
Q 043248 124 LHSNYVLHRDLKCSNIFLTKDQ---DVRLGDFGLAKTL 158 (1092)
Q Consensus 124 LHSkGIIHRDLKPENILLD~dG---~LKLiDFGLA~~l 158 (1092)
||.+||+|+|+++.|||++.++ .+.|+||+.+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999887 7999999877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-06 Score=101.17 Aligned_cols=238 Identities=16% Similarity=0.231 Sum_probs=154.4
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcce--------EEEEEEecCeE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVE--------FKEAWVEKGCY 80 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVK--------L~gvF~e~d~~ 80 (1092)
..+.||+|+-+-+|....-. .. +.|+....-.... . +.+..|... .||-+-. |++ -+.+..
T Consensus 15 ~gr~LgqGgea~ly~l~e~~--d~-VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G--~~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR--DQ-VAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHG--GRRGKV 84 (637)
T ss_pred CCccccCCccceeeecchhh--ch-hheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhC--CCccce
Confidence 35779999999999865432 22 4455543221111 1 112222222 3443322 111 122333
Q ss_pred EEEEEeecCCCCHHHHHH-----HcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 81 VCIVTGYCEGGDMAELMK-----KSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLk-----kk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
+.++|..+.|..--..|. ++....+.+..+.+..+.|+.+.+.||..|.+-+|+.++|||+.+++.+.|+|=...
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 678888887764333332 122234678999999999999999999999999999999999999999999987655
Q ss_pred ccccccccCccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhC-CCCCcccCh----HHHHH-Hh-----
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDM----AGLIS-KI----- 219 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~----~dli~-kI----- 219 (1092)
..-..+.....-+|...|.+||.-. +..-+...|.|.||+++|+||.| +.||.+... ..-.. .|
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 5545555566778999999999754 33346789999999999999886 999976321 00000 11
Q ss_pred -----hccCCCCCC-----CCCCHHHHHHHHHhccc--CCCCCCCHHHHH
Q 043248 220 -----NRSSIGPLP-----SCYSPSLKTLIKGMLRK--NPEHRPSASELL 257 (1092)
Q Consensus 220 -----~~~~i~plP-----s~iS~eLkDLIrkcLqk--DPskRPSaeELL 257 (1092)
....+.+.| +-+++.+..|..+|+.. ++.-|||++..+
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 111111111 23578899999999876 356899987544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.7e-07 Score=101.75 Aligned_cols=138 Identities=22% Similarity=0.228 Sum_probs=104.0
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc--------------------ccHHHHHHHHHHHHHHHhcCCC--C
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR--------------------QTERCRRSAHQEMALIARVQHP--Y 66 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~--------------------~se~~~r~f~rEIqILkqL~HP--N 66 (1092)
.+..+||-|.-+.||.|.+. .|.++|+|.-+... +....+....+|+.+|.+|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46789999999999999974 78999999754321 1122345688999999999765 6
Q ss_pred cceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC
Q 043248 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD 146 (1092)
Q Consensus 67 IVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~ 146 (1092)
+.+-+++ + .-++||||++|..|...- ++.+.+..++..|+.-+..+-..||||+|+++-||+++.+|.
T Consensus 173 VP~P~~~----n-RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----N-RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----c-cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 7776653 2 235999999997776543 234555666677777777777999999999999999999999
Q ss_pred EEEeecCcccccc
Q 043248 147 VRLGDFGLAKTLK 159 (1092)
Q Consensus 147 LKLiDFGLA~~l~ 159 (1092)
+.++||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999996554433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.9e-08 Score=116.96 Aligned_cols=244 Identities=20% Similarity=0.247 Sum_probs=168.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY-IVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN-IVKL~gvF~e~d~~ly 82 (1092)
...-|...+-+++|+++.+|+.+...+...+ .+++... ....-++++|.+++||| .+..++-+ +.+.+.+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~~~~ 310 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-DGEDYLW 310 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-Ccccccc
Confidence 3344556677899999999999876665444 6665543 12334788999999999 66666555 3345889
Q ss_pred EEEeecCCC-CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 83 IVTGYCEGG-DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 83 LVMEYceGG-SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
++|+||.++ +-...+... ...|-+-+...+.+.-..+|+|+|+..=+|+| ||+.. .+..++.||+....+...
T Consensus 311 i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcc
Confidence 999999887 222111100 01134455666777778899999998888998 77766 478999999998887766
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-CCC-CC-CCCCHHHH-H
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-IGP-LP-SCYSPSLK-T 237 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-i~p-lP-s~iS~eLk-D 237 (1092)
....+..+++.++|||+.....+....|+|++|+--.+|.-|-+|-...-. ....+.... ... .. ..++.-+. +
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~~~~~ 462 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPVFHRD 462 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcccccC
Confidence 566778899999999999999999999999999877777777766543110 000000000 000 00 11222222 4
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+...|+...|..|+....++.|.+|..
T Consensus 463 ~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 463 FPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CcccccCCCCCCCcchhhHHHHHHhcc
Confidence 888999999999999999998888865
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=5e-06 Score=89.07 Aligned_cols=139 Identities=15% Similarity=0.137 Sum_probs=100.7
Q ss_pred eecCceEEEEEEEcCCCcEEEEEEEecc-c---ccHHHHHHHHHHHHHHHhcCCCC--cceEEEEEEec----CeEEEEE
Q 043248 15 GRGAFGAAILVNHRAEKKKYVLKKIRLA-R---QTERCRRSAHQEMALIARVQHPY--IVEFKEAWVEK----GCYVCIV 84 (1092)
Q Consensus 15 GkGgFGtVYLA~dK~tGk~VAIKkIkks-~---~se~~~r~f~rEIqILkqL~HPN--IVKL~gvF~e~----d~~lyLV 84 (1092)
|+||.+-||..... |+.|-+|.-..- . ........|.+|+..|++|..-+ +.++. ++... ....+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 67899999998753 346888865311 0 10113467899999999986433 44444 23211 1345799
Q ss_pred EeecCC-CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--EEEeecCccc
Q 043248 85 TGYCEG-GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD--VRLGDFGLAK 156 (1092)
Q Consensus 85 MEYceG-GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~--LKLiDFGLA~ 156 (1092)
+|-++| .+|.+++........++.+...++.++...|+-||..|+.|+|+.+.|||++.+|. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997754 58988887644334678888899999999999999999999999999999987777 9999996554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.5e-06 Score=88.36 Aligned_cols=139 Identities=18% Similarity=0.249 Sum_probs=89.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHH------HHHHHHHHHHHhcCC---CCcceEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCR------RSAHQEMALIARVQH---PYIVEFKEAWV 75 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~------r~f~rEIqILkqL~H---PNIVKL~gvF~ 75 (1092)
++|.+.+.+-.....-|.+.. -+|+.+++|..+..... +... ....+++..+..+.. -.+..++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 578888888888877777765 46788999977543211 1111 113344444444432 22223222221
Q ss_pred ec----CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEee
Q 043248 76 EK----GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 76 e~----d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiD 151 (1092)
.. ....+|||||++|..|.++.. +++ .+...|.+++.-||+.|++|+|.+|.|+++.. +.++++|
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID 177 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIID 177 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEE
Confidence 11 124568999999988877542 333 24456777899999999999999999999985 4599999
Q ss_pred cCcccc
Q 043248 152 FGLAKT 157 (1092)
Q Consensus 152 FGLA~~ 157 (1092)
|+....
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 976543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.2e-06 Score=101.76 Aligned_cols=146 Identities=16% Similarity=0.208 Sum_probs=92.4
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc--------------------------------HHHHHH------HH
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT--------------------------------ERCRRS------AH 53 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s--------------------------------e~~~r~------f~ 53 (1092)
+.|+.++.|+||.|..+. |+.||||+.+..-.. +...+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999999865 999999997543110 111112 23
Q ss_pred HHHHHHHhcC----CCCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 043248 54 QEMALIARVQ----HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYV 129 (1092)
Q Consensus 54 rEIqILkqL~----HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGI 129 (1092)
+|..-+.++. ..--+.+-.+|-+-...-.|+|||++|..+.+...-.. ..++.+.+.....++. +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 3444444332 22222222333232223359999999999998843222 2256444443333322 223334799
Q ss_pred cccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 130 LHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 130 IHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
+|.|.+|.||+++.+|.+.+.|||+...+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999998877644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.1e-05 Score=79.36 Aligned_cols=141 Identities=18% Similarity=0.250 Sum_probs=83.3
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEec--CeEEEEEEe
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP--YIVEFKEAWVEK--GCYVCIVTG 86 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HP--NIVKL~gvF~e~--d~~lyLVME 86 (1092)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|... .+.+++.+.... ....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998755 48899987543 3345677888888888533 356666543322 235789999
Q ss_pred ecCCCCHHH----------------HHHH---c--CCCCCCHH---------HHHHH------------HHHHHH-HHHH
Q 043248 87 YCEGGDMAE----------------LMKK---S--NGAYFPEE---------KLCKW------------FAQLLL-AVDY 123 (1092)
Q Consensus 87 YceGGSL~D----------------LLkk---k--~gk~LSEe---------qI~kI------------a~QILs-ALaY 123 (1092)
+++|..+.. .+.. . ....+... ..... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999998887 1111 1 00011100 00000 111222 3333
Q ss_pred HHH-------CCccccCCCCCcEEEc-CCCCEEEeecCcccc
Q 043248 124 LHS-------NYVLHRDLKCSNIFLT-KDQDVRLGDFGLAKT 157 (1092)
Q Consensus 124 LHS-------kGIIHRDLKPENILLD-~dG~LKLiDFGLA~~ 157 (1092)
+++ ..++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 3599999999999999 566678999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.3e-06 Score=102.20 Aligned_cols=202 Identities=21% Similarity=0.272 Sum_probs=144.8
Q ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEecCe---EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 043248 50 RSAHQEMALIARVQHPYIVEFKEAWVEKGC---YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126 (1092)
Q Consensus 50 r~f~rEIqILkqL~HPNIVKL~gvF~e~d~---~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS 126 (1092)
....-|+..+.++.|+|++.++.|-.+... ...+..+||.+.++...+...+. ++....+.+..+++.||+|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHH
Confidence 345567788888899999999987655432 22355678999999999987765 7889999999999999999999
Q ss_pred CCccccCCCCC---cEEEcCCCCEEEe--ecCccccccccccCccccCCCCcCCchhhccCCCCc--cccchhHHHHHHH
Q 043248 127 NYVLHRDLKCS---NIFLTKDQDVRLG--DFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGF--KSDIWSLGCCMYE 199 (1092)
Q Consensus 127 kGIIHRDLKPE---NILLD~dG~LKLi--DFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~--KSDVWSLGVILYE 199 (1092)
....|.-|... +.-.+..+...+. ||+.+..+..........-...|.++|......+.. ..|+|.+|.++..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 95555444333 2223344455555 888887776555555556677788899887666654 4699999999999
Q ss_pred HHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 200 MAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 200 LLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
+..|..+-..... ... .++........+++.+|+.-+.++|+++.+++.|+|..
T Consensus 385 ~~~~~~i~~~~~~---~~~-------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 385 LSQGEDISEKSAV---PVS-------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred hhhcCcccccccc---hhh-------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 9887654321110 000 11111222677999999999999999999999999874
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.7e-05 Score=83.06 Aligned_cols=136 Identities=15% Similarity=0.121 Sum_probs=80.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc--ceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI--VEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI--VKL~gvF~e~d~~lyLVMEYce 89 (1092)
.+||+|..+.||+. .+..+++|....... ...+.+|.++++.+..-.+ .+.+.+. +....+++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~-~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLV-EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEE-ecCCeeeeeeeecC
Confidence 67899999999984 245677888764331 2345789999988864444 5566554 33445678999999
Q ss_pred CCC-HH--------------HHHHH----cCC---CCCCHHH-HHHHHHH----------HHHH-HHHHHH----CCccc
Q 043248 90 GGD-MA--------------ELMKK----SNG---AYFPEEK-LCKWFAQ----------LLLA-VDYLHS----NYVLH 131 (1092)
Q Consensus 90 GGS-L~--------------DLLkk----k~g---k~LSEeq-I~kIa~Q----------ILsA-LaYLHS----kGIIH 131 (1092)
|.. +. ..+.+ -.. ....... ...+..+ +... ..+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 964 21 11111 000 0111111 1111111 1111 222221 23789
Q ss_pred cCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 132 RDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 132 RDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999877 99999987753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.8e-07 Score=115.70 Aligned_cols=258 Identities=14% Similarity=0.088 Sum_probs=171.1
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEec---ccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cC
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRL---ARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE-KG 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkk---s~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e-~d 78 (1092)
.++..|++.=-+|-|.++.--....+.. .+-+|+.+. ....+-.++....|...++...|+++...+.=... ..
T Consensus 1226 s~~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1226 SAMEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred HHhhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 4566666655555555443222211222 123333322 12223334455556566666789988775543322 22
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEcCCCCEEEee
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYLHSNY-----VLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--gk~LSEeqI~kIa~QILsALaYLHSkG-----IIHRDLKPENILLD~dG~LKLiD 151 (1092)
...|++++||.+|.+++.|.+.- ...+.+..+.....+.+.+..-+|+.. .+|++||+-|.+|..+.++++.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 34578999999999999997532 222444445555555577777777542 68999999999999999999999
Q ss_pred cCccccc-cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCC
Q 043248 152 FGLAKTL-KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC 230 (1092)
Q Consensus 152 FGLA~~l-~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~ 230 (1092)
+|+.+.. .........++++.|+.+++.+.-.++.+.|+|..|+.+|.+..|..+|.......+...+.......++..
T Consensus 1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l 1463 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKL 1463 (2724)
T ss_pred cccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccccccc
Confidence 9999933 333445567889999999999999999999999999999999999988866555444444444444455555
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
.+.++-.+...+|-..-..||.-...+.-+.|
T Consensus 1464 ~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1464 KPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred CCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 55555555555666666779988888876655
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.9e-05 Score=91.64 Aligned_cols=143 Identities=13% Similarity=0.165 Sum_probs=91.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-----------------------------HHHHHHHHHHH------
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-----------------------------ERCRRSAHQEM------ 56 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-----------------------------e~~~r~f~rEI------ 56 (1092)
+.||..+.|+||.|..+. |..||||+-+..-.. ++..+.+..|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 678999999999999876 999999986533111 11222222222
Q ss_pred H----HHHhcCCCC------cceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 043248 57 A----LIARVQHPY------IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126 (1092)
Q Consensus 57 q----ILkqL~HPN------IVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS 126 (1092)
+ +.+.+.|-+ |.++|-.+ ...-.|+||||+|..+.++-.-.. ..++...+...+.+...-. |-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHH--HHh
Confidence 2 222333555 44444332 223459999999988876543221 1267766555444443322 234
Q ss_pred CCccccCCCCCcEEEcC----CCCEEEeecCcccccccc
Q 043248 127 NYVLHRDLKCSNIFLTK----DQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~----dG~LKLiDFGLA~~l~~d 161 (1092)
.|++|+|-+|.||+++. ++.+.+.|||+.....+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 68999999999999984 557999999998776543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=80.05 Aligned_cols=146 Identities=16% Similarity=0.106 Sum_probs=97.6
Q ss_pred CCeEEEEEE---eecCceEEEEEEEcCCCcEEEEEEEecccccH----------------------HHHHHHHHHHHHHH
Q 043248 6 DQYEIMEQI---GRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----------------------RCRRSAHQEMALIA 60 (1092)
Q Consensus 6 DrYeIlKkL---GkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----------------------~~~r~f~rEIqILk 60 (1092)
+++.+.... ..|.-+.||+|.. .++..+|+|+++.....- ....-..+|+.-|+
T Consensus 45 ~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~ 123 (268)
T COG1718 45 SRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK 123 (268)
T ss_pred cCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 344454444 4566668999985 568899999885431110 01112446777777
Q ss_pred hcC--CCCcceEEEEEEecCeEEEEEEeecCCCC-HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCC
Q 043248 61 RVQ--HPYIVEFKEAWVEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKC 136 (1092)
Q Consensus 61 qL~--HPNIVKL~gvF~e~d~~lyLVMEYceGGS-L~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKP 136 (1092)
++. +-.+.+-+.++ .-.|||||+...- -.-.|+.. .+...++..+..++++.+.-|-. .|+||+||+.
T Consensus 124 R~~eAGVrvP~Pi~~~-----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE 195 (268)
T COG1718 124 RAYEAGVRVPEPIAFR-----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE 195 (268)
T ss_pred HHHHcCCCCCCceeec-----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence 774 44556666543 1248999986431 11112211 13444688888999999888877 8999999999
Q ss_pred CcEEEcCCCCEEEeecCcccccccc
Q 043248 137 SNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 137 ENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
-|||+. ++.+.|+|||-|....+.
T Consensus 196 yNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 196 YNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hheEEE-CCeEEEEECccccccCCC
Confidence 999999 889999999988876643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=90.50 Aligned_cols=149 Identities=16% Similarity=0.314 Sum_probs=91.6
Q ss_pred EEEEEeecCceEEEEEEEcCCC--cEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCc--ceEEEEEEecC--eEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEK--KKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYI--VEFKEAWVEKG--CYVC 82 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tG--k~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNI--VKL~gvF~e~d--~~ly 82 (1092)
-++.|+.|.++.+|+......+ ..+++|+........ ....+.+|+.+|+.|. |.+| ++++.++.+.. ...|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3678899999999998765432 467777764332111 1346778999999995 6665 77777665432 3467
Q ss_pred EEEeecCCCCHHH--------------------HHHHcCC------------C--CCCHHHHHHHHHH------------
Q 043248 83 IVTGYCEGGDMAE--------------------LMKKSNG------------A--YFPEEKLCKWFAQ------------ 116 (1092)
Q Consensus 83 LVMEYceGGSL~D--------------------LLkkk~g------------k--~LSEeqI~kIa~Q------------ 116 (1092)
+||||++|..+.+ .|..-.. . .+-..++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999864321 1111000 0 0112233332222
Q ss_pred ---HHHHHHHHHH-----------CCccccCCCCCcEEEcCC-CC-EEEeecCcccccc
Q 043248 117 ---LLLAVDYLHS-----------NYVLHRDLKCSNIFLTKD-QD-VRLGDFGLAKTLK 159 (1092)
Q Consensus 117 ---ILsALaYLHS-----------kGIIHRDLKPENILLD~d-G~-LKLiDFGLA~~l~ 159 (1092)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|+||.++..-.
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2233566642 249999999999999853 33 5799999887644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=76.56 Aligned_cols=76 Identities=12% Similarity=0.077 Sum_probs=49.9
Q ss_pred EEeecCc-eEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEEEeecCC
Q 043248 13 QIGRGAF-GAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIVTGYCEG 90 (1092)
Q Consensus 13 kLGkGgF-GtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLVMEYceG 90 (1092)
.|-.|.. ..||++... +..+++|+..... ...+.+|+.+++.+. +--+.+++.+.... ...++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCC
Confidence 4455555 678998653 3677788765432 234567888888774 34466777666443 356799999999
Q ss_pred CCHHHH
Q 043248 91 GDMAEL 96 (1092)
Q Consensus 91 GSL~DL 96 (1092)
.+|...
T Consensus 77 ~~l~~~ 82 (244)
T cd05150 77 VPAAAL 82 (244)
T ss_pred ccHhHh
Confidence 877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00035 Score=73.75 Aligned_cols=75 Identities=12% Similarity=0.086 Sum_probs=45.4
Q ss_pred EEEEeecCceE-EEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC---CcceEEEEEEecC--eEEEEE
Q 043248 11 MEQIGRGAFGA-AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP---YIVEFKEAWVEKG--CYVCIV 84 (1092)
Q Consensus 11 lKkLGkGgFGt-VYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HP---NIVKL~gvF~e~d--~~lyLV 84 (1092)
++.|+.|+... ||... ..+++|...... ....+.+|+.++..|... -+.++++.....+ ...|+|
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 35678777774 88762 346777654321 234677899998888532 3444443322211 234789
Q ss_pred EeecCCCCHH
Q 043248 85 TGYCEGGDMA 94 (1092)
Q Consensus 85 MEYceGGSL~ 94 (1092)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0005 Score=72.78 Aligned_cols=130 Identities=20% Similarity=0.192 Sum_probs=92.5
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc-eEEEEEEecCeEEEEEEee
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV-EFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIV-KL~gvF~e~d~~lyLVMEY 87 (1092)
++.+.||+|.+|.||++.+. |..+|+|+-+.+ ..+..+..|.++|+.+.--++- ++|.| ..+ .+.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y--g~~---~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY--GED---FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe--chh---hhhhhh
Confidence 35678999999999999875 458888886543 3356788899999999877664 44433 222 366999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCcEEEcCCCCEEEeecCccccc
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLK-CSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLK-PENILLD~dG~LKLiDFGLA~~l 158 (1092)
+.|-.|.++-... . ++-+..+++.-.-|-..||-|+.|. |..++|..++.+.|+||..|..-
T Consensus 94 i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9998887765421 1 2334455666666777899999875 55555555669999999988743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0019 Score=69.28 Aligned_cols=128 Identities=21% Similarity=0.254 Sum_probs=88.8
Q ss_pred CCeEEEEEEeecCc-eEEEEEEEcCCCcEEEEEEEec---ccc-------c--H-------HHHHHHHHHHHHHH---hc
Q 043248 6 DQYEIMEQIGRGAF-GAAILVNHRAEKKKYVLKKIRL---ARQ-------T--E-------RCRRSAHQEMALIA---RV 62 (1092)
Q Consensus 6 DrYeIlKkLGkGgF-GtVYLA~dK~tGk~VAIKkIkk---s~~-------s--e-------~~~r~f~rEIqILk---qL 62 (1092)
..++.++.||.|.- |.||++.. .|+.||+|.+.. ... . + ....-|..|-.... .+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 99999986 577999999321 100 0 0 12223455555444 44
Q ss_pred CCCCc--ceEEEEEEecC-----------------eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHH
Q 043248 63 QHPYI--VEFKEAWVEKG-----------------CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123 (1092)
Q Consensus 63 ~HPNI--VKL~gvF~e~d-----------------~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaY 123 (1092)
.+.++ |++++|+.-.. ....||.||..... .+... -+.+|+.-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 56677 99999874331 23468888876543 12333 34567777889
Q ss_pred HHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 124 LHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999986 3489999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00034 Score=73.15 Aligned_cols=101 Identities=20% Similarity=0.170 Sum_probs=78.5
Q ss_pred HHHHHHHhcCC-CCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 043248 54 QEMALIARVQH-PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK-SNGAYFPEEKLCKWFAQLLLAVDYLHS---NY 128 (1092)
Q Consensus 54 rEIqILkqL~H-PNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkk-k~gk~LSEeqI~kIa~QILsALaYLHS---kG 128 (1092)
.|.-+++.+.+ +++++++|+| + -++|.||...++++..-.. .....-++..+.+|+.++++.+.+|+. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---C--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888876 6999999988 2 2468999987766532000 000125799999999999999999997 45
Q ss_pred ccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 129 IIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
+...|++++||.++.+|++|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998765543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0013 Score=68.68 Aligned_cols=75 Identities=5% Similarity=0.145 Sum_probs=47.8
Q ss_pred EEEEeecCceEEEEEEEcC-CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCeEEEEEEeec
Q 043248 11 MEQIGRGAFGAAILVNHRA-EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY-IVEFKEAWVEKGCYVCIVTGYC 88 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~-tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN-IVKL~gvF~e~d~~lyLVMEYc 88 (1092)
++.|..|-...+|++.... .++.|++|........ .-...+|+.+++.+...+ .++++..+ . + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~---~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATF-Q-N---GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEe-C-C---cEEEEee
Confidence 4678888889999997543 3567888876532111 112236888888885433 44554432 2 2 3799999
Q ss_pred CCCCH
Q 043248 89 EGGDM 93 (1092)
Q Consensus 89 eGGSL 93 (1092)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 99765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0028 Score=67.34 Aligned_cols=133 Identities=19% Similarity=0.238 Sum_probs=89.7
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEeccc--------------ccHHHHHHHHHHHHHHHhcC------CCCcceE
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR--------------QTERCRRSAHQEMALIARVQ------HPYIVEF 70 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~--------------~se~~~r~f~rEIqILkqL~------HPNIVKL 70 (1092)
...||+|+.-.||.--+ .....||++.... ......+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35799999999887543 3445788876554 01112345556666666655 7889999
Q ss_pred EEEEEecCeEEEEEEeecC------CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 71 KEAWVEKGCYVCIVTGYCE------GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 71 ~gvF~e~d~~lyLVMEYce------GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
+++. +.+.-..+|+|.+. ..+|.++++... +++ .+.. .+-.-..||-+++|+.+||+|.||++...
T Consensus 83 ~G~v-eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFV-ETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEE-ecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence 9976 44445678888752 347899996543 555 3333 44445678889999999999999999643
Q ss_pred C----CEEEee-cCc
Q 043248 145 Q----DVRLGD-FGL 154 (1092)
Q Consensus 145 G----~LKLiD-FGL 154 (1092)
. .++|+| ||.
T Consensus 155 ~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCceEEEEEeCCCC
Confidence 2 478887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0012 Score=78.61 Aligned_cols=163 Identities=22% Similarity=0.248 Sum_probs=108.4
Q ss_pred HHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 043248 51 SAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130 (1092)
Q Consensus 51 ~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGII 130 (1092)
.+..-+++++.+.|+|+.+++.+-........+|||++ +.+|+++++..... .. +++ .+|+.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~---~~-------s~~-------~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK---DE-------SLL-------AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc---hh-------hhc-------ccccc
Confidence 45566789999999999999987655555688999999 57999998865421 11 110 22222
Q ss_pred ccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc
Q 043248 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF 210 (1092)
Q Consensus 131 HRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~ 210 (1092)
|- | .++++| ...... | ...++++|||++|.++.++.-|...|...
T Consensus 90 ~~-----~-------~~~~td----~~~t~~--------------~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 90 HL-----N-------IIYITD----HFLTKY--------------P-----SPIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred ee-----h-------hhhccc----cccccC--------------C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 21 1 223333 000000 0 11225999999999999999998888766
Q ss_pred ChHHHHHHhhccCCCC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 211 DMAGLISKINRSSIGP-----------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 211 d~~dli~kI~~~~i~p-----------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
...+....+.+-...+ +.-..+..+.+++.+|+-..|..||...++.+++-|.+..
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 5555555554322211 1112466788999999999999999999999999998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0023 Score=69.78 Aligned_cols=76 Identities=13% Similarity=0.194 Sum_probs=48.1
Q ss_pred EEEEeecCceEEEEEEEcC------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEEE
Q 043248 11 MEQIGRGAFGAAILVNHRA------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~lyL 83 (1092)
++.|..|-...+|++.... .++.|++|+....... .....+|+.+++.+...++ .+++.++ . + .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIF-P-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEe-C-C---Cc
Confidence 4667778888999987543 2578889986543211 1234567777777753333 4555444 2 2 26
Q ss_pred EEeecCCCCHH
Q 043248 84 VTGYCEGGDMA 94 (1092)
Q Consensus 84 VMEYceGGSL~ 94 (1092)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0084 Score=65.94 Aligned_cols=31 Identities=29% Similarity=0.311 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.|+||+|+++.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998655568999987753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00047 Score=78.52 Aligned_cols=137 Identities=20% Similarity=0.244 Sum_probs=97.2
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc--------------------cHHHHHHHHHHHHHHHhcCCCC-
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--------------------TERCRRSAHQEMALIARVQHPY- 66 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~--------------------se~~~r~f~rEIqILkqL~HPN- 66 (1092)
|.+.++||-|.-+.||.+-+ ..|.++++|.-+..+. ..-.+-...+|+..|+.|....
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 45788999999999999987 4678888886433211 1112234667999999885422
Q ss_pred -cceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 043248 67 -IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ 145 (1092)
Q Consensus 67 -IVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG 145 (1092)
+++.+++. .-|+|||++.|..|...-.- ..+..+...++.-+.-|-.+|+||+|+.=-||+++.++
T Consensus 173 pVPkpiD~~-----RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPIDHN-----RHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCccccc-----ceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 44444332 34699999999888765422 22334555666667778899999999999999999999
Q ss_pred CEEEeecCccccc
Q 043248 146 DVRLGDFGLAKTL 158 (1092)
Q Consensus 146 ~LKLiDFGLA~~l 158 (1092)
.++++||--....
T Consensus 240 ~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 240 KIVVIDFPQMVST 252 (465)
T ss_pred CEEEeechHhhcc
Confidence 9999999654443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0084 Score=64.11 Aligned_cols=134 Identities=13% Similarity=0.179 Sum_probs=76.3
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEEEEEeecCCCC
Q 043248 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVCIVTGYCEGGD 92 (1092)
Q Consensus 14 LGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~lyLVMEYceGGS 92 (1092)
+..|-.+.+|+.. .+++.+++|......... .-...+|..+++.+....+ .+++... .+ ++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~---~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--EH---WLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--CC---EEEEEeccCcc
Confidence 4567788899886 456678888654321111 0123568888888864433 4444332 22 48999999876
Q ss_pred HHH--------------HHHHcC-----CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCccccCCC
Q 043248 93 MAE--------------LMKKSN-----GAYFPE-EKLCKWFAQL---------LLAVDYLHS--------NYVLHRDLK 135 (1092)
Q Consensus 93 L~D--------------LLkkk~-----gk~LSE-eqI~kIa~QI---------LsALaYLHS--------kGIIHRDLK 135 (1092)
+.. .+.+-. +..++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 532 111111 111221 2222332222 111222222 248999999
Q ss_pred CCcEEEcCCCCEEEeecCcccc
Q 043248 136 CSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 136 PENILLD~dG~LKLiDFGLA~~ 157 (1092)
|.||+++.++ +.|+||..+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999876 89999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0092 Score=64.69 Aligned_cols=139 Identities=17% Similarity=0.158 Sum_probs=80.2
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceEEEE-----EEecCeEEEE
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY--IVEFKEA-----WVEKGCYVCI 83 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN--IVKL~gv-----F~e~d~~lyL 83 (1092)
++.|..|....+|++.. .+..+++|+... .. ...+..|+.++..|.+.+ +.+++.. +..-++..++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 56777888889999864 345688888754 11 234556777777774332 4444431 1122235679
Q ss_pred EEeecCCCCHHH--------H---HHH---c--C--C-----CCCCHHHH----------HHHHHHHHHHHHHHHH----
Q 043248 84 VTGYCEGGDMAE--------L---MKK---S--N--G-----AYFPEEKL----------CKWFAQLLLAVDYLHS---- 126 (1092)
Q Consensus 84 VMEYceGGSL~D--------L---Lkk---k--~--g-----k~LSEeqI----------~kIa~QILsALaYLHS---- 126 (1092)
|++|++|..+.. + +.+ . . . ....+... ......+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999876421 1 110 0 0 0 00000000 0011122334444443
Q ss_pred ---CCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 127 ---NYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 127 ---kGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.++||+|+.|.|||++.++.+.|+||+.+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999987767899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.015 Score=64.09 Aligned_cols=140 Identities=19% Similarity=0.200 Sum_probs=78.9
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceEEEE-----EEecCeEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY--IVEFKEA-----WVEKGCYVC 82 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN--IVKL~gv-----F~e~d~~ly 82 (1092)
-++.++.|....+|++.. . +..+++|+...... ...+..|+.++..|...+ +++++.. +..-+...+
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred eccccCCccccceEEEEe-C-CCcEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 356677787789999864 3 34677887654211 123445666676664322 3444331 111234568
Q ss_pred EEEeecCCCCHH-----------HHHH---HcCCCCCC--------HH---HH-H-----------HHHHHHHHHHHHHH
Q 043248 83 IVTGYCEGGDMA-----------ELMK---KSNGAYFP--------EE---KL-C-----------KWFAQLLLAVDYLH 125 (1092)
Q Consensus 83 LVMEYceGGSL~-----------DLLk---kk~gk~LS--------Ee---qI-~-----------kIa~QILsALaYLH 125 (1092)
+||+|++|..+. ..+. .... .++ .. .. . .....+...++++.
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~-~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGA-HFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhc-cCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 999999885431 1111 1000 010 00 00 0 01112333455554
Q ss_pred H-------CCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 126 S-------NYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 126 S-------kGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
. .++||+|+++.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 579999999999999988767899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.018 Score=63.99 Aligned_cols=78 Identities=10% Similarity=-0.012 Sum_probs=53.5
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC---CCcceEEEEEEec--CeEEEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH---PYIVEFKEAWVEK--GCYVCIV 84 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H---PNIVKL~gvF~e~--d~~lyLV 84 (1092)
-.+.||.|..+.||..... ++ .+++|..+. .. ....+.+|...|+.|.. -.++++++++... ....+||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3567999999999999643 23 466666432 11 12467789999988853 3578888766432 2456799
Q ss_pred EeecCCCCH
Q 043248 85 TGYCEGGDM 93 (1092)
Q Consensus 85 MEYceGGSL 93 (1092)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.026 Score=65.71 Aligned_cols=141 Identities=15% Similarity=0.158 Sum_probs=94.8
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEEeccc-----------------------cc-HHHHHHHHHHHHHHHhcCCCCcc
Q 043248 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-----------------------QT-ERCRRSAHQEMALIARVQHPYIV 68 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-----------------------~s-e~~~r~f~rEIqILkqL~HPNIV 68 (1092)
.|.-|.-+.||.|.. .+|..+|||+++-+. .. ...+-....|+.-|++|+.-.|.
T Consensus 151 CiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 151 CISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred ccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 355577778999985 678889999864221 01 11223456688888888765543
Q ss_pred eEEEEEEecCeEEEEEEeecCCCCHH-HHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEcCCCC
Q 043248 69 EFKEAWVEKGCYVCIVTGYCEGGDMA-ELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH-SNYVLHRDLKCSNIFLTKDQD 146 (1092)
Q Consensus 69 KL~gvF~e~d~~lyLVMEYceGGSL~-DLLkkk~gk~LSEeqI~kIa~QILsALaYLH-SkGIIHRDLKPENILLD~dG~ 146 (1092)
----++.. + + .|||+|+.+.... -.|+. ..++...+..+-.|++.-+.-|- .+++||.||.=-|+|+- +|.
T Consensus 230 ~PePIlLk-~-h-VLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 230 CPEPILLK-N-H-VLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCceeee-c-c-eEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence 32222222 1 2 4899999642221 12222 23788888888888888887764 67999999999999997 789
Q ss_pred EEEeecCcccccccc
Q 043248 147 VRLGDFGLAKTLKAD 161 (1092)
Q Consensus 147 LKLiDFGLA~~l~~d 161 (1092)
+.|+|.+-+......
T Consensus 303 lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDHP 317 (520)
T ss_pred EEEEEccccccCCCh
Confidence 999999988766544
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.049 Score=63.75 Aligned_cols=79 Identities=11% Similarity=0.061 Sum_probs=51.2
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecc-----cccHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCeEEE
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-----RQTERCRRSAHQEMALIARVQ---HPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks-----~~se~~~r~f~rEIqILkqL~---HPNIVKL~gvF~e~d~~ly 82 (1092)
.+.||.|.+..||.+.....++.++||.-... ............|...|+.+. -.++++++.+ +.+ ..+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~-~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE-LAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC-CCE
Confidence 47899999999999998644468999974311 100112345556777777652 3457777754 333 346
Q ss_pred EEEeecCCCC
Q 043248 83 IVTGYCEGGD 92 (1092)
Q Consensus 83 LVMEYceGGS 92 (1092)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998744
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.063 Score=58.42 Aligned_cols=29 Identities=28% Similarity=0.405 Sum_probs=25.5
Q ss_pred CCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.++||+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.037 Score=61.11 Aligned_cols=31 Identities=29% Similarity=0.363 Sum_probs=25.8
Q ss_pred CccccCCCCCcEEEcCCCC-EEEeecCccccc
Q 043248 128 YVLHRDLKCSNIFLTKDQD-VRLGDFGLAKTL 158 (1092)
Q Consensus 128 GIIHRDLKPENILLD~dG~-LKLiDFGLA~~l 158 (1092)
.++|+|+++.|||++.++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999997565 569999987654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.041 Score=62.54 Aligned_cols=138 Identities=11% Similarity=0.175 Sum_probs=79.4
Q ss_pred EEEEeecCceEEEEEEEcC----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEEEEE
Q 043248 11 MEQIGRGAFGAAILVNHRA----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~lyLVM 85 (1092)
++.|-.|-...+|++.... .++.|++|...... +.... -.+|+.+++.+..-++ .++++.+ ..+ .|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~-~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRF-PNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEE-CCc----eEE
Confidence 4566668888999987432 24678888775432 11112 2568888888864444 4556554 222 578
Q ss_pred eecCCCCHHHH--------------HHHcCC------C-CCCHHHHHHHHHHHH-----------------HHHHHH---
Q 043248 86 GYCEGGDMAEL--------------MKKSNG------A-YFPEEKLCKWFAQLL-----------------LAVDYL--- 124 (1092)
Q Consensus 86 EYceGGSL~DL--------------Lkkk~g------k-~LSEeqI~kIa~QIL-----------------sALaYL--- 124 (1092)
+|++|.+|... +++-.. . ......+..++.++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99887665321 111100 0 111233333332221 112222
Q ss_pred -H----HCCccccCCCCCcEEEcC-CCCEEEeecCccc
Q 043248 125 -H----SNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAK 156 (1092)
Q Consensus 125 -H----SkGIIHRDLKPENILLD~-dG~LKLiDFGLA~ 156 (1092)
. ...++|+|+++.|||++. ++.+.|+||.++.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999986 4679999998765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.056 Score=60.99 Aligned_cols=139 Identities=13% Similarity=0.197 Sum_probs=78.2
Q ss_pred EEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEEEEEe
Q 043248 11 MEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~lyLVME 86 (1092)
++.|..|=...+|++..... +..|++++...... ... .-.+|..+++.+..-++ +++++++ ..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~I-dR~~E~~il~~l~~~gl~P~~l~~~-~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVI-DRERELQAIKYLSAAGFGAKLLGVF-GNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEe-chHHHHHHHHHHHhcCCCCceeEEe-CCc----Eeeh
Confidence 35565588888999875432 33788887754321 111 12457888888865555 4566554 333 5889
Q ss_pred ecCCCCHHH--------------HHHHcCCCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 043248 87 YCEGGDMAE--------------LMKKSNGAY------F-PEEKLCKWFAQL----------------------LLAVDY 123 (1092)
Q Consensus 87 YceGGSL~D--------------LLkkk~gk~------L-SEeqI~kIa~QI----------------------LsALaY 123 (1092)
|++|..|.. .+++-.... + -...+..++.++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 988765421 111111100 1 122333333222 111222
Q ss_pred HH----HCC----ccccCCCCCcEEEcC-CCCEEEeecCcccc
Q 043248 124 LH----SNY----VLHRDLKCSNIFLTK-DQDVRLGDFGLAKT 157 (1092)
Q Consensus 124 LH----SkG----IIHRDLKPENILLD~-dG~LKLiDFGLA~~ 157 (1092)
+. ..+ ++|.|+.+.|||+++ ++.++|+||..|-.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 21 122 789999999999975 46899999987743
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.041 Score=64.07 Aligned_cols=120 Identities=18% Similarity=0.299 Sum_probs=78.8
Q ss_pred CCCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEc
Q 043248 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLT 142 (1092)
Q Consensus 64 HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD 142 (1092)
-++..+.+-+-.+.+.|.|++|++. |+.|. .++. -..+++..|+++.+..|.-+..+ .+-||++...||||+
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId 356 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID 356 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceee-eeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence 3444444422225566888999886 44443 3332 24678889999988888777765 588999999999999
Q ss_pred CCCCEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCC 196 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVI 196 (1092)
+|+|-|+||-+++.-...... .-...--|-.+.|.. +.+.+||-+--.
T Consensus 357 -~GnvtLIDfklsRl~~~q~~i----sy~rldhp~lF~G~d-d~QFeIYrlMr~ 404 (488)
T COG5072 357 -EGNVTLIDFKLSRLSYSQGII----SYNRLDHPDLFNGVD-DYQFEIYRLMRR 404 (488)
T ss_pred -cCceEEEEeeeeecccCCcee----eccccCchhhhcCcc-ceeeeHHHHHHH
Confidence 999999999999843322211 112233455565433 677888865433
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.14 Score=56.71 Aligned_cols=30 Identities=17% Similarity=0.211 Sum_probs=27.3
Q ss_pred CccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 128 YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 128 GIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.13 Score=60.45 Aligned_cols=77 Identities=13% Similarity=0.210 Sum_probs=47.7
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEE----ecccccHHHHHHHHHHHHHHHhcC--CC-CcceEEEEEEecCeEEEE
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKI----RLARQTERCRRSAHQEMALIARVQ--HP-YIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkI----kks~~se~~~r~f~rEIqILkqL~--HP-NIVKL~gvF~e~d~~lyL 83 (1092)
.+.||.|.-..||.+.+...++.|+||.- +..........+..-|...|+.+. .| +++++|. | +.+ ...+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e-~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSV-MNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcH-HhhH
Confidence 67899999999999998544567888854 211111112334455666666653 34 4556653 3 333 3458
Q ss_pred EEeecCC
Q 043248 84 VTGYCEG 90 (1092)
Q Consensus 84 VMEYceG 90 (1092)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.12 Score=59.03 Aligned_cols=150 Identities=17% Similarity=0.206 Sum_probs=82.5
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceEEEEEEecC-eEEEEEE
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY--IVEFKEAWVEKG-CYVCIVT 85 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN--IVKL~gvF~e~d-~~lyLVM 85 (1092)
.+++.+-.|..-.+|..... ++.+++. ...............+|+.+|+.+.--- +...++++.+.. ...+.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34455533433445555543 6777777 3211122223456677888888774322 233444443333 3457899
Q ss_pred eecCCCCH------------------HHHHHHc------CC------CCCCHHHHHHHHHHH--------------HHHH
Q 043248 86 GYCEGGDM------------------AELMKKS------NG------AYFPEEKLCKWFAQL--------------LLAV 121 (1092)
Q Consensus 86 EYceGGSL------------------~DLLkkk------~g------k~LSEeqI~kIa~QI--------------LsAL 121 (1092)
+|++|..+ .+.|..- +. ..+-..++..+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99988322 1222210 00 001112222233222 1224
Q ss_pred HHHHHC--------CccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 122 DYLHSN--------YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 122 aYLHSk--------GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
.||+.+ .++|+|+.+.||+++..+.+-|+||+++..-++.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 555543 3899999999999999888999999998766543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.13 Score=59.94 Aligned_cols=75 Identities=12% Similarity=0.131 Sum_probs=44.7
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEEecc-----cccHHHHHHHHHHHHHHHhcC--CC-CcceEEEEEEecCeEEEEE
Q 043248 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLA-----RQTERCRRSAHQEMALIARVQ--HP-YIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~tGk~VAIKkIkks-----~~se~~~r~f~rEIqILkqL~--HP-NIVKL~gvF~e~d~~lyLV 84 (1092)
.||.|....||.+.+...++.|+||.-... ........+..-|...|+... .| .++++|. | +.+ ...+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e-~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTE-MAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccc-cceeh
Confidence 579999999999997544468999864211 011111233445666666553 34 4555553 3 334 34589
Q ss_pred EeecCC
Q 043248 85 TGYCEG 90 (1092)
Q Consensus 85 MEYceG 90 (1092)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.49 Score=56.02 Aligned_cols=76 Identities=16% Similarity=0.116 Sum_probs=47.6
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc--cH---HHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCeEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--TE---RCRRSAHQEMALIARVQ---HPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~--se---~~~r~f~rEIqILkqL~---HPNIVKL~gvF~e~d~~l 81 (1092)
..+.||.|....||+..+. +..|+||.-..... .. ....+...|+..|+.+. ..+++++|.+.. + ..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d-~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--T-MA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--C-CC
Confidence 3678999999999998863 45688886541110 00 11223334566666553 247888886653 2 34
Q ss_pred EEEEeecCC
Q 043248 82 CIVTGYCEG 90 (1092)
Q Consensus 82 yLVMEYceG 90 (1092)
++||||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 589999977
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.88 Score=59.16 Aligned_cols=31 Identities=35% Similarity=0.466 Sum_probs=26.1
Q ss_pred CCccccCCCCCcEEEcCCC--CEE-EeecCcccc
Q 043248 127 NYVLHRDLKCSNIFLTKDQ--DVR-LGDFGLAKT 157 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG--~LK-LiDFGLA~~ 157 (1092)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999775 555 999997754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.48 Score=49.51 Aligned_cols=30 Identities=40% Similarity=0.547 Sum_probs=20.9
Q ss_pred CccccCCCCCcEEE-cCCCCEEEeecCcccc
Q 043248 128 YVLHRDLKCSNIFL-TKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 128 GIIHRDLKPENILL-D~dG~LKLiDFGLA~~ 157 (1092)
-++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48899999999999 7889999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.21 Score=58.05 Aligned_cols=77 Identities=9% Similarity=0.113 Sum_probs=43.9
Q ss_pred EEEEEeecCceEEEEEEEcCC-CcE-----EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAE-KKK-----YVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVC 82 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~t-Gk~-----VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~ly 82 (1092)
.++.|..|-...+|++..... +.. |.+..... ..... -.-.+|+.+++.|...++ .++++.|. + +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~--~---g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG--D---F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceE-eccHHHHHHHHHHHhCCCCCeEEEecC--C---E
Confidence 345666688889999875432 122 33332111 11111 112458888888865555 55666552 2 4
Q ss_pred EEEeecCCCCHH
Q 043248 83 IVTGYCEGGDMA 94 (1092)
Q Consensus 83 LVMEYceGGSL~ 94 (1092)
+|.||++|-.|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 899999987653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.22 E-value=2.7 Score=47.48 Aligned_cols=28 Identities=29% Similarity=0.290 Sum_probs=23.9
Q ss_pred CCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 58899998765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.59 Score=52.62 Aligned_cols=75 Identities=12% Similarity=0.085 Sum_probs=45.1
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCeEEEEEE
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ---HPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~---HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+-.+.|+.|....+|... .+++.+.+|.-.... ...+..|..-|+.|. --.+++++.+....+. .+|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEE
Confidence 345779999999999987 678889999876321 234667777777773 3457788877755443 46999
Q ss_pred eecCCC
Q 043248 86 GYCEGG 91 (1092)
Q Consensus 86 EYceGG 91 (1092)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.73 E-value=0.3 Score=54.22 Aligned_cols=85 Identities=18% Similarity=0.174 Sum_probs=59.6
Q ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH--C
Q 043248 50 RSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS--N 127 (1092)
Q Consensus 50 r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS--k 127 (1092)
..+..++.++.+++ .|++|.. +++..+.++.|+|-.... . ...++..=+.+|.-+|+ .
T Consensus 103 ~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i-----------~----~~N~i~agi~~L~~fH~~~~ 162 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI-----------N----FSNFITAGIKDLMDFHSENQ 162 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc-----------c----hhHHHHHhHHHHHHhhccCC
Confidence 34567788887765 7888873 455677899999943110 1 11122222466888894 3
Q ss_pred CccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 128 YVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 128 GIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhh
Confidence 699999999999999999999999763
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.91 E-value=1.5 Score=52.08 Aligned_cols=76 Identities=12% Similarity=0.174 Sum_probs=45.7
Q ss_pred EEEEEeecCceEEEEEEEcCC--------CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeE
Q 043248 10 IMEQIGRGAFGAAILVNHRAE--------KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCY 80 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~t--------Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~ 80 (1092)
-++.|..|-.-.+|++..... ++.|++++...... ... .-.+|+.+++.+...+| .++++.| . +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~lI-dR~~E~~v~~~ls~~gi~P~l~~~f-~-g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--ELY-NPISEFEVYKTMSKYRIAPQLLNTF-S-G-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--cee-CHHHHHHHHHHHHHCCCCCceEEEe-C-C--
Confidence 457777788888999875422 46788887644321 111 12346777777754444 3556554 2 2
Q ss_pred EEEEEeecCCCCH
Q 043248 81 VCIVTGYCEGGDM 93 (1092)
Q Consensus 81 lyLVMEYceGGSL 93 (1092)
+.|.||++|-.|
T Consensus 182 -g~I~efi~g~~l 193 (442)
T PTZ00296 182 -GRIEEWLYGDPL 193 (442)
T ss_pred -CEEEEeeCCccC
Confidence 357899988643
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.24 E-value=1.7 Score=51.91 Aligned_cols=60 Identities=20% Similarity=0.205 Sum_probs=45.1
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEcC
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL-HSNYVLHRDLKCSNIFLTK 143 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYL-HSkGIIHRDLKPENILLD~ 143 (1092)
..||-+|..|..+..+++... .+++....++.-...||.-+ --.+++|.|++|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 357888999999999998765 35656666666666665443 3568999999999999953
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=86.23 E-value=1 Score=50.08 Aligned_cols=45 Identities=24% Similarity=0.269 Sum_probs=33.4
Q ss_pred HHHHHHHHHHHHHHC--CccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 113 WFAQLLLAVDYLHSN--YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 113 Ia~QILsALaYLHSk--GIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.+..+-.++.-+|.. =++|+|+.|+|+|++..+.++|+||-.|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444444444433 389999999999999889999999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1092 | ||||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-59 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-45 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-44 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-44 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-35 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-35 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-35 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-32 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-32 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-32 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-32 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-32 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-32 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-32 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-32 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-32 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-32 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-31 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-31 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-31 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-31 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-31 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-31 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-30 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-30 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-30 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-30 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-30 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-29 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-29 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-29 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-29 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-29 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-29 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-29 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-29 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-29 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-29 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-28 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-28 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-28 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-28 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-28 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-28 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-27 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-27 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-27 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-27 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-27 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-27 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-26 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-26 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-26 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-26 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-26 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-26 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-26 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-26 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-25 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-25 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-25 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-25 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-25 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-25 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-25 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-25 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-24 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-24 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-24 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-24 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-24 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-24 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-24 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-24 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-24 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-24 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-24 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-24 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-24 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-24 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-24 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-24 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-24 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-24 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-24 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-24 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-24 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-23 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-23 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-23 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-23 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-23 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-23 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-23 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-23 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-23 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-23 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-23 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-23 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-23 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-23 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-23 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-23 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-23 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-23 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-23 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-22 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-22 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-22 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-22 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-22 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-22 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-22 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-22 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-22 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-22 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-22 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-22 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-22 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-22 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-22 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-22 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-22 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-22 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-22 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-22 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-22 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-22 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-22 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-22 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-21 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-21 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-21 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-21 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-21 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-21 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-21 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-21 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-21 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-21 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-21 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-21 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-21 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-21 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-21 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-21 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-21 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-21 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-21 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-21 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-21 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-21 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-21 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-21 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-21 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-21 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-21 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-21 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-21 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-20 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-20 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-20 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-20 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-19 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-19 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-19 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-19 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-19 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-19 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-19 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-18 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-18 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-18 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-18 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-18 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-18 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-18 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-18 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-18 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-18 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-18 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-18 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-17 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-16 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-15 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-15 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-15 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-13 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-13 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-08 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-08 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-08 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-08 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 |
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-143
Identities = 107/311 (34%), Positives = 187/311 (60%), Gaps = 5/311 (1%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
M++Y +++IG G+FG AILV + ++YV+K+I ++R + + R + +E+A++A +
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+HP IV+++E++ E G + IV YCEGGD+ + + G F E+++ WF Q+ LA+
Sbjct: 81 KHPNIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLAD 181
++H +LHRD+K NIFLTKD V+LGDFG+A+ L + +LA + +GTP Y+ PE+ +
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
PY KSDIW+LGC +YE+ + AF+A M L+ KI S P+ YS L++L+
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259
Query: 242 MLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAESQNSS 301
+ ++NP RPS + +L+ F+ ++++ P + E + + ++ +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKF---LSPQLIAEEFCLKTFSKFGSQPIPAKRPA 316
Query: 302 SSASDKDSLRS 312
S + + +
Sbjct: 317 SGQNSISVMPA 327
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 413 bits (1065), Expect = e-137
Identities = 101/278 (36%), Positives = 148/278 (53%), Gaps = 9/278 (3%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
M SR + YE++ IG G++G + +++ K V K++ TE ++ E+ L+
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 61 RVQHPYIVEFKEAWVEK-GCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQL 117
++HP IV + + +++ + IV YCEGGD+A ++ Y EE + + QL
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 118 LLAVDYLHS-----NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTP 171
LA+ H + VLHRDLK +N+FL Q+V+LGDFGLA+ L D A + VGTP
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
YM PE + + Y KSDIWSLGC +YE+ A P F AF L KI +P Y
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
S L +I ML HRPS E+L++P + +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 395 bits (1016), Expect = e-130
Identities = 78/279 (27%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 1 MESR-MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALI 59
++ R ++ +E IG G FG HR + K YV+K+++ + A +E+ +
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKAL 58
Query: 60 ARVQHPYIVEFKEAWVE---------------KGCYVCIVTGYCEGGDMAELMKKSNGAY 104
A++ H IV + W K + I +C+ G + + ++K G
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 105 FPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164
+ + F Q+ VDY+HS +++RDLK SNIFL + V++GDFGL +LK D
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI 224
+ GT YM PE ++ YG + D+++LG + E+ AF+ + + +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH--VCDTAFETSKFFTDLRD--- 233
Query: 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
G + + KTL++ +L K PE RP+ SE+L+ +
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-126
Identities = 87/270 (32%), Positives = 143/270 (52%), Gaps = 8/270 (2%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIA 60
+ + + I ++IGRG F + LKK+++ + R +E+ L+
Sbjct: 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQLL 118
++ HP ++++ +++E + IV + GD++ ++K K PE + K+F QL
Sbjct: 88 QLNHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVGTPNYMCPE 177
A++++HS V+HRD+K +N+F+T V+LGD GL + + A S+VGTP YM PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA--FDMAGLISKINRSSIGPLPS-CYSPS 234
+ + Y FKSDIWSLGC +YEMAA + F ++ L KI + PLPS YS
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
L+ L+ + +PE RP + + H
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-118
Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 28/284 (9%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
+ +E ++ +GRG FG ++ + Y +K+IRL + E R +E+ +A+++H
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEH 62
Query: 65 PYIVEFKEAWVEKGC-----------YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLC-K 112
P IV + AW+EK Y+ I C ++ + M E +C
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 113 WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV----- 167
F Q+ AV++LHS ++HRDLK SNIF T D V++GDFGL + D+ +V
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 168 --------VGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI 219
VGT YM PE + Y K DI+SLG ++E+ P + ++ +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV 240
Query: 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
PL + P +++ ML +P RP A ++++ +
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-108
Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 10/267 (3%)
Query: 1 MESR-MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALI 59
ES ++ + ++G G++G V + + + Y +K+ + + R E+
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 60 ARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+V QHP V ++AW E G + + T C G + + + GA PE ++ + L
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGI-LYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTL 167
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
LA+ +LHS ++H D+K +NIFL +LGDFGL L G P YM PEL
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRP-AFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
L YG +D++SLG + E+A + L + S L++
Sbjct: 228 LQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP---PEFTAGLSSELRS 283
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQH 264
++ ML +P+ R +A LL P L+
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-106
Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 31/287 (10%)
Query: 1 MESRM-DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALI 59
M+SR ++ +E+IG G FG+ R + Y +K+ + ++A +E+
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 60 ARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSN--GAYFPEEKLCKWFAQ 116
A + QH ++V + AW E ++ I YC GG +A+ + ++ +YF E +L Q
Sbjct: 65 AVLGQHSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQD-------------------VRLGDFGLAKT 157
+ + Y+HS ++H D+K SNIF+++ ++GD G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 158 LKADDLASSVVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLI 216
+ G ++ E+L + + K+DI++L + A P + D
Sbjct: 184 I---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237
Query: 217 SKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+I + + +P S L+K M+ +PE RPSA L+KH L
Sbjct: 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-102
Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 38/293 (12%)
Query: 3 SR-MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
R +E + +G+GAFG + + + + Y +KKIR TE + E+ L+A
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLAS 58
Query: 62 VQHPYIVEFKEAWVE------------KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEK 109
+ H Y+V + AW+E K + I YCE G + +L+ N ++
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDE 117
Query: 110 LCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA--------- 160
+ F Q+L A+ Y+HS ++HRDLK NIF+ + ++V++GDFGLAK +
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 161 ------DDLASSVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKAFDMA 213
D +S +GT Y+ E+L Y K D++SLG +EM P +
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERV 235
Query: 214 GLISKINRSSI---GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
++ K+ SI K +I+ ++ +P RP A LL +L
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 2e-82
Identities = 59/279 (21%), Positives = 106/279 (37%), Gaps = 23/279 (8%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
Y ++++G G F LV + Y LK+I Q +R A +E + HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHPN 87
Query: 67 IVEFKEAWVEK---GCYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFAQLLLAV 121
I+ + + ++ + + G + ++ K G + E+++ + +
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK----------ADDLASSVVGTP 171
+ +H+ HRDLK +NI L + L D G ++ T
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 172 NYMCPELLADIPY---GFKSDIWSLGCCMYEMAAHRPAFKAFDMAG--LISKINRSSIGP 226
+Y PEL + + ++D+WSLGC +Y M + G + + P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHP-FLQH 264
+S +L L+ M+ +P RP LL LQ
Sbjct: 268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 3e-82
Identities = 67/334 (20%), Positives = 125/334 (37%), Gaps = 74/334 (22%)
Query: 3 SR-MDQYEIMEQIGRGAFGAAILVNH----------------RAEKKKYVLKKIRLARQ- 44
SR + +E ++ +GRG FG + R ++ V+++++ +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 45 ---------------------------------------TERCRRSAHQEMALIARVQHP 65
+ + ++ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLC-KWFAQLLLAVDYL 124
V + K + I C ++ + M + E +C F Q+ AV++L
Sbjct: 122 NTVGQLQPSSPKVY-LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV-------------VGTP 171
HS ++HRDLK SNIF T D V++GDFGL + D+ +V VGT
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
YM PE + Y K DI+SLG ++E+ + +I+ + L +
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQK 298
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
P +++ ML +P RP A++++++ ++
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-72
Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 12/261 (4%)
Query: 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFK 71
+IGRG+F + +++ + T+ R+ +E ++ +QHP IV F
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 72 EAWV---EKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN- 127
++W + + +VT G + +K+ + L W Q+L + +LH+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 128 -YVLHRDLKCSNIFLT-KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYG 185
++HRDLKC NIF+T V++GD GLA +A A +V+GTP +M PE+ + Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYEE-KYD 207
Query: 186 FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSCYSPSLKTLIKGML 243
D+++ G CM EMA + A I + S + P P +K +I+G +
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 244 RKNPEHRPSASELLKHPFLQH 264
R+N + R S +LL H F Q
Sbjct: 268 RQNKDERYSIKDLLNHAFFQE 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-69
Identities = 80/325 (24%), Positives = 144/325 (44%), Gaps = 27/325 (8%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP- 65
Y I++QIG G V + +K+ Y +K + L + S E+A + ++Q
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 66 -YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
I+ + + Y+ +V C D+ +KK + ++ +L AV +
Sbjct: 69 DKIIRLYDYEITDQ-YIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTI 124
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLAD 181
H + ++H DLK +N L D ++L DFG+A ++ D + S VGT NYM PE + D
Sbjct: 125 HQHGIVHSDLKPANF-LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 182 IP-----------YGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGPLP 228
+ KSD+WSLGC +Y M + F+ ++ L + I+ + P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAH 288
L+ ++K L+++P+ R S ELL HP++Q Q P A + E+ +
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ---IQTHPVNQMAKGTTEEMKYVLG 300
Query: 289 ESRRCMAESQNSSSSASDKDSLRSG 313
+ + + ++ + + G
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGG 325
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 4e-69
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 24/288 (8%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP- 65
Y I++QIG G V + +K+ Y +K + L + S E+A + ++Q
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 66 -YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
I+ + + Y+ +V C D+ +KK + ++ +L AV +
Sbjct: 88 DKIIRLYDYEITDQ-YIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTI 143
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLAD 181
H + ++H DLK +N + ++L DFG+A ++ D + S VGT NYM PE + D
Sbjct: 144 HQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 182 IP-----------YGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGPLP 228
+ KSD+WSLGC +Y M + F+ ++ L + I+ + P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPA 276
L+ ++K L+++P+ R S ELL HP++Q
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-66
Identities = 80/325 (24%), Positives = 144/325 (44%), Gaps = 27/325 (8%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP- 65
Y I++QIG G V + +K+ Y +K + L + S E+A + ++Q
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 66 -YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
I+ + + Y+ +V C D+ +KK + ++ +L AV +
Sbjct: 116 DKIIRLYDYEITDQ-YIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTI 171
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLAD 181
H + ++H DLK +N FL D ++L DFG+A ++ D + S VG NYM PE + D
Sbjct: 172 HQHGIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 182 IP-----------YGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGPLP 228
+ KSD+WSLGC +Y M + F+ ++ L + I+ + P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAH 288
L+ ++K L+++P+ R S ELL HP++Q Q P A + E+ +
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ---IQTHPVNQMAKGTTEEMKYVLG 347
Query: 289 ESRRCMAESQNSSSSASDKDSLRSG 313
+ + + ++ + + G
Sbjct: 348 QLVGLNSPNSILKAAKTLYEHYSGG 372
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-66
Identities = 74/302 (24%), Positives = 118/302 (39%), Gaps = 33/302 (10%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HP 65
+ + + G F ++Y LK RL E R+ QE+ + ++ HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 66 YIVEF-------KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
IV+F KE ++T C+G + L K + + + K F Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 119 LAVDYLHSN--YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS---------- 166
AV ++H ++HRDLK N+ L+ ++L DFG A T+ S
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 167 ---VVGTPNYMCPELL---ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN 220
TP Y PE++ ++ P G K DIW+LGC +Y + + F+ G +I
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRIV 262
Query: 221 RSSIG-PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACS 279
P +LI+ ML+ NPE R S +E++ P P
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELL 322
Query: 280 PE 281
+
Sbjct: 323 EQ 324
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-64
Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 17/288 (5%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMA 57
+Y +G+G F ++ K+ + K + Q E+ E++
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EIS 67
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+ + H ++V F + E +V +V C + EL K+ E + + Q+
Sbjct: 68 IHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQI 124
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCP 176
+L YLH N V+HRDLK N+FL +D +V++GDFGLA ++ D + GTPNY+ P
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236
E+L+ + F+ D+WS+GC MY + +P F+ + +I ++ +P +P
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAA 243
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPI 284
+LI+ ML+ +P RP+ +ELL F F Y P P C P
Sbjct: 244 SLIQKMLQTDPTARPTINELLNDEF---FTSGYIPARLPITCLTIPPR 288
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 6e-64
Identities = 79/266 (29%), Positives = 135/266 (50%), Gaps = 13/266 (4%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMAL 58
+++ +++ +G+G+F + +K + A +R + E+ +
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN----EVKI 64
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+++HP I+E + E YV +V C G+M +K F E + + Q++
Sbjct: 65 HCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQII 122
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPE 177
+ YLHS+ +LHRDL SN+ LT++ ++++ DFGLA LK ++ GTPNY+ PE
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
+ +G +SD+WSLGC Y + RP F + ++K+ + +PS S K
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY-EMPSFLSIEAKD 241
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263
LI +LR+NP R S S +L HPF+
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-63
Identities = 84/307 (27%), Positives = 143/307 (46%), Gaps = 23/307 (7%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEM 56
+Y +G+G F ++ K+ + K + Q E+ E+
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EI 92
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQ 116
++ + H ++V F + E +V +V C + EL K+ E + + Q
Sbjct: 93 SIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQ 149
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMC 175
++L YLH N V+HRDLK N+FL +D +V++GDFGLA ++ D + GTPNY+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
PE+L+ + F+ D+WS+GC MY + +P F+ + +I ++ +P +P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVA 268
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPI------SIAHE 289
+LI+ ML+ +P RP+ +ELL F F Y P P C P S+
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEF---FTSGYIPARLPITCLTIPPRFSIAPSSLDPS 325
Query: 290 SRRCMAE 296
+R+ +
Sbjct: 326 NRKPLTV 332
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-61
Identities = 77/268 (28%), Positives = 116/268 (43%), Gaps = 19/268 (7%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
+ ++GRG+FG + + + +KK+RL +E+ A +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSS 109
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P IV A V +G +V I EGG + +L+K+ PE++ + Q L ++YL
Sbjct: 110 PRIVPLYGA-VREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYL 166
Query: 125 HSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKTLKADDLAS------SVVGTPNYMCPE 177
H+ +LH D+K N+ L+ D L DFG A L+ D L + GT +M PE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI--NRSSIGPLPSCYSPSL 235
++ P K DIWS C M M + + L KI I +P +P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQ 263
I+ LRK P HR SA EL +
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-61
Identities = 68/265 (25%), Positives = 123/265 (46%), Gaps = 14/265 (5%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMAL 58
++ +EI +G+G FG L + K LK ++ A + RR E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR----EVEI 62
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ ++HP I+ + V ++ Y G + ++K + F E++ + +L
Sbjct: 63 QSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELA 119
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
A+ Y HS V+HRD+K N+ L ++++ DFG + + + GT +Y+ PE+
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEM 178
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ + K D+WSLG YE +P F+A +I+R P + + L
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDL 237
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQ 263
I +L+ NP RP E+L+HP++
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-60
Identities = 59/278 (21%), Positives = 119/278 (42%), Gaps = 14/278 (5%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMAL 58
+D ++I +G+G FG L + K LK ++ + RR E+ +
Sbjct: 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR----EIEI 67
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ ++HP I+ + + ++ + G++ + ++K F E++ + +L
Sbjct: 68 QSHLRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELA 124
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
A+ Y H V+HRD+K N+ + ++++ DFG + ++ GT +Y+ PE+
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTMCGTLDYLPPEM 183
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ + K D+W G YE P F + +I + P S K L
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDL 242
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPA 276
I +LR +P R +++HP+++ + P +
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-60
Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 12/259 (4%)
Query: 14 IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEA 73
+G+G +G + + + +K+I + R + H+E+AL ++H IV++ +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 74 WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLLAVDYLHSNYVLHR 132
+ ++ I GG ++ L++ G E+ ++ Q+L + YLH N ++HR
Sbjct: 88 -FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 133 DLKCSNIFL-TKDQDVRLGDFGLAKTL-KADDLASSVVGTPNYMCPE--LLADIPYGFKS 188
D+K N+ + T +++ DFG +K L + + GT YM PE YG +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 189 DIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGP-LPSCYSPSLKTLIKGMLRK 245
DIWSLGC + EMA +P F A + K+ + P +P S K I
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 246 NPEHRPSASELLKHPFLQH 264
+P+ R A++LL FL+
Sbjct: 266 DPDKRACANDLLVDEFLKV 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-60
Identities = 58/300 (19%), Positives = 109/300 (36%), Gaps = 49/300 (16%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQEMALIARV 62
+ + + +G+GA H+ + V I R + R E ++ ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 63 QHPYIVEFKEAWVEKGC-YVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLA 120
H IV+ E + ++ +C G + L + SN PE + ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQD----VRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
+++L N ++HR++K NI +D +L DFG A+ L+ D+ S+ GT Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 177 ELLADI--------PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG----LISKINR--- 221
++ YG D+WS+G Y A F+ F+ ++ KI
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 222 -----------------SSIGPLPSCYSPSLKT----LIKGMLRKNPEHRPSASELLKHP 260
S P+ S L+ ++ +L + E +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-59
Identities = 81/272 (29%), Positives = 128/272 (47%), Gaps = 22/272 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI---RLARQTERCRRSAHQEMALIARV 62
D + ++G GAFG LV R+ + V+K I R E+ E+ ++ +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA----EIEVLKSL 77
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM-----KKSNGAYFPEEKLCKWFAQL 117
HP I++ E + E + IV CEGG EL+ ++ G E + + Q+
Sbjct: 78 DHPNIIKIFEVF-EDYHNMYIVMETCEGG---ELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 118 LLAVDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYM 174
+ A+ Y HS +V+H+DLK NI F +++ DFGLA+ K+D+ +++ GT YM
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYS 232
PE+ FK DIWS G MY + F + + K +
Sbjct: 194 APEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252
Query: 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
P L+K ML K+PE RPSA+++L H + +
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-57
Identities = 68/270 (25%), Positives = 131/270 (48%), Gaps = 12/270 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++Y I+ +G+G+FG + R +++Y +K I A + + +E+ L+ ++ HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
I++ E + IV GG++ + + K F E + Q+ + Y+H
Sbjct: 82 NIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH 138
Query: 126 SNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
+ ++HRDLK NI +K++D +++ DFGL+ + + +GT Y+ PE+L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG- 197
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSLKTL 238
Y K D+WS G +Y + + P F + ++ ++ S K L
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA-FDLPQWRTISDDAKDL 256
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268
I+ ML +P R +A++ L+HP++Q + +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 2e-57
Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 13/266 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D Y++ E++G+GAF H+ ++ K I + + R + +E + ++QHP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV ++ E+ + +V GG++ E ++ + ++ E Q+L ++ Y
Sbjct: 66 NIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYC 121
Query: 125 HSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
HSN ++HR+LK N+ +K + V+L DFGLA + + GTP Y+ PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSLKT 237
PY DIW+ G +Y + P F D L ++I + PS +P K+
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKS 240
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263
LI ML NP+ R +A + LK P++
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWIC 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 3e-57
Identities = 80/271 (29%), Positives = 126/271 (46%), Gaps = 26/271 (9%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI--RLARQTERCRRSAHQEMALIARVQ 63
+ ME +G GAF LV R K + LK I A + E+A++ +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN----EIAVLKKIK 64
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL----MKKSNGAYFPEEKLCKWFAQLLL 119
H IV ++ E + +V GG EL +++ + E+ Q+L
Sbjct: 65 HENIVTLED-IYESTTHYYLVMQLVSGG---ELFDRILERG---VYTEKDASLVIQQVLS 117
Query: 120 AVDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
AV YLH N ++HRDLK N+ +LT +++ + + DFGL+K + + + S+ GTP Y+ P
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAP 176
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----S 232
E+LA PY D WS+G Y + P F + L KI S + S
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FESPFWDDIS 235
Query: 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S K I +L K+P R + + L HP++
Sbjct: 236 ESAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-57
Identities = 68/265 (25%), Positives = 130/265 (49%), Gaps = 12/265 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++Y I+ +G+G+FG + R +++Y +K I A + + +E+ L+ ++ HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
I++ E + IV GG++ + + K F E + Q+ + Y+H
Sbjct: 82 NIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH 138
Query: 126 SNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
+ ++HRDLK NI +K++D +++ DFGL+ + + +GT Y+ PE+L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG- 197
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI----GPLPSCYSPSLKTL 238
Y K D+WS G +Y + + P F + ++ ++ + S K L
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI-SDDAKDL 256
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQ 263
I+ ML +P R +A++ L+HP++Q
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-57
Identities = 67/265 (25%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ Y+ ++++G GA+G +L + + +K IR + +E+A++ + HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
I++ + + +K +V +GG++ + + F E Q+L V YLH
Sbjct: 97 NIMKLYDFFEDKR-NYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH 153
Query: 126 SNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
+ ++HRDLK N+ +K++D +++ DFGL+ + +GT Y+ PE+L
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK- 212
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----PLPSCYSPSLKTL 238
Y K D+WS+G ++ + A P F ++ K+ + + S K L
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDL 271
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQ 263
IK ML+ + + R SA + L+HP+++
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIK 296
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-57
Identities = 76/260 (29%), Positives = 132/260 (50%), Gaps = 6/260 (2%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ + +E+IG+G+FG +K +K I L + QE+ ++++ P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 80
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
Y+ ++ +++ K + I+ Y GG +L++ E ++ ++L +DYLH
Sbjct: 81 YVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 136
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPELLADIPY 184
S +HRD+K +N+ L++ +V+L DFG+A L + ++ VGTP +M PE++ Y
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
K+DIWSLG E+A P ++ I +++ L YS LK ++ L
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 256
Query: 245 KNPEHRPSASELLKHPFLQH 264
K P RP+A ELLKH F+
Sbjct: 257 KEPSFRPTAKELLKHKFILR 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-56
Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 22/269 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI--RLARQTERCRRSAHQEMALIARVQ 63
Y + IGRG++G + + + + KKI +R ++ E+ ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMKSLD 64
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAV 121
HP I+ E + E + +V C GG EL ++ F E + +L AV
Sbjct: 65 HPNIIRLYETF-EDNTDIYLVMELCTGG---ELFERVVHKR-VFRESDAARIMKDVLSAV 119
Query: 122 DYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
Y H V HRDLK N FLT D ++L DFGLA K + + VGTP Y+ P++
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPS 234
L YG + D WS G MY + P F A + ++ KI + P SP
Sbjct: 180 LEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT-FPEKDWLNVSPQ 237
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
++LI+ +L K+P+ R ++ + L+H + +
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFE 266
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-56
Identities = 66/316 (20%), Positives = 127/316 (40%), Gaps = 54/316 (17%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI---RLARQTERCRRSAHQEMALIARV 62
+Y + IG+G++G + + +K + ++ + + E+ L+ ++
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGD------------------------------ 92
HP I E + ++ Y+C+V C GG
Sbjct: 86 HHPNIARLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 93 --------MAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144
++S E+ + Q+ A+ YLH+ + HRD+K N + +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 145 QD--VRLGDFGLAKTLKADDLA-----SSVVGTPNYMCPELL--ADIPYGFKSDIWSLGC 195
+ ++L DFGL+K + ++ GTP ++ PE+L + YG K D WS G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 196 CMYEMAAHRPAFKAFDMAGLISKINRSSI---GPLPSCYSPSLKTLIKGMLRKNPEHRPS 252
++ + F + A IS++ + P + SP + L+ +L +N + R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 253 ASELLKHPFLQHFVDQ 268
A L+HP++ F D+
Sbjct: 325 AMRALQHPWISQFSDK 340
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 1e-56
Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 13/278 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQH 64
D+Y+ +G+G+FG IL + ++ +K I + + + + S +E+ L+ ++ H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P I++ E + +KG Y +V GG++ + + F E + Q+L + Y+
Sbjct: 86 PNIMKLYEFFEDKG-YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYM 142
Query: 125 HSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
H N ++HRDLK N+ +K +D +R+ DFGL+ +A +GT Y+ PE+L
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG 202
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI----GPLPSCYSPSLKT 237
Y K D+WS G +Y + + P F + ++ K+ + S S K
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV-SESAKD 260
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
LI+ ML P R SA + L H ++Q + + P
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-56
Identities = 70/264 (26%), Positives = 139/264 (52%), Gaps = 13/264 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ ++++E++G G++G+ H+ + +K++ + + +E++++ + P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII----KEISIMQQCDSP 84
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++V++ ++ K + IV YC G ++++++ N E+++ L ++YLH
Sbjct: 85 HVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLH 142
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPELLADIPY 184
+HRD+K NI L + +L DFG+A L ++V+GTP +M PE++ +I Y
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPL--PSCYSPSLKTLIK 240
+DIWSLG EMA +P + D+ + I I + P +S + +K
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPY--ADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 241 GMLRKNPEHRPSASELLKHPFLQH 264
L K+PE R +A++LL+HPF++
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRS 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-56
Identities = 76/264 (28%), Positives = 131/264 (49%), Gaps = 13/264 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+Y E+IG+GA G A ++ ++++ L +Q ++ E+ ++ ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV + ++++ G + +V Y GG + +++ ++ E ++ + L A+++LH
Sbjct: 78 NIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPELLADIPY 184
SN V+HRD+K NI L D V+L DFG + + S++VGTP +M PE++ Y
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPL--PSCYSPSLKTLIK 240
G K DIWSLG EM P + + L + I + L P S + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 241 GMLRKNPEHRPSASELLKHPFLQH 264
L + E R SA ELL+H FL+
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFLKI 275
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 4e-56
Identities = 80/308 (25%), Positives = 128/308 (41%), Gaps = 49/308 (15%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
E + D +E + ++G G G V+H+ K I L R +E+ ++
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHE 87
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
PYIV F A+ G + I + +GG + +++KK+ PE+ L K ++ +
Sbjct: 88 CNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGL 144
Query: 122 DYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
YL + ++HRD+K SNI + +++L DFG++ L D +A+S VGT +YM PE L
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQ 203
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-------------------------- 214
Y +SDIWS+G + EMA R D
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 215 ----------------LISKINRSSIGPLPS-CYSPSLKTLIKGMLRKNPEHRPSASELL 257
L+ I LPS +S + + L KNP R +L+
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323
Query: 258 KHPFLQHF 265
H F++
Sbjct: 324 VHAFIKRS 331
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-56
Identities = 59/299 (19%), Positives = 110/299 (36%), Gaps = 49/299 (16%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQEMALIARV 62
+ + + +G+GA H+ + V I R + R E ++ ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 63 QHPYIVEFKEAWVEKGC-YVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLA 120
H IV+ E + ++ +C G + L + SN PE + ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQD----VRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
+++L N ++HR++K NI +D +L DFG A+ L+ D+ S+ GT Y+ P
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 177 ELLADI--------PYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---------------- 212
++ YG D+WS+G Y A F+ F+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 213 AGLISKINRSSIGP------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
+G IS + ++ GP L L ++ +L + E +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-56
Identities = 67/274 (24%), Positives = 123/274 (44%), Gaps = 14/274 (5%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
++ ++ E + ++G G G + R +K++R + E + ++ ++ +
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLK 79
Query: 62 -VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
PYIV+ ++ V I AE +KK PE L K ++ A
Sbjct: 80 SHDCPYIVQCFGTFITNTD-VFIAMELMGTC--AEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 121 VDYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE-- 177
+ YL + V+HRD+K SNI L + ++L DFG++ L D G YM PE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196
Query: 178 ---LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRSSIGPLPS--CY 231
Y ++D+WSLG + E+A + +K +++K+ + LP +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
S ++ +K L K+ RP ++LL+H F++ +
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-56
Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 24/270 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D +E+ ++GRGA + +K Y LK ++ + R E+ ++ R+ HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----EIGVLLRLSHP 108
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL----MKKSNGAYFPEEKLCKWFAQLLLAV 121
I++ KE + E + +V GG EL ++K Y+ E Q+L AV
Sbjct: 109 NIIKLKEIF-ETPTEISLVLELVTGG---ELFDRIVEKG---YYSERDAADAVKQILEAV 161
Query: 122 DYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
YLH N ++HRDLK N+ + T D +++ DFGL+K ++ L +V GTP Y PE+
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGLISKINRSSIGPLPSCY----SP 233
L YG + D+WS+G Y + F + +I S + S
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-FISPWWDEVSL 280
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ K L++ ++ +P+ R + + L+HP++
Sbjct: 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-55
Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 13/266 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D Y++ E++G+GAF H+ ++ K I + + R + +E + ++QHP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV ++ E+ + +V GG++ E ++ + ++ E Q+L ++ Y
Sbjct: 89 NIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYC 144
Query: 125 HSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
HSN ++HR+LK N+ +K + V+L DFGLA + + GTP Y+ PE+L
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSLKT 237
PY DIW+ G +Y + P F D L ++I + PS +P K+
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKS 263
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263
LI ML NP+ R +A + LK P++
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWIC 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 13/275 (4%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
ME + D E + ++GRGA+G + H + +K+IR ++ ++ ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISM 60
Query: 61 R-VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQL 117
R V P+ V F A +G V I + + + K+ G PE+ L K +
Sbjct: 61 RTVDCPFTVTFYGALFREGD-VWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 118 LLAVDYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
+ A+++LHS V+HRD+K SN+ + V++ DFG++ L D G YM P
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 177 E----LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRSSIGPLPS-C 230
E L Y KSDIWSLG M E+A R + ++ + ++ LP+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238
Query: 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
+S L+KN + RP+ EL++HPF
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-55
Identities = 82/276 (29%), Positives = 138/276 (50%), Gaps = 31/276 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR-VQH 64
D YE+ E IG G++ H+A ++ +K I ++ +R +E+ ++ R QH
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQH 75
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL----MKKSNGAYFPEEKLCKWFAQLLLA 120
P I+ K+ + + G YV +VT +GG EL +++ +F E + +
Sbjct: 76 PNIITLKDVY-DDGKYVYVVTELMKGG---ELLDKILRQK---FFSEREASAVLFTITKT 128
Query: 121 VDYLHSNYVLHRDLKCSNI-FLTKDQD---VRLGDFGLAKTLKADD-LASSVVGTPNYMC 175
V+YLH+ V+HRDLK SNI ++ + + +R+ DFG AK L+A++ L + T N++
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---AGLISKINRSSIGPLPSCY- 231
PE+L Y DIWSLG +Y M F ++++I L Y
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS-LSGGYW 247
Query: 232 ---SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
S + K L+ ML +P R +A+ +L+HP++ H
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-------ERCRRSAHQEMAL 58
+ YE E +GRG H+ K+Y +K I + + R + +E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 59 IARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL----MKKSNGAYFPEEKLCKW 113
+ +V HP I++ K+ + E + +V + G EL +K E++ K
Sbjct: 77 LRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG---ELFDYLTEKV---TLSEKETRKI 129
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNY 173
LL + LH ++HRDLK NI L D +++L DFG + L + V GTP+Y
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 174 MCPELLADI------PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL 227
+ PE++ YG + D+WS G MY + A P F ++ I +
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY-QF 248
Query: 228 PSCY----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTF 273
S S ++K L+ L P+ R +A E L HPF Q +V + F
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRHF 298
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-55
Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 16/269 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +EI+ ++G GAFG ++ K I + E E+ ++A HP
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIVEIEILATCDHP 76
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
YIV+ A+ + I+ +C GG + +M + + E ++ Q+L A+++LH
Sbjct: 77 YIVKLLGAYY-HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLH 134
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPELLA---- 180
S ++HRDLK N+ +T + D+RL DFG++ S +GTP +M PE++
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 181 -DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPL--PSCYSPSL 235
D PY +K+DIWSLG + EMA P ++ + + KI +S L PS +S
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPH--HELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQH 264
+ +K L KNPE RPSA++LL+HPF+
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSS 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-55
Identities = 67/270 (24%), Positives = 130/270 (48%), Gaps = 16/270 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR----QTERCRRSAHQEMALIAR 61
D YE+ E++G G F + K+Y K I+ R + R +E+ ++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
++HP I+ + + E V ++ GG++ + + + E++ ++ Q+L V
Sbjct: 65 IRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGV 121
Query: 122 DYLHSNYVLHRDLKCSNI-FLTKDQD---VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
YLHS + H DLK NI L K+ ++L DFG+A ++A + ++ GTP ++ PE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SP 233
++ P G ++D+WS+G Y + + F ++ I+ + Y S
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD-FDEEYFSNTSE 240
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
K I+ +L K+P+ R + ++ L+H +++
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-55
Identities = 79/290 (27%), Positives = 139/290 (47%), Gaps = 33/290 (11%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAH------- 53
+++QY + ++IG+G++G L + + Y VL K +L RQ RR
Sbjct: 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 54 --------------QEMALIARVQHPYIVEFKEAWVE-KGCYVCIVTGYCEGGDMAELMK 98
QE+A++ ++ HP +V+ E + ++ +V G +M+
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG---PVME 127
Query: 99 KSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158
E++ +F L+ ++YLH ++HRD+K SN+ + +D +++ DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 159 K-ADDLASSVVGTPNYMCPELLADI--PY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAG 214
K +D L S+ VGTP +M PE L++ + G D+W++G +Y + F +
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 215 LISKINRSSIG-PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
L SKI ++ P + LK LI ML KNPE R E+ HP++
Sbjct: 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-55
Identities = 75/264 (28%), Positives = 132/264 (50%), Gaps = 13/264 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +IG G+ G L + ++ +K + L +Q R E+ ++ QH
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+VE ++++ G + ++ + +GG + +++ + EE++ +L A+ YLH
Sbjct: 103 NVVEMYKSYL-VGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH 158
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMCPELLADIPY 184
+ V+HRD+K +I LT D V+L DFG + D S+VGTP +M PE+++ Y
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPL--PSCYSPSLKTLIK 240
+ DIWSLG + EM P + F + + + ++ S L SP L+ ++
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPY--FSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 241 GMLRKNPEHRPSASELLKHPFLQH 264
ML ++P+ R +A ELL HPFL
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQ 300
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 8e-55
Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 16/271 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI---RLARQTERCRRSAHQEMALIARV 62
D YE+ E IG+G F +R +++ +K + + +E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE--LMKKSNGAYFPEEKLCKWFAQLLLA 120
+HP+IVE E + G + +V + +G D+ + + G + E + Q+L A
Sbjct: 84 KHPHIVELLETYSSDG-MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 121 VDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTL-KADDLASSVVGTPNYMCP 176
+ Y H N ++HRD+K + +K+ V+LG FG+A L ++ +A VGTP++M P
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----S 232
E++ PYG D+W G ++ + + F L I + + S
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY-KMNPRQWSHIS 260
Query: 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S K L++ ML +P R + E L HP+L+
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-55
Identities = 70/281 (24%), Positives = 126/281 (44%), Gaps = 23/281 (8%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-----------QTERCRRSAHQ 54
+ Y + ++G GA+G +L + + +K I+ ++ E+ +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
E++L+ + HP I++ + + E Y +VT + EGG++ E + + F E
Sbjct: 96 EISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIM 152
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTP 171
Q+L + YLH + ++HRD+K NI K+ +++ DFGL+ D +GT
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----PL 227
Y+ PE+L Y K D+WS G MY + P F + +I K+ +
Sbjct: 213 YYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268
+ S K LIK ML + R +A E L +++ + +
Sbjct: 272 KNI-SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-54
Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 14/268 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++Y++ E++G+GAF ++Y I + + R + +E + ++HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV ++ E+G + ++ GG++ E ++ + Y+ E Q+L AV +
Sbjct: 71 NIVRLHDSISEEG-HHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHC 126
Query: 125 HSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLA-SSVVGTPNYMCPELLA 180
H V+HR+LK N+ +K + V+L DFGLA ++ + A GTP Y+ PE+L
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSLK 236
PYG D+W+ G +Y + P F D L +I + PS +P K
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY-DFPSPEWDTVTPEAK 245
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQH 264
LI ML NP R +A+E LKHP++ H
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISH 273
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-54
Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 16/289 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIAR 61
D Y+I E++G G F ++ +Y K I+ A + R +E++++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
V H ++ + + E V ++ GG++ + + + EE+ + Q+L V
Sbjct: 72 VLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGV 128
Query: 122 DYLHSNYVLHRDLKCSNI-FLTKDQD---VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
+YLH+ + H DLK NI L K+ ++L DFGLA ++ ++ GTP ++ PE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SP 233
++ P G ++D+WS+G Y + + F ++ I S + S
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD-FDEEFFSHTSE 247
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEK 282
K I+ +L K R + E L+HP++ +Q + + E
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 78/277 (28%), Positives = 136/277 (49%), Gaps = 26/277 (9%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QH 64
+E++E +G G +G H + +K + + E QE+ ++ + H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHH 80
Query: 65 PYIVEFKEAWVEKGCYVC-----IVTGYCEGGDMAELMKKSNGAYFPEEK---LCKWFAQ 116
I + A+++K +V +C G + +L+K + G EE +C+ +
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR---E 137
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL-ASSVVGTPNYMC 175
+L + +LH + V+HRD+K N+ LT++ +V+L DFG++ L ++ +GTP +M
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 176 PELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPL- 227
PE++A D Y FKSD+WSLG EMA P DM + + I R+ L
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--CDMHPMRALFLIPRNPAPRLK 255
Query: 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
+S ++ I+ L KN RP+ +L+KHPF++
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 3e-54
Identities = 83/277 (29%), Positives = 128/277 (46%), Gaps = 26/277 (9%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI---RLARQTERCRRSAH---QEMALI 59
D+Y + + +G GA G L R KK +K I + A + R A E+ ++
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQL 117
++ HP I++ K + + Y IV EGG EL K N E +F Q+
Sbjct: 70 KKLNHPCIIKIKNFFDAEDYY--IVLELMEGG---ELFDKVVGNK-RLKEATCKLYFYQM 123
Query: 118 LLAVDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYM 174
LLAV YLH N ++HRDLK N+ ++++D +++ DFG +K L L ++ GTP Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 175 CPELLADI---PYGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGLISKINRSSIGPLPSC 230
PE+L + Y D WSLG ++ + P F L +I
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FIPE 242
Query: 231 Y----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S L+K +L +P+ R + E L+HP+LQ
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-54
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 15/277 (5%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
+ + + + +IGRGA+G+ + H+ + +K+IR + ++ ++ ++ R
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMR 76
Query: 62 -VQHPYIVEFKEAWVEKGCYVCIVTGYCEGG--DMAELMKKSNGAYFPEEKLCKWFAQLL 118
PYIV+F A +G I + + PEE L K +
Sbjct: 77 SSDCPYIVQFYGALFREGD-CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 119 LAVDYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
A+++L N ++HRD+K SNI L + +++L DFG++ L + G YM PE
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195
Query: 178 ----LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINRSSIGPLPSC-- 230
+ Y +SD+WSLG +YE+A R + ++ + ++++ + L +
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 231 --YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
+SPS + L K+ RP ELLKHPF+ +
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-54
Identities = 64/270 (23%), Positives = 128/270 (47%), Gaps = 16/270 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIAR 61
D Y+ E++G G F ++ +Y K I+ + + R +E++++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+QHP ++ E + E V ++ GG++ + + + EE+ ++ Q+L V
Sbjct: 71 IQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGV 127
Query: 122 DYLHSNYVLHRDLKCSNI-FLTKDQD---VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
YLHS + H DLK NI L ++ +++ DFGLA + + ++ GTP ++ PE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SP 233
++ P G ++D+WS+G Y + + F ++ ++ + Y S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-FEDEYFSNTSA 246
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
K I+ +L K+P+ R + + L+HP+++
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-54
Identities = 65/324 (20%), Positives = 114/324 (35%), Gaps = 61/324 (18%)
Query: 1 MESRMD---QYEIMEQIGRGA--FGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQE 55
M S + YE++ IG+G L ++ + +++I L + E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
+ + HP IV ++ ++ + +VT + G +L+ E +
Sbjct: 77 LHVSKLFNHPNIVPYRATFI-ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--------DLASSV 167
+L A+DY+H +HR +K S+I ++ D V L ++ + D
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 168 VGTPNYMCPELLA--DIPYGFKSDIWSLGCCMYEMA------AHRPAFKAFDM------- 212
V ++ PE+L Y KSDI+S+G E+A PA +
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 213 --------------------------------AGLISKINRSSIGPLPSCYSPSLKTLIK 240
+ S P +SP ++
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 241 GMLRKNPEHRPSASELLKHPFLQH 264
L++NP+ RPSAS LL H F +
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQ 339
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 6e-54
Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 22/272 (8%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR--QTERCRRSAHQEMAL 58
R + ++ + +G G+F +L A ++Y +L+K + + + R E +
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR----ERDV 83
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
++R+ HP+ V+ + + + Y + G++ + ++K F E + A+++
Sbjct: 84 MSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIV 140
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK---TLKADDLASSVVGTPNYMC 175
A++YLH ++HRDLK NI L +D +++ DFG AK A+S VGT Y+
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
PELL + SD+W+LGC +Y++ A P F+A + + KI + P + P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKA 259
Query: 236 KTLIKGMLRKNPEHRP------SASELLKHPF 261
+ L++ +L + R L HPF
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-54
Identities = 59/267 (22%), Positives = 119/267 (44%), Gaps = 18/267 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQH 64
++Y I E +GRG FG + KK Y+ K +++ ++ E++++ +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVD 122
I+ E++ E + ++ + G ++ ++ ++ E ++ + Q+ A+
Sbjct: 61 RNILHLHESF-ESMEELVMIFEFISGL---DIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 123 YLHSNYVLHRDLKCSNIFLT--KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
+LHS+ + H D++ NI + +++ +FG A+ LK D + P Y PE+
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSLK 236
+D+WSLG +Y + + F A +I I + S
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT-FDEEAFKEISIEAM 235
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ +L K + R +ASE L+HP+L+
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-54
Identities = 82/277 (29%), Positives = 125/277 (45%), Gaps = 26/277 (9%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH------QEMALI 59
D+Y + + +G GA G L R KK ++ I + R A E+ ++
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQL 117
++ HP I++ K + + Y IV EGG EL K N E +F Q+
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY--IVLELMEGG---ELFDKVVGNK-RLKEATCKLYFYQM 248
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLT---KDQDVRLGDFGLAKTLKADDLASSVVGTPNYM 174
LLAV YLH N ++HRDLK N+ L+ +D +++ DFG +K L L ++ GTP Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 175 CPELLADI---PYGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGLISKINRSSIGPLPSC 230
PE+L + Y D WSLG ++ + P F L +I
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FIPE 367
Query: 231 Y----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S L+K +L +P+ R + E L+HP+LQ
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-53
Identities = 73/288 (25%), Positives = 141/288 (48%), Gaps = 24/288 (8%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQEMALIAR 61
D +EI+ IG+G+FG +V KK Y + K + + E R+ +E+ ++
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQG 71
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
++HP++V ++ ++ + +V GGD+ ++++ +F EE + + +L++A+
Sbjct: 72 LEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMAL 128
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
DYL + ++HRD+K NI L + V + DF +A L + +++ GT YM PE+ +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 182 IP---YGFKSDIWSLGCCMYEMAAHRPAF---KAFDMAGLISKINRSSIGPLPSCYSPSL 235
Y F D WSLG YE+ R + + ++ + + PS +S +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-TYPSAWSQEM 247
Query: 236 KTLIKGMLRKNPEHR-PSASELLKHPFLQHFVD-------QYRPTFPP 275
+L+K +L NP+ R S++ P++ ++ + P F P
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND-INWDAVFQKRLIPGFIP 294
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 77/284 (27%), Positives = 128/284 (45%), Gaps = 30/284 (10%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D YE+ E IG GA +K+K +K+I L + +E+ +++ HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQCHHP 73
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK------KSNGAYFPEEKLCKWFAQLLL 119
IV + ++V + +V GG + +++K + E + ++L
Sbjct: 74 NIVSYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS------SVVGTPNY 173
++YLH N +HRD+K NI L +D V++ DFG++ L + + VGTP +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 174 MCPELLADI-PYGFKSDIWSLGCCMYEMA------AHRPAFKAFDMAGLISK------IN 220
M PE++ + Y FK+DIWS G E+A P K + +
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQNDPPSLET 249
Query: 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
+ Y S + +I L+K+PE RP+A+ELL+H F Q
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-53
Identities = 64/276 (23%), Positives = 122/276 (44%), Gaps = 5/276 (1%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
+ + Y +++ IG+G F L H ++ +K I + + +E+ ++
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
+ HP IV+ E E + ++ Y GG++ + + +G E++ F Q++ A
Sbjct: 70 ILNHPNIVKLFEVI-ETEKTLYLIMEYASGGEVFDYLVA-HG-RMKEKEARSKFRQIVSA 126
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
V Y H ++HRDLK N+ L D ++++ DFG + + G P Y PEL
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 181 DIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239
Y G + D+WSLG +Y + + F ++ L ++ R +P S + L+
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLL 245
Query: 240 KGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
K L NP R + +++K ++ ++
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-53
Identities = 71/289 (24%), Positives = 129/289 (44%), Gaps = 16/289 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIAR 61
D Y+I E++G G F ++ +Y K I+ A + CR +E++++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
V HP I+ + + E V ++ GG++ + + + EE+ + Q+L V
Sbjct: 72 VLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGV 128
Query: 122 DYLHSNYVLHRDLKCSNI-FLTKDQD---VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
+YLH+ + H DLK NI L K+ ++L DFGLA ++ ++ GTP ++ PE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SP 233
++ P G ++D+WS+G Y + + F ++ I S + S
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD-FDEEFFSQTSE 247
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEK 282
K I+ +L K R + E L+HP++ Q + + E
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-53
Identities = 66/267 (24%), Positives = 121/267 (45%), Gaps = 11/267 (4%)
Query: 6 DQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
+ Y + +++GRG F ++ ++Y K ++ R+ + CR E+A++ +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 65 -PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
P ++ E + E + ++ Y GG++ L E + + Q+L V Y
Sbjct: 88 CPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 124 LHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
LH N ++H DLK NI + +++ DFG+++ + ++GTP Y+ PE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSLK 236
P +D+W++G Y + H F D I++ ++ S
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-YSEETFSSVSQLAT 265
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQ 263
I+ +L KNPE RP+A L H +LQ
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQ 292
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-52
Identities = 76/323 (23%), Positives = 140/323 (43%), Gaps = 20/323 (6%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK---KIRLARQTERCRRSAHQ---E 55
+Y M +G GAFG + + K+ V+K K ++ + E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM-AELMKKSNGAYFPEEKLCKWF 114
+A+++RV+H I++ + + +G + ++ + G D+ A + + E F
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIF 136
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYM 174
QL+ AV YL ++HRD+K NI + +D ++L DFG A L+ L + GT Y
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196
Query: 175 CPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233
PE+L PY G + ++WSLG +Y + F + + ++I P S
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAI-HPPYLVSK 249
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRC 293
L +L+ G+L+ PE R + +L+ P++ V+ T+ + + +
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAA--S 307
Query: 294 MAESQNSSSSASDKDSLRSGDRN 316
+ S S + L G+ +
Sbjct: 308 LEMGNRSLSDVAQAQELCGGEGH 330
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-52
Identities = 82/301 (27%), Positives = 131/301 (43%), Gaps = 28/301 (9%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH--QEMALIAR 61
+ D +EI++ IGRGAF +V + + Y +K + +R + +E ++
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVN 117
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+I + A+ ++ Y+ +V Y GGD+ L+ K G P E + A++++A+
Sbjct: 118 GDRRWITQLHFAFQDEN-YLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAI 175
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCPELL 179
D +H +HRD+K NI L + +RL DFG L+AD + VGTP+Y+ PE+L
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 180 -------ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----NRSSIGPLP 228
YG + D W+LG YEM + F A A KI S+ +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295
Query: 229 SCYSPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQHFVD-----QYRPTFPPAACSP 280
+ I+ +L PE R A + HPF +D P F P
Sbjct: 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG-LDWDGLRDSVPPFTPDFEGA 353
Query: 281 E 281
Sbjct: 354 T 354
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-52
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 29/279 (10%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR------QTERCRRSAHQEMALI 59
+Y+ + IGRG HRA ++ +K + + Q E R + +E ++
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 60 ARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL----MKKSNGAYFPEEKLCKWF 114
+V HP+I+ ++ E ++ +V G EL +K E++
Sbjct: 154 RQVAGHPHIITLIDS-YESSSFMFLVFDLMRKG---ELFDYLTEKV---ALSEKETRSIM 206
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYM 174
LL AV +LH+N ++HRDLK NI L + +RL DFG + L+ + + GTP Y+
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 175 CPELL------ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP 228
PE+L YG + D+W+ G ++ + A P F ++ I
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ-FS 325
Query: 229 SCY----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S S ++K LI +L+ +PE R +A + L+HPF +
Sbjct: 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-52
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 36/282 (12%)
Query: 6 DQYEIM---EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
Y++ + +G G+F H+ + + +K I R ++ E+ +
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQK----EITALKLC 62
Query: 63 Q-HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL----MKKSNGAYFPEEKLCKWFAQL 117
+ HP IV+ E + + +V GG EL KK +F E + +L
Sbjct: 63 EGHPNIVKLHEVF-HDQLHTFLVMELLNGG---ELFERIKKKK---HFSETEASYIMRKL 115
Query: 118 LLAVDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADD-LASSVVGTPNY 173
+ AV ++H V+HRDLK N+ F ++ + +++ DFG A+ D+ + T +Y
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEM-------AAHRPAFKAFDMAGLISKINRSSIGP 226
PELL Y D+WSLG +Y M +H + ++ KI +
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS- 234
Query: 227 LPSCY----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
S K LI+G+L +P R S L + +LQ
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-52
Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 19/269 (7%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI--RLARQTERCRRSAHQEMALIARVQ 63
D Y+I+E++G GAFG +A + +V K I + E++++ ++
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN----EISIMNQLH 106
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAV 121
HP ++ +A+ E + ++ + GG EL + + E ++ + Q +
Sbjct: 107 HPKLINLHDAF-EDKYEMVLILEFLSGG---ELFDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 122 DYLHSNYVLHRDLKCSNIFLT--KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELL 179
++H + ++H D+K NI K V++ DFGLA L D++ T + PE++
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSL 235
P GF +D+W++G Y + + F D + + R SP
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSSVSPEA 281
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQH 264
K IK +L+K P R + + L+HP+L+
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKG 310
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-51
Identities = 86/302 (28%), Positives = 137/302 (45%), Gaps = 32/302 (10%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAH--QEMAL 58
+ +EI++ IGRGAFG +V + K + +L K + ++ E +A +E +
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE----TACFREERDV 127
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ +I A+ + + +V Y GGD+ L+ K PEE + A+++
Sbjct: 128 LVNGDSKWITTLHYAFQDDN-NLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMV 185
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCP 176
+A+D +H + +HRD+K NI + + +RL DFG L D +S VGTP+Y+ P
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 177 ELLADIP-----YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----NRSSIGPL 227
E+L + YG + D WSLG CMYEM F A + KI R
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305
Query: 228 PSCYSPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQHFVD-----QYRPTFPPAACS 279
+ S + K LI+ ++ + EHR + KHPF +D + P S
Sbjct: 306 VTDVSENAKDLIRRLI-CSREHRLGQNGIEDFKKHPFFSG-IDWDNIRNCEAPYIPEVSS 363
Query: 280 PE 281
P
Sbjct: 364 PT 365
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 2e-51
Identities = 43/310 (13%), Positives = 82/310 (26%), Gaps = 42/310 (13%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRL-ARQTERCRRSAHQEMALIARVQHP 65
+ +++E + G LV + + LK + A + H+ AR+
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 66 YIVEFKEAW-------------------------VEKGCYVCIVTGYCEG--GDMAELMK 98
E ++ ++ + +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 99 K--SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156
L AQL+ L S ++H N+F+ D + LGD
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 157 TLKADDLASSVVGTPNYMCPELL--ADIPYGFKSDIWSLGCCMYEMAAHRPAFK------ 208
K + Y E L + + + W LG +Y + F
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 209 --AFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266
++ L S + +KTLI L + R E ++ P
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360
Query: 267 DQYRPTFPPA 276
++ +
Sbjct: 361 NEISSSLSTG 370
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 192 bits (488), Expect = 2e-51
Identities = 69/286 (24%), Positives = 107/286 (37%), Gaps = 19/286 (6%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR---LARQTERCRRSAHQEMALIA 60
+E+ E++G G FG + H+ ++ +K+ R + ER E+ ++
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL----EIQIMK 67
Query: 61 RVQHPYIVEFKE-----AWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWF 114
++ HP +V +E + + YCEGGD+ + L + N E +
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLKADDLASSVVGTP 171
+ + A+ YLH N ++HRDLK NI L ++ D G AK L +L + VGT
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
Y+ PELL Y D WS G +E F R Y
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF--VDQY-RPTFP 274
+ + P H +LQ Q R T P
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 80/298 (26%), Positives = 139/298 (46%), Gaps = 27/298 (9%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKK---YVLKKIRLARQTERCRRSAH--QEMAL 58
R + +E++ +G+G +G V + +K ++ A + +AH E +
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 59 IARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQ 116
+ V+HP+IV+ A+ K + ++ Y GG++ +++ F E+ C + A+
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGK---LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAE 129
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMC 175
+ +A+ +LH +++RDLK NI L V+L DFGL K ++ + + GT YM
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
PE+L + D WSLG MY+M P F + I KI + + LP +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEA 248
Query: 236 KTLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAACSPE 281
+ L+K +L++N R A E+ HPF +H ++ + P F P S E
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH-INWEELLARKVEPPFKPLLQSEE 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-51
Identities = 87/299 (29%), Positives = 147/299 (49%), Gaps = 33/299 (11%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKK---Y---VLKKIRL-ARQTERCRRSAHQEMA 57
Q+E+++ +G+G+FG LV + Y VLKK L R R + E
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK----MERD 78
Query: 58 LIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
++ V HP+IV+ A+ K + ++ + GGD+ + K F EE + + A
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGK---LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLA 133
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYM 174
+L LA+D+LHS +++RDLK NI L ++ ++L DFGL+K ++ + A S GT YM
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234
PE++ + +D WS G M+EM F+ D ++ I ++ + +P SP
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPE 252
Query: 235 LKTLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAACSPE 281
++L++ + ++NP +R E+ +H F +D + P F PA PE
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST-IDWNKLYRREIHPPFKPATGRPE 310
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-51
Identities = 88/302 (29%), Positives = 140/302 (46%), Gaps = 39/302 (12%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
M+ ++ ++ +G+G FG ILV +A + Y +L+K + TE
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR----- 57
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKLCK 112
++ +HP++ K A+ +C V Y GG+ L ++ F EE+
Sbjct: 58 ----VLQNTRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRER---VFTEERARF 109
Query: 113 WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTP 171
+ A+++ A++YLHS V++RD+K N+ L KD +++ DFGL K + + GTP
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
Y+ PE+L D YG D W LG MYEM R F D L I I P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTL 228
Query: 232 SPSLKTLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAACS 279
SP K+L+ G+L+K+P+ R A E+++H F ++ + P F P S
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS-INWQDVVQKKLLPPFKPQVTS 287
Query: 280 PE 281
Sbjct: 288 EV 289
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-51
Identities = 71/284 (25%), Positives = 129/284 (45%), Gaps = 18/284 (6%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQT---ERCRRSAHQEMA 57
+ +Y + + +G G++G V + +LKK +L R ++ E+
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK----EIQ 58
Query: 58 LIARVQHPYIVEFKEAW-VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQ 116
L+ R++H +++ + E+ + +V YC G M E++ FP + +F Q
Sbjct: 59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA---KTLKADDLASSVVGTPNY 173
L+ ++YLHS ++H+D+K N+ LT +++ G+A ADD + G+P +
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 174 MCPELLADI-PY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
PE+ + + GFK DIWS G +Y + F+ ++ L I + S +P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AIPGDC 236
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
P L L+KGML P R S ++ +H + + P
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 6e-51
Identities = 48/287 (16%), Positives = 93/287 (32%), Gaps = 32/287 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
+ +G GAF K+K+VLK + A E Q M +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI--GTQLMERLK 122
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGG---DMAELMKKSNGAYFPEEKLCKWFAQL 117
++F A + + +V G + L K + P+ + + ++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS-VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLT-----------KDQDVRLGDFGLAKTLKA---DDL 163
L ++ +H ++H D+K N L + L D G + +K +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS 223
++ T + C E+L++ P+ ++ D + + +Y M G K
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK--VKNEGGECKPEG-- 297
Query: 224 IGPLPSCYSPSL-KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
+ ML H + +LL+ + F Y
Sbjct: 298 --LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-51
Identities = 70/266 (26%), Positives = 131/266 (49%), Gaps = 15/266 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQH 64
+ + +IG G+FGA + +KK+ + + + + +E+ + +++H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P ++++ ++ + +V YC G ++L++ E ++ L + YL
Sbjct: 114 PNTIQYRGCYL-REHTAWLVMEYCLGS-ASDLLEVHKKP-LQEVEIAAVTHGALQGLAYL 170
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA---D 181
HS+ ++HRD+K NI L++ V+LGDFG A + A+S VGTP +M PE++ +
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 227
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPL-PSCYSPSLKTL 238
Y K D+WSLG E+A +P F+M + + I ++ L +S +
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285
Query: 239 IKGMLRKNPEHRPSASELLKHPFLQH 264
+ L+K P+ RP++ LLKH F+
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-51
Identities = 71/303 (23%), Positives = 131/303 (43%), Gaps = 36/303 (11%)
Query: 6 DQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ- 63
D Y++ + +G G G + HR +K LK + + + R+ E+ +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQ----EVDHHWQASG 80
Query: 64 HPYIVEFKEA---WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
P+IV + + I+ EGG++ +++ F E + + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 121 VDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
+ +LHS+ + HRD+K N+ + +K++D ++L DFG AK + L + TP Y+ PE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPE 199
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA----FDMAGLISKINRSSIGPLPSCY-- 231
+L Y D+WSLG MY + P F + G+ +I G P+
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG-FPNPEWS 258
Query: 232 --SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHE 289
S K LI+ +L+ +P R + ++ + HP++ + P+ P+ A
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ-----------SMVVPQTPLHTARV 307
Query: 290 SRR 292
+
Sbjct: 308 LQE 310
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-51
Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 18/274 (6%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMAL 58
++ Y + + +G G FG + H+ K +K KIR + +R E+
Sbjct: 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQN 64
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQ 116
+ +HP+I++ + +V Y GG EL +G E + + F Q
Sbjct: 65 LKLFRHPHIIKLYQVI-STPTDFFMVMEYVSGG---ELFDYICKHG-RVEEMEARRLFQQ 119
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
+L AVDY H + V+HRDLK N+ L + ++ DFGL+ + + + G+PNY P
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 177 ELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
E+++ Y G + DIWS G +Y + F + L KI +P + S+
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSV 238
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
TL+ ML+ +P R + ++ +H + + + Y
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSY 272
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 8e-51
Identities = 42/313 (13%), Positives = 80/313 (25%), Gaps = 50/313 (15%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR-- 61
R +G+ A + + + + + + +E L R
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 62 ------------------------VQHPYIVEFKEA---WVEKGCYVCIVTGYCEGGDMA 94
Q ++ + +
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 95 ELM--KKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDF 152
E++ S + Q++ + LH ++H L+ +I L + V L F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 153 GLAKTLKADDLASSVVGTPNYMCPELLAD-----------IPYGFKSDIWSLGCCMYEMA 201
D + + PEL A F D W+LG +Y +
Sbjct: 251 EHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 202 AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
G I RS ++ L++G LR E R + ++ P
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKN-----IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362
Query: 262 LQHFVDQYRPTFP 274
+ + P
Sbjct: 363 YEQLRTELSAALP 375
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-51
Identities = 62/273 (22%), Positives = 110/273 (40%), Gaps = 25/273 (9%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHP 65
+ + +G GA G + + + +K+I C A +E+ L+ +HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHP 78
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++ + + + I C + E +++ + A+ + Q + +LH
Sbjct: 79 NVIRYFCT-EKDRQFQYIAIELC-AATLQEYVEQKDFAH-LGLEPITLLQQTTSGLAHLH 135
Query: 126 SNYVLHRDLKCSNI-FLTKDQD----VRLGDFGLAKTLKADDLA----SSVVGTPNYMCP 176
S ++HRDLK NI + + DFGL K L + S V GT ++ P
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 177 ELLADIP---YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPL--PSC 230
E+L++ + DI+S GC Y + + F + S+ L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ LI+ M+ +P+ RPSA +LKHPF
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-50
Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 16/269 (5%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIA 60
+ + +G+G FG RA K Y KK+ R+ E + E ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN---EKQILE 239
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
+V ++V A+ K +C+V GGD+ + A FPE + + A++
Sbjct: 240 KVNSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
++ LH +++RDLK NI L +R+ D GLA + VGT YM PE++
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKT 237
+ Y F D W+LGC +YEM A + F+ ++ R +SP ++
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS 418
Query: 238 LIKGMLRKNPEHR-----PSASELLKHPF 261
L +L K+P R SA E+ +HP
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-50
Identities = 69/306 (22%), Positives = 120/306 (39%), Gaps = 49/306 (16%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEK------KKYVLKKIRLARQTERCRRSAH-- 53
+ ++ Y I+ + +G F IL + +K +L+K R ++ + S
Sbjct: 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 54 -----QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK---------K 99
E+ +I +++ Y + + V I+ Y E ++K K
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMEND---SILKFDEYFFVLDK 142
Query: 100 SNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158
+ + P + + +L + Y+H+ + HRD+K SNI + K+ V+L DFG ++
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE-Y 201
Query: 159 KADDLASSVVGTPNYMCPELLADIP--YGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGL 215
D GT +M PE ++ G K DIWSLG C+Y M + F + L
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 216 ISKINR------------------SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELL 257
+ I + S +K LRKNP R ++ + L
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321
Query: 258 KHPFLQ 263
KH +L
Sbjct: 322 KHEWLA 327
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-50
Identities = 71/310 (22%), Positives = 134/310 (43%), Gaps = 35/310 (11%)
Query: 6 DQYEIMEQ-IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ- 63
D Y++ Q +G G G + + ++ ++K+ LK ++ + RR E+ L R
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARR----EVELHWRASQ 113
Query: 64 HPYIVEFKEA---WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
P+IV + + IV +GG++ ++ F E + + + A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 121 VDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
+ YLHS + HRD+K N+ + +K + ++L DFG AK + + ++ TP Y+ PE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIGPLPSCY-- 231
+L Y D+WSLG MY + P F + G+ ++I P+
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWS 292
Query: 232 --SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHE 289
S +K LI+ +L+ P R + +E + HP++ + P+ P+ +
Sbjct: 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ-----------STKVPQTPLHTSRV 341
Query: 290 SRRCMAESQN 299
+ ++
Sbjct: 342 LKEDKERWED 351
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-50
Identities = 77/299 (25%), Positives = 139/299 (46%), Gaps = 28/299 (9%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAH--QEMAL 58
+ ++I+ +G G+FG L+ R + Y VLKK + R + H E +
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV----EHTNDERLM 59
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
++ V HP+I+ + + + ++ Y EGG++ L++KS FP + A++
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVC 116
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
LA++YLHS +++RDLK NI L K+ +++ DFG AK D+ ++ GTP+Y+ PE+
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEV 174
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
++ PY D WS G +YEM A F + KI + + P ++ +K L
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDL 233
Query: 239 IKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAACSPEKPIS 285
+ ++ ++ R ++ HP+ + V + P + S
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE-VVWEKLLSRNIETPYEPPIQQGQGDTS 291
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-50
Identities = 74/295 (25%), Positives = 138/295 (46%), Gaps = 28/295 (9%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAH--QEMAL 58
++DQ++ ++ +G G+FG +LV H+ Y +L K ++ + + H E +
Sbjct: 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ----IEHTLNEKRI 94
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ V P++V+ + ++ + + +V Y GG+M +++ F E + AQ++
Sbjct: 95 LQAVNFPFLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIV 151
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
L +YLHS +++RDLK N+ + + +++ DFG AK + ++ GTP + PE+
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEI 209
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ Y D W+LG +YEMAA P F A + KI + PS +S LK L
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDL 268
Query: 239 IKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAACSPE 281
++ +L+ + R +++ H + D + F P P
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT-TDWIAIYQRKVEAPFIPKFKGPG 322
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-50
Identities = 68/316 (21%), Positives = 129/316 (40%), Gaps = 22/316 (6%)
Query: 1 MESR-MDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQEM 56
M ++ +++++ +G GA+G L +R ++ ++ R E ++ E+
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EI 56
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWF 114
+ + H +V+F E + YC GG EL + + PE ++F
Sbjct: 57 CINKMLNHENVVKFYGHRREGN-IQYLFLEYCSGG---ELFDRIEPDI-GMPEPDAQRFF 111
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK---ADDLASSVVGTP 171
QL+ V YLH + HRD+K N+ L + ++++ DFGLA + + L + + GT
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 172 NYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAF-KAFDMAGLISKINRSSIGPLPS 229
Y+ PELL + D+WS G + M A + + D S P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 230 CY-SPSLKTLIKGMLRKNPEHRPSASELLKHP-FLQHFVDQYRPTFPPAACSPEKPISIA 287
+ L+ +L +NP R + ++ K + + + + E P +
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFS 291
Query: 288 HESRRCMAESQNSSSS 303
+ + S +S+S
Sbjct: 292 KHIQSNLDFSPVNSAS 307
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-50
Identities = 64/287 (22%), Positives = 119/287 (41%), Gaps = 23/287 (8%)
Query: 1 MESR-MDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAHQEM 56
M ++ +++++ +G GA+G L +R ++ ++ R E ++ E+
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EI 56
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWF 114
+ + H +V+F E + YC GG EL + + PE ++F
Sbjct: 57 CINKMLNHENVVKFYGHRREGN-IQYLFLEYCSGG---ELFDRIEPDI-GMPEPDAQRFF 111
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK---ADDLASSVVGTP 171
QL+ V YLH + HRD+K N+ L + ++++ DFGLA + + L + + GT
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 172 NYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAF-KAFDMAGLISKINRSSIGPLPS 229
Y+ PELL + D+WS G + M A + + D S P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 230 CY-SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
+ L+ +L +NP R + ++ K + + + P
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG--AKRP 276
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-49
Identities = 86/327 (26%), Positives = 137/327 (41%), Gaps = 19/327 (5%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKI-RLARQTERCRRSAHQEMALIARV 62
D+Y+ ++ IG G FG A L+ + K+ +K I R A E +R E+ +
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSL 73
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+HP IV FKE + ++ I+ Y GG++ E + + F E++ +F QLL V
Sbjct: 74 RHPNIVRFKEVILTPT-HLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVS 130
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRL--GDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
Y HS + HRDLK N L RL DFG +K+ S VGTP Y+ PE+L
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 181 DIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-----PLPSCYSPS 234
Y G +D+WS G +Y M F+ + K + + P SP
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACS---PEKPISIAHESR 291
LI + +P R S E+ H + + PE+P+
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310
Query: 292 RCMAESQNSSSSASDKDSLRSGDRNIS 318
+ ++E+ + D + + ++
Sbjct: 311 QIISEATIPAVRNRCLDDFMTDNLDLD 337
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-49
Identities = 81/302 (26%), Positives = 138/302 (45%), Gaps = 39/302 (12%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
+ + ++ IG+G+FG +L H+AE+ Y VL+K + + +ER
Sbjct: 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER------ 89
Query: 54 QEMALIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLC 111
L+ V+HP++V ++ +K + V Y GG++ +++ F E +
Sbjct: 90 --NVLLKNVKHPFLVGLHFSFQTADK---LYFVLDYINGGELFYHLQRER--CFLEPRAR 142
Query: 112 KWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGT 170
+ A++ A+ YLHS +++RDLK NI L + L DFGL K ++ + S+ GT
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGT 202
Query: 171 PNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC 230
P Y+ PE+L PY D W LG +YEM P F + + A + I + L
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPN 261
Query: 231 YSPSLKTLIKGMLRKNPEHR----PSASELLKHPFLQHFVD-------QYRPTFPPAACS 279
+ S + L++G+L+K+ R E+ H F ++ + P F P
Sbjct: 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL-INWDDLINKKITPPFNPNVSG 320
Query: 280 PE 281
P
Sbjct: 321 PN 322
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-49
Identities = 88/301 (29%), Positives = 142/301 (47%), Gaps = 34/301 (11%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLARQTERCRRSAH--QEMAL 58
+ + YE+++ IGRGAFG LV H++ +K Y +L K + ++++ SA +E +
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD----SAFFWEERDI 122
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+A P++V+ A+ + Y+ +V Y GGD+ LM + PE+ + A+++
Sbjct: 123 MAFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVV 178
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--DLASSVVGTPNYMCP 176
LA+D +HS +HRD+K N+ L K ++L DFG + + + VGTP+Y+ P
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 177 ELL----ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-NRSSIGPLPSCY 231
E+L D YG + D WS+G +YEM F A + G SKI N + P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
Query: 232 --SPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQHFVD-------QYRPTFPPAACS 279
S K LI L + E R E+ +H F ++ P S
Sbjct: 299 DISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLFFKN-DQWAWETLRDTVAPVVPDLSS 356
Query: 280 P 280
Sbjct: 357 D 357
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-49
Identities = 67/267 (25%), Positives = 114/267 (42%), Gaps = 15/267 (5%)
Query: 6 DQYEI--MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
Y + E +G G FG A K K I+ + + E++++ ++
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLD 144
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAV 121
H +++ +A+ E + +V Y +GG EL + E + Q+ +
Sbjct: 145 HANLIQLYDAF-ESKNDIVLVMEYVDGG---ELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 122 DYLHSNYVLHRDLKCSNI-FLTKDQD-VRLGDFGLAKTLKADDLASSVVGTPNYMCPELL 179
++H Y+LH DLK NI + +D +++ DFGLA+ K + GTP ++ PE++
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 260
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---GPLPSCYSPSLK 236
F +D+WS+G Y + + F + A ++ I S K
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQ 263
I +L K R SASE LKHP+L
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLS 347
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-49
Identities = 63/264 (23%), Positives = 121/264 (45%), Gaps = 11/264 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D Y+I E++G GAFG V RA + K + ++++ + +E+ ++ ++HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHP 214
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V +A+ E + ++ + GG++ E + + E++ ++ Q+ + ++H
Sbjct: 215 TLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH 272
Query: 126 SNYVLHRDLKCSNI-FLTKDQD-VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
N +H DLK NI F TK + ++L DFGL L GT + PE+ P
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY----SPSLKTLI 239
G+ +D+WS+G Y + + F + + + + S K I
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-MDDSAFSGISEDGKDFI 391
Query: 240 KGMLRKNPEHRPSASELLKHPFLQ 263
+ +L +P R + + L+HP+L
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLT 415
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-49
Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 36/299 (12%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
+++ + + + +G+G+FG L + + + LKK + E+
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR----- 69
Query: 54 QEMALIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLC 111
L +HP++ + E + V Y GGD+ ++ + F +
Sbjct: 70 ---VLSLAWEHPFLTHMFCTFQTKEN---LFFVMEYLNGGDLMYHIQSCH--KFDLSRAT 121
Query: 112 KWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVGT 170
+ A+++L + +LHS +++RDLK NI L KD +++ DFG+ K + D ++ GT
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 181
Query: 171 PNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC 230
P+Y+ PE+L Y D WS G +YEM + F D L I + P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRW 240
Query: 231 YSPSLKTLIKGMLRKNPEHR-PSASELLKHPFLQHFVD-------QYRPTFPPAACSPE 281
K L+ + + PE R ++ +HP + ++ + P F P SP
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE-INWEELERKEIDPPFRPKVKSPF 298
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-49
Identities = 79/296 (26%), Positives = 124/296 (41%), Gaps = 33/296 (11%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIA 60
D + +GRG FG +A K Y KK+ R+ + E ++A
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV---EKKILA 240
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM-----KKSNGAYFPEEKLCKWFA 115
+V +IV A+ K +C+V GGD + + F E + + A
Sbjct: 241 KVHSRFIVSLAYAFETKT-DLCLVMTIMNGGD---IRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYM 174
Q++ +++LH +++RDLK N+ L D +VR+ D GLA GTP +M
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCY 231
PELL Y F D ++LG +YEM A R F+A ++ + + P +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416
Query: 232 SPSLKTLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPP 275
SP+ K + +L+K+PE R S L HP + + P F P
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD-ISWRQLEAGMLTPPFVP 471
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 73/330 (22%), Positives = 126/330 (38%), Gaps = 68/330 (20%)
Query: 6 DQYEIMEQ-IGRGAFGAAILVNHRAEKKKYVLKKI--RLARQTERCRRSAHQEMALIARV 62
D Y++ E +G GA + ++Y +K I + R R E+ ++ +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR----EVEMLYQC 67
Query: 63 Q-HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAEL----MKKSNGAYFPEEKLCKWFAQL 117
Q H ++E E + E+ +V GG + K+ +F E + +
Sbjct: 68 QGHRNVLELIEFF-EEEDRFYLVFEKMRGG---SILSHIHKRR---HFNELEASVVVQDV 120
Query: 118 LLAVDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSV------- 167
A+D+LH+ + HRDLK NI +Q V++ DF L +K + S +
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 168 -VGTPNYMCPELL-----ADIPYGFKSDIWSLGCCMY---------------EMAAHRPA 206
G+ YM PE++ Y + D+WSLG +Y + R
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 207 FKAFDMAGLISKINRSSIGPLPSCY----SPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
L I P S + K LI +L ++ + R SA+++L+HP++
Sbjct: 241 ACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 263 QHFVDQYRPTFPPAACSPEKPISIAHESRR 292
Q C+PE + +R
Sbjct: 300 QG-------------CAPENTLPTPMVLQR 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-49
Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 14/271 (5%)
Query: 9 EIMEQIGRGAFGAAILVNHRAE-KKKYV-LKKIRLARQTERCRRSAHQEMALIARVQHPY 66
I E+IG G+FG V HRAE V +K + +E+A++ R++HP
Sbjct: 40 NIKEKIGAGSFGT---V-HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV F A + IVT Y G + L K E + + ++YLH
Sbjct: 96 IVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 126 SN--YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCPELLADI 182
+ ++HR+LK N+ + K V++ DFGL++ + L+S S GTP +M PE+L D
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTLIKG 241
P KSD++S G ++E+A + + + A +++ + +P +P + +I+G
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 242 MLRKNPEHRPSASELLKHPFLQHFVDQYRPT 272
P RPS + ++ L+ + P
Sbjct: 275 CWTNEPWKRPSFATIMDL--LRPLIKSAVPP 303
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-49
Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 19/287 (6%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEM 56
+ + Y I E +G G+FG L H ++K LK ++ + R R E+
Sbjct: 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EI 60
Query: 57 ALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWF 114
+ + ++HP+I++ + + +V Y G EL E++ ++F
Sbjct: 61 SYLKLLRHPHIIKLYDVI-TTPTDIVMVIEYAGG----ELFDYIVEKK-RMTEDEGRRFF 114
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYM 174
Q++ A++Y H + ++HRDLK N+ L + +V++ DFGL+ + + + G+PNY
Sbjct: 115 QQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174
Query: 175 CPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233
PE++ Y G + D+WS G +Y M R F + L K+N +P SP
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY-VMPDFLSP 233
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSP 280
++LI+ M+ +P R + E+ + P+ + Y S
Sbjct: 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-48
Identities = 88/297 (29%), Positives = 142/297 (47%), Gaps = 28/297 (9%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALI 59
M+++E ++ +G+G FG ILV +A + Y +K ++ +A+ + E ++
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVL 202
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKLCKWFAQLL 118
+HP++ K ++ +C V Y GG+ L ++ F E++ + A+++
Sbjct: 203 QNSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIV 258
Query: 119 LAVDYLHSNY-VLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTPNYMCP 176
A+DYLHS V++RDLK N+ L KD +++ DFGL K +K + GTP Y+ P
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236
E+L D YG D W LG MYEM R F D L I I P P K
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAK 377
Query: 237 TLIKGMLRKNPEHR----PS-ASELLKHPFLQHFVD-------QYRPTFPPAACSPE 281
+L+ G+L+K+P+ R A E+++H F + + P F P S
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG-IVWQHVYEKKLSPPFKPQVTSET 433
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-48
Identities = 72/297 (24%), Positives = 133/297 (44%), Gaps = 26/297 (8%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR----LARQTERCRRSAHQEMALIA 60
M+ + + IGRG FG K Y +K + +Q E + ++L++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
P+IV A+ + + GGD+ + + F E + + A+++L
Sbjct: 248 TGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILG 304
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
++++H+ +V++RDLK +NI L + VR+ D GLA + VGT YM PE+L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQ 363
Query: 181 D-IPYGFKSDIWSLGCCMYEMAAHRPAFKAF---DMAGLISKINRSSIGPLPSCYSPSLK 236
+ Y +D +SLGC ++++ F+ D + ++ LP +SP L+
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELR 422
Query: 237 TLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAACSPE 281
+L++G+L+++ R A E+ + PF + +D +Y P P
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS-LDWQMVFLQKYPPPLIPPRGEVN 478
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-48
Identities = 76/305 (24%), Positives = 132/305 (43%), Gaps = 43/305 (14%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
+D +E + +G+G+FG +L + Y VLKK + + TE+
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR----- 75
Query: 54 QEMALIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKL 110
L HP++ + + ++ + V + GGD M + K F E +
Sbjct: 76 ---ILSLARNHPFLTQLFCCFQTPDR---LFFVMEFVNGGDLMFHIQKSR---RFDEARA 126
Query: 111 CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVG 169
+ A+++ A+ +LH +++RDLK N+ L + +L DFG+ K + ++ G
Sbjct: 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG 186
Query: 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS 229
TP+Y+ PE+L ++ YG D W++G +YEM F+A + L I + P+
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPT 245
Query: 230 CYSPSLKTLIKGMLRKNPEHR------PSASELLKHPFLQHFVD-------QYRPTFPPA 276
++K + KNP R +L+HPF + +D Q P F P
Sbjct: 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE-IDWAQLNHRQIEPPFRPR 304
Query: 277 ACSPE 281
S E
Sbjct: 305 IKSRE 309
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-48
Identities = 84/314 (26%), Positives = 137/314 (43%), Gaps = 52/314 (16%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
+ ++++ IGRG++ +LV + + Y V+KK + QTE+
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK------ 60
Query: 54 QEMALIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKL 110
HP++V + + + V Y GGD M + ++ PEE
Sbjct: 61 --HVFEQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQRQR---KLPEEHA 112
Query: 111 CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVG 169
+ A++ LA++YLH +++RDLK N+ L + ++L D+G+ K L+ D S+ G
Sbjct: 113 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG---------LISKIN 220
TPNY+ PE+L YGF D W+LG M+EM A R F + L I
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232
Query: 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHR------PSASELLKHPFLQHFVD------- 267
I +P S +++K L K+P+ R +++ HPF ++ VD
Sbjct: 233 EKQI-RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN-VDWDMMEQK 290
Query: 268 QYRPTFPPAACSPE 281
Q P F P
Sbjct: 291 QVVPPFKPNISGEF 304
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-48
Identities = 68/303 (22%), Positives = 133/303 (43%), Gaps = 42/303 (13%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
++ + + +G+G+FG +L + + Y +LKK + + E+
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR----- 72
Query: 54 QEMALIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKL 110
L + P++ + + +++ + V Y GGD M + + F E
Sbjct: 73 ---VLALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVG---RFKEPHA 123
Query: 111 CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKADDLASSVVG 169
+ A++ + + +L S +++RDLK N+ L + +++ DFG+ K + + G
Sbjct: 124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG 183
Query: 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS 229
TP+Y+ PE++A PYG D W+ G +YEM A + F+ D L I ++ P
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPK 242
Query: 230 CYSPSLKTLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAA 277
S + KG++ K+P R ++ +H F ++ +D + +P + P A
Sbjct: 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY-IDWEKLERKEIQPPYKPKA 301
Query: 278 CSP 280
C
Sbjct: 302 CGR 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-48
Identities = 74/303 (24%), Positives = 129/303 (42%), Gaps = 35/303 (11%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M++YE + +IG G++G +R + +KK + ++ A +E+ ++ +++H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P +V E + K + +V YC+ + + + PE + Q L AV++
Sbjct: 62 PNLVNLLEVFRRKRR-LHLVFEYCDH-TVLHELDRYQRG-VPEHLVKSITWQTLQAVNFC 118
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVGTPNYMCPE-LLADI 182
H + +HRD+K NI +TK ++L DFG A+ L D V T Y PE L+ D
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI-------------------- 219
YG D+W++GC E+ + P + D LI K
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 220 ----NRSSIGPLPSCY---SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPT 272
+ + PL + S L+KG L +P R + +LL HP+ ++ +
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298
Query: 273 FPP 275
Sbjct: 299 KEH 301
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-47
Identities = 94/440 (21%), Positives = 174/440 (39%), Gaps = 45/440 (10%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-----KIRLARQTERCRRSAHQEMAL 58
++ Y + + +G G FG + H K +K KIR + RR E+
Sbjct: 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQN 69
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQ 116
+ +HP+I++ + + +V Y GG EL NG E++ + F Q
Sbjct: 70 LKLFRHPHIIKLYQVI-STPSDIFMVMEYVSGG---ELFDYICKNG-RLDEKESRRLFQQ 124
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
+L VDY H + V+HRDLK N+ L + ++ DFGL+ + + + G+PNY P
Sbjct: 125 ILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184
Query: 177 ELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
E+++ Y G + DIWS G +Y + F + L KI I P +PS+
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI-CDGIFYTPQYLNPSV 243
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMA 295
+L+K ML+ +P R + ++ +H + + + +Y P+ S I E+ + +
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTM----IDDEALKEVC 299
Query: 296 ESQNSSSSASDKDSLRSGDRNISATV---LNSENKATDTDLISIDDEDGPEQPPPCEEEH 352
E S L + + V L +N+ + D PP
Sbjct: 300 EKFECSEE-EVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEA---KDFYLATSPPD----- 350
Query: 353 GPDVCIVKMDERAVMKPSHSEQISTVESKQPKTIKSIMMALKEGKVRENGSPMRSTRTKA 412
+ + H E++ + ++ P+ ++ +++
Sbjct: 351 -------SFLDDHHLTRPHPERVPFLVAETPRARHTLDELNP----QKSKHQGVRKAKWH 399
Query: 413 VGTPTQRCNTEASPKVLKPC 432
+G +Q + +V +
Sbjct: 400 LGIRSQSRPNDIMAEVCRAI 419
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-47
Identities = 78/283 (27%), Positives = 128/283 (45%), Gaps = 30/283 (10%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAE-KKKYV-LKKIRLARQTERCRRSAHQEMALIARV 62
+ E+ E +GRGAFG V +A+ + K V +K+I +E R++ E+ ++RV
Sbjct: 7 YKEIEVEEVVGRGAFGV---V-CKAKWRAKDVAIKQIE----SESERKAFIVELRQLSRV 58
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELM-KKSNGAYFPEEKLCKWFAQLLLAV 121
HP IV+ A + VC+V Y EGG + ++ Y+ W Q V
Sbjct: 59 NHPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 122 DYLHS---NYVLHRDLKCSNIFLTKDQDV-RLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
YLHS ++HRDLK N+ L V ++ DFG A ++ ++ G+ +M PE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFK-----AFDMAGLISKINRSSIGPLPSCYS 232
+ Y K D++S G ++E+ R F AF + + R PL
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP---PLIKNLP 230
Query: 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
+++L+ K+P RPS E++K + H + + P
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKI--MTHLMRYFPGADEP 271
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-47
Identities = 78/301 (25%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKK---KYV-LKKIRLARQTERCRR---SAHQE 55
+YE + +IG GA+G ++A +V LK +R+ S +E
Sbjct: 6 MATSRYEPVAEIGVGAYG----TVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 56 MAL---IARVQHPYIVEFKEAWVEKGCY----VCIVTGYCEGGDMAELMKKSNGAYFPEE 108
+AL + +HP +V + V +V + + D+ + K+ P E
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 120
Query: 109 KLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVV 168
+ Q L +D+LH+N ++HRDLK NI +T V+L DFGLA+ + VV
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI------ 219
T Y PE+L Y D+WS+GC EM +P F D G I +
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 220 -----------------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
+ + S L+ ML NP R SA L+H +L
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300
Query: 263 Q 263
Sbjct: 301 H 301
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-46
Identities = 84/314 (26%), Positives = 137/314 (43%), Gaps = 52/314 (16%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
+ ++++ IGRG++ +LV + + Y V+KK + QTE+
Sbjct: 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK------ 103
Query: 54 QEMALIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKL 110
HP++V + + + V Y GGD M + ++ PEE
Sbjct: 104 --HVFEQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQRQR---KLPEEHA 155
Query: 111 CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVG 169
+ A++ LA++YLH +++RDLK N+ L + ++L D+G+ K L+ D S+ G
Sbjct: 156 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG---------LISKIN 220
TPNY+ PE+L YGF D W+LG M+EM A R F + L I
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHR------PSASELLKHPFLQHFVD------- 267
I +P S +++K L K+P+ R +++ HPF ++ VD
Sbjct: 276 EKQI-RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN-VDWDMMEQK 333
Query: 268 QYRPTFPPAACSPE 281
Q P F P
Sbjct: 334 QVVPPFKPNISGEF 347
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-46
Identities = 84/314 (26%), Positives = 129/314 (41%), Gaps = 38/314 (12%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQEMAL---IA 60
QYE + +IG GA+G ++V LK++R+ E S +E+A+ +
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 61 RVQHPYIVEFKE----AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQ 116
+HP +V + + ++ + +V + + D+ + K P E + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
LL +D+LHS+ V+HRDLK NI +T ++L DFGLA+ +SVV T Y P
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI----NRSS---IGP 226
E+L Y D+WS+GC EM +P F+ D G I +
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 227 LPSCYSPSLKT----------------LIKGMLRKNPEHRPSASELLKHPFLQHF---VD 267
LP S L+ L NP R SA L HP+ Q +
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308
Query: 268 QYRPTFPPAACSPE 281
PP+ + E
Sbjct: 309 NLDSHLPPSQNTSE 322
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-46
Identities = 72/318 (22%), Positives = 134/318 (42%), Gaps = 42/318 (13%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M++YE + +G G++G + ++ + +KK + + ++ A +E+ L+ +++H
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
+V E +K +V + + + + ++ + + K+ Q++ + +
Sbjct: 84 ENLVNLLEVCKKKKR-WYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFC 140
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-DDLASSVVGTPNYMCPE-LLADI 182
HS+ ++HRD+K NI +++ V+L DFG A+TL A ++ V T Y PE L+ D+
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI-------------------- 219
YG D+W++GC + EM P F D I
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 220 ----NRSSIGPLPSCY---SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPT 272
PL Y S + L K L +P+ RP +ELL H F Q
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD------- 313
Query: 273 FPPAACSPEKPISIAHES 290
S E + + ++
Sbjct: 314 GFAERFSQELQLKVQKDA 331
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-46
Identities = 42/340 (12%), Positives = 91/340 (26%), Gaps = 44/340 (12%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR-- 61
R +G+ A + + + + + + +E L R
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 62 ---------------------VQHPYIVEFKEAWVEKGC------YVCIVTGYCEGGDMA 94
V+ P + +++ +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 95 ELM--KKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDF 152
E++ S + Q++ + LH ++H L+ +I L + V L F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 153 GLAKTLKADDLAS--SVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRP 205
A ++ P +L F D W+LG +Y +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 206 AFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
G I RS ++ L++G LR E R + ++ P +
Sbjct: 316 PNTDDAALGGSEWIFRSCKNI-----PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370
Query: 266 VDQYRPTFPPAACSPEKPISIAHESRRCMAESQNSSSSAS 305
+ P + +P ++ + ++ +
Sbjct: 371 RTELSAA-LPLYQTDGEPTREGGAPPSGTSQPDEAGAAEA 409
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-46
Identities = 77/306 (25%), Positives = 135/306 (44%), Gaps = 35/306 (11%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKK---Y---VLKKIRLARQTERCRRSAHQEMA 57
++ +E+++ +G GA+G LV + Y VLKK + ++ + + +
Sbjct: 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 58 LIARVQHPYIVEFKEAW--VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
L Q P++V A+ K + ++ Y GG++ + + F E ++ +
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETK---LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVG 166
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK--TLKADDLASSVVGTPNY 173
+++LA+++LH +++RD+K NI L + V L DFGL+K + A GT Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 174 MCPELLADIPYGF-KS-DIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSIGPL 227
M P+++ G K+ D WSLG MYE+ F A + +I +S P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-PY 285
Query: 228 PSCYSPSLKTLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPP 275
P S K LI+ +L K+P+ R A E+ +H F Q ++ + F P
Sbjct: 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK-INWDDLAAKKVPAPFKP 344
Query: 276 AACSPE 281
Sbjct: 345 VIRDEL 350
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 43/297 (14%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKK--KYV-LKKIRLARQTERCRRSAHQEMAL 58
+ M++Y+ +E++G G +G V ++A+ + V LK+IRL + E +A +E++L
Sbjct: 17 QGLMEKYQKLEKVGEGTYG----VVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISL 72
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ + HP IV + + C + +V + E D+ +++ ++ + ++ + QLL
Sbjct: 73 LKELHHPNIVSLIDVIHSERC-LTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLL 129
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK--TLKADDLASSVVGTPNYMCP 176
V + H + +LHRDLK N+ + D ++L DFGLA+ + VV T Y P
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 177 E-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI------------- 219
+ L+ Y DIWS+GC EM +P F D I I
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 220 -------------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ + + L+ ML +P R SA + + HP+ +
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 40/292 (13%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK--KYV-LKKIRLARQTERCRRSAHQEMALIAR 61
M++Y +E+IG G +G V ++A+ + LKKIRL ++ E + +E++++
Sbjct: 1 MEKYHGLEKIGEGTYG----VVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE 56
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
++H IV+ + K + +V + + D+ +L+ G + QLL +
Sbjct: 57 LKHSNIVKLYDVIHTKKR-LVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGI 113
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGTPNYMCPE-LL 179
Y H VLHRDLK N+ + ++ ++++ DFGLA+ + + T Y P+ L+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI----------------- 219
Y DIWS+GC EM P F D I +I
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 220 --------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S L+ ML+ +P R +A + L+H + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-45
Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 26/292 (8%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQEMALIARVQ 63
+Q EI E IG+G FG V + V ++ I + R E ++ +E+ + +
Sbjct: 32 FEQLEIGELIGKGRFGQ---V-YHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H +V F A + I+T C+G + +++ + K + +++ + Y
Sbjct: 88 HENVVLFMGACMSPPHL-AIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGY 145
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA------SSVVGTPNYMCPE 177
LH+ +LH+DLK N+F V + DFGL G ++ PE
Sbjct: 146 LHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 178 LL---------ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP 228
++ +P+ SD+++LG YE+ A FK +I ++ L
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264
Query: 229 SC-YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACS 279
+ ++ E RP+ ++L+ L+ + R P
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLPKRNRRLSHPGHFW 314
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-44
Identities = 57/295 (19%), Positives = 110/295 (37%), Gaps = 46/295 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMA-LIARVQH 64
+ + +G G+ G + + + +K++ + A E+ L H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDH 68
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK-----SNGAYFPEEKLCKWFAQLLL 119
P ++ + + ++ I C ++ +L++ N E Q+
Sbjct: 69 PNVIRYYCS-ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 120 AVDYLHSNYVLHRDLKCSNIFLT-------------KDQDVRLGDFGLAKTLKADDLA-- 164
V +LHS ++HRDLK NI ++ ++ + + DFGL K L + +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 165 ---SSVVGTPNYMCPELLADI-------PYGFKSDIWSLGCCMYEM--AAHRPAFKAFDM 212
++ GT + PELL + DI+S+GC Y + P +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 213 AGLISKINRSSIGPLPSCY----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
I + S+ + + LI M+ +P RP+A ++L+HP
Sbjct: 247 ESNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQEMALIARVQ 63
Q + ++IG G+FG V ++ + V +K + + T + ++ E+ ++ + +
Sbjct: 23 DGQITVGQRIGSGSFGT---V-YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
H I+ F + IVT +CEG + + S F +KL Q +DY
Sbjct: 79 HVNILLFM-GYSTAPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDY 135
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS---SVVGTPNYMCPELLA 180
LH+ ++HRDLK +NIFL +D V++GDFGLA + + G+ +M PE++
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 181 D---IPYGFKSDIWSLGCCMYEMAA-------HRPAFKAFDMAGLISKINRSSIGPLPSC 230
PY F+SD+++ G +YE+ + +M G + + S
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--RGSLSPDLSKVRSN 253
Query: 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
+K L+ L+K + RPS +L ++
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAE--IEEL 286
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-44
Identities = 86/348 (24%), Positives = 150/348 (43%), Gaps = 50/348 (14%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKK---KYV-LKKIRLARQTERC---RRSAH 53
++SR +YE ++ +G G F ++A K + V +KKI+L ++E R+A
Sbjct: 5 VKSRAKRYEKLDFLGEGQFA----TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
+E+ L+ + HP I+ +A+ K + +V + E D+ ++K N + +
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSN-ISLVFDFMET-DLEVIIK-DNSLVLTPSHIKAY 117
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT--LKADDLASSVVGTP 171
L ++YLH +++LHRDLK +N+ L ++ ++L DFGLAK+ VV T
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TR 176
Query: 172 NYMCPELL--ADIPYGFKSDIWSLGCCMYEMAAHRPAF----------KAFDMAG----- 214
Y PELL A + YG D+W++GC + E+ P + F+ G
Sbjct: 177 WYRAPELLFGARM-YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235
Query: 215 ------------LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262
+ + S L LI+G+ NP R +A++ LK +
Sbjct: 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY- 294
Query: 263 QHFVDQYRPTFPPAACSPEKPISIAHESRRCMAESQNSSSSASDKDSL 310
F ++ PT P P+ E + + A ++ L
Sbjct: 295 --FSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGL 340
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 1e-43
Identities = 67/301 (22%), Positives = 129/301 (42%), Gaps = 38/301 (12%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY---VLKKIRLAR-------QTERCRRSAH 53
++ + + +G+G+FG +L + + Y +LKK + + E+
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR----- 393
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGD-MAELMKKSNGAYFPEEKLCK 112
L + P++ + + + V Y GGD M + + F E
Sbjct: 394 ---VLALPGKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVF 446
Query: 113 WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK-TLKADDLASSVVGTP 171
+ A++ + + +L S +++RDLK N+ L + +++ DFG+ K + + GTP
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
+Y+ PE++A PYG D W+ G +YEM A + F+ D L I ++ P
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSM 565
Query: 232 SPSLKTLIKGMLRKNPEHR-----PSASELLKHPFLQHFVD-------QYRPTFPPAACS 279
S + KG++ K+P R ++ +H F ++ +D + +P + P A
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY-IDWEKLERKEIQPPYKPKASG 624
Query: 280 P 280
Sbjct: 625 R 625
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 38/269 (14%), Positives = 101/269 (37%), Gaps = 19/269 (7%)
Query: 9 EIMEQIGRGAFGAAILVNHRAE-KKKYV-LKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+ ++ G + + + + +K +++ + R R ++E + HP
Sbjct: 13 NFLTKLNENHSGE---L-WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 67 IVEFKEAWVE-KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++ A + ++T + G + ++ + + + K+ + + +LH
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 126 S--NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
+ + L ++ + +D R+ + + + + + P ++ PE L P
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKP 184
Query: 184 YGF---KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTLI 239
+D+WS ++E+ F + K+ + P +P SP + L+
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLM 244
Query: 240 KGMLRKNPEHRPSASELLKHPFLQHFVDQ 268
K + ++P RP ++ L+ D+
Sbjct: 245 KICMNEDPAKRPKFDMIVPI--LEKMQDK 271
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-43
Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 6 DQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-Q 63
D Y++ + +G G G + + ++ ++K+ LK ++ + RR E+ L R Q
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARR----EVELHWRASQ 69
Query: 64 HPYIVEFKEA---WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
P+IV + + IV +GG++ ++ F E + + + A
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 121 VDYLHSNYVLHRDLKCSNI-FLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
+ YLHS + HRD+K N+ + +K + ++L DFG A E
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KE 169
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA----GLISKINRSSIGPLPSCY-- 231
+ Y D+WSLG MY + P F + G+ ++I P+
Sbjct: 170 TTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWS 227
Query: 232 --SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHE 289
S +K LI+ +L+ P R + +E + HP++ + P+ P+ +
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ-----------STKVPQTPLHTSRV 276
Query: 290 SRR 292
+
Sbjct: 277 LKE 279
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-43
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 44/295 (14%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK---KYV-LKKIRLARQTERCRRSAHQEMALIA 60
M +YE +E+IG G +G +A+ + + V LK++RL E SA +E+ L+
Sbjct: 1 MQKYEKLEKIGEGTYG----TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++H IV + + +V +C+ D+ + NG E + + QLL
Sbjct: 57 ELKHKNIVRLHDVLHSDKK-LTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKG 113
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK--TLKADDLASSVVGTPNYMCPE- 177
+ + HS VLHRDLK N+ + ++ +++L +FGLA+ + ++ VV T Y P+
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 178 LLADIPYGFKSDIWSLGCCMYEMA-AHRPAFKA---FDMAGLISKI-------------- 219
L Y D+WS GC E+A A RP F D I ++
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 220 -----------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+S+ + + + + L++ +L+ NP R SA E L+HP+
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-43
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 28/293 (9%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ----EMA 57
E+ +Y + +G+G FG + ++ + +K I R S E+A
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 58 LIARV----QHPYIVEFKEAWVEKGCYVCIVTGY-CEGGDMAE-LMKKSNGAYFPEEKLC 111
L+ +V HP ++ + W E +V D+ + + +K E
Sbjct: 87 LLWKVGAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSR 142
Query: 112 KWFAQLLLAVDYLHSNYVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTLKADDLASSVVGT 170
+F Q++ A+ + HS V+HRD+K NI + + +L DFG L + GT
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-DGT 201
Query: 171 PNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHR-PAFKAFDMAGLISKINRSSIGPLP 228
Y PE ++ Y + +WSLG +Y+M P F+ +I + + P
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP----FER---DQEILEAEL-HFP 253
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPE 281
+ SP LI+ L P RPS E+L P++Q P+ P
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ--TPAEDVPLNPSKGGPA 304
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 25/267 (9%)
Query: 9 EIMEQIGRGAFGAAILVNHRAE-KKKYV-LKKIRLARQTERCRRSA--HQEMALIARVQH 64
+ E IG G FG V +RA V +K R + + QE L A ++H
Sbjct: 10 TLEEIIGIGGFGK---V-YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P I+ + +++ C+V + GG + ++ P + L W Q+ ++YL
Sbjct: 66 PNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYL 121
Query: 125 HSN---YVLHRDLKCSNIFLTKDQD--------VRLGDFGLAKTLKADDLASSVVGTPNY 173
H ++HRDLK SNI + + + +++ DFGLA+ S G +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAW 180
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-NRSSIGPLPSCYS 232
M PE++ + SD+WS G ++E+ F+ D + + P+PS
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 233 PSLKTLIKGMLRKNPEHRPSASELLKH 259
L++ +P RPS + +L
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-43
Identities = 77/334 (23%), Positives = 128/334 (38%), Gaps = 51/334 (15%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
+ +YE + +IG+G FG HR +K LKK+ + + E +A +E+ ++ +
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 63 QHPYIVEFKEAWVEKGCYVC-------IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
+H +V E K +V +CE D+A L+ + F ++ +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS-NVLVKFTLSEIKRVMQ 131
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN--- 172
LL + Y+H N +LHRD+K +N+ +T+D ++L DFGLA+ + T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 173 --YMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI----NRS 222
Y PE LL + YG D+W GC M EM P + LIS++
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251
Query: 223 S---IGPLPSC--------YSPSLKT-------------LIKGMLRKNPEHRPSASELLK 258
+ +K LI +L +P R + + L
Sbjct: 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 259 HPFLQHFVDQYRPTFPPAACSPEKPISIAHESRR 292
H F F P+ ++ E
Sbjct: 312 HDF---FWSDPMPSDLKGM--LSTHLTSMFEYLA 340
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-43
Identities = 70/301 (23%), Positives = 119/301 (39%), Gaps = 29/301 (9%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ----EMA 57
E QY++ +G G FG+ ++ +K + R ++ E+
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 58 LIARVQH--PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKW 113
L+ +V ++ + W E+ ++ E +L GA EE +
Sbjct: 99 LLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPV--QDLFDFITERGA-LQEELARSF 154
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTLKADDLASSVVGTPN 172
F Q+L AV + H+ VLHRD+K NI + +++L DFG LK D + + GT
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRV 213
Query: 173 YMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
Y PE + Y G + +WSLG +Y+M F+ +I R +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQV-FFRQRV 266
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESR 291
S + LI+ L P RP+ E+ HP++Q P + S++
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ-------DVLLPQETAEIHLHSLSPGPS 319
Query: 292 R 292
+
Sbjct: 320 K 320
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 77/334 (23%), Positives = 133/334 (39%), Gaps = 51/334 (15%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK---KYV-LKKIRLARQTERCRRSAHQEMALIA 60
M+ Y ++++G G + ++ + K V LK+IRL E +A +E++L+
Sbjct: 1 METYIKLDKLGEGTYA----TVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLK 55
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++H IV + + + +V Y + D+ + + G + + QLL
Sbjct: 56 DLKHANIVTLHDIIHTEKS-LTLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQLLRG 112
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA--KTLKADDLASSVVGTPNYMCPE- 177
+ Y H VLHRDLK N+ + + +++L DFGLA K++ + VV T Y P+
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI--------------- 219
LL Y + D+W +GC YEMA RP F + I +I
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 220 -----------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268
++ L+ +L+ +R SA + +KHPF F+
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF---FLSL 288
Query: 269 YRPTFP---PAACSPEKPISIAHESRRCMAESQN 299
+ K I + E+ A +
Sbjct: 289 GERIHKLPDTTSIFALKEIQLQKEASLRSAHHHH 322
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 53/274 (19%), Positives = 102/274 (37%), Gaps = 25/274 (9%)
Query: 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSA-----HQEMALIARVQ 63
E +QIG+G FG +K +K + L +E+ +++ +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
HP IV+ +V + GD+ + + + L ++Y
Sbjct: 82 HPNIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEY 137
Query: 124 LHSN--YVLHRDLKCSNIFLTKDQD-----VRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
+ + ++HRDL+ NIFL + ++ DFGL++ S ++G +M P
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAP 195
Query: 177 ELLA--DIPYGFKSDIWSLGCCMYEMAAHRPAFK---AFDMAGLISKINRSSIGPLPSCY 231
E + + Y K+D +S +Y + F + + +P
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255
Query: 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
P L+ +I+ +P+ RP S ++K L
Sbjct: 256 PPRLRNVIELCWSGDPKKRPHFSYIVKE--LSEL 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 77/317 (24%), Positives = 127/317 (40%), Gaps = 55/317 (17%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKK---KYV-LKKIRLARQTERCRRSAHQEMAL 58
S Q++ +E++G G + ++ K YV LK+++L E +A +E++L
Sbjct: 2 SSSSQFKQLEKLGNGTYA----TVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIREISL 56
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSN----GAYFPEEKLCKWF 114
+ ++H IV + + + +V + + D+ + M + +
Sbjct: 57 MKELKHENIVRLYDVIHTENK-LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA--KTLKADDLASSVVGTPN 172
QLL + + H N +LHRDLK N+ + K ++LGDFGLA + + +S VV T
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173
Query: 173 YMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI--------- 219
Y P+ L+ Y DIWS GC + EM +P F + LI I
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 220 -----------------NRSSIGPLPSCYSPSLKT----LIKGMLRKNPEHRPSASELLK 258
R L L + G+L+ NP+ R SA + L
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293
Query: 259 HPFLQHFVDQYRPTFPP 275
HP+ F + Y
Sbjct: 294 HPW---FAEYYHHASMG 307
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 50/302 (16%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKK---KYV-LKKIRLARQTERCRRSAHQEMAL 58
+ +D+Y + ++G G +G ++A + V +K+IRL + E +A +E++L
Sbjct: 31 TSIDRYRRITKLGEGTYG----EVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSL 86
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ +QH I+E K + ++ Y E D+ + M K+ + + QL+
Sbjct: 87 LKELQHRNIIELKSVIHHNHR-LHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLI 142
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVR-----LGDFGLA--KTLKADDLASSVVGTP 171
V++ HS LHRDLK N+ L+ +GDFGLA + ++ T
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TL 201
Query: 172 NYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKI-------- 219
Y PE LL Y DIWS+ C EM P F D I ++
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 220 ------------------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPF 261
++ L + L+ ML +P R SA L+HP+
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 262 LQ 263
Sbjct: 322 FS 323
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 67/297 (22%), Positives = 124/297 (41%), Gaps = 23/297 (7%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
R E +G+G FG AI V HR + V+K++ R E +R+ +E+ ++
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRC 63
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
++HP +++F + K + +T Y +GG + ++K + +P + + + +
Sbjct: 64 LEHPNVLKF-IGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGM 121
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS---------------S 166
YLHS ++HRDL N + ++++V + DFGLA+ + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 167 VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM--AGLISKINRSSI 224
VVG P +M PE++ Y K D++S G + E+ A + +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPE 281
P PS + +PE RPS +L +L+ P +
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHLAGHLPLGPQLEQ 296
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-36
Identities = 80/385 (20%), Positives = 139/385 (36%), Gaps = 79/385 (20%)
Query: 2 ESRMDQYEIM-EQIGRGAFGAAILVNHRAEK--KKYVLKKIRLARQTERCRRSAHQEMAL 58
E D +E ++GRG +G + K K Y LK+I SA +E+AL
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIAL 71
Query: 59 IARVQHPYIVEFKEAWVEKG-CYVCIVTGYCEGGDMAELMK-------KSNGAYFPEEKL 110
+ ++HP ++ ++ ++ V ++ Y E D+ ++K P +
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 111 CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD----VRLGDFGLAKT----LKADD 162
Q+L + YLH+N+VLHRDLK +NI + + V++ D G A+ LK
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 163 LASSVVGTPNYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA------------ 209
VV T Y PE LL Y DIW++GC E+ P F
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250
Query: 210 FDMAGLISKI------------------------------NRSSIGPLPSCYSPSLKT-- 237
D I + S+ + +
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310
Query: 238 --LIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMA 295
L++ +L +P R ++ + ++ P+ F++ PT A + R +
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPY---FLEDPLPTSDVFAGCQIP-----YPKREFLT 362
Query: 296 ESQNSSSSASDKDSLRSGDRNISAT 320
E + + G+ + + T
Sbjct: 363 EEEPDDKGDKKNQQQQQGNNHTNGT 387
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 86/326 (26%), Positives = 133/326 (40%), Gaps = 50/326 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+Y + IG GA+G K + +KKI C+R +E+ ++ R +H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-TLREIKILLRFRHE 85
Query: 66 YIVE----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
I+ + +E+ V IV E D+ +L+K + + +C + Q+L +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH---LSNDHICYFLYQILRGL 141
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV----VGTPNYMCPE 177
Y+HS VLHRDLK SN+ L D+++ DFGLA+ D + V T Y PE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 178 -LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLIS 217
+L Y DIWS+GC + EM ++RP F + +I+
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 218 KINRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKHPFLQHFV 266
R+ + LP L+ ML NP R + L HP+L+ +
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY- 320
Query: 267 DQYRPTFPPAACSPEKPISIAHESRR 292
Y P+ P A E P E
Sbjct: 321 --YDPSDEPIA---EAPFKFDMELDD 341
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 68/322 (21%), Positives = 113/322 (35%), Gaps = 53/322 (16%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER----------CRRSAHQE 55
Y + I G++GA E +K++ R C+R +E
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKR-VLRE 79
Query: 56 MALIARVQHPYIVE----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLC 111
+ L+ HP I+ F + +VT D+A+++ + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH-DQRIVISPQHIQ 137
Query: 112 KWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP 171
+ +LL + LH V+HRDL NI L + D+ + DF LA+ AD + V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 172 NYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD------------------- 211
Y PE ++ + D+WS GC M EM + F+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 212 MAGLISKINRSSI-GPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKH 259
+ S R + L + + + LI ML NP+ R S + L+H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 260 PFLQHFVDQYRPTFPPAACSPE 281
P+ + + P S
Sbjct: 318 PYFESL---FDPLDLTEGLSER 336
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-35
Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 27/260 (10%)
Query: 6 DQYEIMEQIGRGAFGAAIL-VNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
QYE+ I G G L ++ + VLK + + E A E +A V H
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVH 138
Query: 65 PYIV------EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
P IV E + + Y IV Y G + + P + + ++L
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEIL 192
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
A+ YLHS +++ DLK NI LT++Q ++L D G + + + GTP + PE+
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI---NSFGYLYGTPGFQAPEI 248
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ P +DI+++G + + P + GL P+ Y S L
Sbjct: 249 VRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD------PVLKTY-DSYGRL 300
Query: 239 IKGMLRKNPEHRP-SASELL 257
++ + +P R +A E+
Sbjct: 301 LRRAIDPDPRQRFTTAEEMS 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 67/295 (22%), Positives = 122/295 (41%), Gaps = 29/295 (9%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKK---YVLKKI---RLARQ---TERCRRSAHQEMAL 58
Y+I++++G G G + + + AE V K + +R R H
Sbjct: 13 YKIVDKLGGG--GMSTV--YLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN---- 64
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+++ H IV + E CY +V Y EG ++E ++ +G + + Q+L
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIES-HGP-LSVDTAINFTNQIL 121
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCP 176
+ + H ++HRD+K NI + ++ +++ DFG+AK L L + V+GT Y P
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP--- 233
E +DI+S+G +YEM P F + K + S+ + +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241
Query: 234 -SLKTLIKGMLRKNPEHRP-SASELLKHPFLQHFVDQYRPTFPPAACSPEKPISI 286
SL +I K+ +R + E+ L + + R K I++
Sbjct: 242 QSLSNVILRATEKDKANRYKTIQEMKDD--LSSVLHENRANEDVYELDKMKTIAV 294
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-35
Identities = 76/328 (23%), Positives = 126/328 (38%), Gaps = 63/328 (19%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+++ +G GA+G H+ + +KKI + R +E+ ++ +H
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-TLREIKILKHFKHE 69
Query: 66 YIVE----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKL----CKWFA-Q 116
I+ + E V I+ + D+ ++ + L ++F Q
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST--------QMLSDDHIQYFIYQ 120
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN---- 172
L AV LH + V+HRDLK SN+ + + D+++ DFGLA+ + +S
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 173 -------YMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA--------------- 209
Y PE +L Y D+WS GC + E+ RP F
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 210 -----FDMAGLISKINRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSA 253
D+ + S R I LP + L+ L++ ML +P R +A
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 254 SELLKHPFLQHFVD-QYRPTFPPAACSP 280
E L+HP+LQ + D P P S
Sbjct: 301 KEALEHPYLQTYHDPNDEPEGEPIPPSF 328
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 71/358 (19%), Positives = 127/358 (35%), Gaps = 80/358 (22%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ--- 63
+Y ++ ++G G F L +K +R + +A E+ L+ RV
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDAD 76
Query: 64 --------HPYIVEFKEAWVEKGCY---VCIVTGYCE--GGDMAELMKKSNGAYFPEEKL 110
+I++ + + KG V +V E G ++ L+KK P +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF---EVLGENLLALIKKYEHRGIPLIYV 133
Query: 111 CKWFAQLLLAVDYLHSNY-VLHRDLKCSNIFLTKDQD------VRLGDFGLAKTLKADDL 163
+ QLLL +DY+H ++H D+K N+ + +++ D G A D+
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEH 191
Query: 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA-------------- 209
++ + T Y PE+L P+G +DIWS C ++E+ F+
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 210 -----------------------FDMAGLISKINRSSIGPLPSC----------YSPSLK 236
F+ GL+ I++ PL + +
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFP--PAACSPEKPISIAHESRR 292
+ ML+ +P R A L+ HP+L+ + P S E R
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVRD 369
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 77/325 (23%), Positives = 136/325 (41%), Gaps = 53/325 (16%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQH 64
Y +G GA+G+ + +K +KK+ + +R A++E+ L+ +QH
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR-AYRELLLLKHMQH 82
Query: 65 PYIVEFK-----EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLL 118
++ + + +V + + D+ ++M E+ ++ Q+L
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----FSEEKIQYLVYQML 136
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE- 177
+ Y+HS V+HRDLK N+ + +D ++++ DFGLA+ AD + V T Y PE
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEV 194
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISK 218
+L+ + Y DIWS+GC M EM + FK D + L K
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 219 INRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
+S I LP L++ ML + + R +A++ L HPF + F
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF-- 312
Query: 268 QYRPTFPPAACSPEKPISIAHESRR 292
P A ++P + E +
Sbjct: 313 -RDPEEETEA---QQPFDDSLEHEK 333
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 72/310 (23%), Positives = 117/310 (37%), Gaps = 54/310 (17%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+Y ++ +G G G K+ +KKI L + A +E+ +I R+ H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKH-ALREIKIIRRLDHD 68
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGD----MAELMK-------KSNGAYFPEEKLCKWF 114
IV+ E G + G + + E M+ + E+ + F
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL---LEEHARLF 125
Query: 115 A-QLLLAVDYLHSNYVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTLKADDLASSV----V 168
QLL + Y+HS VLHRDLK +N+F+ T+D +++GDFGLA+ + +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 169 GTPNYMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFK------------------- 208
T Y P LL+ Y D+W+ GC EM + F
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 209 AFDMAGLISKINRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELL 257
D L+S I + L ++ +L +P R +A E L
Sbjct: 246 EEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 258 KHPFLQHFVD 267
HP++ +
Sbjct: 305 SHPYMSIYSF 314
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 61/308 (19%), Positives = 118/308 (38%), Gaps = 57/308 (18%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ- 63
D Y+++ ++GRG + + +K V+K ++ ++ + R E+ ++ ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-----EIKILENLRG 89
Query: 64 HPYIVE----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
P I+ K+ + + D +L + + + + ++L
Sbjct: 90 GPNIITLADIVKDP--VSRTPALVFE-HVNNTDFKQLYQT-----LTDYDIRFYMYEILK 141
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
A+DY HS ++HRD+K N+ + + +RL D+GLA+ + V + + PEL
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 179 LADIP-YGFKSDIWSLGCCMYEMAAHR-PAFKAFD----------------MAGLISKIN 220
L D Y + D+WSLGC + M + P F D + I K N
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 221 ----RSSIGPLPSCYSPSLKTLIKG----------------MLRKNPEHRPSASELLKHP 260
L + + +LR + + R +A E ++HP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 261 FLQHFVDQ 268
+ V
Sbjct: 322 YFYTVVKD 329
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-34
Identities = 77/370 (20%), Positives = 128/370 (34%), Gaps = 61/370 (16%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+ Y + IG G+FG + +KK+ R E+ ++ ++
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNR----ELQIMRKLD 105
Query: 64 HPYIVEFKEAWVEKG-----CYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKLCKWFA- 115
H IV + + G Y+ +V Y + + + P K +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVI-YVKLYMY 163
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDV-RLGDFGLAKTLKADDLASSVVGTPNYM 174
QL ++ Y+HS + HRD+K N+ L D V +L DFG AK L + S + + Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 175 CPEL-LADIPYGFKSDIWSLGCCMYEMAAHRPAFK---AFDMAGLISKI----NRSSIG- 225
PEL Y D+WS GC + E+ +P F D I K+ R I
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283
Query: 226 ----------------PLPSCYSPSLKT----LIKGMLRKNPEHRPSASELLKHPFLQ-- 263
P + P L +L P R + E H F
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343
Query: 264 HFVDQYRPTFPPA-----------ACSPE--KPISIAHESRRCMAESQNSSSSASDKDSL 310
+ P + +P + H + A + ++++ASD ++
Sbjct: 344 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTG 403
Query: 311 RSGDRNISAT 320
G N +A+
Sbjct: 404 DRGQTNNAAS 413
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 60/298 (20%), Positives = 112/298 (37%), Gaps = 55/298 (18%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAE-KKKYV-LKKIRLARQTERCRRSAHQEMALIARVQ 63
Q ++++QIG+G +G V + + + V +K + R E+ ++
Sbjct: 37 KQIQMVKQIGKGRYGE---V-WMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVLMR 89
Query: 64 HPYIVEFKEAWVEKGCYV---CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
H I+ F A ++ ++T Y E G + + +K + + + K +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSG 146
Query: 121 VDYLHSNY--------VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-----DDLASSV 167
+ +LH+ + HRDLK NI + K+ + D GLA + D ++
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 168 VGTPNYMCPELLA------DIPYGFKSDIWSLGCCMYEMA----------AHRPAFKAF- 210
VGT YM PE+L +D++S G ++E+A ++ +
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 211 -------DMAGLISKIN-RSSIGPLPSCYS--PSLKTLIKGMLRKNPEHRPSASELLK 258
DM ++ R S S + L+ NP R +A + K
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-34
Identities = 74/323 (22%), Positives = 131/323 (40%), Gaps = 56/323 (17%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQ 63
+ +Y+ ++ IG GA G ++ +KK+ Q + +R A++E+ L+ V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR-AYRELVLMKCVN 82
Query: 64 HPYIVEFK-----EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
H I+ + +E+ V IV + ++ ++++ E++ Q+L
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME----LDHERMSYLLYQML 137
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
+ +LHS ++HRDLK SNI + D +++ DFGLA+T + + V T Y PE+
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKA----------FDMAG-----LISKIN--- 220
+ + Y DIWS+GC M EM F + G + K+
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 221 RSSIGPLPSCYSPSLKT-----------------------LIKGMLRKNPEHRPSASELL 257
R+ + P S + L+ ML + R S E L
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 258 KHPFLQHFVDQYRPTFPPAACSP 280
+HP++ + Y P+ A
Sbjct: 318 QHPYINVW---YDPSEAEAPPPK 337
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 73/326 (22%), Positives = 120/326 (36%), Gaps = 52/326 (15%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
MD++++ G+G FG L ++ +KK+ + R Q M +A
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNR-ELQIMQDLAV 75
Query: 62 VQHPYIVEFKEAWVEKG------CYVCIVTGYCEGGDMAELMKKSNGAYFP-EEKLCKWF 114
+ HP IV+ + + G Y+ +V Y + + L K F
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 115 A-QLLLAVDYLH--SNYVLHRDLKCSNIFL-TKDQDVRLGDFGLAKTLKADDLASSVVGT 170
QL+ ++ LH S V HRD+K N+ + D ++L DFG AK L + + + +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 171 PNYMCPEL-LADIPYGFKSDIWSLGCCMYEMAAHRPAFK---AFDMAGLISKI----NRS 222
Y PEL + Y DIWS+GC EM P F+ + I ++ +R
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254
Query: 223 SIGPLPSCYS----PSLKT--------------------LIKGMLRKNPEHRPSASELLK 258
+ L ++ + K L+ +L+ PE R E L
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314
Query: 259 HPFLQHFVDQYR-PTFPPAACSPEKP 283
HP+ D+ P
Sbjct: 315 HPYF----DELHDPATKLPNNKDLPE 336
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 7e-34
Identities = 69/266 (25%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAE---KKKYV-LKKIR--LARQT---ERCRRSAHQEMAL 58
Y + +GRG G V + AE +++ V LK + L+ R +R A
Sbjct: 36 YRLRRLVGRGGMGD---V-YEAEDTVRERIVALKLMSETLSSDPVFRTRMQREAR----T 87
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
R+Q P++V + G + G D+A ++++ G P + Q+
Sbjct: 88 AGRLQEPHVVPIHDFGEIDGQLY-VDMRLINGVDLAAMLRR-QGPLAPPRAV-AIVRQIG 144
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCP 176
A+D H+ HRD+K NI ++ D L DFG+A + L + VGT YM P
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP--- 233
E ++ +++DI++L C +YE P ++ D ++ +I P PS P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAI-PRPSTVRPGIP 262
Query: 234 -SLKTLIKGMLRKNPEHR-PSASELL 257
+ +I + KNPE R + +L
Sbjct: 263 VAFDAVIARGMAKNPEDRYVTCGDLS 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 61/311 (19%), Positives = 109/311 (35%), Gaps = 61/311 (19%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAE-KKKYV-LKKIRLARQTERCRRSAHQE--MALIAR 61
+ E IG+G FG V R + + + V +K R RS +E +
Sbjct: 42 RTIVLQESIGKGRFGE---V-WRGKWRGEEVAVKIFS-----SREERSWFREAEIYQTVM 92
Query: 62 VQHPYIVEFKEAWVEKGCYV---CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
++H I+ F A + +V+ Y E G + + + + E + K
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTA 149
Query: 119 LAVDYLHSNY--------VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-----ADDLAS 165
+ +LH + HRDLK NI + K+ + D GLA D +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 166 SVVGTPNYMCPELL------ADIPYGFKSDIWSLGCCMYEMA----------AHRPAFKA 209
VGT YM PE+L ++DI+++G +E+A ++ +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 210 F--------DMAGLISKIN-RSSIGPLPSCYS--PSLKTLIKGMLRKNPEHRPSASELLK 258
+M ++ + R +I + +++ N R +A + K
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 259 HPFLQHFVDQY 269
L Q
Sbjct: 330 T--LSQLSQQE 338
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 63/299 (21%)
Query: 9 EIMEQIGRGAFGAAILVNHRAE-KKKYV-LKKIRLARQTERCRRSAHQE--MALIARVQH 64
++E +G+G +G V R + + V +K R +S +E + ++H
Sbjct: 11 TLLECVGKGRYGE---V-WRGSWQGENVAVKIFS-----SRDEKSWFRETELYNTVMLRH 61
Query: 65 PYIVEFKEA---WVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
I+ F + + ++T Y E G + + ++ + + + +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGL 118
Query: 122 DYLHSNY--------VLHRDLKCSNIFLTKDQDVRLGDFGLAK-----TLKADDLASSVV 168
+LH + HRDLK NI + K+ + D GLA T + D + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 169 GTPNYMCPELLADIP------YGFKSDIWSLGCCMYEMA----------AHRPAFKAFDM 212
GT YM PE+L + + DIW+ G ++E+A ++P F +D+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF--YDV 236
Query: 213 AGLISKINRSSIG--------PLPSCYS-----PSLKTLIKGMLRKNPEHRPSASELLK 258
+P+ + SL L+K +NP R +A + K
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-33
Identities = 86/326 (26%), Positives = 123/326 (37%), Gaps = 60/326 (18%)
Query: 2 ESRMDQYEIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRL-ARQTERCRRSAHQEMA 57
E R Y + IG G+FG A LV E + +KK+ R R E+
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLV----ESDEVAIKKVLQDKRFKNR-------ELQ 84
Query: 58 LIARVQHPYIVEFKEAWVEKG-----CYVCIVTGYCEGGDMAELMK--KSNGAYFPEEKL 110
++ V+HP +V+ K + G ++ +V Y + + P L
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML-L 142
Query: 111 CKWFA-QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDV-RLGDFGLAKTLKADDLASSVV 168
K + QLL ++ Y+HS + HRD+K N+ L V +L DFG AK L A + S +
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 169 GTPNYMCPEL-LADIPYGFKSDIWSLGCCMYEMAAHRPAFK---AFDMAGLISKI----N 220
+ Y PEL Y DIWS GC M E+ +P F D I K+ +
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262
Query: 221 RSSIG-----------------PLPSCYSPSLKT----LIKGMLRKNPEHRPSASELLKH 259
R I P + P LI +L P R +A E L H
Sbjct: 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
Query: 260 PFLQHFVDQYR-PTFPPAACSPEKPI 284
PF D+ R P+
Sbjct: 323 PFF----DELRTGEARMPNGRELPPL 344
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 72/325 (22%), Positives = 135/325 (41%), Gaps = 53/325 (16%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQH 64
++Y+ + +G GA+G+ + +KK+ + +R ++E+ L+ ++H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKH 87
Query: 65 PYIVEFK-----EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLL 118
++ +E+ V +VT D+ ++K + ++ Q+L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-CQKL---TDDHVQFLIYQIL 142
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE- 177
+ Y+HS ++HRDLK SN+ + +D ++++ DFGLA+ D + V T Y PE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYVATRWYRAPEI 200
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISK 218
+L + Y DIWS+GC M E+ R F D + + S+
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 219 INRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
R+ I L + L++ ML + + R +A++ L H + +
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY-- 318
Query: 268 QYRPTFPPAACSPEKPISIAHESRR 292
+ P P A P + ESR
Sbjct: 319 -HDPDDEPVA----DPYDQSLESRD 338
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 47/309 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQH 64
Y ++ +G GA+GA K +KK+ + +R A++E+ L+ ++H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMRH 83
Query: 65 PYIVEFKEAWVEKGCY-----VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLL 118
++ + + +V + D+ +LMK E ++ Q+L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGEDRIQFLVYQML 138
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE- 177
+ Y+H+ ++HRDLK N+ + +D ++++ DFGLA+ AD + V T Y PE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEV 196
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------------------MAGLISK 218
+L + Y DIWS+GC M EM + FK D + L S
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 219 INRSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
++ + LP + L++ ML + E R +A E L HP+ + D
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 268 -QYRPTFPP 275
+ P
Sbjct: 317 TEDEPQVQK 325
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-32
Identities = 72/323 (22%), Positives = 130/323 (40%), Gaps = 58/323 (17%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQH 64
+Y+ ++ IG GA G + +KK+ Q + +R A++E+ L+ V H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYRELVLMKCVNH 120
Query: 65 PYIVEFK-----EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLL 118
I+ + +E+ V +V + ++ ++++ + + + Q+L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQML 174
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
+ +LHS ++HRDLK SNI + D +++ DFGLA+T + + V T Y PE+
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKA----------FDMAG-----LISKIN--- 220
+ + Y DIWS+GC M EM H+ F + G + K+
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 221 RSSIGPLPSCYSPSLKT-----------------------LIKGMLRKNPEHRPSASELL 257
R+ + P + L+ ML +P R S + L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 258 KHPFLQHFVDQYRPTFPPAACSP 280
+HP++ + Y P A
Sbjct: 355 QHPYINVW---YDPAEVEAPPPQ 374
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 72/351 (20%), Positives = 126/351 (35%), Gaps = 79/351 (22%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
E+ +Y + + +G G+FG V K++ LKK+ + R E+ ++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--QDPRYKNR----ELDIMKV 56
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGA------------------ 103
+ H I++ + + G + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 104 --YFPE-----------------EKLCKWFA-QLLLAVDYLHSNYVLHRDLKCSNIFL-T 142
Y P+ L + QL AV ++HS + HRD+K N+ + +
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 143 KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL-LADIPYGFKSDIWSLGCCMYEMA 201
KD ++L DFG AK L + + + + + Y PEL L Y D+WS+GC E+
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 202 AHRPAFK---AFDMAGLISKI----NRSSIGPLPSCYS----PSLKT------------- 237
+P F + D I +I + + + Y+ P+LK
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296
Query: 238 ----LIKGMLRKNPEHRPSASELLKHPFLQHFVDQYR-PTFPPAACSPEKP 283
L++ +LR P+ R + E + HPF D R + P
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFF----DHLRNSYESEVKNNSNFP 343
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 79/301 (26%), Positives = 131/301 (43%), Gaps = 34/301 (11%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKK---YVLKKI---RLARQTE---RCRRSAHQEMAL 58
YE+ E +G G G + + H A + V K+ LAR R RR A
Sbjct: 14 YELGEILGFG--GMSEV--HLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQN---- 65
Query: 59 IARVQHPYIVE---FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
A + HP IV EA G IV Y +G + +++ G P+ + + A
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAI-EVIA 123
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA----SSVVGTP 171
A+++ H N ++HRD+K +NI ++ V++ DFG+A+ + + ++V+GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 172 NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
Y+ PE +SD++SLGC +YE+ P F D ++ + PS
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSAR 242
Query: 232 ----SPSLKTLIKGMLRKNPEHRP-SASELLKHPFLQHFVDQYRPTFPPAACSPEKPISI 286
S L ++ L KNPE+R +A+E+ L + P P E+ +
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD--LVRVHNGEPPEAPKVLTDAERTSLL 300
Query: 287 A 287
+
Sbjct: 301 S 301
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-29
Identities = 81/389 (20%), Positives = 135/389 (34%), Gaps = 115/389 (29%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQH 64
D Y I IGRG++G L + +K +KK+ C+R +E+ ++ R++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLKS 84
Query: 65 PYIV------------EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCK 112
YI+ +F E + IV + D+ +L K F E+ K
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELY--------IVLEIADS-DLKKLFKTPI---FLTEEHIK 132
Query: 113 WFA-QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTP 171
LLL +++H + ++HRDLK +N L +D V++ DFGLA+T+ ++ + V
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 172 N-----------------------YMCPE-LLADIPYGFKSDIWSLGCCMYEM------- 200
Y PE +L Y DIWS GC E+
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 201 ----AAHRPAFKAF------------------------------------DMAGLISKIN 220
P F D+ +
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312
Query: 221 RSSIGPLPSCYSPSLKT-----------LIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269
I P +LK L++ ML+ NP R + + L HP+L+
Sbjct: 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV---R 369
Query: 270 RPTFPPAACSPEKPISIAHESRRCMAESQ 298
+ + K I + + ++E+Q
Sbjct: 370 KKKLENFS---TKKIILPFDDWMVLSETQ 395
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 60/307 (19%), Positives = 111/307 (36%), Gaps = 65/307 (21%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
+ +++E RG FG E YV KI Q ++ + E+ +
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNE---YVAVKI-FPIQDKQSWQ-NEYEVYSLPG 74
Query: 62 VQHPYIVEF-------KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
++H I++F V+ ++T + E G +++ +K + +LC
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDL----WLITAFHEKGSLSDFLKANV---VSWNELCHIA 127
Query: 115 AQLLLAVDYLHSNY----------VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164
+ + YLH + + HRD+K N+ L + + DFGLA +A A
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 165 ---SSVVGTPNYMCPELL-----ADIPYGFKSDIWSLGCCMYEMA-----------AHRP 205
VGT YM PE+L + D++++G ++E+A +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 206 AFKAF--------DMAGLISKIN-RSSIGPLPSCYSP-----SLKTLIKGMLRKNPEHRP 251
F+ DM ++ R + + L I+ + E R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 252 SASELLK 258
SA + +
Sbjct: 305 SAGCVGE 311
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 76/345 (22%), Positives = 131/345 (37%), Gaps = 88/345 (25%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++YEI+ +G G FG + A K V KI R + R +A E+ ++ +++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEK 76
Query: 66 ------YIVEFKEAWVEKGCYVCIVTGYCE--GGDMAELMKKSNGAYFPEEKLCKWFA-Q 116
V + + G ++CI E G + E +K++N +P + A Q
Sbjct: 77 DKENKFLCVLMSDWFNFHG-HMCIAF---ELLGKNTFEFLKENNFQPYPL-PHVRHMAYQ 131
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLT-------------------KDQDVRLGDFGLAKT 157
L A+ +LH N + H DLK NI K+ +R+ DFG A T
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-T 190
Query: 158 LKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAG 214
+ +++V T +Y PE++ ++ + D+WS+GC ++E F+ +
Sbjct: 191 FDHEHH-TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 215 LISKINRSSIGPLP--------------------------------------------SC 230
++ KI +GP+P S
Sbjct: 250 MMEKI----LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
L L++ ML +P R + +E L HPF + R
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTS 350
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 74/340 (21%), Positives = 134/340 (39%), Gaps = 96/340 (28%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH- 64
+ + ++ ++G G FG +L H KK Y +K +R ++ RSA E ++ ++Q+
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQND 91
Query: 65 ----PYIVEFKEAWVEKGCYVCIVTGYCE--GGDMAELMKKSNGAYFPEEKLCKWFA-QL 117
IV++ ++ ++C++ E G + E++ ++N F + K + ++
Sbjct: 92 DINNNNIVKYHGKFMYYD-HMCLIF---EPLGPSLYEIITRNNYNGFHI-EDIKLYCIEI 146
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLT-------------------------KDQDVRLGDF 152
L A++YL + H DLK NI L K ++L DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 153 GLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA--- 209
G A T K+D S++ T Y PE++ ++ + SD+WS GC + E+ F+
Sbjct: 207 GCA-TFKSDYH-GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264
Query: 210 FDMAGLISKINRSSIGPLPS---------------------------------------- 229
+ ++ I I P+P
Sbjct: 265 MEHLAMMESI----IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 230 ------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ +L+ +P RPS +ELLKH FL+
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 75/332 (22%), Positives = 127/332 (38%), Gaps = 88/332 (26%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+YEI++ +G GAFG + ++V KI + +R +A E+ ++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI--VKNVDRYCEAARSEIQVLEHLNTT 71
Query: 66 ------YIVEFKEAWVEKGCYVCIVTGYCE--GGDMAELMKKSNGAYFPEEKLCKWFA-Q 116
V+ E + G ++CIV E G + +K++ F + A Q
Sbjct: 72 DPNSTFRCVQMLEWFEHHG-HICIVF---ELLGLSTYDFIKENGFLPFRL-DHIRKMAYQ 126
Query: 117 LLLAVDYLHSNYVLHRDLKCSNIFLT-------------------KDQDVRLGDFGLAKT 157
+ +V++LHSN + H DLK NI + D+++ DFG A T
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-T 185
Query: 158 LKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAG 214
+ S++V T +Y PE++ + + D+WS+GC + E F +
Sbjct: 186 YDDEHH-STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 215 LISKINRSSIGPLPSC---------------------------YSPSLKTL--------- 238
++ +I +GPLP S + K L
Sbjct: 245 MMERI----LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 239 --------IKGMLRKNPEHRPSASELLKHPFL 262
I+ ML +P R + E LKHPF
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 83/389 (21%), Positives = 130/389 (33%), Gaps = 107/389 (27%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQH 64
D+YEI IG G++G + EK+ +KKI + C+R +E+A++ R+ H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-ILREIAILNRLNH 111
Query: 65 PYIVE----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA-QLLL 119
++V+ VEK + +V + D +L + E K LL+
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYL---TELHIKTLLYNLLV 167
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN------- 172
V Y+HS +LHRDLK +N + +D V++ DFGLA+T+ + +S +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 173 ---------------------YMCPE-LLADIPYGFKSDIWSLGCCMYEM---------- 200
Y PE +L Y D+WS+GC E+
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 201 -AAHRPAFK---------------------------------------AFDMAGLISKIN 220
A P F D+ L +
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347
Query: 221 RSSIGPLPSCYSPSLKTLIKG-----------MLRKNPEHRPSASELLKHPFLQHFVDQY 269
+ I P L ML NP R + +E L HPF +
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV---R 404
Query: 270 RPTFPPAACSPEKPISIAHESRRCMAESQ 298
A + + + M E Q
Sbjct: 405 IAEVETNA---TEKVRLPFNDWMNMDEPQ 430
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 58/309 (18%), Positives = 112/309 (36%), Gaps = 64/309 (20%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAE-KKKYVLKKIRLARQTERCRRSAHQEMALIARVQ 63
+D +++E IGRG +GA V ++ ++ V K+ + + + + + + ++
Sbjct: 12 LDNLKLLELIGRGRYGA---V-YKGSLDERPVAVKV-FSFANRQNFINE-KNIYRVPLME 65
Query: 64 HPYIVEFKEAWVEKGCYV----CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
H I F +V Y G + + + C+ +
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTR 122
Query: 120 AVDYLHSNY---------VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA------ 164
+ YLH+ + HRDL N+ + D + DFGL+ L + L
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 165 ---SSVVGTPNYMCPELLADI-------PYGFKSDIWSLGCCMYEMA------------- 201
S VGT YM PE+L + D+++LG +E+
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 202 AHRPAFKAF--------DMAGLISKIN-RSSIGPLPSCYSPSLKTLIKGMLR---KNPEH 249
++ AF+ DM L+S+ R S ++++L + + ++ E
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 250 RPSASELLK 258
R +A +
Sbjct: 303 RLTAQXAEE 311
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 79/365 (21%), Positives = 137/365 (37%), Gaps = 101/365 (27%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQ- 63
+YE+++++G+GA+G R + +KKI A + + +R +E+ ++ +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR-TFREIMILTELSG 67
Query: 64 HPYIV---------EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
H IV ++ V +V Y E D+ +++ +N E ++
Sbjct: 68 HENIVNLLNVLRADNDRD--------VYLVFDYMET-DLHAVIR-ANIL---EPVHKQYV 114
Query: 115 A-QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN- 172
QL+ + YLHS +LHRD+K SNI L + V++ DFGL+++ ++ +
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 173 ---------------------YMCPE-LLADIPYGFKSDIWSLGCCMYEMAAHRPAFK-- 208
Y PE LL Y D+WSLGC + E+ +P F
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 209 -----------------AFDMAGLISKINRSSIGPLPSCYSPSLKT-------------- 237
D+ + S ++ I L
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294
Query: 238 -------------LIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPI 284
L+ +L+ NP R SA++ LKHPF+ F + P P + I
Sbjct: 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN---PNEEPNC---DHII 348
Query: 285 SIAHE 289
+I
Sbjct: 349 TIPIN 353
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 64/349 (18%), Positives = 125/349 (35%), Gaps = 89/349 (25%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH- 64
+YE+++ IG+G+FG + + LK +R +R R A +E+ ++ ++
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQ 153
Query: 65 -----PYIVEFKEAWVEKGCYVCIVTGYCE--GGDMAELMKKSNGAYFPEEKLCKWFAQL 117
++ E + + ++C+ E ++ EL+KK+ F + K+ +
Sbjct: 154 DKDNTMNVIHMLENFTFRN-HICMTF---ELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLT--KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMC 175
L +D LH N ++H DLK NI L +++ DFG + + + + Y
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYRA 267
Query: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKINRSSIGPLPS--- 229
PE++ YG D+WSLGC + E+ P D + ++ +G
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL----LGMPSQKLL 323
Query: 230 -----------------------------------------CYSPSLKTLIKGM------ 242
P + +
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 243 -----LRK----NPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEK 282
L++ +P R + + L+HP+L+ + P P + K
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLR----RRLPKPPTGEKTSVK 428
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 70/338 (20%), Positives = 121/338 (35%), Gaps = 84/338 (24%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D+YEI IG+G+FG + R E++ +K I+ + A E+ L+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKH 110
Query: 66 ------YIVEFKEAWVEKGCYVCIVTGYCE--GGDMAELMKKSNGAYFPEEKLCKWFAQL 117
YIV K ++ + ++C+V E ++ +L++ +N K+ Q+
Sbjct: 111 DTEMKYYIVHLKRHFMFRN-HLCLVF---EMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 118 LLAVDYLHSNY--VLHRDLKCSNIFLT--KDQDVRLGDFGLAKTLKADDLASSVVGTPNY 173
A+ +L + ++H DLK NI L K +++ DFG + + + + Y
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFY 224
Query: 174 MCPELLADIPYGFKSDIWSLGCC---------------------------------MYEM 200
PE+L +PY D+WSLGC + +
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284
Query: 201 AAHRPAF---------------------KAFDMAGLISKINRSSIGPLPSCYSPSLKT-- 237
A F K L + + + GP S T
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344
Query: 238 -------LIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268
LI ML +P+ R L+H F + D+
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-26
Identities = 69/302 (22%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 5 MDQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYV-LKKIRLARQTERCRRSAH 53
D + ++Q+G+G FG + + V +KK++ + TE R
Sbjct: 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFE 90
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCK 112
+E+ ++ +QH IV++K G + ++ Y G + + ++K + KL +
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQ 149
Query: 113 WFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGT 170
+ +Q+ ++YL + Y+ HRDL NI + + V++GDFGL K L D +
Sbjct: 150 YTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 171 --P-NYMCPELLADIPYGFKSDIWSLGCCMYEM-----AAHRPAFKAFDMAG-------- 214
P + PE L + + SD+WS G +YE+ + P + M G
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 215 ---LISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQ 268
LI + + P P + + M N RPS +L + DQ
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIYMI---MTECWNNNVNQRPSFRDL--ALRVDQIRDQ 323
Query: 269 YR 270
Sbjct: 324 MA 325
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 73/366 (19%), Positives = 118/366 (32%), Gaps = 116/366 (31%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-- 63
+Y ++ ++G G F L + KK+V K+ + E +A E+ L+ V+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKV--VKSAEHYTETALDEIRLLKSVRNS 93
Query: 64 ---HP---YIV----EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
P +V +FK + V G ++C+V G + + + KSN P + K
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVN-GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 114 FAQLLLAVDYLHS-NYVLHRDLKCSNIFLT------------------------------ 142
Q+L +DYLH+ ++H D+K NI L+
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 143 -------------------KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
+ V++ D G A + + T Y E+L
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIGSG 269
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG---------------------LISKINRS 222
Y +DIWS C +E+A F+ LI S
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 223 S-----------IGPLPSCYSPS---------------LKTLIKGMLRKNPEHRPSASEL 256
I L + ML PE R +A+E
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 257 LKHPFL 262
L+HP+L
Sbjct: 390 LRHPWL 395
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 58/268 (21%), Positives = 113/268 (42%), Gaps = 24/268 (8%)
Query: 6 DQYEIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
+++ ++ +G GAFG + + + K V K + + + E ++A V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+P++ V ++T G + + +++ + + L W Q+ ++
Sbjct: 75 DNPHVCRL-LGICLTST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMN 131
Query: 123 YLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT--P-NYMCPEL 178
YL V HRDL N+ + Q V++ DFGLAK L A++ G P +M E
Sbjct: 132 YLEDRRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 179 LADIPYGFKSDIWSLGCCMYEMAA--HRP--AFKAFDMAGLISKINRSSIGPLPSCYSPS 234
+ Y +SD+WS G ++E+ +P A +++ ++ K R P P +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICTID 247
Query: 235 LKTLIKGMLR---KNPEHRPSASELLKH 259
+ + M + + + RP EL+
Sbjct: 248 VYMI---MRKCWMIDADSRPKFRELIIE 272
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 9 EIMEQIGRGAFGA---AILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQEMALIARVQH 64
+ + +G G FG + V +K ++ A + R QE+ ++ + H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYH 92
Query: 65 PYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
+I+++K + G + +V Y G + + + + + +L + Q+ + Y
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAY 149
Query: 124 LHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTP-NYMCPEL 178
LH+ +Y+ HRDL N+ L D+ V++GDFGLAK + +P + PE
Sbjct: 150 LHAQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 179 LADIPYGFKSDIWSLGCCMYEM-----AAHRPAFKAFDMAG----------LISKINRSS 223
L + + + SD+WS G +YE+ ++ P K ++ G L + R
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 224 IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFP 274
P P + L+K RP+ L P L+ ++Y+ P
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENL--IPILKTVHEKYQGQAP 317
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 43/300 (14%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQE 55
D + ++Q+G+G FG + + V K L TE R +E
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFERE 61
Query: 56 MALIARVQHPYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
+ ++ +QH IV++K G + ++ Y G + + ++K + KL ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYT 120
Query: 115 AQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGT-- 170
+Q+ ++YL + Y+ HRDL NI + + V++GDFGL K L D +
Sbjct: 121 SQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 171 P-NYMCPELLADIPYGFKSDIWSLGCCMYEM-----AAHRPAFKAFDMAG---------- 214
P + PE L + + SD+WS G +YE+ + P + M G
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 215 -LISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQYR 270
LI + + P P + + M N RPS +L + D
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMI---MTECWNNNVNQRPSFRDL--ALRVDQIRDNMA 294
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 13/271 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ + EQIGRG FG RA+ +K R + QE ++ + HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHP 172
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV + + IV +GGD ++ GA + L + ++YL
Sbjct: 173 NIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNY----MCPELLAD 181
S +HRDL N +T+ +++ DFG+++ A+S G PE L
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS-GGLRQVPVKWTAPEALNY 289
Query: 182 IPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239
Y +SD+WS G ++E P + + + P P ++ L+
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348
Query: 240 KGMLRKNPEHRPSASELLKHPFLQHFVDQYR 270
+ P RPS S + + LQ ++R
Sbjct: 349 EQCWAYEPGQRPSFSTIYQ--ELQSIRKRHR 377
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 17/275 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ + ++G+G FG V I+ + + QE ++ +++H
Sbjct: 184 ESLRLEVKLGQGCFGE---V-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+ E+ Y IVT Y G + + +K G Y +L AQ+ + Y+
Sbjct: 240 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTP-NYMCPELLADIP 183
+HRDL+ +NI + ++ ++ DFGLA+ ++ ++ A P + PE
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 184 YGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
+ KSD+WS G + E+ P + ++ ++ R P P SL L+
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 416
Query: 242 MLRKNPEHRPSASELLKHPFLQHFVD----QYRPT 272
RK PE RP+ L FL+ + QY+P
Sbjct: 417 CWRKEPEERPTFEYLQA--FLEDYFTSTEPQYQPG 449
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 52/258 (20%), Positives = 111/258 (43%), Gaps = 9/258 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLK-KIRLARQTERCRRSAHQEMALIARVQH 64
+ ++G G +G V + KKY L ++ ++ +E A++ ++H
Sbjct: 220 TDITMKHKLGGGQYGE---V-YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 275
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P +V+ + I+T + G++ + +++ N L Q+ A++YL
Sbjct: 276 PNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNY--MCPELLADI 182
+HR+L N + ++ V++ DFGL++ + D + PE LA
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 183 PYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
+ KSD+W+ G ++E+A + + D++ + + + P + L++
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 454
Query: 242 MLRKNPEHRPSASELLKH 259
+ NP RPS +E+ +
Sbjct: 455 CWQWNPSDRPSFAEIHQA 472
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 37/293 (12%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQ 54
D + +G G FG + V +K ++ +
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKK 72
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
E+ ++ + H IV++K E G + ++ + G + E + K N ++ K+
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKY 131
Query: 114 FAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGT- 170
Q+ +DYL S YV HRDL N+ + + V++GDFGL K ++ D + +
Sbjct: 132 AVQICKGMDYLGSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 171 -P-NYMCPELLADIPYGFKSDIWSLGCCMYEM-----AAHRPAFKAFDMAG--------- 214
P + PE L + SD+WS G ++E+ + P M G
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 215 -LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266
L++ + P P + L++ P +R S L + +
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL--IEGFEALL 301
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 44/306 (14%)
Query: 6 DQYEI-------MEQIGRGAFGA---AILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQ 54
D + Q+G+G FG+ V +K+++ ++ +R +
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQ-QRDFQR 73
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCY-VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
E+ ++ + +IV+++ G + +V Y G + + +++ + A +L +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLY 132
Query: 114 FAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVG 169
+Q+ ++YL S V HRDL NI + + V++ DFGLAK L D +
Sbjct: 133 SSQICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 170 TP-NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-----RPAFKAFDMAG--------- 214
+P + PE L+D + +SD+WS G +YE+ + P+ + M G
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 215 -LISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQYR 270
L+ + P P + L M +P+ RPS S L P L R
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHEL---MKLCWAPSPQDRPSFSAL--GPQLDMLWSGSR 306
Query: 271 PTFPPA 276
A
Sbjct: 307 GCETHA 312
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 57/267 (21%), Positives = 115/267 (43%), Gaps = 22/267 (8%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
+++ ++ +G GAFG + + + K V K + + + E ++A V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+P++ V ++T G + + +++ + + L W Q+ ++
Sbjct: 75 DNPHVCRL-LGICLTST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMN 131
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT--P-NYMCPELL 179
YL ++HRDL N+ + Q V++ DFGLAK L A++ G P +M E +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 180 ADIPYGFKSDIWSLGCCMYEMAA--HRP--AFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
Y +SD+WS G ++E+ +P A +++ ++ K R P P + +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICTIDV 248
Query: 236 KTLIKGMLR---KNPEHRPSASELLKH 259
+ M++ + + RP EL+
Sbjct: 249 YMI---MVKCWMIDADSRPKFRELIIE 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 11/272 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ + ++G+G FG V I+ + + QE ++ +++H
Sbjct: 267 ESLRLEVKLGQGCFGE---V-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+ E+ Y IVT Y G + + +K G Y +L AQ+ + Y+
Sbjct: 323 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTP-NYMCPELLADIP 183
+HRDL+ +NI + ++ ++ DFGLA+ ++ ++ A P + PE
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+ KSD+WS G + E+ R + ++ ++ R P P SL L+
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 500
Query: 243 LRKNPEHRPSASELLKH--PFLQHFVDQYRPT 272
RK PE RP+ L + QY+P
Sbjct: 501 WRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 68/284 (23%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 6 DQYEI-------MEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQE 55
YEI IG G FG I ++ +K + ++ R QE
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQE 441
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
+ + HP+IV+ + + V I+ C G++ ++ L +
Sbjct: 442 ALTMRQFDHPHIVKL-IGVITENP-VWIIMELCTLGELRSFLQV-RKFSLDLASLILYAY 498
Query: 116 QLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG-TP-N 172
QL A+ YL S +V HRD+ N+ ++ + V+LGDFGL++ ++ + G P
Sbjct: 499 QLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSC 230
+M PE + + SD+W G CM+E+ +P F+ +I +I P+P
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPPN 616
Query: 231 YSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQYRP 271
P+L +L M + +P RP +EL L +++ +
Sbjct: 617 CPPTLYSL---MTKCWAYDPSRRPRFTEL--KAQLSTILEEEKL 655
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 27/283 (9%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQE 55
YEI IG G FG I ++ +K + ++ R QE
Sbjct: 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQE 66
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
+ + HP+IV+ + + V I+ C G++ ++ L +
Sbjct: 67 ALTMRQFDHPHIVKL-IGVITENP-VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAY 123
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NY 173
QL A+ YL S +HRD+ N+ ++ + V+LGDFGL++ ++ + G P +
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
M PE + + SD+W G CM+E+ +P F+ +I +I P+P
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPPNC 242
Query: 232 SPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQYRP 271
P+L +L M + +P RP +EL L +++ +
Sbjct: 243 PPTLYSL---MTKCWAYDPSRRPRFTEL--KAQLSTILEEEKA 280
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 20/278 (7%)
Query: 6 DQYEI-------MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL 58
D +EI +++G G FG V A K+ ++ + + E +
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGE---V-WMATYNKHTKVAVKTMKPGSMSVEAFLAEANV 236
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ +QH +V+ ++ Y I+T + G + + +K G+ P KL + AQ+
Sbjct: 237 MKTLQHDKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NYMCP 176
+ ++ +HRDL+ +NI ++ ++ DFGLA+ ++ ++ + P + P
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234
E + + KSD+WS G + E+ + P + +I + R P P
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENCPEE 413
Query: 235 LKTLIKGMLRKNPEHRPSASELLKH--PFLQHFVDQYR 270
L ++ + PE RP+ + F QY
Sbjct: 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 63/324 (19%), Positives = 117/324 (36%), Gaps = 35/324 (10%)
Query: 9 EIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++ +G G FG + + K V K+ + + ++ M I + H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+IV + +VT Y G + + +++ GA + L W Q+ + YL
Sbjct: 76 HIVRL-LGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLE 132
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT--P-NYMCPELLADI 182
+ ++HR+L N+ L V++ DFG+A L DD P +M E +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 183 PYGFKSDIWSLGCCMYEMAA--HRP--AFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
Y +SD+WS G ++E+ P + ++ L+ K R P + + +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL---AQPQICTIDVYMV 249
Query: 239 IKGMLR---KNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMA 295
M++ + RP+ EL A P + + I ES +A
Sbjct: 250 ---MVKCWMIDENIRPTFKEL--ANEFTRM-----------ARDPPRYLVIKRESGPGIA 293
Query: 296 ESQNSSSSASDKDSLRSGDRNISA 319
+ K + +
Sbjct: 294 PGPEPHGLTNKKLEEVELEPELDL 317
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 58/272 (21%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6 DQYEI-------MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ---- 54
D++E+ ++G G +G V + KK + +A +T + +
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGE---V-YEGVWKK---YSLTVAVKTLKEDTMEVEEFLK 58
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
E A++ ++HP +V+ + I+T + G++ + +++ N L
Sbjct: 59 EAAVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-N 172
Q+ A++YL +HRDL N + ++ V++ DFGL++ + D + P
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSC 230
+ PE LA + KSD+W+ G ++E+A P + D++ + + + P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYRMERPEG 236
Query: 231 YSPSLKTLIKGMLR---KNPEHRPSASELLKH 259
+ L M NP RPS +E+ +
Sbjct: 237 CPEKVYEL---MRACWQWNPSDRPSFAEIHQA 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 27/284 (9%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQE 55
QY I +G G FG + NH+ EK +K + T + E
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSE 63
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
++ + HP+IV+ +E+ I+ G++ +++ N L +
Sbjct: 64 AVIMKNLDHPHIVKL-IGIIEEEP-TWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSL 120
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NY 173
Q+ A+ YL S +HRD+ NI + + V+LGDFGL++ ++ +D + V P +
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
M PE + + SD+W CM+E+ +P F + +I + + P P
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVLEKGDRLPKPDLC 239
Query: 232 SPSLKTLIKGMLR---KNPEHRPSASELLKH--PFLQHFVDQYR 270
P L TL M R +P RP +EL+ Q D
Sbjct: 240 PPVLYTL---MTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 56/281 (19%), Positives = 108/281 (38%), Gaps = 33/281 (11%)
Query: 6 DQYEIME--------QIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ 54
+ + ++G G FG+ + R ++ +K ++ + +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLK-QGTEKADTEEMMR 59
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
E ++ ++ +PYIV + + +V GG + + + P + +
Sbjct: 60 EAQIMHQLDNPYIVRL-IGVCQAEA-LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELL 116
Query: 115 AQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGT-- 170
Q+ + + YL N+V HRDL N+ L ++ DFGL+K L ADD ++
Sbjct: 117 HQVSMGMKYLEEKNFV-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 171 P-NYMCPELLADIPYGFKSDIWSLGCCMYEMAA--HRPAFKAFDMAGLISKINRSSIGPL 227
P + PE + + +SD+WS G M+E + +P +K +++ I +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFIEQGKRMEC 234
Query: 228 PSCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHF 265
P P L L M E RP + ++
Sbjct: 235 PPECPPELYAL---MSDCWIYKWEDRPDFLTV--EQRMRAC 270
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 66/298 (22%), Positives = 121/298 (40%), Gaps = 22/298 (7%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQEMALIAR 61
+ IG G FG +L +K+ V +K ++ A TE+ R E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 102
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
H I+ E + K + I+T Y E G + + +++ +G F +L + +
Sbjct: 103 FSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGM 160
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGT--P-NYMCPE 177
YL + +HRDL NI + + ++ DFGL++ L+ D + + G P + PE
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 178 LLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
++ + SD+WS G M+E+ RP + ++ IN P P ++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAINDGFRLPTPMDCPSAI 279
Query: 236 KTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHES 290
L M++ + RP +++ L + A P I + S
Sbjct: 280 YQL---MMQCWQQERARRPKFADI--VSILDKLIRAPDSLKTLADFDPRVSIRLPSTS 332
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 71/270 (26%), Positives = 112/270 (41%), Gaps = 21/270 (7%)
Query: 9 EIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
I + IG G G L +K ++ A TER RR E +++ + HP
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHP 110
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
I+ E V +G IVT Y E G + ++ +G F +L + + YL
Sbjct: 111 NIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLS 168
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGT--P-NYMCPELLAD 181
+HRDL N+ + + ++ DFGL++ L+ D D A + G P + PE +A
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 182 IPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239
+ SD+WS G M+E+ RP + +IS + P P +L L
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSVEEGYRLPAPMGCPHALHQL- 286
Query: 240 KGMLR---KNPEHRPSASELLKHPFLQHFV 266
ML K+ RP S++ L +
Sbjct: 287 --MLDCWHKDRAQRPRFSQI--VSVLDALI 312
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 63/282 (22%), Positives = 115/282 (40%), Gaps = 26/282 (9%)
Query: 6 DQYEI-------MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL 58
D++E+ +E++G G FG V + ++ +Q + E L
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGE---V-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL 61
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ ++QH +V ++ Y I+T Y E G + + +K +G KL AQ+
Sbjct: 62 MKQLQHQRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NYMCP 176
+ ++ +HRDL+ +NI ++ ++ DFGLA+ ++ ++ + P + P
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234
E + + KSD+WS G + E+ P + +I + R P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 235 LKTLIKGML---RKNPEHRPSASELLKH--PFLQHFVDQYRP 271
L L M ++ PE RP+ L F QY+P
Sbjct: 239 LYQL---MRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 31/261 (11%), Positives = 67/261 (25%), Gaps = 54/261 (20%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKK---YV-LKKIRL-----ARQTERCRRSAHQEMAL 58
Y ++ G +A V L + +
Sbjct: 33 YRLLIFHGGVPPLQF----WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL----R 84
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
++R+ P + + V +V + GG + E+ + P + + L
Sbjct: 85 LSRIDKPGVARVLDV-VHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAI-RAMQSLA 139
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
A D H V S + ++ D DV L
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP---------------------- 177
Query: 179 LADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS------CYS 232
+ DI +G +Y + +R + ++ R + G
Sbjct: 178 ----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233
Query: 233 PSLKTLIKGMLRKNPEHRPSA 253
+ + ++ + R ++
Sbjct: 234 FQISAVAARSVQGDGGIRSAS 254
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 58/291 (19%), Positives = 112/291 (38%), Gaps = 26/291 (8%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
Q+ + +G+G FG A L K +K ++ +E A +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 63 QHPYIVE-----FKEAWVEKGCYVCIVTGYCEGGDMAELMKKS----NGAYFPEEKLCKW 113
HP++ + + + ++ + + GD+ + S N P + L ++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT--P 171
+ ++YL S +HRDL N L +D V + DFGL++ + + D + P
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 172 -NYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLP 228
++ E LAD Y SD+W+ G M+E+ P + + A + + + + P
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYLIGGNRLKQP 261
Query: 229 SCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQYRPTFPPA 276
+ L M + +P+ RPS + L L++ +
Sbjct: 262 PECMEEVYDL---MYQCWSADPKQRPSFTCLRME--LENILGHLSVLSTSQ 307
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 55/265 (20%), Positives = 107/265 (40%), Gaps = 25/265 (9%)
Query: 9 EIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSA-HQEMALIARVQH 64
++E++G G+FG + +K ++ ++ +E+ + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
++ V + +VT G + + ++K + +F L ++ Q+ + YL
Sbjct: 81 RNLIRL-YGVVLTPP-MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTP-NYMCPELLA 180
S +HRDL N+ L V++GDFGL + L +D + P + PE L
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 181 DIPYGFKSDIWSLGCCMYEMAA--HRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSL 235
+ SD W G ++EM P + + + ++ KI++ G P P +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDKE--GERLPRPEDCPQDI 254
Query: 236 KTLIKGMLR---KNPEHRPSASELL 257
+ M++ PE RP+ L
Sbjct: 255 YNV---MVQCWAHKPEDRPTFVALR 276
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 58/271 (21%), Positives = 99/271 (36%), Gaps = 19/271 (7%)
Query: 2 ESRMDQYEIMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL 58
E IGRG FG L+++ +K +K + E +
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGII 79
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ HP ++ + +V Y + GD+ ++ + L + Q+
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVA 138
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN-----Y 173
+ YL S +HRDL N L + V++ DFGLA+ + + S T +
Sbjct: 139 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
M E L + KSD+WS G ++E+ P + + + + + P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLLQPEYC 257
Query: 232 SPSLKTLIKGMLR---KNPEHRPSASELLKH 259
L + ML+ E RPS SEL+
Sbjct: 258 PDPLYEV---MLKCWHPKAEMRPSFSELVSR 285
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 54/284 (19%), Positives = 115/284 (40%), Gaps = 31/284 (10%)
Query: 2 ESRMDQYEI--------MEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRR 50
E R + + +++G G FG + K V K ++ +
Sbjct: 5 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAV-KILKNEANDPALKD 63
Query: 51 SAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKL 110
E ++ ++ +PYIV E +V E G + + +++ + ++ +
Sbjct: 64 ELLAEANVMQQLDNPYIVRM-IGICEAES-WMLVMEMAELGPLNKYLQQ--NRHVKDKNI 119
Query: 111 CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVG 169
+ Q+ + + YL + +HRDL N+ L ++ DFGL+K L+AD + +
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 170 T--P-NYMCPELLADIPYGFKSDIWSLGCCMYEMAAH--RPAFKAFDMAGLISKINRSSI 224
P + PE + + KSD+WS G M+E ++ +P ++ + + + + +
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGER 238
Query: 225 GPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHF 265
P+ + L M + E+RP + + L+++
Sbjct: 239 MGCPAGCPREMYDL---MNLCWTYDVENRPGFAAV--ELRLRNY 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 59/272 (21%), Positives = 121/272 (44%), Gaps = 19/272 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++ +++++G G FG V + K +++ ++ QE + ++ HP
Sbjct: 8 EEITLLKELGSGQFGV---V-KLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+F K + IVT Y G + ++ S+G +L + + + +L
Sbjct: 64 KLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NYMCPELLADIP 183
S+ +HRDL N + +D V++ DFG+ + + D SSV P + PE+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 184 YGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
Y KSD+W+ G M+E+ P + + + ++ K+++ P S ++ +
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI--- 237
Query: 242 MLR---KNPEHRPSASELLKHPFLQHFVDQYR 270
M + PE RP+ +LL ++ ++ +
Sbjct: 238 MYSCWHELPEKRPTFQQLLS--SIEPLREKDK 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 60/268 (22%), Positives = 110/268 (41%), Gaps = 19/268 (7%)
Query: 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
+++IG G FG V H I+ R+ +E ++ ++ HP +V
Sbjct: 11 TFVQEIGSGQFGL---V-HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
+ + +C+VT + E G +++ ++ F E L + + YL
Sbjct: 67 QL-YGVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-NYMCPELLADIPYGF 186
V+HRDL N + ++Q +++ DFG+ + + D SS P + PE+ + Y
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 187 KSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244
KSD+WS G M+E+ P ++ + ++ I+ P S + + M
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDISTGFRLYKPRLASTHVYQI---MNH 240
Query: 245 ---KNPEHRPSASELLKHPFLQHFVDQY 269
+ PE RP+ S L L +
Sbjct: 241 CWRERPEDRPAFSRL--LRQLAEIAESG 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 23/288 (7%)
Query: 10 IMEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
I + +G G FG + L ++ +K ++ TE+ RR E +++ + HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
I+ E V K V IVT Y E G + ++K + F +L + + YL
Sbjct: 108 IIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSD 165
Query: 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGT--P-NYMCPELLADI 182
+HRDL NI + + ++ DFGL + L+ D + A + G P + PE +A
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 183 PYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
+ SD+WS G ++E+ RP + +I ++ P P +L L
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL-- 282
Query: 241 GMLR---KNPEHRPSASELLKHPFLQHFV--DQYRPTFPPAACSPEKP 283
ML K+ +RP ++ L + AA P
Sbjct: 283 -MLDCWQKDRNNRPKFEQI--VSILDKLIRNPGSLKIITSAAARPSNL 327
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 59/286 (20%), Positives = 102/286 (35%), Gaps = 26/286 (9%)
Query: 2 ESRMDQYEIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL 58
E IGRG FG L+++ +K +K + E +
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGII 143
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ HP ++ + +V Y + GD+ ++ + L + Q+
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVA 202
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN-----Y 173
+ +L S +HRDL N L + V++ DFGLA+ + + S T +
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCY 231
M E L + KSD+WS G ++E+ P + + + + + P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLLQPEYC 321
Query: 232 SPSLKTLIKGMLR---KNPEHRPSASEL-------LKHPFLQHFVD 267
L + ML+ E RPS SEL +H+V
Sbjct: 322 PDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 364
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 5e-20
Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 25/266 (9%)
Query: 13 QIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE 69
++G G FG+ + + + + K ++ + +E ++ ++ +PYIV
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAI-KVLK-QGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 70 FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NY 128
+ + +V GG + + + P + + Q+ + + YL N+
Sbjct: 401 L-IGVCQAEA-LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-SSVVGT--P-NYMCPELLADIPY 184
V HR+L N+ L ++ DFGL+K L ADD ++ P + PE + +
Sbjct: 458 V-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 185 GFKSDIWSLGCCMYEMAA--HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+SD+WS G M+E + +P +K +++ I + P P L L M
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFIEQGKRMECPPECPPELYAL---M 572
Query: 243 LR---KNPEHRPSASELLKHPFLQHF 265
E RP + ++
Sbjct: 573 SDCWIYKWEDRPDFLTV--EQRMRAC 596
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 62/287 (21%), Positives = 108/287 (37%), Gaps = 34/287 (11%)
Query: 1 MESRMDQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYVLKKIRLARQTERCRR 50
++++++ I + +G G FG L K +K ++L ++R
Sbjct: 22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81
Query: 51 SAHQEMALIARVQHPYIVEF------KEAWVEKGCYVCIVTGYCEGGDMAELMKKS---- 100
E A + HP ++ + ++ + + GD+ + S
Sbjct: 82 EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM--VILPFMKYGDLHTYLLYSRLET 139
Query: 101 NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160
+ P + L K+ + L ++YL + LHRDL N L D V + DFGL+K + +
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199
Query: 161 DDLASSVVGT--P-NYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGL 215
D P ++ E LAD Y KSD+W+ G M+E+A P + +
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-YPGVQNHEM 258
Query: 216 ISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLKH 259
+ P L + M R +P RP+ S L
Sbjct: 259 YDYLLHGHRLKQPEDCLDELYEI---MYSCWRTDPLDRPTFSVLRLQ 302
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 34/281 (12%)
Query: 6 DQYEI-------MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ---- 54
+EI ++++G G FG V + + + +A + + +
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGV---V-KYGKWR----GQYDVAIKMIKEGSMSEDEFIE 68
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWF 114
E ++ + H +V+ K + I+T Y G + + + F ++L +
Sbjct: 69 EAKVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMC 126
Query: 115 AQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT-P-N 172
+ A++YL S LHRDL N + V++ DFGL++ + D+ SSV P
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSC 230
+ PE+L + KSDIW+ G M+E+ P ++ F + I + P
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHIAQGLRLYRPHL 245
Query: 231 YSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVDQ 268
S + T+ M + + RP+ L + +D+
Sbjct: 246 ASEKVYTI---MYSCWHEKADERPTFKIL--LSNILDVMDE 281
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 54/288 (18%), Positives = 108/288 (37%), Gaps = 53/288 (18%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRRSAHQEMA 57
++ + ++G+G+FG + ++ + + + + R R E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEAS 80
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM--------AELMKKSNGAYFPEEK 109
++ ++V V +G ++ GD+ + A K
Sbjct: 81 VMKEFNCHHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 110 LCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG 169
+ + ++ + YL++N +HRDL N + +D V++GDFG+ + + D
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------- 192
Query: 170 TPNY-------------MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAG 214
Y M PE L D + SD+WS G ++E+A A +P ++
Sbjct: 193 ---YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQ 248
Query: 215 LISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKH 259
++ + + P L L M NP+ RPS E++
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFEL---MRMCWQYNPKMRPSFLEIISS 293
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 59/283 (20%), Positives = 119/283 (42%), Gaps = 40/283 (14%)
Query: 2 ESRMDQYEI-------MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH- 53
E + + ++ IG+G FG V + ++A + + A
Sbjct: 182 EFYRSGWALNMKELKLLQTIGKGEFGD---V-MLG-----DYRGNKVAVKC--IKNDATA 230
Query: 54 ----QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEK 109
E +++ +++H +V+ VE+ + IVT Y G + + ++ + +
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 290
Query: 110 LCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG 169
L K+ + A++YL N +HRDL N+ +++D ++ DFGL K + +S+
Sbjct: 291 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT 345
Query: 170 T--P-NYMCPELLADIPYGFKSDIWSLGCCMYEMAAHR----PAFKAFDMAGLISKINRS 222
P + PE L + + KSD+WS G ++E+ + P D+ + K +
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 405
Query: 223 SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265
P P++ ++K + RP+ +L + L+H
Sbjct: 406 ---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE--QLEHI 443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 53/284 (18%), Positives = 102/284 (35%), Gaps = 42/284 (14%)
Query: 9 EIMEQIGRGAFG------AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
E +G+G F + ++ + VL K+ L + S + ++++++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-LDKAHRNYSESFFEAASMMSKL 69
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
H ++V G +V + + G + +KK N + QL A+
Sbjct: 70 SHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMH 127
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQD--------VRLGDFGLAKTLKADDLASSVVGTPNY- 173
+L N ++H ++ NI L +++D ++L D G++ T+ D
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------IL 177
Query: 174 ------MCPELLAD-IPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSI 224
+ PE + + +D WS G ++E+ +P A D +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFYEDRHQ 236
Query: 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268
P P L LI + P+HRPS + L
Sbjct: 237 LPAPKA--AELANLINNCMDYEPDHRPSFRAI--IRDLNSLFTP 276
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 54/274 (19%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 6 DQYEI-------MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAH----- 53
+ + ++ IG+G FG + + ++A + + A
Sbjct: 14 SGWALNMKELKLLQTIGKGEFG---------DVMLGDYRGNKVAVKC--IKNDATAQAFL 62
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW 113
E +++ +++H +V+ VE+ + IVT Y G + + ++ + + L K+
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 114 FAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGT--P 171
+ A++YL N +HRDL N+ +++D ++ DFGL K + +S+ P
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 177
Query: 172 -NYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLP 228
+ PE L + + KSD+WS G ++E+ P + + ++ ++ + P
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVEKGYKMDAP 236
Query: 229 SCYSPSLKTLIKGML---RKNPEHRPSASELLKH 259
P++ + M + RPS +L +
Sbjct: 237 DGCPPAVYEV---MKNCWHLDAAMRPSFLQLREQ 267
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 63/292 (21%), Positives = 111/292 (38%), Gaps = 41/292 (14%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRRSAHQEMA 57
ME++G FG L ++ LK + R E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD----KAEGPLREEFRHEAM 64
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQ 116
L AR+QHP +V V K + ++ YC GD+ E L+ +S + +
Sbjct: 65 LRARLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 117 LLLAVD-------------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163
L D YL S++V+H+DL N+ + +V++ D GL + + A D
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 164 ASSVVGTP---NYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISK 218
+ + +M PE + + SDIWS G ++E+ +P + + ++
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQDVVEM 242
Query: 219 INRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLKHPFLQHFVD 267
I + P P + L M+ + P RP ++ H L+ + +
Sbjct: 243 IRNRQVLPCPDDCPAWVYAL---MIECWNEFPSRRPRFKDI--HSRLRAWGN 289
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 36/289 (12%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV--LKKIRLARQTERCRRSAHQEMALIA 60
+ ++G GAFG A N K K + +K ++ T R+ +E L+
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLT 72
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLL 119
+QH +IV+F G + +V Y + GD+ + L A + + L
Sbjct: 73 NLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 120 AVD-------------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS 166
YL S + +HRDL N + + V++GDFG+++ + + D
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 167 VVGTP---NYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINR 221
T +M PE + + +SD+WS G ++E+ +P + +I I +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-WFQLSNTEVIECITQ 250
Query: 222 SSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLKHPFLQHFVD 267
+ P + + ML ++ P+ R + E+ + L
Sbjct: 251 GRVLERPRVCPKEVYDV---MLGCWQREPQQRLNIKEI--YKILHALGK 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 65/298 (21%), Positives = 110/298 (36%), Gaps = 55/298 (18%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV--LKKIRLARQTERCRRSAHQEMALIA 60
+ ++G GAFG A N E+ K + +K ++ A +E R+ +E L+
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 98
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLLL 119
+QH +IV F +G + +V Y GD+ L A L L
Sbjct: 99 MLQHQHIVRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 120 ------AVD------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV 167
A YL + +HRDL N + + V++GDFG+++ + + D
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----- 212
Query: 168 VGTPNY-------------MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDM 212
Y M PE + + +SD+WS G ++E+ +P +
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQLSN 266
Query: 213 AGLISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVD 267
I I + P P + + M + P+ R S ++ H LQ
Sbjct: 267 TEAIDCITQGRELERPRACPPEVYAI---MRGCWQREPQQRHSIKDV--HARLQALAQ 319
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 52/264 (19%), Positives = 100/264 (37%), Gaps = 19/264 (7%)
Query: 9 EIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
IG+G FG ++ + + +K + + + +E L+ + HP
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHP 82
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
++ + ++ Y GD+ + ++ S + L + Q+ ++YL
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPN-----YMCPELLA 180
+HRDL N L + V++ DFGLA+ + + S + E L
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 181 DIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238
+ KSD+WS G ++E+ P ++ D L + + P P SL +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV 260
Query: 239 IKGMLR---KNPEHRPSASELLKH 259
M + +P RP+ L+
Sbjct: 261 ---MQQCWEADPAVRPTFRVLVGE 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 56/313 (17%), Positives = 105/313 (33%), Gaps = 61/313 (19%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKY-----VLKKIRLARQTERCRRSAHQEMA 57
++ +G GAFG + + L + +E+ E
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEAL 85
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+I++ H IV + I+ GGD+ ++++ L L
Sbjct: 86 IISKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA--MLDL 142
Query: 118 L-LAVD------YLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLKADDLASSV 167
L +A D YL N+ +HRD+ N LT ++GDFG+A+ +
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----- 197
Query: 168 VGTPNY-------------MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDM 212
Y M PE + + K+D WS G ++E+ + P + +
Sbjct: 198 -----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSN 251
Query: 213 AGLISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKHPFLQHFVD-- 267
++ + P + + M + PE RP+ + +L+ +++
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILER--IEYCTQDP 306
Query: 268 QYRPTFPPAACSP 280
T P P
Sbjct: 307 DVINTALPIEYGP 319
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 53/290 (18%), Positives = 99/290 (34%), Gaps = 57/290 (19%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKY-----VLKKIRLARQTERCRRSAHQEMA 57
++ +G GAFG + + L + +E+ E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEAL 126
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+I++ H IV + I+ GGD+ ++++ L L
Sbjct: 127 IISKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA--MLDL 183
Query: 118 L-LAVD------YLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLKADDLASSV 167
L +A D YL N+ +HRD+ N LT ++GDFG+A+ +
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 238
Query: 168 VGTPNY-------------MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDM 212
Y M PE + + K+D WS G ++E+ + P + +
Sbjct: 239 -----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSN 292
Query: 213 AGLISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLKH 259
++ + P + + M + PE RP+ + +L+
Sbjct: 293 QEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILER 339
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 46/178 (25%)
Query: 54 QEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC-EGGDMA---ELMKKSNG----AYF 105
QE+ ++A+ QH +VE + G+ +G D+ M NG
Sbjct: 79 QEIKVMAKCQHENLVE--------------LLGFSSDGDDLCLVYVYM--PNGSLLDRLS 122
Query: 106 PEEKLCK--WFAQLLLAVD------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157
+ W + +A +LH N+ +HRD+K +NI L + ++ DFGLA+
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 158 LKADD---LASSVVGTPNYMCPE-----LLADIPYGFKSDIWSLGCCMYEMAAHRPAF 207
+ + S +VGT YM PE + KSDI+S G + E+ PA
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEALRGEITP------KSDIYSFGVVLLEIITGLPAV 234
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 60/308 (19%), Positives = 107/308 (34%), Gaps = 61/308 (19%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYVLK---KIRLARQTERCRRSA 52
++E + +G G FG A V +K K + K+ TE+
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 133
Query: 53 HQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKL 110
EM ++ + +H I+ + + ++ Y G++ E L + +
Sbjct: 134 VSEMEMMKMIGKHKNIINLL-GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 111 CKWFAQLLLAVD-------------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157
+ + + D YL S +HRDL N+ +T++ +++ DFGLA+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 158 LKADDLASSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA--AH 203
+ D Y M PE L D Y +SD+WS G M+E+
Sbjct: 253 INNID---------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 204 RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLKHP 260
P + + L + P+ + L + M P RP+ +L
Sbjct: 304 SP-YPGIPVEELFKLLKEGHRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQL--VE 357
Query: 261 FLQHFVDQ 268
L +
Sbjct: 358 DLDRILTL 365
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-16
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 44/176 (25%)
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYC-EGGDMA---ELMKKSN------GAY 104
E+ ++ +HP++V G+C E +M + M+ N G+
Sbjct: 85 EIETLSFCRHPHLVSL--------------IGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 105 FPEEKLCKWFAQLLLAVD------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158
P + W +L + + YLH+ ++HRD+K NI L ++ ++ DFG++K
Sbjct: 131 LPTMSM-SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 159 KADD---LASSVVGTPNYMCPE-----LLADIPYGFKSDIWSLGCCMYEMAAHRPA 206
D L++ V GT Y+ PE L + KSD++S G ++E+ R A
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-----KSDVYSFGVVLFEVLCARSA 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 64/310 (20%), Positives = 109/310 (35%), Gaps = 67/310 (21%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRRSAHQEMA 57
+ E + IG GAFG A + + LK+ + + +E A
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAA 102
Query: 58 LIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKW---- 113
L+A +P IV+ G +C++ Y GD+ E ++ +
Sbjct: 103 LMAEFDNPNIVKL-LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 114 -----------FAQLL-LAVD------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155
A+ L +A YL +HRDL N + ++ V++ DFGL+
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 156 KTLKADDLASSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA-- 201
+ + + D Y M PE + Y +SD+W+ G ++E+
Sbjct: 222 RNIYSAD---------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 202 AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR---KNPEHRPSASELLK 258
+P + +I + +I P L L M K P RPS +
Sbjct: 273 GLQP-YYGMAHEEVIYYVRDGNILACPENCPLELYNL---MRLCWSKLPADRPSFCSI-- 326
Query: 259 HPFLQHFVDQ 268
H LQ ++
Sbjct: 327 HRILQRMCER 336
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 60/292 (20%), Positives = 108/292 (36%), Gaps = 52/292 (17%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYVLK---KIRLARQTERCRRSAHQEMALI 59
D+ + + +G GAFG A V +K K + K+ TE+ EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 60 ARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQL 117
+ +H I+ + + ++ Y G++ E L + + + +
Sbjct: 95 KMIGKHKNIINLL-GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 118 LLAVD-------------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164
+ D YL S +HRDL N+ +T++ +++ DFGLA+ + D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-- 211
Query: 165 SSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAF 210
Y M PE L D Y +SD+WS G M+E+ P +
Sbjct: 212 -------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGI 263
Query: 211 DMAGLISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLKH 259
+ L + P+ + L + M P RP+ +L++
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQLVED 312
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 55/319 (17%), Positives = 113/319 (35%), Gaps = 74/319 (23%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRR 50
++E + +G G FG A + + LK+ + R
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----ASPSELR 71
Query: 51 SAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM----------------- 93
E ++ +V HP++++ + + ++ Y + G +
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLY-GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 94 -----AELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVR 148
+ + + L + Q+ + YL ++HRDL NI + + + ++
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK 190
Query: 149 LGDFGLAKTLKADDLASSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCC 196
+ DFGL++ + +D +Y M E L D Y +SD+WS G
Sbjct: 191 ISDFGLSRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 197 MYEMA--AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRP 251
++E+ P + L + + P S + L ML ++ P+ RP
Sbjct: 242 LWEIVTLGGNP-YPGIPPERLFNLLKTGHRMERPDNCSEEMYRL---MLQCWKQEPDKRP 297
Query: 252 SASELLKHPFLQHFVDQYR 270
+++ K L+ + + R
Sbjct: 298 VFADISKD--LEKMMVKRR 314
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 63/301 (20%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRR 50
++E + +GRGAFG A LK+ T R
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHR 75
Query: 51 SAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEK 109
+ E+ ++ + H +V A + G + ++ +C+ G+++ ++ + P +
Sbjct: 76 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 110 LCKWFAQLLL--------AVD------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155
+ + L + +L S +HRDL NI L++ V++ DFGLA
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 156 KTLKADDLASSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA-- 201
+ + D +Y M PE + D Y +SD+WS G ++E+
Sbjct: 196 RDIYKDP---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 202 AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLK 258
P ++ + P +P + ML P RP+ SEL++
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVE 303
Query: 259 H 259
H
Sbjct: 304 H 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 62/321 (19%), Positives = 113/321 (35%), Gaps = 69/321 (21%)
Query: 6 DQYEI-------MEQIGRGAFG------AAILVNHRAEKKKYV----LKKIRLARQTERC 48
++E+ + +G GAFG A L + + V LK TE+
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKD 117
Query: 49 RRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKS------- 100
EM ++ + +H I+ + + ++ Y G++ E ++
Sbjct: 118 LSDLISEMEMMKMIGKHKNIINLL-GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 101 -------NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153
+ L Q+ ++YL S +HRDL N+ +T+D +++ DFG
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236
Query: 154 LAKTLKADDLASSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA 201
LA+ + D Y M PE L D Y +SD+WS G ++E+
Sbjct: 237 LARDIHHID---------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
Query: 202 --AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASEL 256
P + + L + PS + L + M P RP+ +L
Sbjct: 288 TLGGSP-YPGVPVEELFKLLKEGHRMDKPSNCTNELYMM---MRDCWHAVPSQRPTFKQL 343
Query: 257 LKH--PFLQHFVDQYRPTFPP 275
++ + +Q +
Sbjct: 344 VEDLDRIVALTSNQEMGYYHH 364
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 60/312 (19%), Positives = 107/312 (34%), Gaps = 68/312 (21%)
Query: 6 DQYEI-------MEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRR 50
++E + +G GAFG A LK R
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTERE 71
Query: 51 SAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM---------------- 93
+ E+ +++ + H IV G ++T YC GD+
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLL-GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 94 AELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153
+ + + + E L + Q+ + +L S +HRDL NI LT + ++ DFG
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 154 LAKTLKADDLASSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA 201
LA+ +K D NY M PE + + Y F+SD+WS G ++E+
Sbjct: 191 LARDIKNDS---------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 202 --AHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASEL 256
P + I P + + M +P RP+ ++
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI---MKTCWDADPLKRPTFKQI 298
Query: 257 LKHPFLQHFVDQ 268
++ ++ + +
Sbjct: 299 VQL--IEKQISE 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 61/303 (20%), Positives = 106/303 (34%), Gaps = 57/303 (18%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRRSAHQEMA 57
+ + + +G GAFG A E LK + + E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS----TAHADEKEALMSELK 101
Query: 58 LIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM------------AELMKKSNGAY 104
+++ + QH IV G V ++T YC GD+ + +
Sbjct: 102 IMSHLGQHENIVNLL-GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 105 FPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164
L + +Q+ + +L S +HRD+ N+ LT ++GDFGLA+ + D
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-- 218
Query: 165 SSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAF 210
NY M PE + D Y +SD+WS G ++E+ P
Sbjct: 219 -------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271
Query: 211 DMAGLISKINRSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLKHPFLQHFVD 267
+ + P+ ++ ++ M P HRP+ ++ LQ
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSI---MQACWALEPTHRPTFQQICSF--LQEQAQ 326
Query: 268 QYR 270
+ R
Sbjct: 327 EDR 329
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 57/282 (20%), Positives = 102/282 (36%), Gaps = 40/282 (14%)
Query: 6 DQYEIMEQIGRGAFGA---AILVNHRAEKKKYV--LKKIRLARQTERCRRSAHQEMALIA 60
+ + + IG G FG A + + +K+ ++ R E+ ++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLC 80
Query: 61 RV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAE-LMKKSNGAYFPEEKLCKWFAQLL 118
++ HP I+ E Y+ + Y G++ + L K P + A L
Sbjct: 81 KLGHHPNIINL-LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 119 LAVD-------------YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165
+ YL +HRDL NI + ++ ++ DFGL++ ++
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYV 196
Query: 166 SVVGT--P-NYMCPELLADIPYGFKSDIWSLGCCMYEMA--AHRPAFKAFDMAGLISKIN 220
P +M E L Y SD+WS G ++E+ P + A L K+
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLP 255
Query: 221 RSSIGPLPSCYSPSLKTLIKGML---RKNPEHRPSASELLKH 259
+ P + L M R+ P RPS +++L
Sbjct: 256 QGYRLEKPLNCDDEVYDL---MRQCWREKPYERPSFAQILVS 294
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 3e-13
Identities = 40/332 (12%), Positives = 80/332 (24%), Gaps = 92/332 (27%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT------ERCRRSAHQEMAL- 58
++ + E+IG G FG A+ +K I + ++ E+ +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 59 --------IARVQHPYIVEFKEAWVEKGCY-----------------------------V 81
+ + +G Y +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY-VLHRDLKCSNIF 140
IV + GG +++ QL ++ ++ HRDL N+
Sbjct: 138 FIVLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 141 LTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEM 200
L K +L K+ + + I Y ++
Sbjct: 195 LKKTSLKKLHYTLNGKSST--------IPSCGLQVSI----IDYTLSRLERDGIVVFCDV 242
Query: 201 AAHRPAF--------KAFDMAGLISKINRSSIGPLPSCY--SPSLKTLIKGMLRKNPEHR 250
+ F + + + P + ++K M K +
Sbjct: 243 SMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT 302
Query: 251 P--------------------SASELLKHPFL 262
P SA++LL L
Sbjct: 303 PAMKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 44/217 (20%), Positives = 79/217 (36%), Gaps = 27/217 (12%)
Query: 7 QYEIMEQIGRGAFG--------AAILVNHRAEKKKYVLK----KIRLARQTERCRRSAHQ 54
Q+++ R G + + + +K+K+ LK RL + +R+A
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 55 EMAL----IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKL 110
+ I V + Y +V G + + S E +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 111 CKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL-TKDQD-VRLGDFGLAKTLK--------A 160
+ +LL A+++LH N +H ++ NIF+ +DQ V L +G A
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCM 197
+ S G ++ +L +SD+ SLG CM
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 50/238 (21%), Positives = 86/238 (36%), Gaps = 56/238 (23%)
Query: 6 DQYEIMEQIGRGAFG---AAILVNHRAEKKKYV-----LKKIRLARQTERCRRSAHQEMA 57
+ E + +G GAFG A LK+ R + E+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELK 100
Query: 58 LIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM---------------------AE 95
++ ++ H IV + ++ YC GD+
Sbjct: 101 MMTQLGSHENIVNLL-GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 96 LMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155
L ++ + E L + Q+ +++L +HRDL N+ +T + V++ DFGLA
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 156 KTLKADDLASSVVGTPNY------------MCPELLADIPYGFKSDIWSLGCCMYEMA 201
+ + +D NY M PE L + Y KSD+WS G ++E+
Sbjct: 220 RDIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 3/126 (2%)
Query: 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSN 138
+ + E + + E L + Q+ +++L S +HRDL N
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 223
Query: 139 IFLTKDQDVRLGDFGLAKTLKADD--LASSVVGTP-NYMCPELLADIPYGFKSDIWSLGC 195
I L++ V++ DFGLA+ + D + P +M PE + D Y +SD+WS G
Sbjct: 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283
Query: 196 CMYEMA 201
++E+
Sbjct: 284 LLWEIF 289
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 38/222 (17%), Positives = 78/222 (35%), Gaps = 37/222 (16%)
Query: 7 QYEIMEQIGRGAFG----AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
+++ IG+G FG A + + + K+ + E+ R
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-----GPLFTELKFYQRA 90
Query: 63 QHPYIVEFKEAWVEKG------CYVCIVTGYCE-----------GGDMAELMKKSNGAYF 105
P ++ + + + G D+ ++ + + F
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR-F 149
Query: 106 PEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL-TKDQD-VRLGDFGLAKTLKAD-- 161
+ + + ++L ++Y+H + +H D+K SN+ L K+ D V L D+GLA +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 162 ------DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCM 197
D GT + + + + D+ LG CM
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 31/217 (14%)
Query: 1 MESRM-DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ---EM 56
ME R+ ++Y + +IG G+FG L A ++ A + E + Q E
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEV-------AIKLECVKTKHPQLHIES 55
Query: 57 ALIARVQH-PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
+ +Q I + E V ++ G + +L + F + +
Sbjct: 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVME--LLGPSLEDLFNFCSRK-FSLKTVLLLAD 112
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLKADDLAS------- 165
Q++ ++Y+HS +HRD+K N + + V + DFGLAK + D +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR--DARTHQHIPYR 170
Query: 166 ---SVVGTPNYMCPELLADIPYGFKSDIWSLG-CCMY 198
++ GT Y I + D+ SLG MY
Sbjct: 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 42/187 (22%), Positives = 77/187 (41%), Gaps = 53/187 (28%)
Query: 55 EMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMA----ELMKKSNG-------A 103
E+ +I+ H ++ + G+C M +NG
Sbjct: 77 EVEMISMAVHRNLLR--------------LRGFCMTPTERLLVYPYM--ANGSVASCLRE 120
Query: 104 YFPEEKLCKWFAQLLLAVD------YLH--SN-YVLHRDLKCSNIFLTKDQDVRLGDFGL 154
+ W + +A+ YLH + ++HRD+K +NI L ++ + +GDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 155 AKTLKADD--LASSVVGTPNYMCPELLADIPYG------FKSDIWSLGCCMYEMAAHRPA 206
AK + D + ++V GT ++ PE Y K+D++ G + E+ +
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPE------YLSTGKSSEKTDVFGYGVMLLELITGQ-- 232
Query: 207 FKAFDMA 213
+AFD+A
Sbjct: 233 -RAFDLA 238
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 43/218 (19%), Positives = 84/218 (38%), Gaps = 32/218 (14%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
Q+ + ++IG G FG L + +K +++ Q E+ RV
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE---NGPLFSELKFYQRVAKKD 94
Query: 67 IVEFKEAWVEKG------CYVCIVTGYCE-----------GGDMAELMKKSNGAYFPEEK 109
++ + Y +T + G D+ ++ + NG F +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGT-FKKST 152
Query: 110 LCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL-TKDQD-VRLGDFGLAKTLKAD------ 161
+ + ++L ++Y+H N +H D+K +N+ L K+ D V L D+GL+ +
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 162 --DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCM 197
+ GT + + + +SD+ LG CM
Sbjct: 213 QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM 250
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 34/214 (15%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ---EMALIARV 62
Y++ +IG G+FG + ++ A + E R A Q E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQV-------AIKFEPRRSDAPQLRDEYRTYKLL 62
Query: 63 QH-PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
I E V ++ G + +L+ F + + Q+L V
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVID--LLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARV 119
Query: 122 DYLHSNYVLHRDLKCSNIFL-----TKDQD-VRLGDFGLAKTLKADDLAS---------- 165
+H +++RD+K N FL +K+ + + + DFG+ K D +
Sbjct: 120 QSIHEKSLVYRDIKPDN-FLIGRPNSKNANMIYVVDFGMVK--FYRDPVTKQHIPYREKK 176
Query: 166 SVVGTPNYMCPELLADIPYGFKSDIWSLG-CCMY 198
++ GT YM + D+ +LG MY
Sbjct: 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 39/208 (18%), Positives = 73/208 (35%), Gaps = 24/208 (11%)
Query: 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY 66
+ + ++IG G FG L + + +K L R + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 67 IVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS 126
I + ++ G + +L + F + + QL+ ++Y+HS
Sbjct: 67 IPQVYYFGPCGKYNAMVLE--LLGPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVHS 123
Query: 127 NYVLHRDLKCSNIFL-----TKDQDVRLGDFGLAKTLKADDLAS----------SVVGTP 171
+++RD+K N + Q + + DF LAK + D + S+ GT
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--EYIDPETKKHIPYREHKSLTGTA 181
Query: 172 NYMCPELLADIPYGFKSDIWSLG-CCMY 198
YM + D+ +LG MY
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMY 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 26/210 (12%)
Query: 1 MESRM-DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQ---EM 56
ME R+ +++ + +IG G+FG L + ++ A + E + Q E
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV-------AIKLENVKTKHPQLLYES 53
Query: 57 ALIARVQ-HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
+ +Q I + VE V ++ G + +L + + +
Sbjct: 54 KIYRILQGGTGIPNVRWFGVEGDYNVLVMD--LLGPSLEDLFNFCSRK-LSLKTVLMLAD 110
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLKADDLAS------- 165
Q++ V+++HS LHRD+K N + + V + DFGLAK +
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 166 -SVVGTPNYMCPELLADIPYGFKSDIWSLG 194
++ GT Y I + D+ SLG
Sbjct: 171 KNLTGTARYASVNTHLGIEQSRRDDLESLG 200
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 5e-08
Identities = 52/441 (11%), Positives = 113/441 (25%), Gaps = 152/441 (34%)
Query: 1 MESRMDQ-YE-IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER------CRRSA 52
+E + Y+ +M I + Y+ ++ RL + R
Sbjct: 83 VEEVLRINYKFLMSPI------KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 53 HQEM--ALIARVQHPYIV--------------------------EFKEAWVEKGC----- 79
+ ++ AL+ ++ +FK W+
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 80 ---------YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
I + D + +K + +LL + Y + VL
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 131 ----------HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
+L C + T+ + V D L+++ L
Sbjct: 251 LNVQNAKAWNAFNLSCKILLTTRFKQV------------TDFLSAATT------THISLD 292
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS--C-YSPSLKT 237
D ++ L+ K LP +P +
Sbjct: 293 HHSMTLTPD---------------------EVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 238 LIKGMLRKNPEH----RPSASELLKHPFLQHFVDQYRPT-----------FPPAACSPEK 282
+I +R + + L ++ ++ P FPP+A P
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTT-IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI 390
Query: 283 -------------PISIAHE-SRRCMAESQNSSSSAS------DKDSLRSGDRNISATVL 322
+ + ++ + + E Q S+ S + + + +++
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV 450
Query: 323 NSEN--KATDTDLISIDDEDG 341
+ N K D+D + D
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 5e-07
Identities = 69/464 (14%), Positives = 126/464 (27%), Gaps = 122/464 (26%)
Query: 691 SEEFLSCNDDIPSSRPS-IDDTTLSCPYTNDDKPLNRPSTRDDIPSIMLSMRVDAPLLRP 749
E D + + +D+ C D + SI+ +D ++
Sbjct: 12 GEHQYQYKDILSVFEDAFVDN--FDCKDVQD-------MPK----SILSKEEIDHIIMSK 58
Query: 750 DTKD------DAPLSQPS--------TKDDAHLSWPSTKDDTRLSQLSTKDDTTLCC--P 793
D LS+ + + + T Q S +
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 794 ATKDDTPLSRPSTKDNTYSERPSAKDDTSLN--RPST-----------KDDTPLNRTSSR 840
D+ + K N +P K +L RP+ K T +
Sbjct: 119 LYNDNQVFA----KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK--TWVALDVCL 172
Query: 841 SDVPVQSNPP------TASNSDEKFTLRELL-------SSVAESTPSVPSSISPTQNNLQ 887
VQ N + T+ E+L S S+I +++Q
Sbjct: 173 -SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 888 LDKGIILQNPVIEKSGAGQRPPAF---DDVIH--VIRHSSFRVGSEQPVLETVEVGVQNV 942
+ +L++ +V + +F + + +L T V
Sbjct: 232 AELRRLLKSK--------PYENCLLVLLNVQNAKAWN--AFNLSC-KILLTTRFKQV--T 278
Query: 943 DVGKLINVVRDELEMRNMA-TPVALKSSSCSESVSLKSNISDQSGDK---EMDVRNPNSA 998
D L+ +M TP E SL D E+ NP
Sbjct: 279 DFLSAATTTHISLDHHSMTLTP--------DEVKSLLLKYLDCRPQDLPREVLTTNP--R 328
Query: 999 AISNSSEQSKPNSPVTEDETPVKEILDVRSFRQ-RADALEGLLELSAELL----QQNRLE 1053
+S +E S + T D ++ D L ++E S +L + +
Sbjct: 329 RLSIIAE-SIRDGLATWDN-----------WKHVNCDKLTTIIESSLNVLEPAEYRKMFD 376
Query: 1054 ELAVVLKPFGKD-KVSPRET--AIWLAKSLK--GMMIEECGRSS 1092
L+V F + P IW +++ + + S
Sbjct: 377 RLSV----FPPSAHI-PTILLSLIWFDVIKSDVMVVVNKLHKYS 415
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 7e-05
Identities = 71/488 (14%), Positives = 140/488 (28%), Gaps = 137/488 (28%)
Query: 532 NTVSNTMKVAPMVAPKELE---NTPHQVPNG-RLIRIYRQNSQESQKAVVGHSRGMPTES 587
V + K +++ +E++ + V RL +E + V + +
Sbjct: 36 KDVQDMPK--SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE---EVLRIN 90
Query: 588 SNSVSSSVSIQAFELCDDATTPFIDMTEQTHND-----DDTIVRHEALEALPPGCSQSHL 642
+ S + + + T +I+ ++ +ND + R + L + L
Sbjct: 91 YKFLMSPIKTEQRQPSMM-TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL-----RQAL 144
Query: 643 RSDKSGST--------SGENLRHDHKTVMCSTDTSEDLLCLQKITGSDGRISSKAPSEEF 694
+ SG KT + + ++ K + F
Sbjct: 145 LELRPAKNVLIDGVLGSG-------KTWV----ALDVC--------LSYKVQCKMDFKIF 185
Query: 695 -LS---CNDDIPSSRPSIDDTTLSCPYTNDDKPLNRPSTRDDIPSIMLSMRVDAPLL-RP 749
L+ CN +T L + L + L ++D R
Sbjct: 186 WLNLKNCNS---------PETVL--------EMLQK-----------LLYQIDPNWTSRS 217
Query: 750 DTKDDAPLSQPSTKD--DAHLSWPSTK------DDTRLSQLSTKDDTTLCCP---ATKDD 798
D + L S + L + + + + L C T+
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN--VQNAKAWNAFNLSCKILLTTRF- 274
Query: 799 TPLSRPSTKDNTYSERPSAKDDTSLNRPS---TKDDTPLNRTSSRSDVPVQSNPPTASNS 855
K T + SL+ S T D+ + D Q P
Sbjct: 275 --------KQVTDFLSAATTTHISLDHHSMTLTPDEV-KSLLLKYLDCRPQDLPREVLT- 324
Query: 856 DEKFTLRELLSSVAESTPSVPSSISPTQNNLQLDKGIILQNPVIEKSGAGQRPP----AF 911
T LS +AES ++ + ++ DK +IE S P F
Sbjct: 325 ----TNPRRLSIIAESIRDGLATWDNWK-HVNCDK----LTTIIESSLNVLEPAEYRKMF 375
Query: 912 DDVIHVIRHSSFRVGSEQP--VLETVEVGVQNVDVGKLINVVRDELEMRNMATPVALKSS 969
D + + F + P +L + V DV ++N +L ++ ++
Sbjct: 376 DRL--SV----FPPSAHIPTILLSLIWFDVIKSDVMVVVN----KLHKYSL-----VEKQ 420
Query: 970 SCSESVSL 977
++S+
Sbjct: 421 PKESTISI 428
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1092 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.31 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.78 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.65 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.91 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.26 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=516.64 Aligned_cols=263 Identities=40% Similarity=0.794 Sum_probs=237.7
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
+.|++|++++.||+|+||+||+|.++.+|+.||||++............+.+|+.+|++|+|||||+++++|.+.+ .+|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-SLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-EEE
Confidence 3578999999999999999999999999999999999887766666788999999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||+||+|.++|...++..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999999988776678999999999999999999999999999999999999999999999999999876442
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+...++.++....+.+++..+++++++||.+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999999999998888878888899999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||++||.+|||++|+|+||||++-.
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999999999999997643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-58 Score=499.35 Aligned_cols=259 Identities=28% Similarity=0.535 Sum_probs=233.5
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.+.++|++++.||+|+||+||+|.++.+|+.||||++.+.... ....+.+.+|+.+|++|+|||||+++++|.+.+ .+
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~ 107 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KL 107 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EE
Confidence 3567899999999999999999999999999999999765322 223467889999999999999999999996655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|||||||+||+|+++|.+.+. |++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 108 yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 899999999999999988754 999999999999999999999999999999999999999999999999999987533
Q ss_pred ---ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 162 ---DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ---~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+...++.++....+ .++..+++++++|
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dl 264 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDL 264 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHH
Confidence 235578999999999999999999999999999999999999999999999888888887655 4678899999999
Q ss_pred HHHhcccCCCCCCCHHH------HHhChhhHhH
Q 043248 239 IKGMLRKNPEHRPSASE------LLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeE------LLqHPwFq~~ 265 (1092)
|.+||++||.+|+|++| +++||||+.+
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 99999999999999887 6899999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=484.90 Aligned_cols=257 Identities=28% Similarity=0.545 Sum_probs=213.3
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++++|++++.||+|+||+||+|.++.+|+.||||++.+..... .....+.+|+.+|++++|||||+++++|...+ .+
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~ 88 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-EI 88 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EE
Confidence 46899999999999999999999999999999999997654332 33567899999999999999999999996654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
||||||| +|+|.++|.+.+. |++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEeCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 8999999 6799999987654 999999999999999999999999999999999999999999999999999988776
Q ss_pred ccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
....+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+...+...+..... .++..+++++++||.
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSPGAAGLIK 244 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Confidence 66778899999999999998887 6899999999999999999999999888888888776544 467889999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||++||++|||++|+|+||||+.
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHccCChhHCcCHHHHHcCccccc
Confidence 999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-57 Score=497.92 Aligned_cols=253 Identities=31% Similarity=0.535 Sum_probs=228.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.|+++++||+|+||+||+|.++.+|+.||||++....... .+.+.+|+.+|++|+|||||+++++|...+ .+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 56999999999999999999999999999999997654332 356789999999999999999999997765 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~ 164 (1092)
|||+||+|.+++.+. .|++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+... ...
T Consensus 151 Ey~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 151 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 999999999999764 3999999999999999999999999999999999999999999999999999987543 445
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--CCCCCCHHHHHHHHHh
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--lPs~iS~eLkDLIrkc 242 (1092)
.+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+....+..+....... .+..+++++++||.+|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999998888888877654332 2345899999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~ 264 (1092)
|++||++|||++|+|+||||++
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGG
T ss_pred cCCChhHCcCHHHHhcCHhhcC
Confidence 9999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=475.37 Aligned_cols=255 Identities=28% Similarity=0.549 Sum_probs=222.1
Q ss_pred CCe-EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec---CeEE
Q 043248 6 DQY-EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK---GCYV 81 (1092)
Q Consensus 6 DrY-eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~---d~~l 81 (1092)
++| ++.+.||+|+||+||+|.++.++..||+|++............+.+|+.+|++|+|||||+++++|... +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 466 788899999999999999999999999999987766666678899999999999999999999998652 4578
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcC-CCCEEEeecCccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTK-DQDVRLGDFGLAKTL 158 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~-dG~LKLiDFGLA~~l 158 (1092)
|||||||+||+|.++|.+... +++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999999987654 999999999999999999999998 999999999999974 789999999999865
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhccCCC-CCCCCCCHHHH
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRSSIG-PLPSCYSPSLK 236 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~~i~-plPs~iS~eLk 236 (1092)
.. ....+.+||+.|||||++.+ .|+.++|||||||+||+|++|+.||.+... ..+...+...... .++..++++++
T Consensus 183 ~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (290)
T 3fpq_A 183 RA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp CT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred CC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHH
Confidence 43 34567799999999999875 699999999999999999999999986544 3444444443322 34556789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||.+||++||.+|||++|+|+||||++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-56 Score=501.22 Aligned_cols=253 Identities=31% Similarity=0.538 Sum_probs=228.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.|++++.||+|+||.||+|.++.+|+.||||++....... .+.+.+|+.+|++|+|||||+++++|...+ .+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECC-EEEEEE
Confidence 57999999999999999999999999999999997654332 356889999999999999999999997765 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~ 164 (1092)
|||+||+|.++++... |++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+... ...
T Consensus 228 Ey~~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred eCCCCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999999997643 999999999999999999999999999999999999999999999999999877544 345
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHHHh
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIrkc 242 (1092)
.+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+....+..+...... ..+..+++++++||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999888888887665433 23456899999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~ 264 (1092)
|++||.+|||++|+|+||||++
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGG
T ss_pred cCCChhHCcCHHHHhcCHHhcC
Confidence 9999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=487.13 Aligned_cols=257 Identities=30% Similarity=0.541 Sum_probs=222.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++++.||+|+||+||+|++. .+++.||||++............+.+|+.+|++|+|||||+++++|.+.+ .+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT-EE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EE
Confidence 368999999999999999999984 46789999999765432222335778999999999999999999997655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA- 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~- 160 (1092)
|||||||+||+|.++|.+.+. |++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 899999999999999988654 99999999999999999999999999999999999999999999999999986543
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....+.+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+...++.++..... .+|..+++++++||+
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHHH
Confidence 3445678999999999999999999999999999999999999999999999888888877654 467889999999999
Q ss_pred HhcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
+||++||.+||| ++|+++||||+.+
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999999998 5899999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=479.76 Aligned_cols=246 Identities=30% Similarity=0.471 Sum_probs=216.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.++.|++.++||+|+||.||+|.++.+|+.||||++..... ..+|+.+|++|+|||||+++++|.+.+ .+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~-~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGP-WVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETT-EEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECC-EEEE
Confidence 45789999999999999999999999999999999976532 246999999999999999999997655 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~d~ 162 (1092)
|||||+||+|.++|++.+. |++..++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 128 vmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999999987754 99999999999999999999999999999999999999988 69999999999876443
Q ss_pred c------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHH
Q 043248 163 L------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPS 234 (1092)
Q Consensus 163 ~------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~e 234 (1092)
. ....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+...+..++...... .++..++++
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 2 23468999999999999999999999999999999999999999987776677776654432 366789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+.+||.+||++||.+|||+.|+++|
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=479.99 Aligned_cols=258 Identities=30% Similarity=0.478 Sum_probs=224.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----CeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-----GCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-----d~~ 80 (1092)
++|++++.||+|+||+||+|.++.+|+.||||++..........+.+.+|+.+|+.|+|||||+++++|... ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 589999999999999999999999999999999987666666677889999999999999999999988643 256
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|||||||+ |+|.++|...+ .|++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 899999996 57999997654 499999999999999999999999999999999999999999999999999987643
Q ss_pred c-----ccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--------
Q 043248 161 D-----DLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-------- 226 (1092)
Q Consensus 161 d-----~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p-------- 226 (1092)
. ....+.+||++|||||++.+. .|+.++||||||||||+|++|++||.+.+..+++..|......+
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 234567999999999998875 46999999999999999999999999998888777764322111
Q ss_pred ----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 227 ----------------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 227 ----------------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+...+++++++||.+||.+||.+|+|++|+|+||||+.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0124688999999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-54 Score=461.39 Aligned_cols=256 Identities=30% Similarity=0.545 Sum_probs=206.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe-----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC----- 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~----- 79 (1092)
+++|++++.||+|+||+||+|.++.+|+.||||++.... .+...+.+.+|+.+|++|+|||||+++++|.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 467999999999999999999999999999999997654 34445678999999999999999999999976543
Q ss_pred ------EEEEEEeecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeec
Q 043248 80 ------YVCIVTGYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDF 152 (1092)
Q Consensus 80 ------~lyLVMEYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDF 152 (1092)
++|||||||+||+|.+++..... ....+..++.|+.||+.||.|||++|||||||||+||||+.++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 57999999999999999986543 12456778999999999999999999999999999999999999999999
Q ss_pred Ccccccccccc-------------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHH
Q 043248 153 GLAKTLKADDL-------------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISK 218 (1092)
Q Consensus 153 GLA~~l~~d~~-------------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~k 218 (1092)
|+|+.+..... ....+||+.|||||++.+..|+.++|||||||+||||++ ||.... ....+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 99988764322 234589999999999999999999999999999999996 776532 2233344
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+.....++.....++.+.+||++||++||.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 4443333333345677889999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=452.27 Aligned_cols=258 Identities=22% Similarity=0.418 Sum_probs=226.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
++|.+.+.||+|+||.||+|.+. .++..||||++... .....+.|.+|+.+|++|+|||||+++++|.+.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-P 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-E
Confidence 57999999999999999999875 45788999999754 3445678999999999999999999999997655 5
Q ss_pred EEEEEeecCCCCHHHHHHHcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEE
Q 043248 81 VCIVTGYCEGGDMAELMKKSN-----------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~-----------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKL 149 (1092)
+|||||||+||+|.++|...+ ...|++.+++.|+.||+.||.|||+++||||||||+||||+.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 789999999999999998642 345999999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCC
Q 043248 150 GDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIG 225 (1092)
Q Consensus 150 iDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~ 225 (1092)
+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..+......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999987654432 234579999999999999999999999999999999998 99999999988888888888777
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+.|..+++++.+||.+||+.||++|||+.+++ +|++.+...
T Consensus 250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~~~ 290 (299)
T 4asz_A 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLAKA 290 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHHhc
Confidence 88899999999999999999999999999994 578876553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=483.96 Aligned_cols=258 Identities=24% Similarity=0.455 Sum_probs=232.5
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.|+|||||+|+++|.+. ..+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-SEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEE
Confidence 35689999999999999999999999999999999997643 33356788999999999999999999999665 4788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CCEEEeecCccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD--QDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d--G~LKLiDFGLA~~l~~ 160 (1092)
||||||+||+|+++|....+ .|++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|..+..
T Consensus 231 iv~E~~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEeecCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999999999975433 49999999999999999999999999999999999999854 7899999999999887
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPSLKT 237 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~eLkD 237 (1092)
.......+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+...++.++....... ....+++++++
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777778899999999999999999999999999999999999999999999988888887654432 23568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||++||++||.+|||+.|+|+||||+.
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=454.72 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=206.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
-++|++++.||+|+||+||+|.++ .+++.||+|++..... ...+.+|+.+|+.+ +||||++++++|...+ +
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~-~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND-H 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT-E
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC-E
Confidence 468999999999999999999886 4578999999865432 23577899999998 6999999999997655 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCcccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKTLK 159 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~~l~ 159 (1092)
+|||||||+||+|.++++ .|++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 889999999999999984 28999999999999999999999999999999999999876 799999999997654
Q ss_pred ccc-----------------------------cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcc
Q 043248 160 ADD-----------------------------LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKA 209 (1092)
Q Consensus 160 ~d~-----------------------------~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g 209 (1092)
... .....+||++|+|||++.+. .|+.++||||+|||+|+|++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 321 12346899999999999875 489999999999999999999999954
Q ss_pred -cChHHHHHHhhcc-----------------------------------------------------CCCCCCCCCCHHH
Q 043248 210 -FDMAGLISKINRS-----------------------------------------------------SIGPLPSCYSPSL 235 (1092)
Q Consensus 210 -~d~~dli~kI~~~-----------------------------------------------------~i~plPs~iS~eL 235 (1092)
.+..+++..+... ........+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 3433333332110 0001123478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+|||++||++||.+|+|++|+|+||||+.
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=448.41 Aligned_cols=257 Identities=22% Similarity=0.392 Sum_probs=219.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
++|.+.++||+|+||.||+|.++ .++..||||++... .....+.|.+|+.+|++|+|||||+++++|.+.+ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-P 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-E
Confidence 57899999999999999999875 46889999999754 3445678999999999999999999999996655 5
Q ss_pred EEEEEeecCCCCHHHHHHHcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCE
Q 043248 81 VCIVTGYCEGGDMAELMKKSN-------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDV 147 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~-------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~L 147 (1092)
+|||||||+||+|.++|.... ...|++.+++.|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 789999999999999997643 2358999999999999999999999999999999999999999999
Q ss_pred EEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccC
Q 043248 148 RLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSS 223 (1092)
Q Consensus 148 KLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~ 223 (1092)
||+|||+++...... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998765433 2345679999999999999999999999999999999998 999999998888888888777
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
..+.|..+++++.+||.+||++||++|||+.|++++ ++.+.+
T Consensus 278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l~~ 319 (329)
T 4aoj_A 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQ 319 (329)
T ss_dssp CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHhh
Confidence 777888999999999999999999999999999875 665544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=444.44 Aligned_cols=254 Identities=21% Similarity=0.393 Sum_probs=223.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
.++++++++.||+|+||+||+|.+. .+++.||||++..... ....+.|.+|+.+|++|+|||||+++++|.+.+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 3468899999999999999999864 4678999999865432 233567899999999999999999999996654
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
.+|||||||++|+|.++|.... ...|++..+..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 103 -~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 103 -PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp -SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred -EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 5779999999999999997542 1348999999999999999999999999999999999999999
Q ss_pred CCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhh
Q 043248 145 QDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKIN 220 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~ 220 (1092)
+.+||+|||+++...... .....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++...+.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998765432 2345689999999999999999999999999999999998 899999999989888888
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.....+.|..++.++.+|+.+||+.||.+|||+.||+++
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 887778889999999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=442.76 Aligned_cols=250 Identities=25% Similarity=0.425 Sum_probs=209.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.++||+|+||+||+|.++ ..||||+++.........+.|.+|+.+|++|+|||||++++++.+ + .+||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~-~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D-NLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-SCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C-eEEE
Confidence 3578899999999999999999864 359999998766666667889999999999999999999998754 3 4679
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc--
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-- 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-- 161 (1092)
|||||+||+|.++|..... .+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999999986543 4999999999999999999999999999999999999999999999999999876532
Q ss_pred -ccCccccCCCCcCCchhhcc---CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhh-ccCC----CCCCCCCC
Q 043248 162 -DLASSVVGTPNYMCPELLAD---IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN-RSSI----GPLPSCYS 232 (1092)
Q Consensus 162 -~~~st~vGTp~YmAPEVL~g---~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~-~~~i----~plPs~iS 232 (1092)
......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+....+..+. .... ...+..++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 23455789999999999964 468999999999999999999999998866554444433 2222 23456789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.++.+||.+||+.||++|||+.|++++
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=480.57 Aligned_cols=257 Identities=26% Similarity=0.502 Sum_probs=221.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc----cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ----TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~----se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
-+++|++++.||+|+||.||+|.++.+|+.||||++.+... .........+++.+++.++|||||+++++|.+.+
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~- 265 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD- 265 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC-
Confidence 47899999999999999999999999999999999975432 2222333445567777889999999999997655
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|||||||+||+|+++|.+.+. |++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|..+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 78899999999999999988754 9999999999999999999999999999999999999999999999999998876
Q ss_pred ccccCccccCCCCcCCchhhc-cCCCCccccchhHHHHHHHHHhCCCCCcccC---hHHHHHHhhccCCCCCCCCCCHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---MAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELLTGr~PF~g~d---~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
... ..+.+||+.|||||++. +..|+.++||||||||||+|++|++||.+.+ ...+...+.... ..++..+++++
T Consensus 344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-~~~p~~~S~~a 421 (689)
T 3v5w_A 344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSPEL 421 (689)
T ss_dssp SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-CCCCTTSCHHH
T ss_pred CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-CCCCccCCHHH
Confidence 543 45679999999999996 5689999999999999999999999997643 333444444333 35678899999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 236 KTLIKGMLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
++||.+||++||.+|++ ++||++||||+.+
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999999999998 7999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=427.04 Aligned_cols=260 Identities=23% Similarity=0.476 Sum_probs=237.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+ .+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-TLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-EEE
Confidence 4578999999999999999999999999999999999877666666778899999999999999999999986544 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||++|++|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999999987654 9999999999999999999999999999999999999999999999999998887666
Q ss_pred cCccccCCCCcCCchhhccCCCC-ccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYG-FKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS-~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+...+...+..... .+|..++.++.+||++
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKR 247 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Confidence 67778999999999999888874 799999999999999999999999988888887776544 4677789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||..||.+|||++|+++||||+...
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999997643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=444.81 Aligned_cols=260 Identities=22% Similarity=0.437 Sum_probs=223.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC-----CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE-----KKKYVLKKIRLARQTERCRRSAHQEMALIARVQH-PYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t-----Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H-PNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.+... ++.||||++..... ....+.+.+|+.+|.++.| ||||+++++|.+.+
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 46899999999999999999998754 36799999876533 3345679999999999965 89999999997776
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
..+|||||||++|+|.++|+... ...|++..+..|+.||+.||.|||+++||||||||+|||++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 67889999999999999998642 2348999999999999999999999999999999999999999
Q ss_pred CCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChH-HHHHHh
Q 043248 145 QDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMA-GLISKI 219 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~-dli~kI 219 (1092)
+.+||+|||+|+.+.... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.... .+...+
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998765433 2235679999999999999999999999999999999998 99999886543 444555
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
......+.|..+++++.+||.+||+.||.+|||+.|+++| +..+.+
T Consensus 302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~--L~~llq 347 (353)
T 4ase_A 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 347 (353)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHHH
Confidence 5555667888899999999999999999999999999998 555443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=418.14 Aligned_cols=258 Identities=32% Similarity=0.588 Sum_probs=229.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||++++++|...+ .+|
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~ 81 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-EEE
Confidence 57899999999999999999999999999999999975432 1122456788999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-cc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-AD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~d 161 (1092)
+|||||+||+|..++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999999987654 9999999999999999999999999999999999999999999999999998643 33
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+...+..... .++..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Confidence 345667899999999999999999999999999999999999999999888777777765543 4677899999999999
Q ss_pred hcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
||++||.+|| +++++++||||..+
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 99999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=423.20 Aligned_cols=258 Identities=25% Similarity=0.518 Sum_probs=224.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|..+++.+ +||||++++++|...+ .+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-RL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC-EE
Confidence 46899999999999999999999999999999999976432 222345678899999988 7999999999996655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA- 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~- 160 (1092)
|||||||+||+|..++.+... +++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 899999999999999987654 99999999999999999999999999999999999999999999999999986432
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+..++..... .++..++..+.+||+
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILK 256 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Confidence 3345567899999999999999999999999999999999999999999998888888876654 456779999999999
Q ss_pred HhcccCCCCCCCH------HHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPSA------SELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPSa------eELLqHPwFq~~ 265 (1092)
+||++||.+|+++ +++++||||+.+
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999998 999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=401.12 Aligned_cols=258 Identities=29% Similarity=0.504 Sum_probs=218.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-EEEEE
Confidence 58999999999999999999999999999999999876665556677889999999999999999999997655 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
||||++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 999986 6666666543 34999999999999999999999999999999999999999999999999999877533 33
Q ss_pred CccccCCCCcCCchhhccCC-CCccccchhHHHHHHHHHhCCCC-CcccChHHHHHHhhccCC-----------------
Q 043248 164 ASSVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPA-FKAFDMAGLISKINRSSI----------------- 224 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~-yS~KSDVWSLGVILYELLTGr~P-F~g~d~~dli~kI~~~~i----------------- 224 (1092)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.......+.....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45568999999999997765 89999999999999999987766 555555555555432110
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 225 -----------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 225 -----------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
......++.++.+||++||+.||.+|||++|+|+||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01223478899999999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=405.89 Aligned_cols=256 Identities=29% Similarity=0.506 Sum_probs=226.1
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
...++|++++.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||++++++|...+ .+|
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD-ELW 93 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEE
Confidence 45678999999999999999999999999999999997654332 356889999999999999999999997765 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+|||||+|++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEECCTTCBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEECCCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999999998753 8999999999999999999999999999999999999999999999999998765443
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLI 239 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLI 239 (1092)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.......+...... ..+..++..+.+||
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence 344568999999999999999999999999999999999999999988776666655443322 34566899999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+||+.||.+|||+.|+|+||||+.
T Consensus 251 ~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHccCChhHCcCHHHHhhChhhcc
Confidence 9999999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=390.63 Aligned_cols=260 Identities=28% Similarity=0.485 Sum_probs=232.5
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
...++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.++++++||||++++++|...+ ..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-EEE
Confidence 4568999999999999999999999999999999999877666666778899999999999999999999986554 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---EEEeecCcccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLK 159 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~---LKLiDFGLA~~l~ 159 (1092)
+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999999987654 899999999999999999999999999999999999987665 9999999998887
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPSLK 236 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~eLk 236 (1092)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....... ....+++++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 6666667789999999999999999999999999999999999999999988877777766554332 2246799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+||.+||+.||.+|||+.|+|+||||+..
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=418.19 Aligned_cols=257 Identities=29% Similarity=0.516 Sum_probs=229.9
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.|+||||++++++|.+.+ .+|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEEEE
Confidence 5799999999999999999999999999999999877666666678999999999999999999999996655 778999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEEeecCccccccccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKLiDFGLA~~l~~d~ 162 (1092)
|||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 108 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9999999999997654 489999999999999999999999999999999999998654 59999999999887666
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC---CCCCHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP---SCYSPSLKTLI 239 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP---s~iS~eLkDLI 239 (1092)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...+...+......... ..+++++.+||
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 566788999999999999999999999999999999999999999998887777777665443221 34799999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+||++||.+|||+.++|+||||...
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=411.38 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=231.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
...++|++.+.||+|+||.||+|.++.+++.||+|.+.... .....+.+|+.+++.++||||++++++|...+ .+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESME-ELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-EEE
Confidence 56789999999999999999999999999999999987542 23456889999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCCEEEeecCccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK--DQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~--dG~LKLiDFGLA~~l~~ 160 (1092)
+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+..
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999999997543 34999999999999999999999999999999999999987 78999999999998876
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CCCCCHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PSCYSPSLKT 237 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps~iS~eLkD 237 (1092)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+........ ...++.++.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 6656677899999999999998899999999999999999999999999888888887776554322 1357999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
||.+||..||.+|||+.|+|+||||+....
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 999999999999999999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=421.29 Aligned_cols=258 Identities=26% Similarity=0.488 Sum_probs=229.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
..++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.++++++||||++++++|...+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 88 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT- 88 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-
Confidence 3468999999999999999999999999999999997654321 12456889999999999999999999996654
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CEEEeecCcc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ----DVRLGDFGLA 155 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG----~LKLiDFGLA 155 (1092)
.+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 7889999999999999997654 499999999999999999999999999999999999998776 7999999999
Q ss_pred ccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCC
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYS 232 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS 232 (1092)
............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+....+..+....+.. ....++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 98876666677889999999999999999999999999999999999999999988888888877654432 124679
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.++++||.+||.+||.+|||+.|+|+||||+.
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 99999999999999999999999999999973
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=415.56 Aligned_cols=263 Identities=24% Similarity=0.404 Sum_probs=223.7
Q ss_pred CCCCeEEEEEEeec--CceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRG--AFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkG--gFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..++|++++.||+| +||.||+|.++.+++.||||++............+.+|+.+++.++||||++++++|...+ .+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-EL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC-EE
Confidence 56899999999999 9999999999999999999999887666667788999999999999999999999997655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||+|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 89999999999999999875566999999999999999999999999999999999999999999999999988654322
Q ss_pred --------ccCccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-------
Q 043248 162 --------DLASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI------- 224 (1092)
Q Consensus 162 --------~~~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i------- 224 (1092)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 12234579999999999987 6789999999999999999999999987655444443322111
Q ss_pred --------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 225 --------------------------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 225 --------------------------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+.+..+++.+.+||++||++||.+|||+.|+|+||||+.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 123445788999999999999999999999999999998764
Q ss_pred h
Q 043248 267 D 267 (1092)
Q Consensus 267 d 267 (1092)
.
T Consensus 342 ~ 342 (389)
T 3gni_B 342 R 342 (389)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=399.21 Aligned_cols=259 Identities=28% Similarity=0.476 Sum_probs=217.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-RLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-eEEEE
Confidence 68999999999999999999999999999999999777666666778899999999999999999999997655 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999999887654 3999999999999999999999999999999999999999999999999999876533 33
Q ss_pred CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-----------------
Q 043248 164 ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----------------- 225 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----------------- 225 (1092)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 455689999999999976 67899999999999999999999999987766555444321000
Q ss_pred ---CC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 226 ---PL----------PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 226 ---pl----------Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+. ...++..+.+||++||+.||.+|||++|+|+||||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 00 134788999999999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=409.73 Aligned_cols=256 Identities=27% Similarity=0.560 Sum_probs=228.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||++++++|...+ .+|
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~~ 82 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIF 82 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-EEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-EEE
Confidence 5789999999999999999999999999999999997543211 12456778999999999999999999996654 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+|||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999999987553 999999999999999999999999999999999999999999999999999876532
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+......++..... .++..++.++.+||.+|
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence 4467899999999999999999999999999999999999999999888888777776544 46677899999999999
Q ss_pred cccCCCCCC-----CHHHHHhChhhHhH
Q 043248 243 LRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
|..||.+|+ +++++++||||+.+
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999999 99999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=401.62 Aligned_cols=261 Identities=30% Similarity=0.435 Sum_probs=218.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc---HHHHHHHHHHHHHHHhc---CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT---ERCRRSAHQEMALIARV---QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s---e~~~r~f~rEIqILkqL---~HPNIVKL~gvF~e~ 77 (1092)
..++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999999999999999998744311 11112344566666655 599999999999765
Q ss_pred Ce----EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 78 GC----YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 78 d~----~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
.. .+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 43 6789999997 599999998766669999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-------
Q 043248 154 LAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP------- 226 (1092)
Q Consensus 154 LA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p------- 226 (1092)
++............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+......++......+
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 9998776666677899999999999999999999999999999999999999999988777666654321100
Q ss_pred -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 227 -------------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 227 -------------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
....++..+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 112468899999999999999999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=404.84 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=215.7
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
+..+++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++||||++++++|...+ .+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-CL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-CE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-EE
Confidence 346789999999999999999999985 5899999999766554545577889999999999999999999986554 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 899999985 8888887654 34999999999999999999999999999999999999999999999999999877533
Q ss_pred -ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-------------
Q 043248 162 -DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP------------- 226 (1092)
Q Consensus 162 -~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p------------- 226 (1092)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.........+......+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 23445689999999999976 568999999999999999999999998876655555543211110
Q ss_pred ----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 227 ----------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 227 ----------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
....+++++.+||++||++||.+|||+.|+|+||||+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 122367899999999999999999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=418.65 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=214.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecC-eEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKG-CYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d-~~l 81 (1092)
.+++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+++.+. ||||++++++|...+ ..+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 467999999999999999999999999999999999766556666778889999999997 999999999997544 468
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA- 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~- 160 (1092)
|+|||||+ ++|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 89999997 5899999864 389999999999999999999999999999999999999999999999999986532
Q ss_pred ---------------------cccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHH
Q 043248 161 ---------------------DDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISK 218 (1092)
Q Consensus 161 ---------------------d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~k 218 (1092)
.......+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+...++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 112345689999999999976 6789999999999999999999999999887776666
Q ss_pred hhccCCCC----------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCC
Q 043248 219 INRSSIGP----------------------------------------------LPSCYSPSLKTLIKGMLRKNPEHRPS 252 (1092)
Q Consensus 219 I~~~~i~p----------------------------------------------lPs~iS~eLkDLIrkcLqkDPskRPS 252 (1092)
+......+ ....+++++.+||++||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 54211100 11256889999999999999999999
Q ss_pred HHHHHhChhhHhHhh
Q 043248 253 ASELLKHPFLQHFVD 267 (1092)
Q Consensus 253 aeELLqHPwFq~~~d 267 (1092)
++|+|+||||+.+..
T Consensus 323 ~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 323 ANDALKHPFVSIFHN 337 (388)
T ss_dssp HHHHTTSTTTTTTCC
T ss_pred HHHHhCCHHHHHhcC
Confidence 999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=410.27 Aligned_cols=258 Identities=28% Similarity=0.556 Sum_probs=224.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++++ +||||++++++|...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-~~ 85 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RL 85 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC-EE
Confidence 46899999999999999999999999999999999986543 344456788999999988 8999999999996654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-c
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-A 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~ 160 (1092)
|+|||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 899999999999999987654 9999999999999999999999999999999999999999999999999998643 3
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc---------ChHHHHHHhhccCCCCCCCCC
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF---------DMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~---------d~~dli~kI~~~~i~plPs~i 231 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||... ....+...+... ...++..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCC
Confidence 34456678999999999999999999999999999999999999999752 222333444433 33467789
Q ss_pred CHHHHHHHHHhcccCCCCCCCH------HHHHhChhhHhH
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSA------SELLKHPFLQHF 265 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSa------eELLqHPwFq~~ 265 (1092)
+.++.+||++||++||.+||++ +++++||||+.+
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 9999999999999999999995 899999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=433.87 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=218.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||++++++|...+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357999999999999999999999999999999999876666666778999999999999999999999996543
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+||||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 467999999976 57776643 3899999999999999999999999999999999999999999999999999988
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC-----------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL----------- 227 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl----------- 227 (1092)
.........+||++|+|||++.+..|+.++|||||||+||+|++|+.||.+.+..+++.++......+.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 776667778999999999999999999999999999999999999999999887777666543211110
Q ss_pred -------------------CCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 228 -------------------PSC-----------YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 228 -------------------Ps~-----------iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+.. .++++.+||++||.+||.+|||++|+|+||||+.+.+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 000 0467999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=398.73 Aligned_cols=257 Identities=28% Similarity=0.520 Sum_probs=217.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH------------------------HHHHHHHHHHHHH
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE------------------------RCRRSAHQEMALI 59 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se------------------------~~~r~f~rEIqIL 59 (1092)
.+++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4689999999999999999999999999999999987543211 1234688999999
Q ss_pred HhcCCCCcceEEEEEEec-CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 043248 60 ARVQHPYIVEFKEAWVEK-GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSN 138 (1092)
Q Consensus 60 kqL~HPNIVKL~gvF~e~-d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPEN 138 (1092)
++++||||++++++|... +..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999763 4678999999999999886533 349999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCccccccccc-cCccccCCCCcCCchhhccCC---CCccccchhHHHHHHHHHhCCCCCcccChHH
Q 043248 139 IFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLADIP---YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG 214 (1092)
Q Consensus 139 ILLD~dG~LKLiDFGLA~~l~~d~-~~st~vGTp~YmAPEVL~g~~---yS~KSDVWSLGVILYELLTGr~PF~g~d~~d 214 (1092)
||++.++.+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999998775432 334568999999999997755 3788999999999999999999999887776
Q ss_pred HHHHhhccCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 215 LISKINRSSIG-PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 215 li~kI~~~~i~-plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
....+...... +....++..+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 66666544332 23346899999999999999999999999999999996
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=405.93 Aligned_cols=257 Identities=25% Similarity=0.481 Sum_probs=226.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.++|++.+.||+|+||.||+|.++.+++.||+|++....... .....+.+|+.+++.++||||++++++|...+ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-D 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-E
Confidence 467999999999999999999999999999999997653221 12456889999999999999999999996654 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CEEEeecCccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ----DVRLGDFGLAK 156 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG----~LKLiDFGLA~ 156 (1092)
+|+|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 889999999999999997644 499999999999999999999999999999999999998877 79999999999
Q ss_pred cccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCH
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSP 233 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~ 233 (1092)
...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....... ....++.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 8876655667789999999999999999999999999999999999999999888777777665543322 1245789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+.+||++||..||.+|||+.++|+||||+.
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 9999999999999999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=396.74 Aligned_cols=256 Identities=26% Similarity=0.461 Sum_probs=214.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|++++.||+|+||.||+|.+ .+++.||+|++............+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-eEEEE
Confidence 58999999999999999999998 67899999999765444333456789999999999999999999997655 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
|||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 999986 9999998653 34899999999999999999999999999999999999999999999999999876532 22
Q ss_pred CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC------------------
Q 043248 164 ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI------------------ 224 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i------------------ 224 (1092)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 345679999999999976 4589999999999999999999999998777665555432100
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 225 ----------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 225 ----------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
......++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0112347899999999999999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=425.34 Aligned_cols=258 Identities=29% Similarity=0.477 Sum_probs=228.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||++++++|.+.+ .+|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-HHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-EEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-EEEEE
Confidence 36899999999999999999999999999999999877666666678899999999999999999999996554 77899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT---KDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD---~dG~LKLiDFGLA~~l~~d 161 (1092)
||||.||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999999987654 99999999999999999999999999999999999998 4578999999999877644
Q ss_pred c-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHHHHH
Q 043248 162 D-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPSLKT 237 (1092)
Q Consensus 162 ~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~eLkD 237 (1092)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+....... ....+++++++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 3 3356789999999999999999999999999999999999999999988888888877655432 22467999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||.+||++||.+|||+.|+|+||||+..
T Consensus 247 li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=410.89 Aligned_cols=257 Identities=27% Similarity=0.533 Sum_probs=230.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..+++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||++++++|...+ .+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-EE
Confidence 35789999999999999999999999999999999997543211 22456888999999999999999999997654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||+||+|.+++.+.+. +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 899999999999999987654 999999999999999999999999999999999999999999999999999876543
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+..++..... .++..++.++.+||.+
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRN 271 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999888888888776544 4677899999999999
Q ss_pred hcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 242 MLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
||+.||.+||+ ++++++||||+.+
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999998 9999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=386.65 Aligned_cols=258 Identities=28% Similarity=0.493 Sum_probs=228.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.++++++||||++++++|...+ .+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNT-DIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eEEE
Confidence 3468999999999999999999999999999999997654332 456889999999999999999999996554 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCEEEeecCccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---TKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---D~dG~LKLiDFGLA~~l~~ 160 (1092)
||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 84 v~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999987654 8999999999999999999999999999999999999 7788999999999998877
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC---CCCCHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP---SCYSPSLKT 237 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP---s~iS~eLkD 237 (1092)
........||+.|+|||++.+. ++.++|||||||++|+|++|+.||...........+......... ..+++.+.+
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 6666778899999999998764 899999999999999999999999998887777777665443222 257999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
||.+||+.||.+|||+.++|+||||+....
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 999999999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=415.22 Aligned_cols=259 Identities=24% Similarity=0.496 Sum_probs=228.1
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
..+++|++++.||+|+||.||+|.++.+++.||+|++...... ......+.+|..++..+ +||||++++++|...+ .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-~ 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-N 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-E
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-E
Confidence 3578999999999999999999999999999999999764321 11234577888999877 8999999999997655 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+|||||+||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 8899999999999999987654 99999999999999999999999999999999999999999999999999986532
Q ss_pred -cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 043248 161 -DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 161 -d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLI 239 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+...+..... .++..++.++.+||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccCHHHHHHH
Confidence 3345667899999999999999999999999999999999999999999888888877766543 46777999999999
Q ss_pred HHhcccCCCCCCCHH-HHHhChhhHhH
Q 043248 240 KGMLRKNPEHRPSAS-ELLKHPFLQHF 265 (1092)
Q Consensus 240 rkcLqkDPskRPSae-ELLqHPwFq~~ 265 (1092)
.+||..||.+||++. ++++||||+.+
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcCCHhHcCCChHHHHcCccccCC
Confidence 999999999999998 99999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=414.97 Aligned_cols=258 Identities=26% Similarity=0.534 Sum_probs=226.6
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..+++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||++++++|...+ .+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~ 84 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-DI 84 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EE
Confidence 56799999999999999999999999999999999997543221 12346889999999999999999999997655 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+ +|+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 8999999 6799999987654 999999999999999999999999999999999999999999999999999988777
Q ss_pred ccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+... ...++..+++++.+||+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHH
Confidence 77778899999999999988876 78999999999999999999999886655444444332 23467778999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+||+.||.+|||++|+++||||+..
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=407.80 Aligned_cols=259 Identities=30% Similarity=0.520 Sum_probs=220.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH---HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE---RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se---~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
++|++.+.||+|+||.||+|.++.+++.||||++....... ...+.+.+|+.+++.++||||++++++|...+ .+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG-MLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEE
Confidence 57999999999999999999999999999999986532111 12456889999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---EEEeecCcccc
Q 043248 83 IVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKT 157 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~---LKLiDFGLA~~ 157 (1092)
+|||||+|++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888653 2345899999999999999999999999999999999999987654 99999999988
Q ss_pred cccccc-CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC---CCCCH
Q 043248 158 LKADDL-ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP---SCYSP 233 (1092)
Q Consensus 158 l~~d~~-~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP---s~iS~ 233 (1092)
...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.. ......+........+ ..++.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~ 261 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE 261 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence 765433 445789999999999999999999999999999999999999998754 3444455444332221 45799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
++++||.+||.+||.+|||+.++|+||||+...
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 999999999999999999999999999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=421.86 Aligned_cols=258 Identities=28% Similarity=0.573 Sum_probs=222.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|++++.||+|+||.||+|.++.+++.||+|++....... .....+.+|..++.++ +||||++++++|...+ .+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-~~ 128 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RL 128 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC-EE
Confidence 4679999999999999999999999999999999998654332 2345677899999887 8999999999997655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc-ccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT-LKA 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~-l~~ 160 (1092)
|||||||+||+|..++.+... |++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++.. ...
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 899999999999999987654 99999999999999999999999999999999999999999999999999986 334
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC---------hHHHHHHhhccCCCCCCCCC
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---------MAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d---------~~dli~kI~~~~i~plPs~i 231 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... ...+...+.. ....++..+
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~ 285 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSL 285 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCCCCTTS
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccCCCCcC
Confidence 445667899999999999999999999999999999999999999996431 2223333333 333577789
Q ss_pred CHHHHHHHHHhcccCCCCCCCH------HHHHhChhhHhH
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSA------SELLKHPFLQHF 265 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSa------eELLqHPwFq~~ 265 (1092)
+.++++||++||++||.+|+++ +|+++||||+.+
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999999984 899999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=413.52 Aligned_cols=258 Identities=23% Similarity=0.499 Sum_probs=228.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|++++.||+|+||.||+|.++.+++.||+|++...... ......+.+|..++..+ +||||++++++|...+ .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS-EE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC-EE
Confidence 578999999999999999999999999999999999764321 12245677899999887 7999999999996655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-c
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-A 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~ 160 (1092)
|||||||+||+|.+++...+. +++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 899999999999999987654 9999999999999999999999999999999999999999999999999998643 2
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+...+..... .++..++.++.+||+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICK 253 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHH
Confidence 3345567899999999999999999999999999999999999999999888888888776544 467789999999999
Q ss_pred HhcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
+||.+||.+||+ ++++++||||+.+
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999999994 7999999999763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=410.12 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=198.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC---eEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---CYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---~~ly 82 (1092)
.+|.+.+.||+|+||+||+|.+ +|+.||||++...... .....+|+..+.+++|||||++++++.+.+ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4799999999999999999987 5899999998654321 223345777777899999999999998664 3689
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN--------YVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk--------GIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
||||||+||+|.++|+... +++..+..++.|++.||+|||++ +||||||||+||||+.++.+||+|||+
T Consensus 78 lV~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999998753 89999999999999999999987 999999999999999999999999999
Q ss_pred ccccccccc-----CccccCCCCcCCchhhccC------CCCccccchhHHHHHHHHHhCCCCCcccC------------
Q 043248 155 AKTLKADDL-----ASSVVGTPNYMCPELLADI------PYGFKSDIWSLGCCMYEMAAHRPAFKAFD------------ 211 (1092)
Q Consensus 155 A~~l~~d~~-----~st~vGTp~YmAPEVL~g~------~yS~KSDVWSLGVILYELLTGr~PF~g~d------------ 211 (1092)
|+....... ....+||+.|||||++.+. .|+.++|||||||+||||++|.+||....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 987654321 2346899999999999764 36789999999999999999987764321
Q ss_pred ---hHHHHHHhhccCC-CCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 212 ---MAGLISKINRSSI-GPLPSC-----YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 212 ---~~dli~kI~~~~i-~plPs~-----iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
...+...+..... +.+|.. ....+.+|+.+||+.||.+|||+.|+++. ++++.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~--L~~l~ 296 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLS 296 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHH
Confidence 1222333332222 223332 23468899999999999999999999975 55543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=402.21 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=217.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEeccccc--HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQT--ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~s--e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++|++++.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||++++++|...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 4679999999999999999999985 68999999999765322 223456788999999999999999999996654
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.+|+|||||+|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 95 -KLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred -EEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 67899999999999999987654 899999999999999999999999999999999999999999999999999865
Q ss_pred cc-cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 159 KA-DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 159 ~~-d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..... .++..++.++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ 250 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARD 250 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSCHHHHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHH
Confidence 43 2334567899999999999999999999999999999999999999999888877777766544 466778999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 238 LIKGMLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 238 LIrkcLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
||.+||..||.+|| ++.++++||||+.+
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999999999 89999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=399.10 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=214.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++++.||+|+||.||+|.++.+++.||||++..... ....+.+.+|+.++++++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45789999999999999999999999999999999976542 334567899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEEeecCCCCHHHHHHHcCC-CCCC
Q 043248 79 ---------------------------------------------------CYVCIVTGYCEGGDMAELMKKSNG-AYFP 106 (1092)
Q Consensus 79 ---------------------------------------------------~~lyLVMEYceGGSL~DLLkkk~g-k~LS 106 (1092)
.++|+|||||+|++|.+++..... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 247899999999999999987543 2256
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-------------cCccccCCCCc
Q 043248 107 EEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-------------LASSVVGTPNY 173 (1092)
Q Consensus 107 EeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-------------~~st~vGTp~Y 173 (1092)
+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 67799999999999999999999999999999999999999999999998776542 23445799999
Q ss_pred CCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 043248 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSA 253 (1092)
Q Consensus 174 mAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSa 253 (1092)
+|||++.+..++.++|||||||++|+|++|..|+... ......+............++.+.+||.+||+.||.+|||+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 9999999999999999999999999999998776432 22233333333322233457888999999999999999999
Q ss_pred HHHHhChhhHh
Q 043248 254 SELLKHPFLQH 264 (1092)
Q Consensus 254 eELLqHPwFq~ 264 (1092)
.|+|+||||+.
T Consensus 321 ~~~l~~~~f~~ 331 (332)
T 3qd2_B 321 TDIIENAIFEN 331 (332)
T ss_dssp HHHHHSTTCCC
T ss_pred HHHhhchhhhc
Confidence 99999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=386.49 Aligned_cols=258 Identities=26% Similarity=0.490 Sum_probs=224.7
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
-.+++|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|...+ .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 84 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RV 84 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC-EE
Confidence 35789999999999999999999999999999999986543222 22456889999999999999999999996654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 899999999999999987654 899999999999999999999999999999999999999999999999998665433
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..... .++..++..+.+||.+
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 163 R-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 240 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHH
T ss_pred c-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-CCCCcCCHHHHHHHHH
Confidence 2 3456899999999999999999999999999999999999999999888777777665443 4667789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||+.||.+|||+.|+|+||||+..
T Consensus 241 ~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 241 LLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HhccChhhCCCHHHHhhCccccCC
Confidence 999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=420.75 Aligned_cols=258 Identities=31% Similarity=0.591 Sum_probs=219.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||++++++|...+ .+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-EEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-EEE
Confidence 45789999999999999999999999999999999975432 2233456778999999999999999999997665 688
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA- 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~- 160 (1092)
||||||+|++|.+++..... +++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||++.....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999999987654 9999999999999999999998 9999999999999999999999999999986433
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||...+...+...+..... .++..+++++.+||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLS 381 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHH
Confidence 3345567899999999999999999999999999999999999999999888777777765544 467779999999999
Q ss_pred HhcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 241 GMLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
+||++||.+|| +++|+++||||+.+
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999 99999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=403.23 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=210.3
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||++++++|...+ .+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-RLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-EEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-EEE
Confidence 3578999999999999999999999999999999999776555555667889999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-----CCCCEEEeecCcccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT-----KDQDVRLGDFGLAKT 157 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD-----~dG~LKLiDFGLA~~ 157 (1092)
||||||+| +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++..
T Consensus 110 lv~e~~~~-~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCCC-CHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 99999985 99999987654 99999999999999999999999999999999999995 444599999999987
Q ss_pred cccc-ccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---------
Q 043248 158 LKAD-DLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--------- 226 (1092)
Q Consensus 158 l~~d-~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--------- 226 (1092)
.... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 6533 234456789999999999774 58999999999999999999999999888776666654321110
Q ss_pred --------C------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 227 --------L------------PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 227 --------l------------Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+ +..++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 0 1116789999999999999999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=403.46 Aligned_cols=259 Identities=23% Similarity=0.424 Sum_probs=217.0
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|++++.||+|+||.||+|.++.+++.||+|++...... .....+.+|+.+++.++||||++++++|...+ .+|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGN-IQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSS-EEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-eEE
Confidence 3578999999999999999999999999999999998754332 23456889999999999999999999986554 778
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d- 161 (1092)
+|||||+|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999999987543 3999999999999999999999999999999999999999999999999999876432
Q ss_pred --ccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHH-HHHhhcc-CCCCCCCCCCHHHH
Q 043248 162 --DLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL-ISKINRS-SIGPLPSCYSPSLK 236 (1092)
Q Consensus 162 --~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dl-i~kI~~~-~i~plPs~iS~eLk 236 (1092)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+... ........++..+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 23446789999999999987775 7899999999999999999999987654322 2222221 11122345799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+||.+||+.||.+|||+.|+++||||+..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 99999999999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=405.69 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=207.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||++.++.+++.||+|++...... ...+.+|+.+++.++||||++++++|...+ .+|+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-EEEE
Confidence 468999999999999999999999999999999999764332 245778999999999999999999997655 6889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--EEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD--VRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~--LKLiDFGLA~~l~~d 161 (1092)
|||||+|++|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 94 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999999987654 999999999999999999999999999999999999987765 999999999866555
Q ss_pred ccCccccCCCCcCCchhhccCCCCcc-ccchhHHHHHHHHHhCCCCCcccCh----HHHHHHhhccCCC-CCCCCCCHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFK-SDIWSLGCCMYEMAAHRPAFKAFDM----AGLISKINRSSIG-PLPSCYSPSL 235 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~K-SDVWSLGVILYELLTGr~PF~g~d~----~dli~kI~~~~i~-plPs~iS~eL 235 (1092)
......+||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+... ...+..+...... +....+++++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 55566789999999999988888655 8999999999999999999987443 3333333332222 2233579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+||.+||++||.+|||+.|+++||||.+.
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 252 CHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=402.72 Aligned_cols=260 Identities=25% Similarity=0.438 Sum_probs=213.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||++++++|...+ .+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-SLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-CEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-EEEEE
Confidence 58999999999999999999999999999999998754321 11224557999999999999999999996655 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
|||++| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred eccccc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 999975 9999988754 35899999999999999999999999999999999999999999999999999866533 23
Q ss_pred CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC----------------
Q 043248 164 ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---------------- 226 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---------------- 226 (1092)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 345688999999999976 568999999999999999999999999988776666654321111
Q ss_pred -------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 227 -------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 227 -------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
....++.++.+||.+||+.||.+|||++|+|+||||..+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 112468899999999999999999999999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=386.06 Aligned_cols=264 Identities=39% Similarity=0.686 Sum_probs=232.9
Q ss_pred CccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCe
Q 043248 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE-KGC 79 (1092)
Q Consensus 1 MEsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e-~d~ 79 (1092)
|-.++++|++++.||+|+||.||++.++.+++.||+|.+............+.+|+.++++++||||++++++|.. .+.
T Consensus 1 ~p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp --CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred CCCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 4567899999999999999999999999999999999998776666667789999999999999999999998865 346
Q ss_pred EEEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEcCCCCEEEeec
Q 043248 80 YVCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNY-----VLHRDLKCSNIFLTKDQDVRLGDF 152 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkG-----IIHRDLKPENILLD~dG~LKLiDF 152 (1092)
.+|+||||++|++|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 789999999999999999764 2344899999999999999999999999 999999999999999999999999
Q ss_pred Cccccccccc-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCC
Q 043248 153 GLAKTLKADD-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 153 GLA~~l~~d~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~i 231 (1092)
|++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.......++..+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence 9998765432 223457999999999999989999999999999999999999999998888888888777777788889
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+.++.+||.+||+.||.+|||+.++|+|+|+..
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=384.26 Aligned_cols=259 Identities=22% Similarity=0.440 Sum_probs=228.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|...+ .+|
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 90 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-RIY 90 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-EEE
Confidence 4689999999999999999999999999999999987543221 12356889999999999999999999986654 778
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 99999999999999987654 899999999999999999999999999999999999999999999999999766533
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..... .++..++..+.+||.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 246 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISKL 246 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-CCCCcCCHHHHHHHHHH
Confidence 23456899999999999999999999999999999999999999998887777666655433 46677899999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHhHhh
Q 043248 243 LRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|..||.+|||++++++||||+....
T Consensus 247 l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 247 LRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp SCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred hhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999986544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=380.48 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=217.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.++..+ +||||++++++|...+ .+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-HMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-EEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-eEEE
Confidence 4689999999999999999999999999999999987655444566788999999999 9999999999997655 7789
Q ss_pred EEeecCCCCHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-----------------
Q 043248 84 VTGYCEGGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD----------------- 144 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~--gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d----------------- 144 (1092)
||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999998642 1348999999999999999999999999999999999999844
Q ss_pred --CCEEEeecCccccccccccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhc
Q 043248 145 --QDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR 221 (1092)
Q Consensus 145 --G~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~ 221 (1092)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.++|.... ....+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~ 242 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQ 242 (289)
T ss_dssp -CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHT
T ss_pred CceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHc
Confidence 37999999999877643 234699999999999765 56789999999999999999998876543 3344555
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 222 SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 222 ~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.....++..++.++.+||.+||+.||.+|||+.++|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 55666778899999999999999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=408.61 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=213.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||++++++|...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 468999999999999999999999999999999999876555666678899999999999999999999997554
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+|||||++ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 378899999975 78888853 3899999999999999999999999999999999999999999999999999887
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC-----------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL----------- 227 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl----------- 227 (1092)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+......+.
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 665555667899999999999999999999999999999999999999999887776666544321110
Q ss_pred ------------------------CC------CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 228 ------------------------PS------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 228 ------------------------Ps------~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+. ..+.++++||++||..||.+|||++|+|+||||+.+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 328 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence 00 014678999999999999999999999999999876553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=418.98 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=203.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----e
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----C 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~ 79 (1092)
..++|++++.||+|+||.||+|.++.+++.||||++..........+.+.+|+.+|+.++||||++++++|.... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 357899999999999999999999999999999999776566666778999999999999999999999985442 4
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||++ ++|.+++.... .|++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEeccc-cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 6889999985 69999997654 49999999999999999999999999999999999999999999999999998764
Q ss_pred ccc----------------------------cCccccCCCCcCCchhh-ccCCCCccccchhHHHHHHHHHh--------
Q 043248 160 ADD----------------------------LASSVVGTPNYMCPELL-ADIPYGFKSDIWSLGCCMYEMAA-------- 202 (1092)
Q Consensus 160 ~d~----------------------------~~st~vGTp~YmAPEVL-~g~~yS~KSDVWSLGVILYELLT-------- 202 (1092)
... .....+||++|+|||++ .+..|+.++||||||||||+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 321 23456899999999986 56679999999999999999998
Q ss_pred ---CCCCCcccCh--------------------HHHHHHhhcc------------------------------CCCCCCC
Q 043248 203 ---HRPAFKAFDM--------------------AGLISKINRS------------------------------SIGPLPS 229 (1092)
Q Consensus 203 ---Gr~PF~g~d~--------------------~dli~kI~~~------------------------------~i~plPs 229 (1092)
|+++|.+.+. .+++..+... .+.....
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7777766431 1121111100 0001123
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+++++.+||++||.+||.+|||++|+|+||||+.+..
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 45899999999999999999999999999999987643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=395.69 Aligned_cols=257 Identities=25% Similarity=0.460 Sum_probs=226.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.++|++.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.++++++||||++++++|...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-D 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-E
Confidence 357999999999999999999999999999999997643221 12456889999999999999999999986654 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CEEEeecCccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ----DVRLGDFGLAK 156 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG----~LKLiDFGLA~ 156 (1092)
+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 889999999999999998654 489999999999999999999999999999999999999887 79999999998
Q ss_pred cccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CCCCCH
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PSCYSP 233 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps~iS~ 233 (1092)
............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+........ ...++.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 87766556677899999999999999999999999999999999999999999888777777765443321 245789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 9999999999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=385.13 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=207.8
Q ss_pred CccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 1 MEsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
|+-..++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.++..+++.++||||++++++|...+ .
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~ 80 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-D 80 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-S
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-C
Confidence 455678999999999999999999999999999999999766555555555666666788899999999999997655 5
Q ss_pred EEEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 81 VCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
+|+||||++| +|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 7799999975 888887642 334599999999999999999999998 999999999999999999999999999988
Q ss_pred ccccccCccccCCCCcCCchhh----ccCCCCccccchhHHHHHHHHHhCCCCCccc-ChHHHHHHhhccCC-CCCCCCC
Q 043248 158 LKADDLASSVVGTPNYMCPELL----ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSI-GPLPSCY 231 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL----~g~~yS~KSDVWSLGVILYELLTGr~PF~g~-d~~dli~kI~~~~i-~plPs~i 231 (1092)
...........||+.|+|||++ .+..++.++|||||||++|+|++|+.||... .............. ......+
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 7766555666899999999996 5667899999999999999999999999863 33333333333332 2334568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 99999999999999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=397.58 Aligned_cols=252 Identities=26% Similarity=0.488 Sum_probs=216.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----CCCcceEEEEEEecCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-----HPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-----HPNIVKL~gvF~e~d~ 79 (1092)
.++|++++.||+|+||.||+|.+..+++.||||++... ....+.+..|+.+++.+. ||||++++++|...+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~- 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD- 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT-
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC-
Confidence 47999999999999999999999999999999998643 334456778999999997 999999999997765
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC----------------
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---------------- 143 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---------------- 143 (1092)
.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 688999999 899999999877667999999999999999999999999999999999999975
Q ss_pred ---------CCCEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH
Q 043248 144 ---------DQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG 214 (1092)
Q Consensus 144 ---------dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d 214 (1092)
++.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+...
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence 788999999999865432 456789999999999999999999999999999999999999998877665
Q ss_pred HHHHhhccCCC-------------------------CCCC--------------------CCCHHHHHHHHHhcccCCCC
Q 043248 215 LISKINRSSIG-------------------------PLPS--------------------CYSPSLKTLIKGMLRKNPEH 249 (1092)
Q Consensus 215 li~kI~~~~i~-------------------------plPs--------------------~iS~eLkDLIrkcLqkDPsk 249 (1092)
....+...... .++. ..++.+.+||.+||+.||.+
T Consensus 267 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 346 (360)
T 3llt_A 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346 (360)
T ss_dssp HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhh
Confidence 55544322110 0011 12377889999999999999
Q ss_pred CCCHHHHHhChhhH
Q 043248 250 RPSASELLKHPFLQ 263 (1092)
Q Consensus 250 RPSaeELLqHPwFq 263 (1092)
|||+.|+|+||||+
T Consensus 347 Rpta~elL~hp~f~ 360 (360)
T 3llt_A 347 RPSPAELLKHKFLE 360 (360)
T ss_dssp SCCHHHHTTSGGGC
T ss_pred CCCHHHHhcCcccC
Confidence 99999999999995
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=399.65 Aligned_cols=261 Identities=25% Similarity=0.416 Sum_probs=206.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||+|.++.+++.||+|++...... .....+.+|+.++++++||||++++++|... ..+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTE-NKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-TEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-CeEEE
Confidence 468999999999999999999999999999999999754321 1234677899999999999999999998654 47889
Q ss_pred EEeecCCCCHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 84 VTGYCEGGDMAELMKKSN----GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~----gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
||||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999998 59999987642 1348999999999999999999999999999999999999999999999999998765
Q ss_pred cc-ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-------------
Q 043248 160 AD-DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI------------- 224 (1092)
Q Consensus 160 ~d-~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i------------- 224 (1092)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 33 23445689999999999976 4689999999999999999999999998877666655532100
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 225 --------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 225 --------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
......++.++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0012257889999999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=416.02 Aligned_cols=258 Identities=27% Similarity=0.566 Sum_probs=225.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.+|+.++||||++++++|...+ .+|
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~ 91 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMF 91 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEE
Confidence 468999999999999999999999999999999999754321 122457889999999999999999999997655 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+|||||.||+|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 92 lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999999998654 49999999999999999999999999999999999999999999999999999887766
Q ss_pred cCccccCCCCcCCchhhcc---CCCCccccchhHHHHHHHHHhCCCCCcccC---hHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 163 LASSVVGTPNYMCPELLAD---IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---MAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g---~~yS~KSDVWSLGVILYELLTGr~PF~g~d---~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.... .......+.. ....++..++..+.
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~p~~~s~~~~ 248 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-TVVTYPSAWSQEMV 248 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-CCCCCCTTSCHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-cccCCCCcCCHHHH
Confidence 6778899999999999964 458999999999999999999999997533 3333333333 33456778999999
Q ss_pred HHHHHhcccCCCCCCC-HHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPS-ASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPS-aeELLqHPwFq~~ 265 (1092)
+||.+||++||.+||+ ++++++||||..+
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 9999999999999998 9999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=406.52 Aligned_cols=262 Identities=25% Similarity=0.468 Sum_probs=220.6
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec----
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK---- 77 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~---- 77 (1092)
+...++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||++++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567899999999999999999999999999999999875432 233699999999999999999998543
Q ss_pred ---------------------------------CeEEEEEEeecCCCCHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHH
Q 043248 78 ---------------------------------GCYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVD 122 (1092)
Q Consensus 78 ---------------------------------d~~lyLVMEYceGGSL~DLLkk--k~gk~LSEeqI~kIa~QILsALa 122 (1092)
+.++++|||||+| +|.+++.. ..+..+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 2358899999985 88887764 23445999999999999999999
Q ss_pred HHHHCCccccCCCCCcEEEc-CCCCEEEeecCccccccccccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHH
Q 043248 123 YLHSNYVLHRDLKCSNIFLT-KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEM 200 (1092)
Q Consensus 123 YLHSkGIIHRDLKPENILLD-~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYEL 200 (1092)
|||++||+||||||+|||++ .++.+||+|||++..+..........||+.|+|||++.+. .|+.++|||||||++|+|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999999999997 6789999999999988766666778899999999998765 489999999999999999
Q ss_pred HhCCCCCcccChHHHHHHhhccCCC----------------------------CCCCCCCHHHHHHHHHhcccCCCCCCC
Q 043248 201 AAHRPAFKAFDMAGLISKINRSSIG----------------------------PLPSCYSPSLKTLIKGMLRKNPEHRPS 252 (1092)
Q Consensus 201 LTGr~PF~g~d~~dli~kI~~~~i~----------------------------plPs~iS~eLkDLIrkcLqkDPskRPS 252 (1092)
++|+.||.+.+..+.+..+...... .++..++.++.+||.+||++||.+|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999998877666665431100 134557899999999999999999999
Q ss_pred HHHHHhChhhHhHhhhcC
Q 043248 253 ASELLKHPFLQHFVDQYR 270 (1092)
Q Consensus 253 aeELLqHPwFq~~~d~~~ 270 (1092)
+.|+|+||||+.+...+.
T Consensus 316 ~~e~l~hp~f~~~~~~~~ 333 (383)
T 3eb0_A 316 PYEAMAHPFFDHLRNSYE 333 (383)
T ss_dssp HHHHHTSGGGHHHHHC--
T ss_pred HHHHhcCHHHHHHHhhcc
Confidence 999999999998876544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=382.94 Aligned_cols=260 Identities=25% Similarity=0.500 Sum_probs=223.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++||||++++++|...+ .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT-DV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC-eE
Confidence 68999999999999999999999999999999987653221 12457889999999999999999999996654 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CEEEeecCcccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ----DVRLGDFGLAKT 157 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG----~LKLiDFGLA~~ 157 (1092)
|+||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 899999999999999987553 89999999999999999999999999999999999998877 799999999988
Q ss_pred ccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHH
Q 043248 158 LKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPS 234 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~e 234 (1092)
...........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....... ....++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 766555566789999999999999999999999999999999999999999988777777665543322 12457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+.+||.+||..||.+|||+.++|+||||+.....
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 9999999999999999999999999999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=420.92 Aligned_cols=257 Identities=27% Similarity=0.528 Sum_probs=224.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-EEEEE
Confidence 46899999999999999999999999999999999754333233467889999999999999999999996654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT---KDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD---~dG~LKLiDFGLA~~l~~d 161 (1092)
||||.|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+...
T Consensus 100 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999999987654 99999999999999999999999999999999999995 4557999999999887766
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~eLkDL 238 (1092)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+...++..+....... ....+++++++|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66667789999999999976 59999999999999999999999999998888888877654432 224579999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
|++||++||.+|||+.++|+||||+.+
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=387.34 Aligned_cols=257 Identities=30% Similarity=0.515 Sum_probs=215.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.++.++..||+|++....... ..+.+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-NMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheecCC-eEEEE
Confidence 468999999999999999999999999999999997654322 2456889999999999999999999996554 67899
Q ss_pred EeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCEEEeecCcccccc
Q 043248 85 TGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---TKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---D~dG~LKLiDFGLA~~l~ 159 (1092)
|||++|++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999998653 23459999999999999999999999999999999999999 445789999999998877
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKT 237 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkD 237 (1092)
.........||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+...... .....+++.+.+
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVD 257 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHH
T ss_pred CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHH
Confidence 666566778999999999986 46899999999999999999999999988877766665543322 222347899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||.+||+.||.+|||+.|+|+||||++
T Consensus 258 li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=411.88 Aligned_cols=258 Identities=28% Similarity=0.515 Sum_probs=220.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHH-HHhcCCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMAL-IARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqI-LkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|++++.||+|+||.||+|.++.+++.||+|++....... .....+.+|..+ ++.++||||++++++|...+ .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~-~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS-EE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC-EE
Confidence 4679999999999999999999999999999999997664332 233456667766 56789999999999997655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-c
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-A 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~ 160 (1092)
|+|||||+||+|.+++.+... +++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 899999999999999987654 8999999999999999999999999999999999999999999999999998643 3
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...+...+..... .++..++..+++||+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLE 271 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHH
Confidence 3445677999999999999999999999999999999999999999999888888888776544 356678999999999
Q ss_pred HhcccCCCCCCCH----HHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPSA----SELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPSa----eELLqHPwFq~~ 265 (1092)
+||++||.+|+++ .++++||||+.+
T Consensus 272 ~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 272 GLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999999986 799999999763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=407.94 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=218.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----e
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-----C 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-----~ 79 (1092)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||++++++|...+ .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999999999999999999766566666778999999999999999999999997553 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 468999999 78999999873 38999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC---------------
Q 043248 160 ADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS--------------- 223 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~--------------- 223 (1092)
.. ....+||++|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+...++..+....
T Consensus 180 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 180 SE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp SS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred cc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 33 456789999999999977 689999999999999999999999999887766665553211
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 ---------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 ---------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+..+...+++.+.+||.+||..||.+|||++++|+||||+.+.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 11123456899999999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=421.35 Aligned_cols=259 Identities=31% Similarity=0.523 Sum_probs=225.0
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
...++|++++.||+|+||.||+|.++.+++.||+|++....... .....+.+|+.+++.++||||++++++|.+.+ .+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-YL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EE
Confidence 35689999999999999999999999999999999997532111 11234778999999999999999999997654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|||||||+||+|.+++.... +++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~~~---~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 89999999999999997643 899999999999999999999999999999999999999999999999999877654
Q ss_pred c--cCccccCCCCcCCchhhccCC----CCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC---CCCCCCCCC
Q 043248 162 D--LASSVVGTPNYMCPELLADIP----YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS---IGPLPSCYS 232 (1092)
Q Consensus 162 ~--~~st~vGTp~YmAPEVL~g~~----yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~---i~plPs~iS 232 (1092)
. .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+...+..++.... ..+....++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 3 234678999999999997665 7899999999999999999999999998888888776532 223334689
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHhChhhHhH
Q 043248 233 PSLKTLIKGMLRKNPEH--RPSASELLKHPFLQHF 265 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~~ 265 (1092)
.++++||++||..+|.+ |++++|+++||||+.+
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999988 9999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=419.66 Aligned_cols=259 Identities=25% Similarity=0.467 Sum_probs=224.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|++++.||+|+||.||+|.++.++..||+|++............+.+|+.+++.++||||++++++|...+ .+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-NYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEEEE
Confidence 4799999999999999999999999999999999765443333567889999999999999999999996654 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCEEEeecCccccccccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD---QDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d---G~LKLiDFGLA~~l~~d~ 162 (1092)
|||.||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++..+....
T Consensus 116 e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999999987654 9999999999999999999999999999999999999764 459999999999887766
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CCCCCHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PSCYSPSLKTLI 239 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps~iS~eLkDLI 239 (1092)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....+...+........ ...++..+++||
T Consensus 194 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 272 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence 6677889999999999864 699999999999999999999999999988888888876654322 245799999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
++||++||.+|||+.++|+||||+.....
T Consensus 273 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 273 KQMLQFDSQRRISAQQALEHPWIKEMCSK 301 (494)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred HHHCCCChhhCccHHHHhcCcccccCccc
Confidence 99999999999999999999999886543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=381.03 Aligned_cols=258 Identities=25% Similarity=0.472 Sum_probs=218.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...+ .+|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 87 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-DFF 87 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-eEE
Confidence 468999999999999999999999999999999998754321 122457889999999999999999999986654 778
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+++++|.+++..... +++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999987654 8999999999999999999999999999999999999999999999999998877665
Q ss_pred cCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...........+.... ..++..++..+.+||.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMH 244 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHH
Confidence 5566789999999999988776 689999999999999999999999887777766665543 34667789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||+.||.+|||+.++++||||+..
T Consensus 245 ~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 245 MLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.93 Aligned_cols=260 Identities=28% Similarity=0.494 Sum_probs=227.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-------ccHHHHHHHHHHHHHHHhcC-CCCcceEEEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-------QTERCRRSAHQEMALIARVQ-HPYIVEFKEAW 74 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-------~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF 74 (1092)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+.+|+.+++++. ||||++++++|
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45789999999999999999999999999999999997543 11334567889999999995 99999999998
Q ss_pred EecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 75 VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 75 ~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
... ..+|+||||+++++|.+++..... +++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 94 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETN-TFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECS-SEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccC-CeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 654 578899999999999999987643 89999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCccccCCCCcCCchhhc------cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC-
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLA------DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL- 227 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~------g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl- 227 (1092)
+.............|++.|+|||++. ...++.++|||||||++|+|++|..||...........+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98877666566778999999999985 45678999999999999999999999998887777666655443321
Q ss_pred --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 228 --PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 228 --Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
...++..+.+||.+||+.||.+|||+.++|+||||+.+
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 23578999999999999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=384.66 Aligned_cols=260 Identities=30% Similarity=0.579 Sum_probs=201.2
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..++++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++||||++++++|...+ .
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 85 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-Y 85 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-E
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-e
Confidence 357899999999999999999999999999999999996543211 12356889999999999999999999986654 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 889999999999999998653 3589999999999999999999999999999999999999999999999999987653
Q ss_pred c-ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 043248 161 D-DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 161 d-~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLI 239 (1092)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..++.++.+||
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 243 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY-EMPSFLSIEAKDLI 243 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC-CCCTTSCHHHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc-CCccccCHHHHHHH
Confidence 3 223456799999999999998999999999999999999999999988766555555443332 35667899999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+||..||.+|||++++|+||||..
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred HHHcccCHhhCCCHHHHhcCccccC
Confidence 9999999999999999999999965
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=399.82 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=219.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK----- 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~----- 77 (1092)
..+++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 357899999999999999999999999999999999866554443445677899999999999999999998764
Q ss_pred --CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 78 --GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 78 --d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
+..+|+|||||++ +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468899999985 8888876543 34999999999999999999999999999999999999999999999999999
Q ss_pred cccccc-----ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCC
Q 043248 156 KTLKAD-----DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS 229 (1092)
Q Consensus 156 ~~l~~d-----~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs 229 (1092)
..+... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+........+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 876522 22345678999999999976 568999999999999999999999999988776666654322111111
Q ss_pred C-------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 230 C-------------------------------YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 230 ~-------------------------------iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
. .++.+.+||.+||++||.+|||++|+|+||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 0 2677999999999999999999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=396.31 Aligned_cols=262 Identities=24% Similarity=0.470 Sum_probs=218.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ---TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~---se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||++++++|...+ .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ-YI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC-eE
Confidence 3689999999999999999999999999999999875421 2234567889999999999999999999996654 78
Q ss_pred EEEEeecCCCCHHHHHHHc--------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 043248 82 CIVTGYCEGGDMAELMKKS--------------------------------------NGAYFPEEKLCKWFAQLLLAVDY 123 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk--------------------------------------~gk~LSEeqI~kIa~QILsALaY 123 (1092)
|+|||||+|++|.+++... ....+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 8999999999999998521 01124678899999999999999
Q ss_pred HHHCCccccCCCCCcEEEcCCC--CEEEeecCccccccccc-----cCccccCCCCcCCchhhcc--CCCCccccchhHH
Q 043248 124 LHSNYVLHRDLKCSNIFLTKDQ--DVRLGDFGLAKTLKADD-----LASSVVGTPNYMCPELLAD--IPYGFKSDIWSLG 194 (1092)
Q Consensus 124 LHSkGIIHRDLKPENILLD~dG--~LKLiDFGLA~~l~~d~-----~~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLG 194 (1092)
||++||+||||||+|||++.++ .+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999998764321 2345679999999999965 6789999999999
Q ss_pred HHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 195 CCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 195 VILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|++|+|++|+.||.+.........+........ ...+++++.+||.+||++||.+||++.++|+||||+.+.+
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999999888777777665543321 2237899999999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=410.29 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=207.8
Q ss_pred cCCCCeEEE-EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHH-hcCCCCcceEEEEEEe---c
Q 043248 3 SRMDQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA-RVQHPYIVEFKEAWVE---K 77 (1092)
Q Consensus 3 sRIDrYeIl-KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILk-qL~HPNIVKL~gvF~e---~ 77 (1092)
..+++|.+. +.||+|+||.||+|.++.+++.||||++... ..+.+|+.++. .++||||++++++|.. .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 356789987 7899999999999999999999999998643 24557787764 4589999999999864 2
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCEEEeecCc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQDVRLGDFGL 154 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG~LKLiDFGL 154 (1092)
...+|||||||+||+|.+++.......|++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 457899999999999999998765556999999999999999999999999999999999999997 78899999999
Q ss_pred cccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH----HHHHHhhccCCC---CC
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA----GLISKINRSSIG---PL 227 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~----dli~kI~~~~i~---pl 227 (1092)
+............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...... .....+....+. +.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 99876655566788999999999999999999999999999999999999999765432 123333332222 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
...++.++.+||++||..||.+|||+.++|+||||..
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 2468999999999999999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=397.46 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=219.4
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
...+++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||++++++|...+ .+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-RW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-EE
Confidence 35789999999999999999999999999999999999877666666778889999999999999999999997655 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 89999999999988876544 3999999999999999999999999999999999999999999999999999876543
Q ss_pred -ccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC----------------
Q 043248 162 -DLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS---------------- 223 (1092)
Q Consensus 162 -~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~---------------- 223 (1092)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 334556899999999999775 78999999999999999999999999877665554432110
Q ss_pred -----CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 224 -----IGP---------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 224 -----i~p---------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
... ....++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000 01246899999999999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=380.82 Aligned_cols=256 Identities=28% Similarity=0.529 Sum_probs=220.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec---CeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK---GCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~---d~~l 81 (1092)
-..|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.++++++||||++++++|... ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3468999999999999999999999999999999987766666678899999999999999999999998753 4678
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc-CCCCEEEeecCccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLT-KDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD-~dG~LKLiDFGLA~~l 158 (1092)
|+||||+++++|.+++..... +++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999999987654 899999999999999999999999 99999999999997 7889999999999765
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHH-HHHhhccCC-CCCCCCCCHHHH
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL-ISKINRSSI-GPLPSCYSPSLK 236 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dl-i~kI~~~~i-~plPs~iS~eLk 236 (1092)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ...+..... ..++..+++++.
T Consensus 183 ~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 183 RAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp CTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred ccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence 433 3345679999999998875 589999999999999999999999987544433 333333222 124455788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||.+||+.||.+|||+.++|+||||+.
T Consensus 261 ~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=417.76 Aligned_cols=259 Identities=27% Similarity=0.476 Sum_probs=226.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-----------HHHHHHHHHHHHHHhcCCCCcceEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-----------RCRRSAHQEMALIARVQHPYIVEFKE 72 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-----------~~~r~f~rEIqILkqL~HPNIVKL~g 72 (1092)
..++|++++.||+|+||.||+|.++.++..||+|++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999999999999999997653221 23467889999999999999999999
Q ss_pred EEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEE
Q 043248 73 AWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRL 149 (1092)
Q Consensus 73 vF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKL 149 (1092)
+|... ..+|||||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 114 ~~~~~-~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDK-KYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECS-SEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcC-CEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99655 478899999999999999987654 99999999999999999999999999999999999998776 6999
Q ss_pred eecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC--
Q 043248 150 GDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL-- 227 (1092)
Q Consensus 150 iDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl-- 227 (1092)
+|||++..+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+...++..+........
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999998877666677889999999999875 689999999999999999999999999988888888876654321
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 228 -PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 228 -Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
...++.++++||++||++||.+|||+.|+|+||||+.+.
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 146899999999999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=411.44 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=214.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----e
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----C 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~ 79 (1092)
..++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.++||||++++++|.... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 457999999999999999999999999999999999876666666778999999999999999999999987653 4
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||++ ++|.+++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 6889999997 59999998654 49999999999999999999999999999999999999999999999999998765
Q ss_pred ccc-----------------------cCccccCCCCcCCchhh-ccCCCCccccchhHHHHHHHHHhC-----------C
Q 043248 160 ADD-----------------------LASSVVGTPNYMCPELL-ADIPYGFKSDIWSLGCCMYEMAAH-----------R 204 (1092)
Q Consensus 160 ~d~-----------------------~~st~vGTp~YmAPEVL-~g~~yS~KSDVWSLGVILYELLTG-----------r 204 (1092)
... .....+||++|+|||++ .+..|+.++||||||||||+|++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 432 23567899999999986 566799999999999999999984 4
Q ss_pred CCCcccCh-----------------HHHHHHhhc------------------------cCC-CC-----CCCCCCHHHHH
Q 043248 205 PAFKAFDM-----------------AGLISKINR------------------------SSI-GP-----LPSCYSPSLKT 237 (1092)
Q Consensus 205 ~PF~g~d~-----------------~dli~kI~~------------------------~~i-~p-----lPs~iS~eLkD 237 (1092)
++|.+.+. .+++..+.. ... .+ ....+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 55544321 112211111 000 00 11347999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
||++||+.||.+|||++|+|+||||+.+..
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=381.27 Aligned_cols=257 Identities=29% Similarity=0.571 Sum_probs=228.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||++++++|...+ .+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-FVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-EEE
Confidence 45789999999999999999999999999999999976542 3445667889999999999999999999986654 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d- 161 (1092)
+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999999987653 899999999999999999999999999999999999999999999999999876533
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .++..++..+.+||.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-CCccccCHHHHHHHHH
Confidence 234456799999999999998999999999999999999999999998887776666655433 4667789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||+.||.+|||++++++||||..
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HcccChhhCcCHHHHhhChheec
Confidence 99999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=392.20 Aligned_cols=252 Identities=28% Similarity=0.491 Sum_probs=209.8
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|+++++||+|+||+||+|.++.+++.||||++............+..|+..+..+ +|+||++++++|.+.+ .+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-ILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-EEEEE
Confidence 579999999999999999999999999999999876555554445556666666655 8999999999997655 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
|||| +++|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 9999 669999988765 35999999999999999999999999999999999999999999999999999887766666
Q ss_pred ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC-CCCCCCCCHHHHHHHHHhc
Q 043248 165 SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-GPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-~plPs~iS~eLkDLIrkcL 243 (1092)
....||+.|+|||++.+ .++.++|||||||++|+|++|..+|...... ..+..... ..++..++.++.+||.+||
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHHHHHHHHHc
Confidence 66789999999999886 7999999999999999999997776553322 22222211 1234568999999999999
Q ss_pred ccCCCCCCCHHHHHhChhhHh
Q 043248 244 RKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwFq~ 264 (1092)
+.||.+|||+.|+|+||||++
T Consensus 290 ~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 290 EPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGSC
T ss_pred CCChhhCcCHHHHHhCccccC
Confidence 999999999999999999963
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=419.13 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=228.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++.+.||+|+||.||+|.++.+++.||||++...... ......+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 104 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-YFYLV 104 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEEEE
Confidence 5799999999999999999999999999999999654322 223467889999999999999999999996654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---TKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---D~dG~LKLiDFGLA~~l~~d 161 (1092)
||||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999998654 39999999999999999999999999999999999999 46788999999999887766
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~eLkDL 238 (1092)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+.......+....... ....+++++++|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence 65666789999999999977 69999999999999999999999999998888888887665432 124579999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|++||++||.+|||+.|+|+||||+.+..
T Consensus 262 i~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 262 IRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 99999999999999999999999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=398.46 Aligned_cols=260 Identities=26% Similarity=0.492 Sum_probs=222.1
Q ss_pred CCCeEEE-EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEE
Q 043248 5 MDQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 5 IDrYeIl-KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~ly 82 (1092)
-++|.+. +.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.+. ||||++++++|...+ .+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~-~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS-EII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC-eEE
Confidence 3578888 8999999999999999999999999999765544444567889999999994 699999999996554 688
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCEEEeecCcccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG~LKLiDFGLA~~l~ 159 (1092)
+|||||.|++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999999987655566999999999999999999999999999999999999987 7899999999999887
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCHHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLK 236 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~eLk 236 (1092)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...... .....++..+.
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence 665566778999999999999999999999999999999999999999998877776666544332 33456899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+||.+||+.||.+|||++++|+||||+.+
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 99999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=400.85 Aligned_cols=254 Identities=30% Similarity=0.554 Sum_probs=217.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.++|++++.||+|+||.||+|.++.+++.||+|++..... ...+|+.++.++ +||||++++++|.+. ..+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDG-KYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcC-CEEEE
Confidence 4679999999999999999999999999999999976542 234678888887 799999999999654 47889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-C---CEEEeecCcccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-Q---DVRLGDFGLAKTLK 159 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G---~LKLiDFGLA~~l~ 159 (1092)
|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+... + .+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999999998754 49999999999999999999999999999999999998543 3 49999999998765
Q ss_pred cc-ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcc---cChHHHHHHhhccCCCC---CCCCCC
Q 043248 160 AD-DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA---FDMAGLISKINRSSIGP---LPSCYS 232 (1092)
Q Consensus 160 ~d-~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g---~d~~dli~kI~~~~i~p---lPs~iS 232 (1092)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.. .....+...+....+.. ....++
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 43 334567899999999999988899999999999999999999999986 34455666665544332 235689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.++++||++||..||.+|||+.++|+||||..+..
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 99999999999999999999999999999977544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=400.46 Aligned_cols=253 Identities=27% Similarity=0.500 Sum_probs=203.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... ..+.+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-EISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-eEEEE
Confidence 467999999999999999999999999999999997543 2346778999999999999999999996654 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG~LKLiDFGLA~~l~~d 161 (1092)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 127 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp ECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999997654 4899999999999999999999999999999999999975 789999999999887766
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH-HHHHhhccCCC---CCCCCCCHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-LISKINRSSIG---PLPSCYSPSLKT 237 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d-li~kI~~~~i~---plPs~iS~eLkD 237 (1092)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+...... +....++.++.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 55667789999999999999999999999999999999999999997755443 44444443322 233568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||++||+.||.+|||+.++|+||||..
T Consensus 285 li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 285 LVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=408.89 Aligned_cols=257 Identities=25% Similarity=0.486 Sum_probs=226.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||+|.++.+++.||+|++..... .....+.+|+.+|+.++||||++++++|.... .+|+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~l 125 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-EMVL 125 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-EEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-EEEE
Confidence 45789999999999999999999999999999999975432 23457889999999999999999999996654 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCCEEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK--DQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~--dG~LKLiDFGLA~~l~~d 161 (1092)
|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999997543 34899999999999999999999999999999999999974 467999999999988766
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~eLkDL 238 (1092)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...... .....++.++.+|
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 5556678999999999999999999999999999999999999999998877777777654432 2334679999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
|.+||+.||.+|||+.++|+||||+.
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHcCCChhHCcCHHHHhhCccccC
Confidence 99999999999999999999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=391.04 Aligned_cols=258 Identities=29% Similarity=0.562 Sum_probs=228.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||++++++|...+ .+|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-FVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-eEE
Confidence 45789999999999999999999999999999999976532 3445677889999999999999999999996654 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d- 161 (1092)
+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999999987653 899999999999999999999999999999999999999999999999999876533
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .++..++..+.+||++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHHH
Confidence 234456799999999999999999999999999999999999999998877776666655443 4667789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||+.||.+|||+.++|+||||...
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=422.52 Aligned_cols=257 Identities=25% Similarity=0.502 Sum_probs=230.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|.+.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||++++++|...+ .+|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~ 92 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-DIF 92 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEE
Confidence 5789999999999999999999999999999999997543221 22457889999999999999999999996654 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+|||||+|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999999997644 49999999999999999999999999999999999999999999999999999887766
Q ss_pred cCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......+..++..... ..+..+++++.+||++
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLKH 249 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHHH
Confidence 6677899999999999988776 7899999999999999999999999888787777766543 4567789999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||..||.+|||+.++++||||+.
T Consensus 250 ~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 250 MLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HcCCCchhCcCHHHHHhCHHhhh
Confidence 99999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=383.22 Aligned_cols=261 Identities=25% Similarity=0.489 Sum_probs=223.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc--HHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-Ce
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT--ERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GC 79 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s--e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~ 79 (1092)
..+++|++.+.||+|+||.||++.+..++..||+|++...... ......+.+|+.++++++||||+++++++... ..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 4578999999999999999999999999999999999754321 12346788999999999999999999998533 35
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+|||||+++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 678999999876 8888887666679999999999999999999999999999999999999999999999999998765
Q ss_pred cc---ccCccccCCCCcCCchhhccCCC--CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHH
Q 043248 160 AD---DLASSVVGTPNYMCPELLADIPY--GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 160 ~d---~~~st~vGTp~YmAPEVL~g~~y--S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~e 234 (1092)
.. .......|++.|+|||++.+... +.++|||||||++|+|++|+.||...+.......+..... .++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 239 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AIPGDCGPP 239 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCCSSSCHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CCCCccCHH
Confidence 32 22345679999999999976543 7899999999999999999999999888777777765543 466778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+.+||.+||..||.+|||+.++++||||+..
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=389.48 Aligned_cols=252 Identities=29% Similarity=0.517 Sum_probs=221.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
.|+..+.||+|+||.||+|.++.+|+.||||++....... .+.+.+|+.+++.++||||++++++|...+ .+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNVVEMYKSYLVGE-ELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCcceEEEEEEECC-EEEEEEe
Confidence 3888999999999999999999999999999997654322 356789999999999999999999997765 6789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
|++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 123 ~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999999998653 38999999999999999999999999999999999999999999999999998765432 334
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC--CCCCCCHHHHHHHHHhc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p--lPs~iS~eLkDLIrkcL 243 (1092)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....... ....+++.+.+||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 5689999999999999999999999999999999999999999888777766665543332 23357899999999999
Q ss_pred ccCCCCCCCHHHHHhChhhHh
Q 043248 244 RKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwFq~ 264 (1092)
+.||.+|||+.++|+||||..
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGG
T ss_pred cCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=419.09 Aligned_cols=260 Identities=29% Similarity=0.509 Sum_probs=223.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER-CRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~-~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++|++++.||+|+||.||+|.++.+++.||+|++........ ....+.+|+.++..++||||++++++|.+.+ .+|
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-~~~ 150 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN-NLY 150 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS-EEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-EEE
Confidence 45799999999999999999999999999999999975322111 1223778999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||+||+|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 9999999999999998743 349999999999999999999999999999999999999999999999999998765443
Q ss_pred c--CccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc----CCCCCCCCC
Q 043248 163 L--ASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS----SIGPLPSCY 231 (1092)
Q Consensus 163 ~--~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~----~i~plPs~i 231 (1092)
. ....+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+..+...++... .++.....+
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 2 34468999999999997 567899999999999999999999999998888877777542 222333458
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHHhChhhHhH
Q 043248 232 SPSLKTLIKGMLRKNPEH--RPSASELLKHPFLQHF 265 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPsk--RPSaeELLqHPwFq~~ 265 (1092)
++++++||++||..+|++ |++++|+++||||+.+
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 999999999999998888 9999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=414.25 Aligned_cols=259 Identities=29% Similarity=0.491 Sum_probs=222.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++|++++.||+|+||.||+|.++.+++.||+|++.+..... .....+.+|..++..++||||++++++|...+ .+|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN-YLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS-EEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-EEE
Confidence 4679999999999999999999999999999999997543211 12345778999999999999999999996655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||+||+|.+++.+.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 138 lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999998754 249999999999999999999999999999999999999999999999999998776543
Q ss_pred c--CccccCCCCcCCchhhc-------cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc----CCCCCCC
Q 043248 163 L--ASSVVGTPNYMCPELLA-------DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS----SIGPLPS 229 (1092)
Q Consensus 163 ~--~st~vGTp~YmAPEVL~-------g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~----~i~plPs 229 (1092)
. ....+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+...+..++... .+...+.
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 2 33568999999999997 357899999999999999999999999998888777777542 2223346
Q ss_pred CCCHHHHHHHHHhcccCCCCC---CCHHHHHhChhhHhH
Q 043248 230 CYSPSLKTLIKGMLRKNPEHR---PSASELLKHPFLQHF 265 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskR---PSaeELLqHPwFq~~ 265 (1092)
.++.++++||++||. +|.+| ++++|+++||||+.+
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 789999999999999 99998 599999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=385.18 Aligned_cols=260 Identities=30% Similarity=0.457 Sum_probs=220.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc-CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEe----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR-AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV---QHPYIVEFKEAWVE---- 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK-~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL---~HPNIVKL~gvF~e---- 76 (1092)
.++|++++.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.+ +||||++++++|..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999995 6789999999875433222223455667666665 89999999999862
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
....+|+||||++ ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 4467889999998 599999988766669999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-------------
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS------------- 223 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~------------- 223 (1092)
............|++.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 8765555566789999999999999999999999999999999999999999887766655553210
Q ss_pred -------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 224 -------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 224 -------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
...+...++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 001234578999999999999999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=395.41 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=219.8
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----eEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----CYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~~l 81 (1092)
++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.++++++||||++++++|.... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 59999999999999999999999999999999997543 3444567889999999999999999999986543 467
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||++| +|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEcccCc-CHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 899999975 9999997643 899999999999999999999999999999999999999999999999999877543
Q ss_pred cc----CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-----------
Q 043248 162 DL----ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----------- 225 (1092)
Q Consensus 162 ~~----~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----------- 225 (1092)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 22 345689999999998754 55899999999999999999999999887766655554321100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 226 -------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 226 -------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.....++.++.+||.+||++||.+|||+.|+|+||||+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 012456899999999999999999999999999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=383.76 Aligned_cols=259 Identities=28% Similarity=0.538 Sum_probs=217.1
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec----
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK---- 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~---- 77 (1092)
...++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++++ +||||++++++|...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 4568999999999999999999999999999999998755332 24677899999999 799999999999764
Q ss_pred -CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 78 -GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 78 -d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 4578999999999999999987654569999999999999999999999999999999999999999999999999998
Q ss_pred ccccc-ccCccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-CCCC
Q 043248 157 TLKAD-DLASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-PLPS 229 (1092)
Q Consensus 157 ~l~~d-~~~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~-plPs 229 (1092)
..... .......|++.|+|||++. +..++.++|||||||++|+|++|..||...........+...... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 257 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence 76533 2234567999999999996 567899999999999999999999999887766665555444332 2345
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.++..+.+||.+||..||.+||++.++++||||+.
T Consensus 258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 68999999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=385.80 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=209.8
Q ss_pred CCCCeEEE-EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIl-KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
..++|++. +.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++.++ +||||++++++|...+ .+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEED-RF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-EE
Confidence 34689996 7899999999999999999999999999765322 245688999999985 7999999999997655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---EEEeecCccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTL 158 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~---LKLiDFGLA~~l 158 (1092)
|+|||||+|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 899999999999999987653 899999999999999999999999999999999999988775 999999998865
Q ss_pred cccc--------cCccccCCCCcCCchhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccCh-------------
Q 043248 159 KADD--------LASSVVGTPNYMCPELLAD-----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM------------- 212 (1092)
Q Consensus 159 ~~d~--------~~st~vGTp~YmAPEVL~g-----~~yS~KSDVWSLGVILYELLTGr~PF~g~d~------------- 212 (1092)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 4221 1234569999999999975 5689999999999999999999999976532
Q ss_pred --HHHHHHhhccCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 213 --AGLISKINRSSIGPLP----SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 213 --~dli~kI~~~~i~plP----s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
..+...+...... ++ ..++.++.+||++||+.||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2233444433322 22 3578999999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=382.22 Aligned_cols=254 Identities=30% Similarity=0.504 Sum_probs=221.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+...... ....+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTT-HYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCC-EEEEE
Confidence 46899999999999999999999999999999999754322 2356889999999999999999999986654 77899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---TKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---D~dG~LKLiDFGLA~~l~~d 161 (1092)
|||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999999999987653 8999999999999999999999999999999999999 67889999999999765433
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~eLkDL 238 (1092)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.......+...+...... +....++.++.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 334567999999999999999999999999999999999999999988877777777655432 3345689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
|.+||..||.+|||+.++|+||||+.
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHcCCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=396.85 Aligned_cols=255 Identities=27% Similarity=0.503 Sum_probs=224.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc------cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ------TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~------se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
++|++.+.||+|+||.||+|.++.+|+.||||++..... .....+.+.+|+.+++++ +||||++++++|...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS- 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence 579999999999999999999999999999999875431 123356788999999999 799999999998664
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
...|+||||++|++|.+++..... +++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 478899999999999999987643 999999999999999999999999999999999999999999999999999888
Q ss_pred cccccCccccCCCCcCCchhhcc------CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CC
Q 043248 159 KADDLASSVVGTPNYMCPELLAD------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PS 229 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g------~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps 229 (1092)
.........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...........+........ ..
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 76666667889999999999864 3588999999999999999999999998877777766665443321 14
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
.++..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 5788999999999999999999999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=391.81 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=212.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH--PYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H--PNIVKL~gvF~e~d~~l 81 (1092)
.-++|++++.||+|+||.||++.+ .+++.||||++............+.+|+.+++.++| +||+++++++...+ .+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC-EE
Confidence 346899999999999999999997 468899999998776666667789999999999986 99999999986654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|||||| .+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+...
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 899995 5789999998765 499999999999999999999999999999999999997 678999999999877543
Q ss_pred c---cCccccCCCCcCCchhhcc-----------CCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhh-ccCCC
Q 043248 162 D---LASSVVGTPNYMCPELLAD-----------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKIN-RSSIG 225 (1092)
Q Consensus 162 ~---~~st~vGTp~YmAPEVL~g-----------~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~-~~~i~ 225 (1092)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||..... ......+. .....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 3 2345689999999999965 6789999999999999999999999986432 22233332 23334
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.++...+.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 566777899999999999999999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=391.92 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=219.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||++++++|...+ .+|+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-EEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-EEEE
Confidence 3578999999999999999999999999999999997653 3445677899999999999999999999997655 6789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||++|++|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999999987654 89999999999999999999996 9999999999999999999999999999766432
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHH------------------------
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISK------------------------ 218 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~k------------------------ 218 (1092)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 24456899999999999999999999999999999999999999987654332221
Q ss_pred ------------------hhccCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 219 ------------------INRSSIGPL-PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 219 ------------------I~~~~i~pl-Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+........ ...++.++.+||++||+.||.+|||++|+|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 111212222 234789999999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=403.50 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=220.2
Q ss_pred CeEE--EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 7 QYEI--MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 7 rYeI--lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.++++++||||++++++|...+ .+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKN-DIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEE
Confidence 4555 6789999999999999999999999999976432 33567889999999999999999999996655 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE--cCCCCEEEeecCccccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL--TKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL--D~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 165 ~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999999999987643 348999999999999999999999999999999999999 566789999999999887666
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CCCCCHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PSCYSPSLKTLI 239 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps~iS~eLkDLI 239 (1092)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+........ ...+++++.+||
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 66677899999999999999999999999999999999999999999888877777766544322 245799999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+||++||.+|||+.|+|+||||....
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=387.29 Aligned_cols=252 Identities=23% Similarity=0.447 Sum_probs=213.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec-CeEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEK-GCYVC 82 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~-d~~ly 82 (1092)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.++++++ ||||+++++++... ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 478999999999999999999999999999999987432 356789999999997 99999999999764 45678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCcccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~d 161 (1092)
+||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999998853 89999999999999999999999999999999999999777 8999999999987766
Q ss_pred ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCccc-ChHHHHHHhh-------------ccCC--
Q 043248 162 DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKIN-------------RSSI-- 224 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~-d~~dli~kI~-------------~~~i-- 224 (1092)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||... .....+..+. ....
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 66677789999999999977 67899999999999999999999999532 2222221111 0000
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 225 ---------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 225 ---------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
...+..++.++.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 011222689999999999999999999999999999998654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=380.04 Aligned_cols=256 Identities=29% Similarity=0.558 Sum_probs=228.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
-++|++++.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||++++++|...+ .+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-KLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-THHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 357999999999999999999999999999999997654322 3467889999999999999999999997655 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 99 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 9999999999998653 48999999999999999999999999999999999999999999999999998765443 2
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.......++..++..+.+||.+||
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence 34567999999999999999999999999999999999999999988777777766666666677789999999999999
Q ss_pred ccCCCCCCCHHHHHhChhhHhH
Q 043248 244 RKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 244 qkDPskRPSaeELLqHPwFq~~ 265 (1092)
..||.+|||+.++++||||...
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=405.47 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=215.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----CeE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-----GCY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-----d~~ 80 (1092)
.+|++++.||+|+||.||+|.++.+++.||||++.... +...+|+.+|+.|+||||++++++|... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 37999999999999999999999999999999986542 1234699999999999999999988643 245
Q ss_pred EEEEEeecCCCCHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCcccc
Q 043248 81 VCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKT 157 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkk--k~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~~ 157 (1092)
+++||||+++ +|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 7899999986 67776653 233459999999999999999999999999999999999999965 5689999999998
Q ss_pred ccccccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-------------
Q 043248 158 LKADDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS------------- 223 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~------------- 223 (1092)
+.........+||++|+|||++.+. .|+.++||||||||||+|++|+.||.+.+..+++.++....
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 7666556678899999999999764 79999999999999999999999999887666555543210
Q ss_pred ------CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 ------IGP---------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 ------i~p---------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+.. ++..++.++.+||.+||.+||.+|||+.|+|+||||+.+..
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 000 23356899999999999999999999999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=379.14 Aligned_cols=258 Identities=26% Similarity=0.515 Sum_probs=225.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++...+ .+|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC-eEEEE
Confidence 46899999999999999999999999999999999765544334567889999999999999999999986654 77899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD---QDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d---G~LKLiDFGLA~~l~~d 161 (1092)
|||+.+++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999999887653 8999999999999999999999999999999999999764 46999999999887665
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~eLkDL 238 (1092)
.......|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+....... ....++.++.+|
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 55556678999999999876 48999999999999999999999999988877777776554332 124579999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
|.+||..||.+|||+.++|+||||+.+.
T Consensus 257 i~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=380.34 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=215.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEE-cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC------cceEEEEEEec
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNH-RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY------IVEFKEAWVEK 77 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~d-K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN------IVKL~gvF~e~ 77 (1092)
.++|++++.||+|+||.||+|.+ +.+++.||+|++... ......+.+|+.+++.++|++ |++++++|...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 47999999999999999999998 568899999998643 334567888999999887654 99999999765
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--------------
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-------------- 143 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-------------- 143 (1092)
+ .+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~-~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 G-HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp T-EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred C-cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 5 788999999 889999998877666999999999999999999999999999999999999987
Q ss_pred -----CCCEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHH
Q 043248 144 -----DQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISK 218 (1092)
Q Consensus 144 -----dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~k 218 (1092)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 667999999999875433 3456899999999999999999999999999999999999999988776554443
Q ss_pred hhccCC-------------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 043248 219 INRSSI-------------------------------------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASE 255 (1092)
Q Consensus 219 I~~~~i-------------------------------------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeE 255 (1092)
+..... .......+.++.+||.+||+.||.+|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 322100 0011123567899999999999999999999
Q ss_pred HHhChhhHhHhh
Q 043248 256 LLKHPFLQHFVD 267 (1092)
Q Consensus 256 LLqHPwFq~~~d 267 (1092)
+|+||||+.+..
T Consensus 326 ll~hp~f~~~~~ 337 (339)
T 1z57_A 326 ALKHPFFDLLKK 337 (339)
T ss_dssp HTTSGGGGGGGC
T ss_pred HhcCHHHHHHhc
Confidence 999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=387.01 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=219.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC---e
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---C 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---~ 79 (1092)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++.... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 46899999999999999999999999999999999976532 3445667889999999999999999999987543 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+|||||+|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 46899999999999999987654 8999999999999999999999999999999999999999999999999998765
Q ss_pred ccc----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCC
Q 043248 160 ADD----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYS 232 (1092)
Q Consensus 160 ~d~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS 232 (1092)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+ ....++
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 432 2234579999999999999999999999999999999999999999888776666555443322 234589
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.++.+||.+||+.||.+||++.+++.|+|++..
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 999999999999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=394.41 Aligned_cols=260 Identities=28% Similarity=0.496 Sum_probs=212.0
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH---HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE---RCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se---~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||++++++|...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 467889999999999999999999999999999999987543222 12346789999999999999999999996554
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 86 -~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 86 -NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp -CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred -ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 67799999986 8998887643 35899999999999999999999999999999999999999999999999999877
Q ss_pred ccc-ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC----------
Q 043248 159 KAD-DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---------- 226 (1092)
Q Consensus 159 ~~d-~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---------- 226 (1092)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+......+
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 533 33455789999999999965 458999999999999999999999999988776666654321100
Q ss_pred -----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 227 -----------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 227 -----------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+...++.++.+||.+||..||.+|||+.|+|+||||..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 01345789999999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=376.04 Aligned_cols=257 Identities=23% Similarity=0.429 Sum_probs=217.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|++++.||+|+||.||+|.++.+++.||+|++...... .....+.+|+.+++.++||||+++++++...+ .+|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-EEEEE
Confidence 57899999999999999999999999999999999755432 23467889999999999999999999987654 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc---
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD--- 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d--- 161 (1092)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+...
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999986543 4899999999999999999999999999999999999999999999999999876432
Q ss_pred ccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHH-HHHHhhcc-CCCCCCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-LISKINRS-SIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~d-li~kI~~~-~i~plPs~iS~eLkDL 238 (1092)
.......|++.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ....+... ........++..+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 23455689999999999987665 789999999999999999999998755432 22222221 1112234579999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
|.+||+.||.+|||+.++++||||+..
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccCh
Confidence 999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=392.38 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=210.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC--------CCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ--------HPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~--------HPNIVKL~gvF~e 76 (1092)
.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ |+||++++++|..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999999999999999999743 334567889999999985 7889999999873
Q ss_pred ---cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCC-------
Q 043248 77 ---KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQ------- 145 (1092)
Q Consensus 77 ---~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG------- 145 (1092)
.+..+|+||||+ +++|.+++.......+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 345789999999 56777777766555699999999999999999999998 999999999999998775
Q ss_pred ------------------------------------------CEEEeecCccccccccccCccccCCCCcCCchhhccCC
Q 043248 146 ------------------------------------------DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183 (1092)
Q Consensus 146 ------------------------------------------~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~ 183 (1092)
.+||+|||++...... ....+||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 7999999999876543 44568999999999999999
Q ss_pred CCccccchhHHHHHHHHHhCCCCCcccCh------HHHHHHhhccCC---------------------------------
Q 043248 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDM------AGLISKINRSSI--------------------------------- 224 (1092)
Q Consensus 184 yS~KSDVWSLGVILYELLTGr~PF~g~d~------~dli~kI~~~~i--------------------------------- 224 (1092)
|+.++|||||||+||+|++|+.||...+. ...+..+.....
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 99999999999999999999999976431 111111111000
Q ss_pred --------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 225 --------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 225 --------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
..++...+..+.+||.+||++||.+|||+.|+|+||||+
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 001122346788999999999999999999999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=398.04 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=217.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH------HHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER------CRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~------~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
.++|++++.||+|+||.||+|.++.+++.||||++........ ....+.+|+.++++++||||++++++|...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4689999999999999999999999999999999976532211 2235677999999999999999999996554
Q ss_pred eEEEEEEeecCCC-CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 79 CYVCIVTGYCEGG-DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 79 ~~lyLVMEYceGG-SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.+|+||||+.+| +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 103 -~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 -FFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp -EEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -EEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 778999999766 99999987543 99999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 158 LKADDLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .. ......+..++.++.
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV-EAAIHPPYLVSKELM 252 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT-TTCCCCSSCCCHHHH
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH-hhccCCCcccCHHHH
Confidence 877666677889999999999988777 8899999999999999999999976332 11 112234566899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||.+||+.||.+|||+.++++||||+.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccC
Confidence 9999999999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=386.33 Aligned_cols=255 Identities=19% Similarity=0.345 Sum_probs=214.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-eEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-CYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~~lyL 83 (1092)
-++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.++++++||||+++++++.... ..+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 468999999999999999999999999999999997543222 2456779999999999999999999987654 36789
Q ss_pred EEeecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCEEEeecCccccc
Q 043248 84 VTGYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL----TKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL----D~dG~LKLiDFGLA~~l 158 (1092)
|||||+|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999986532 238999999999999999999999999999999999999 77778999999999988
Q ss_pred cccccCccccCCCCcCCchhhc--------cCCCCccccchhHHHHHHHHHhCCCCCcccC----hHHHHHHhhccCCC-
Q 043248 159 KADDLASSVVGTPNYMCPELLA--------DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSIG- 225 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~--------g~~yS~KSDVWSLGVILYELLTGr~PF~g~d----~~dli~kI~~~~i~- 225 (1092)
.........+||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ....+.++......
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 7766666778999999999986 5678999999999999999999999997432 23333433322110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhCh
Q 043248 226 -----------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHP 260 (1092)
Q Consensus 226 -----------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHP 260 (1092)
.+...++..+.+||++||+.||.+|||++|+|+||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 11122456789999999999999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=403.56 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=217.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc------CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV------QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL------~HPNIVKL~gvF~e~ 77 (1092)
..++|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.+ +|+||++++++|...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 346899999999999999999999999999999999753 33445677788888887 577999999999766
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--EEEeecCcc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD--VRLGDFGLA 155 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~--LKLiDFGLA 155 (1092)
+ .+|+||||+. ++|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 172 ~-~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 172 N-HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp T-EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred C-eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 5 7889999996 59999999877667999999999999999999999999999999999999999887 999999999
Q ss_pred ccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC----------
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---------- 225 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---------- 225 (1092)
...... ....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+.+..+......
T Consensus 250 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 250 CYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred eecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 765433 44678999999999999999999999999999999999999999988776655544321000
Q ss_pred ------------------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 043248 226 ------------------------------------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELL 257 (1092)
Q Consensus 226 ------------------------------------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELL 257 (1092)
.++...++.+.+||++||+.||.+|||++|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 01223478899999999999999999999999
Q ss_pred hChhhHhH
Q 043248 258 KHPFLQHF 265 (1092)
Q Consensus 258 qHPwFq~~ 265 (1092)
+||||+..
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=386.70 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=212.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc------cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ------TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~------se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++||||++++++|....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3689999999999999999999999999999999865432 1122345789999999999999999999986544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---EEEeecCcc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLA 155 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~---LKLiDFGLA 155 (1092)
+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 89 --~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 --YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp --EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred --eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 689999999999999987544 4999999999999999999999999999999999999987664 999999999
Q ss_pred ccccccccCccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChH-HHHHHhhccCCCC---CC
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRSSIGP---LP 228 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~-dli~kI~~~~i~p---lP 228 (1092)
.............||+.|+|||++. ...++.++|||||||++|+|++|..||...... .....+....... ..
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 8876554445668999999999974 467899999999999999999999999765432 2233333332222 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 457899999999999999999999999999999964
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=432.05 Aligned_cols=258 Identities=23% Similarity=0.496 Sum_probs=229.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
.+++|++++.||+|+||.||+|.++.+++.||||++..... .......+..|..++..+ +||||++++++|... ..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-SEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-CEE
Confidence 57899999999999999999999999999999999975422 112235677899999887 799999999988654 478
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc-c
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK-A 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~-~ 160 (1092)
||||||++||+|.+++...+. |++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++.... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 899999999999999988654 9999999999999999999999999999999999999999999999999998643 3
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+...+...+..... .++..++.++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHH
Confidence 3345667899999999999999999999999999999999999999999998888888877654 467789999999999
Q ss_pred HhcccCCCCCCCH-----HHHHhChhhHhH
Q 043248 241 GMLRKNPEHRPSA-----SELLKHPFLQHF 265 (1092)
Q Consensus 241 kcLqkDPskRPSa-----eELLqHPwFq~~ 265 (1092)
+||++||.+|+++ +||++||||+.+
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999997 999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=376.16 Aligned_cols=255 Identities=27% Similarity=0.559 Sum_probs=216.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||+|.+..+|+.||+|.+..... ...+.+|+.+++.++||||+++++++...+ .+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNT-DLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCC-EEEE
Confidence 35689999999999999999999999999999999976533 245778999999999999999999997655 6789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999997543 349999999999999999999999999999999999999999999999999998765432
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIK 240 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIr 240 (1092)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ..+..++..+.+||.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 234567999999999999989999999999999999999999999887766555544433222 234557899999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||..||.+|||+.++|+||||+.
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred HHccCChhhCcCHHHHHhCHHHhc
Confidence 999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=388.66 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=207.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.+++|++.+.||+|+||.||+|.++.+++.||||++...... ...+.+++..+..++||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 468999999999999999999999999999999998654322 234567888889999999999999996533
Q ss_pred -eEEEEEEeecCCCCHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEcC-CCCEEEeec
Q 043248 79 -CYVCIVTGYCEGGDMAELMKK--SNGAYFPEEKLCKWFAQLLLAVDYLH--SNYVLHRDLKCSNIFLTK-DQDVRLGDF 152 (1092)
Q Consensus 79 -~~lyLVMEYceGGSL~DLLkk--k~gk~LSEeqI~kIa~QILsALaYLH--SkGIIHRDLKPENILLD~-dG~LKLiDF 152 (1092)
.++|+||||+++ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 357899999986 55554442 23345899999999999999999999 999999999999999996 889999999
Q ss_pred CccccccccccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------
Q 043248 153 GLAKTLKADDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-------- 223 (1092)
Q Consensus 153 GLA~~l~~d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-------- 223 (1092)
|++..+..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 999988766666677899999999999664 48999999999999999999999999887766665553311
Q ss_pred -----------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 224 -----------------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 224 -----------------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+......++.++.+||.+||++||.+|||+.|+|+||||+.+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 011222356789999999999999999999999999999986543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=426.74 Aligned_cols=260 Identities=28% Similarity=0.497 Sum_probs=227.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||++++++|...+ .+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-ALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-EEE
Confidence 3578999999999999999999999999999999997543221 12356788999999999999999999996655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||+||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999999999987665569999999999999999999999999999999999999999999999999999887665
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC----hHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d----~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... ...+...+.. ....++..++.++++|
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQARSL 419 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHHHHH
Confidence 5566799999999999999999999999999999999999999998753 2233333332 3334667899999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 239 IKGMLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
|++||++||.+|| +++|+++||||+.+
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999 89999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=397.41 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=213.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEecCeEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ--HPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~--HPNIVKL~gvF~e~d~~lyL 83 (1092)
++|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|++|+ ||||+++++++...+ .+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-EEEE
Confidence 459999999999999999999865 899999999877666666788999999999996 599999999886655 6889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||| +.+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus 134 v~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 999 56789999998765 489999999999999999999999999999999999996 6899999999998775433
Q ss_pred --cCccccCCCCcCCchhhcc-----------CCCCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHHhhcc-CCCCC
Q 043248 163 --LASSVVGTPNYMCPELLAD-----------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINRS-SIGPL 227 (1092)
Q Consensus 163 --~~st~vGTp~YmAPEVL~g-----------~~yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~kI~~~-~i~pl 227 (1092)
.....+||+.|+|||++.+ ..|+.++||||||||||+|++|+.||.... ....+..+... ....+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 2345689999999999965 468999999999999999999999998653 22333444332 23345
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+...+.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 6667899999999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=391.57 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=197.6
Q ss_pred CCCeEEE---EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeE
Q 043248 5 MDQYEIM---EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIl---KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~ 80 (1092)
.++|++. +.||+|+||.||+|.++.+++.||+|++.... ...+.+|+.+++.+. ||||++++++|.... .
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQL-H 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-E
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-E
Confidence 4678886 78999999999999999999999999996532 345678999999997 999999999996554 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEEeecCcccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRLGDFGLAKT 157 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKLiDFGLA~~ 157 (1092)
+|+|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 789999999999999998764 499999999999999999999999999999999999998766 799999999987
Q ss_pred cccc-ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC-------hHHHHHHhhccCCCCCC-
Q 043248 158 LKAD-DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD-------MAGLISKINRSSIGPLP- 228 (1092)
Q Consensus 158 l~~d-~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d-------~~dli~kI~~~~i~plP- 228 (1092)
.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+ .......+.........
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 6543 23456689999999999999999999999999999999999999997643 23455555544332211
Q ss_pred --CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 229 --SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 229 --s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
..+++++++||.+||..||.+|||+.++++||||+.
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 247999999999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=402.15 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=203.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----Ce
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-----GC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-----d~ 79 (1092)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||++++++|... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4799999999999999999999999999999999976655556667889999999999999999999998643 24
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 578999999 68999998763 39999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-------------
Q 043248 160 ADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------- 225 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------- 225 (1092)
.. ....+||++|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+...++..+......
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 184 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred cc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 33 445789999999999977 67899999999999999999999999988876666555331100
Q ss_pred ---------C--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 226 ---------P--------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 226 ---------p--------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. .....++.+.+||.+||.+||.+|||+.++|+||||+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0 11245789999999999999999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=406.86 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=206.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT------ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s------e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.++.+++.||+|++...... ......+.+|+.+|++++||||++++++|.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 47899999999999999999999999999999999764321 1222357899999999999999999999843 3
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEEeecCcc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRLGDFGLA 155 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKLiDFGLA 155 (1092)
.+|+|||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 213 -~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 -DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -EEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -ceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4679999999999999887544 499999999999999999999999999999999999997554 4999999999
Q ss_pred ccccccccCccccCCCCcCCchhhcc---CCCCccccchhHHHHHHHHHhCCCCCcccChH-HHHHHhhccCCCCC---C
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLAD---IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLISKINRSSIGPL---P 228 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~g---~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~-dli~kI~~~~i~pl---P 228 (1092)
............+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...... .....+........ .
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 98877666677899999999999853 57889999999999999999999999865433 23333333333222 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
..++..+.+||.+||++||.+|||++|+|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 457999999999999999999999999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=399.44 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=212.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----e
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-----C 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-----~ 79 (1092)
..+|++.+.||+|+||.||+|.+..++. ||+|++..... ...+|+.+++.++||||++++++|...+ .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999987765 88888764322 2236999999999999999999986543 3
Q ss_pred EEEEEEeecCCCCHHHHHH-HcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCEEEeecCcccc
Q 043248 80 YVCIVTGYCEGGDMAELMK-KSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT-KDQDVRLGDFGLAKT 157 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLk-kk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD-~dG~LKLiDFGLA~~ 157 (1092)
++|+|||||+++.+..+.. ......+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 5789999998754333332 12234599999999999999999999999999999999999999 789999999999998
Q ss_pred ccccccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-------------
Q 043248 158 LKADDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS------------- 223 (1092)
Q Consensus 158 l~~d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~------------- 223 (1092)
..........+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 7766666678899999999999764 58999999999999999999999999987766655553310
Q ss_pred ------CC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 ------IG---------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 ------i~---------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+. .++..+++++.+||.+||++||.+|||+.|+|+||||+.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 123347889999999999999999999999999999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=375.02 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=204.3
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|++++.||+|+||.||+|.++.+++.||||++..........+.+.++..+++.++||||++++++|...+ .+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-DVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-cEE
Confidence 3578999999999999999999999999999999999876555555556666667888899999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
+||||+ ++.+..++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999 566766665543 3599999999999999999999995 9999999999999999999999999999877665
Q ss_pred ccCccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCccc-ChHHHHHHhhccCCCCCC--CCCCH
Q 043248 162 DLASSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAF-DMAGLISKINRSSIGPLP--SCYSP 233 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~-d~~dli~kI~~~~i~plP--s~iS~ 233 (1092)
.......|++.|+|||++. +..++.++|||||||++|+|++|+.||... .....+..+.......++ ..++.
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 5555678999999999994 567899999999999999999999999873 444555555544433333 35799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
++.+||.+||+.||.+||++.++++||||+.+..
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 9999999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=382.44 Aligned_cols=260 Identities=20% Similarity=0.358 Sum_probs=205.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCc---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE-
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY- 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk---~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~- 80 (1092)
.++|++.+.||+|+||.||+|.+..++. .||+|++..........+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999999887765 899999876544444567889999999999999999999999765532
Q ss_pred ----EEEEEeecCCCCHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeec
Q 043248 81 ----VCIVTGYCEGGDMAELMKKSNG----AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDF 152 (1092)
Q Consensus 81 ----lyLVMEYceGGSL~DLLkkk~g----k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDF 152 (1092)
.|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 3899999999999999975431 24899999999999999999999999999999999999999999999999
Q ss_pred CccccccccccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCC
Q 043248 153 GLAKTLKADDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLP 228 (1092)
Q Consensus 153 GLA~~l~~d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plP 228 (1092)
|++......... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........+
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 261 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP 261 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC
Confidence 999876544322 23456788999999999999999999999999999999 99999998888888887777666777
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCC-------HHHHHhChhhHh
Q 043248 229 SCYSPSLKTLIKGMLRKNPEHRPS-------ASELLKHPFLQH 264 (1092)
Q Consensus 229 s~iS~eLkDLIrkcLqkDPskRPS-------aeELLqHPwFq~ 264 (1092)
..++.++.+||.+||+.||.+||| +++++.|+|+..
T Consensus 262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 889999999999999999999999 677778888764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=387.60 Aligned_cols=261 Identities=23% Similarity=0.453 Sum_probs=222.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEE-----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVN-----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~-----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~ 77 (1092)
..++|++.+.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.++.++ +||||++++++|...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 35799999999999999999999 55667899999997543 333456789999999999 789999999999887
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCC-------------------------------------------------------
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNG------------------------------------------------------- 102 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~g------------------------------------------------------- 102 (1092)
+..+|+|||||+||+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 7778899999999999999986542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc---cCccccCC
Q 043248 103 ---------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGT 170 (1092)
Q Consensus 103 ---------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~---~~st~vGT 170 (1092)
..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 128999999999999999999999999999999999999999999999999998764332 23345788
Q ss_pred CCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHH-HHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCC
Q 043248 171 PNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG-LISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPE 248 (1092)
Q Consensus 171 p~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~d-li~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPs 248 (1092)
+.|+|||++.+..|+.++|||||||++|+|++ |..||.+..... ....+........+..+++++.+||.+||+.||.
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 338 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 338 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999999998 999998865433 3344444445567778999999999999999999
Q ss_pred CCCCHHHHHhChhhHhHhh
Q 043248 249 HRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 249 kRPSaeELLqHPwFq~~~d 267 (1092)
+|||+.++++| |+.+..
T Consensus 339 ~Rps~~ell~~--L~~~~~ 355 (359)
T 3vhe_A 339 QRPTFSELVEH--LGNLLQ 355 (359)
T ss_dssp GSCCHHHHHHH--HHHHHH
T ss_pred hCCCHHHHHHH--HHHHHH
Confidence 99999999998 665543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=375.75 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=210.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-------
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE------- 76 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e------- 76 (1092)
.-++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 3579999999999999999999999999999999987543 3445678899999999999999999998742
Q ss_pred ------cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCEEE
Q 043248 77 ------KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT-KDQDVRL 149 (1092)
Q Consensus 77 ------~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD-~dG~LKL 149 (1092)
....+|+||||++ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 2357889999998 5999998642 489999999999999999999999999999999999997 4668999
Q ss_pred eecCcccccccc----ccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC
Q 043248 150 GDFGLAKTLKAD----DLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI 224 (1092)
Q Consensus 150 iDFGLA~~l~~d----~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i 224 (1092)
+|||++...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999876432 22344578999999998865 6789999999999999999999999998776655555432211
Q ss_pred C-----------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 225 G-----------------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 225 ~-----------------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
. .....++.++.+||++||+.||.+|||+.++|+||||+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 0 1124578999999999999999999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=389.78 Aligned_cols=253 Identities=26% Similarity=0.519 Sum_probs=220.5
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++||||++++++|...+ .+|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-eEEEE
Confidence 459999999999999999999999999999999976533 3344567889999999999999999999997655 77899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||||. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 99997 58888886544 34999999999999999999999999999999999999999999999999999876533
Q ss_pred ccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-CCCCCCCHHHHHHHH
Q 043248 165 SSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG-PLPSCYSPSLKTLIK 240 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~-plPs~iS~eLkDLIr 240 (1092)
...+||+.|+|||++. +..++.++|||||||++|+|++|+.||...+.......+...... ..+..++..+.+||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 3568999999999985 567899999999999999999999999988776666666554433 234568999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||+.||.+|||++++|+||||..
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHcccChhhCcCHHHHhhChhhhc
Confidence 999999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=403.78 Aligned_cols=253 Identities=15% Similarity=0.128 Sum_probs=207.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-ccHHHHHHHHHHH---HHHHhcCCCCcceEE-------EE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEM---ALIARVQHPYIVEFK-------EA 73 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~se~~~r~f~rEI---qILkqL~HPNIVKL~-------gv 73 (1092)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999997542 2233456788999 555566899999998 66
Q ss_pred EEecCe----------------EEEEEEeecCCCCHHHHHHHcCCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcc
Q 043248 74 WVEKGC----------------YVCIVTGYCEGGDMAELMKKSNGAYFPE-------EKLCKWFAQLLLAVDYLHSNYVL 130 (1092)
Q Consensus 74 F~e~d~----------------~lyLVMEYceGGSL~DLLkkk~gk~LSE-------eqI~kIa~QILsALaYLHSkGII 130 (1092)
+...+. ..||||||+ +|+|.+++..... +++ ..++.|+.||+.||+|||++||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc--cccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 654432 378999999 5799999987532 444 88889999999999999999999
Q ss_pred ccCCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCCcCCchhhccC-----------CCCccccchhHHHHHHH
Q 043248 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI-----------PYGFKSDIWSLGCCMYE 199 (1092)
Q Consensus 131 HRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~-----------~yS~KSDVWSLGVILYE 199 (1092)
||||||+||||+.++.+||+|||++..... .....+| +.|+|||++.+. .|+.++|||||||+||+
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999999986443 3445678 999999999887 89999999999999999
Q ss_pred HHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 200 MAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 200 LLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
|++|+.||.+.........+.. ....+++++.+||.+||+.||.+|||+.++|+||||+.+...
T Consensus 306 lltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHHSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHHCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 9999999987654443333322 235679999999999999999999999999999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=376.65 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=214.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.++|++++.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.++++++||||+++++++...+ .+|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-CYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-EEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-eEEE
Confidence 468999999999999999999999999999999986543 34455678899999999999999999999986554 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 89 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999999987653 99999999999999999999999999999999999999999999999999987754432
Q ss_pred --CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC----CCCCCCHHHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP----LPSCYSPSLKT 237 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p----lPs~iS~eLkD 237 (1092)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........+........ ....++..+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 334679999999999999999999999999999999999999999887766655554443332 34568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
+|.+||.+||.+||+..+.+.+.|.
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHhcCCHhHccccHHHHHHHHH
Confidence 9999999999999965555555543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=376.50 Aligned_cols=257 Identities=33% Similarity=0.595 Sum_probs=216.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||++++++|...+ .+|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-eEEEE
Confidence 4689999999999999999999999999999999865432 22456888999999999999999999997654 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
|||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 95 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp EECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EEeCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 999999999999886543 4999999999999999999999999999999999999999999999999987644321 22
Q ss_pred CccccCCCCcCCchhh-----ccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHH
Q 043248 164 ASSVVGTPNYMCPELL-----ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLK 236 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL-----~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLk 236 (1092)
.....|++.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+...... ..+..++..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 3456799999999998 3667899999999999999999999999988877666666554332 23456789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+||.+||..||.+|||+.++++||||+..
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=390.77 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=216.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe-----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC----- 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~----- 79 (1092)
.++|++.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||++++++|...+.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 378999999999999999999999999999999998766666667889999999999999999999999976553
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 2489999997 58888773 238999999999999999999999999999999999999999999999999998665
Q ss_pred ccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-------------
Q 043248 160 ADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------- 225 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------- 225 (1092)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 196 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 AE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred cC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 33 445689999999999977 78899999999999999999999999987766655554321100
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 226 -----------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 226 -----------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.....+++.+.+||++||+.||.+|||+.|+|+||||+.+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 112346899999999999999999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=382.89 Aligned_cols=260 Identities=26% Similarity=0.446 Sum_probs=216.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
-..++|++.+.||+|+||.||+|.+ ++..||+|++............+.+|+.++++++||||++++++|...+ .+|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-CCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-ceE
Confidence 4467999999999999999999976 5789999999877666666778999999999999999999999986555 578
Q ss_pred EEEeecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
+|||||+|++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999986431 23899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhh-ccCCCCCCCCCCHHHHH
Q 043248 160 ADD-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN-RSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 160 ~d~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~-~~~i~plPs~iS~eLkD 237 (1092)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. ......++..+++.+.+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 432 2345689999999999999999999999999999999999999999888777666654 33344577889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
||.+||+.||.+|||+.++++. ++.+..
T Consensus 271 li~~~l~~dP~~Rps~~~ll~~--L~~~~~ 298 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMDL--LRPLIK 298 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH--HHHHHC
T ss_pred HHHHHccCChhhCcCHHHHHHH--HHHHHH
Confidence 9999999999999999999973 555444
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=381.89 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=226.6
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~ 77 (1092)
...++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.++++++||||++++++|...
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 34579999999999999999999997 455899999987543 344567789999999999999999999998654
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSN----------------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLK 135 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~----------------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLK 135 (1092)
+ .+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 123 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 123 K-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred C-ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 4 6789999999999999998742 1458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccC
Q 043248 136 CSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFD 211 (1092)
Q Consensus 136 PENILLD~dG~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d 211 (1092)
|+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999998764332 2234568899999999999899999999999999999998 999999988
Q ss_pred hHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 212 MAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 212 ~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.......+........+..++..+.+||++||+.||.+|||+.+++++ |+.+..
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~--L~~~~~ 335 (343)
T 1luf_A 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI--LQRMCE 335 (343)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTTC
T ss_pred hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH--HHHHHh
Confidence 888888887777767788899999999999999999999999999975 665543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=381.89 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=216.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec----C
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK----G 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~----d 78 (1092)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 35679999999999999999999999999999999996542 344456788999999999999999999987654 2
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 56889999997 5999999864 3899999999999999999999999999999999999999999999999999876
Q ss_pred ccccc-----------CccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC--
Q 043248 159 KADDL-----------ASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI-- 224 (1092)
Q Consensus 159 ~~d~~-----------~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i-- 224 (1092)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 53221 223578999999998754 6789999999999999999999999998776554443321100
Q ss_pred ---------------------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 225 ---------------------G--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 225 ---------------------~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
. .....++.++.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 01235789999999999999999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=387.95 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=211.0
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc---------ccHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR---------QTERCRRSAHQEMALIARVQHPYIVEFKEA 73 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~---------~se~~~r~f~rEIqILkqL~HPNIVKL~gv 73 (1092)
...++|++++.||+|+||.||+|.+.. +..||||++.... ......+.+.+|+.++++++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346899999999999999999999865 8999999985432 123345778999999999999999999999
Q ss_pred EEecC----eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEE
Q 043248 74 WVEKG----CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 74 F~e~d----~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKL 149 (1092)
|...+ ..+|+||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 86532 47899999998 58888887543 35999999999999999999999999999999999999999999999
Q ss_pred eecCccccccccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-----
Q 043248 150 GDFGLAKTLKADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS----- 223 (1092)
Q Consensus 150 iDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~----- 223 (1092)
+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999987666655666789999999999976 678999999999999999999999999877666555543210
Q ss_pred ------------------CC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 224 ------------------IG--------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 224 ------------------i~--------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.. .....+++.+.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 00 112346888999999999999999999999999999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=378.25 Aligned_cols=261 Identities=29% Similarity=0.531 Sum_probs=198.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||++++++|...+ .+|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS-CEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEE
Confidence 46799999999999999999999999999999998865432 223456889999999999999999999997665 5779
Q ss_pred EEeecCCCCHHHHHHHc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 84 VTGYCEGGDMAELMKKS------NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk------~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
||||++|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999999999752 234589999999999999999999999999999999999999999999999999876
Q ss_pred ccccc------cCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-----
Q 043248 158 LKADD------LASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----- 225 (1092)
Q Consensus 158 l~~d~------~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----- 225 (1092)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 64321 2234579999999999975 56899999999999999999999999887665554444332221
Q ss_pred ----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 226 ----PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 226 ----plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.....++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 22345789999999999999999999999999999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=395.81 Aligned_cols=259 Identities=16% Similarity=0.170 Sum_probs=198.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhc--CCCCcceEE-------EEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV--QHPYIVEFK-------EAWV 75 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL--~HPNIVKL~-------gvF~ 75 (1092)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 469999999999999999999999999999999987654 334455677775544444 699988855 4444
Q ss_pred ecC----------------eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHH------HHHHHHHHHHHHHHHHCCccccC
Q 043248 76 EKG----------------CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKL------CKWFAQLLLAVDYLHSNYVLHRD 133 (1092)
Q Consensus 76 e~d----------------~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI------~kIa~QILsALaYLHSkGIIHRD 133 (1092)
..+ ..+|||||||+ ++|.+++...+. .+.+..+ ..++.||+.||+|||++||+|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 332 45789999998 799999987532 2455555 67779999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeecCccccccccccCccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccC
Q 043248 134 LKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD 211 (1092)
Q Consensus 134 LKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d 211 (1092)
|||+||||+.++.+||+|||++...... .....||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999999876533 224567799999999987 789999999999999999999999998763
Q ss_pred hHHH--HHHh------hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 212 MAGL--ISKI------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 212 ~~dl--i~kI------~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.... .... ......+....++..+.+||.+||++||.+|||+.++|+||||+.+...
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 2210 0000 0011112234679999999999999999999999999999999887553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=367.94 Aligned_cols=254 Identities=24% Similarity=0.431 Sum_probs=224.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.++++++||||++++++|.+.+ .+|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC-ceEEE
Confidence 478999999999999999999986 57789999998655443 45889999999999999999999986655 57899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999997654 358999999999999999999999999999999999999999999999999998765432
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
......|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..++..+.+||.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 2334567788999999999999999999999999999999 999999988888888887776666778889999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||+.||.+|||+.++++| ++.+.
T Consensus 243 ~l~~~p~~Rps~~~ll~~--l~~l~ 265 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ--LAEIA 265 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HccCCcccCcCHHHHHHH--HHHHH
Confidence 999999999999999987 55544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=418.12 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=225.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.++++++||||++++++|...+ .+|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~l~ 261 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-DLC 261 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-EEE
Confidence 4589999999999999999999999999999999997543221 12356888999999999999999999986654 788
Q ss_pred EEEeecCCCCHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSN--GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~--gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|||||+||+|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999999998653 34599999999999999999999999999999999999999999999999999988765
Q ss_pred ccc-CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC----hHHHHHHhhccCCCCCCCCCCHHH
Q 043248 161 DDL-ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 161 d~~-~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d----~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.. ...+...+.... ..++..++..+
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 420 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYPDKFSPAS 420 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCCTTSCHHH
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCCcccCHHH
Confidence 443 345689999999999999999999999999999999999999998753 344444444433 34677899999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 236 KTLIKGMLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
.+||++||++||.+||+ ++++++||||+.+
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 99999999999999996 5899999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=368.21 Aligned_cols=253 Identities=31% Similarity=0.585 Sum_probs=207.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-------
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK------- 77 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~------- 77 (1092)
.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++++++||||++++++|...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 36899999999999999999999999999999998643 34456788999999999999999999988653
Q ss_pred -----CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeec
Q 043248 78 -----GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDF 152 (1092)
Q Consensus 78 -----d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDF 152 (1092)
...+|+||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998654 34789999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc---------------ccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcc-cChHHH
Q 043248 153 GLAKTLKAD---------------DLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGL 215 (1092)
Q Consensus 153 GLA~~l~~d---------------~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g-~d~~dl 215 (1092)
|++...... .......|++.|+|||++.+. .++.++|||||||++|+|++ ||.. ......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999876422 123346799999999999764 68999999999999999998 5543 333344
Q ss_pred HHHhhccCC---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 216 ISKINRSSI---GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 216 i~kI~~~~i---~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
...+..... ..++...+..+.+||++||+.||.+|||+.++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 444433222 2344556788999999999999999999999999999953
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=384.55 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=216.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe-----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC----- 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~----- 79 (1092)
.++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||++++++|...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999999999999999998766666667789999999999999999999999876542
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 3589999997 588877642 38999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc----------------
Q 043248 160 ADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS---------------- 222 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~---------------- 222 (1092)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 178 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 AE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 33 345689999999999976 67899999999999999999999999987765554443221
Q ss_pred --------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 223 --------------SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 223 --------------~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+......++.++.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 11123345789999999999999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=390.84 Aligned_cols=260 Identities=22% Similarity=0.416 Sum_probs=226.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-------CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-------AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWV 75 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-------~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~ 75 (1092)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||++++++|.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3478999999999999999999975 345679999997653 344566789999999999 8999999999986
Q ss_pred ecCeEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 043248 76 EKGCYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL 141 (1092)
Q Consensus 76 e~d~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL 141 (1092)
..+ .+|+||||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 158 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 158 QDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSS-SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred cCC-CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 554 67899999999999999987542 348899999999999999999999999999999999999
Q ss_pred cCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHH
Q 043248 142 TKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLIS 217 (1092)
Q Consensus 142 D~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~ 217 (1092)
+.++.+||+|||++........ .....||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.....+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987654322 233567889999999999999999999999999999999 999999988888887
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 218 KINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 218 kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+........+..++.++.+||.+||+.||.+||++.|++++ ++.+..
T Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~--L~~il~ 364 (370)
T 2psq_A 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILT 364 (370)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHH
Confidence 777776667788899999999999999999999999999986 665543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=382.81 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=223.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCc---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk---~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..++|++.+.||+|+||.||+|.+..++. .||||++.... .....+.+.+|+.++++++||||++++++|... ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-RL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-GC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-Cc
Confidence 45789999999999999999999986555 49999997543 344567789999999999999999999998554 46
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 789999999999999997654 3499999999999999999999999999999999999999999999999999987754
Q ss_pred ccc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 161 DDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 161 d~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 283 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHAL 283 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHH
Confidence 321 223356778999999999899999999999999999998 999999998888888888776667788899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+||.+||..||.+|||+.++++. ++.+..
T Consensus 284 ~~li~~~l~~dp~~Rps~~eil~~--L~~l~~ 313 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPRFSQIVSV--LDALIR 313 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence 999999999999999999999974 666554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=377.76 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=212.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCC-cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC------cceEEEEEEec
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEK-KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY------IVEFKEAWVEK 77 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tG-k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN------IVKL~gvF~e~ 77 (1092)
.++|++++.||+|+||.||+|.+..++ ..||+|++... ......+.+|+.+++.++|++ ++.++++|...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 479999999999999999999998777 68999998643 334567788999999997765 89999988665
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----------------
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---------------- 141 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---------------- 141 (1092)
+ .+||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~-~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 95 G-HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp T-EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred C-eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 5 778999999 6688888877665669999999999999999999999999999999999999
Q ss_pred ---cCCCCEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHH
Q 043248 142 ---TKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISK 218 (1092)
Q Consensus 142 ---D~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~k 218 (1092)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56788999999999865433 3456899999999999999999999999999999999999999988776554443
Q ss_pred hhccCCC-------------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 043248 219 INRSSIG-------------------------------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASE 255 (1092)
Q Consensus 219 I~~~~i~-------------------------------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeE 255 (1092)
+...... ......+.++.+||++||+.||.+|||+.|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 3221100 001112457889999999999999999999
Q ss_pred HHhChhhHhHh
Q 043248 256 LLKHPFLQHFV 266 (1092)
Q Consensus 256 LLqHPwFq~~~ 266 (1092)
+|+||||+.+.
T Consensus 331 ~l~hp~f~~~~ 341 (355)
T 2eu9_A 331 ALLHPFFAGLT 341 (355)
T ss_dssp HTTSGGGGGCC
T ss_pred HhcChhhcCCC
Confidence 99999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=374.25 Aligned_cols=260 Identities=20% Similarity=0.363 Sum_probs=225.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3578999999999999999999983 456889999987543 3444577899999999999999999999986554
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNG----------------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKC 136 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~g----------------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKP 136 (1092)
.+|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 100 -PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 57799999999999999987542 2389999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccCh
Q 043248 137 SNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDM 212 (1092)
Q Consensus 137 ENILLD~dG~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~ 212 (1092)
+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765432 1234567889999999999899999999999999999999 9999998888
Q ss_pred HHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 213 AGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 213 ~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
......+........+..++..+.+||.+||+.||.+|||+.+++++ |+.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~--l~~~~~ 311 (314)
T 2ivs_A 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD--LEKMMV 311 (314)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence 77777777666667778899999999999999999999999999987 655543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=377.32 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=216.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||++++++|...+ .+|+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-RLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-eeEE
Confidence 468999999999999999999999999999999988543 3455678999999999999999999999997655 6789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999999998754 3499999999999999999999999999999999999999999999999999987654322
Q ss_pred C---------------ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH-----HHHHhhccC
Q 043248 164 A---------------SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG-----LISKINRSS 223 (1092)
Q Consensus 164 ~---------------st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d-----li~kI~~~~ 223 (1092)
. ...+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence 1 15679999999999999999999999999999999999999987532211 0111111
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 224 IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 224 i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
...+..+++.+.+||.+||+.||.+|||+.++++ |++.+...
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~~ 283 (310)
T 3s95_A 242 -RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMH 283 (310)
T ss_dssp -HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHH
T ss_pred -ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHHh
Confidence 1235667889999999999999999999999997 57766543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=390.77 Aligned_cols=258 Identities=28% Similarity=0.510 Sum_probs=215.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEecccc--cHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQ--TERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~--se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~ 77 (1092)
.+++|++++.||+|+||.||+|.+. .+++.||||++..... .......+.+|+.+++.+ +||||++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3579999999999999999999984 5899999999864321 111224566799999999 699999999998665
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
+ .+|||||||++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 132 ~-~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 T-KLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp T-EEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred c-eEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 5 67899999999999999987653 99999999999999999999999999999999999999999999999999987
Q ss_pred ccccc--cCccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCCcccC----hHHHHHHhhccCCCCCCC
Q 043248 158 LKADD--LASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSIGPLPS 229 (1092)
Q Consensus 158 l~~d~--~~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF~g~d----~~dli~kI~~~~i~plPs 229 (1092)
+.... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.... ...+...+.. ....++.
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 287 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQ 287 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCCT
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCCCc
Confidence 64332 2345689999999999975 357899999999999999999999997543 2223333322 3345677
Q ss_pred CCCHHHHHHHHHhcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
.++..+.+||.+||.+||.+|| +++++++||||+.+
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 7899999999999999999999 99999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=364.99 Aligned_cols=252 Identities=21% Similarity=0.391 Sum_probs=222.1
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
+-..++|++++.||+|+||.||+|.++ ++..||+|++....... ..+.+|+.++++++||||++++++|...+ .+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEY-PI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS-SE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCC-ce
Confidence 456789999999999999999999876 56789999997654433 45789999999999999999999985544 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 89999999999999998754 24899999999999999999999999999999999999999999999999999876544
Q ss_pred cc--CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 162 DL--ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~--~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
.. .....|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+..+++.+.+|
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 32 223456778999999999899999999999999999998 999999988888888887776666778889999999
Q ss_pred HHHhcccCCCCCCCHHHHHhC
Q 043248 239 IKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqH 259 (1092)
|.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=390.25 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=214.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CC-----CcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HP-----YIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HP-----NIVKL~gvF~e~ 77 (1092)
.+++|++.+.||+|+||.||+|.++.+++.||||++... ......+.+|+.+++.++ |+ +|++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 468999999999999999999999999999999999743 334556778888888885 54 499999999766
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEc--CCCCEEEeecC
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH--SNYVLHRDLKCSNIFLT--KDQDVRLGDFG 153 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLH--SkGIIHRDLKPENILLD--~dG~LKLiDFG 153 (1092)
+ .+||||||+++ +|.+++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 129 ~-~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 N-HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp T-EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred C-ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 5 78899999965 9999999876566999999999999999999999 57999999999999995 46789999999
Q ss_pred ccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-------
Q 043248 154 LAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP------- 226 (1092)
Q Consensus 154 LA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p------- 226 (1092)
++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 207 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 207 SSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp TCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred Cceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 99877533 456789999999999999999999999999999999999999999887766665554311000
Q ss_pred ----------CCC------------------C----------------------------CCHHHHHHHHHhcccCCCCC
Q 043248 227 ----------LPS------------------C----------------------------YSPSLKTLIKGMLRKNPEHR 250 (1092)
Q Consensus 227 ----------lPs------------------~----------------------------iS~eLkDLIrkcLqkDPskR 250 (1092)
++. . ...++.+||.+||+.||.+|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 000 0 01378999999999999999
Q ss_pred CCHHHHHhChhhHhHh
Q 043248 251 PSASELLKHPFLQHFV 266 (1092)
Q Consensus 251 PSaeELLqHPwFq~~~ 266 (1092)
||+.|+|+||||+...
T Consensus 365 pta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 365 IQPYYALQHSFFKKTA 380 (382)
T ss_dssp CCHHHHTTSGGGCC--
T ss_pred CCHHHHhcCcccccCC
Confidence 9999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=385.84 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=219.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHH---------------HHHHHHHHHHHHHhcCCCCcc
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER---------------CRRSAHQEMALIARVQHPYIV 68 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~---------------~~r~f~rEIqILkqL~HPNIV 68 (1092)
.+++|++++.||+|+||.||+|.+ +++.||+|.+........ ....+.+|+.++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 358999999999999999999998 899999999875432110 116788999999999999999
Q ss_pred eEEEEEEecCeEEEEEEeecCCCCHHHH------HHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEE
Q 043248 69 EFKEAWVEKGCYVCIVTGYCEGGDMAEL------MKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFL 141 (1092)
Q Consensus 69 KL~gvF~e~d~~lyLVMEYceGGSL~DL------Lkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILL 141 (1092)
+++++|...+ .+|+||||++|++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 107 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 107 TCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCSEEEESSS-EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred eEEEEEeeCC-eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999997655 78899999999999998 655435569999999999999999999999 999999999999999
Q ss_pred cCCCCEEEeecCccccccccccCccccCCCCcCCchhhccC-CCCc-cccchhHHHHHHHHHhCCCCCcccCh-HHHHHH
Q 043248 142 TKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI-PYGF-KSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISK 218 (1092)
Q Consensus 142 D~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~-~yS~-KSDVWSLGVILYELLTGr~PF~g~d~-~dli~k 218 (1092)
+.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|+|++|..||..... ......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99999999999999876544 34556899999999999877 6666 99999999999999999999988766 566666
Q ss_pred hhccCCCCCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 219 INRSSIGPLP-------------------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 219 I~~~~i~plP-------------------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+...... ++ ..++.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 265 i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 265 IRTKNIE-YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HTSCCCC-CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhccCcC-CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 6544332 23 568999999999999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=367.03 Aligned_cols=255 Identities=21% Similarity=0.357 Sum_probs=220.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||++.+. ++..||+|++....... ..+.+|+.++++++||||++++++|...+ .+|+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC-CeEE
Confidence 4579999999999999999999876 67789999998654443 45789999999999999999999986544 6779
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 97 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999999999986432 49999999999999999999999999999999999999999999999999998765432
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+........+..+++.+.+||.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHH
Confidence 2233457788999999999899999999999999999998 99999998888888888777666677888999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+||+.+|.+|||+.++++| ++.+.
T Consensus 256 ~~l~~~p~~Rps~~~ll~~--L~~~~ 279 (283)
T 3gen_A 256 SCWHEKADERPTFKILLSN--ILDVM 279 (283)
T ss_dssp HTTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHccCChhHCcCHHHHHHH--HHHHh
Confidence 9999999999999999987 55443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=382.90 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=210.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----------CCCcceEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-----------HPYIVEFKEA 73 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-----------HPNIVKL~gv 73 (1092)
.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.++++++ |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 57999999999999999999999999999999999743 233456788999998886 8999999999
Q ss_pred EEecC---eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcC------
Q 043248 74 WVEKG---CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTK------ 143 (1092)
Q Consensus 74 F~e~d---~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~------ 143 (1092)
|...+ ..+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 87543 3788999999 88999999986666699999999999999999999998 9999999999999953
Q ss_pred CCCEEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh------HHHHH
Q 043248 144 DQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM------AGLIS 217 (1092)
Q Consensus 144 dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~------~dli~ 217 (1092)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+.
T Consensus 174 ~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred cceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 347999999999876543 3456899999999999999999999999999999999999999986431 11111
Q ss_pred HhhccC-----------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 043248 218 KINRSS-----------------------------------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASEL 256 (1092)
Q Consensus 218 kI~~~~-----------------------------------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeEL 256 (1092)
.+.... ...++..++.++.+||.+||+.||.+|||+.|+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 111100 001223346789999999999999999999999
Q ss_pred HhChhhHhHh
Q 043248 257 LKHPFLQHFV 266 (1092)
Q Consensus 257 LqHPwFq~~~ 266 (1092)
|+||||+...
T Consensus 332 l~hp~f~~~~ 341 (373)
T 1q8y_A 332 VNHPWLKDTL 341 (373)
T ss_dssp HTCGGGTTCT
T ss_pred hhChhhhccc
Confidence 9999998644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=369.36 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=212.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.+ ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NP 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--Cc
Confidence 457999999999999999999998654 456999988654 234456778999999999999999999999843 34
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 679999999999999998654 3489999999999999999999999999999999999999999999999999987754
Q ss_pred ccc--CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 161 DDL--ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 161 d~~--~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......+.+..+++.+.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 248 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 248 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 432 223457789999999999999999999999999999996 99999988887887777776666778889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||.+||..||.+|||+.+++++ |+.+.
T Consensus 249 li~~~l~~~p~~Rps~~~l~~~--l~~~~ 275 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKAQ--LSTIL 275 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence 9999999999999999999986 55544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=368.16 Aligned_cols=257 Identities=27% Similarity=0.498 Sum_probs=213.0
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
++|.....||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||++++++|...+ .+++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-FIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-cEEEEE
Confidence 344445589999999999999999999999999876532 23467889999999999999999999997655 678999
Q ss_pred eecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCEEEeecCccccccccc-
Q 043248 86 GYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-DQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-dG~LKLiDFGLA~~l~~d~- 162 (1092)
||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999999987532 34679999999999999999999999999999999999987 8899999999998765432
Q ss_pred cCccccCCCCcCCchhhccCC--CCccccchhHHHHHHHHHhCCCCCcccChHH--HHHHhhccCCCCCCCCCCHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIP--YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG--LISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~--yS~KSDVWSLGVILYELLTGr~PF~g~d~~d--li~kI~~~~i~plPs~iS~eLkDL 238 (1092)
......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ............++..++.++.+|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence 234567999999999997644 8899999999999999999999997654322 112222233445677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
|.+||+.||.+|||+.++|+||||+..
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=362.49 Aligned_cols=251 Identities=15% Similarity=0.282 Sum_probs=219.7
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~l 81 (1092)
-.+++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.++++++||||++++++|... ...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 35689999999999999999999984 88999999987766666677899999999999999999999998765 2567
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
++||||++|++|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+.....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 89999999999999998766556999999999999999999999999 9999999999999999999999998876543
Q ss_pred ccccCccccCCCCcCCchhhccCCCCc---cccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc-CCCCCCCCCCHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGF---KSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS-SIGPLPSCYSPSL 235 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~---KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~-~i~plPs~iS~eL 235 (1092)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||...........+... ....++..++..+
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 23457899999999998765544 799999999999999999999988777665555433 3445677899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhC
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+||.+||+.||.+|||+.++++.
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=388.52 Aligned_cols=257 Identities=18% Similarity=0.287 Sum_probs=222.3
Q ss_pred CCCeEEEEEEeecCceEEEEEE-----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVN-----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~-----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
.++|++++.||+|+||.||+|. +..++..||||++.... .......+.+|+.++++++||||++++++|....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 4689999999999999999999 45678899999986442 3344557889999999999999999999986554
Q ss_pred EEEEEEeecCCCCHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CEEEee
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNG-----AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ---DVRLGD 151 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~g-----k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG---~LKLiD 151 (1092)
..|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 56799999999999999987542 3489999999999999999999999999999999999999655 499999
Q ss_pred cCcccccccc---ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCC
Q 043248 152 FGLAKTLKAD---DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPL 227 (1092)
Q Consensus 152 FGLA~~l~~d---~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~pl 227 (1092)
||++...... .......||+.|+|||++.+..|+.++|||||||++|+|++ |..||...........+........
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~ 307 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 307 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999865332 22334678999999999999999999999999999999998 9999999988888888887776677
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
+..++..+.+||.+||+.||.+|||+.++++|.++.
T Consensus 308 ~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 888999999999999999999999999999997654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=370.81 Aligned_cols=259 Identities=24% Similarity=0.429 Sum_probs=214.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEE----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVN----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d- 78 (1092)
..++|++++.||+|+||.||+|. +..+++.||+|++... .....+.+.+|+.++++++||||++++++|...+
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35799999999999999999998 5678999999998754 3444567889999999999999999999986543
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+|+|||||++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred CceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 357899999999999999987543 4899999999999999999999999999999999999999999999999999877
Q ss_pred cccc----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH----------------HHHHH
Q 043248 159 KADD----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA----------------GLISK 218 (1092)
Q Consensus 159 ~~d~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~----------------dli~k 218 (1092)
.... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 5432 123345777899999999999999999999999999999999998653211 22333
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+......+.+..++.++.+||.+||+.||.+|||+.++++. ++.+.+
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~--L~~l~~ 291 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR--VDQIRD 291 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHHH
Confidence 33444556677899999999999999999999999999975 555543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=364.25 Aligned_cols=246 Identities=30% Similarity=0.560 Sum_probs=215.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---------
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE--------- 76 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e--------- 76 (1092)
++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.++++++||||++++++|..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 58999999999999999999999999999999997643 246689999999999999999998854
Q ss_pred ------cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEe
Q 043248 77 ------KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLG 150 (1092)
Q Consensus 77 ------~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLi 150 (1092)
....+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 23457899999999999999987655569999999999999999999999999999999999999999999999
Q ss_pred ecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCC
Q 043248 151 DFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSC 230 (1092)
Q Consensus 151 DFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~ 230 (1092)
|||++.............|++.|+|||++.+..++.++|||||||++|+|++|..||.... .....+... .++..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~---~~~~~ 239 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG---IISDI 239 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTT---CCCTT
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhcc---ccccc
Confidence 9999988776655666789999999999999999999999999999999999999886432 222333322 34566
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
++..+.+||.+||..||.+|||+.++++|.|.
T Consensus 240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 89999999999999999999999999999664
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.05 Aligned_cols=261 Identities=21% Similarity=0.411 Sum_probs=223.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEE--EEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY--VLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~V--AIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~ 80 (1092)
.+++|++.+.||+|+||.||+|.++.++..+ ++|.+.... .....+.+.+|+.+++++ +||||++++++|...+ .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-Y 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-E
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-c
Confidence 3579999999999999999999999998866 888886432 233446688999999999 8999999999996655 7
Q ss_pred EEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC
Q 043248 81 VCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD 146 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~ 146 (1092)
+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 889999999999999998653 235899999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCC
Q 043248 147 VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIG 225 (1092)
Q Consensus 147 LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~ 225 (1092)
+||+|||++.............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 260 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC
Confidence 99999999986554444445567899999999999899999999999999999998 99999998888888887776666
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
..+..++..+.+||.+||..||.+|||+.+++++ +..+...
T Consensus 261 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~ 301 (327)
T 1fvr_A 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEE 301 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHHh
Confidence 6777899999999999999999999999999987 6655543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=367.13 Aligned_cols=258 Identities=19% Similarity=0.352 Sum_probs=227.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
...++|++.+.||+|+||.||+|.++.++..||+|.+..... ..+.+.+|+.++++++||||++++++|...+ .+|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~ 85 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFY 85 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CEE
Confidence 346789999999999999999999999999999999975432 2456889999999999999999999986554 578
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999999998766679999999999999999999999999999999999999999999999999998776443
Q ss_pred c--CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 043248 163 L--ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 163 ~--~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLI 239 (1092)
. .....|++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+........+..+++.+.+||
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 2 233457889999999999999999999999999999999 9999998887777777776666667788999999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+||..||.+|||+.++++. |+.+.
T Consensus 246 ~~~l~~dp~~Rps~~~~~~~--l~~~~ 270 (288)
T 3kfa_A 246 RACWQWNPSDRPSFAEIHQA--FETMF 270 (288)
T ss_dssp HHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHhCCChhhCcCHHHHHHH--HHHHH
Confidence 99999999999999999874 44443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.16 Aligned_cols=261 Identities=27% Similarity=0.481 Sum_probs=193.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMA-LIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIq-ILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..++|++++.||+|+||.||+|.++.+++.||||++........ ...+.+|+. +++.++||||++++++|...+ .+|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-~~~ 97 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREG-DCW 97 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-EEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-ceE
Confidence 46899999999999999999999999999999999976543333 344555555 777789999999999997655 778
Q ss_pred EEEeecCCCCHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 83 IVTGYCEGGDMAELMKK---SNGAYFPEEKLCKWFAQLLLAVDYLHSN-YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkk---k~gk~LSEeqI~kIa~QILsALaYLHSk-GIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
+||||+++ +|.+++.. .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999986 88888764 2234589999999999999999999999 9999999999999999999999999999887
Q ss_pred cccccCccccCCCCcCCchhh----ccCCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhccCCCCC----CC
Q 043248 159 KADDLASSVVGTPNYMCPELL----ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRSSIGPL----PS 229 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL----~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~~i~pl----Ps 229 (1092)
..........||+.|+|||++ .+..++.++|||||||++|+|++|+.||..... ......+.......+ ..
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence 655445556899999999998 466789999999999999999999999987542 222222222222222 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.++..+.+||.+||+.||.+|||+.++++||||.....
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 57899999999999999999999999999999987543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=394.20 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=193.5
Q ss_pred CCeEE-EEEEeecCceEEEEEEEc--CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCeEE
Q 043248 6 DQYEI-MEQIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE-KGCYV 81 (1092)
Q Consensus 6 DrYeI-lKkLGkGgFGtVYLA~dK--~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e-~d~~l 81 (1092)
+.|++ .++||+|+||.||+|.++ .+++.||+|++...... ..+.+|+.+|++|+||||++++++|.. .+..+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 46777 458999999999999976 56889999999755433 356789999999999999999999975 35688
Q ss_pred EEEEeecCCCCHHHHHHHcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCEEEe
Q 043248 82 CIVTGYCEGGDMAELMKKSN-------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL----TKDQDVRLG 150 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~-------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL----D~dG~LKLi 150 (1092)
||||||++| +|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999975 8888886431 1248999999999999999999999999999999999999 677899999
Q ss_pred ecCcccccccc----ccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccCh---------HHHH
Q 043248 151 DFGLAKTLKAD----DLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---------AGLI 216 (1092)
Q Consensus 151 DFGLA~~l~~d----~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~---------~dli 216 (1092)
|||++..+... ......+||+.|+|||++.+. .|+.++|||||||+||+|++|++||.+... .+++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999876543 223457899999999999874 589999999999999999999999976443 1222
Q ss_pred HHhhccCCCC-------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 217 SKINRSSIGP-------------------------------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 217 ~kI~~~~i~p-------------------------------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..+......+ .....+..+.+||++||.+||.+|||++|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 2221110000 011226789999999999999999999999999
Q ss_pred hhhHh
Q 043248 260 PFLQH 264 (1092)
Q Consensus 260 PwFq~ 264 (1092)
|||..
T Consensus 335 p~f~~ 339 (405)
T 3rgf_A 335 PYFLE 339 (405)
T ss_dssp GGGTS
T ss_pred hhhcc
Confidence 99974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=358.14 Aligned_cols=255 Identities=24% Similarity=0.436 Sum_probs=223.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||++.+. ++..||+|++....... +.+.+|+.++++++||||++++++|...+ .+|+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 80 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICL 80 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SCEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCC-CeEE
Confidence 3579999999999999999999986 67889999998655443 46889999999999999999999986654 5779
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999999998754 348999999999999999999999999999999999999999999999999998764332
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
......|+..|+|||++.+..++.++|||||||++|+|++ |+.||...........+........+..++..+.+||.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 2234567889999999998899999999999999999999 99999998888888777776666667778999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+||+.||.+|||+.+++++ ++.+.
T Consensus 240 ~~l~~~p~~Rps~~~ll~~--L~~l~ 263 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQ--LAEIA 263 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHccCChhhCcCHHHHHHH--HHHHH
Confidence 9999999999999999986 55544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=382.03 Aligned_cols=260 Identities=23% Similarity=0.417 Sum_probs=227.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC-------CcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE-------KKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t-------Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e 76 (1092)
.++|++.+.||+|+||.||+|.+... +..||+|++... ........+.+|+.+++++ +||||++++++|..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47899999999999999999997643 357999999765 3344557788999999999 99999999999866
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
.+ .+|+|||||+|++|.+++..... ..+++..++.|+.||+.||.|||++||+||||||+||||+
T Consensus 147 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 147 DG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CC-ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 54 57899999999999999987642 3489999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998765432 2334567889999999999999999999999999999999 9999999888888888
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+........+..++.++.+||.+||+.||.+|||+.+++++ ++.+...
T Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~~~ 353 (382)
T 3tt0_A 306 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVAL 353 (382)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHH
Confidence 87776777788899999999999999999999999999997 6666543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=368.76 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=217.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC---CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe--
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA---EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC-- 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~---tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~-- 79 (1092)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..........+.+.+|+.++++++||||++++++|...+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998875 45689999998766666666789999999999999999999999876543
Q ss_pred --EEEEEEeecCCCCHHHHHHHc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecC
Q 043248 80 --YVCIVTGYCEGGDMAELMKKS----NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153 (1092)
Q Consensus 80 --~lyLVMEYceGGSL~DLLkkk----~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFG 153 (1092)
..|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 358999999999999999642 23459999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCC
Q 043248 154 LAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPS 229 (1092)
Q Consensus 154 LA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs 229 (1092)
++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc
Confidence 9987654321 233467889999999999999999999999999999999 999999888877777777766667778
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.++..+.+||.+||..||.+|||+.+++++ ++.+..
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~l~~ 308 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ--LEKLLE 308 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHH
Confidence 899999999999999999999999999987 666554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=361.25 Aligned_cols=252 Identities=25% Similarity=0.498 Sum_probs=205.6
Q ss_pred CccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH--HHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE--RCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 1 MEsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se--~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
++-.+++|++.+.||+|+||.||+|.+. +..||+|++....... ...+.+.+|+.+++.++||||++++++|...+
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 4567899999999999999999999974 7899999986543222 23467889999999999999999999986544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEcC--------CCCE
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY---VLHRDLKCSNIFLTK--------DQDV 147 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG---IIHRDLKPENILLD~--------dG~L 147 (1092)
.+|+||||++|++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 80 -NLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred -ceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 678999999999999998543 4999999999999999999999999 899999999999986 6779
Q ss_pred EEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-CCC
Q 043248 148 RLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-IGP 226 (1092)
Q Consensus 148 KLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-i~p 226 (1092)
||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ..+
T Consensus 156 kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 156 KITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234 (271)
T ss_dssp EECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred EEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence 999999998765433 235679999999999999999999999999999999999999999887766655554433 335
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+..++..+.+||.+||+.||.+|||+.|+++|
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 677789999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=369.96 Aligned_cols=261 Identities=23% Similarity=0.449 Sum_probs=221.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEE-----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNH-----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~d-----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~ 77 (1092)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||++++++|...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 357999999999999999999985 3567899999997653 334456788999999999 799999999999877
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK 143 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~ 143 (1092)
+..+|+|||||+|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 7778899999999999999987543 12889999999999999999999999999999999999999
Q ss_pred CCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChH-HHHHH
Q 043248 144 DQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMA-GLISK 218 (1092)
Q Consensus 144 dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~-dli~k 218 (1092)
++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 99999999999987654321 234568899999999999999999999999999999998 99999876543 33344
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+........+..+++.+.++|.+||+.||.+|||+.++++| ++.+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~ 310 (316)
T 2xir_A 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 310 (316)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHh
Confidence 44444455677789999999999999999999999999997 655543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=378.39 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=187.8
Q ss_pred CCCCeEEEE-EEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec---Ce
Q 043248 4 RMDQYEIME-QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK---GC 79 (1092)
Q Consensus 4 RIDrYeIlK-kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~---d~ 79 (1092)
..++|++++ .||+|+||.||+|.++.+++.||+|++.... .. ..+....++.+.||||++++++|... +.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457999965 6999999999999999999999999986532 11 12233345677999999999998652 45
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCEEEeecCccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD---QDVRLGDFGLAK 156 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d---G~LKLiDFGLA~ 156 (1092)
.+|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 68899999999999999998766679999999999999999999999999999999999999764 459999999998
Q ss_pred cccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHH----HHhhccC---CCCCCC
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLI----SKINRSS---IGPLPS 229 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli----~kI~~~~---i~plPs 229 (1092)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.... ..+...
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 180 ETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp EC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred ecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence 76533 244568899999999998888999999999999999999999999775543321 1111111 112224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 230 ~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 6899999999999999999999999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=366.20 Aligned_cols=258 Identities=19% Similarity=0.343 Sum_probs=219.8
Q ss_pred CCCCeEEEE-EEeecCceEEEEEEE--cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIME-QIGRGAFGAAILVNH--RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlK-kLGkGgFGtVYLA~d--K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..++|++.+ .||+|+||.||+|.+ ..+++.||+|++..........+.+.+|+.+++.++||||+++++++ ..+ .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~-~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE-S 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS-S
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC-C
Confidence 346899998 999999999999954 56678999999976654445567899999999999999999999998 333 4
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred cEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 679999999999999998754 399999999999999999999999999999999999999999999999999987654
Q ss_pred ccc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 161 DDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 161 d~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
... .....|++.|+|||++.+..++.++|||||||++|+|++ |+.||...........+........+..++..+
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 322 223356788999999998889999999999999999999 999999988887777777766667778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+||.+||+.||.+||++.++++. |+.++.
T Consensus 250 ~~li~~~l~~dp~~Rps~~~l~~~--L~~~~~ 279 (291)
T 1xbb_A 250 YDLMNLCWTYDVENRPGFAAVELR--LRNYYY 279 (291)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH--HHHHHH
Confidence 999999999999999999999973 555443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.62 Aligned_cols=254 Identities=20% Similarity=0.337 Sum_probs=222.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++|++.+.||+|+||.||+|.++ .+++.||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 3478999999999999999999887 467889999987543 3334557889999999999999999999986544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEe
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLG 150 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLi 150 (1092)
.+|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 102 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 102 -PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred -ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 6779999999999999997632 1347899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCC
Q 043248 151 DFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGP 226 (1092)
Q Consensus 151 DFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~p 226 (1092)
|||++........ .....|++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC
Confidence 9999987654322 233467889999999999999999999999999999999 899999988888888877776667
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 778899999999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.23 Aligned_cols=256 Identities=21% Similarity=0.377 Sum_probs=214.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEE----EEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKY----VLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~V----AIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++||||++++++|....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 468999999999999999999998887765 666654322 2233467889999999999999999999997654
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
.++|+||+.+|+|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred eEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 5689999999999999987543 499999999999999999999999999999999999999999999999999987654
Q ss_pred cccC---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 161 DDLA---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 161 d~~~---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
.... ....||..|+|||++.+..|+.++|||||||++|+|++ |+.||.+.........+......+.+..++..+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 4322 23456889999999999999999999999999999999 9999998887777777766666667788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+||.+||+.||.+||++.+++++ ++.+.
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~--l~~~~ 277 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIE--FSKMA 277 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH--HHHHH
Confidence 99999999999999999999987 55443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=367.21 Aligned_cols=255 Identities=29% Similarity=0.480 Sum_probs=210.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEecCeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ--HPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~--HPNIVKL~gvF~e~d~~l 81 (1092)
.-++|++++.||+|+||.||++.+. +++.||+|++............+.+|+.++++++ |+||+++++++...+ .+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS-EE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC-EE
Confidence 3467999999999999999999985 5889999999876666666778999999999997 599999999986655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+...
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 89999 55789999998764 489999999999999999999999999999999999996 589999999999876543
Q ss_pred c---cCccccCCCCcCCchhhcc-----------CCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhc-cCCC
Q 043248 162 D---LASSVVGTPNYMCPELLAD-----------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINR-SSIG 225 (1092)
Q Consensus 162 ~---~~st~vGTp~YmAPEVL~g-----------~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~-~~i~ 225 (1092)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.. ....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 2 2234579999999999875 4688999999999999999999999976432 223333322 2233
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 226 plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.++...+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 456677899999999999999999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=363.27 Aligned_cols=260 Identities=20% Similarity=0.298 Sum_probs=221.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..+|++.+.||+|+||.||+|.+..+ +..||+|.+... ........+.+|+.++++++||||+++++++...+...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 35799999999999999999997543 345888888653 33444567889999999999999999999977777778
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 89999999999999997643 45899999999999999999999999999999999999999999999999999876543
Q ss_pred cc-----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 162 DL-----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 162 ~~-----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
.. .....||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+........+..++..+
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 261 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHH
Confidence 32 233467889999999999999999999999999999999 778888877777777777666666778889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.+||.+||+.||.+|||+.++++. ++.+...
T Consensus 262 ~~li~~~l~~~p~~Rps~~ell~~--L~~~~~~ 292 (298)
T 3f66_A 262 YEVMLKCWHPKAEMRPSFSELVSR--ISAIFST 292 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH--HHHHHHh
Confidence 999999999999999999999985 6665554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=364.60 Aligned_cols=259 Identities=21% Similarity=0.390 Sum_probs=219.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEE-----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNH-----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~d-----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+++++ +||||++++++|...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46899999999999999999985 45778999999976533 33457789999999999 9999999999986655
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGA----------------YFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk----------------~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
.+|+||||+++++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 101 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred -CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 567999999999999999876432 489999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.+||+|||++........ .....|++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 999999999999987764432 234567889999999999999999999999999999998 9999987665443333
Q ss_pred h-hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 219 I-NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 219 I-~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. ........+..++..+.+||.+||+.||.+|||+.+++++ ++....
T Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~ 307 (313)
T 1t46_A 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL--IEKQIS 307 (313)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH--HHHHHH
Confidence 3 3333334566789999999999999999999999999986 665544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=387.07 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=223.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.++.++..||+|.+... ........+.+|+.+|++++||||+++++++...+ .+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-SCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-CcEEE
Confidence 46899999999999999999999999999999998754 23444567889999999999999999999986554 57799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||||+||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 191 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999998654 24899999999999999999999999999999999999999999999999999865433211
Q ss_pred ---ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 165 ---SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 165 ---st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
....++..|+|||++.+..|+.++|||||||++|+|++ |..||...........+......+.+..++.++.+||.
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 12235678999999998899999999999999999998 99999998887777777766666778889999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+||+.||.+|||+.++++. ++.+..
T Consensus 350 ~cl~~dP~~Rps~~~i~~~--L~~i~~ 374 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQE--LQSIRK 374 (377)
T ss_dssp HHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHcCCCchhCcCHHHHHHH--HHHHHh
Confidence 9999999999999999974 555443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.44 Aligned_cols=259 Identities=19% Similarity=0.319 Sum_probs=222.6
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCc---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk---~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.|++.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.+++.++||||++++++|...+...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 57778999999999999999766554 79999986533 334467788999999999999999999999877766689
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999997643 458999999999999999999999999999999999999999999999999998664332
Q ss_pred ----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 163 ----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 163 ----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
......|++.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+........+..++..+.+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence 2334568889999999999999999999999999999999 56667777777777777766666777889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHhhhc
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~d~~ 269 (1092)
||.+||+.||.+|||+.++++. ++.+....
T Consensus 260 li~~~l~~~p~~Rps~~~ll~~--l~~~~~~l 289 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVGE--VEQIVSAL 289 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH--HHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHHHH--HHHHHHHH
Confidence 9999999999999999999985 66666544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=362.88 Aligned_cols=260 Identities=21% Similarity=0.351 Sum_probs=223.7
Q ss_pred ccCCCCeEEEE-EEeecCceEEEEEEEc--CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 2 ESRMDQYEIME-QIGRGAFGAAILVNHR--AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 2 EsRIDrYeIlK-kLGkGgFGtVYLA~dK--~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
+...++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++++++||||+++++++. .+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 34567898887 9999999999999864 467889999997653 3445677899999999999999999999983 33
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 4789999999999999997543 34999999999999999999999999999999999999999999999999999877
Q ss_pred ccccc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCH
Q 043248 159 KADDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233 (1092)
Q Consensus 159 ~~d~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~ 233 (1092)
..... .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+........+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 240 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCH
Confidence 54322 223457889999999998899999999999999999998 9999998888777777777666677888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+.+||.+||+.||.+||++.++++| +..+..
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~--l~~~~~ 272 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQR--MRACYY 272 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHH
Confidence 99999999999999999999999997 444433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=359.52 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=218.8
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..++|++.+.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS--
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--
Confidence 457999999999999999999987643 4469999987653 3344577899999999999999999999985443
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
.|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 579999999999999998754 3489999999999999999999999999999999999999999999999999987654
Q ss_pred ccc--CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 161 DDL--ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 161 d~~--~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
... .....|++.|+|||++.+..++.++|||||||++|+|++ |+.||...........+......+.+..+++.+.+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 245 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 332 234567889999999999999999999999999999998 99999887777777777666666677789999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||.+||..||.+|||+.+++++ ++.+.
T Consensus 246 li~~~l~~~p~~Rps~~ell~~--L~~~~ 272 (281)
T 3cc6_A 246 LMTRCWDYDPSDRPRFTELVCS--LSDVY 272 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHccCCchhCcCHHHHHHH--HHHHH
Confidence 9999999999999999999986 55543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.00 Aligned_cols=263 Identities=32% Similarity=0.598 Sum_probs=209.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~-~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..+++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++||||++++++|...+ .+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-EL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-cE
Confidence 35689999999999999999999999999999999997533 33445677889999999999999999999997755 67
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 82 CIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 8999999999999999752 33458999999999999999999999999999999999999999999999999998765
Q ss_pred ccc-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--hHHHHHHhhccCCCCCC-CCCCHHH
Q 043248 160 ADD-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGPLP-SCYSPSL 235 (1092)
Q Consensus 160 ~d~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--~~dli~kI~~~~i~plP-s~iS~eL 235 (1092)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.. .......+........+ ..++.++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 432 2345679999999999999999999999999999999999999997643 33444444444443333 5689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.+||.+||..||.+|||+.+++++ ++.+...
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~--l~~l~~~ 298 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDV--AKRMHAC 298 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH--HHHHHHh
Confidence 999999999999999999999975 6665443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.65 Aligned_cols=255 Identities=15% Similarity=0.177 Sum_probs=213.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyL 83 (1092)
-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+ +|+||+++++++.... .+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-HNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT-EEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCc-eeEE
Confidence 46899999999999999999999999999999998654322 3467899999999 7999999999886554 7789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-----EEEeecCccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD-----VRLGDFGLAKTL 158 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~-----LKLiDFGLA~~l 158 (1092)
||||+ |++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 84 v~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99999 899999998754 34999999999999999999999999999999999999987776 999999999877
Q ss_pred ccccc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC---hHHHHHHhhcc----C
Q 043248 159 KADDL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---MAGLISKINRS----S 223 (1092)
Q Consensus 159 ~~d~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d---~~dli~kI~~~----~ 223 (1092)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .......+... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 54322 345679999999999999999999999999999999999999998743 22333332221 1
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 224 IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 224 i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.......++.++.+||.+||+.||.+||++.++++. |+.+...
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~--l~~~~~~ 284 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL--FSKVLER 284 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH--HHHHHHH
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH--HHHHHHh
Confidence 112334689999999999999999999999999975 6666554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=359.81 Aligned_cols=256 Identities=22% Similarity=0.410 Sum_probs=221.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++++.||+|+||.||+|.+. ++..||+|.+...... ...+.+|+.++++++||||+++++++... .+|+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE--PIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcCC--CcEE
Confidence 3478999999999999999999975 5678999999765433 35688999999999999999999988533 4679
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||++|++|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999999999755433489999999999999999999999999999999999999999999999999987754432
Q ss_pred --CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....|+..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+........+..++..+.+||.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHH
Confidence 234467889999999998899999999999999999999 99999998887777777766556677788999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+||..||.+|||+.++++. ++.+..
T Consensus 245 ~~l~~~p~~Rps~~~l~~~--l~~~~~ 269 (279)
T 1qpc_A 245 LCWKERPEDRPTFDYLRSV--LEDFFT 269 (279)
T ss_dssp HHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHhccChhhCCCHHHHHHH--HHHHHH
Confidence 9999999999999999974 555444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=363.49 Aligned_cols=253 Identities=23% Similarity=0.435 Sum_probs=213.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++.+.||+|+||.||++.+ +++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..+|+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 457999999999999999999987 47899999987543 245688999999999999999999998766667889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999999998764444899999999999999999999999999999999999999999999999999865533
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
.....+++.|+|||++.+..++.++|||||||++|+|++ |+.||...........+........+..+++.+.+||.+|
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 250 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 250 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 234467899999999999999999999999999999998 9999998887777777766655667778999999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
|..||.+|||+.++++. |+.+.
T Consensus 251 l~~~p~~Rps~~~l~~~--L~~i~ 272 (278)
T 1byg_A 251 WHLDAAMRPSFLQLREQ--LEHIK 272 (278)
T ss_dssp TCSSGGGSCCHHHHHHH--HHHHH
T ss_pred hcCChhhCCCHHHHHHH--HHHHH
Confidence 99999999999999974 55443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=361.74 Aligned_cols=250 Identities=22% Similarity=0.396 Sum_probs=211.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc--HHHH---HHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT--ERCR---RSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s--e~~~---r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... .... +.+.+|+.++++++||||++++++|....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 357999999999999999999999999999999998654322 1111 57889999999999999999999985544
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCC-----EEEee
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTKDQD-----VRLGD 151 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~dG~-----LKLiD 151 (1092)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 97 ---~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 ---RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ---EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred ---eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 58999999999999987654 35999999999999999999999999 999999999999988776 99999
Q ss_pred cCccccccccccCccccCCCCcCCchhh--ccCCCCccccchhHHHHHHHHHhCCCCCcccChHHH--HHHhhc-cCCCC
Q 043248 152 FGLAKTLKADDLASSVVGTPNYMCPELL--ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINR-SSIGP 226 (1092)
Q Consensus 152 FGLA~~l~~d~~~st~vGTp~YmAPEVL--~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dl--i~kI~~-~~i~p 226 (1092)
||++...... .....||+.|+|||++ ....++.++|||||||++|+|++|+.||........ ...+.. .....
T Consensus 173 fg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 9999855432 4456899999999999 445678999999999999999999999987553332 333322 33345
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
++..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 677889999999999999999999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=377.55 Aligned_cols=257 Identities=20% Similarity=0.321 Sum_probs=217.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcE----EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKK----YVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~----VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
..++|++++.||+|+||.||+|.+..++.. ||+|.+..... ......+.+|+.++++++||||+++++++.. .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--S 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--S
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 357899999999999999999999888876 66666643221 1112356679999999999999999998853 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 4779999999999999998653 348999999999999999999999999999999999999999999999999998875
Q ss_pred ccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 160 ADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 160 ~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
... ......|+..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........+..++.++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence 433 2344568889999999999999999999999999999999 999999888777777777666666777789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+||.+||..||.+|||+.++++| |+.+.
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~--l~~~~ 275 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANE--FTRMA 275 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHH--HHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 999999999999999999999997 55543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=370.77 Aligned_cols=261 Identities=22% Similarity=0.415 Sum_probs=224.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-------CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-------AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWV 75 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-------~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~ 75 (1092)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||++++++|.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3479999999999999999999986 457789999987543 344456788999999999 8999999999986
Q ss_pred ecCeEEEEEEeecCCCCHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 043248 76 EKGCYVCIVTGYCEGGDMAELMKKSNG--------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL 141 (1092)
Q Consensus 76 e~d~~lyLVMEYceGGSL~DLLkkk~g--------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL 141 (1092)
..+ .+|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 112 ~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 112 QDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp SSS-CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cCC-ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 544 67899999999999999986542 248999999999999999999999999999999999999
Q ss_pred cCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHH
Q 043248 142 TKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLIS 217 (1092)
Q Consensus 142 D~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~ 217 (1092)
+.++.+||+|||++........ .....|++.|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987654322 234467889999999998899999999999999999999 999999988888777
Q ss_pred HhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 218 KINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 218 kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
.+........+..++..+.+||.+||..||.+|||+.+++++ ++.+...
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~l~~~ 319 (334)
T 2pvf_A 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILTL 319 (334)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHhc
Confidence 777766666778899999999999999999999999999987 6666543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=364.03 Aligned_cols=253 Identities=21% Similarity=0.379 Sum_probs=212.0
Q ss_pred CCCeEEEEEEeecCceEEEEEE----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-e
Q 043248 5 MDQYEIMEQIGRGAFGAAILVN----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-C 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~ 79 (1092)
.++|++++.||+|+||.||+|. +..+++.||+|++..... ......+.+|+.+++.++||||++++++|...+ .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3569999999999999999999 567899999999875432 223467889999999999999999999997653 4
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred eEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 57899999999999999976543 49999999999999999999999999999999999999999999999999998776
Q ss_pred ccc----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCccc---------------ChHHHHHHhh
Q 043248 160 ADD----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAF---------------DMAGLISKIN 220 (1092)
Q Consensus 160 ~d~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~---------------d~~dli~kI~ 220 (1092)
... ......||..|+|||++.+..++.++|||||||++|+|++|..||... ........+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 443 234457888999999999999999999999999999999999886432 1223333344
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.....+.+..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 444556677899999999999999999999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=370.24 Aligned_cols=258 Identities=22% Similarity=0.388 Sum_probs=218.7
Q ss_pred CCCeEEEEEEeecCceEEEEEE----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-cCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVN----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE-KGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e-~d~ 79 (1092)
.++|++++.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 3689999999999999999999 46789999999987543 3445678999999999999999999998874 456
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||++|++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred eEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 78899999999999999987543 48999999999999999999999999999999999999999999999999998765
Q ss_pred ccc----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh---------------HHHHHHhh
Q 043248 160 ADD----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---------------AGLISKIN 220 (1092)
Q Consensus 160 ~d~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~---------------~dli~kI~ 220 (1092)
... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 432 23345688899999999998999999999999999999999999965432 22333334
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.....+.+..+++.+.+||.+||+.||.+|||+.+++++ ++.+..
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~~ 303 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ--LDMLWS 303 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHC--
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHh
Confidence 444556677889999999999999999999999999976 555443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=388.65 Aligned_cols=253 Identities=23% Similarity=0.441 Sum_probs=222.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||++.+. ++.||||++.... ..+.+.+|+.+|++++||||+++++++......+||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 4678999999999999999999875 7799999997643 235688999999999999999999998877667889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
|||||++|+|.+++...+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999999999876656899999999999999999999999999999999999999999999999999865432
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
.....++..|+|||++.+..++.++|||||||+||+|++ |+.||......+....+......+.+..+++.+.+||.+|
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 422 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 233467889999999999999999999999999999998 9999998887777777776666677888999999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
|..||.+|||+.++++. ++.+.
T Consensus 423 l~~dp~~Rpt~~~l~~~--L~~i~ 444 (450)
T 1k9a_A 423 WHLDAATRPTFLQLREQ--LEHIR 444 (450)
T ss_dssp TCSSGGGSCCHHHHHHH--HHHHH
T ss_pred cCCChhHCcCHHHHHHH--HHHHH
Confidence 99999999999999873 54443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=364.65 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=206.5
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
..+++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||++++++|...+ .+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG-QL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC-eE
Confidence 467899999999999999999999999999999999876543 3445678899999999999999999999997655 77
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 899999999999999987653 899999999999999999999999999999999999999999999999999876543
Q ss_pred c--cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHH
Q 043248 162 D--LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKT 237 (1092)
Q Consensus 162 ~--~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkD 237 (1092)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... ..+..++.++.+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 2 233567999999999999999999999999999999999999999887665444444332221 245668999999
Q ss_pred HHHHhcccCCCCCC-CHHHHHhC
Q 043248 238 LIKGMLRKNPEHRP-SASELLKH 259 (1092)
Q Consensus 238 LIrkcLqkDPskRP-SaeELLqH 259 (1092)
||.+||+.||.+|| +++++++.
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHhccCCHHHHHHhHHHHHHH
Confidence 99999999999999 88888763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=371.08 Aligned_cols=259 Identities=18% Similarity=0.289 Sum_probs=218.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEE-----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVN-----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~-----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
..++|++++.||+|+||.||+|. +..++..||+|.+.... .......+.+|+.++++++||||+++++++...+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34799999999999999999999 56778899999986442 3444567889999999999999999999986654
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCEEEe
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNG-----AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD---QDVRLG 150 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~g-----k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d---G~LKLi 150 (1092)
.+|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+
T Consensus 107 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 107 -PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred -CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 56799999999999999987542 348999999999999999999999999999999999999854 459999
Q ss_pred ecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCC
Q 043248 151 DFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGP 226 (1092)
Q Consensus 151 DFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~p 226 (1092)
|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 265 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence 999997654332 2234578999999999999899999999999999999998 999999888877777777766666
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+..++..+.+||.+||+.||.+||++.++++|.|+..
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 77889999999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=371.28 Aligned_cols=258 Identities=21% Similarity=0.344 Sum_probs=214.9
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~ 77 (1092)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++++ +||||++++++|...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3478999999999999999999973 456789999997543 233346788999999999 899999999998665
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNG---------------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKC 136 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~g---------------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKP 136 (1092)
+ .+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 122 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 122 G-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp S-SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred C-ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 4 57799999999999999986542 2378999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccCh
Q 043248 137 SNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDM 212 (1092)
Q Consensus 137 ENILLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~ 212 (1092)
+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654332 234567889999999999999999999999999999998 9999988665
Q ss_pred HHHHHHh-hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 213 AGLISKI-NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 213 ~dli~kI-~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
......+ ........+..++.++.+||.+||..||.+|||+.++++| |+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--l~~~ 332 (344)
T 1rjb_A 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF--LGCQ 332 (344)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH--HHHH
Confidence 4444333 3333445667789999999999999999999999999987 4443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=370.09 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=207.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhc----CCCCcceEEEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARV----QHPYIVEFKEAW 74 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL----~HPNIVKL~gvF 74 (1092)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.++.++ +|+||++++++|
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999999999999999996553322 1223456799999998 899999999998
Q ss_pred EecCeEEEEEEee-cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCEEEeec
Q 043248 75 VEKGCYVCIVTGY-CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT-KDQDVRLGDF 152 (1092)
Q Consensus 75 ~e~d~~lyLVMEY-ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD-~dG~LKLiDF 152 (1092)
...+ .+++|||| +.+++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~-~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQE-GFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCC-eEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 6654 66799999 789999999987653 89999999999999999999999999999999999999 7889999999
Q ss_pred CccccccccccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCC
Q 043248 153 GLAKTLKADDLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY 231 (1092)
Q Consensus 153 GLA~~l~~d~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~i 231 (1092)
|++....... .....|+..|+|||++.+..+ +.++|||||||++|+|++|+.||..... +.. ....++..+
T Consensus 185 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-~~~~~~~~~ 256 (312)
T 2iwi_A 185 GSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE-AELHFPAHV 256 (312)
T ss_dssp SSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-TCCCCCTTS
T ss_pred chhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh-hccCCcccC
Confidence 9998776443 445679999999999987666 4589999999999999999999976421 111 122356778
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 232 SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 232 S~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 999999999999999999999999999999976544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=356.39 Aligned_cols=256 Identities=20% Similarity=0.277 Sum_probs=214.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++++..+.++...+...|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999999999999999998765432 34778999999999999888777777777788999
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---TKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---D~dG~LKLiDFGLA~~l~~d 161 (1092)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9999 899999998544 349999999999999999999999999999999999999 47889999999999877654
Q ss_pred cc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh---HHHHHHhhcc----CCCC
Q 043248 162 DL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---AGLISKINRS----SIGP 226 (1092)
Q Consensus 162 ~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~---~dli~kI~~~----~i~p 226 (1092)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+... ....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 32 2456899999999999999999999999999999999999999986332 1222222211 1111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+...+++++.+||.+||+.||.+|||+.++++. |+.+...
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--l~~~~~~ 281 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL--FRNLFHR 281 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH--HHHHHHH
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH--HHHHHHh
Confidence 235689999999999999999999999999974 6665543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.13 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=210.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++++..+.++...+...|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 46899999999999999999999999999999987654322 34778999999999999888888777777788999
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---TKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---D~dG~LKLiDFGLA~~l~~d 161 (1092)
|||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999 8999999986443 49999999999999999999999999999999999999 78889999999999877544
Q ss_pred cc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---HHHHHhhc----cCCCC
Q 043248 162 DL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKINR----SSIGP 226 (1092)
Q Consensus 162 ~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---dli~kI~~----~~i~p 226 (1092)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... .....+.. .....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 22 23568999999999999999999999999999999999999999764321 22222211 11111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
....++.++.+||.+||+.||.+|||+.++++. |+.+...
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~~~~~ 281 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL--FRNLFHR 281 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH--HHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH--HHHHHHH
Confidence 235678999999999999999999999999973 6665543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.83 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=208.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---cCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE---KGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e---~d~~l 81 (1092)
.++|++++.||+|+||.||++.+..+++.||+|++... .......+.+|+.+++.++||||++++++|.. ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46899999999999999999999999999999998653 33445678899999999999999999999863 23578
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 82 CIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
|+||||+.+++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 8999999999999999863 23459999999999999999999999999999999999999999999999999987654
Q ss_pred cccc----------CccccCCCCcCCchhhccCC---CCccccchhHHHHHHHHHhCCCCCcccCh--HHHHHHhhccCC
Q 043248 160 ADDL----------ASSVVGTPNYMCPELLADIP---YGFKSDIWSLGCCMYEMAAHRPAFKAFDM--AGLISKINRSSI 224 (1092)
Q Consensus 160 ~d~~----------~st~vGTp~YmAPEVL~g~~---yS~KSDVWSLGVILYELLTGr~PF~g~d~--~dli~kI~~~~i 224 (1092)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ......+.....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence 2211 12346899999999997554 68999999999999999999999965211 111222222222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 225 ~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+.+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 33455689999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=367.34 Aligned_cols=259 Identities=20% Similarity=0.338 Sum_probs=216.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCC----cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEK----KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tG----k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
..++|++.+.||+|+||.||+|.++.++ ..||+|.+.... .......+.+|+.++++++||||+++++++... .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-K 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-S
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-C
Confidence 3568999999999999999999987653 359999987543 344456788999999999999999999998554 4
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+||||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 6789999999999999998753 349999999999999999999999999999999999999999999999999998765
Q ss_pred cccc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHH
Q 043248 160 ADDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 160 ~d~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~e 234 (1092)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+......+.+..++..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence 4321 122346788999999999999999999999999999998 99999988888887777766666677788999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+.+||.+||+.||.+||++.+++++ ++.+..
T Consensus 279 l~~li~~~l~~~p~~Rps~~~l~~~--L~~~~~ 309 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPKFADIVSI--LDKLIR 309 (333)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH--HHHHHh
Confidence 9999999999999999999999986 555543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=373.83 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=213.9
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhcC--CCCcceEEEEEEe
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARVQ--HPYIVEFKEAWVE 76 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL~--HPNIVKL~gvF~e 76 (1092)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.++++++ |+||++++++|..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34678999999999999999999999999999999997653221 11234667999999996 5999999999966
Q ss_pred cCeEEEEEEeecCC-CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCEEEeecCc
Q 043248 77 KGCYVCIVTGYCEG-GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT-KDQDVRLGDFGL 154 (1092)
Q Consensus 77 ~d~~lyLVMEYceG-GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD-~dG~LKLiDFGL 154 (1092)
.+ .+++||||+.+ ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 120 ~~-~~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PD-SFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SS-EEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CC-cEEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 55 67899999976 899999987653 89999999999999999999999999999999999999 678999999999
Q ss_pred cccccccccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCH
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~ 233 (1092)
+...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +... ...++..++.
T Consensus 197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-~~~~~~~~~~ 268 (320)
T 3a99_A 197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRVSS 268 (320)
T ss_dssp CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCCCH
T ss_pred ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-cccccccCCH
Confidence 9877643 2345679999999999987665 7889999999999999999999976421 1111 1235567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
++.+||.+||+.||.+|||++++++||||+..
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 99999999999999999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=360.38 Aligned_cols=247 Identities=20% Similarity=0.332 Sum_probs=208.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCC-------cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEK-------KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE 76 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tG-------k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e 76 (1092)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.++++++||||++++++|..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 4579999999999999999999998877 4699999865432 234678899999999999999999999966
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--------EE
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD--------VR 148 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~--------LK 148 (1092)
.+ ..|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 84 ~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 84 GD-ENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TT-CCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CC-CCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 55 5679999999999999998754 34899999999999999999999999999999999999998887 99
Q ss_pred EeecCccccccccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhC-CCCCcccChHHHHHHhhccCCCC
Q 043248 149 LGDFGLAKTLKADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGP 226 (1092)
Q Consensus 149 LiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~dli~kI~~~~i~p 226 (1092)
|+|||++...... ....|++.|+|||++.+ ..++.++|||||||++|+|++| .+||.............. ...
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~ 236 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQ 236 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCC
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCC
Confidence 9999998765432 23568899999999987 7789999999999999999995 555555554444333332 234
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
++..++.++.+||.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 556678899999999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.57 Aligned_cols=253 Identities=18% Similarity=0.241 Sum_probs=210.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyL 83 (1092)
-++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++++| +||||+++++++...+ .+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-YNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT-EEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC-ccEE
Confidence 36899999999999999999999999999999998754322 3477899999999 9999999999987655 7789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-----EEEeecCccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD-----VRLGDFGLAKTL 158 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~-----LKLiDFGLA~~l 158 (1092)
||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..+
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 899999998753 35999999999999999999999999999999999999998887 999999999876
Q ss_pred ccccc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC---hHHHHHHhhccCCC--
Q 043248 159 KADDL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---MAGLISKINRSSIG-- 225 (1092)
Q Consensus 159 ~~d~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d---~~dli~kI~~~~i~-- 225 (1092)
..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ....+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 54322 245789999999999999999999999999999999999999998743 33333333221111
Q ss_pred --CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 226 --PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 226 --plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+...++ ++.+||.+||..||.+||+++++++. |+.+..
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~--l~~~~~ 281 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKL--FTDLFD 281 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHH--HHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHH--HHHHHH
Confidence 1112234 99999999999999999999999973 555544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=359.64 Aligned_cols=254 Identities=27% Similarity=0.452 Sum_probs=194.2
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEE-------ec
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWV-------EK 77 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~-------e~ 77 (1092)
.+|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4899999999999999999999999999999998544 3344567889999999996 999999999985 33
Q ss_pred CeEEEEEEeecCCCCHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKS-NGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk-~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
...+|+||||+. |+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 456889999996 6999988752 3345999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccC-------------ccccCCCCcCCchhh---ccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHH
Q 043248 155 AKTLKADDLA-------------SSVVGTPNYMCPELL---ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISK 218 (1092)
Q Consensus 155 A~~l~~d~~~-------------st~vGTp~YmAPEVL---~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~k 218 (1092)
+......... ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876543221 145699999999998 566789999999999999999999999987554433222
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. ...+....++..+.+||++||+.||.+|||+.|+++| ++.+..
T Consensus 265 ~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~--l~~~~~ 308 (337)
T 3ll6_A 265 K---YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIAA 308 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred c---ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence 2 1223445567889999999999999999999999998 444443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=359.79 Aligned_cols=250 Identities=27% Similarity=0.474 Sum_probs=201.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.-++|++.+.||+|+||.||++.+. ..||+|++............+.+|+.++++++||||+++++++ .. ..+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~-~~~~l 96 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA-PQLAI 96 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS-SSCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC-CccEE
Confidence 3578999999999999999999864 3599999987766666778899999999999999999999865 33 34679
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc--
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-- 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-- 161 (1092)
|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999996543 34999999999999999999999999999999999999999999999999999865432
Q ss_pred -ccCccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHh-hccCC----CCCCCCCC
Q 043248 162 -DLASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-NRSSI----GPLPSCYS 232 (1092)
Q Consensus 162 -~~~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI-~~~~i----~plPs~iS 232 (1092)
.......||+.|+|||++. +..++.++|||||||++|+|++|+.||........+... ..... ......++
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence 2234567999999999996 667889999999999999999999999876544433333 22222 22345678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..+.+||.+||..||.+|||+.++++.
T Consensus 256 ~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 256 KRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 999999999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=369.46 Aligned_cols=257 Identities=21% Similarity=0.388 Sum_probs=215.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEE----EEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKY----VLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~V----AIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
..++|++++.||+|+||.||+|.+..+++.+ ++|.+.... .......+.+|+.++++++||||++++++|....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 3578999999999999999999998888766 555554322 1223457889999999999999999999997654
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.++|+||+.+++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred -ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 6689999999999999987543 49999999999999999999999999999999999999999999999999998765
Q ss_pred cccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 160 ADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 160 ~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
.... .....||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.........+......+.+..++.++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 4332 223456788999999999999999999999999999999 999999988877777777776667788899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+||.+||..||.+|||+.++++. |+.+.
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~~--L~~~~ 277 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELIIE--FSKMA 277 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence 999999999999999999999974 55554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.30 Aligned_cols=261 Identities=22% Similarity=0.420 Sum_probs=217.9
Q ss_pred CCe-EEEEEEeecCceEEEEEEE----cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-Ce
Q 043248 6 DQY-EIMEQIGRGAFGAAILVNH----RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GC 79 (1092)
Q Consensus 6 DrY-eIlKkLGkGgFGtVYLA~d----K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~ 79 (1092)
++| ++++.||+|+||.||++.+ ..+++.||+|++... ........+.+|+.++++++||||++++++|... ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 455 9999999999999988754 457899999999765 3344567789999999999999999999999875 36
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|+||||+++++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred eEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 7889999999999999997654 8999999999999999999999999999999999999999999999999998876
Q ss_pred ccc----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---------------HHHHHhh
Q 043248 160 ADD----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---------------GLISKIN 220 (1092)
Q Consensus 160 ~d~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---------------dli~kI~ 220 (1092)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 542 233456888999999999989999999999999999999999999753221 2223333
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhhcCCC
Q 043248 221 RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPT 272 (1092)
Q Consensus 221 ~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~~~P~ 272 (1092)
.....+.+..++.++.+||++||+.||.+|||+.++++ +|+.+...+...
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~~~~~~~ 315 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVHEKYQGQ 315 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHHHC-
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHHHhhccC
Confidence 34455667788999999999999999999999999996 477776655433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.68 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=205.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC---eE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---CY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---~~ 80 (1092)
..++|++++.||+|+||.||+|.+. ++.||||++..... ......+|+.++++++||||++++++|.... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 4578999999999999999999875 78999999965432 2344566999999999999999999998753 45
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCcEEEcCCCCEEEe
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN----------YVLHRDLKCSNIFLTKDQDVRLG 150 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk----------GIIHRDLKPENILLD~dG~LKLi 150 (1092)
+|+|||||++|+|.+++.... +++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 789999999999999998743 89999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccccccc---CccccCCCCcCCchhhcc-----CCCCccccchhHHHHHHHHHhCCCCCcccC-----------
Q 043248 151 DFGLAKTLKADDL---ASSVVGTPNYMCPELLAD-----IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----------- 211 (1092)
Q Consensus 151 DFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g-----~~yS~KSDVWSLGVILYELLTGr~PF~g~d----------- 211 (1092)
|||++..+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654332 334679999999999976 345678899999999999999999997532
Q ss_pred -----hHHHHHHhhccCCCC-CCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 212 -----MAGLISKINRSSIGP-LPSC-----YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 212 -----~~dli~kI~~~~i~p-lPs~-----iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.......+......+ ++.. .+.++.+||.+||+.||.+|||+.++++. ++.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~--L~~l~ 317 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER--ITQMQ 317 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence 122222222222221 1111 23459999999999999999999999975 55443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.34 Aligned_cols=259 Identities=22% Similarity=0.407 Sum_probs=217.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCc-----EEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKK-----KYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk-----~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~ 77 (1092)
..++|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.+ +||||++++++|...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 45789999999999999999999977664 79999987553 333456788999999999 899999999998655
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSN------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ 145 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG 145 (1092)
+ .+|+|||||++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 123 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 123 G-PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp S-SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred C-ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 4 6789999999999999998642 23489999999999999999999999999999999999999999
Q ss_pred CEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhc
Q 043248 146 DVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINR 221 (1092)
Q Consensus 146 ~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~ 221 (1092)
.+||+|||++........ .....|++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999987654322 234567889999999999999999999999999999998 9999987665444444333
Q ss_pred -cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 222 -SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 222 -~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
......+..++..+.+||.+||+.||.+|||+.+++++ ++...
T Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~--L~~~~ 325 (333)
T 2i1m_A 282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF--LQEQA 325 (333)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH--HHHHH
Confidence 33334566789999999999999999999999999984 65543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=380.05 Aligned_cols=258 Identities=22% Similarity=0.389 Sum_probs=211.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc---CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR---AEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK---~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++.+.||+|+||.||+|.++ .++..||||.+.... .....+.+.+|+.++++++||||++++++|...+ .+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK-PV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-ce
Confidence 458999999999999999999987 567789999997653 3445678999999999999999999999986544 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 89999999999999998654 35999999999999999999999999999999999999999999999999999876543
Q ss_pred cc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 162 DL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 162 ~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
.. .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+......+.+..++..+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 280 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY 280 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 21 112345778999999999999999999999999999997 9999999888887777766655566777899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
+||.+||+.||.+||++.++++. +..+..
T Consensus 281 ~li~~cl~~dp~~RPs~~~i~~~--L~~~~~ 309 (373)
T 2qol_A 281 QLMLDCWQKDRNNRPKFEQIVSI--LDKLIR 309 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHhCcChhhCcCHHHHHHH--HHHHHh
Confidence 99999999999999999999974 555544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=385.44 Aligned_cols=250 Identities=20% Similarity=0.392 Sum_probs=219.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||+|.+. .+..||||++...... .+.+.+|+.+|++++||||+++++++. ...+||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEE
Confidence 3468999999999999999999985 4678999999765432 457889999999999999999999885 335779
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
|||||.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999999986543458999999999999999999999999999999999999999999999999998765432
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
......++..|+|||++.+..|+.++|||||||+||+|++ |+.||.+....+....+......+.+..++.++.+||.
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 419 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 419 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1233456788999999998899999999999999999999 99999998888888888777666778889999999999
Q ss_pred HhcccCCCCCCCHHHHHhC
Q 043248 241 GMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqH 259 (1092)
+||..||.+|||++++++.
T Consensus 420 ~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 420 RCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=391.92 Aligned_cols=251 Identities=19% Similarity=0.357 Sum_probs=222.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.++.++..||||.+...... .+.+.+|+.+|++++||||++++++|...+ .+|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC-cEEEE
Confidence 46799999999999999999999999999999999765432 356889999999999999999999986554 57799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
||||++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999999986666699999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....++..|+|||++.+..|+.++|||||||+||+|++ |..||.+.+.......+........+..++..+.+||.+
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 454 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 454 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 223456788999999999899999999999999999998 999999988777777776666666788899999999999
Q ss_pred hcccCCCCCCCHHHHHhC
Q 043248 242 MLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqH 259 (1092)
||+.||.+|||+.++++.
T Consensus 455 cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 455 CWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCcChhHCcCHHHHHHH
Confidence 999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=355.86 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=197.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEec---C
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR--VQHPYIVEFKEAWVEK---G 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkq--L~HPNIVKL~gvF~e~---d 78 (1092)
..++|++++.||+|+||.||+|.+ +++.||||++.... ...+.+|..++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 456999999999999999999987 68999999986542 2334556666666 7999999999987543 3
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEcCCCCEEEe
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH--------SNYVLHRDLKCSNIFLTKDQDVRLG 150 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLH--------SkGIIHRDLKPENILLD~dG~LKLi 150 (1092)
..+|+||||+++|+|.++++.. .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred ceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 5688999999999999999543 4899999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccccccc-----CccccCCCCcCCchhhccC------CCCccccchhHHHHHHHHHhC----------CCCCcc
Q 043248 151 DFGLAKTLKADDL-----ASSVVGTPNYMCPELLADI------PYGFKSDIWSLGCCMYEMAAH----------RPAFKA 209 (1092)
Q Consensus 151 DFGLA~~l~~d~~-----~st~vGTp~YmAPEVL~g~------~yS~KSDVWSLGVILYELLTG----------r~PF~g 209 (1092)
|||++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999976654322 2345899999999999876 455799999999999999999 888865
Q ss_pred cC----hHHHHHHhh-cc-CCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 210 FD----MAGLISKIN-RS-SIGPLPS-----CYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 210 ~d----~~dli~kI~-~~-~i~plPs-----~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.. ......... .. ....++. .++..+.+||.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 32 112222221 11 1112221 245689999999999999999999999974
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.90 Aligned_cols=237 Identities=25% Similarity=0.444 Sum_probs=196.1
Q ss_pred cCCCCeEEE-EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHH-HhcCCCCcceEEEEEEe---c
Q 043248 3 SRMDQYEIM-EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALI-ARVQHPYIVEFKEAWVE---K 77 (1092)
Q Consensus 3 sRIDrYeIl-KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqIL-kqL~HPNIVKL~gvF~e---~ 77 (1092)
..+++|.++ +.||+|+||.||+|.++.+++.||+|++... ..+.+|+.++ +.++||||++++++|.. .
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 457899998 7899999999999999999999999998643 3456788887 56689999999999865 2
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCEEEeecCc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQDVRLGDFGL 154 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG~LKLiDFGL 154 (1092)
+..+|+|||||+|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 457889999999999999999876667999999999999999999999999999999999999998 78899999999
Q ss_pred cccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC---CCCCC---
Q 043248 155 AKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS---IGPLP--- 228 (1092)
Q Consensus 155 A~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~---i~plP--- 228 (1092)
+.... +..|+.++|||||||++|+|++|+.||...........+.... ...++
T Consensus 167 a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 167 AKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp CEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 86543 2357789999999999999999999997755433222221111 11122
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 229 -SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 229 -s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
..++.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 457999999999999999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=372.74 Aligned_cols=260 Identities=15% Similarity=0.223 Sum_probs=206.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC-----CcEEEEEEEecccccHH---------HHHHHHHHHHHHHhcCCCCcceE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE-----KKKYVLKKIRLARQTER---------CRRSAHQEMALIARVQHPYIVEF 70 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t-----Gk~VAIKkIkks~~se~---------~~r~f~rEIqILkqL~HPNIVKL 70 (1092)
.++|++.+.||+|+||.||+|.++.+ ++.||+|++........ ....+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998765 58899999875532110 01234456667788899999999
Q ss_pred EEEEEec---CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCC
Q 043248 71 KEAWVEK---GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT--KDQ 145 (1092)
Q Consensus 71 ~gvF~e~---d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD--~dG 145 (1092)
++++... ..++||||||| |++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 9998764 25689999999 999999998753 3599999999999999999999999999999999999998 788
Q ss_pred CEEEeecCccccccccccC--------ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH-HHH
Q 043248 146 DVRLGDFGLAKTLKADDLA--------SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA-GLI 216 (1092)
Q Consensus 146 ~LKLiDFGLA~~l~~d~~~--------st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~-dli 216 (1092)
.+||+|||++..+...... ...+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.... ...
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876543221 3345999999999999999999999999999999999999999863221 111
Q ss_pred HHhhc---cCCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 217 SKINR---SSIG------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 217 ~kI~~---~~i~------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
..... ..+. .....++.++.+||..||..+|.+||++.++++ +|..+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~--~l~~~~~~ 330 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD--ILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH--HHHHHHHH
Confidence 11110 0000 012457899999999999999999999999997 36665553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=367.16 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=210.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC--------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcce-------
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA--------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVE------- 69 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~--------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVK------- 69 (1092)
-++|++.+.||+|+||.||+|.+.. .++.||+|.+... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4799999999999999999999987 4889999998754 35778999999999999887
Q ss_pred --------EEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 043248 70 --------FKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL 141 (1092)
Q Consensus 70 --------L~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL 141 (1092)
+++++...+..+|+||||+ |++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777777677889999999 9999999997634459999999999999999999999999999999999999
Q ss_pred cCCC--CEEEeecCcccccccccc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC
Q 043248 142 TKDQ--DVRLGDFGLAKTLKADDL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD 211 (1092)
Q Consensus 142 D~dG--~LKLiDFGLA~~l~~d~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d 211 (1092)
+.++ .+||+|||++..+..... .....||+.|+|||++.+..++.++|||||||+||+|++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9988 899999999987654321 234589999999999999999999999999999999999999998754
Q ss_pred --hHHHHHHhh--ccCCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhhc
Q 043248 212 --MAGLISKIN--RSSIGPLP------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269 (1092)
Q Consensus 212 --~~dli~kI~--~~~i~plP------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~~ 269 (1092)
......... ......+. ..++.++.+||.+||..||.+|||++++++. |+.+....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~~~~~~ 338 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN--LEALLQDL 338 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH--HHHHHHHT
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH--HHHHHHhc
Confidence 222222111 11111111 2468999999999999999999999999984 66665543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=381.62 Aligned_cols=254 Identities=19% Similarity=0.344 Sum_probs=211.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-eEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-CYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~~lyL 83 (1092)
-++|++.+.||+|+||.||+|.++.+++.||||++....... ..+.+.+|+.++++++||||+++++++...+ ..+|+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 468999999999999999999999999999999997543222 2456778999999999999999999987654 36789
Q ss_pred EEeecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCEEEeecCccccc
Q 043248 84 VTGYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL----TKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL----D~dG~LKLiDFGLA~~l 158 (1092)
|||||+|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999999999976432 238999999999999999999999999999999999999 66778999999999988
Q ss_pred cccccCccccCCCCcCCchhhcc--------CCCCccccchhHHHHHHHHHhCCCCCcccC----hHHHHHHhhccCCC-
Q 043248 159 KADDLASSVVGTPNYMCPELLAD--------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSIG- 225 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g--------~~yS~KSDVWSLGVILYELLTGr~PF~g~d----~~dli~kI~~~~i~- 225 (1092)
.........+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.... ....+.++......
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 77666667889999999999865 567889999999999999999999997532 23444444332211
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 226 -----------------------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 226 -----------------------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+...++..+.+||++||+.||++||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 0112245678899999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.36 Aligned_cols=252 Identities=17% Similarity=0.226 Sum_probs=201.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC---CCcEEEEEEEecccccHH---------HHHHHHHHHHHHHhcCCCCcceEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA---EKKKYVLKKIRLARQTER---------CRRSAHQEMALIARVQHPYIVEFKE 72 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~---tGk~VAIKkIkks~~se~---------~~r~f~rEIqILkqL~HPNIVKL~g 72 (1092)
.++|++.+.||+|+||.||+|.+.. ++..||+|++........ ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 888999999876532110 1134668889999999999999999
Q ss_pred EEEec---CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC--CE
Q 043248 73 AWVEK---GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ--DV 147 (1092)
Q Consensus 73 vF~e~---d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG--~L 147 (1092)
++... ...+|+||||| |++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 98773 56889999999 999999998665 499999999999999999999999999999999999999887 99
Q ss_pred EEeecCcccccccccc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHH
Q 043248 148 RLGDFGLAKTLKADDL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISK 218 (1092)
Q Consensus 148 KLiDFGLA~~l~~d~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~k 218 (1092)
||+|||++..+..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999987653321 1345799999999999999999999999999999999999999965221 111111
Q ss_pred hhccCCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 219 INRSSIGPL---------PSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 219 I~~~~i~pl---------Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
........+ ...++.++.+||.+||..||.+||+++++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111111111 12688999999999999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=360.14 Aligned_cols=252 Identities=28% Similarity=0.525 Sum_probs=206.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||++.+. ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEE
Confidence 3579999999999999999999874 788999998643 234678899999999999999999998753 2579
Q ss_pred EEeecCCCCHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCcEEEcCCCC-EEEeecCccccc
Q 043248 84 VTGYCEGGDMAELMKKSNG-AYFPEEKLCKWFAQLLLAVDYLHS---NYVLHRDLKCSNIFLTKDQD-VRLGDFGLAKTL 158 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~g-k~LSEeqI~kIa~QILsALaYLHS---kGIIHRDLKPENILLD~dG~-LKLiDFGLA~~l 158 (1092)
||||++|++|.+++..... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999999986542 247899999999999999999999 89999999999999998886 799999999766
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--hHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--MAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+........+..++..+.
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 157 QTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred ccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence 432 334579999999999999999999999999999999999999997543 2333444444555566777899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+||.+||+.||.+|||+++++++ +..+...
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~--L~~~~~~ 264 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKI--MTHLMRY 264 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH--HHHHGGG
T ss_pred HHHHHHhcCChhhCcCHHHHHHH--HHHHHHh
Confidence 99999999999999999999986 5555443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=354.27 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=207.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC-CCc--EEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA-EKK--KYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~-tGk--~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
.++|++++.||+|+||.||+|.+.. ++. .||+|++..... .......+.+|+.++++++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 4689999999999999999998654 333 689998865432 2234567889999999999999999999986654
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 679999999999999998753 2489999999999999999999999999999999999999999999999999987754
Q ss_pred cc----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccC-CCCCCCCCCHH
Q 043248 161 DD----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSS-IGPLPSCYSPS 234 (1092)
Q Consensus 161 d~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~-i~plPs~iS~e 234 (1092)
.. ......|+..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+.... ..+.+..++..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 32 1234567889999999998889999999999999999999 999999988877777765443 33456678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
+.+||.+||..||.+|||+.+++++ |+..
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~~--l~~~ 282 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRDF--LLEA 282 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH--HHHh
Confidence 9999999999999999999999974 5543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=370.16 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=210.2
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
+...++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.+++.++||||++++++|...+ .+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ--GIEEFETEIETLSFCRHPHLVSLIGFCDERN-EM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS--HHHHHHHHHHGGGSCCCTTBCCEEEECCCTT-CC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-eE
Confidence 456789999999999999999999964 6899999988654332 3467889999999999999999999986554 67
Q ss_pred EEEEeecCCCCHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNG--AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~g--k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 799999999999999865432 348999999999999999999999999999999999999999999999999998654
Q ss_pred cc---ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHH---H----HHhhccCC-----
Q 043248 160 AD---DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL---I----SKINRSSI----- 224 (1092)
Q Consensus 160 ~d---~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dl---i----~kI~~~~i----- 224 (1092)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ . ........
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 32 223345689999999999988999999999999999999999999976432211 0 00111100
Q ss_pred ----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 225 ----GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 225 ----~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
...+..++..+.+|+.+||+.||.+|||+.++++| ++...
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~l 314 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK--LEYAL 314 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHh
Confidence 11122235678999999999999999999999987 44443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=383.64 Aligned_cols=254 Identities=22% Similarity=0.412 Sum_probs=216.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|++++||||+++++++.. ..+|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEE
Confidence 4689999999999999999999865 467999999765433 3568899999999999999999999855 346799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
|||+++|+|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999999765444589999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....++..|+|||++.+..++.++|||||||+||+|++ |+.||.+....+....+......+.+..++..+.+||.+
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 223456788999999999899999999999999999999 999999988888888877766667788899999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||+.||.+|||++++++. ++.+.
T Consensus 417 cl~~dP~~Rpt~~~l~~~--L~~~~ 439 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQAF--LEDYF 439 (452)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHTTT
T ss_pred HccCChhhCcCHHHHHHH--HHHHh
Confidence 999999999999999973 44443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=377.03 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=212.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCC---cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEK---KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tG---k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++...+...|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35889999999999999999976443 458889886533 23345678999999999999999999998876666778
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 168 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999997644 358999999999999999999999999999999999999999999999999998664332
Q ss_pred c-----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHH
Q 043248 163 L-----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 163 ~-----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLk 236 (1092)
. .....|++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+........+..++..+.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 223457789999999999999999999999999999999 7889987776666666666666666778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhHhhhc
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFVDQY 269 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~~d~~ 269 (1092)
+||.+||..||.+|||+.+++++ ++.+...+
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~--L~~i~~~~ 357 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR--ISAIFSTF 357 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH--HHHHHHTC
T ss_pred HHHHHHcCCChhhCcCHHHHHHH--HHHHHHhc
Confidence 99999999999999999999986 66665543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=360.22 Aligned_cols=261 Identities=20% Similarity=0.310 Sum_probs=200.6
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----cC
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE----KG 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e----~d 78 (1092)
-.+++|++++.||+|+||.||+|.+ +++.||||++....... .....|+..+..++|+||+++++++.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh---HHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 3578999999999999999999976 68999999997543211 122334444556899999999976543 23
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEcCCCCEEE
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN---------YVLHRDLKCSNIFLTKDQDVRL 149 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk---------GIIHRDLKPENILLD~dG~LKL 149 (1092)
..+|+|||||++|+|.+++.... +++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 46789999999999999998754 68999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccccc---------cCccccCCCCcCCchhhcc-------CCCCccccchhHHHHHHHHHhCCCCCcccCh-
Q 043248 150 GDFGLAKTLKADD---------LASSVVGTPNYMCPELLAD-------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM- 212 (1092)
Q Consensus 150 iDFGLA~~l~~d~---------~~st~vGTp~YmAPEVL~g-------~~yS~KSDVWSLGVILYELLTGr~PF~g~d~- 212 (1092)
+|||++..+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998765332 1234579999999999976 4567899999999999999999776633211
Q ss_pred -----------------HHHHHHhh-ccCCCCCCCC------CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 213 -----------------AGLISKIN-RSSIGPLPSC------YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 213 -----------------~dli~kI~-~~~i~plPs~------iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
......+. ......++.. ++..+.+||.+||+.||.+|||+.|+++. ++.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~--L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER--MAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH--HHHHHHH
Confidence 11111111 1122233333 23479999999999999999999999975 7776665
Q ss_pred cCCCC
Q 043248 269 YRPTF 273 (1092)
Q Consensus 269 ~~P~~ 273 (1092)
+....
T Consensus 320 ~~~~~ 324 (336)
T 3g2f_A 320 WERNK 324 (336)
T ss_dssp CCC--
T ss_pred HHhcc
Confidence 55443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=353.42 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=198.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEecC---e
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR--VQHPYIVEFKEAWVEKG---C 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkq--L~HPNIVKL~gvF~e~d---~ 79 (1092)
.++|++++.||+|+||.||+|.+. ++.||+|++..... ..+.+|..++.. ++||||+++++++.... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 368999999999999999999875 89999999865422 223345555544 48999999999987663 5
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCCEEEee
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN--------YVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk--------GIIHRDLKPENILLD~dG~LKLiD 151 (1092)
.+|+|||||++++|.++++... +++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEeccCCCcHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 7889999999999999997653 89999999999999999999999 999999999999999999999999
Q ss_pred cCcccccccccc-----CccccCCCCcCCchhhccCCCCcc------ccchhHHHHHHHHHhC----------CCCCccc
Q 043248 152 FGLAKTLKADDL-----ASSVVGTPNYMCPELLADIPYGFK------SDIWSLGCCMYEMAAH----------RPAFKAF 210 (1092)
Q Consensus 152 FGLA~~l~~d~~-----~st~vGTp~YmAPEVL~g~~yS~K------SDVWSLGVILYELLTG----------r~PF~g~ 210 (1092)
||++..+..... ....+||+.|+|||++.+..+... +|||||||++|+|++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999976654322 235689999999999988776655 9999999999999999 6677542
Q ss_pred C-----hHHHHHHhhccC-CCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 211 D-----MAGLISKINRSS-IGPLPS-----CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 211 d-----~~dli~kI~~~~-i~plPs-----~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. .......+.... ...++. .++.++.+||.+||+.||.+|||+.++++| ++.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l~~ 331 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT--LAKMSE 331 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH--HHHHHh
Confidence 1 112222222111 122222 345679999999999999999999999997 666554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=389.05 Aligned_cols=254 Identities=22% Similarity=0.410 Sum_probs=221.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|++|+|+||+++++++.. ..+|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEe
Confidence 4689999999999999999999865 467999999765433 3568899999999999999999998855 347799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||||++|+|.++|....+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999999976544458999999999999999999999999999999999999999999999999998765432
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
......++..|+|||++.+..|+.++|||||||+||+|++ |+.||.+....+....+......+.+..++..+.+||.+
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 499 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1233457788999999999899999999999999999999 999999988888888877766666778899999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||+.||++|||++++++. |+.+.
T Consensus 500 cl~~dP~~RPt~~~l~~~--L~~~~ 522 (535)
T 2h8h_A 500 CWRKEPEERPTFEYLQAF--LEDYF 522 (535)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHTSS
T ss_pred HcCCChhHCcCHHHHHHH--HHHHh
Confidence 999999999999999973 54443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=357.35 Aligned_cols=258 Identities=23% Similarity=0.419 Sum_probs=214.3
Q ss_pred CCCeEEEEEEeecCceEEEEEE----EcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-e
Q 043248 5 MDQYEIMEQIGRGAFGAAILVN----HRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG-C 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~----dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d-~ 79 (1092)
.++|++++.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4579999999999999999998 46689999999987542 334567889999999999999999999886543 3
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 5789999999999999998754 348999999999999999999999999999999999999999999999999998775
Q ss_pred cccc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh----------------HHHHHHh
Q 043248 160 ADDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM----------------AGLISKI 219 (1092)
Q Consensus 160 ~d~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~----------------~dli~kI 219 (1092)
.... .....++..|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 4432 2334677889999999988899999999999999999999999864311 0122223
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
......+.+..++.++.+||.+||+.||.+|||+.++++. ++.+.+
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~--L~~l~~ 322 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR--VDQIRD 322 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHH
Confidence 3333445677789999999999999999999999999974 555443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=362.13 Aligned_cols=245 Identities=18% Similarity=0.258 Sum_probs=198.4
Q ss_pred CCCeEEEEEEeecCceEEEEE-----EEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILV-----NHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ---HPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA-----~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~---HPNIVKL~gvF~e 76 (1092)
-++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 467999999999999999999 467889999999997543 235667888888887 9999999999976
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC----------
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKS---NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---------- 143 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk---~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---------- 143 (1092)
.+ ..|||||||+||+|.+++... ....+++..++.|+.||+.||+|||++||+||||||+||||+.
T Consensus 139 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 139 QN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp SS-CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred CC-CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 65 567999999999999999753 2345999999999999999999999999999999999999998
Q ss_pred -CCCEEEeecCcccccc---ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHh
Q 043248 144 -DQDVRLGDFGLAKTLK---ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI 219 (1092)
Q Consensus 144 -dG~LKLiDFGLA~~l~---~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI 219 (1092)
++.+||+|||++..+. ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ .+
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~ 295 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--KP 295 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--EE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--ee
Confidence 8899999999997653 33344567899999999999999999999999999999999999999965432110 00
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhCh
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHP 260 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHP 260 (1092)
...+... ..++.+.+++..||+.+|.+|++..+.+.+.
T Consensus 296 -~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 296 -EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp -CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred -chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 0111111 2467899999999999999996655555543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=392.51 Aligned_cols=253 Identities=19% Similarity=0.350 Sum_probs=216.7
Q ss_pred eEE-EEEEeecCceEEEEEEE--cCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 8 YEI-MEQIGRGAFGAAILVNH--RAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 8 YeI-lKkLGkGgFGtVYLA~d--K~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+.+ .+.||+|+||.||+|.+ +.+++.||||++..........+.+.+|+.+|++++||||++++++|... .+|||
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEE
Confidence 444 35899999999999965 45678999999987655444567899999999999999999999998543 36799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
||||++|+|.+++.... .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 448 ~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999999998654 499999999999999999999999999999999999999999999999999987754332
Q ss_pred ---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 043248 164 ---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 164 ---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLI 239 (1092)
.....||+.|+|||++.+..|+.++|||||||+||+|++ |+.||.+.........+........+..++.++.+||
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 223456788999999999999999999999999999998 9999999988888888887777778888999999999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+||..||.+||++.++++. |+.++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~~--L~~~~ 630 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVELR--LRNYY 630 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHHH--HHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH--HHHHH
Confidence 99999999999999999874 44443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.33 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=204.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+.+|+.+++.++||||++++++|...+ ..|+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-CCEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCC-ceEE
Confidence 457899999999999999999985 468999999987543221 1235788999999999999999999986655 5679
Q ss_pred EEeecCCCCHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 84 VTGYCEGGDMAELMKKSNG--AYFPEEKLCKWFAQLLLAVDYLHSN---YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~g--k~LSEeqI~kIa~QILsALaYLHSk---GIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
||||+++++|.+++..... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 9999999999999986532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred cccc--cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccC--------hHHHHHHhhccC-C---
Q 043248 159 KADD--LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD--------MAGLISKINRSS-I--- 224 (1092)
Q Consensus 159 ~~d~--~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d--------~~dli~kI~~~~-i--- 224 (1092)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............ .
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred CcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence 5332 2344569999999999998899999999999999999999999995311 111111111110 0
Q ss_pred ------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 225 ------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 225 ------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
...+...+..+.+|+.+||+.||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 305 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence 01111224679999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=352.28 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=205.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEecC---eE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR--VQHPYIVEFKEAWVEKG---CY 80 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkq--L~HPNIVKL~gvF~e~d---~~ 80 (1092)
++|++.+.||+|+||.||++.+ +++.||+|++.... ...+.+|+.++.. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 6899999999999999999987 58999999986432 2456778888887 78999999999997665 26
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEcCCCCEEEeec
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH--------SNYVLHRDLKCSNIFLTKDQDVRLGDF 152 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLH--------SkGIIHRDLKPENILLD~dG~LKLiDF 152 (1092)
+|+||||+++++|.+++.... +++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eEEEEeecCCCcHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 889999999999999998643 899999999999999999999 899999999999999999999999999
Q ss_pred Cccccccccc-----cCccccCCCCcCCchhhccCC------CCccccchhHHHHHHHHHhC----------CCCCcccC
Q 043248 153 GLAKTLKADD-----LASSVVGTPNYMCPELLADIP------YGFKSDIWSLGCCMYEMAAH----------RPAFKAFD 211 (1092)
Q Consensus 153 GLA~~l~~d~-----~~st~vGTp~YmAPEVL~g~~------yS~KSDVWSLGVILYELLTG----------r~PF~g~d 211 (1092)
|++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998765443 234568999999999997652 34689999999999999999 78886542
Q ss_pred -----hHHHHHHhhccCC-CCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 212 -----MAGLISKINRSSI-GPLPS-----CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 212 -----~~dli~kI~~~~i-~plPs-----~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
...+...+..... ..++. ..+..+.+||.+||+.||.+|||+.++++| ++.+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~--L~~i~~~ 337 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQ 337 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH--HHHHHHH
Confidence 2333333332222 22222 223578999999999999999999999987 6665543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=386.22 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=215.9
Q ss_pred CCeEEEE-EEeecCceEEEEEEEcC--CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIME-QIGRGAFGAAILVNHRA--EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlK-kLGkGgFGtVYLA~dK~--tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
++|.+.+ .||+|+||.||+|.++. ++..||||++..... ....+.+.+|+.+|++++||||++++++|... .+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEESS--SEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC--CeE
Confidence 4566666 89999999999998763 556799999976432 22346788999999999999999999998653 478
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 412 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999997543 459999999999999999999999999999999999999999999999999998765432
Q ss_pred cC----ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 163 LA----SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 163 ~~----st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
.. ....+++.|+|||++.+..|+.++|||||||+||+|++ |+.||.+.+..+....+........+..++.++.+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 11 22345689999999999999999999999999999998 99999998888888888777767778889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
||.+||..+|.+||++.++++. ++.++.
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~--L~~~~~ 598 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQR--MRACYY 598 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH--HHHHHH
Confidence 9999999999999999999763 444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=356.64 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=207.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||.||+|.+.. .||+|++..........+.+.+|+.++++++||||+++++++...+ .+|+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~i 106 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-HLAI 106 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-CEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-ceEE
Confidence 46899999999999999999998854 4999998765433333345678999999999999999999997655 5789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc--
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-- 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-- 161 (1092)
||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp ECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999999997643 3589999999999999999999999999999999999998 789999999998765321
Q ss_pred ----ccCccccCCCCcCCchhhcc---------CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCC
Q 043248 162 ----DLASSVVGTPNYMCPELLAD---------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP 228 (1092)
Q Consensus 162 ----~~~st~vGTp~YmAPEVL~g---------~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plP 228 (1092)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 264 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence 22334568999999999964 45789999999999999999999999988877777666655443332
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 229 -SCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 229 -s~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
..++.++.+||.+||..||.+|||+.++++.
T Consensus 265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3578899999999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=368.12 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=191.1
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+.+|+.+++++ +||||+++++++... ..+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTD-RFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC-CeEEEE
Confidence 345667899999999998754 5679999999987542 24567899999886 899999999988654 478899
Q ss_pred EeecCCCCHHHHHHHcCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-------------CC
Q 043248 85 TGYCEGGDMAELMKKSNGAY-----FPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-------------QD 146 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~-----LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-------------G~ 146 (1092)
||||+ |+|.+++....... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 59999998654211 1233467899999999999999999999999999999754 37
Q ss_pred EEEeecCcccccccccc-----CccccCCCCcCCchhhcc-------CCCCccccchhHHHHHHHHHh-CCCCCcccChH
Q 043248 147 VRLGDFGLAKTLKADDL-----ASSVVGTPNYMCPELLAD-------IPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMA 213 (1092)
Q Consensus 147 LKLiDFGLA~~l~~d~~-----~st~vGTp~YmAPEVL~g-------~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~ 213 (1092)
+||+|||++........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999988764321 234579999999999975 678999999999999999998 99999765433
Q ss_pred HHHHHhhccCC--CCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 214 GLISKINRSSI--GPLP----SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 214 dli~kI~~~~i--~plP----s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
. ..+..... .... ..++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 2 12222111 1111 123578999999999999999999999999999953
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=349.98 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=202.1
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccc--ccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR--QTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~--~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
|...+.||+|+||.||+|.+ ++..||+|++.... ........+.+|+.++++++||||+++++++...+ .+|+||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-DLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC-ceEEEE
Confidence 34458999999999999985 67899999986542 22334567889999999999999999999986554 677999
Q ss_pred eecCCCCHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 86 GYCEGGDMAELMKKSN-GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~-gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9999999999997542 3458999999999999999999999999999999999999999999999999998765432
Q ss_pred -cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHH----HHHHhhc----------cCCCCC
Q 043248 163 -LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAG----LISKINR----------SSIGPL 227 (1092)
Q Consensus 163 -~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~d----li~kI~~----------~~i~pl 227 (1092)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... +...+.. ......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 2334679999999999876 58899999999999999999999997644322 1111111 111222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+..++..+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 33345779999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=372.12 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=195.5
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+|.+.+.||+|+||+||. ....+++.||||++...... .+.+|+.+|+.+ +||||+++++++.... .+||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQ-FQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCC-EEEEEE
Confidence 599999999999999764 34568899999998654322 245799999999 7999999999986655 678999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CC--CEEEeecCccccccc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQ--DVRLGDFGLAKTLKA 160 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG--~LKLiDFGLA~~l~~ 160 (1092)
|||. |+|.+++..... .+.+..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||++.....
T Consensus 98 E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp ECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred ECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9997 599999986553 3566677899999999999999999999999999999953 23 588999999987754
Q ss_pred cc----cCccccCCCCcCCchhhc---cCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCC--CCC
Q 043248 161 DD----LASSVVGTPNYMCPELLA---DIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPL--PSC 230 (1092)
Q Consensus 161 d~----~~st~vGTp~YmAPEVL~---g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~pl--Ps~ 230 (1092)
.. .....+||+.|+|||++. +..++.++|||||||++|+|++ |..||...........+........ ...
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 32 234567999999999997 4567889999999999999999 9999976554433332222222111 122
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 231 YSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
.+..+.+||.+||+.||.+|||+.++++||||..+
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 35668999999999999999999999999999654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=376.00 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=206.7
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|+|++++..+.+|.......|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999988755432 24678999999998866555555555666688899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCEEEeecCcccccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFL---TKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILL---D~dG~LKLiDFGLA~~l~~d 161 (1092)
|||+ +++|.+++..... .|++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 82 me~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9999 8999999986443 49999999999999999999999999999999999999 57889999999999877644
Q ss_pred cc--------CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh---HHHHHHhhcc----CCCC
Q 043248 162 DL--------ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM---AGLISKINRS----SIGP 226 (1092)
Q Consensus 162 ~~--------~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~---~dli~kI~~~----~i~p 226 (1092)
.. ....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+... ...+.++... ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 32 2256899999999999999999999999999999999999999987443 2222222211 1112
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
+...++.++.+||.+||+.+|.+||++.+|++
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33567899999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=368.16 Aligned_cols=254 Identities=15% Similarity=0.134 Sum_probs=199.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCC-CCc---------c-----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQH-PYI---------V----- 68 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~H-PNI---------V----- 68 (1092)
..+|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+.+|+.+++.+.| .|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44688999999999999999999999999999998743322 2234568899999999977 221 1
Q ss_pred -------eEEEEEEec----CeEEEEEEeecCCCCHHHHHHH-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 043248 69 -------EFKEAWVEK----GCYVCIVTGYCEGGDMAELMKK-----SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHR 132 (1092)
Q Consensus 69 -------KL~gvF~e~----d~~lyLVMEYceGGSL~DLLkk-----k~gk~LSEeqI~kIa~QILsALaYLHSkGIIHR 132 (1092)
.++.++... ...++++|+++ +++|.+++.. .....+++..++.++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111111111 12356777776 5799999962 223347788999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeecCccccccccccCccccCCCCcCCchhh----------ccCCCCccccchhHHHHHHHHHh
Q 043248 133 DLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELL----------ADIPYGFKSDIWSLGCCMYEMAA 202 (1092)
Q Consensus 133 DLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL----------~g~~yS~KSDVWSLGVILYELLT 202 (1092)
||||+||||+.++.+||+|||++...... ....+| +.|+|||++ .+..|+.++|||||||++|+|++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999998876544 455678 999999999 55568899999999999999999
Q ss_pred CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 203 HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 203 Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|+.||...........+... ...++..+.+||.+||+.||.+||++.++++||||+.+..
T Consensus 313 g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp SSCCCCTTGGGSCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CCCCCCCcchhhhHHHHHhh-----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 99999876654443333221 2357899999999999999999999999999999988754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=381.44 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=220.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCC---CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAE---KKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~t---Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.+ ..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cc
Confidence 346899999999999999999998654 457899988654 234456778999999999999999999999843 34
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 679999999999999998654 3489999999999999999999999999999999999999999999999999987754
Q ss_pred ccc--CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 161 DDL--ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 161 d~~--~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
... .....|++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+......+.+..++..+.+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 623 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 623 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence 432 223457789999999999999999999999999999997 99999998888888888777767788889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||.+||..||.+|||+.++++. +..+.
T Consensus 624 li~~~l~~dP~~RPs~~el~~~--L~~il 650 (656)
T 2j0j_A 624 LMTKCWAYDPSRRPRFTELKAQ--LSTIL 650 (656)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence 9999999999999999999975 55443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=355.43 Aligned_cols=244 Identities=18% Similarity=0.207 Sum_probs=194.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc------cHHHHHHHHHHHHHHHhcC---------CCCcce
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ------TERCRRSAHQEMALIARVQ---------HPYIVE 69 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~------se~~~r~f~rEIqILkqL~---------HPNIVK 69 (1092)
.++|++++.||+|+||.||+|.+ +|+.||||++..... .....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 689999999976532 1122356778999888885 888888
Q ss_pred EEEEEEec-----------------------------CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHH
Q 043248 70 FKEAWVEK-----------------------------GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120 (1092)
Q Consensus 70 L~gvF~e~-----------------------------d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsA 120 (1092)
+++++... ...+|||||||++|++.+.+.+ ..+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 88775421 4578899999999977766643 348999999999999999
Q ss_pred HHHHH-HCCccccCCCCCcEEEcCCC--------------------CEEEeecCccccccccccCccccCCCCcCCchhh
Q 043248 121 VDYLH-SNYVLHRDLKCSNIFLTKDQ--------------------DVRLGDFGLAKTLKADDLASSVVGTPNYMCPELL 179 (1092)
Q Consensus 121 LaYLH-SkGIIHRDLKPENILLD~dG--------------------~LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL 179 (1092)
|.||| ++||+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 99999999999999999887 8999999999877633 45899999999999
Q ss_pred ccCCCCccccchhHHHH-HHHHHhCCCCCcccCh-HHHHHHhhcc-CCCC-----CCCCCCHHHHHHHHHhcccCCCCCC
Q 043248 180 ADIPYGFKSDIWSLGCC-MYEMAAHRPAFKAFDM-AGLISKINRS-SIGP-----LPSCYSPSLKTLIKGMLRKNPEHRP 251 (1092)
Q Consensus 180 ~g~~yS~KSDVWSLGVI-LYELLTGr~PF~g~d~-~dli~kI~~~-~i~p-----lPs~iS~eLkDLIrkcLqkDPskRP 251 (1092)
.+.. +.++||||||++ .++++.|..||..... ......+... .... .+..+++++++||++||++|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 8766 899999998777 7788999999965321 1122222211 1111 12236789999999999977
Q ss_pred CHHHHH-hChhhH
Q 043248 252 SASELL-KHPFLQ 263 (1092)
Q Consensus 252 SaeELL-qHPwFq 263 (1092)
|++|+| +||||+
T Consensus 324 sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHCGGGC
T ss_pred CHHHHHhcCCCcC
Confidence 999999 999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=392.80 Aligned_cols=267 Identities=24% Similarity=0.370 Sum_probs=216.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-----c
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVE-----K 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e-----~ 77 (1092)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.++++++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3568999999999999999999999999999999998754 334456778999999999999999999998743 1
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---EEEeecC
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSN-GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFG 153 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~-gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~---LKLiDFG 153 (1092)
+...|+|||||+|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 446789999999999999998643 235899999999999999999999999999999999999997765 9999999
Q ss_pred ccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHh----------h---
Q 043248 154 LAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----------N--- 220 (1092)
Q Consensus 154 LA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI----------~--- 220 (1092)
++.............||+.|+|||++.+..++.++|||||||++|+|++|..||........+... .
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 999887766667789999999999999999999999999999999999999999764322111000 0
Q ss_pred -cc-----CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhhhcC
Q 043248 221 -RS-----SI----GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYR 270 (1092)
Q Consensus 221 -~~-----~i----~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d~~~ 270 (1092)
.. .. ..+...++..+.+||.+||..||.+|||+.++++||||+.+.+...
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00 00 0122235688999999999999999999999999999998876544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.87 Aligned_cols=228 Identities=15% Similarity=0.105 Sum_probs=189.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++.+++||||+++++++...+ .+|+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-GGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-cEEE
Confidence 37899999999999999999999999999999999765432 455678899999999999999999999997655 6789
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
||||++|++|.+++... .....+..|+.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999999532 4667789999999999999999999999999999999999999998554
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhh---ccCCC---CCCCCCCHHHHH
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN---RSSIG---PLPSCYSPSLKT 237 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~---~~~i~---plPs~iS~eLkD 237 (1092)
|++ .++.++|||||||++|+|++|+.||.+.+....+.... ..... .....+++++.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 333 37899999999999999999999998765432211111 11111 123568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||.+||++||.+| |+.++++. +....
T Consensus 239 li~~~l~~dP~~R-s~~el~~~--L~~~~ 264 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNL--MQQAT 264 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHH--HHHHH
T ss_pred HHHHHcccCCccC-CHHHHHHH--HHHHh
Confidence 9999999999999 99999984 55543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=377.47 Aligned_cols=245 Identities=23% Similarity=0.318 Sum_probs=202.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC-CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA-EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC---- 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~-tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~---- 79 (1092)
.++|++.+.||+|+||.||++.+.. +++.||||++.... .......+.+|+.++++++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3799999999999999999999976 78999999886542 34445678899999999999999999999987653
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+||||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||++....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 26899999999999998754 48999999999999999999999999999999999999875 89999999998765
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLI 239 (1092)
.. ...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+.....+ ........+++.+.+||
T Consensus 233 ~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 233 SF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------PEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp CC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------CTTCHHHHHCHHHHHHH
T ss_pred cC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-------cccccccccCHHHHHHH
Confidence 43 456899999999999765 48999999999999999999999875321100 00000011357899999
Q ss_pred HHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 240 KGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 240 rkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.+||++||.+||+..+.+.|+|+....
T Consensus 302 ~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 302 RRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred hhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999886543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=311.53 Aligned_cols=231 Identities=15% Similarity=0.108 Sum_probs=159.2
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEEeccc--------ccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEEEE
Q 043248 13 QIGRGAFGAAILVNHRAEKKKYVLKKIRLAR--------QTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 13 kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~--------~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.++.|++|.++.+.....|+.|+||.+.... ..+...+.+.+|+.+|+++ .|+||++++++|.+ +..+||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence 4566777777777777789999999996542 2234456799999999999 79999999999855 457889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-c
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-D 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~ 162 (1092)
|||||+|++|.++|.+.+ .+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... .
T Consensus 320 VMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 999999999999998754 37765 47899999999999999999999999999999999999999999877543 3
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
...+.+||+.|||||++.+ .+..++|+|++|+++|+|+++..+|.. .+..... . ...+..++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~~--------~l~~~~~----~--~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWLY--------AVWQEPV----E--RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHHHHH--------HHHTSCG----G--GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchhHH--------HhhcCCC----C--CCcHHHHHHHH
Confidence 3456789999999999976 467889999999999988776544321 1111100 0 11245677777
Q ss_pred cccCCCCCCCHHHHHhChhhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~ 264 (1092)
+..++..|+.......|+|...
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~ 481 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWIIA 481 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHHH
Confidence 8888888887777777777644
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=266.40 Aligned_cols=183 Identities=21% Similarity=0.174 Sum_probs=142.8
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT------ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s------e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++||+|+||.||++ ...+..+++|+....... ....+.+.+|+.++++++||||+++..++...+ ..||
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-NKRI 416 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-TTEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-ccEE
Confidence 3578999999999999 446788999986543211 122456899999999999999995444444433 3579
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
|||||+|++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999999865 5689999999999999999999999999999998 999999999998765321
Q ss_pred --------CccccCCCCcCCchhhcc--CCCCccccchhHHHHHHHHHhCCCCC
Q 043248 164 --------ASSVVGTPNYMCPELLAD--IPYGFKSDIWSLGCCMYEMAAHRPAF 207 (1092)
Q Consensus 164 --------~st~vGTp~YmAPEVL~g--~~yS~KSDVWSLGVILYELLTGr~PF 207 (1092)
....+||+.|||||++.+ ..|+..+|+|+..+-.++.+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 235689999999999976 66888899999998888877766555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=223.40 Aligned_cols=158 Identities=16% Similarity=0.186 Sum_probs=124.5
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----------------HHHHHHHHHHHHHHhcCCCCcceEE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----------------RCRRSAHQEMALIARVQHPYIVEFK 71 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----------------~~~r~f~rEIqILkqL~HPNIVKL~ 71 (1092)
|.+.+.||+|+||.||+|.+ .+|+.||+|.+....... .....+.+|+.++++++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 889999999986432211 23567889999999998 4 6666
Q ss_pred EEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEee
Q 043248 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 72 gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiD 151 (1092)
+++... ..|+|||||+|++|.+ +. + .....++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 168 ~~~~~~--~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAWE--GNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEEE--TTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEecc--ceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 655443 3579999999999988 42 1 23557999999999999999999999999999999 99999999
Q ss_pred cCccccccccccCccccCCCCcCCchhhcc----------CCCCccccchhH
Q 043248 152 FGLAKTLKADDLASSVVGTPNYMCPELLAD----------IPYGFKSDIWSL 193 (1092)
Q Consensus 152 FGLA~~l~~d~~~st~vGTp~YmAPEVL~g----------~~yS~KSDVWSL 193 (1092)
||++.. +..|+|||++.. ..|+..+|+|.+
T Consensus 236 FG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999864 346889998854 345666666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=190.00 Aligned_cols=141 Identities=18% Similarity=0.175 Sum_probs=110.9
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcE--EEEEEEeccccc----------------------HHHHHHHHHHHHHHHhc
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKK--YVLKKIRLARQT----------------------ERCRRSAHQEMALIARV 62 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~--VAIKkIkks~~s----------------------e~~~r~f~rEIqILkqL 62 (1092)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.+|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999788999 999987543211 11223678899999999
Q ss_pred CCCCc--ceEEEEEEecCeEEEEEEeecCC-C----CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCC
Q 043248 63 QHPYI--VEFKEAWVEKGCYVCIVTGYCEG-G----DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH-SNYVLHRDL 134 (1092)
Q Consensus 63 ~HPNI--VKL~gvF~e~d~~lyLVMEYceG-G----SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLH-SkGIIHRDL 134 (1092)
.|++| +.++.+ . ..||||||+.+ | .|.+++.. +++..+..++.||+.+|.||| ++||+||||
T Consensus 128 ~~~~i~~p~~~~~--~---~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY--M---KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE--E---TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc--C---CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 88864 444432 1 34699999942 3 77776532 235578899999999999999 999999999
Q ss_pred CCCcEEEcCCCCEEEeecCcccccc
Q 043248 135 KCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 135 KPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
||+|||++. .++|+|||+|....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETT
T ss_pred CHHHEEEcC--cEEEEECcccccCC
Confidence 999999997 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=178.27 Aligned_cols=140 Identities=20% Similarity=0.253 Sum_probs=103.4
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc---------------cH-----HHHHHHHHHHHHHHhcCCCCc
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ---------------TE-----RCRRSAHQEMALIARVQHPYI 67 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~---------------se-----~~~r~f~rEIqILkqL~HPNI 67 (1092)
|+|.+.||.|+||.||+|.+. +|+.||||+++.... .. ..+-...+|+..|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999974 699999998753211 00 011123467888888865554
Q ss_pred ceEEEEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-
Q 043248 68 VEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQD- 146 (1092)
Q Consensus 68 VKL~gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~- 146 (1092)
.-.. .+.... .+|||||++|+.|..+. .......++.||+.+|.|||++|||||||||.|||++.+|.
T Consensus 176 ~vp~-p~~~~~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPE-PIAQSR--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCC-EEEEET--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCe-eeeccC--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 3222 121222 25999999998886542 22345678999999999999999999999999999987763
Q ss_pred ---------EEEeecCcccccc
Q 043248 147 ---------VRLGDFGLAKTLK 159 (1092)
Q Consensus 147 ---------LKLiDFGLA~~l~ 159 (1092)
+.|+||+-+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 8999999876544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=3.8e-12 Score=130.67 Aligned_cols=143 Identities=14% Similarity=0.115 Sum_probs=111.2
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~l 81 (1092)
..++.|++...+|.|+++.||.+.. .+..+++|......... ...+.+|+.+++.|. +..+.++++++... ...
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecC-Cce
Confidence 3568899999999999999999974 36789999986532111 234778999999884 67788899887654 467
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS----------------------------------- 126 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS----------------------------------- 126 (1092)
|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 89999999999987631 122345788999999999998
Q ss_pred ------------------------CCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 127 ------------------------NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 127 ------------------------kGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998655567999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=9.3e-11 Score=118.15 Aligned_cols=138 Identities=16% Similarity=0.111 Sum_probs=98.7
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceEEEEEEecCeE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY--IVEFKEAWVEKGCY 80 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN--IVKL~gvF~e~d~~ 80 (1092)
..+..|.+..+.+.|.++.||++.. .+|..+++|...... ...+.+|+.+++.+.+.+ +.+++.++...+ .
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~-~ 89 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAG-R 89 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-C
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCC-C
Confidence 4566788755555666799999964 567789999876431 134667888888886544 566887765543 5
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY-------------------------------- 128 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG-------------------------------- 128 (1092)
.|+||||++|.+|. .. . .. ...++.++...|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp EEEEEECCSSEETT--TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CEEEEEecCCcccC--cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 77999999998884 11 1 12 2256677777777777643
Q ss_pred --------------------------ccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 129 --------------------------VLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 129 --------------------------IIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998665567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1e-09 Score=118.58 Aligned_cols=143 Identities=9% Similarity=0.153 Sum_probs=104.9
Q ss_pred EEEEEEeecCceEEEEEEEcCCCcEEEEEEEe--cccccHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEecC--eEEE
Q 043248 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARVQ--HPYIVEFKEAWVEKG--CYVC 82 (1092)
Q Consensus 9 eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIk--ks~~se~~~r~f~rEIqILkqL~--HPNIVKL~gvF~e~d--~~ly 82 (1092)
.-++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.|. +..+++++.++.... ...|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34688999999999998753 4678888765 32211 12346778999999997 455788888775442 3467
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS------------------------------------ 126 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS------------------------------------ 126 (1092)
+||||++|..+.+.. ...++......++.+++..|+.||+
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999998775411 1237788889999999999999997
Q ss_pred ----------------------CCccccCCCCCcEEEcCCCC--EEEeecCccccc
Q 043248 127 ----------------------NYVLHRDLKCSNIFLTKDQD--VRLGDFGLAKTL 158 (1092)
Q Consensus 127 ----------------------kGIIHRDLKPENILLD~dG~--LKLiDFGLA~~l 158 (1092)
.+++|+|+++.|||++.++. +.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=7.5e-10 Score=117.17 Aligned_cols=183 Identities=17% Similarity=0.223 Sum_probs=123.7
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCC--cceEEEEEEecC--eEEEEEE
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPY--IVEFKEAWVEKG--CYVCIVT 85 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPN--IVKL~gvF~e~d--~~lyLVM 85 (1092)
++.++.|.+..||.+. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+ ...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4569999999999874 45888886432 33457888999999884 333 344544332222 1347899
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS--------------------------------------- 126 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS--------------------------------------- 126 (1092)
++++|..|...... .++..+...++.|+...|+.||+
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99999988764432 26788888899999999999986
Q ss_pred -------------------CCccccCCCCCcEEEcC--CCCEEEeecCccccccccccCccccCCCCc---CCchhhcc-
Q 043248 127 -------------------NYVLHRDLKCSNIFLTK--DQDVRLGDFGLAKTLKADDLASSVVGTPNY---MCPELLAD- 181 (1092)
Q Consensus 127 -------------------kGIIHRDLKPENILLD~--dG~LKLiDFGLA~~l~~d~~~st~vGTp~Y---mAPEVL~g- 181 (1092)
..++|+|+++.||+++. .+.+.|+||+.+....... .......+ ..|+.+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHH
Confidence 13699999999999997 4457899999886543211 00111111 33333211
Q ss_pred -CCC------------CccccchhHHHHHHHHHhCCCCCcc
Q 043248 182 -IPY------------GFKSDIWSLGCCMYEMAAHRPAFKA 209 (1092)
Q Consensus 182 -~~y------------S~KSDVWSLGVILYELLTGr~PF~g 209 (1092)
..| ....++|++|.++|.+.+|..+|..
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 011 1235899999999999999988754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.2e-06 Score=93.84 Aligned_cols=136 Identities=18% Similarity=0.173 Sum_probs=96.2
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC---CcceEEEEEEecCeEEEEEEee
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP---YIVEFKEAWVEKGCYVCIVTGY 87 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HP---NIVKL~gvF~e~d~~lyLVMEY 87 (1092)
++.++.|....||+. +..+++|+-.. ......+.+|+.+|+.|.+. .+.+++.+........|+||||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 466899999999998 46688887532 23346788999999999753 3566776664444556799999
Q ss_pred cCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 043248 88 CEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN---------------------------------------- 127 (1092)
Q Consensus 88 ceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk---------------------------------------- 127 (1092)
++|..|....-. .++......++.++...|+.||+.
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 999888764221 145555555666666666666632
Q ss_pred --------------------CccccCCCCCcEEEcC---CCCE-EEeecCcccccc
Q 043248 128 --------------------YVLHRDLKCSNIFLTK---DQDV-RLGDFGLAKTLK 159 (1092)
Q Consensus 128 --------------------GIIHRDLKPENILLD~---dG~L-KLiDFGLA~~l~ 159 (1092)
.++|+|+++.|||++. ++.+ .|+||+.+....
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3589999999999987 4554 899999876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=5.3e-06 Score=85.31 Aligned_cols=139 Identities=14% Similarity=0.127 Sum_probs=97.1
Q ss_pred CeEEEEEEeecCce-EEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEEEEE
Q 043248 7 QYEIMEQIGRGAFG-AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 7 rYeIlKkLGkGgFG-tVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.|+. +.+..|..| .||.......+..+++|..... ....+.+|..+|+.|. +--+.+++.++...+ ..|+|
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~-~~~lv 98 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD-DAWLL 98 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT-EEEEE
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC-eEEEE
Confidence 4444 344556555 6899887777888999987543 2345778999998884 333677887776554 67799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSN------------------------------------- 127 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSk------------------------------------- 127 (1092)
||+++|.++.+...... .....+..++...|..||..
T Consensus 99 me~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 99999998887664321 22334555666666666621
Q ss_pred ---------------------CccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 128 ---------------------YVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 128 ---------------------GIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.++|+|+.+.|||++.++.+-|+||+.+...
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1689999999999997766779999987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=7e-05 Score=78.72 Aligned_cols=30 Identities=17% Similarity=0.308 Sum_probs=27.1
Q ss_pred CCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999878899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=3e-05 Score=85.01 Aligned_cols=79 Identities=13% Similarity=0.107 Sum_probs=48.1
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc--cH---HHHHHHHHHHHHHHhcCC--CC-cceEEEEEEecCeEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--TE---RCRRSAHQEMALIARVQH--PY-IVEFKEAWVEKGCYV 81 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~--se---~~~r~f~rEIqILkqL~H--PN-IVKL~gvF~e~d~~l 81 (1092)
-.+.||.|.++.||.+.....++.|++|....... .. .....+..|..+++.+.. +. +.+++. + +.+ ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~-d~~-~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-DTE-MA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ETT-TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E-cCC-cc
Confidence 35789999999999997666678899997643211 00 012345668888887742 33 445653 3 333 24
Q ss_pred EEEEeecCCC
Q 043248 82 CIVTGYCEGG 91 (1092)
Q Consensus 82 yLVMEYceGG 91 (1092)
++||||++|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 6999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=6.3e-05 Score=80.89 Aligned_cols=85 Identities=13% Similarity=0.086 Sum_probs=52.6
Q ss_pred EEEEEE-eecCceEEEEEEEc--C----CCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCC---CCcceEEEEEEec
Q 043248 9 EIMEQI-GRGAFGAAILVNHR--A----EKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQH---PYIVEFKEAWVEK 77 (1092)
Q Consensus 9 eIlKkL-GkGgFGtVYLA~dK--~----tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~H---PNIVKL~gvF~e~ 77 (1092)
...+.| +.|....+|++... . ++..+++|+...... .......+.+|+.+++.|.. -.+.+++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88989999988653 1 256788887654320 00001235567777777742 3567777765433
Q ss_pred C--eEEEEEEeecCCCCH
Q 043248 78 G--CYVCIVTGYCEGGDM 93 (1092)
Q Consensus 78 d--~~lyLVMEYceGGSL 93 (1092)
. ...|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 2 235689999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00048 Score=76.68 Aligned_cols=33 Identities=18% Similarity=0.269 Sum_probs=28.2
Q ss_pred HCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 126 SkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
...++|+|+++.|||++.++ ++|+||+.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 45799999999999998776 9999999886543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00093 Score=70.69 Aligned_cols=135 Identities=13% Similarity=0.091 Sum_probs=72.9
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEEEEEeec-
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVCIVTGYC- 88 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~lyLVMEYc- 88 (1092)
++.|+.|....+|++ ..+++|+....... . -...+|+.+++.+...++ .+++.++ .+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~--~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~-~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE--Y-INRANEAVAAREAAKAGVSPEVLHVD--PA-TGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TT-TCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc--e-eCHHHHHHHHHHHHHcCCCCceEEEE--CC-CCEEEEeecC
Confidence 788999999999999 45788877542110 0 112346766766643233 4666443 22 124899999
Q ss_pred CCCCHHH---------------HHHHc-C-CCCC----C-HHHHHHHHHH--------------HHHHHHHHH----H--
Q 043248 89 EGGDMAE---------------LMKKS-N-GAYF----P-EEKLCKWFAQ--------------LLLAVDYLH----S-- 126 (1092)
Q Consensus 89 eGGSL~D---------------LLkkk-~-gk~L----S-EeqI~kIa~Q--------------ILsALaYLH----S-- 126 (1092)
+|.+|.. .+.+- . ...+ . ...+..+..+ +...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6654421 11110 0 0001 1 1111111111 111111111 1
Q ss_pred --CCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 127 --NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 127 --kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 23899999999999 55678999999887643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0035 Score=68.51 Aligned_cols=76 Identities=12% Similarity=0.010 Sum_probs=56.6
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEecCeEEEEEEe
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ---HPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~---HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
-.+.|+.|.+..+|++.. ++..+++|...... ...+.+|+..|+.|. ...+++++.+.... ...++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEE
Confidence 357799999999999874 46788898876431 345778888888874 35678888776544 46789999
Q ss_pred ecCCCCH
Q 043248 87 YCEGGDM 93 (1092)
Q Consensus 87 YceGGSL 93 (1092)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0014 Score=70.00 Aligned_cols=33 Identities=27% Similarity=0.329 Sum_probs=27.8
Q ss_pred CCccccCCCCCcEEEcCC----CCEEEeecCcccccc
Q 043248 127 NYVLHRDLKCSNIFLTKD----QDVRLGDFGLAKTLK 159 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~d----G~LKLiDFGLA~~l~ 159 (1092)
..++|+|+.+.|||++.+ +.+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999874 679999999886543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0039 Score=66.36 Aligned_cols=136 Identities=20% Similarity=0.121 Sum_probs=92.5
Q ss_pred CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCccccccccccCccccC
Q 043248 91 GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVG 169 (1092)
Q Consensus 91 GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~st~vG 169 (1092)
.+|.++|...+ .+|+|+++|.++.|.+.+|.-+-. +.-..+=+.|..|+|..+|.|.+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 37999998765 469999999999999999877622 2223445668999999999988774 2111 11
Q ss_pred CCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhccc----
Q 043248 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK---- 245 (1092)
Q Consensus 170 Tp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqk---- 245 (1092)
...+.+||.+. ...+.+.=|||||+++|.-+--..+ ...+..+|+.+..||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhccccc
Confidence 22466788763 3456788999999999998732211 123345899999999999755
Q ss_pred ---------------------CCCCCCCHHHHHh
Q 043248 246 ---------------------NPEHRPSASELLK 258 (1092)
Q Consensus 246 ---------------------DPskRPSaeELLq 258 (1092)
.+..|.++.+|++
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccCcCCHHHHHH
Confidence 2457888988885
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0028 Score=66.95 Aligned_cols=142 Identities=17% Similarity=0.149 Sum_probs=75.5
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceEEEE-----EEecCeEEE
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY--IVEFKEA-----WVEKGCYVC 82 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN--IVKL~gv-----F~e~d~~ly 82 (1092)
-++.|+.|....+|++... +| .+++|....... ...+..|+.+++.|...+ +.+++.. +..-+...+
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 3567888888999998753 33 688898765211 123445666666663212 2333311 011123567
Q ss_pred EEEeecCCCCHH-----------HH---HHHcC-C---C---CCCHHHHHH---------------HHHHHHHHHHHHHH
Q 043248 83 IVTGYCEGGDMA-----------EL---MKKSN-G---A---YFPEEKLCK---------------WFAQLLLAVDYLHS 126 (1092)
Q Consensus 83 LVMEYceGGSL~-----------DL---Lkkk~-g---k---~LSEeqI~k---------------Ia~QILsALaYLHS 126 (1092)
+||+|++|..+. .. +.... . . ......... +...+...+.++..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999986431 01 11110 0 0 001000000 00113344555552
Q ss_pred -------CCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 127 -------NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 127 -------kGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998765568999987753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0075 Score=63.36 Aligned_cols=78 Identities=6% Similarity=-0.000 Sum_probs=53.1
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC---CcceEEEEEEecCeEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP---YIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HP---NIVKL~gvF~e~d~~lyL 83 (1092)
+..-++.+|.|..+.||++.. .+|+.|++|+....... ....+.+|+..|+.|.-- -+++++.+ ... ++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~---~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR---TL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT---EE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc---eE
Confidence 345578899999999999985 57889999976433211 123467799888888422 34555543 222 58
Q ss_pred EEeecCCCC
Q 043248 84 VTGYCEGGD 92 (1092)
Q Consensus 84 VMEYceGGS 92 (1092)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.013 Score=61.94 Aligned_cols=139 Identities=14% Similarity=0.155 Sum_probs=76.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceEEEE----EEecCeEEEEEE
Q 043248 12 EQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY--IVEFKEA----WVEKGCYVCIVT 85 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN--IVKL~gv----F~e~d~~lyLVM 85 (1092)
..|+ |....||++.. .+|+.+++|......... ..+..|+.+++.|.... +++++.. +...+...++||
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4566 88889998764 346679999986432222 34555777777664222 3444432 011133567899
Q ss_pred eecCCCCHH-----H------HH---HHc--CC-----CCCCHHHH----------------------HHHHHHHHHHHH
Q 043248 86 GYCEGGDMA-----E------LM---KKS--NG-----AYFPEEKL----------------------CKWFAQLLLAVD 122 (1092)
Q Consensus 86 EYceGGSL~-----D------LL---kkk--~g-----k~LSEeqI----------------------~kIa~QILsALa 122 (1092)
+|++|..+. . .+ ... .. ..+..... ..++.+++..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999875421 1 11 110 00 01221110 111122222222
Q ss_pred HH----HHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 123 YL----HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 123 YL----HSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22 123589999999999998 4 899999987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.013 Score=66.28 Aligned_cols=74 Identities=14% Similarity=0.144 Sum_probs=48.7
Q ss_pred EEEEEeecCceEEEEEEEcC-------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEE
Q 043248 10 IMEQIGRGAFGAAILVNHRA-------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYV 81 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~-------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~l 81 (1092)
-++.|+.|....||++.... .+..+++|+.... .. ...+.+|+.+++.|...++ +++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---
Confidence 35778899999999998643 2578889887432 11 1234468888888753334 6677654 23
Q ss_pred EEEEeecCCCC
Q 043248 82 CIVTGYCEGGD 92 (1092)
Q Consensus 82 yLVMEYceGGS 92 (1092)
.+||||++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 27899998733
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.026 Score=64.86 Aligned_cols=75 Identities=12% Similarity=0.173 Sum_probs=47.7
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEecCeEEEEEEeecC
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI-VEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNI-VKL~gvF~e~d~~lyLVMEYce 89 (1092)
++.|+.|-...+|++.....+..|++|+....... .. .-.+|+.+++.|...++ .++++++ .+. +||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~G---~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--II-NREREKKISCILYNKNIAKKIYVFF--TNG---RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CS-CHHHHHHHHHHHTTSSSBCCEEEEE--TTE---EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hc-CHHHHHHHHHHHHhcCCCCCEEEEe--CCe---EEEEeeC
Confidence 57788899999999987544578888876432110 00 01468888888865555 5677665 232 5999998
Q ss_pred CCCH
Q 043248 90 GGDM 93 (1092)
Q Consensus 90 GGSL 93 (1092)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.20 E-value=0.01 Score=64.61 Aligned_cols=74 Identities=9% Similarity=0.113 Sum_probs=42.7
Q ss_pred EEEEeecCceEEEEEEEcC--------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCeEE
Q 043248 11 MEQIGRGAFGAAILVNHRA--------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY-IVEFKEAWVEKGCYV 81 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~--------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN-IVKL~gvF~e~d~~l 81 (1092)
++.|+.|....+|++.... .+..+++|+....... . .....|+.+++.|...+ ..+++..+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG--- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--e-ecHHHHHHHHHHHHhcCCCCceEEec--CC---
Confidence 5678888889999998643 1367888876532111 0 01245777777774333 45666543 33
Q ss_pred EEEEeecCCCC
Q 043248 82 CIVTGYCEGGD 92 (1092)
Q Consensus 82 yLVMEYceGGS 92 (1092)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 47999998854
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.011 Score=66.48 Aligned_cols=139 Identities=14% Similarity=0.121 Sum_probs=81.0
Q ss_pred EEEEeecCceEEEEEEEcC-------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecCeEEE
Q 043248 11 MEQIGRGAFGAAILVNHRA-------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH-PYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~-------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H-PNIVKL~gvF~e~d~~ly 82 (1092)
++.|..|-...+|++.... +++.|++++...... ......+|..+++.|.. .-..++++++ .+.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~g--- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVF--PEG--- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEE--TTE---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEc--CCc---
Confidence 3567778888999998642 357888888532111 12344578888887742 2235666554 232
Q ss_pred EEEeecCCCCHH--------------HHHHHc---C---CCCC--CHHHHHHHHHHHHH-------------------HH
Q 043248 83 IVTGYCEGGDMA--------------ELMKKS---N---GAYF--PEEKLCKWFAQLLL-------------------AV 121 (1092)
Q Consensus 83 LVMEYceGGSL~--------------DLLkkk---~---gk~L--SEeqI~kIa~QILs-------------------AL 121 (1092)
+||||++|..|. ..|.+- . +... -+.++..|+.++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999885542 111111 0 1111 24566666655432 23
Q ss_pred HHHH----HC----CccccCCCCCcEEEcCC----CCEEEeecCcccc
Q 043248 122 DYLH----SN----YVLHRDLKCSNIFLTKD----QDVRLGDFGLAKT 157 (1092)
Q Consensus 122 aYLH----Sk----GIIHRDLKPENILLD~d----G~LKLiDFGLA~~ 157 (1092)
.+|. .. .++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3333 22 48999999999999876 6899999987754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.42 E-value=0.1 Score=56.81 Aligned_cols=33 Identities=12% Similarity=0.293 Sum_probs=28.2
Q ss_pred CCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 358999999999999987889999998776543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.91 E-value=0.14 Score=57.09 Aligned_cols=29 Identities=31% Similarity=0.426 Sum_probs=24.5
Q ss_pred ccccCCCCCcEEE------cCCCCEEEeecCcccc
Q 043248 129 VLHRDLKCSNIFL------TKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 129 IIHRDLKPENILL------D~dG~LKLiDFGLA~~ 157 (1092)
++|+|+.+.|||+ +.+..++|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.26 E-value=0.83 Score=52.11 Aligned_cols=74 Identities=9% Similarity=0.133 Sum_probs=45.9
Q ss_pred EEEEeecCceEEEEEEEcCC-------CcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecCeEEE
Q 043248 11 MEQIGRGAFGAAILVNHRAE-------KKKYVLKKIRLARQTERCRRSAHQEMALIARVQH-PYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~t-------Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H-PNIVKL~gvF~e~d~~ly 82 (1092)
++.|..|-...+|++..... +..|++++..... ... -...+|+.+++.|.. .-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~---~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKF-YDSKVELDVFRYLSNINIAPNIIADF--PE---G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT---E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC---C
Confidence 46788888899999986521 5778888864321 111 012357777777642 2245666433 33 4
Q ss_pred EEEeecCCCC
Q 043248 83 IVTGYCEGGD 92 (1092)
Q Consensus 83 LVMEYceGGS 92 (1092)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 7899999865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1092 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-83 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-76 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-75 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-73 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-72 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-72 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-71 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-71 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-70 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-70 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-70 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-67 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-65 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-64 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-63 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-62 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-60 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-60 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-59 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-59 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-58 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-57 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-57 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-55 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-54 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-53 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-39 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-22 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (685), Expect = 9e-83
Identities = 101/269 (37%), Positives = 147/269 (54%), Gaps = 9/269 (3%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
SR + YE++ IG G++G + +++ K V K++ TE ++ E+ L+ +
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 63 QHPYIVEFKEAWVEK-GCYVCIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLL 119
+HP IV + + +++ + IV YCEGGD+A ++ K Y EE + + QL L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 120 AVDYLH-----SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNY 173
A+ H + VLHRDLK +N+FL Q+V+LGDFGLA+ L D A + VGTP Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233
M PE + + Y KSDIWSLGC +YE+ A P F AF L KI +P YS
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 234 SLKTLIKGMLRKNPEHRPSASELLKHPFL 262
L +I ML HRPS E+L++P +
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 2e-76
Identities = 66/260 (25%), Positives = 124/260 (47%), Gaps = 6/260 (2%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQ 63
++ +EI +G+G FG L + K LK + A+ + +E+ + + ++
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
HP I+ + + V ++ Y G + ++K + F E++ + +L A+ Y
Sbjct: 65 HPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 121
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
HS V+HRD+K N+ L ++++ DFG + +++ GT +Y+ PE++
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 180
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243
+ K D+WSLG YE +P F+A +I+R P + + LI +L
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLL 239
Query: 244 RKNPEHRPSASELLKHPFLQ 263
+ NP RP E+L+HP++
Sbjct: 240 KHNPSQRPMLREVLEHPWIT 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 1e-75
Identities = 84/266 (31%), Positives = 136/266 (51%), Gaps = 12/266 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D +EI+ ++G GAFG ++ K I ++E E+ ++A HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHP 69
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV+ +A+ + + I+ +C GG + +M + E ++ Q L A++YLH
Sbjct: 70 NIVKLLDAFYYEN-NLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH 127
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL-KADDLASSVVGTPNYMCPELLA---- 180
N ++HRDLK NI T D D++L DFG++ + S +GTP +M PE++
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 181 -DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKT 237
D PY +K+D+WSLG + EMA P + ++ KI +S L PS +S + K
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263
+K L KN + R + S+LL+HPF+
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 245 bits (626), Expect = 2e-73
Identities = 69/315 (21%), Positives = 133/315 (42%), Gaps = 10/315 (3%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIAR 61
+ +D Y+I E++G GAFG V RA + K + ++++ + +E+ ++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSV 79
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
++HP +V +A+ + + ++ + GG++ E + + E++ ++ Q+ +
Sbjct: 80 LRHPTLVNLHDAFEDDN-EMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGL 137
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELL 179
++H N +H DLK NI T + ++L DFGL L GT + PE+
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLK 236
P G+ +D+WS+G Y + + F + + + S S K
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAE 296
I+ +L +P R + + L+HP+L R + P++ K E
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS-RYTKIRDSIKTKYDAWPE 316
Query: 297 SQNSSSSASDKDSLR 311
S+ SLR
Sbjct: 317 PLPPLGRISNYSSLR 331
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 241 bits (617), Expect = 3e-73
Identities = 77/278 (27%), Positives = 128/278 (46%), Gaps = 20/278 (7%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRL-------ARQTERCRRSAHQEMAL 58
+ YE E +GRG H+ K+Y +K I + A + + R + +E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 59 IARVQ-HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+ +V HP I++ K+ E + +V + G++ + + + E++ K L
Sbjct: 63 LRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRAL 119
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
L + LH ++HRDLK NI L D +++L DFG + L + V GTP+Y+ PE
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 178 LLA------DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---GPLP 228
++ YG + D+WS G MY + A P F ++ I + P
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266
YS ++K L+ L P+ R +A E L HPF Q +V
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 3e-72
Identities = 60/265 (22%), Positives = 120/265 (45%), Gaps = 10/265 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +++++ +G GA+G L +R ++ +K + + R + C + +E+ + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHE 63
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+F +G + YC GG++ + ++ G PE ++F QL+ V YLH
Sbjct: 64 NVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 120
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADI 182
+ HRD+K N+ L + ++++ DFGLA + ++ L + + GT Y+ PELL
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 183 PY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLP--SCYSPSLKTLI 239
+ D+WS G + M A + + + L + L+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 240 KGMLRKNPEHRPSASELLKHPFLQH 264
+L +NP R + ++ K +
Sbjct: 241 HKILVENPSARITIPDIKKDRWYNK 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 241 bits (617), Expect = 4e-72
Identities = 71/315 (22%), Positives = 136/315 (43%), Gaps = 11/315 (3%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
S D Y+I+E++G GAFG +A + +V K I ++ E++++ ++
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--VKNEISIMNQL 83
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
HP ++ +A+ +K + ++ + GG++ + + E ++ + Q +
Sbjct: 84 HHPKLINLHDAFEDKY-EMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLK 141
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
++H + ++H D+K NI + V++ DFGLA L D++ T + PE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 201
Query: 181 DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---GPLPSCYSPSLKT 237
P GF +D+W++G Y + + F D + + R S SP K
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAES 297
IK +L+K P R + + L+HP+L+ P + K E
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS--RYNKIRQKIKEKYADWPAP 319
Query: 298 QNSSSSASDKDSLRS 312
Q + ++ SLR
Sbjct: 320 QPAIGRIANFSSLRK 334
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 4e-72
Identities = 81/307 (26%), Positives = 131/307 (42%), Gaps = 49/307 (15%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
ME + D +E + ++G G G V+H+ K I L + R +E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLH 59
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
PYIV F A+ G + I + +GG + +++KK+ PE+ L K ++
Sbjct: 60 ECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKG 116
Query: 121 VDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELL 179
+ YL + ++HRD+K SNI + +++L DFG++ L D +A+S VGT +YM PE L
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 175
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD---------------------------- 211
Y +SDIWS+G + EMA R D
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 212 --------------MAGLISKINRSSIGPLPS-CYSPSLKTLIKGMLRKNPEHRPSASEL 256
+ L+ I LPS +S + + L KNP R +L
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 257 LKHPFLQ 263
+ H F++
Sbjct: 296 MVHAFIK 302
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 1e-71
Identities = 77/264 (29%), Positives = 127/264 (48%), Gaps = 12/264 (4%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYI 67
+ +IGRG+F + +++ + T+ R+ +E ++ +QHP I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 68 VEFKEAW---VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
V F ++W V+ + +VT G + +K+ + L W Q+L + +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFL 128
Query: 125 HSN--YVLHRDLKCSNIFLT-KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
H+ ++HRDLKC NIF+T V++GD GLA LK A +V+GTP +M PE+ +
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE 187
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP--LPSCYSPSLKTLI 239
Y D+++ G CM EMA + A I + S + P P +K +I
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 240 KGMLRKNPEHRPSASELLKHPFLQ 263
+G +R+N + R S +LL H F Q
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 7e-71
Identities = 74/261 (28%), Positives = 129/261 (49%), Gaps = 9/261 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+Y E+IG+GA G A ++ ++++ L +Q ++ E+ ++ ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV + ++++ + +V Y GG + +++ ++ E ++ + L A+++LH
Sbjct: 78 NIVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLADIPY 184
SN V+HRD+K NI L D V+L DFG + + S++VGTP +M PE++ Y
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 185 GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL--PSCYSPSLKTLIKGM 242
G K DIWSLG EM P + + + I + L P S + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 243 LRKNPEHRPSASELLKHPFLQ 263
L + E R SA ELL+H FL+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 234 bits (597), Expect = 5e-70
Identities = 70/263 (26%), Positives = 126/263 (47%), Gaps = 11/263 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA-RQTERCRRSAHQEMALIARVQH 64
+ + +IG G+FGA + +KK+ + +Q+ + +E+ + +++H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P ++++ ++ + +V YC G L E ++ L + YL
Sbjct: 75 PNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA---D 181
HS+ ++HRD+K NI L++ V+LGDFG A + A+S VGTP +M PE++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 188
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS-CYSPSLKTLIK 240
Y K D+WSLG E+A +P + + I ++ L S +S + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 241 GMLRKNPEHRPSASELLKHPFLQ 263
L+K P+ RP++ LLKH F+
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 5e-70
Identities = 72/270 (26%), Positives = 131/270 (48%), Gaps = 14/270 (5%)
Query: 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARV 62
R + ++ + +G G+F +L A ++Y +K + E +E +++R+
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
HP+ V+ + + + Y + G++ + ++K F E + A+++ A++
Sbjct: 66 DHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALE 122
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELL 179
YLH ++HRDLK NI L +D +++ DFG AK L + A+S VGT Y+ PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLI 239
+ SD+W+LGC +Y++ A P F+A + + KI + P + P + L+
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLV 241
Query: 240 KGMLRKNPEHRPSASE------LLKHPFLQ 263
+ +L + R E L HPF +
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 234 bits (597), Expect = 6e-70
Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 10/264 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
D Y+ + +G GAF IL + +K +K I + S E+A++ +++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHP 67
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
IV + + G ++ ++ GG++ + + + ++ E + Q+L AV YLH
Sbjct: 68 NIVALDDIYESGG-HLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH 124
Query: 126 SNYVLHRDLKCSNIFLT---KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADI 182
++HRDLK N+ +D + + DFGL+K + S+ GTP Y+ PE+LA
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---GPLPSCYSPSLKTLI 239
PY D WS+G Y + P F + A L +I ++ P S S K I
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 240 KGMLRKNPEHRPSASELLKHPFLQ 263
+ ++ K+PE R + + L+HP++
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 9e-70
Identities = 66/312 (21%), Positives = 132/312 (42%), Gaps = 14/312 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++Y I E +GRG FG + KK Y+ K +++ + +E++++ +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHR 61
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
I+ E++ + ++ + G D+ E + + E ++ + Q+ A+ +LH
Sbjct: 62 NILHLHESFESME-ELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH 119
Query: 126 SNYVLHRDLKCSNIFLTKDQD--VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
S+ + H D++ NI + +++ +FG A+ LK D + P Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY---SPSLKTLIK 240
+D+WSLG +Y + + F A +I I + + S +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMAESQNS 300
+L K + R +ASE L+HP+L+ +++ K H + S
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT----LKHRRYYHTLIKKDLNMVVS 295
Query: 301 SSSASDKDSLRS 312
++ S ++RS
Sbjct: 296 AARISCGGAIRS 307
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 6e-67
Identities = 64/265 (24%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
Q + ++IG G+FG +K + + T + ++ E+ ++ + +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
I+ F + IVT +CEG + + F KL Q +DYLH
Sbjct: 65 NILLFMG--YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH 121
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELL--- 179
+ ++HRDLK +NIFL +D V++GDFGLA + G+ +M PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-----NRSSIGPLPSCYSPS 234
PY F+SD+++ G +YE+ + + + I + + + S +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 235 LKTLIKGMLRKNPEHRPSASELLKH 259
+K L+ L+K + RP ++L
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 9e-67
Identities = 58/261 (22%), Positives = 121/261 (46%), Gaps = 11/261 (4%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M + ++++ IG+G FG +L ++R K +K I+ + E +++ +++H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA----EASVMTQLRH 59
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
+V+ VE+ + IVT Y G + + ++ + + L K+ + A++YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPY 184
N +HRDL N+ +++D ++ DFGL K + + PE L + +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREKKF 177
Query: 185 GFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243
KSD+WS G ++E+ + R + + ++ ++ + P P++ ++K
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 244 RKNPEHRPSASELLKHPFLQH 264
+ RPS +L + L+H
Sbjct: 238 HLDAAMRPSFLQLREQ--LEH 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-65
Identities = 73/323 (22%), Positives = 139/323 (43%), Gaps = 19/323 (5%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIR--LARQTERCRRSAHQEMALIARV 62
++ + + + +G+G+FG L + + + +K ++ + + + ++ L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
+HP++ + K + V Y GGD+ ++ + F + + A+++L +
Sbjct: 61 EHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQ 117
Query: 123 YLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLAD 181
+LHS +++RDLK NI L KD +++ DFG+ K D ++ GTP+Y+ PE+L
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
Y D WS G +YEM + F D L I + P K L+
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLVK 236
Query: 242 MLRKNPEHRPSA-SELLKHPFLQHFV------DQYRPTFPPAACSPEKPISIAHESRRCM 294
+ + PE R ++ +HP + + P F P SP + E
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEF---- 292
Query: 295 AESQNSSSSASDKDSLRSGDRNI 317
++ S +D+ + S D+N+
Sbjct: 293 -LNEKPRLSFADRALINSMDQNM 314
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 2e-64
Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 22/274 (8%)
Query: 5 MDQYEIMEQ-IGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV- 62
+D Y++ Q +G G G + + ++ ++K+ LK ++ + R E+ L R
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRAS 62
Query: 63 QHPYIVEFKEAW---VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
Q P+IV + + + IV +GG++ ++ F E + + +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLKADDLASSVVGTPNYMCP 176
A+ YLHS + HRD+K N+ T + ++L DFG AK + + ++ TP Y+ P
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFD----MAGLISKINRSSI---GPLPS 229
E+L Y D+WSLG MY + P F + G+ ++I P S
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 230 CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S +K LI+ +L+ P R + +E + HP++
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 2e-63
Identities = 65/269 (24%), Positives = 126/269 (46%), Gaps = 14/269 (5%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR----QTERCRRSAHQEMALIAR 61
D Y+ E++G G F ++ +Y K I+ R + R +E++++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+QHP ++ E + K V ++ GG++ + + + EE+ ++ Q+L V
Sbjct: 70 IQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGV 126
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQD----VRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
YLHS + H DLK NI L +++ DFGLA + + ++ GTP ++ PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI---GPLPSCYSPS 234
++ P G ++D+WS+G Y + + F ++ ++ + S S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
K I+ +L K+P+ R + + L+HP+++
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 213 bits (544), Expect = 1e-62
Identities = 74/316 (23%), Positives = 142/316 (44%), Gaps = 21/316 (6%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQ 63
+ ++I+ +G G+FG L+ R + Y +K ++ + + E +++ V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
HP+I+ + + ++ Y EGG++ L++KS FP + A++ LA++Y
Sbjct: 63 HPFIIRMWGTFQDAQQI-FMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEY 119
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIP 183
LHS +++RDLK NI L K+ +++ DFG AK + D+ ++ GTP+Y+ PE+++ P
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKP 177
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243
Y D WS G +YEM A F + KI + + P ++ +K L+ ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI 236
Query: 244 RKNPEHR-----PSASELLKHPFLQHFV------DQYRPTFPPAACSPEKPISIAHESRR 292
++ R ++ HP+ + V + P ++ + +
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP---PIQQGQGDTSQFDK 293
Query: 293 CMAESQNSSSSASDKD 308
E N D
Sbjct: 294 YPEEDINYGVQGEDPY 309
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-62
Identities = 87/290 (30%), Positives = 138/290 (47%), Gaps = 17/290 (5%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQ 63
M+ ++ ++ +G+G FG ILV +A + Y +K +R + E ++ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
HP++ K A+ +C V Y GG++ + + F EE+ + A+++ A++Y
Sbjct: 64 HPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEY 120
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLADI 182
LHS V++RD+K N+ L KD +++ DFGL K +D + GTP Y+ PE+L D
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
YG D W LG MYEM R F D L I I P SP K+L+ G+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGL 239
Query: 243 LRKNPEHRPS-----ASELLKHPFLQHF------VDQYRPTFPPAACSPE 281
L+K+P+ R A E+++H F + P F P S
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-61
Identities = 58/263 (22%), Positives = 113/263 (42%), Gaps = 11/263 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +++E++G G FG + + K +K ++ + + E L+ ++QH
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQ 68
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V ++ Y I+T Y E G + + +K +G KL AQ+ + ++
Sbjct: 69 RLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD--LASSVVGTPNYMCPELLADIP 183
+HRDL+ +NI ++ ++ DFGLA+ ++ ++ + PE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+ KSD+WS G + E+ H R + +I + R P L L++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 243 LRKNPEHRPSASELLKHPFLQHF 265
++ PE RP+ L L+ F
Sbjct: 247 WKERPEDRPTFDYLRSV--LEDF 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 4e-61
Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 35/292 (11%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYV-LKKIRLARQTERCRRSAHQE---MALIAR 61
QYE + +IG GA+G ++V LK++R+ E S +E + +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 62 VQHPYIVEFKEAWV----EKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+HP +V + ++ + +V + + + + K P E + QL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
L +D+LHS+ V+HRDLK NI +T ++L DFGLA+ +SVV T Y PE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI------------------ 219
+L Y D+WS+GC EM +P F+ + KI
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 220 --------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
+ I + K L+ L NP R SA L HP+ Q
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-61
Identities = 60/271 (22%), Positives = 114/271 (42%), Gaps = 11/271 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ + ++G+G FG + + +K ++ + + QE ++ +++H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHE 72
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+ E+ Y IVT Y G + + +K G Y +L AQ+ + Y+
Sbjct: 73 KLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCPELLADIP 183
+HRDL+ +NI + ++ ++ DFGLA+ ++ ++ + PE
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+ KSD+WS G + E+ R + ++ ++ R P P SL L+
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250
Query: 243 LRKNPEHRPSASELLK--HPFLQHFVDQYRP 271
RK PE RP+ L + QY+P
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 207 bits (527), Expect = 8e-61
Identities = 61/269 (22%), Positives = 113/269 (42%), Gaps = 13/269 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIARVQH 64
D+YE+ E +G G L + +K +R + +E A + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 65 PYIVEFKEAWVEK---GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
P IV + + G IV Y +G + +++ ++ + A A+
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQAL 124
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD----LASSVVGTPNYMCPE 177
++ H N ++HRD+K +NI ++ V++ DFG+A+ + ++V+GT Y+ PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSPS 234
+SD++SLGC +YE+ P F + + R P S
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
L ++ L KNPE+R + ++ ++
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-60
Identities = 56/271 (20%), Positives = 110/271 (40%), Gaps = 15/271 (5%)
Query: 4 RMDQYEIME-QIGRGAFGAAILVNHRAEKKK--YVLKKIRLARQTERCRRSAHQEMALIA 60
+ D I + ++G G FG+ +R KK+ +K ++ + + +E ++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMH 64
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++ +PYIV + + +V GG + + + P + + Q+ +
Sbjct: 65 QLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMG 121
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD----LASSVVGTPNYMCP 176
+ YL +HRDL N+ L ++ DFGL+K L ADD S+ + P
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
E + + +SD+WS G M+E ++ + +K +++ I + P P L
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241
Query: 236 KTLIKGMLRKNPEHRPSASEL---LKHPFLQ 263
L+ E RP + ++ +
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 3e-60
Identities = 55/257 (21%), Positives = 109/257 (42%), Gaps = 9/257 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++++G G FG R + +K I+ +E +E ++ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHE 59
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+ ++ + I+T Y G + +++ F ++L + + A++YL
Sbjct: 60 KLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE 117
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS--VVGTPNYMCPELLADIP 183
S LHRDL N + V++ DFGL++ + D+ SS + PE+L
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+ KSDIW+ G M+E+ + + ++ F + I + P S + T++
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 243 LRKNPEHRPSASELLKH 259
+ + RP+ LL +
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-60
Identities = 48/261 (18%), Positives = 112/261 (42%), Gaps = 14/261 (5%)
Query: 13 QIGRGAFGAAILVNHRAEK--KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEF 70
++G G FG ++ +K K +K ++ + E ++ ++ +PYIV
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 71 KEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVL 130
+ +V E G + + ++++ + ++ + + Q+ + + YL + +
Sbjct: 74 IGICEAESWM--LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 131 HRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD----LASSVVGTPNYMCPELLADIPYGF 186
HRDL N+ L ++ DFGL+K L+AD+ + + PE + +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 187 KSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRK 245
KSD+WS G M+E ++ + ++ + + + + + P+ + L+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 246 NPEHRPSASEL---LKHPFLQ 263
+ E+RP + + L++ +
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 204 bits (520), Expect = 8e-60
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 34/289 (11%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M++Y +E+IG G +G + + + LKKIRL ++ E + +E++++ ++H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV+ + K + +V + + L G + QLL + Y
Sbjct: 60 SNIVKLYDVIHTK-KRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYC 116
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-SVVGTPNYMCPELLA-DI 182
H VLHRDLK N+ + ++ ++++ DFGLA+ + T Y P++L
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---------------- 226
Y DIWS+GC EM P F A + +I R P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 227 ------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
S L+ ML+ +P R +A + L+H + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-59
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 32/293 (10%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M+ ++ +E+IG G +G ++ + LKKIRL +TE +A +E++L+ + H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P IV+ + + + +V + D+ + M S P + + QLL + +
Sbjct: 61 PNIVKLLDVIHTEN-KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLADIP 183
HS+ VLHRDLK N+ + + ++L DFGLA+ + V T Y PE+L
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 184 Y-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---------------- 226
Y DIWSLGC EM R F + +I R+ P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 227 ------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
+ ++L+ ML +P R SA L HPF Q
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 206 bits (524), Expect = 2e-59
Identities = 69/273 (25%), Positives = 128/273 (46%), Gaps = 16/273 (5%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR----QTERCRRSAHQEMALIA 60
M+ + + IGRG FG K Y +K + R Q E + ++L++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
P+IV A+ + + GGD+ + + F E + + A+++L
Sbjct: 63 TGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILG 119
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA 180
++++H+ +V++RDLK +NI L + VR+ D GLA + + VGT YM PE+L
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQ 178
Query: 181 D-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGL--ISKINRSSIGPLPSCYSPSLKT 237
+ Y +D +SLGC ++++ F+ I ++ + LP +SP L++
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 238 LIKGMLRKNPEHRPS-----ASELLKHPFLQHF 265
L++G+L+++ R A E+ + PF +
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-59
Identities = 64/266 (24%), Positives = 115/266 (43%), Gaps = 18/266 (6%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER----CRRSAHQEMALIAR 61
QY++ +G G FG+ ++ +K + R ++ E+ L+ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 62 VQ--HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
V ++ + + +V I+ D+ + + + EE +F Q+L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKADDLASSVVGTPNYMCPEL 178
AV + H+ VLHRD+K NI + ++ +++L DFG LK D + + GT Y PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 180
Query: 179 LADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237
+ Y G + +WSLG +Y+M F+ + +I R + S +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV-FFRQRVSSECQH 233
Query: 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263
LI+ L P RP+ E+ HP++Q
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 8e-59
Identities = 65/269 (24%), Positives = 126/269 (46%), Gaps = 12/269 (4%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLAR-QTERCRRSAHQEMALIAR 61
+++DQ++ ++ +G G+FG +LV H+ Y +K + + + E ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
V P++V+ + ++ + ++ G + L + F E + AQ++L
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTF 154
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
+YLHS +++RDLK N+ + + +++ DFG AK + ++ GTP + PE++
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS 212
Query: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
Y D W+LG +YEMAA P F A + KI + PS +S LK L++
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRN 271
Query: 242 MLRKNPEHR-----PSASELLKHPFLQHF 265
+L+ + R +++ H +
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 60/257 (23%), Positives = 116/257 (45%), Gaps = 9/257 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ +++IG G FG L K K +K IR +E +E ++ ++ HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHP 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+V+ +E+ +C+V + E G +++ ++ F E L + + YL
Sbjct: 61 KLVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS--VVGTPNYMCPELLADIP 183
V+HRDL N + ++Q +++ DFG+ + + D SS + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
Y KSD+WS G M+E+ + + ++ + ++ I+ P S + ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 243 LRKNPEHRPSASELLKH 259
++ PE RP+ S LL+
Sbjct: 239 WKERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 10/270 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--TERCRRSAHQEMALIARVQ 63
++ E+ IG G FG + + + + I+ + ++ R QE + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
HP+IV+ E V I+ C G++ ++ + L + QL A+ Y
Sbjct: 67 HPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCPELLAD 181
L S +HRD+ N+ ++ + V+LGDFGL++ ++ AS +M PE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 182 IPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240
+ SD+W G CM+E+ H F+ +I +I P+P P+L +L+
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 241 GMLRKNPEHRPSASELLKHPFLQHFVDQYR 270
+P RP +EL L +++ +
Sbjct: 244 KCWAYDPSRRPRFTELKAQ--LSTILEEEK 271
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-58
Identities = 56/289 (19%), Positives = 109/289 (37%), Gaps = 32/289 (11%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKY----VLKKIRLARQTERCRRSAHQEMA 57
E + E + +G GAFG + K V K+ + R + E+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 58 LIARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAY------------ 104
++ ++ H IV A G + ++ YC GD+ ++ +
Sbjct: 93 MMTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 105 ---------FPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155
E L + Q+ +++L +HRDL N+ +T + V++ DFGLA
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 156 KTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFD 211
+ + +D + + +M PE L + Y KSD+WS G ++E+ + +
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 212 MAGLISKINRSSI-GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
+ K+ ++ P + + +++ + RPS L
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-58
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 35/299 (11%)
Query: 9 EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE---RCRRSAHQEMALIARVQHP 65
E ++ +G G F + + +KKI+L ++E R+A +E+ L+ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
I+ +A+ K + +V + E + S + + L ++YLH
Sbjct: 61 NIIGLLDAFGHKS-NISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLH 117
Query: 126 SNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLASSVVGTPNYMCPELLADI-P 183
+++LHRDLK +N+ L ++ ++L DFGLAK+ + + V T Y PELL
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 184 YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP----------------- 226
YG D+W++GC + E+ P +++I + P
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 227 ----------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
+ S L LI+G+ NP R +A++ LK + + P
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-58
Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 46/306 (15%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
+ +YE + +IG+G FG HR +K LKK+ + + E +A +E+ ++ +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 63 QHPYIVEFKEAWVEKG-------CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFA 115
+H +V E K + +V +CE L F ++ +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQ 124
Query: 116 QLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA-----SSVVGT 170
LL + Y+H N +LHRD+K +N+ +T+D ++L DFGLA+ + ++ V T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 171 PNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS 229
Y PELL + YG D+W GC M EM P + ++ I++ P
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 230 -------------------------------CYSPSLKTLIKGMLRKNPEHRPSASELLK 258
P LI +L +P R + + L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
Query: 259 HPFLQH 264
H F
Sbjct: 305 HDFFWS 310
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 3e-57
Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 28/286 (9%)
Query: 1 MESRM-DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALI 59
ME R+ ++Y + +IG G+FG L A ++ +K + + + H E +
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIY 56
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
+Q + +G Y +V E + F + + Q++
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMIS 114
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQD---VRLGDFGLAKTLKADDL--------ASSVV 168
++Y+HS +HRD+K N + + V + DFGLAK + ++
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS----- 223
GT Y I + D+ SLG + ++ A K R S
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 224 --IGPLPSCYSPSLKTLIKGMLRKNPEHRPSAS---ELLKHPFLQH 264
I L Y T + + +P S +L ++ F +
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 5e-57
Identities = 53/264 (20%), Positives = 102/264 (38%), Gaps = 13/264 (4%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKK---YVLKKIRLAR-QTERCRRSAHQEMALIAR 61
++E++G G+FG A K +K ++ +E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
+ H ++ + +VT G + + ++K G +F L ++ Q+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGM 124
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD----LASSVVGTPNYMCPE 177
YL S +HRDL N+ L V++GDFGL + L +D + + PE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIG-PLPSCYSPSL 235
L + SD W G ++EM + + + + + ++ KI++ P P +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 236 KTLIKGMLRKNPEHRPSASELLKH 259
++ PE RP+ L
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-57
Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH 64
M +YE +E+IG G +G +R + LK++RL E SA +E+ L+ ++H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
IV + + +V +C+ + E + + QLL + +
Sbjct: 61 KNIVRLHDVLHSD-KKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFC 117
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LASSVVGTPNYMCPELLADIP 183
HS VLHRDLK N+ + ++ +++L +FGLA+ S+ V T Y P++L
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 184 -YGFKSDIWSLGCCMYEMA-AHRPAFKAFDMAGLISKINRSSIGP--------------- 226
Y D+WS GC E+A A RP F D+ + +I R P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 227 -------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
+ + + + L++ +L+ NP R SA E L+HP+ F
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-56
Identities = 83/316 (26%), Positives = 132/316 (41%), Gaps = 47/316 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+Y + IG GA+G K + +KKI C+R +E+ ++ R +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR-TLREIKILLRFRHE 66
Query: 66 YIVEFKEAW----VEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
I+ + +E+ V +VT + G D+ +L+K + + +C + Q+L +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQ---HLSNDHICYFLYQILRGL 122
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD----DLASSVVGTPNYMCPE 177
Y+HS VLHRDLK SN+ L D+++ DFGLA+ D + V T Y PE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 178 LLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----------------- 219
++ Y DIWS+GC + EM ++RP F ++ I
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 220 -------------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266
N+ L L+ ML NP R + L HP+L+ +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY- 301
Query: 267 DQYRPTFPPAACSPEK 282
Y P+ P A +P K
Sbjct: 302 --YDPSDEPIAEAPFK 315
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-56
Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 51/319 (15%)
Query: 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV 62
+ + +Y+ ++ IG GA G + +KK+ Q + + A++E+ L+ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 63 QHPYIVEFKEAWVEKGC-----YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
H I+ + + V +V + + + E++ Q+
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQM 128
Query: 118 LLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE 177
L + +LHS ++HRDLK SNI + D +++ DFGLA+T + + V T Y PE
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY------ 231
++ + Y DIWS+GC M EM H+ F D +K+ P P
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 232 -----------------------------------SPSLKTLIKGMLRKNPEHRPSASEL 256
+ + L+ ML +P R S +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 257 LKHPFLQHFVDQYRPTFPP 275
L+HP++ + D PP
Sbjct: 309 LQHPYINVWYDPAEVEAPP 327
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 1e-56
Identities = 57/274 (20%), Positives = 117/274 (42%), Gaps = 13/274 (4%)
Query: 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ--TERCRRSAHQEMALI 59
E + +I + IG G FG + + K+ + I+ + TE+ RR E +++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
+ HP ++ + + V I+T + E G + +++++G F +L +
Sbjct: 82 GQFDHPNVIHLEGVVTKST-PVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAA 139
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSV------VGTPNY 173
+ YL +HRDL NI + + ++ DFGL++ L+ D + +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 174 MCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYS 232
PE + + SD+WS G M+E+ ++ + +I+ I + P P
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259
Query: 233 PSLKTLIKGMLRKNPEHRPSASELLKH--PFLQH 264
+L L+ +K+ HRP +++ +++
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-56
Identities = 57/311 (18%), Positives = 119/311 (38%), Gaps = 12/311 (3%)
Query: 4 RMDQYEIMEQIGRGAFG----AAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALI 59
+ +++ ++ +G GAFG + K +K++R A + + + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVM 65
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
A V +P++ + ++T G + + +++ + L W Q+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAK 122
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCP 176
++YL ++HRDL N+ + Q V++ DFGLAK L A++ A +M
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 177 ELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235
E + Y +SD+WS G ++E+ + + + S + + P P + +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPPAACSPEKPISIAHESRRCMA 295
++ + + RP EL+ Q + ++ R M
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMD 302
Query: 296 ESQNSSSSASD 306
E +D
Sbjct: 303 EEDMDDVVDAD 313
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 2e-56
Identities = 56/295 (18%), Positives = 106/295 (35%), Gaps = 35/295 (11%)
Query: 1 MESRMDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQE 55
+E + E + IG GAFG +K ++ + + +E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQRE 66
Query: 56 MALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAY----------- 104
AL+A +P IV+ +C++ Y GD+ E ++ +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 105 -----------FPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153
+ Q+ + YL +HRDL N + ++ V++ DFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 154 LAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKA 209
L++ + + D + +M PE + Y +SD+W+ G ++E+ + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 210 FDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264
+I + +I P L L++ K P RPS + + LQ
Sbjct: 246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 3e-56
Identities = 55/288 (19%), Positives = 115/288 (39%), Gaps = 20/288 (6%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARV- 62
+ + + IG G FG + + + + R+ ++ R E+ ++ ++
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKK--------------SNGAYFPEE 108
HP I+ A +G Y+ + Y G++ + ++K S + +
Sbjct: 69 HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 109 KLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVV 168
+L + A + +DYL +HRDL NI + ++ ++ DFGL++ + +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 169 GTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPL 227
+M E L Y SD+WS G ++E+ + + A L K+ +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
P + L++ R+ P RPS +++L L +++ +
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERKTYVNT 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 1e-55
Identities = 50/257 (19%), Positives = 110/257 (42%), Gaps = 9/257 (3%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRL-ARQTERCRRSAHQEMALIARVQH 64
+ ++G G +G + +K ++ + E + E A++ ++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 72
Query: 65 PYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYL 124
P +V+ + + I+T + G++ + +++ N L Q+ A++YL
Sbjct: 73 PNLVQLLGVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 125 HSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASS--VVGTPNYMCPELLADI 182
+HRDL N + ++ V++ DFGL++ + D + + PE LA
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 183 PYGFKSDIWSLGCCMYEMAAHR-PAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241
+ KSD+W+ G ++E+A + + D++ + + + P + L++
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 242 MLRKNPEHRPSASELLK 258
+ NP RPS +E+ +
Sbjct: 252 CWQWNPSDRPSFAEIHQ 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 6e-55
Identities = 61/298 (20%), Positives = 101/298 (33%), Gaps = 42/298 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
Y + IG G+FG + +KK+ + R ++E+ ++ ++ H
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHC 73
Query: 66 YIVEFKEAWVEKG-----CYVCIVTGYCEGGDMAELMKKSN-GAYFPEEKLCKWFAQLLL 119
IV + + G Y+ +V Y S P + + QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAKTLKADDLASSVVGTPNYMCP-E 177
++ Y+HS + HRD+K N+ L D ++L DFG AK L + S + + Y P
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 178 LLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY------ 231
+ Y D+WS GC + E+ +P F + +I + P
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 232 ----------------------SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
P L +L P R + E H F D
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-54
Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 42/298 (14%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
Y ++ +G GA+GA K +KK+ Q+E + A++E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 66 YIVEFKEAWVEKGC-----YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLA 120
++ + + +V + G D+ +LMK E+++ Q+L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKG 133
Query: 121 VDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPE-LL 179
+ Y+H+ ++HRDLK N+ + +D ++++ DFGLA+ +AD + V T Y PE +L
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEVIL 191
Query: 180 ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI-------------------- 219
+ Y DIWS+GC M EM + FK D + +I
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 220 ----------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267
+ + + SP L++ ML + E R +A E L HP+ + D
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 3e-54
Identities = 73/298 (24%), Positives = 133/298 (44%), Gaps = 25/298 (8%)
Query: 5 MDQYEIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLAR--QTERCRRSAHQEMALI 59
++ +E+++ +G GA+G ++ K Y +K ++ A Q + E ++
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 60 ARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLL 119
++ + + + ++ Y GG++ + + F E ++ + +++L
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVL 140
Query: 120 AVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--ASSVVGTPNYMCPE 177
A+++LH +++RD+K NI L + V L DFGL+K AD+ A GT YM P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 178 LL--ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYS 232
++ D + D WSLG MYE+ F ++I+R + P P S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 233 PSLKTLIKGMLRKNPEHRPS-----ASELLKHPFLQ--HFVDQYRPTFPPAACSPEKP 283
K LI+ +L K+P+ R A E+ +H F Q ++ D P P KP
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA----PFKP 314
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-53
Identities = 58/278 (20%), Positives = 114/278 (41%), Gaps = 24/278 (8%)
Query: 6 DQYEIMEQIGRGAFGA-----AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
D+ ++ + +GRGAFG A ++ A + +K ++ R + LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAY--------------FP 106
H +V A + G + ++ +C+ G+++ ++ +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 107 EEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD---L 163
E L + Q+ +++L S +HRDL NI L++ V++ DFGLA+ + D
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK-INR 221
+M PE + D Y +SD+WS G ++E+ + + + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 222 SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
+ P +P + + P RP+ SEL++H
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 186 bits (472), Expect = 9e-53
Identities = 59/300 (19%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ- 63
D Y+++ ++GRG + + +K V+K ++ + ++ +E+ ++ ++
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRG 88
Query: 64 HPYIVEFKEAWVEKGC-YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
P I+ + + +V + D +L + + + + ++L A+D
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALD 143
Query: 123 YLHSNYVLHRDLKCSNIFLT-KDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
Y HS ++HRD+K N+ + + + +RL D+GLA+ + V + + PELL D
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 182 IP-YGFKSDIWSLGCCMYEMAAHRPAFKA----FDMAGLISKI----------------- 219
Y + D+WSLGC + M + F +D I+K+
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 220 ----------------NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263
R SP + +LR + + R +A E ++HP+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 54/257 (21%), Positives = 97/257 (37%), Gaps = 11/257 (4%)
Query: 12 EQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV 68
E IGRG FG L+++ +K +K + + E ++ HP ++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 91
Query: 69 EFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY 128
+ +V Y + GD+ ++ + L + Q+ + +L S
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 129 VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS-----SVVGTPNYMCPELLADIP 183
+HRDL N L + V++ DFGLA+ + + S +M E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 184 YGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242
+ KSD+WS G ++E+ P + + + + + P L ++
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270
Query: 243 LRKNPEHRPSASELLKH 259
E RPS SEL+
Sbjct: 271 WHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 57/265 (21%), Positives = 108/265 (40%), Gaps = 10/265 (3%)
Query: 2 ESRMDQYEIMEQIGRGAFGA---AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMAL 58
E + IG G FG +L +K+ V K A TE+ R E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 59 IARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLL 118
+ + H I+ + + + I+T Y E G + + +++ +G F +L +
Sbjct: 63 MGQFSHHNIIRLEGVISKYK-PMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIA 120
Query: 119 LAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA----SSVVGTPNYM 174
+ YL + +HRDL NI + + ++ DFGL++ L+ D A S +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 175 CPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSP 233
PE ++ + SD+WS G M+E+ + + ++ IN P P
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240
Query: 234 SLKTLIKGMLRKNPEHRPSASELLK 258
++ L+ ++ RP ++++
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-50
Identities = 57/280 (20%), Positives = 110/280 (39%), Gaps = 28/280 (10%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKK-------KYVLKKIRLARQTERCRRSAHQEMAL 58
D+ + + +G GAFG +L K K +K ++ TE+ EM +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEM 71
Query: 59 IARV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMK--------------KSNGA 103
+ + +H I+ + + ++ Y G++ E ++ +
Sbjct: 72 MKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 104 YFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163
+ L Q+ ++YL S +HRDL N+ +T+D +++ DFGLA+ + D
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 164 ASS---VVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKI 219
+M PE L D Y +SD+WS G ++E+ + + L +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
PS + L +++ P RP+ +L++
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-50
Identities = 57/280 (20%), Positives = 114/280 (40%), Gaps = 29/280 (10%)
Query: 6 DQYEIMEQIGRGAFGA-----AILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
++ + +G GAFG A + +K ++ + R + E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLS 81
Query: 61 RV-QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAY--------------- 104
+ H IV A G ++T YC GD+ +++ ++
Sbjct: 82 YLGNHMNIVNLLGACTIGG-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 105 -FPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162
E L + Q+ + +L S +HRDL NI LT + ++ DFGLA+ +K D
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 163 --LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKI 219
+ + +M PE + + Y F+SD+WS G ++E+ + + + K+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 220 NRSSIGPL-PSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
+ L P + ++K +P RP+ ++++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-50
Identities = 67/313 (21%), Positives = 128/313 (40%), Gaps = 41/313 (13%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
++Y+ + +G GA+G+ + +KK+ Q+ + ++E+ L+ ++H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 66 YIVEFKEAWVEKGCYV----CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAV 121
++ + + + + G D+ ++K ++ + Q+L +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 122 DYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLAD 181
Y+HS ++HRDLK SN+ + +D ++++ DFGLA+ DD + V T Y PE++ +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLN 192
Query: 182 -IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCY--------- 231
+ Y DIWS+GC M E+ R F D + I R P
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 232 ---------------------SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD-QY 269
+P L++ ML + + R +A++ L H + + D
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 270 RPTFPPAACSPEK 282
P P S E
Sbjct: 313 EPVADPYDQSFES 325
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (445), Expect = 1e-49
Identities = 40/273 (14%), Positives = 86/273 (31%), Gaps = 26/273 (9%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
Y++ +IG G+FG + ++ +K + R E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD----EYRTYKLLAGC 60
Query: 66 YIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH 125
+ + ++G + +V G + +L+ G F + + Q+L V +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 126 SNYVLHRDLKCSNIFLTK-----DQDVRLGDFGLAKTLKADD--------LASSVVGTPN 172
+++RD+K N + + + + DFG+ K + ++ GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINR-------SSIG 225
YM + D+ +LG ++ A K R + +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 226 PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
L + + + + P L
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 5e-49
Identities = 52/271 (19%), Positives = 110/271 (40%), Gaps = 19/271 (7%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIA 60
++ + ++G+G+FG + + + +K + A + R R E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMK 78
Query: 61 RVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAY--------FPEEKLCK 112
++V V +G ++ GD+ ++ A K+ +
Sbjct: 79 EFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 113 WFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL---ASSVVG 169
++ + YL++N +HRDL N + +D V++GDFG+ + + D +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 170 TPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLP 228
+M PE L D + SD+WS G ++E+A ++ ++ + + P
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 229 SCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259
L L++ + NP+ RPS E++
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-47
Identities = 54/296 (18%), Positives = 99/296 (33%), Gaps = 51/296 (17%)
Query: 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHP 65
+ E IG+G FG R ++ +K + R E+ ++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE---AEIYQTVMLRHE 57
Query: 66 YIVEFKEAWVEKGC---YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVD 122
I+ F A + + +V+ Y E G + + + + E + K +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 114
Query: 123 YLHSNY--------VLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-----LASSVVG 169
+LH + HRDLK NI + K+ + D GLA + + VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 170 TPNYMCPELLAD------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFD------------ 211
T YM PE+L D ++DI+++G +E+A +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 212 -------MAGLISKINRSSI--GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258
+ + R +I + +++ N R +A + K
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 1e-39
Identities = 57/330 (17%), Positives = 114/330 (34%), Gaps = 62/330 (18%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLA--------RQTERCRRSAHQEMALI 59
Y ++ ++G G F L +K +R + + +R +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 60 ARVQHPYIVEFKEAWVE--KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQL 117
+ +I++ + + ++ G ++ L+KK P + + QL
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 118 LLAVDYLHSNY-VLHRDLKCSNIFLTKD----QDVRLGDFGLAKTLKADDLASSVVGTPN 172
LL +DY+H ++H D+K N+ + +++ L D+ ++ + T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 173 YMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA----------------------- 209
Y PE+L P+G +DIWS C ++E+ F+
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 210 --------------FDMAGLISKINRSSIGPL----------PSCYSPSLKTLIKGMLRK 245
F+ GL+ I++ PL + + + ML+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 246 NPEHRPSASELLKHPFLQHFVDQYRPTFPP 275
+P R A L+ HP+L+ + P
Sbjct: 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 5e-22
Identities = 30/206 (14%), Positives = 65/206 (31%), Gaps = 30/206 (14%)
Query: 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTER----CRRSAHQEMALIARVQ 63
I + +G G A + + V+K ++ + + R +++A
Sbjct: 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 64 HPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDY 123
+ +G V V + + EL+ E + +L V
Sbjct: 61 ARNEFRALQKL--QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 124 LHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLASSVVGTPNYMCPELLA-DI 182
+ ++H DL N+ ++ ++ + + DF + V E+L D+
Sbjct: 119 FYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS------------VEVGEEGWREILERDV 165
Query: 183 ---------PYGFKSDIWSLGCCMYE 199
Y + DI S + +
Sbjct: 166 RNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1092 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.56 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=468.03 Aligned_cols=256 Identities=26% Similarity=0.503 Sum_probs=231.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||+||+|.++.+++.||+|++....... .....+.+|+.++++++|||||+++++|.+.+ .+|
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~ 82 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RVY 82 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-EEE
Confidence 4789999999999999999999999999999999997543222 23456889999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||+||+|.+++.+... +++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|.......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999999987654 9999999999999999999999999999999999999999999999999998765433
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+...+..++..... .++..+++++++||.+|
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRL 238 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHHH
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999888888888776554 46778999999999999
Q ss_pred cccCCCCCCCHHHHHhChhhHh
Q 043248 243 LRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 243 LqkDPskRPSaeELLqHPwFq~ 264 (1092)
|++||.+|||++|+|+||||+.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=471.02 Aligned_cols=260 Identities=39% Similarity=0.696 Sum_probs=225.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-CeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-d~~l 81 (1092)
+|.++|++++.||+|+||+||+|.++.+|+.||+|.+......+.....+.+|+.+|++++|||||+++++|.+. +..+
T Consensus 1 sr~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CCchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 467999999999999999999999999999999999987766666677899999999999999999999998754 4568
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 82 CIVTGYCEGGDMAELMKKS--NGAYFPEEKLCKWFAQLLLAVDYLHSNY-----VLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk--~gk~LSEeqI~kIa~QILsALaYLHSkG-----IIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
|||||||+||+|.+++.+. ....+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 8999999999999999753 2345999999999999999999999976 99999999999999999999999999
Q ss_pred cccccccc-cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCH
Q 043248 155 AKTLKADD-LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSP 233 (1092)
Q Consensus 155 A~~l~~d~-~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~ 233 (1092)
+..+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++..++.......++..+++
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 240 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 98876543 34567899999999999999999999999999999999999999999999888888888877788889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFL 262 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwF 262 (1092)
++.+||.+||+.||.+|||++|+|+|||+
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-56 Score=467.16 Aligned_cols=257 Identities=23% Similarity=0.418 Sum_probs=218.2
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++++.||+|+||+||+|.++.+|+.||||++...... ...+.+.+|+.+|++++|||||+++++|.+.+ .+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-eeEE
Confidence 368999999999999999999999999999999999765432 23456889999999999999999999997755 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc--
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-- 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-- 161 (1092)
|||||+||+|.++|.... .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 vmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999999996544 4999999999999999999999999999999999999999999999999999877533
Q ss_pred -ccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc--CCCCCCCCCCHHHHH
Q 043248 162 -DLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS--SIGPLPSCYSPSLKT 237 (1092)
Q Consensus 162 -~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~--~i~plPs~iS~eLkD 237 (1092)
......+||+.|||||++.+..| +.++|||||||+||+|++|+.||............... ........+++++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 23456789999999999988776 67899999999999999999999875543332222222 222233467999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||.+||++||++|||++|+|+||||++
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=467.62 Aligned_cols=254 Identities=29% Similarity=0.511 Sum_probs=226.6
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||+||+|.++.+|+.||||++....... .+.+.+|+.+|++++|||||+++++|...+ .+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEE
Confidence 358999999999999999999999999999999997654333 356889999999999999999999997766 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
||||+||+|.+++.+. .+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..+.... .
T Consensus 96 mEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 9999999999988764 39999999999999999999999999999999999999999999999999999875443 4
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHHHHHH
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkDLIrk 241 (1092)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+...... ..+..+++++++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999988877766666544332 3456689999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||++||.+|||++|+|+||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999963
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=468.03 Aligned_cols=259 Identities=28% Similarity=0.531 Sum_probs=228.4
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.+.++|++++.||+|+||+||+|.++.+|+.||||++...... ....+.+.+|+.+|++++||||++++++|.+.+ .+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~ 83 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KL 83 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-EE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-EE
Confidence 4567899999999999999999999999999999999754322 223467889999999999999999999996654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|||||||+||+|.+++...+. |++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+...
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 899999999999999987754 999999999999999999999999999999999999999999999999999877543
Q ss_pred c---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 162 D---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
. .....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+...+..++..... .++..+++++++|
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDL 240 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHH
Confidence 2 33457899999999999999999999999999999999999999999988888888876654 4677899999999
Q ss_pred HHHhcccCCCCCCCHHH------HHhChhhHhH
Q 043248 239 IKGMLRKNPEHRPSASE------LLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeE------LLqHPwFq~~ 265 (1092)
|++||++||.+|||++| +++||||+.+
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999999987 5889999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=470.62 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=221.8
Q ss_pred CccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 1 MESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 1 MEsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
||-+-++|++++.||+|+||+||+|.++.+|+.||+|++..... ......+.+|+.+|++++|||||+++++|.+.+ .
T Consensus 1 ~el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~ 78 (322)
T d1s9ja_ 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-E 78 (322)
T ss_dssp CCCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-E
T ss_pred CCCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-E
Confidence 67778999999999999999999999999999999999976532 334567889999999999999999999997655 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
+|||||||+||+|.+++.+.+. +++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|..+.
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 8899999999999999987654 9999999999999999999997 599999999999999999999999999998765
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHH-----------------------
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLI----------------------- 216 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli----------------------- 216 (1092)
.. .....+||++|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.....
T Consensus 157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 43 345679999999999999999999999999999999999999999765432211
Q ss_pred -------------------HHhhccCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 217 -------------------SKINRSSIGPLP-SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 217 -------------------~kI~~~~i~plP-s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
..+.......++ ..++.++++||.+||++||.+|||++|+|+||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 111111111122 23688999999999999999999999999999998643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=465.85 Aligned_cols=258 Identities=29% Similarity=0.520 Sum_probs=210.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..-++|++++.||+|+||+||+|.++.+++.||||++....... ....+.+|+.+|++++|||||+++++|...+ .+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~ 83 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGG-HLY 83 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEE
Confidence 34567999999999999999999999999999999997654332 2356789999999999999999999996554 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCCEEEeecCcccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT---KDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD---~dG~LKLiDFGLA~~l~ 159 (1092)
||||||+||+|.++|...+ .|++..++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||++....
T Consensus 84 lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999999998754 499999999999999999999999999999999999995 46889999999999887
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCHHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLK 236 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~eLk 236 (1092)
........+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.....+...+...... +....+++++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 776677789999999999999999999999999999999999999999998888888777765443 33456899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
+||.+||++||.+|||++|+|+||||+.
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999999963
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=451.93 Aligned_cols=254 Identities=28% Similarity=0.551 Sum_probs=221.0
Q ss_pred CCe-EEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec---CeEE
Q 043248 6 DQY-EIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK---GCYV 81 (1092)
Q Consensus 6 DrY-eIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~---d~~l 81 (1092)
++| ++.+.||+|+||+||+|.++.++..||+|++..........+.+.+|+.+|++++|||||+++++|... +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 456 788899999999999999999999999999987766666677899999999999999999999998653 4678
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc-CCCCEEEeecCccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNY--VLHRDLKCSNIFLT-KDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkG--IIHRDLKPENILLD-~dG~LKLiDFGLA~~l 158 (1092)
|||||||+||+|.+++.+... +++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999999987654 999999999999999999999999 99999999999996 4789999999999865
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccCh-HHHHHHhhccCCC-CCCCCCCHHHH
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDM-AGLISKINRSSIG-PLPSCYSPSLK 236 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~-~dli~kI~~~~i~-plPs~iS~eLk 236 (1092)
... .....+||+.|||||++.+ .|+.++|||||||+||+|++|+.||.+... ..+...+...... .++..++++++
T Consensus 166 ~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 166 RAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp CTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred cCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence 433 3456789999999999876 699999999999999999999999987544 3444444443222 34556789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
+||.+||++||++|||++|+|+||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=468.66 Aligned_cols=258 Identities=32% Similarity=0.589 Sum_probs=233.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+.... ......+.+|+.+|++++||||++++++|.+.+ .+|
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~ 81 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-ccc
Confidence 478999999999999999999999999999999999764322 223466889999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc-c
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA-D 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~-d 161 (1092)
+|||||+||+|.+++.+.+. +++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.... .
T Consensus 82 iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999998764 99999999999999999999999999999999999999999999999999987643 3
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+...+...+..... .+|..+++++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHh
Confidence 445678999999999999999999999999999999999999999999998888888876654 5678899999999999
Q ss_pred hcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 242 MLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
||++||.+|++ ++|+++||||+.+
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999994 9999999999763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=459.94 Aligned_cols=254 Identities=32% Similarity=0.565 Sum_probs=224.4
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
+.|++++.||+|+||.||+|.++.++..||+|++...... ..+.+.+|+.+|++++|||||+++++|...+ .+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-eEEEEE
Confidence 4699999999999999999999999999999999764322 2456889999999999999999999997765 678999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-ccC
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DLA 164 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~~ 164 (1092)
|||+||+|.+++.+.. ..|++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 89 Ey~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp ECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred ecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999999987654 34999999999999999999999999999999999999999999999999999866433 234
Q ss_pred ccccCCCCcCCchhhc-----cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC--CCCCCCCHHHHH
Q 043248 165 SSVVGTPNYMCPELLA-----DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG--PLPSCYSPSLKT 237 (1092)
Q Consensus 165 st~vGTp~YmAPEVL~-----g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~--plPs~iS~eLkD 237 (1092)
...+||+.|+|||++. +..|+.++|||||||+||+|++|+.||.+.+....+.++...... ..+..+++++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 556899999999999999999999999998888887777765433 234578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
||++||++||.+|||++|+|+||||+
T Consensus 248 li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-54 Score=470.88 Aligned_cols=259 Identities=24% Similarity=0.446 Sum_probs=231.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
..+++|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+.+ .+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-EMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-EEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEE
Confidence 45789999999999999999999999999999999997653 333567889999999999999999999997655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCCEEEeecCccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK--DQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~--dG~LKLiDFGLA~~l~~ 160 (1092)
||||||+||+|.+++....+ .+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||++..+..
T Consensus 100 ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999999999965433 4999999999999999999999999999999999999964 57899999999998887
Q ss_pred cccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CCCCCHHHHH
Q 043248 161 DDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PSCYSPSLKT 237 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps~iS~eLkD 237 (1092)
.......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+++..+........ ...+++++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 7767778999999999999999999999999999999999999999999988888888876554322 2457999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 238 LIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||.+||++||.+|||++|+|+||||+..
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=454.17 Aligned_cols=257 Identities=25% Similarity=0.484 Sum_probs=230.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ 80 (1092)
-++|++++.||+|+||+||+|.++.+|+.||||++....... .....+.+|+.+|++|+|||||+++++|.+.+ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-D 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-E
Confidence 357999999999999999999999999999999997543221 12467889999999999999999999996655 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CEEEeecCccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ----DVRLGDFGLAK 156 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG----~LKLiDFGLA~ 156 (1092)
+|||||||+||+|.++|...+. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 8899999999999999987654 99999999999999999999999999999999999998776 49999999999
Q ss_pred cccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC---CCCCCCH
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP---LPSCYSP 233 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p---lPs~iS~ 233 (1092)
............||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+......++....... .+..++.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 8877776777899999999999999999999999999999999999999999998888888877654432 2356899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
++++||++||++||.+|||++|+|+||||+.
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-54 Score=469.22 Aligned_cols=258 Identities=25% Similarity=0.483 Sum_probs=231.7
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
.+++|++++.||+|+||.||+|.++.+|+.||||++..... .....+.+|+.+|++|+|||||+++++|.+.+ .+||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~i 103 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-EMVL 103 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-EEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEE
Confidence 45789999999999999999999999999999999976542 23467889999999999999999999997654 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCCEEEeecCcccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT--KDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD--~dG~LKLiDFGLA~~l~~d 161 (1092)
|||||+||+|.+++.... ..|++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+...
T Consensus 104 vmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999999886543 3499999999999999999999999999999999999997 5689999999999998877
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~eLkDL 238 (1092)
.......||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+...++.++...... .....+++++++|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 7777789999999999999999999999999999999999999999999888888888765443 2335689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
|.+||++||.+|||++|+|+||||+..
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-53 Score=458.12 Aligned_cols=255 Identities=27% Similarity=0.559 Sum_probs=230.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
+++|++++.||+|+||+||+|.++.+|+.||||++...... ....+.+.+|+.+|++++|||||+++++|...+ .+|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-EEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-eeee
Confidence 67899999999999999999999999999999999754322 123467889999999999999999999997655 7889
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL 163 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~ 163 (1092)
|||||+||+|..++..... +++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|......
T Consensus 82 vmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999999987664 899999999999999999999999999999999999999999999999999887543
Q ss_pred CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhc
Q 043248 164 ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGML 243 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcL 243 (1092)
....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+......++..... .++..++++++++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHh
Confidence 4567899999999999999999999999999999999999999999998888888876654 467789999999999999
Q ss_pred ccCCCCCC-----CHHHHHhChhhHhH
Q 043248 244 RKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 244 qkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
.+||.+|+ |++++|+||||+.+
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hhCHHhccccchhhHHHHHcCcccccC
Confidence 99999996 99999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-53 Score=455.04 Aligned_cols=252 Identities=26% Similarity=0.501 Sum_probs=223.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVT 85 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVM 85 (1092)
.|++++.||+|+||+||+|.++.+|+.||||++...... ....+.+.+|+.+|++|+|||||+++++|.+.+ .+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-EEEEEE
Confidence 499999999999999999999999999999999766543 344567899999999999999999999997655 788999
Q ss_pred eecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccCc
Q 043248 86 GYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLAS 165 (1092)
Q Consensus 86 EYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~s 165 (1092)
|||.||+|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---C
T ss_pred EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---C
Confidence 9999999987776654 4999999999999999999999999999999999999999999999999999876543 4
Q ss_pred cccCCCCcCCchhhcc---CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-CCCCCCHHHHHHHHH
Q 043248 166 SVVGTPNYMCPELLAD---IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP-LPSCYSPSLKTLIKG 241 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g---~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p-lPs~iS~eLkDLIrk 241 (1092)
..+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+......+.++....... .+..+++++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 5689999999999864 468999999999999999999999999888877777776655443 345689999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~ 264 (1092)
||++||.+|||++|+|+||||.+
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HCcCChhHCcCHHHHHhCHHhcC
Confidence 99999999999999999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=455.48 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=231.9
Q ss_pred ccCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 2 ESRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 2 EsRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
+..+++|++++.||+|+||+||+|.++.+|+.||||.+...... ...+.+|+.+|+.++|||||+++++|.+.+ .+
T Consensus 1 ~~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~ 76 (321)
T d1tkia_ 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESME-EL 76 (321)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EE
T ss_pred CCCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EE
Confidence 35689999999999999999999999999999999999765322 345789999999999999999999997655 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CCEEEeecCcccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD--QDVRLGDFGLAKTLK 159 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d--G~LKLiDFGLA~~l~ 159 (1092)
|||||||+||+|.++|...+ ..|++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 89999999999999997654 349999999999999999999999999999999999999854 479999999999887
Q ss_pred ccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCC---CCCCCHHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPL---PSCYSPSLK 236 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~pl---Ps~iS~eLk 236 (1092)
........+||+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+....+.++........ ...++++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 76666778899999999999999999999999999999999999999999998888888876654321 235899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 237 TLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 237 DLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+||++||.+||.+|||++|+|+||||++..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999997643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-53 Score=461.87 Aligned_cols=256 Identities=27% Similarity=0.533 Sum_probs=230.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE-RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se-~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
.+++|++++.||+|+||.||+|.++.+|+.||||++....... .....+.+|+.+|+.++|||||+++++|.... .+|
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~ 117 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-ccc
Confidence 4689999999999999999999999999999999987543221 22456889999999999999999999996655 678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
+||||+.||+|..++.+.+. |++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999999988764 999999999999999999999999999999999999999999999999999887643
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHh
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGM 242 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkc 242 (1092)
....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+...+..++..... .++..+++++.+||++|
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999988888888876654 45678999999999999
Q ss_pred cccCCCCCC-----CHHHHHhChhhHhH
Q 043248 243 LRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 243 LqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
|++||.+|+ |++++++||||+.+
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hhhCHHhccccccccHHHHHcCccccCC
Confidence 999999995 99999999999763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-52 Score=443.38 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=229.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-------HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-------ERCRRSAHQEMALIARVQ-HPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-------e~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e 76 (1092)
.++|++++.||+|+||+||+|.++.+|+.||||++...... +.....+.+|+.++++|+ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 58999999999999999999999999999999999765321 234557889999999997 9999999999965
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
++ .+|||||||+||+|.++|+..+. +++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~-~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NT-FFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SS-EEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred Cc-ceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 54 78899999999999999987654 9999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCccccCCCCcCCchhhcc------CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CC
Q 043248 157 TLKADDLASSVVGTPNYMCPELLAD------IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PL 227 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g------~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---pl 227 (1092)
.+.........+||+.|+|||++.+ ..|+.++||||+||+||+|++|+.||.+.+.......+...... +.
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8877666677899999999999853 35688999999999999999999999999888877777655432 23
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
...+|+++++||.+||++||.+|||++|+|+||||+++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 34689999999999999999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-52 Score=456.47 Aligned_cols=258 Identities=26% Similarity=0.512 Sum_probs=219.5
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT----ERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s----e~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
.+++|++++.||+|+||.||+|.++.+|+.||||++...... ........+++.+++.++|||||+++++|...+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~- 80 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD- 80 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC-
Confidence 478999999999999999999999999999999998654321 122223345577788889999999999996655
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~ 159 (1092)
.+|||||||+||+|.++|.+... +++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|..+.
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 78899999999999999987654 8999999999999999999999999999999999999999999999999998776
Q ss_pred ccccCccccCCCCcCCchhhc-cCCCCccccchhHHHHHHHHHhCCCCCcccChHHHH--HHhhccCCCCCCCCCCHHHH
Q 043248 160 ADDLASSVVGTPNYMCPELLA-DIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLI--SKINRSSIGPLPSCYSPSLK 236 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~-g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli--~kI~~~~i~plPs~iS~eLk 236 (1092)
... ....+||+.|+|||++. +..|+.++|||||||+||+|++|+.||.+....... ..........++..++++++
T Consensus 159 ~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 159 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred CCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 543 45678999999999996 457899999999999999999999999875543322 22222333456778999999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHhChhhHhH
Q 043248 237 TLIKGMLRKNPEHRPS-----ASELLKHPFLQHF 265 (1092)
Q Consensus 237 DLIrkcLqkDPskRPS-----aeELLqHPwFq~~ 265 (1092)
+||.+||++||.+||| ++|+++||||+.+
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999999 7999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=451.23 Aligned_cols=257 Identities=24% Similarity=0.492 Sum_probs=226.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEeccccc-HHHHHHHHHHHHHHH-hcCCCCcceEEEEEEecCeEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQT-ERCRRSAHQEMALIA-RVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~s-e~~~r~f~rEIqILk-qL~HPNIVKL~gvF~e~d~~ly 82 (1092)
|++|++++.||+|+||+||+|.++.+|+.||||++.+.... ....+.+.+|..++. .++|||||+++++|.+.+ .+|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLF 79 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-cee
Confidence 68999999999999999999999999999999999754321 122345556666654 689999999999996655 788
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD- 161 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d- 161 (1092)
||||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999999987664 899999999999999999999999999999999999999999999999999876543
Q ss_pred ccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 162 DLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 162 ~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...+..++..... .++..+++++++||++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCccCCHHHHHHHHH
Confidence 334557899999999999999999999999999999999999999999998888888876543 5677899999999999
Q ss_pred hcccCCCCCCCHH-HHHhChhhHhH
Q 043248 242 MLRKNPEHRPSAS-ELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRPSae-ELLqHPwFq~~ 265 (1092)
||++||.+|||+. ++++||||+.+
T Consensus 237 ~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred hcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999995 89999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=440.40 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=218.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+|+|++++.||+|+||+||+|.++.+|+.||||++......+.....+.+|+.+|++++|||||+++++|...+ .+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-KLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-ceeEE
Confidence 68999999999999999999999999999999999765544444567889999999999999999999997755 78899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc-cc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD-DL 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d-~~ 163 (1092)
||||.+ .+..++.......+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|...... ..
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999975 5666666555566999999999999999999999999999999999999999999999999999877543 34
Q ss_pred CccccCCCCcCCchhhccCC-CCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-----------------
Q 043248 164 ASSVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG----------------- 225 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~-yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~----------------- 225 (1092)
.....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+.++......
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 55678999999999987666 488999999999999999999999988877666655321000
Q ss_pred C-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 226 P-----------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 226 p-----------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
. ....++.++++||++||.+||.+|||++|+|+||||+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 012357899999999999999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=439.72 Aligned_cols=260 Identities=30% Similarity=0.438 Sum_probs=219.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCC-CcEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEe----
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAE-KKKYVLKKIRLARQTERCRRSAHQEMALIARV---QHPYIVEFKEAWVE---- 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~t-Gk~VAIKkIkks~~se~~~r~f~rEIqILkqL---~HPNIVKL~gvF~e---- 76 (1092)
.++|++++.||+|+||+||+|.+..+ ++.||||++......+.....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999765 66799999876543333233455677776665 79999999999863
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAK 156 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~ 156 (1092)
.+..+|++||||+++.+.... ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346789999999886665444 3444569999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC-------------
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS------------- 223 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~------------- 223 (1092)
...........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+.++....
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 8877777778899999999999999999999999999999999999999999988777666653210
Q ss_pred -------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 224 -------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 224 -------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
...+...+++.+++||++||++||.+|||++|+|+||||+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 011344578999999999999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=453.39 Aligned_cols=253 Identities=26% Similarity=0.471 Sum_probs=217.1
Q ss_pred CCCCeEEEE-EEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe---cC
Q 043248 4 RMDQYEIME-QIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE---KG 78 (1092)
Q Consensus 4 RIDrYeIlK-kLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e---~d 78 (1092)
.+++|+++. .||+|+||+||+|.++.+++.||||++... ..+.+|+.++.++ +|||||+++++|.. .+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 578999985 599999999999999999999999998643 3466799887654 89999999999865 24
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCEEEeecCcc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQDVRLGDFGLA 155 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG~LKLiDFGLA 155 (1092)
..+|||||||+||+|+++|.+.+...|++..++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67899999999999999998766567999999999999999999999999999999999999985 457999999999
Q ss_pred ccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHh----hccCCCCCC---
Q 043248 156 KTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI----NRSSIGPLP--- 228 (1092)
Q Consensus 156 ~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI----~~~~i~plP--- 228 (1092)
............+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+.......+ ..... .++
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~~~~~ 240 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPE 240 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SCCTTH
T ss_pred eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-CCCCcc
Confidence 9887777777889999999999999999999999999999999999999999886644433322 22221 122
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 229 -SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 229 -s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
..+++++++||++||++||++|||+.|+|+||||.+
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 247899999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=439.58 Aligned_cols=252 Identities=26% Similarity=0.452 Sum_probs=210.6
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH---HHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 10 IMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE---RCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se---~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
.+++||+|+||+||+|.++.+|+.||||++....... ...+.+.+|+.+|++++|||||+++++|...+ .+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-ceeehhh
Confidence 4789999999999999999999999999987554322 22356889999999999999999999996655 6789999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-cCc
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-LAS 165 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~~s 165 (1092)
||.|+++..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99988777665433 349999999999999999999999999999999999999999999999999998775443 345
Q ss_pred cccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC-------------------
Q 043248 166 SVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG------------------- 225 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~------------------- 225 (1092)
..+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+++.++......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999865 46799999999999999999999999998887777666432100
Q ss_pred C--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 226 P--------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 226 p--------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
. ....+++++.+||++||++||++|||++|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0 11246889999999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.8e-51 Score=428.12 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=214.0
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
+++|++++.||+|+||+||+|.++ +|+.||||++......+.....+.+|+.+|++++||||++++++|...+ .+|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEE
Confidence 689999999999999999999985 7899999999766544444567889999999999999999999997665 57799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|||+.++.+..+.... ..+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 9999887666665543 349999999999999999999999999999999999999999999999999998775433 2
Q ss_pred CccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC------------------
Q 043248 164 ASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI------------------ 224 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i------------------ 224 (1092)
.....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+++.++.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3456799999999999654 569999999999999999999999998877666665432100
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 225 ----------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 225 ----------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
......+++.+.+||++||++||++|||+.|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123446889999999999999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=430.68 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=212.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccH----HHHHHHHHHHHHHHhcC--CCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTE----RCRRSAHQEMALIARVQ--HPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se----~~~r~f~rEIqILkqL~--HPNIVKL~gvF~e~d 78 (1092)
-++|++.+.||+|+||+||+|.++.+|+.||||++....... .....+.+|+.+|++++ |||||+++++|...+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999999999999999997543211 11233568999999997 899999999996655
Q ss_pred eEEEEEEeecCC-CCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCEEEeecCccc
Q 043248 79 CYVCIVTGYCEG-GDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD-QDVRLGDFGLAK 156 (1092)
Q Consensus 79 ~~lyLVMEYceG-GSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d-G~LKLiDFGLA~ 156 (1092)
.+|+||||+.+ +++.+++..... +++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 83 -~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 -SFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp -EEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -eEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 77899999976 688888887654 9999999999999999999999999999999999999854 789999999998
Q ss_pred cccccccCccccCCCCcCCchhhccCCC-CccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCCCCCHHH
Q 043248 157 TLKADDLASSVVGTPNYMCPELLADIPY-GFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPSCYSPSL 235 (1092)
Q Consensus 157 ~l~~d~~~st~vGTp~YmAPEVL~g~~y-S~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs~iS~eL 235 (1092)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+. +.... ..++..+++++
T Consensus 160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~-~~~~~~~s~~~ 231 (273)
T d1xwsa_ 160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ-VFFRQRVSSEC 231 (273)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC-CCCSSCCCHHH
T ss_pred ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhcc-cCCCCCCCHHH
Confidence 76543 3456789999999999987665 6789999999999999999999976431 22222 24567799999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 236 KTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
++||++||++||.+|||++|+|+||||+..
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-50 Score=421.21 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=215.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC---eE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---CY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---~~ 80 (1092)
-++|++.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++...+ ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4689999999999999999999999999999999976543 3445667999999999999999999999997654 46
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
+|||||||+|++|.+++...+. +++.+++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 8899999999999999987654 99999999999999999999999999999999999999999999999999876543
Q ss_pred cc----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCC---CCCCCCCH
Q 043248 161 DD----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIG---PLPSCYSP 233 (1092)
Q Consensus 161 d~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~---plPs~iS~ 233 (1092)
.. .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+......++...... .....+++
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 32 344568999999999999999999999999999999999999999998887777666554432 23456899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
++.+||.+||++||.+||+..+.|.|+|++
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999999999999544445567664
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=426.08 Aligned_cols=253 Identities=22% Similarity=0.412 Sum_probs=222.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.++ ++..||||++....... +.+.+|+.+|++++|||||++++++.+. .+|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE--PIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeeccC--CeEEE
Confidence 379999999999999999999975 57889999997654433 5688999999999999999999987543 35799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc--
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-- 162 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-- 162 (1092)
||||++|+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999999998865554459999999999999999999999999999999999999999999999999999876443
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
......||+.|+|||++.+..|+.++|||||||+||||+| |.+||...........+........+..+++++.+||.+
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence 2345679999999999998899999999999999999999 566677777777888887777777888899999999999
Q ss_pred hcccCCCCCCCHHHHHh--ChhhH
Q 043248 242 MLRKNPEHRPSASELLK--HPFLQ 263 (1092)
Q Consensus 242 cLqkDPskRPSaeELLq--HPwFq 263 (1092)
||+.||++|||++++++ |+||.
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999998 77775
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=421.01 Aligned_cols=255 Identities=23% Similarity=0.433 Sum_probs=214.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|.++ ++..||||++....... +.+.+|+.++++++||||++++++|...+ .+|||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCC-ceEEE
Confidence 468999999999999999999986 56789999997654433 46889999999999999999999996655 57799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
||||++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999999987654 3589999999999999999999999999999999999999999999999999987754432
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.......+...+........|..+++++.+||.+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 234679999999999999999999999999999999998 677788888878888887777777788899999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
||+.||++|||++|+++| ++++.+
T Consensus 238 cl~~~p~~Rps~~~il~~--L~~i~e 261 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ--LAEIAE 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HccCCHhHCcCHHHHHHH--HHHHHh
Confidence 999999999999999997 665543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=433.64 Aligned_cols=257 Identities=27% Similarity=0.465 Sum_probs=216.6
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC-----
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----- 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----- 78 (1092)
.-++|++++.||+|+||+||+|.++.+|+.||||++......+...+.+.+|+.+|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357999999999999999999999999999999999876666777788999999999999999999999997654
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
..+||||||| |.+|..+++... |++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 2578999999 668888876543 999999999999999999999999999999999999999999999999999877
Q ss_pred cccccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccC--------------
Q 043248 159 KADDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSS-------------- 223 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~-------------- 223 (1092)
... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 172 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred CCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 543 4567899999999998764 56899999999999999999999998877655544332210
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 224 ----------------IGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 224 ----------------i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
.......+++++.+||++||.+||.+|||+.|+|+||||+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 1112345789999999999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=429.65 Aligned_cols=255 Identities=19% Similarity=0.357 Sum_probs=222.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||+||+|.++.+++.||||++...... .+.+.+|+.+|++++|||||+++++|.+.+ .+|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC-eeEEE
Confidence 46899999999999999999999999999999998765433 356889999999999999999999996655 56799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
||||++|+|.+++.......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999999887667799999999999999999999999999999999999999999999999999988765432
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCC-CcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPA-FKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~P-F~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....|++.|+|||++.+..|+.++|||||||++|+|++|..| |.+.+...+...+......+.+..+++++.+||.+
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 251 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHH
Confidence 2334588999999999999999999999999999999996554 55666666666666666667788899999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhH
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
||++||.+|||++|+++ +|+.+
T Consensus 252 cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 252 CWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp HTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HcCCCHhHCcCHHHHHH--HHHHH
Confidence 99999999999999976 45543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-50 Score=428.58 Aligned_cols=257 Identities=22% Similarity=0.401 Sum_probs=213.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCc---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKK---KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk---~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++.+.||+|+||+||+|.++.+++ .||||++.... .....+.+.+|+.+|++|+|||||+++++|...+ .+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EE
Confidence 5789999999999999999999987765 57888876543 3445567999999999999999999999996554 67
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|||||||+||+|.+++....+ .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 899999999999999886543 4999999999999999999999999999999999999999999999999999877543
Q ss_pred ccC------ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHH
Q 043248 162 DLA------SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPS 234 (1092)
Q Consensus 162 ~~~------st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~e 234 (1092)
... ....||+.|||||++.+..|+.++|||||||+||||++ |+.||.+....++...+......+.+..++.+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 321 12457899999999999999999999999999999998 89999999888888888877777788889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 235 LKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 235 LkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+.+||.+||+.||.+|||+.|++++ ++++.
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~--L~~~l 291 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT--LDKMI 291 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH--HHHHh
Confidence 9999999999999999999999975 55443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=415.99 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=221.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
|++|++++.||+|+||+||+|.++.+++.||||+++...........+.+|+.+|+.++||||++++++|.... .+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEE
Confidence 68999999999999999999999999999999999877666666778999999999999999999999996655 67799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-c
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD-L 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~-~ 163 (1092)
|||+.|++|..++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 80 ~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999999988876544 48999999999999999999999999999999999999999999999999998876543 3
Q ss_pred CccccCCCCcCCchhhccCC-CCccccchhHHHHHHHHHhCCCCC-cccChHHHHHHhhcc-------------------
Q 043248 164 ASSVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAF-KAFDMAGLISKINRS------------------- 222 (1092)
Q Consensus 164 ~st~vGTp~YmAPEVL~g~~-yS~KSDVWSLGVILYELLTGr~PF-~g~d~~dli~kI~~~------------------- 222 (1092)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|+.|| .+.+..++..++...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 44556889999999997665 689999999999999999999885 455555555544221
Q ss_pred ---------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 223 ---------SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 223 ---------~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
........+++.+.+||++||++||.+|||++|+|+||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0111334468899999999999999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=424.36 Aligned_cols=248 Identities=19% Similarity=0.356 Sum_probs=213.7
Q ss_pred EEEeecCceEEEEEEEcC--CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEeecC
Q 043248 12 EQIGRGAFGAAILVNHRA--EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTGYCE 89 (1092)
Q Consensus 12 KkLGkGgFGtVYLA~dK~--tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVMEYce 89 (1092)
++||+|+||+||+|.++. +++.||||++..........+.+.+|+.+|++++|||||+++++|..+. +|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~--~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES--WMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS--EEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC--EEEEEEcCC
Confidence 579999999999998654 4578999999765444455678999999999999999999999985433 579999999
Q ss_pred CCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc----Cc
Q 043248 90 GGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL----AS 165 (1092)
Q Consensus 90 GGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~----~s 165 (1092)
+|+|.+++.+... +++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 91 ~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 91 LGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp TEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999999987654 99999999999999999999999999999999999999999999999999987654321 23
Q ss_pred cccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcc
Q 043248 166 SVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLR 244 (1092)
Q Consensus 166 t~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLq 244 (1092)
...||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..++...+......+.+..++.++.+||.+||+
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcC
Confidence 4578999999999999999999999999999999997 899999988888888888777778888999999999999999
Q ss_pred cCCCCCCCHHHHH---hChhhH
Q 043248 245 KNPEHRPSASELL---KHPFLQ 263 (1092)
Q Consensus 245 kDPskRPSaeELL---qHPwFq 263 (1092)
.||.+|||+++++ +|+|++
T Consensus 249 ~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 249 YDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999984 565543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=430.90 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=215.8
Q ss_pred CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----CeEE
Q 043248 7 QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-----GCYV 81 (1092)
Q Consensus 7 rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-----d~~l 81 (1092)
+|+.+++||+|+||+||+|.++.+|+.||||++..... .+.+|+.+|++|+||||++++++|... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999976532 234699999999999999999998643 3468
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCcccccc
Q 043248 82 CIVTGYCEGGDMAELMKK-SNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLK 159 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkk-k~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~ 159 (1092)
|||||||+++.+..+... .....|++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999987644444321 2334599999999999999999999999999999999999999775 89999999999887
Q ss_pred ccccCccccCCCCcCCchhhcc-CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhcc----------------
Q 043248 160 ADDLASSVVGTPNYMCPELLAD-IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRS---------------- 222 (1092)
Q Consensus 160 ~d~~~st~vGTp~YmAPEVL~g-~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~---------------- 222 (1092)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...+..+++.++...
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 7777778899999999998865 57899999999999999999999999988776666555321
Q ss_pred ---CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 223 ---SIG---------PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 223 ---~i~---------plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
... .....+++++.+||.+||.+||.+|||+.|+|+||||+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000 112346889999999999999999999999999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=426.51 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=212.5
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK----- 77 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~----- 77 (1092)
+.+++|++++.||+|+||+||+|.++.+|+.||||++......+.....+.+|+.+|++++||||++++++|...
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 357999999999999999999999999999999999876655554556788999999999999999999998553
Q ss_pred --CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcc
Q 043248 78 --GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLA 155 (1092)
Q Consensus 78 --d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA 155 (1092)
+..+|+|||||.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence 235789999998765554433 3345999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----cCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCCCCC
Q 043248 156 KTLKADD-----LASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPS 229 (1092)
Q Consensus 156 ~~l~~d~-----~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~plPs 229 (1092)
..+.... .....+||++|+|||++.+. .|+.++|||||||++|+|++|+.||.+.........+........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 8665322 23446899999999999765 68999999999999999999999999877666655553321111000
Q ss_pred -------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhH
Q 043248 230 -------------------------------CYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQ 263 (1092)
Q Consensus 230 -------------------------------~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq 263 (1092)
..++.+.+||.+||++||++|||++|+|+||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 0266788999999999999999999999999996
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=423.29 Aligned_cols=254 Identities=21% Similarity=0.376 Sum_probs=221.5
Q ss_pred CCeEEEEE-EeecCceEEEEEEEcC--CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 6 DQYEIMEQ-IGRGAFGAAILVNHRA--EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 6 DrYeIlKk-LGkGgFGtVYLA~dK~--tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
++|.+.+. ||+|+||.||+|.++. ++..||||++.... .....+.+.+|+.+|++++|||||++++++..+ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--eEE
Confidence 67888885 9999999999998764 44579999997553 344567789999999999999999999998543 367
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 85 lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999999986543 359999999999999999999999999999999999999999999999999998775432
Q ss_pred c----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 163 L----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 163 ~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
. .....||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+....++...+......+.|..+++++.+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 2 234578999999999999999999999999999999998 99999998888888888877777888899999999
Q ss_pred HHHHhcccCCCCCCCHHHH---HhChhhH
Q 043248 238 LIKGMLRKNPEHRPSASEL---LKHPFLQ 263 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeEL---LqHPwFq 263 (1092)
||.+||++||++|||+.++ |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999988 5677654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=424.64 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=209.3
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCI 83 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyL 83 (1092)
..++|++.+.||+|+||+||+|.++ ..||||+++.........+.+.+|+.+|++++|||||++++++.+. .+||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP--QLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc--EEEE
Confidence 4578999999999999999999753 3599999977655555667899999999999999999999986433 4679
Q ss_pred EEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc-
Q 043248 84 VTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD- 162 (1092)
Q Consensus 84 VMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~- 162 (1092)
|||||+||+|.+++..... .+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999999986543 49999999999999999999999999999999999999999999999999998765332
Q ss_pred --cCccccCCCCcCCchhhcc---CCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhh-ccCCC----CCCCCCC
Q 043248 163 --LASSVVGTPNYMCPELLAD---IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN-RSSIG----PLPSCYS 232 (1092)
Q Consensus 163 --~~st~vGTp~YmAPEVL~g---~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~-~~~i~----plPs~iS 232 (1092)
......||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+......+.... ..... ..+..++
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 3345689999999999964 358999999999999999999999998866554444333 22222 3456789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 233 PSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 233 ~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
+++.+||.+||+.||.+|||+.|++++
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-50 Score=428.33 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=213.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCc-----EEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCe
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKK-----KYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk-----~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~ 79 (1092)
++|++.+.||+|+||+||+|.++..++ .||+|.+.... .......+.+|+.+|.++ +|||||+++++|...+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 689999999999999999999876654 68999886543 233346788999999998 8999999999996655
Q ss_pred EEEEEEeecCCCCHHHHHHHcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNG---------------------AYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSN 138 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~g---------------------k~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPEN 138 (1092)
.+|||||||+||+|.++|..... ..+++..++.|+.||+.||+|||++|||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 57899999999999999986532 248999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHH
Q 043248 139 IFLTKDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAG 214 (1092)
Q Consensus 139 ILLD~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~d 214 (1092)
||++.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+...
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654432 235678999999999999999999999999999999997 899999876655
Q ss_pred HHHHhh-ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 043248 215 LISKIN-RSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 215 li~kI~-~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqH 259 (1092)
.+.++. .....+.+..+++++++||.+||+.||++|||++||++|
T Consensus 275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555444 334446778899999999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=414.98 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=214.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCC---cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEK---KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tG---k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
.++|++.+.||+|+||.||+|.+..++ ..||||.+... ........+.+|+.+|++++||||++++++|.+ ..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeE
Confidence 479999999999999999999987554 45888887543 334456789999999999999999999999853 357
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|||||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 89999999999999887654 34899999999999999999999999999999999999999999999999999876543
Q ss_pred c--cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHH
Q 043248 162 D--LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTL 238 (1092)
Q Consensus 162 ~--~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDL 238 (1092)
. ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+....+...++......+++..+++++.+|
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 3 2334578999999999999999999999999999999997 899999988888888888877778888999999999
Q ss_pred HHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 239 IKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 239 IrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
|.+||+.||.+|||+.|+++| ++.+.+
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~--L~~i~~ 268 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ--LSTILE 268 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH--HHHHHH
Confidence 999999999999999999987 655543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=415.01 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=224.2
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++++.||+|+||.||+|+++ ++..||||+++...... +.+.+|+.++++++||||++++++|.+.+ .+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSS-SEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCC-ceEEE
Confidence 478999999999999999999985 77899999998765443 46889999999999999999999996654 57899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccccC
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLA 164 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~~ 164 (1092)
||||++|+|..++..... .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 78 ~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999999999876543 4899999999999999999999999999999999999999999999999999876554332
Q ss_pred --ccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 165 --SSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 165 --st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
....||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+....++..++........|..+++++.+||.+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 23578999999999999999999999999999999998 899999999988888888877777888899999999999
Q ss_pred hcccCCCCCCCHHHHHhC
Q 043248 242 MLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqH 259 (1092)
||+.||++|||++++++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=430.45 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=209.4
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEec-----C
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEK-----G 78 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~-----d 78 (1092)
.+++|+++++||+|+||+||+|.++.+|+.||||++............+.+|+.++++++||||++++++|... .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 45899999999999999999999999999999999987766666677899999999999999999999999643 3
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.++|+|||||.|+ +...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 6889999999765 444442 23899999999999999999999999999999999999999999999999999988
Q ss_pred cccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC------------
Q 043248 159 KADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP------------ 226 (1092)
Q Consensus 159 ~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p------------ 226 (1092)
.........+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+...+..++......+
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 77777778899999999999999999999999999999999999999998877665555443211100
Q ss_pred -----------------------CC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 227 -----------------------LP------SCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 227 -----------------------lP------s~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+ ...++++.+||++||.+||++|||++|+|+||||+.+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 00 013567899999999999999999999999999987543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=425.54 Aligned_cols=257 Identities=23% Similarity=0.405 Sum_probs=215.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----eE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----CY 80 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~~ 80 (1092)
-++|++++.||+|+||+||+|.++.+|+.||||++............+.+|+.+|++|+|||||+++++|.... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999999999999999999877666666778899999999999999999999986432 22
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccc
Q 043248 81 VCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKA 160 (1092)
Q Consensus 81 lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~ 160 (1092)
.++||+|+.||+|.+++... .|++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc
Confidence 34566777899999998643 399999999999999999999999999999999999999999999999999976653
Q ss_pred cccCccccCCCCcCCchhhccCC-CCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCCCC-------------
Q 043248 161 DDLASSVVGTPNYMCPELLADIP-YGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGP------------- 226 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~~-yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i~p------------- 226 (1092)
. .....|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.......
T Consensus 174 ~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp G--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred c--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 3 45678999999999876654 5899999999999999999999999887766555553221110
Q ss_pred -----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 227 -----------------LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 227 -----------------lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
....+++++++||++||.+||.+|||+.|+|+||||+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 1134689999999999999999999999999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=423.60 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=212.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC----eEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG----CYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d----~~l 81 (1092)
++|++++.||+|+||+||+|.++.+|+.||||++.... .....+.+.+|+.+|++|+||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 68999999999999999999999999999999997643 3445567889999999999999999999986543 234
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
|++ +|+.||+|.+++.... +++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 87 ~l~-~~~~~g~L~~~l~~~~---l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEE-EECCCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEE-EeecCCchhhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 454 5666899999997643 999999999999999999999999999999999999999999999999999876543
Q ss_pred c----cCccccCCCCcCCchhh-ccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhhccCC------------
Q 043248 162 D----LASSVVGTPNYMCPELL-ADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSI------------ 224 (1092)
Q Consensus 162 ~----~~st~vGTp~YmAPEVL-~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~~~~i------------ 224 (1092)
. .....+||+.|+|||++ .+..|+.++||||+||++|+|++|+.||.+.+..+..........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 24556799999999998 455679999999999999999999999988765544444321100
Q ss_pred -------------C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 225 -------------G-----PLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 225 -------------~-----plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
. .....++.++++||.+||++||.+|||++|+|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 012346889999999999999999999999999999976543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-49 Score=419.05 Aligned_cols=252 Identities=22% Similarity=0.423 Sum_probs=212.0
Q ss_pred CCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEec-CeEE
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEK-GCYV 81 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~-d~~l 81 (1092)
..++|+++++||+|+||+||+|.++.+|+.||||++.... .+.+.+|+.+|++++ ||||++++++|... ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 3578999999999999999999999999999999987543 346788999999995 99999999999754 3568
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CEEEeecCccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQ-DVRLGDFGLAKTLKA 160 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG-~LKLiDFGLA~~l~~ 160 (1092)
|+|||||.+++|..+. +.|++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 8999999999987753 2499999999999999999999999999999999999998765 599999999998877
Q ss_pred cccCccccCCCCcCCchhhccC-CCCccccchhHHHHHHHHHhCCCCCcccC-hHHHHHHhhc-------------c---
Q 043248 161 DDLASSVVGTPNYMCPELLADI-PYGFKSDIWSLGCCMYEMAAHRPAFKAFD-MAGLISKINR-------------S--- 222 (1092)
Q Consensus 161 d~~~st~vGTp~YmAPEVL~g~-~yS~KSDVWSLGVILYELLTGr~PF~g~d-~~dli~kI~~-------------~--- 222 (1092)
.......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.... ...+...+.. .
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 7777788999999999998765 57999999999999999999999997543 2222111100 0
Q ss_pred --------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhH
Q 043248 223 --------------------SIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHF 265 (1092)
Q Consensus 223 --------------------~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~ 265 (1092)
........+++++.+||++||.+||.+|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0001123368899999999999999999999999999999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=419.29 Aligned_cols=253 Identities=22% Similarity=0.418 Sum_probs=215.4
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLV 84 (1092)
.++|++.+.||+|+||+||+|.++.+ ..||||++....... +.+.+|+.+|++++|||||+++++|.+.+ +|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~~~--~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS--CEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEecCC--eEEE
Confidence 47999999999999999999998755 579999997655433 56889999999999999999999985433 5799
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc-
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL- 163 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~- 163 (1092)
||||++|+|..++.......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999999998765545599999999999999999999999999999999999999999999999999987754432
Q ss_pred -CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhC-CCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 164 -ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 164 -~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....||+.|+|||++.+..++.++|||||||+||||++| .++|.......++..+......+.+..+++++++||.+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence 2346799999999999999999999999999999999995 56666777777888887777777888899999999999
Q ss_pred hcccCCCCCCCHHHHHh--ChhhH
Q 043248 242 MLRKNPEHRPSASELLK--HPFLQ 263 (1092)
Q Consensus 242 cLqkDPskRPSaeELLq--HPwFq 263 (1092)
||+.||++|||++++++ |+||.
T Consensus 250 cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HcccCHhHCcCHHHHHHHHhhhhc
Confidence 99999999999999986 55554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=416.92 Aligned_cols=250 Identities=21% Similarity=0.381 Sum_probs=214.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCc----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKK----KYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk----~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
++|++++.||+|+||+||+|.++.+|+ .||+|++.... .....+.+.+|+.++++++|||||+++++|.+.+ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS--E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--e
Confidence 679999999999999999999988876 47788775432 2223567899999999999999999999997654 4
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
+++|||+.+++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 57889999999999888754 45999999999999999999999999999999999999999999999999999887543
Q ss_pred cc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHH
Q 043248 162 DL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKT 237 (1092)
Q Consensus 162 ~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkD 237 (1092)
.. .....||+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.....+...+......+.+..+++++.+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 32 233568999999999999999999999999999999998 89999988877777777777767788889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhC
Q 043248 238 LIKGMLRKNPEHRPSASELLKH 259 (1092)
Q Consensus 238 LIrkcLqkDPskRPSaeELLqH 259 (1092)
||.+||+.||.+|||+.|+++|
T Consensus 245 li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=407.63 Aligned_cols=259 Identities=19% Similarity=0.334 Sum_probs=214.8
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCC----cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEK----KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tG----k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d 78 (1092)
-..+.|++.++||+|+||.||+|.++.++ ..||||++..... ......+.+|+.+|++++|||||++++++.+.+
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 34578999999999999999999987655 4699999975533 334557889999999999999999999996655
Q ss_pred eEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTL 158 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l 158 (1092)
.+++|||||.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 83 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred -ceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 5679999999999999887654 35999999999999999999999999999999999999999999999999999876
Q ss_pred ccccc----CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhC-CCCCcccChHHHHHHhhccCCCCCCCCCCH
Q 043248 159 KADDL----ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPLPSCYSP 233 (1092)
Q Consensus 159 ~~d~~----~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~dli~kI~~~~i~plPs~iS~ 233 (1092)
..... .....||+.|+|||++.+..|+.++|||||||+||||++| .+||.......+...+......+.+..++.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 54321 2235689999999999999999999999999999999985 556666677777777777777778888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 234 SLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 234 eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
++.+||.+||+.||++|||+.|+++. ++.+.
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~--L~~l~ 271 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSI--LDKLI 271 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHH--HHHHh
Confidence 99999999999999999999999973 55444
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=410.36 Aligned_cols=259 Identities=22% Similarity=0.442 Sum_probs=209.9
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
.++|++++.||+|+||.||+|.+.. +++.||||++...... ...+.+.+|..++.++ +|+||+.+++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3789999999999999999999764 3468999998754333 3345677777777776 6899999999987777
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKD 144 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~d 144 (1092)
..+|+|||||+||+|.++|.... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 77899999999999999997642 2348899999999999999999999999999999999999999
Q ss_pred CCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhC-CCCCcccChHH-HHHHh
Q 043248 145 QDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAG-LISKI 219 (1092)
Q Consensus 145 G~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~d-li~kI 219 (1092)
+.+||+|||+|+...... ......||+.|+|||++.+..|+.++|||||||++|||++| .+||.+..... ....+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998664332 23456799999999999999999999999999999999986 56887765443 34444
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 220 NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 220 ~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
........+..+++++.+||.+||+.||.+|||++|+++| ++++.
T Consensus 251 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~il 295 (299)
T d1ywna1 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLL 295 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence 5555566778899999999999999999999999999998 66554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=409.58 Aligned_cols=254 Identities=23% Similarity=0.436 Sum_probs=217.9
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~ly 82 (1092)
-.+++|++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|+.++++++||||++++++|.+....+|
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 35689999999999999999999984 7889999997543 23568899999999999999999999876666678
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCccccccccc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADD 162 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~ 162 (1092)
||||||++|+|.++|.+.....+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999999997655445899999999999999999999999999999999999999999999999999876543
Q ss_pred cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 043248 163 LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSSIGPLPSCYSPSLKTLIKG 241 (1092)
Q Consensus 163 ~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~i~plPs~iS~eLkDLIrk 241 (1092)
.....++..|+|||++.+..|+.++|||||||++|||++ |++||......++...+......+++..+++++.+||.+
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 345678999999999999999999999999999999998 799999888888888888877778888999999999999
Q ss_pred hcccCCCCCCCHHHHHhChhhHhHh
Q 043248 242 MLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 242 cLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
||++||.+|||+.+++++ ++++.
T Consensus 236 cl~~dP~~Rps~~~l~~~--L~~i~ 258 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQ--LEHIK 258 (262)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HcccCHhHCcCHHHHHHH--HHHHH
Confidence 999999999999999985 66554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=411.14 Aligned_cols=259 Identities=21% Similarity=0.408 Sum_probs=223.1
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCCcE--EEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecCeEE
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEKKK--YVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tGk~--VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d~~l 81 (1092)
+++|++.+.||+|+||.||+|.++.+|.. ||||++..... ....+.+.+|+.+|+++ +|||||+++++|...+ .+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-EE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-ee
Confidence 46999999999999999999999988875 56677654322 23356789999999999 7999999999997655 67
Q ss_pred EEEEeecCCCCHHHHHHHc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCE
Q 043248 82 CIVTGYCEGGDMAELMKKS--------------NGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDV 147 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk--------------~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~L 147 (1092)
|||||||+||+|.++|... ....|++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 8999999999999999754 23459999999999999999999999999999999999999999999
Q ss_pred EEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhC-CCCCcccChHHHHHHhhccCCCC
Q 043248 148 RLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGP 226 (1092)
Q Consensus 148 KLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~dli~kI~~~~i~p 226 (1092)
||+|||++.............||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+...+...+......+
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999999877665555567899999999999999999999999999999999996 46898888888888888777777
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 227 LPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 227 lPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.+..+++++++||.+||+.||++|||+.|+++| |+.+.+
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~--L~~i~~ 285 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLE 285 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHHh
Confidence 888899999999999999999999999999987 666654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=419.13 Aligned_cols=259 Identities=27% Similarity=0.497 Sum_probs=218.1
Q ss_pred CCCCeEEEEEEeecCceEEEEEEE---cCCCcEEEEEEEecccc--cHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEec
Q 043248 4 RMDQYEIMEQIGRGAFGAAILVNH---RAEKKKYVLKKIRLARQ--TERCRRSAHQEMALIARVQH-PYIVEFKEAWVEK 77 (1092)
Q Consensus 4 RIDrYeIlKkLGkGgFGtVYLA~d---K~tGk~VAIKkIkks~~--se~~~r~f~rEIqILkqL~H-PNIVKL~gvF~e~ 77 (1092)
.+++|++++.||+|+||+||+|.+ +.+|+.||||.+..... .......+.+|+.+|++++| |||++++++|...
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 468899999999999999999997 44689999999865432 12224567789999999976 8999999998666
Q ss_pred CeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 78 GCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 78 d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
. .+|+|||||.||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 102 ~-~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 T-KLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp T-EEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred C-ceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 5 77899999999999999988765 88999999999999999999999999999999999999999999999999987
Q ss_pred cccc--ccCccccCCCCcCCchhhccC--CCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHhh---ccCCCCCCCC
Q 043248 158 LKAD--DLASSVVGTPNYMCPELLADI--PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKIN---RSSIGPLPSC 230 (1092)
Q Consensus 158 l~~d--~~~st~vGTp~YmAPEVL~g~--~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI~---~~~i~plPs~ 230 (1092)
+... .......|++.|++||.+.+. .++.++|||||||+||+|++|+.||.+.........+. .....+++..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 6433 334567899999999999754 46889999999999999999999998765443333332 2334456778
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHHhChhhHhH
Q 043248 231 YSPSLKTLIKGMLRKNPEHRP-----SASELLKHPFLQHF 265 (1092)
Q Consensus 231 iS~eLkDLIrkcLqkDPskRP-----SaeELLqHPwFq~~ 265 (1092)
+++++.+||++||++||.+|+ |++|+|+||||+.+
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 999999999999999999999 58999999999763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=405.12 Aligned_cols=260 Identities=22% Similarity=0.346 Sum_probs=225.3
Q ss_pred CccCCCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 043248 1 MESRMDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWV 75 (1092)
Q Consensus 1 MEsRIDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~ 75 (1092)
||.-.++|++++.||+|+||+||+|.++. ++..||||++.... .......+.+|+.+|++++||||++++++|.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34456789999999999999999999763 56789999987543 3445677899999999999999999999996
Q ss_pred ecCeEEEEEEeecCCCCHHHHHHHcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 043248 76 EKGCYVCIVTGYCEGGDMAELMKKSN----------------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRD 133 (1092)
Q Consensus 76 e~d~~lyLVMEYceGGSL~DLLkkk~----------------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRD 133 (1092)
..+ ..++||||+++|+|.++|.... ...|++..++.|+.||+.||+|||++||||||
T Consensus 87 ~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 87 VGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp SSS-SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred cCC-ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 654 5779999999999999997532 22488999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCC-CCCcc
Q 043248 134 LKCSNIFLTKDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHR-PAFKA 209 (1092)
Q Consensus 134 LKPENILLD~dG~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr-~PF~g 209 (1092)
|||+||||+.++.+||+|||++..+.... ......|++.|+|||++.+..|+.++|||||||++|||++|. +||.+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998765432 233567899999999999999999999999999999999985 78999
Q ss_pred cChHHHHHHhhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHh
Q 043248 210 FDMAGLISKINRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQH 264 (1092)
Q Consensus 210 ~d~~dli~kI~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~ 264 (1092)
.+..+....+......+.+..+++++.+||.+||+.+|.+|||+.|+++ +|++
T Consensus 246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~ 298 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR 298 (301)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence 9988988998888887888899999999999999999999999999976 3554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=404.24 Aligned_cols=258 Identities=23% Similarity=0.425 Sum_probs=220.3
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcCCC-------cEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRAEK-------KKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVE 76 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~tG-------k~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e 76 (1092)
.++|++++.||+|+||.||+|.+..++ ..||||++..... ......+.+|..++.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 379999999999999999999987654 4799999976543 34456788898888888 79999999999966
Q ss_pred cCeEEEEEEeecCCCCHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 77 KGCYVCIVTGYCEGGDMAELMKKSN--------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 77 ~d~~lyLVMEYceGGSL~DLLkkk~--------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
.+ .+|+|||||++|+|.++|.... ...|++..++.|+.||+.||.|||++|||||||||+|||++
T Consensus 91 ~~-~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 91 DG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SS-SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CC-eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 54 6789999999999999997653 23489999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.+||+|||++........ .....|++.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999987765432 334678999999999999999999999999999999997 7999999888888888
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 219 INRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 219 I~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+......+.+..+++++.+||.+||++||.+|||+.|+++. ++++.
T Consensus 250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~--L~~i~ 295 (299)
T d1fgka_ 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIV 295 (299)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHH--HHHHh
Confidence 87777777888899999999999999999999999999983 55543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=400.43 Aligned_cols=250 Identities=21% Similarity=0.372 Sum_probs=206.3
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCC-C--cEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAE-K--KKYVLKKIRLARQ-TERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~t-G--k~VAIKkIkks~~-se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~l 81 (1092)
++|++++.||+|+||.||+|.+... + ..||||++..... .....+.+.+|+.+|++++||||++++++|.+. .+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence 5799999999999999999987543 2 3689998865433 223456789999999999999999999999543 45
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccc
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKAD 161 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d 161 (1092)
++|||||++|+|.+++....+ .|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred heeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 799999999999998876543 4999999999999999999999999999999999999999999999999999987543
Q ss_pred c----cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHHhhccC-CCCCCCCCCHHH
Q 043248 162 D----LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISKINRSS-IGPLPSCYSPSL 235 (1092)
Q Consensus 162 ~----~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~kI~~~~-i~plPs~iS~eL 235 (1092)
. ......|+..|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..+...++.... ..+.+..++.++
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 2 2334568889999999999999999999999999999997 899999999888888876554 345677899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHh
Q 043248 236 KTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 236 kDLIrkcLqkDPskRPSaeELLq 258 (1092)
.+||.+||.+||++|||+.++++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=398.04 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=221.8
Q ss_pred CCCeEEEEEEeecCceEEEEEEEcC-----CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHRA-----EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK~-----tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
.++|++.+.||+|+||.||+|.++. ++..||||++.... .......+.+|+.++++++||||++++++|...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~- 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC-
Confidence 4799999999999999999998863 35789999997543 3444567899999999999999999999996555
Q ss_pred EEEEEEeecCCCCHHHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEee
Q 043248 80 YVCIVTGYCEGGDMAELMKKSN--------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~--------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiD 151 (1092)
.+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 5779999999999999987531 23478999999999999999999999999999999999999999999999
Q ss_pred cCcccccccccc---CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhC-CCCCcccChHHHHHHhhccCCCCC
Q 043248 152 FGLAKTLKADDL---ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAH-RPAFKAFDMAGLISKINRSSIGPL 227 (1092)
Q Consensus 152 FGLA~~l~~d~~---~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTG-r~PF~g~d~~dli~kI~~~~i~pl 227 (1092)
||++..+..... .....||+.|+|||.+.+..|+.++|||||||+||||++| .+||.+.+....+..+......+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~ 256 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 999987754432 2345789999999999999999999999999999999998 588999888888888888777778
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 228 PSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 228 Ps~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
+..+++.+.+||.+||+++|++|||+.++++
T Consensus 257 p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8889999999999999999999999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=394.19 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=214.6
Q ss_pred EEEEEeecCceEEEEEEEcCCC---cEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCeEEEEEEe
Q 043248 10 IMEQIGRGAFGAAILVNHRAEK---KKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGCYVCIVTG 86 (1092)
Q Consensus 10 IlKkLGkGgFGtVYLA~dK~tG---k~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~~lyLVME 86 (1092)
+.++||+|+||+||+|.+..++ ..||||++... ........+.+|+.+|++++||||+++++++...+..+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4678999999999999986643 35899998653 3445567899999999999999999999998877778889999
Q ss_pred ecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEeecCcccccccccc---
Q 043248 87 YCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDL--- 163 (1092)
Q Consensus 87 YceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiDFGLA~~l~~d~~--- 163 (1092)
||++|+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++........
T Consensus 110 ~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999987654 3478899999999999999999999999999999999999999999999999987654432
Q ss_pred --CccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcc-cChHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 043248 164 --ASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKA-FDMAGLISKINRSSIGPLPSCYSPSLKTLIK 240 (1092)
Q Consensus 164 --~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g-~d~~dli~kI~~~~i~plPs~iS~eLkDLIr 240 (1092)
.....||+.|+|||++.+..++.++|||||||+||||++|..||.. .+..+....+........+..+++++.+||.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~ 268 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence 2235689999999999999999999999999999999997766654 4444555666666666778889999999999
Q ss_pred HhcccCCCCCCCHHHHHhChhhHhHhhh
Q 043248 241 GMLRKNPEHRPSASELLKHPFLQHFVDQ 268 (1092)
Q Consensus 241 kcLqkDPskRPSaeELLqHPwFq~~~d~ 268 (1092)
+||++||++|||+.|+++| ++.+...
T Consensus 269 ~cl~~dP~~RPs~~ei~~~--L~~i~~~ 294 (311)
T d1r0pa_ 269 KCWHPKAEMRPSFSELVSR--ISAIFST 294 (311)
T ss_dssp HHTCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred HHcCCCHhHCcCHHHHHHH--HHHHHHh
Confidence 9999999999999999997 6666554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-46 Score=389.62 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=205.9
Q ss_pred CccCCC-CeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecCe
Q 043248 1 MESRMD-QYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKGC 79 (1092)
Q Consensus 1 MEsRID-rYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d~ 79 (1092)
|+-+++ +|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++|+|++.++..+...+.
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 778885 799999999999999999999999999999998764332 246789999999988877666666656666
Q ss_pred EEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCEEEeecCccc
Q 043248 80 YVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK---DQDVRLGDFGLAK 156 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~---dG~LKLiDFGLA~ 156 (1092)
.+++|||||+ ++|...+.... ..+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|.
T Consensus 77 ~~~ivme~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 77 YNVMVMELLG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEEEcC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 8889999995 57777666544 35999999999999999999999999999999999999864 4469999999999
Q ss_pred cccccc--------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChHHHHHHh---hc----
Q 043248 157 TLKADD--------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKI---NR---- 221 (1092)
Q Consensus 157 ~l~~d~--------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~dli~kI---~~---- 221 (1092)
.+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 875432 234568999999999999999999999999999999999999999875443222221 11
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---HhChhh
Q 043248 222 SSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASEL---LKHPFL 262 (1092)
Q Consensus 222 ~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeEL---LqHPwF 262 (1092)
.....+...+++++.+||.+||+.+|.+||+++++ |+|+|.
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11112345689999999999999999999998765 556554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=391.72 Aligned_cols=258 Identities=21% Similarity=0.396 Sum_probs=218.5
Q ss_pred CCCeEEEEEEeecCceEEEEEEEc-----CCCcEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEecC
Q 043248 5 MDQYEIMEQIGRGAFGAAILVNHR-----AEKKKYVLKKIRLARQTERCRRSAHQEMALIARV-QHPYIVEFKEAWVEKG 78 (1092)
Q Consensus 5 IDrYeIlKkLGkGgFGtVYLA~dK-----~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL-~HPNIVKL~gvF~e~d 78 (1092)
.++|++.+.||+|+||.||+|.++ .+++.||||++..... ......+.+|+.+++.+ +|||||++++++...+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 479999999999999999999864 4677899999976543 33456788999999999 6999999999996654
Q ss_pred eEEEEEEeecCCCCHHHHHHHcC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 043248 79 CYVCIVTGYCEGGDMAELMKKSN----------------GAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLT 142 (1092)
Q Consensus 79 ~~lyLVMEYceGGSL~DLLkkk~----------------gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD 142 (1092)
.+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 101 -~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred -EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 5789999999999999998643 22489999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCccccccccc---cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHh-CCCCCcccChHHHHHH
Q 043248 143 KDQDVRLGDFGLAKTLKADD---LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAA-HRPAFKAFDMAGLISK 218 (1092)
Q Consensus 143 ~dG~LKLiDFGLA~~l~~d~---~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLT-Gr~PF~g~d~~dli~k 218 (1092)
.++.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++ |.+||........+.+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998775432 2234678999999999999999999999999999999998 6777777665554444
Q ss_pred h-hccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHh
Q 043248 219 I-NRSSIGPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFV 266 (1092)
Q Consensus 219 I-~~~~i~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~ 266 (1092)
+ ........+..++.++.+||.+||+.||++|||++++++ .+++..
T Consensus 260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~--~L~~~i 306 (311)
T d1t46a_ 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEKQI 306 (311)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhh
Confidence 4 344455567778999999999999999999999999997 355443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-43 Score=371.57 Aligned_cols=253 Identities=15% Similarity=0.189 Sum_probs=207.4
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEecCeEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH-PYIVEFKEAWVEKGCYVCIV 84 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H-PNIVKL~gvF~e~d~~lyLV 84 (1092)
++|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.|+| +|++.+++++.... ..|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-HNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT-EEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCC-ccEEE
Confidence 5899999999999999999999999999999988654322 245678889999875 89999998886555 67899
Q ss_pred EeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-----CCCEEEeecCcccccc
Q 043248 85 TGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTK-----DQDVRLGDFGLAKTLK 159 (1092)
Q Consensus 85 MEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~-----dG~LKLiDFGLA~~l~ 159 (1092)
|||| |++|.+++...+ ..+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+.+.
T Consensus 80 me~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 679999987654 35999999999999999999999999999999999999974 5679999999998765
Q ss_pred ccc--------cCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH---HHHHHhhc----cCC
Q 043248 160 ADD--------LASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA---GLISKINR----SSI 224 (1092)
Q Consensus 160 ~d~--------~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~---dli~kI~~----~~i 224 (1092)
... .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.... ....++.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 331 233568999999999999999999999999999999999999999864432 22222211 111
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 225 GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 225 ~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
..+...+++++.+|+..|+..+|++||+.+.+.+ +|..+..
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~--~l~~~~~ 278 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLE 278 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH--HHHHHHH
Confidence 2234568899999999999999999999888765 3555544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=376.90 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=197.7
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceEEEEEEecC---eEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIVEFKEAWVEKG---CYVC 82 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIVKL~gvF~e~d---~~ly 82 (1092)
.+|.+.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+.+++||||+++++++...+ ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5799999999999999999986 6889999998654321 122334666667889999999999998654 4689
Q ss_pred EEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCcEEEcCCCCEEEeecCc
Q 043248 83 IVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS--------NYVLHRDLKCSNIFLTKDQDVRLGDFGL 154 (1092)
Q Consensus 83 LVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS--------kGIIHRDLKPENILLD~dG~LKLiDFGL 154 (1092)
||||||++|+|.++|++.. +++..++.++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999998753 8999999999999999999996 5999999999999999999999999999
Q ss_pred cccccccc-----cCccccCCCCcCCchhhccCC------CCccccchhHHHHHHHHHhCCCCCcccC------------
Q 043248 155 AKTLKADD-----LASSVVGTPNYMCPELLADIP------YGFKSDIWSLGCCMYEMAAHRPAFKAFD------------ 211 (1092)
Q Consensus 155 A~~l~~d~-----~~st~vGTp~YmAPEVL~g~~------yS~KSDVWSLGVILYELLTGr~PF~g~d------------ 211 (1092)
+....... .....+||+.|+|||++.+.. ++.++|||||||+||||++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98775432 233568999999999987642 5678999999999999999998874311
Q ss_pred ---hHHHHHHhhccCC-CCCCCCC-----CHHHHHHHHHhcccCCCCCCCHHHHHhChhhHhHhh
Q 043248 212 ---MAGLISKINRSSI-GPLPSCY-----SPSLKTLIKGMLRKNPEHRPSASELLKHPFLQHFVD 267 (1092)
Q Consensus 212 ---~~dli~kI~~~~i-~plPs~i-----S~eLkDLIrkcLqkDPskRPSaeELLqHPwFq~~~d 267 (1092)
.......+..... +.++..+ ...+.+|+.+||+.||++|||+.|++++ +.++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~ 297 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHHH
Confidence 1122222222222 2222222 2458899999999999999999999985 555544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-43 Score=372.26 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=199.6
Q ss_pred CCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----------CCCcceEEEEE
Q 043248 6 DQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-----------HPYIVEFKEAW 74 (1092)
Q Consensus 6 DrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-----------HPNIVKL~gvF 74 (1092)
+||++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 47999999999999999999999999999999997542 33456778888888875 57899999988
Q ss_pred Eec-CeEEEEEEeecCCC-CHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCC-----
Q 043248 75 VEK-GCYVCIVTGYCEGG-DMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHS-NYVLHRDLKCSNIFLTKDQD----- 146 (1092)
Q Consensus 75 ~e~-d~~lyLVMEYceGG-SL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHS-kGIIHRDLKPENILLD~dG~----- 146 (1092)
... ....+++|+++..+ .............+++..++.++.||+.||.|||+ +||+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 653 34555666665443 44444555555669999999999999999999998 89999999999999986653
Q ss_pred -EEEeecCccccccccccCccccCCCCcCCchhhccCCCCccccchhHHHHHHHHHhCCCCCcccChH------HHHHHh
Q 043248 147 -VRLGDFGLAKTLKADDLASSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA------GLISKI 219 (1092)
Q Consensus 147 -LKLiDFGLA~~l~~d~~~st~vGTp~YmAPEVL~g~~yS~KSDVWSLGVILYELLTGr~PF~g~d~~------dli~kI 219 (1092)
++|+|||.+...... ....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...... ..+...
T Consensus 170 ~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 999999999866533 45678999999999999999999999999999999999999999754321 111110
Q ss_pred hc--------------------------cCC---------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 043248 220 NR--------------------------SSI---------------GPLPSCYSPSLKTLIKGMLRKNPEHRPSASELLK 258 (1092)
Q Consensus 220 ~~--------------------------~~i---------------~plPs~iS~eLkDLIrkcLqkDPskRPSaeELLq 258 (1092)
.. ..+ .......++++.+||.+||.+||.+|||++|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000 0011223678999999999999999999999999
Q ss_pred ChhhHhH
Q 043248 259 HPFLQHF 265 (1092)
Q Consensus 259 HPwFq~~ 265 (1092)
||||+..
T Consensus 328 Hp~f~~~ 334 (362)
T d1q8ya_ 328 HPWLKDT 334 (362)
T ss_dssp CGGGTTC
T ss_pred CcccCCC
Confidence 9999853
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.5e-23 Score=207.05 Aligned_cols=167 Identities=14% Similarity=0.132 Sum_probs=124.3
Q ss_pred eEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccc----------------cHHHHHHHHHHHHHHHhcCCCCcceEE
Q 043248 8 YEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ----------------TERCRRSAHQEMALIARVQHPYIVEFK 71 (1092)
Q Consensus 8 YeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~----------------se~~~r~f~rEIqILkqL~HPNIVKL~ 71 (1092)
|.+.++||+|+||.||+|.+. +|+.||||+++.... .......+.+|+..+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999984 689999998753211 111234456789999999999999987
Q ss_pred EEEEecCeEEEEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCEEEee
Q 043248 72 EAWVEKGCYVCIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLHSNYVLHRDLKCSNIFLTKDQDVRLGD 151 (1092)
Q Consensus 72 gvF~e~d~~lyLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLHSkGIIHRDLKPENILLD~dG~LKLiD 151 (1092)
++. .. ++||||+++..+.. +++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+|
T Consensus 81 ~~~--~~---~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 81 AWE--GN---AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EEE--TT---EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred Eec--CC---EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 642 22 58999998865432 5566678899999999999999999999999999999854 599999
Q ss_pred cCccccccccccCccccCCCCcCCch--h---hccCCCCccccchhHHHHH
Q 043248 152 FGLAKTLKADDLASSVVGTPNYMCPE--L---LADIPYGFKSDIWSLGCCM 197 (1092)
Q Consensus 152 FGLA~~l~~d~~~st~vGTp~YmAPE--V---L~g~~yS~KSDVWSLGVIL 197 (1092)
||+|......... .|.... . +....|+.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999776533211 111110 0 1235788999999976433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=1.2e-06 Score=87.26 Aligned_cols=143 Identities=13% Similarity=0.121 Sum_probs=91.1
Q ss_pred cCCCCeEEEEEEeecCceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEecCeEE
Q 043248 3 SRMDQYEIMEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQ-HPYIVEFKEAWVEKGCYV 81 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~-HPNIVKL~gvF~e~d~~l 81 (1092)
..+..|++.+..+.++-+.||.+. .++..+++|+........ ...+.+|...+..|. +--+.+++.++... ...
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecC-Cce
Confidence 456788888876666667899875 456678888875432211 224567888877774 33357777666544 467
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------
Q 043248 82 CIVTGYCEGGDMAELMKKSNGAYFPEEKLCKWFAQLLLAVDYLH------------------------------------ 125 (1092)
Q Consensus 82 yLVMEYceGGSL~DLLkkk~gk~LSEeqI~kIa~QILsALaYLH------------------------------------ 125 (1092)
|+||++++|..+....... .....++.++...|+.||
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 7999999998876543211 011112223333333333
Q ss_pred -----------------HC------CccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 126 -----------------SN------YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 126 -----------------Sk------GIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.. .++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11 278999999999999766667999987754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.50 E-value=9e-05 Score=79.96 Aligned_cols=79 Identities=11% Similarity=0.096 Sum_probs=46.4
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEEecccc-----cHHHHHHHHHHHHHHHhcC-C--CCcceEEEEEEecCeEEE
Q 043248 11 MEQIGRGAFGAAILVNHRAEKKKYVLKKIRLARQ-----TERCRRSAHQEMALIARVQ-H--PYIVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~tGk~VAIKkIkks~~-----se~~~r~f~rEIqILkqL~-H--PNIVKL~gvF~e~d~~ly 82 (1092)
.+.||.|....||.+.+..+++.|++|.-..... ......+...|...|+.+. + ..+++++.+ +.+. .+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~-~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC-CE
Confidence 5679999999999999877788999996532110 0001123445777776652 2 345666643 3332 35
Q ss_pred EEEeecCCCC
Q 043248 83 IVTGYCEGGD 92 (1092)
Q Consensus 83 LVMEYceGGS 92 (1092)
+|||++++..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.44 E-value=0.00014 Score=71.67 Aligned_cols=147 Identities=15% Similarity=0.098 Sum_probs=83.7
Q ss_pred cCCCCeEEEEEEeecCc-eEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEecCe
Q 043248 3 SRMDQYEIMEQIGRGAF-GAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQH--PYIVEFKEAWVEKGC 79 (1092)
Q Consensus 3 sRIDrYeIlKkLGkGgF-GtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~H--PNIVKL~gvF~e~d~ 79 (1092)
.++..+++. .+..|.. +.||.... ..+..+++|....... ..+.+|...++.|.. -.+.+++.+..+. .
T Consensus 8 ~~l~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~ 79 (255)
T d1nd4a_ 8 ERLFGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA-G 79 (255)
T ss_dssp TTTTTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-S
T ss_pred HhccCCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc-c
Confidence 455566663 4455554 67898875 4566688887654432 235567777776643 2356677665544 4
Q ss_pred EEEEEEeecCCCCHHH--------------HHHHcCC-----CCCC--HHHHHHHH--------------------HHHH
Q 043248 80 YVCIVTGYCEGGDMAE--------------LMKKSNG-----AYFP--EEKLCKWF--------------------AQLL 118 (1092)
Q Consensus 80 ~lyLVMEYceGGSL~D--------------LLkkk~g-----k~LS--EeqI~kIa--------------------~QIL 118 (1092)
..++||+|++|.++.+ .+.+-.. ..+. ........ ....
T Consensus 80 ~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 80 RDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp CEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ceEEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 6679999998865522 1111100 0000 00000000 0011
Q ss_pred HHHHHHHHC-------CccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 119 LAVDYLHSN-------YVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 119 sALaYLHSk-------GIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
..+..+... .++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 223333332 279999999999999766678999987654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.06 E-value=0.0054 Score=65.29 Aligned_cols=74 Identities=15% Similarity=0.148 Sum_probs=47.9
Q ss_pred EEEEeecCceEEEEEEEcC-------CCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEecCeEEE
Q 043248 11 MEQIGRGAFGAAILVNHRA-------EKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPY-IVEFKEAWVEKGCYVC 82 (1092)
Q Consensus 11 lKkLGkGgFGtVYLA~dK~-------tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPN-IVKL~gvF~e~d~~ly 82 (1092)
++.|+.|-.-.+|++.... ..+.|++++.... .... ...+|..+++.+.-.+ ..+++++| .+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~i---dr~~E~~i~~~ls~~gl~Pkll~~~--~~---g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETES---HLVAESVIFTLLSERHLGPKLYGIF--SG---G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHH---HHHHHHHHHHHHHHTTSSSCEEEEE--TT---E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhh---HHHHHHHHHHHHHhCCCCCeEEEEc--CC---c
Confidence 4788999999999998753 3456777666422 2221 2346888888775334 45777665 23 3
Q ss_pred EEEeecCCCCH
Q 043248 83 IVTGYCEGGDM 93 (1092)
Q Consensus 83 LVMEYceGGSL 93 (1092)
+||||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.86 E-value=0.016 Score=60.05 Aligned_cols=69 Identities=12% Similarity=0.116 Sum_probs=42.3
Q ss_pred ceEEEEEEEcCCCcEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc--eEEE----EEEecCeEEEEEEeecCCC
Q 043248 19 FGAAILVNHRAEKKKYVLKKIRLARQTERCRRSAHQEMALIARVQHPYIV--EFKE----AWVEKGCYVCIVTGYCEGG 91 (1092)
Q Consensus 19 FGtVYLA~dK~tGk~VAIKkIkks~~se~~~r~f~rEIqILkqL~HPNIV--KL~g----vF~e~d~~lyLVMEYceGG 91 (1092)
--.||++.. .+|..|++|+.+...... ..+..|+..+..|...+|. ..+. .....+...+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999985 578889999987654443 3456677777777432221 1110 1112244677899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.56 E-value=0.011 Score=60.11 Aligned_cols=31 Identities=35% Similarity=0.367 Sum_probs=27.1
Q ss_pred CCccccCCCCCcEEEcCCCCEEEeecCcccc
Q 043248 127 NYVLHRDLKCSNIFLTKDQDVRLGDFGLAKT 157 (1092)
Q Consensus 127 kGIIHRDLKPENILLD~dG~LKLiDFGLA~~ 157 (1092)
.|+||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999877778999998753
|